,CID,name,smiles,7.1-Drug Indication,8.1-Pharmacodynamics,8.2-MeSH Pharmacological Classification,"8.5-Absorption, Distribution and Excretion",8.6-Metabolism/Metabolites,8.7-Biological Half-Life
0,3080001,"Thiourea, bis(1-methyl-2-pyrrolidinylidene)-",CN1CCC2C1=NC(=S)NC23CCCN3C,,,,,,
1,3080002,(1-Methylpiperidin-2-ylidene)thiourea,CN1CCCCC1=NC(=S)N,,,,,,
2,3080003,"1,4-Diethoxy-5-ethyl-6-methyl-6H-pyridazino(4,5-b)carbazole",CCC1=C2C(=CC3=C1C(=NN=C3OCC)OCC)C4=CC=CC=C4N2C,,,,,,
3,3080004,"6H-Pyridazino(4,5-b)carbazole, 1,4-diethoxy-5-ethyl-",CCC1=C2C(=C3C=CC=CC3=N2)C=C4C1=C(NN=C4OCC)OCC,,,,,,
4,3080005,"11H-Pyrido(2,1-b)quinazoline-2-carboxamide, 8-(1-methylethyl)-11-oxo-N-1H-tetrazol-5-yl-",CC(C)C1=CN2C(=NC3=C(C2=O)C=C(C=C3)C(=O)NC4=NNN=N4)C=C1,,,,,,
5,3080006,"2-Hydroxy-7-methylbenzotriazolo[5,4-b][1,5]naphthyridine",CC1=C2C(=NC=C1)C=C3C(=N2)C=CC4=NN(N=C43)O,,,,,,
6,3080007,CID 3080007,CC1=C(NC(=NC1=O)NCC=CCOC2=CC=CC(=C2)CN3CCCCC3)C.Cl,,,,,,
7,3080008,"11H-Pyrido(2,1-b)quinazolin-11-one, 8-(1-methylethyl)-2-(1H-tetrazol-5-yl)-",CC(C)C1=CN2C(=NC3=C(C2=O)C=C(C=C3)C4=NNN=N4)C=C1,,,,,,
8,3080009,"Quinoline, 2-(2-(4-(2,4-dimethylphenyl)-1-piperazinyl)ethyl)-, dihydrochloride",CC1=CC(=C(C=C1)N2CCN(CC2)CCC3=NC4=CC=CC=C4C=C3)C.Cl.Cl,,,,,,
9,3080010,"Quinoline, 2-[2-[4-(2,4-dimethylphenyl)-1-piperazinyl]ethyl]-",CC1=CC(=C(C=C1)N2CCN(CC2)CCC3=NC4=CC=CC=C4C=C3)C,,,,,,
10,3080011,alpha-((4-Phenyl-1-piperazinyl)methyl)-2-quinolinemethanol,C1CN(CCN1CC(C2=NC3=CC=CC=C3C=C2)O)C4=CC=CC=C4,,,,,,
11,3080012,alpha-((4-Methyl-1-piperazinyl)methyl)-2-quinolinemethanol,CN1CCN(CC1)CC(C2=NC3=CC=CC=C3C=C2)O,,,,,,
12,3080013,alpha-(4-Morpholinylmethyl)-2-quinolinemethanol,C1COCCN1CC(C2=NC3=CC=CC=C3C=C2)O,,,,,,
13,3080014,alpha-(2-Piperidinylmethyl)-2-quinolinemethanol,C1CCN(CC1)CC(C2=NC3=CC=CC=C3C=C2)O,,,,,,
14,3080015,alpha-((4-(3-Methylphenyl)-1-piperazinyl)methyl)-2-quinolinemethanol,CC1=CC(=CC=C1)N2CCN(CC2)CC(C3=NC4=CC=CC=C4C=C3)O,,,,,,
15,3080016,2-(1-Methyl-2-(4-phenyl-1-piperazinyl)ethyl)quinoline,CC(CN1CCN(CC1)C2=CC=CC=C2)C3=NC4=CC=CC=C4C=C3,,,,,,
16,3080017,2-(1-Methyl-2-(4-(3-methylphenyl)-1-piperazinyl)ethyl)quinoline,CC1=CC(=CC=C1)N2CCN(CC2)CC(C)C3=NC4=CC=CC=C4C=C3,,,,,,
17,3080018,"Quinoline, 4-(2-(4-phenyl-1-piperazinyl)ethyl)-",C1CN(CCN1CCC2=CC=NC3=CC=CC=C23)C4=CC=CC=C4,,,,,,
18,3080019,"Quinoline, 4-(2-(4-morpholinyl)ethyl)-",C1COCCN1CCC2=CC=NC3=CC=CC=C23,,,,,,
19,3080020,"Quinoline, 4-(2-(4-(2-methylphenyl)-1-piperazinyl)ethyl)-",CC1=CC=CC=C1N2CCN(CC2)CCC3=CC=NC4=CC=CC=C34,,,,,,
20,3080021,"Quinoline, 4-(2-(4-(3-methylphenyl)-1-piperazinyl)ethyl)-",CC1=CC(=CC=C1)N2CCN(CC2)CCC3=CC=NC4=CC=CC=C34,,,,,,
21,3080022,"Isoquinoline, 1-(2-(4-phenyl-1-piperazinyl)ethyl)-",C1CN(CCN1CCC2=NC=CC3=CC=CC=C32)C4=CC=CC=C4,,,,,,
22,3080023,"Isoquinoline, 1-(2-(4-morpholinyl)ethyl)-",C1COCCN1CCC2=NC=CC3=CC=CC=C32,,,,,,
23,3080024,"Isoquinoline, 1-(2-(1-piperidinyl)ethyl)-",C1CCN(CC1)CCC2=NC=CC3=CC=CC=C32,,,,,,
24,3080025,"Isoquinoline, 1-(2-(4-(2-methylphenyl)-1-piperazinyl)ethyl)-",CC1=CC=CC=C1N2CCN(CC2)CCC3=NC=CC4=CC=CC=C43,,,,,,
25,3080026,(+-)-2-(((2-Hydroxypropyl)amino)methyl)-9H-xanthen-9-one hydrochloride,CC(CNCC1=CC2=C(C=C1)OC3=CC=CC=C3C2=O)O.Cl,,,,,,
26,3080027,2-[(2-Hydroxypropylamino)methyl]xanthen-9-one,CC(CNCC1=CC2=C(C=C1)OC3=CC=CC=C3C2=O)O,,,,,,
27,3080028,(+-)-2-(((1-(Hydroxymethyl)propyl)amino)methyl)-9H-xanthen-9-one hydrochloride,CCC(CO)NCC1=CC2=C(C=C1)OC3=CC=CC=C3C2=O.Cl,,,,,,
28,3080029,2-[(1-Hydroxybutan-2-ylamino)methyl]xanthen-9-one,CCC(CO)NCC1=CC2=C(C=C1)OC3=CC=CC=C3C2=O,,,,,,
29,3080030,"9H-Xanthen-9-one, 2-(((1-(hydroxymethyl)-1-methylethyl)amino)methyl)-, hydrochloride",CC(C)(CO)NCC1=CC2=C(C=C1)OC3=CC=CC=C3C2=O.Cl,,,,,,
30,3080031,2-[[(1-Hydroxy-2-methylpropan-2-yl)amino]methyl]xanthen-9-one,CC(C)(CO)NCC1=CC2=C(C=C1)OC3=CC=CC=C3C2=O,,,,,,
31,3080032,alpha-(Chloromethyl)-6-nitro-1H-benzimidazole-1-ethanol,C1=CC2=C(C=C1[N+](=O)[O-])N(C=N2)CC(CCl)O,,,,,,
32,3080033,CID 3080033,COC1=CC=CC(=C1)NC(=S)NN=CC2=CC=CN2,,,,,,
33,3080034,CID 3080034,CN1C=CC=C1C=NNC(=O)NC2=CC3=C(CCCC3)C=C2,,,,,,
34,3080035,1-(3-Methoxyphenyl)-3-[(1-methylpyrrol-2-yl)methylideneamino]thiourea,CN1C=CC=C1C=NNC(=S)NC2=CC(=CC=C2)OC,,,,,,
35,3080036,"9H-Xanthen-9-one, 2-(((1-(hydroxymethyl)propyl)amino)methyl)-, hydrochloride, (R)-",CC[C@H](CO)NCC1=CC2=C(C=C1)OC3=CC=CC=C3C2=O.Cl,,,,,,
36,3080037,2-[[[(2R)-1-hydroxybutan-2-yl]amino]methyl]xanthen-9-one,CC[C@H](CO)NCC1=CC2=C(C=C1)OC3=CC=CC=C3C2=O,,,,,,
37,3080038,"Pyrano(3,2-a)carbazol-3(5H)-one, 6,11-dihydro-6,6-dimethyl-",CC1(CC2=C(C=CC(=O)O2)C3=C1C4=CC=CC=C4N3)C,,,,,,
38,3080039,"Pyrano(3,2-a)carbazol-3(5H)-one, 6,11-dihydro-",C1CC2=C(C=CC(=O)O2)C3=C1C4=CC=CC=C4N3,,,,,,
39,3080040,"3H-Pyrido(3,2-a)carbazol-3-one, 4,5,6,11-tetrahydro-6,6-dimethyl-",CC1(CC2=C(C=CC(=O)N2)C3=C1C4=CC=CC=C4N3)C,,,,,,
40,3080041,"3H-Pyrido(3,2-a)carbazol-3-one, 4,5,6,11-tetrahydro-",C1CC2=C(C=CC(=O)N2)C3=C1C4=CC=CC=C4N3,,,,,,
41,3080042,"3H-Pyrido(3,2-a)carbazol-3-one, 4,5,6,11-tetrahydro-4-(phenylmethyl)-",C1CC2=C(C=CC(=O)N2CC3=CC=CC=C3)C4=C1C5=CC=CC=C5N4,,,,,,
42,3080043,"3H-Pyrido(3,2-a)carbazol-3-one, 4,5,6,11-tetrahydro-4-(2-(dimethylamino)ethyl)-",CN(C)CCN1C2=C(C=CC1=O)C3=C(CC2)C4=CC=CC=C4N3,,,,,,
43,3080044,"3H-Pyrido(3,2-a)carbazol-3-one, 4,5,6,11-tetrahydro-6,6-dimethyl-4-(2-(dimethylamino)ethyl)-",CC1(CC2=C(C=CC(=O)N2CCN(C)C)C3=C1C4=CC=CC=C4N3)C,,,,,,
44,3080045,"3H-Pyrido(3,2-a)carbazol-3-one, 4,11-dihydro-",C1=CC=C2C(=C1)C3=C(N2)C4=C(C=C3)NC(=O)C=C4,,,,,,
45,3080046,"N-(Phenylmethyl)-11H-pyrido(3,2-a)carbazol-3-amine monohydrochloride",C1=CC=C(C=C1)CNC2=NC3=C(C=C2)C4=C(C=C3)C5=CC=CC=C5N4.Cl,,,,,,
46,3080047,"N-benzyl-11H-pyrido[3,2-a]carbazol-3-amine",C1=CC=C(C=C1)CNC2=NC3=C(C=C2)C4=C(C=C3)C5=CC=CC=C5N4,,,,,,
47,3080048,"1,2-Ethanediamine, N,N-diethyl-N'-11H-pyrido(3,2-a)carbazol-3-yl-, dihydrochloride",CCN(CC)CCNC1=NC2=C(C=C1)C3=C(C=C2)C4=CC=CC=C4N3.Cl.Cl,,,,,,
48,3080049,"N',N'-diethyl-N-(11H-pyrido[3,2-a]carbazol-3-yl)ethane-1,2-diamine",CCN(CC)CCNC1=NC2=C(C=C1)C3=C(C=C2)C4=CC=CC=C4N3,,,,,,
49,3080050,"11H-Pyrido(3,2-a)carbazole, 3-(4-morpholinyl)-, monohydrochloride",C1COCCN1C2=NC3=C(C=C2)C4=C(C=C3)C5=CC=CC=C5N4.Cl,,,,,,
50,3080051,"4-(11H-pyrido[3,2-a]carbazol-3-yl)morpholine",C1COCCN1C2=NC3=C(C=C2)C4=C(C=C3)C5=CC=CC=C5N4,,,,,,
51,3080052,"11H-Pyrido(3,2-a)carbazole, 3-(1-piperidinyl)-",C1CCN(CC1)C2=NC3=C(C=C2)C4=C(C=C3)C5=CC=CC=C5N4,,,,,,
52,3080053,"11H-Pyrido(3,2-a)carbazole, 3-(4-methyl-1-piperazinyl)-",CN1CCN(CC1)C2=NC3=C(C=C2)C4=C(C=C3)C5=CC=CC=C5N4,,,,,,
53,3080054,"11H-Pyrido(3,2-a)carbazole, 3-chloro-11-ethyl-",CCN1C2=CC=CC=C2C3=C1C4=C(C=C3)N=C(C=C4)Cl,,,,,,
54,3080055,"11H-Pyrido(3,2-a)carbazole, 3-chloro-11-(phenylmethyl)-",C1=CC=C(C=C1)CN2C3=CC=CC=C3C4=C2C5=C(C=C4)N=C(C=C5)Cl,,,,,,
55,3080056,"11H-Pyrido(3,2-a)carbazole-11-ethanamine, 3-chloro-N,N-diethyl-",CCN(CC)CCN1C2=CC=CC=C2C3=C1C4=C(C=C3)N=C(C=C4)Cl,,,,,,
56,3080057,"11H-Pyrido(3,2-a)carbazole-11-ethanamine, 3-chloro-N,N-dimethyl-",CN(C)CCN1C2=CC=CC=C2C3=C1C4=C(C=C3)N=C(C=C4)Cl,,,,,,
57,3080058,"11H-Pyrido(3,2-a)carbazole-11-propanamine, 3-chloro-N,N-dimethyl-",CN(C)CCCN1C2=CC=CC=C2C3=C1C4=C(C=C3)N=C(C=C4)Cl,,,,,,
58,3080059,"11H-Pyrido(3,2-a)carbazole, 11-(phenylmethyl)-3-(1-piperidinyl)-",C1CCN(CC1)C2=NC3=C(C=C2)C4=C(C=C3)C5=CC=CC=C5N4CC6=CC=CC=C6,,,,,,
59,3080060,"11H-Pyrido(3,2-a)carbazole, 3-(4-morpholinyl)-11-(phenylmethyl)-",C1COCCN1C2=NC3=C(C=C2)C4=C(C=C3)C5=CC=CC=C5N4CC6=CC=CC=C6,,,,,,
60,3080061,"11H-Pyrido(3,2-a)carbazole, 3-(4-methyl-1-piperazinyl)-11-(phenylmethyl)-",CN1CCN(CC1)C2=NC3=C(C=C2)C4=C(C=C3)C5=CC=CC=C5N4CC6=CC=CC=C6,,,,,,
61,3080062,N-(1-Methyl-2-phenylethyl)-2-oxo-1-pyrrolidineacetamide,CC(CC1=CC=CC=C1)NC(=O)CN2CCCC2=O,,,,,,
62,3080063,"1-Pyrrolidineethanethioamide, N-(phenylmethyl)-2-thioxo-",C1CC(=S)N(C1)CC(=S)NCC2=CC=CC=C2,,,,,,
63,3080064,(1-Chloroethylideneamino) ethyl carbonate,CCOC(=O)ON=C(C)Cl,,,,,,
64,3080065,CID 3080065,CCOC(=O)ON=C(C(C)C)Cl,,,,,,
65,3080066,"beta-D-Fructopyranose, 1,2:4,5-bis-O-(1-methylethylidene)-, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetate",CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O[C@H]4[C@H]5[C@@H](CO[C@]46COC(O6)(C)C)OC(O5)(C)C,,,,,,
66,3080067,"3,4-Dimethoxy-gamma-oxo-N,N,N-trimethylbenzenepropanaminium iodide",C[N+](C)(C)CCC(=O)C1=CC(=C(C=C1)OC)OC.[I-],,,,,,
67,3080068,"Benzamide, 2-hydroxy-3-(1H-imidazol-4-ylmethyl)-N-methyl-, monohydrochloride",CNC(=O)C1=CC=CC(=C1O)CC2=CN=CN2.Cl,,,,,,
68,3080069,3-((1H-Imidazol-5-yl)methyl)-2-hydroxy-N-methylbenzamide,CNC(=O)C1=CC=CC(=C1O)CC2=CN=CN2,,,,,,
69,3080070,"Benzamide, 2-hydroxy-3-(1-(1H-imidazol-4-yl)ethyl)-, monohydrochloride",CC(C1=C(C(=CC=C1)C(=O)N)O)C2=CN=CN2.Cl,,,,,,
70,3080071,2-hydroxy-3-[1-(1H-imidazol-5-yl)ethyl]benzamide,CC(C1=C(C(=CC=C1)C(=O)N)O)C2=CN=CN2,,,,,,
71,3080072,"Benzamide, 2-hydroxy-3-(1-(1H-imidazol-4-yl)ethyl)-, monohydrochloride, (+)-",C[C@@H](C1=C(C(=CC=C1)C(=O)N)O)C2=CN=CN2.Cl,,,,,,
72,3080073,2-hydroxy-3-[(1S)-1-(1H-imidazol-5-yl)ethyl]benzamide,C[C@@H](C1=C(C(=CC=C1)C(=O)N)O)C2=CN=CN2,,,,,,
73,3080074,"Benzamide, 2,6-dihydroxy-3-(1H-imidazol-4-ylmethyl)-, monohydrochloride",C1=CC(=C(C(=C1CC2=CN=CN2)O)C(=O)N)O.Cl,,,,,,
74,3080075,"2,6-dihydroxy-3-(1H-imidazol-5-ylmethyl)benzamide",C1=CC(=C(C(=C1CC2=CN=CN2)O)C(=O)N)O,,,,,,
75,3080076,"2,6-Dihydroxy-3-(1-(1H-imidazol-4-yl)ethyl)benzamide hydrochloride",CC(C1=C(C(=C(C=C1)O)C(=O)N)O)C2=CN=CN2.Cl,,,,,,
76,3080077,"2,6-dihydroxy-3-[1-(1H-imidazol-5-yl)ethyl]benzamide",CC(C1=C(C(=C(C=C1)O)C(=O)N)O)C2=CN=CN2,,,,,,
77,3080078,"Benzamide, 6-hydroxy-3-(1H-imidazol-4-ylmethyl)-2-methyl-, monohydrochloride",CC1=C(C=CC(=C1C(=O)N)O)CC2=CN=CN2.Cl,,,,,,
78,3080079,6-hydroxy-3-[(1H-imidazol-4-yl)methyl]-2-methylbenzamide,CC1=C(C=CC(=C1C(=O)N)O)CC2=CN=CN2,,,,,,
79,3080080,"Benzamide, 2-hydroxy-3-(1H-imidazol-4-ylmethyl)-6-methyl-, monohydrochloride",CC1=C(C(=C(C=C1)CC2=CN=CN2)O)C(=O)N.Cl,,,,,,
80,3080081,2-hydroxy-3-(1H-imidazol-5-ylmethyl)-6-methylbenzamide,CC1=C(C(=C(C=C1)CC2=CN=CN2)O)C(=O)N,,,,,,
81,3080082,"N,2-Dihydroxy-3-((1H-imidazol-4-yl)methyl)benzamide hydrochloride",C1=CC(=C(C(=C1)C(=O)NO)O)CC2=CN=CN2.Cl,,,,,,
82,3080083,"N,2-dihydroxy-3-(1H-imidazol-5-ylmethyl)benzamide",C1=CC(=C(C(=C1)C(=O)NO)O)CC2=CN=CN2,,,,,,
83,3080084,2-Hydroxy-3-(1H-imidazol-4-ylmethyl)-4-methylbenzamide,CC1=C(C(=C(C=C1)C(=O)N)O)CC2=CN=CN2,,,,,,
84,3080085,"N,N-Dimethyl-2-hydroxy-3-(1H-imidazol-4-ylmethyl)benzamide",CN(C)C(=O)C1=CC=CC(=C1O)CC2=CN=CN2,,,,,,
85,3080086,2-Hydroxy-N-(2-hydroxyethyl)-3-((1H-imidazol-4-yl)methyl)benzamide hydrochloride,C1=CC(=C(C(=C1)C(=O)NCCO)O)CC2=CN=CN2.Cl,,,,,,
86,3080087,2-hydroxy-N-(2-hydroxyethyl)-3-(1H-imidazol-5-ylmethyl)benzamide,C1=CC(=C(C(=C1)C(=O)NCCO)O)CC2=CN=CN2,,,,,,
87,3080088,"Benzamide, 3-(1H-imidazol-4-ylmethyl)-2-methoxy-, monohydrochloride",COC1=C(C=CC=C1C(=O)N)CC2=CN=CN2.Cl,,,,,,
88,3080089,3-(1H-imidazol-5-ylmethyl)-2-methoxybenzamide,COC1=C(C=CC=C1C(=O)N)CC2=CN=CN2,,,,,,
89,3080090,"Benzamide, 2-hydroxy-5-(1H-imidazol-4-ylmethyl)-",C1=CC(=C(C=C1CC2=CN=CN2)C(=O)N)O,,,,,,
90,3080091,"Benzoic acid, 2-hydroxy-3-(1H-imidazol-4-ylmethyl)-, hydrazide",C1=CC(=C(C(=C1)C(=O)NN)O)CC2=CN=CN2,,,,,,
91,3080092,CID 3080092,CC1=NC(=C(N1C2=NN=C(S2)SC(=O)CNC3=CC=CC4=CC=CC=C43)O)C=C5C=NC6=CC=CC=C65,,,,,,
92,3080093,"S-[5-[5-hydroxy-4-(indol-3-ylidenemethyl)-2-methylimidazol-1-yl]-1,3,4-thiadiazol-2-yl] 2-anilinoethanethioate",CC1=NC(=C(N1C2=NN=C(S2)SC(=O)CNC3=CC=CC=C3)O)C=C4C=NC5=CC=CC=C54,,,,,,
93,3080094,"S-[5-[5-hydroxy-4-(indol-3-ylidenemethyl)-2-methylimidazol-1-yl]-1,3,4-thiadiazol-2-yl] 2-(2-methylanilino)ethanethioate",CC1=CC=CC=C1NCC(=O)SC2=NN=C(S2)N3C(=NC(=C3O)C=C4C=NC5=CC=CC=C54)C,,,,,,
94,3080095,CID 3080095,CC1=NC(=C(N1C2=NN=C(S2)SC(=O)CNC3=CC=CC=C3Cl)O)C=C4C=NC5=CC=CC=C54,,,,,,
95,3080096,"S-[5-[5-hydroxy-4-(indol-3-ylidenemethyl)-2-methylimidazol-1-yl]-1,3,4-thiadiazol-2-yl] 2-(4-chloroanilino)ethanethioate",CC1=NC(=C(N1C2=NN=C(S2)SC(=O)CNC3=CC=C(C=C3)Cl)O)C=C4C=NC5=CC=CC=C54,,,,,,
96,3080097,CID 3080097,CC1=NC(=C(N1C2=NN=C(S2)SC(=O)CNC3=CC(=CC=C3)[N+](=O)[O-])O)C=C4C=NC5=CC=CC=C54,,,,,,
97,3080098,"S-[5-[5-hydroxy-4-(indol-3-ylidenemethyl)-2-methylimidazol-1-yl]-1,3,4-thiadiazol-2-yl] 2-(4-methoxyanilino)ethanethioate",CC1=NC(=C(N1C2=NN=C(S2)SC(=O)CNC3=CC=C(C=C3)OC)O)C=C4C=NC5=CC=CC=C54,,,,,,
98,3080099,"Methyl 2-chloro-2-(2,4-dichloro-3-oxo-5-phenylfuran-2-yl)acetate",COC(=O)C(C1(C(=O)C(=C(O1)C2=CC=CC=C2)Cl)Cl)Cl,,,,,,
99,3080100,"Methyl 2,3-dihydro-5-(4-methylphenyl)-3-oxo-alpha,2,4-trichloro-2-furanacetate",CC1=CC=C(C=C1)C2=C(C(=O)C(O2)(C(C(=O)OC)Cl)Cl)Cl,,,,,,
100,3080101,"Methyl 2,3-dihydro-5-(4-methylphenyl)-3-oxo-alpha,2,4-tribromo-2-furanacetate",CC1=CC=C(C=C1)C2=C(C(=O)C(O2)(C(C(=O)OC)Br)Br)Br,,,,,,
101,3080102,"4-(3,5-Di-tert-butyl-4-hydroxybenzylidene)-2-methyl-3-isoxazolidinone",CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=C2CON(C2=O)C,,,,,,
102,3080103,CID 3080103,CC1=NC(=C(N1C2=NN=C(S2)SC(=O)CNC3=CC=CC=C3OC)O)C=C4C=NC5=CC=CC=C54,,,,,,
103,3080104,"3a-Methyl-4,7-hexahydroepoxybenzo(c)thiophene-1,3-dione (3a-alpha,4-beta,7-beta,7a-alpha)-",C[C@]12[C@@H]3CC[C@H]([C@H]1C(=O)SC2=O)O3,,,,,,
104,3080105,"4,7-Epoxybenzo(c)thiophene-1,3-dione, hexahydro-3a,7a-dimethyl-, (3a-alpha,4-beta,7-beta,7a-alpha)-",C[C@@]12[C@H]3CC[C@@H]([C@@]1(C(=O)SC2=O)C)O3,,,,,,
105,3080106,"Hexahydro-4,7-epoxy-1H-indene-3a,7a-dicarboxylic acid, (3a-alpha,4-alpha,7-alpha,7a-alpha)-",C1C[C@]2([C@H]3CC[C@@H]([C@]2(C1)C(=O)O)O3)C(=O)O,,,,,,
106,3080107,"1H,3H-4,7-Epoxy-3a,7a-propanobenzo(c)thiophene-1,3-dione, tetrahydro-, (3a-alpha,4-beta,7-beta,7a-alpha)-",C1CC23C4CCC(C2(C1)C(=O)SC3=O)O4,,,,,,
107,3080108,"5,6-exo-Epoxyendothall thioanhydride",C1C(=O)[C@@H]2[C@H]3[C@H]4[C@H](O4)[C@@H]([C@@H]2S1=O)O3,,,,,,
108,3080109,5-endo-(Ethoxycarbonyl)endothall anhydride,CCOC(=O)[C@@H]1C[C@@H]2[C@@H]3[C@H]([C@H]1O2)C(=O)OC3=O,,,,,,
109,3080110,5-endo-(Ethoxycarbonyl)endothall thioanhydride,CCOC(=O)[C@@H]1C[C@@H]2[C@@H]3[C@H]([C@H]1O2)C(=O)SC3=O,,,,,,
110,3080111,5-endo-Carboxyendothall anhydride,C1[C@H]([C@H]2[C@H]3[C@@H]([C@@H]1O2)C(=O)OC3=O)C(=O)O,,,,,,
111,3080112,5-endo-Carboxyendothall thioanhydride,C1[C@H]([C@H]2[C@H]3[C@@H]([C@@H]1O2)C(=O)SC3=O)C(=O)O,,,,,,
112,3080113,"7-Oxabicyclo(2.2.1)heptane-2,3-dicarboxylic acid, 5-(cyanomethyl)-, (2-exo,3-exo,5-endo)-",C1[C@@H]([C@H]2[C@H]([C@H]([C@@H]1O2)C(=O)O)C(=O)O)CC#N,,,,,,
113,3080114,5-endo-(Cyanomethyl)endothall anhydride,C1[C@@H]([C@H]2[C@@H]3[C@H]([C@@H]1O2)C(=O)OC3=O)CC#N,,,,,,
114,3080115,5-endo-(Cyanomethyl)endothall thioanhydride,C1[C@H]([C@H]2[C@H]3[C@@H]([C@@H]1O2)C(=O)SC3=O)CC#N,,,,,,
115,3080116,Endothall dithioanhydride,C1C[C@H]2[C@H]3[C@@H]([C@@H]1O2)C(=O)SC3=S,,,,,,
116,3080117,"1,3,5-Triazin-2(1H)-one, 4-(4-morpholinyl)-6-propyl-, oxime",CCCC1=NC(=NC(=N1)N2CCOCC2)NO,,,,,,
117,3080118,"1-Propanol, 3-((4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)amino)-",CCCC1=NC(=NC(=N1)N2CCOCC2)NCCCO,,,,,,
118,3080119,"1-Butanol, 4-((4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)amino)-",CCCC1=NC(=NC(=N1)N2CCOCC2)NCCCCO,,,,,,
119,3080120,"1-((4-(4-Morpholinyl)-6-propyl-1,3,5-triazin-2-yl)amino)-2-propanol",CCCC1=NC(=NC(=N1)N2CCOCC2)NCC(C)O,,,,,,
120,3080121,"1-((4-(4-Morpholinyl)-6-propyl-1,3,5-triazin-2-yl)amino)-2-butanol",CCCC1=NC(=NC(=N1)N2CCOCC2)NCC(CC)O,,,,,,
121,3080122,"2-((4-(4-Morpholinyl)-6-propyl-1,3,5-triazin-2-yl)amino)-1-butanol",CCCC1=NC(=NC(=N1)N2CCOCC2)NC(CC)CO,,,,,,
122,3080123,"1-Propanol, 2-methyl-2-((4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)amino)-",CCCC1=NC(=NC(=N1)N2CCOCC2)NC(C)(C)CO,,,,,,
123,3080124,"Ethanol, 2-(methyl(4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)amino)-",CCCC1=NC(=NC(=N1)N(C)CCO)N2CCOCC2,,,,,,
124,3080125,"1,3-Propanediol, 2-(hydroxymethyl)-2-((4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)amino)-",CCCC1=NC(=NC(=N1)N2CCOCC2)NC(CO)(CO)CO,,,,,,
125,3080126,"1,3-Propanediol, 2-methyl-2-((4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)amino)-",CCCC1=NC(=NC(=N1)N2CCOCC2)NC(C)(CO)CO,,,,,,
126,3080127,"Ethanol, 2-((4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)(phenylmethyl)amino)-",CCCC1=NC(=NC(=N1)N(CCO)CC2=CC=CC=C2)N3CCOCC3,,,,,,
127,3080128,"2-((4-(4-Morpholinyl)-6-propyl-1,3,5-triazin-2-yl)amino)-1-phenyl-1,3-propanediol",CCCC1=NC(=NC(=N1)N2CCOCC2)NC(CO)C(C3=CC=CC=C3)O,,,,,,
128,3080129,"2-Propanol, 1-((4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)amino)-, (S)-",CCCC1=NC(=NC(=N1)N2CCOCC2)NC[C@H](C)O,,,,,,
129,3080130,"2-Propanol, 1-((4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)amino)-, (R)-",CCCC1=NC(=NC(=N1)N2CCOCC2)NC[C@@H](C)O,,,,,,
130,3080131,"Cyclohexanol, 1-(((4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)amino)methyl)-",CCCC1=NC(=NC(=N1)N2CCOCC2)NCC3(CCCCC3)O,,,,,,
131,3080132,"1-(4-(4-Morpholinyl)-6-propyl-1,3,5-triazin-2-yl)-2-pyrrolidinemethanol monohydrochloride",CCCC1=NC(=NC(=N1)N2CCCC2CO)N3CCOCC3.Cl,,,,,,
132,3080133,"[1-(4-Morpholin-4-yl-6-propyl-1,3,5-triazin-2-yl)pyrrolidin-2-yl]methanol",CCCC1=NC(=NC(=N1)N2CCCC2CO)N3CCOCC3,,,,,,
133,3080134,"1,3,5-Triazin-2(1H)-one, 4-(4-morpholinyl)-6-propyl-, dimethylhydrazone",CCCC1=NC(=NC(=N1)N2CCOCC2)NN(C)C,,,,,,
134,3080135,"N-(4-Morpholino-6-propyl-1,3,5-triazin-2-yl)acetamide",CCCC1=NC(=NC(=N1)N2CCOCC2)NC(=O)C,,,,,,
135,3080136,"Benzamide, N-(4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)-, monohydrochloride",CCCC1=NC(=NC(=N1)N2CCOCC2)NC(=O)C3=CC=CC=C3.Cl,,,,,,
136,3080137,"N-(4-Propyl-6-morpholino-1,3,5-triazine-2-yl)benzamide",CCCC1=NC(=NC(=N1)N2CCOCC2)NC(=O)C3=CC=CC=C3,,,,,,
137,3080138,"Benzeneacetamide, N-(4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)-",CCCC1=NC(=NC(=N1)N2CCOCC2)NC(=O)CC3=CC=CC=C3,,,,,,
138,3080139,"Propanamide, 2-methyl-N-(4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)-",CCCC1=NC(=NC(=N1)N2CCOCC2)NC(=O)C(C)C,,,,,,
139,3080140,"Acetamide, N-methyl-N-(4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)-",CCCC1=NC(=NC(=N1)N(C)C(=O)C)N2CCOCC2,,,,,,
140,3080141,"Propanamide, N,2-dimethyl-N-(4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)-",CCCC1=NC(=NC(=N1)N(C)C(=O)C(C)C)N2CCOCC2,,,,,,
141,3080142,"Benzamide, N-methyl-N-(4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)-, monohydrochloride",CCCC1=NC(=NC(=N1)N(C)C(=O)C2=CC=CC=C2)N3CCOCC3.Cl,,,,,,
142,3080143,"N-(4-Propyl-6-morpholino-1,3,5-triazine-2-yl)-N-methylbenzamide",CCCC1=NC(=NC(=N1)N(C)C(=O)C2=CC=CC=C2)N3CCOCC3,,,,,,
143,3080144,"Carbamic acid, (4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)-, phenyl ester",CCCC1=NC(=NC(=N1)N2CCOCC2)NC(=O)OC3=CC=CC=C3,,,,,,
144,3080145,"Benzamide, 4-chloro-N-(4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)-, monohydrochloride",CCCC1=NC(=NC(=N1)N2CCOCC2)NC(=O)C3=CC=C(C=C3)Cl.Cl,,,,,,
145,3080146,"4-chloro-N-(4-morpholin-4-yl-6-propyl-1,3,5-triazin-2-yl)benzamide",CCCC1=NC(=NC(=N1)N2CCOCC2)NC(=O)C3=CC=C(C=C3)Cl,,,,,,
146,3080147,"Benzamide, 4-chloro-N-methyl-N-(4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)-",CCCC1=NC(=NC(=N1)N(C)C(=O)C2=CC=C(C=C2)Cl)N3CCOCC3,,,,,,
147,3080148,"Benzamide, 4-methoxy-N-(4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)-, monohydrochloride",CCCC1=NC(=NC(=N1)N2CCOCC2)NC(=O)C3=CC=C(C=C3)OC.Cl,,,,,,
148,3080149,"4-methoxy-N-(4-morpholin-4-yl-6-propyl-1,3,5-triazin-2-yl)benzamide",CCCC1=NC(=NC(=N1)N2CCOCC2)NC(=O)C3=CC=C(C=C3)OC,,,,,,
149,3080150,"Benzamide, 4-methoxy-N-methyl-N-(4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)-, monohydrochloride",CCCC1=NC(=NC(=N1)N(C)C(=O)C2=CC=C(C=C2)OC)N3CCOCC3.Cl,,,,,,
150,3080151,"4-methoxy-N-methyl-N-(4-morpholin-4-yl-6-propyl-1,3,5-triazin-2-yl)benzamide",CCCC1=NC(=NC(=N1)N(C)C(=O)C2=CC=C(C=C2)OC)N3CCOCC3,,,,,,
151,3080152,"Benzamide, 4-methyl-N-(4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)-, monohydrochloride",CCCC1=NC(=NC(=N1)N2CCOCC2)NC(=O)C3=CC=C(C=C3)C.Cl,,,,,,
152,3080153,"4-methyl-N-(4-morpholin-4-yl-6-propyl-1,3,5-triazin-2-yl)benzamide",CCCC1=NC(=NC(=N1)N2CCOCC2)NC(=O)C3=CC=C(C=C3)C,,,,,,
153,3080154,"Benzamide, N,4-dimethyl-N-(4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)-, monohydrochloride",CCCC1=NC(=NC(=N1)N(C)C(=O)C2=CC=C(C=C2)C)N3CCOCC3.Cl,,,,,,
154,3080155,"N,4-dimethyl-N-(4-morpholin-4-yl-6-propyl-1,3,5-triazin-2-yl)benzamide",CCCC1=NC(=NC(=N1)N(C)C(=O)C2=CC=C(C=C2)C)N3CCOCC3,,,,,,
155,3080156,"Benzamide, 3,4-dimethoxy-N-methyl-N-(4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)-",CCCC1=NC(=NC(=N1)N(C)C(=O)C2=CC(=C(C=C2)OC)OC)N3CCOCC3,,,,,,
156,3080157,"Benzamide, 3,4-dimethyl-N-(4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)-",CCCC1=NC(=NC(=N1)N2CCOCC2)NC(=O)C3=CC(=C(C=C3)C)C,,,,,,
157,3080158,"2-((2-Acetoxy)ethyl)amino-4-morpholino-6-propyl-1,3,5-triazine",CCCC1=NC(=NC(=N1)N2CCOCC2)NCCOC(=O)C,,,,,,
158,3080159,"Propanoic acid, 2-methyl-, 2-((4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)amino)ethyl ester",CCCC1=NC(=NC(=N1)N2CCOCC2)NCCOC(=O)C(C)C,,,,,,
159,3080160,"Ethanol, 2-((4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)amino)-, benzoate (ester)",CCCC1=NC(=NC(=N1)N2CCOCC2)NCCOC(=O)C3=CC=CC=C3,,,,,,
160,3080161,"Benzeneacetic acid, 2-((4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)amino)ethyl ester",CCCC1=NC(=NC(=N1)N2CCOCC2)NCCOC(=O)CC3=CC=CC=C3,,,,,,
161,3080162,"Urea, N,N-dimethyl-N'-(4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)-",CCCC1=NC(=NC(=N1)N2CCOCC2)NC(=O)N(C)C,,,,,,
162,3080163,"2-((2-((Aminocarbonyl)oxy)ethyl)amino)-4-morpholino-6-propyl-1,3,5-triazine",CCCC1=NC(=NC(=N1)N2CCOCC2)NCCOC(=O)N,,,,,,
163,3080164,"Acetamide, N-(2-(acetyloxy)ethyl)-N-(4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)-",CCCC1=NC(=NC(=N1)N(CCOC(=O)C)C(=O)C)N2CCOCC2,,,,,,
164,3080165,"1,3,5-Triazin-2-amine, 4-(4-morpholinyl)-6-propyl-, monohydrochloride",CCCC1=NC(=NC(=N1)N2CCOCC2)N.Cl,,,,,,
165,3080166,"2-Amino-4-morpholino-6-propyl-1,3,5-triazine",CCCC1=NC(=NC(=N1)N2CCOCC2)N,,,,,,
166,3080167,"1,3,5-Triazin-2-amine, N-methyl-4-(4-morpholinyl)-6-propyl-, monohydrochloride",CCCC1=NC(=NC(=N1)N2CCOCC2)NC.Cl,,,,,,
167,3080168,"N-Methyl-4-propyl-6-morpholino-1,3,5-triazine-2-amine",CCCC1=NC(=NC(=N1)N2CCOCC2)NC,,,,,,
168,3080169,"Acetamide, N-methyl-N-(4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)-, monohydrochloride",CCCC1=NC(=NC(=N1)N(C)C(=O)C)N2CCOCC2.Cl,,,,,,
169,3080170,2-Methylendothall,CC1([C@H]2CCC(C1C(=O)O)O2)C(=O)O,,,,,,
170,3080171,"1,3,5-Triazin-2-amine, N-(2-methoxyethyl)-4-(4-morpholinyl)-6-propyl-",CCCC1=NC(=NC(=N1)N2CCOCC2)NCCOC,,,,,,
171,3080172,9-O-(R(-)-2-(4'-Chlorophenyl)-2-hydroxybutyryl)retronecine N-oxide,CC[C@@](C1=CC=C(C=C1)Cl)(C(=O)OCC2=CC[N+]3([C@H]2[C@@H](CC3)O)[O-])O,,,,,,
172,3080173,CID 3080173,COC1=C(C=CC(=C1)C=C2C(=O)N(C(=N2)CCNC3=CC=C(C=C3)Cl)C4=NN=C(S4)SCC(=O)NC5=CC=CC=C5)O,,,,,,
173,3080174,CID 3080174,C1=CC=C(C=C1)C=C2C(=O)N(C(=N2)CCNC3=CC=CC=C3Cl)C4=CC=CC=C4C(=O)O,,,,,,
174,3080175,"Ethyl 4-(1-(N,N-dipropylcarbamoyl)ethylamino)-7-trifluoromethylquinoline-3-carboxylate",CCCN(CCC)C(=O)C(C)NC1=C2C=CC(=CC2=NC=C1C(=O)OCC)C(F)(F)F,,,,,,
175,3080176,"3-Quinolinecarboxylic acid, 6-chloro-4-((2-(dipropylamino)-1-methyl-2-oxoethyl)amino)-, ethyl ester, (+-)-",CCCN(CCC)C(=O)C(C)NC1=C2C=C(C=CC2=NC=C1C(=O)OCC)Cl,,,,,,
176,3080177,2-((3-Benzoyl-7-bromo-4-quinolinyl)amino)-N-(4-methoxyphenyl)-N-methylacetamide,CN(C1=CC=C(C=C1)OC)C(=O)CNC2=C3C=CC(=CC3=NC=C2C(=O)C4=CC=CC=C4)Br,,,,,,
177,3080178,"Acetamide, 2-((3-benzoyl-1,5-naphthyridin-4-yl)amino)-N-(4-chlorophenyl)-N-methyl-",CN(C1=CC=C(C=C1)Cl)C(=O)CNC2=C3C(=NC=C2C(=O)C4=CC=CC=C4)C=CC=N3,,,,,,
178,3080179,"(+-)-2-((3-Benzoyl-1,5-naphthyridin-4-yl)amino)-N-(4-chlorophenyl)-N-methylpropanamide",CC(C(=O)N(C)C1=CC=C(C=C1)Cl)NC2=C3C(=NC=C2C(=O)C4=CC=CC=C4)C=CC=N3,,,,,,
179,3080180,"Propanamide, 3-((3-benzoyl-1,5-naphthyridin-4-yl)amino)-N-(4-chlorophenyl)-N-methyl-",CN(C1=CC=C(C=C1)Cl)C(=O)CCNC2=C3C(=NC=C2C(=O)C4=CC=CC=C4)C=CC=N3,,,,,,
180,3080181,"Acetamide, 2-((3-benzoyl-1,5-naphthyridin-4-yl)amino)-N-(2,4-dichlorophenyl)-N-methyl-",CN(C1=C(C=C(C=C1)Cl)Cl)C(=O)CNC2=C3C(=NC=C2C(=O)C4=CC=CC=C4)C=CC=N3,,,,,,
181,3080182,"Pyrazino(1,2-a)indol-1-amine, 3,4-dihydro-8-methoxy-, monohydrochloride",COC1=CC2=C(C=C1)N3CCN=C(C3=C2)N.Cl,,,,,,
182,3080183,"1-Hydrazino-8-methoxy-3,4-dihydropyrazino(1,2-a)indole hydrochloride dihydrate",COC1=CC2=C(C=C1)N3CCN=C(C3=C2)NN.Cl,,,,,,
183,3080184,"Ethanol, 2-((3,4-dihydro-8-methoxypyrazino(1,2-a)indol-1-yl)amino)-, monohydrochloride",COC1=CC2=C(C=C1)N3CCN=C(C3=C2)NCCO.Cl,,,,,,
184,3080185,"Imidazo(2',1':3,4)pyrazino(1,2-a)indole, 2,3,5,6-tetrahydro-10-methoxy-, monohydrochloride",COC1=CC2=C(C=C1)N3CCN4CCN=C4C3=C2.Cl,,,,,,
185,3080186,"13-Methoxy-3,6,9-triazatetracyclo[7.7.0.02,6.010,15]hexadeca-1(16),2,10(15),11,13-pentaene",COC1=CC2=C(C=C1)N3CCN4CCN=C4C3=C2,,,,,,
186,3080187,"2H-Pyrimido(2',1':3,4)pyrazino(1,2-a)indole, 3,4,6,7-tetrahydro-11-methoxy-, monohydrochloride",COC1=CC2=C(C=C1)N3CCN4CCCN=C4C3=C2.Cl,,,,,,
187,3080188,2-Hydroxy-N-(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)-1H-benzimidazole-1-carboximidic acid--hydrogen chloride (1/1),CN1C2CCC1CC(C2)NC(=O)N3C4=CC=CC=C4NC3=O.Cl,,,,,,
188,3080189,CID 3080189,CCCCOCC1=C(C=CC(=C1)C(=O)CC)OCC(CNC(C)C)O.C(=CC(=O)O)C(=O)O,,,,,,
189,3080190,1-[3-(Butoxymethyl)-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]propan-1-one,CCCCOCC1=C(C=CC(=C1)C(=O)CC)OCC(CNC(C)C)O,,,,,,
190,3080191,"Benzoic acid, 2-((4,5-dihydro-2-thiazolyl)amino)-5-methyl-",CC1=CC(=C(C=C1)NC2=NCCS2)C(=O)O,,,,,,
191,3080192,"6-(9-bromo-5-oxo-6H-pyrido[4,3-c][1]benzazepin-11-ylidene)hexanoic acid",C1=CC2=C(C=C1Br)C(=CCCCCC(=O)O)C3=C(C=CN=C3)C(=O)N2,,,,,,
192,3080193,"6-(7-methyl-5-oxo-6H-pyrido[4,3-c][1]benzazepin-11-ylidene)hexanoic acid",CC1=C2C(=CC=C1)C(=CCCCCC(=O)O)C3=C(C=CN=C3)C(=O)N2,,,,,,
193,3080194,"6-(9-Methoxy-6-methyl-5-oxopyrido[4,3-c][1]benzazepin-11-ylidene)hexanoic acid",CN1C2=C(C=C(C=C2)OC)C(=CCCCCC(=O)O)C3=C(C1=O)C=CN=C3,,,,,,
194,3080195,"5-(5-oxo-6H-pyrido[4,3-c][1]benzazepin-11-ylidene)pentanoic acid",C1=CC=C2C(=C1)C(=CCCCC(=O)O)C3=C(C=CN=C3)C(=O)N2,,,,,,
195,3080196,"8-(5-oxo-6H-pyrido[4,3-c][1]benzazepin-11-ylidene)octanoic acid",C1=CC=C2C(=C1)C(=CCCCCCCC(=O)O)C3=C(C=CN=C3)C(=O)N2,,,,,,
196,3080197,CID 3080197,CSC1=NC2=CC=CC=C2C(=CCCCCCCC(=O)O)C3=C1C=CN=C3,,,,,,
197,3080198,CID 3080198,CC=CC1=CC2=CC=CC=C2C(=CCCCCC(=O)O)C3=C1C=CN=C3,,,,,,
198,3080199,"6-(5-oxo-6H-pyrido[4,3-c][1]benzazepin-11-ylidene)hexanoic acid",C1=CC=C2C(=C1)C(=CCCCCC(=O)O)C3=C(C=CN=C3)C(=O)N2,,,,,,
199,3080200,"6-(6-Benzyl-5-oxopyrido[4,3-c][1]benzazepin-11-ylidene)hexanoic acid",C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=CCCCCC(=O)O)C4=C(C2=O)C=CN=C4,,,,,,
200,3080201,"6-(6-Methoxypyrido[4,3-c][2]benzazepin-11-ylidene)hexanoic acid",COC1=NC2=C(C=NC=C2)C(=CCCCCC(=O)O)C3=CC=CC=C31,,,,,,
201,3080202,"6-(6-oxo-5H-pyrido[4,3-c][2]benzazepin-11-ylidene)hexanoic acid",C1=CC=C2C(=C1)C(=CCCCCC(=O)O)C3=C(C=CN=C3)NC2=O,,,,,,
202,3080203,"6-(5,6-Dihydropyrido[4,3-c][1]benzazepin-11-ylidene)hexanoic acid",C1C2=C(C=NC=C2)C(=CCCCCC(=O)O)C3=CC=CC=C3N1,,,,,,
203,3080204,CID 3080204,CSC1=NC2=CC=CC=C2C(=CCCCCC(=O)O)C3=C1C=NC=C3,,,,,,
204,3080205,"6-(5-oxo-6H-pyrido[3,4-c][1]benzazepin-11-ylidene)hexanoic acid",C1=CC=C2C(=C1)C(=CCCCCC(=O)O)C3=C(C=NC=C3)C(=O)N2,,,,,,
205,3080206,CID 3080206,CN1C2=CC=CC=C2C(=CCCCCC(=O)O)C3=C(C1=O)C=NC=C3,,,,,,
206,3080207,"10,11-Dihydro-11-oxo-5H-pyrido(3,4-c)(1)benzazepine-5-hexanoic acid",C1=CC=C2C(=C1)C(C3=C(C=NC=C3)C(=O)N2)CCCCCC(=O)O,,,,,,
207,3080208,CID 3080208,CSC1C2=C(C=CN=C2)C(=CCCCCC(=O)O)C3=CC=CC=C3N1,,,,,,
208,3080209,"6-(5,6-Dihydropyrido[3,4-c][1]benzazepin-11-ylidene)hexanoic acid",C1C2=C(C=CN=C2)C(=CCCCCC(=O)O)C3=CC=CC=C3N1,,,,,,
209,3080210,"2,4-Diazido-6-cyanomethoxy-s-triazine",C(C#N)OC1=NC(=NC(=N1)N=[N+]=[N-])N=[N+]=[N-],,,,,,
210,3080211,CID 3080211,C1=CC=C(C=C1)C2=NC(=C(N2C3=CC=C(C=C3)OC4=CC=C(C=C4)Cl)O)C=C5C=C6C=CC=CC6=N5,,,,,,
211,3080212,CID 3080212,C1=CC=C(C=C1)C2=NC(=C(N2C3=CC=C(C=C3)OC4=CC=CC=C4)O)C=C5C=C6C=CC=CC6=N5,,,,,,
212,3080213,CID 3080213,C1=CC=C(C=C1)C2=NC(=C(N2C3=CC=C(C=C3)OC4=CC=C(C=C4)F)O)C=C5C=C6C=CC=CC6=N5,,,,,,
213,3080214,CID 3080214,CC1=CC=C(C=C1)OC2=CC=C(C=C2)N3C(=NC(=C3O)C=C4C=C5C=CC=CC5=N4)C,,,,,,
214,3080215,CID 3080215,CC1=NC(=C(N1C2=CC=C(C=C2)OC3=CC=C(C=C3)Cl)O)C=C4C=C5C=CC=CC5=N4,,,,,,
215,3080216,CID 3080216,CC1=NC(=C(N1C2=CC=C(C=C2)OC3=CC=CC=C3)O)C=C4C=C5C=CC=CC5=N4,,,,,,
216,3080217,CID 3080217,CC1=NC(=C(N1C2=CC=C(C=C2)OC3=CC=C(C=C3)F)O)C=C4C=C5C=CC=CC5=N4,,,,,,
217,3080218,CID 3080218,CC1=CC=C(C=C1)OC2=CC=C(C=C2)N3C(=C(N=C3C4=CC=CC=C4)C=C5C=NC6=CC=CC=C65)O,,,,,,
218,3080219,CID 3080219,CC(C)(C(=O)[O-])ON=C(C1=CSC(=N1)N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C=CC4=CC(=O)C(=CN4CC(=O)OC)O)C(=O)[O-].[Na+].[Na+],,,,,,
219,3080220,"(6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-3-[2-[5-hydroxy-1-(2-methoxy-2-oxoethyl)-4-oxopyridin-2-yl]ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C=CC4=CC(=O)C(=CN4CC(=O)OC)O)C(=O)O,,,,,,
220,3080221,CID 3080221,CC(C)(C(=O)[O-])ON=C(C1=CSC(=N1)N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C=CC4=CC(=O)C(=CN4CC(=O)[O-])O)C(=O)[O-].[Na+].[Na+],,,,,,
221,3080222,CID 3080222,CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C=CC4=CC(=O)C(=CN4CC(=O)O)O)C(=O)O,,,,,,
222,3080223,CID 3080223,CCSCCOCCNC(=S)[S-].[K+],,,,,,
223,3080224,2-(2-Ethylsulfanylethoxy)ethylcarbamodithioic acid,CCSCCOCCNC(=S)S,,,,,,
224,3080225,CID 3080225,C=COCCN(CCOC=C)C(=S)[S-].[K+],,,,,,
225,3080226,Bis(2-ethenoxyethyl)carbamodithioic acid,C=COCCN(CCOC=C)C(=S)S,,,,,,
226,3080227,"alpha-D-Glucopyranose, 1,2:3,4-bis-O-(1-methylethylidene)-, butanoate",CCCC(=O)OC[C@@H]1[C@@H]2[C@@H]([C@@H]3[C@H](O1)OC(O3)(C)C)OC(O2)(C)C,,,,,,
227,3080228,CID 3080228,COC1=C(C=C(C=C1)C(=NN2CCN(CC2)C3=CC=CC=C3)N=NC4=CC(=CC=C4)Cl)OC,,,,,,
228,3080229,CID 3080229,COC1=C(C=C(C=C1)C(=NN2CCN(CC2)C3=CC=CC=C3)N=NC4=CC=C(C=C4)Cl)OC,,,,,,
229,3080230,"2H-Tetrazolium, 3-(4-chlorophenyl)-5-(2-hydroxyphenyl)-2-((4-phenyl-1-piperazinyl)acetyl)-, chloride",C1CN(CCN1CC(=O)N2N=C(N=[N+]2C3=CC=C(C=C3)Cl)C4=CC=CC=C4O)C5=CC=CC=C5.[Cl-],,,,,,
230,3080231,1-[3-(4-Chlorophenyl)-5-(2-hydroxyphenyl)tetrazol-3-ium-2-yl]-2-(4-phenylpiperazin-1-yl)ethanone,C1CN(CCN1CC(=O)N2N=C(N=[N+]2C3=CC=C(C=C3)Cl)C4=CC=CC=C4O)C5=CC=CC=C5,,,,,,
231,3080232,3-(2-Chlorophenyl)-5-phenyl-2-((4-phenyl-1-piperazinyl)acetyl)-2H-tetrazolium chloride,C1CN(CCN1CC(=O)N2N=C(N=[N+]2C3=CC=CC=C3Cl)C4=CC=CC=C4)C5=CC=CC=C5.[Cl-],,,,,,
232,3080233,1-[3-(2-Chlorophenyl)-5-phenyltetrazol-3-ium-2-yl]-2-(4-phenylpiperazin-1-yl)ethanone,C1CN(CCN1CC(=O)N2N=C(N=[N+]2C3=CC=CC=C3Cl)C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
233,3080234,"Piperazine, 1-phenyl-4-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)-",C1CN(CCN1CC2=NN=C(O2)C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
234,3080235,"2-(5-((4-Phenyl-1-piperazinyl)methyl)-1,3,4-oxadiazol-2-yl)phenol",C1CN(CCN1CC2=NN=C(O2)C3=CC=CC=C3O)C4=CC=CC=C4,,,,,,
235,3080236,"Phenol, 2-methoxy-5-(5-((4-phenyl-1-piperazinyl)methyl)-1,3,4-oxadiazol-2-yl)-",COC1=C(C=C(C=C1)C2=NN=C(O2)CN3CCN(CC3)C4=CC=CC=C4)O,,,,,,
236,3080237,2-Chloro-3-methylsulfanylprop-2-enenitrile,CSC=C(C#N)Cl,,,,,,
237,3080238,3-(3-Chlorophenyl)-5-phenyl-2-((4-phenyl-1-piperazinyl)acetyl)-2H-tetrazolium chloride,C1CN(CCN1CC(=O)N2N=C(N=[N+]2C3=CC(=CC=C3)Cl)C4=CC=CC=C4)C5=CC=CC=C5.[Cl-],,,,,,
238,3080239,1-[3-(3-Chlorophenyl)-5-phenyltetrazol-3-ium-2-yl]-2-(4-phenylpiperazin-1-yl)ethanone,C1CN(CCN1CC(=O)N2N=C(N=[N+]2C3=CC(=CC=C3)Cl)C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
239,3080240,methyl (2S)-3-methyl-2-(3-phenylprop-2-enoylamino)butanoate,CC(C)[C@@H](C(=O)OC)NC(=O)C=CC1=CC=CC=C1,,,,,,
240,3080241,CID 3080241,CCCC[C@@H](C(=O)OC)NC(=O)C=CC1=CC=CC=C1,,,,,,
241,3080242,methyl (2S)-4-methylsulfanyl-2-(3-phenylprop-2-enoylamino)butanoate,COC(=O)[C@H](CCSC)NC(=O)C=CC1=CC=CC=C1,,,,,,
242,3080243,CID 3080243,COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C=CC2=CC=CC=C2,,,,,,
243,3080244,N-(1-hydroxy-4-methylpentan-2-yl)-3-phenylprop-2-enamide,CC(C)CC(CO)NC(=O)C=CC1=CC=CC=C1,,,,,,
244,3080245,Aureobasidin G,CCC(C)C1C(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)N2CCCC2C(=O)N1)CC3=CC=CC=C3)C)CC4=CC=CC=C4)C(C)C)C)C(C)CC)C(C)C)C)CC(C)C)C(C)C)C,,,,,,
245,3080246,Aureobasidin I,CCC(C)C1C(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)N2CCCC2C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)O1)C(C)(C)O)C)CC(C)C)C(C)C)C)CC(C)C)CC3=CC=CC=C3)C)CC4=CC=CC=C4)C(C)C)C,,,,,,
246,3080247,CID 3080247,CC1=NC2=CC=CC=C2C(=O)N1N=C(C3=CC=CC=C3)N=NC4=CC=C(C=C4)C(=O)NN=CC5=CC=CC=C5,,,,,,
247,3080248,CID 3080248,CC1=NC2=CC=CC=C2C(=O)N1N=C(C3=CC=CC=C3)N=NC4=CC=C(C=C4)C(=O)NN=CC5=CC=CC=C5O,,,,,,
248,3080249,N-(benzylideneamino)-4-[[C-(furan-2-yl)-N-(2-methyl-4-oxoquinazolin-3-yl)carbonimidoyl]diazenyl]benzamide,CC1=NC2=CC=CC=C2C(=O)N1N=C(C3=CC=CO3)N=NC4=CC=C(C=C4)C(=O)NN=CC5=CC=CC=C5,,,,,,
249,3080250,CID 3080250,CC1=NC2=CC=CC=C2C(=O)N1N=C(C3=CC=CO3)N=NC4=CC=C(C=C4)C(=O)NN=CC5=CC=CC=C5O,,,,,,
250,3080251,CID 3080251,C1=CC=C(C=C1)C=CC2=NC3=CC=CC=C3C(=O)N2N=C(C4=CC=CC=C4)N=NC5=CC=C(C=C5)C(=O)NN,,,,,,
251,3080252,CID 3080252,C1=CC=C(C=C1)C(=NN2C(=NC3=CC=CC=C3C2=O)C=CC4=CC=CC=C4O)N=NC5=CC=C(C=C5)C(=O)NN,,,,,,
252,3080253,CID 3080253,C1=CC=C(C=C1)C=CC2=NC3=CC=CC=C3C(=O)N2N=C(C4=CC=CO4)N=NC5=CC=C(C=C5)C(=O)NN,,,,,,
253,3080254,CID 3080254,C1=CC=C(C(=C1)C=CC2=NC3=CC=CC=C3C(=O)N2N=C(C4=CC=CO4)N=NC5=CC=C(C=C5)C(=O)NN)O,,,,,,
254,3080255,CID 3080255,CC(C)C[C@@H](C(=O)OC)NC(=O)C=CC1=CC=CC=C1,,,,,,
255,3080256,N-cinnamoyl-d-leucine methyl ester,CC(C)C[C@H](C(=O)OC)NC(=O)C=CC1=CC=CC=C1,,,,,,
256,3080257,N-[(2R)-1-hydroxy-4-methylpentan-2-yl]-3-phenylprop-2-enamide,CC(C)C[C@H](CO)NC(=O)C=CC1=CC=CC=C1,,,,,,
257,3080258,CID 3080258,CN(C)CC1=CC=CC=C1SC2=CC=CC=C2.C(=CC(=O)O)C(=O)O,,,,,,
258,3080259,"N,N-dimethyl-N-[2-(phenylsulfanyl)benzyl]amine",CN(C)CC1=CC=CC=C1SC2=CC=CC=C2,,,,,,
259,3080260,CID 3080260,CCN(CC)CC1=CC=CC=C1SC2=CC=CC=C2.C(=CC(=O)O)C(=O)O,,,,,,
260,3080261,CID 3080261,C1CCN(C1)CC2=CC=CC=C2SC3=CC=CC=C3.C(=CC(=O)O)C(=O)O,,,,,,
261,3080262,CID 3080262,C1CCN(CC1)CC2=CC=CC=C2SC3=CC=CC=C3.C(=CC(=O)O)C(=O)O,,,,,,
262,3080263,1-[(2-Phenylsulfanylphenyl)methyl]piperidine,C1CCN(CC1)CC2=CC=CC=C2SC3=CC=CC=C3,,,,,,
263,3080264,CID 3080264,C1COCCN1CC2=CC=CC=C2SC3=CC=CC=C3.C(=CC(=O)O)C(=O)O,,,,,,
264,3080265,CID 3080265,C1=CC=C(C=C1)SC2=CC=CC=C2CCN.C(=CC(=O)O)C(=O)O,,,,,,
265,3080266,N-Methyl-2-(2-(phenylthio)phenyl)ethylamine oxalate,CNCCC1=CC=CC=C1SC2=CC=CC=C2.C(=O)(C(=O)O)O,,,,,,
266,3080267,CID 3080267,CN(C)CCC1=CC=CC=C1SC2=CC=CC=C2.C(=CC(=O)O)C(=O)O,,,,,,
267,3080268,CID 3080268,CC(CN)C1=CC=CC=C1SC2=CC=CC=C2.C(=CC(=O)O)C(=O)O,,,,,,
268,3080269,2-(2-Phenylsulfanylphenyl)propan-1-amine,CC(CN)C1=CC=CC=C1SC2=CC=CC=C2,,,,,,
269,3080270,N-Methyl-1-(2-(phenylthio)phenyl)-2-propylamine oxalate,CC(CC1=CC=CC=C1SC2=CC=CC=C2)NC.C(=O)(C(=O)O)O,,,,,,
270,3080271,N-methyl-1-(2-phenylsulfanylphenyl)propan-2-amine,CC(CC1=CC=CC=C1SC2=CC=CC=C2)NC,,,,,,
271,3080272,CID 3080272,CC(CN(C)C)C1=CC=CC=C1SC2=CC=CC=C2.C(=CC(=O)O)C(=O)O,,,,,,
272,3080273,"N,N-dimethyl-2-(2-phenylsulfanylphenyl)propan-1-amine",CC(CN(C)C)C1=CC=CC=C1SC2=CC=CC=C2,,,,,,
273,3080274,CID 3080274,CC(CC1=CC=CC=C1S(=O)C2=CC=CC=C2)N.C(=CC(=O)O)C(=O)O,,,,,,
274,3080275,1-[2-(Benzenesulfinyl)phenyl]propan-2-amine,CC(CC1=CC=CC=C1S(=O)C2=CC=CC=C2)N,,,,,,
275,3080276,CID 3080276,CC(CC1=CC=CC=C1S(=O)C2=CC=CC=C2)NC.C(=CC(=O)O)C(=O)O,,,,,,
276,3080277,1-[2-(benzenesulfinyl)phenyl]-N-methylpropan-2-amine,CC(CC1=CC=CC=C1S(=O)C2=CC=CC=C2)NC,,,,,,
277,3080278,CID 3080278,CC(CC1=CC=CC=C1S(=O)C2=CC=CC=C2)N(C)C.C(=CC(=O)O)C(=O)O,,,,,,
278,3080279,"1-[2-(benzenesulfinyl)phenyl]-N,N-dimethylpropan-2-amine",CC(CC1=CC=CC=C1S(=O)C2=CC=CC=C2)N(C)C,,,,,,
279,3080280,Ethyl ((4-(2-benzothiazolyl)phenyl)methyl)(2-oxo-3-thiazolidinyl)phosphinate,CCOP(=O)(CC1=CC=C(C=C1)C2=NC3=CC=CC=C3S2)N4CCSC4=O,,,,,,
280,3080281,"Benzenemethanamine, N,N-dimethyl-2-((2-methoxyphenyl)thio)-, hydrochloride",CN(C)CC1=CC=CC=C1SC2=CC=CC=C2OC.Cl,,,,,,
281,3080282,"Benzenemethanamine, N,N-dimethyl-2-((3-methoxyphenyl)thio)-, hydrochloride",CN(C)CC1=CC=CC=C1SC2=CC=CC(=C2)OC.Cl,,,,,,
282,3080283,"Benzenemethanamine, N,N-dimethyl-2-((4-methoxyphenyl)thio)-, hydrochloride",CN(C)CC1=CC=CC=C1SC2=CC=C(C=C2)OC.Cl,,,,,,
283,3080284,CID 3080284,CN(C)CC1=CC=CC=C1SC2=C(C=C(C=C2)OC)OC.C(=CC(=O)O)C(=O)O,,,,,,
284,3080285,"Benzenemethanamine, 2-((2,4-dimethoxyphenyl)thio)-N,N-dimethyl-, hydrobromide",CN(C)CC1=CC=CC=C1SC2=C(C=C(C=C2)OC)OC.Br,,,,,,
285,3080286,CID 3080286,CN(C)CC1=CC=CC=C1SC2=C(C=CC(=C2)OC)OC.C(=CC(=O)O)C(=O)O,,,,,,
286,3080287,"Benzenemethanamine, 2-((3,4-dimethoxyphenyl)thio)-N,N-dimethyl-, hydrochloride",CN(C)CC1=CC=CC=C1SC2=CC(=C(C=C2)OC)OC.Cl,,,,,,
287,3080288,"Benzenemethanamine, 2-((3-methoxyphenyl)thio)-N-methyl-, hydrochloride",CNCC1=CC=CC=C1SC2=CC=CC(=C2)OC.Cl,,,,,,
288,3080289,N-{2-[(3-methoxyphenyl)sulfanyl]benzyl}-N-methylamine,CNCC1=CC=CC=C1SC2=CC=CC(=C2)OC,,,,,,
289,3080290,"Benzenemethanamine, 2-((4-methoxyphenyl)thio)-N-methyl-, hydrochloride",CNCC1=CC=CC=C1SC2=CC=C(C=C2)OC.Cl,,,,,,
290,3080291,CID 3080291,CNCC1=CC=CC=C1SC2=C(C=C(C=C2)OC)OC.C(=CC(=O)O)C(=O)O,,,,,,
291,3080292,"1-[2-(2,4-dimethoxyphenyl)sulfanylphenyl]-N-methylmethanamine",CNCC1=CC=CC=C1SC2=C(C=C(C=C2)OC)OC,,,,,,
292,3080293,CID 3080293,CNCC1=CC=CC=C1SC2=C(C=CC(=C2)OC)OC.C(=CC(=O)O)C(=O)O,,,,,,
293,3080294,"1-[2-(2,5-dimethoxyphenyl)sulfanylphenyl]-N-methylmethanamine",CNCC1=CC=CC=C1SC2=C(C=CC(=C2)OC)OC,,,,,,
294,3080295,CID 3080295,CNCC1=CC=CC=C1SC2=CC(=C(C=C2)OC)OC.C(=CC(=O)O)C(=O)O,,,,,,
295,3080296,"Benzenemethanamine, 2-((2-methoxyphenyl)thio)-, hydrochloride",COC1=CC=CC=C1SC2=CC=CC=C2CN.Cl,,,,,,
296,3080297,[2-(2-Methoxyphenyl)sulfanylphenyl]methanamine,COC1=CC=CC=C1SC2=CC=CC=C2CN,,,,,,
297,3080298,"Benzenemethanamine, 2-((3-methoxyphenyl)thio)-, hydrochloride",COC1=CC(=CC=C1)SC2=CC=CC=C2CN.Cl,,,,,,
298,3080299,"Benzenemethanamine, 2-((4-methoxyphenyl)thio)-, hydrochloride",COC1=CC=C(C=C1)SC2=CC=CC=C2CN.Cl,,,,,,
299,3080300,[2-(4-Methoxyphenyl)sulfanylphenyl]methanamine,COC1=CC=C(C=C1)SC2=CC=CC=C2CN,,,,,,
300,3080301,CID 3080301,COC1=CC(=C(C=C1)SC2=CC=CC=C2CN)OC.C(=CC(=O)O)C(=O)O,,,,,,
301,3080302,"[2-(2,4-Dimethoxyphenyl)sulfanylphenyl]methanamine",COC1=CC(=C(C=C1)SC2=CC=CC=C2CN)OC,,,,,,
302,3080303,CID 3080303,COC1=CC(=C(C=C1)OC)SC2=CC=CC=C2CN.C(=CC(=O)O)C(=O)O,,,,,,
303,3080304,"[2-(2,5-Dimethoxyphenyl)sulfanylphenyl]methanamine",COC1=CC(=C(C=C1)OC)SC2=CC=CC=C2CN,,,,,,
304,3080305,"2-((3,4-Dimethoxyphenyl)thio)benzenemethanamine hydrochloride",COC1=C(C=C(C=C1)SC2=CC=CC=C2CN)OC.Cl,,,,,,
305,3080306,"[2-(3,4-Dimethoxyphenyl)sulfanylphenyl]methanamine",COC1=C(C=C(C=C1)SC2=CC=CC=C2CN)OC,,,,,,
306,3080307,CID 3080307,CN(C)CC1=CC=CC=C1SC2=CC=CC=C2O.C(=CC(=O)O)C(=O)O,,,,,,
307,3080308,CID 3080308,CN(C)CC1=CC=CC=C1SC2=CC=CC(=C2)O.C(=CC(=O)O)C(=O)O,,,,,,
308,3080309,"Phenol, 3-((2-((dimethylamino)methyl)phenyl)thio)-, hydrobromide",CN(C)CC1=CC=CC=C1SC2=CC=CC(=C2)O.Br,,,,,,
309,3080310,"Phenol, 3-((2-((dimethylamino)methyl)phenyl)thio)-, hydrochloride",CN(C)CC1=CC=CC=C1SC2=CC=CC(=C2)O.Cl,,,,,,
310,3080311,CID 3080311,CN(C)CC1=CC=CC=C1SC2=CC=C(C=C2)O.C(=CC(=O)O)C(=O)O,,,,,,
311,3080312,CID 3080312,CN(C)CC1=CC=CC=C1SC2=C(C=C(C=C2)O)O.C(=CC(=O)O)C(=O)O,,,,,,
312,3080313,"But-2-enedioic acid;2-[2-[(dimethylamino)methyl]phenyl]sulfanylbenzene-1,4-diol",CN(C)CC1=CC=CC=C1SC2=C(C=CC(=C2)O)O.C(=CC(=O)O)C(=O)O,,,,,,
313,3080314,"2-[2-[(Dimethylamino)methyl]phenyl]sulfanylbenzene-1,4-diol",CN(C)CC1=CC=CC=C1SC2=C(C=CC(=C2)O)O,,,,,,
314,3080315,CID 3080315,CN(C)CC1=CC=CC=C1SC2=CC(=C(C=C2)O)O.C(=CC(=O)O)C(=O)O,,,,,,
315,3080316,"4-({2-[(Dimethylamino)methyl]phenyl}sulfanyl)-1,2-benzenediol",CN(C)CC1=CC=CC=C1SC2=CC(=C(C=C2)O)O,,,,,,
316,3080317,CID 3080317,CNCC1=CC=CC=C1SC2=CC=CC=C2O.C(=CC(=O)O)C(=O)O,,,,,,
317,3080318,But-2-enedioic acid;3-[2-(methylaminomethyl)phenyl]sulfanylphenol,CNCC1=CC=CC=C1SC2=CC=CC(=C2)O.C(=CC(=O)O)C(=O)O,,,,,,
318,3080319,CID 3080319,CNCC1=CC=CC=C1SC2=CC=C(C=C2)O.C(=CC(=O)O)C(=O)O,,,,,,
319,3080320,"1,3-Benzenediol, 6-((2-((methylamino)methyl)phenyl)thio)-, hydrobromide",CNCC1=CC=CC=C1SC2=C(C=C(C=C2)O)O.Br,,,,,,
320,3080321,"4-[2-(Methylaminomethyl)phenyl]sulfanylbenzene-1,3-diol",CNCC1=CC=CC=C1SC2=C(C=C(C=C2)O)O,,,,,,
321,3080322,CID 3080322,CNCC1=CC=CC=C1SC2=C(C=CC(=C2)O)O.C(=CC(=O)O)C(=O)O,,,,,,
322,3080323,CID 3080323,CNCC1=CC=CC=C1SC2=CC(=C(C=C2)O)O.C(=CC(=O)O)C(=O)O,,,,,,
323,3080324,"Phenol, 2-((2-(aminomethyl)phenyl)thio)-, hydrochloride",C1=CC=C(C(=C1)CN)SC2=CC=CC=C2O.Cl,,,,,,
324,3080325,CID 3080325,C1=CC=C(C(=C1)CN)SC2=CC=CC=C2O.C(=CC(=O)O)C(=O)O,,,,,,
325,3080326,CID 3080326,C1=CC=C(C(=C1)CN)SC2=CC=CC(=C2)O.C(=CC(=O)O)C(=O)O,,,,,,
326,3080327,3-[2-(Aminomethyl)phenyl]sulfanylphenol,C1=CC=C(C(=C1)CN)SC2=CC=CC(=C2)O,,,,,,
327,3080328,CID 3080328,C1=CC=C(C(=C1)CN)SC2=C(C=CC(=C2)O)O.C(=CC(=O)O)C(=O)O,,,,,,
328,3080329,"2-[2-(Aminomethyl)phenyl]sulfanylbenzene-1,4-diol",C1=CC=C(C(=C1)CN)SC2=C(C=CC(=C2)O)O,,,,,,
329,3080330,"1,2-Benzenediol, 4-((2-(aminomethyl)phenyl)thio)-, hydrobromide",C1=CC=C(C(=C1)CN)SC2=CC(=C(C=C2)O)O.Br,,,,,,
330,3080331,"4-[2-(Aminomethyl)phenyl]sulfanylbenzene-1,2-diol",C1=CC=C(C(=C1)CN)SC2=CC(=C(C=C2)O)O,,,,,,
331,3080332,"Phenol, 4-((2-((bis(1-methylethyl)amino)methyl)phenyl)thio)-, hydrochloride",CC(C)N(CC1=CC=CC=C1SC2=CC=C(C=C2)O)C(C)C.Cl,,,,,,
332,3080333,4-[2-[[Di(propan-2-yl)amino]methyl]phenyl]sulfanylphenol,CC(C)N(CC1=CC=CC=C1SC2=CC=C(C=C2)O)C(C)C,,,,,,
333,3080334,"Phenol, 3-((2-((diethylamino)methyl)phenyl)thio)-, hydrochloride",CCN(CC)CC1=CC=CC=C1SC2=CC=CC(=C2)O.Cl,,,,,,
334,3080335,3-[2-(Diethylaminomethyl)phenyl]sulfanylphenol,CCN(CC)CC1=CC=CC=C1SC2=CC=CC(=C2)O,,,,,,
335,3080336,"Phenol, 4-((2-((diethylamino)methyl)phenyl)thio)-, hydrochloride",CCN(CC)CC1=CC=CC=C1SC2=CC=C(C=C2)O.Cl,,,,,,
336,3080337,4-[2-(Diethylaminomethyl)phenyl]sulfanylphenol,CCN(CC)CC1=CC=CC=C1SC2=CC=C(C=C2)O,,,,,,
337,3080338,"Phenol, 2-((2-((dipropylamino)methyl)phenyl)thio)-, hydrochloride",CCCN(CCC)CC1=CC=CC=C1SC2=CC=CC=C2O.Cl,,,,,,
338,3080339,2-[2-[(Dipropylamino)methyl]phenyl]sulfanylphenol,CCCN(CCC)CC1=CC=CC=C1SC2=CC=CC=C2O,,,,,,
339,3080340,"Phenol, 3-((2-((dipropylamino)methyl)phenyl)thio)-, hydrochloride",CCCN(CCC)CC1=CC=CC=C1SC2=CC=CC(=C2)O.Cl,,,,,,
340,3080341,3-[2-[(Dipropylamino)methyl]phenyl]sulfanylphenol,CCCN(CCC)CC1=CC=CC=C1SC2=CC=CC(=C2)O,,,,,,
341,3080342,"Phenol, 2-((2-((bis(1-methylethyl)amino)methyl)phenyl)thio)-, hydrochloride",CC(C)N(CC1=CC=CC=C1SC2=CC=CC=C2O)C(C)C.Cl,,,,,,
342,3080343,2-[2-[[Di(propan-2-yl)amino]methyl]phenyl]sulfanylphenol,CC(C)N(CC1=CC=CC=C1SC2=CC=CC=C2O)C(C)C,,,,,,
343,3080344,"Phenol, 3-((2-(1-(dimethylamino)ethyl)phenyl)thio)-, hydrobromide, (-)-",CC(C1=CC=CC=C1SC2=CC=CC(=C2)O)N(C)C.Br,,,,,,
344,3080345,3-[2-[1-(Dimethylamino)ethyl]phenyl]sulfanylphenol,CC(C1=CC=CC=C1SC2=CC=CC(=C2)O)N(C)C,,,,,,
345,3080346,"Phenol, 3-((2-((dimethylamino)methyl)phenyl)sulfonyl)-",CN(C)CC1=CC=CC=C1S(=O)(=O)C2=CC=CC(=C2)O,,,,,,
346,3080347,"Phenol, 3-((2-((dimethylamino)methyl)phenyl)sulfonyl)-, N-oxide",C[N+](C)(CC1=CC=CC=C1S(=O)(=O)C2=CC=CC(=C2)O)[O-],,,,,,
347,3080348,CID 3080348,[Li+].C(CNCCSP(=O)(O)[O-])C(=O)N,,,,,,
348,3080349,CID 3080349,[Li+].C(CNCCSP(=O)(O)[O-])C(=S)N,,,,,,
349,3080350,2-[(3-Amino-3-sulfanylidenepropyl)amino]ethylsulfanylphosphonic acid,C(CNCCSP(=O)(O)O)C(=S)N,,,,,,
350,3080351,"Propanimidamide, N-methyl-3-((2-(phosphonothio)ethyl)amino)-, hydrate (1:3)",CN=C(CCNCCSP(=O)(O)O)N,,,,,,
351,3080352,CID 3080352,[Li+].C1CN=C(N1)CCNCCSP(=O)(O)[O-],,,,,,
352,3080353,"2-[2-(4,5-dihydro-1H-imidazol-2-yl)ethylamino]ethylsulfanylphosphonic acid",C1CN=C(N1)CCNCCSP(=O)(O)O,,,,,,
353,3080354,CID 3080354,[Li+].CNC(=O)CCNCCSP(=O)(O)[O-],,,,,,
354,3080355,2-[[3-(Methylamino)-3-oxopropyl]amino]ethylsulfanylphosphonic acid,CNC(=O)CCNCCSP(=O)(O)O,,,,,,
355,3080356,CID 3080356,[Li+].CC(C)(C)NC(=O)CCNCCSP(=O)(O)[O-],,,,,,
356,3080357,2-[[3-(Tert-butylamino)-3-oxopropyl]amino]ethylsulfanylphosphonic acid,CC(C)(C)NC(=O)CCNCCSP(=O)(O)O,,,,,,
357,3080358,CID 3080358,[Li+].CNC(=S)CCNCCSP(=O)(O)[O-],,,,,,
358,3080359,2-[[3-(Methylamino)-3-sulfanylidenepropyl]amino]ethylsulfanylphosphonic acid,CNC(=S)CCNCCSP(=O)(O)O,,,,,,
359,3080360,"Propanimidamide, 3-((2-(phosphonothio)ethyl)amino)-, hydrate (2:1)",C(CNCCSP(=O)(O)O)C(=N)N,,,,,,
360,3080361,"Benzenemethanamine, 2-((2-methoxyphenyl)thio)-N-methyl-, hydrochloride",CNCC1=CC=CC=C1SC2=CC=CC=C2OC.Cl,,,,,,
361,3080362,Diisopropoxyphosphorylchloroformaldoxime,CC(C)OP(=O)(C(=NO)Cl)OC(C)C,,,,,,
362,3080363,1-di(propan-2-yloxy)phosphoryl-N-hydroxymethanimidoyl bromide,CC(C)OP(=O)(C(=NO)Br)OC(C)C,,,,,,
363,3080364,Antibiotic R 106IIa,CC(C)CC1C(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)N2CCCC2C(=O)N1)CC3=CC=CC=C3)C)CC4=CC=CC=C4)C(C)C)C)C(C)C)C(C)(C)O)C)CC(C)C)C(C)C)C,,,,,,
364,3080365,"Benzoic acid, 3,5-dinitro-4-((1-ethylpropyl)amino)-2-methyl-",CCC(CC)NC1=C(C=C(C(=C1[N+](=O)[O-])C)C(=O)O)[N+](=O)[O-],,,,,,
365,3080366,"3,5-Dinitro-4-((1-ethyl-3-hydroxypropyl)amino)-2-methylbenzoic acid",CCC(CCO)NC1=C(C=C(C(=C1[N+](=O)[O-])C)C(=O)O)[N+](=O)[O-],,,,,,
366,3080367,"3,5-Dinitro-4-((1-ethyl-2-hydroxypropyl)amino)-2-methylbenzoic acid",CCC(C(C)O)NC1=C(C=C(C(=C1[N+](=O)[O-])C)C(=O)O)[N+](=O)[O-],,,,,,
367,3080368,"4-((1-(Carboxymethyl)propyl)amino)-3,5-dinitro-2-methylbenzoic acid",CCC(CC(=O)O)NC1=C(C=C(C(=C1[N+](=O)[O-])C)C(=O)O)[N+](=O)[O-],,,,,,
368,3080369,"1H-Benzimidazole-5-carboxylic acid, 2,6-dimethyl-1-(1-ethylpropyl)-7-nitro-",CCC(CC)N1C(=NC2=C1C(=C(C(=C2)C(=O)O)C)[N+](=O)[O-])C,,,,,,
369,3080370,1-Amino-5-chlorouracil,C1=C(C(=O)NC(=O)N1N)Cl,,,,,,
370,3080371,"N-[(4-hydroxy-3-methoxyphenyl)methyl]eicosa-5,8,11,14-tetraenamide",CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCC1=CC(=C(C=C1)O)OC,,,,,,
371,3080372,"2,8,9-Trioxa-5-aza-1-silabicyclo(3.3.3)undecane, 1-(4-ethylphenyl)-",CCC1=CC=C(C=C1)[Si]23OCCN(CCO2)CCO3,,,,,,
372,3080373,"2,8,9-Trioxa-5-aza-1-silabicyclo(3.3.3)undecane, 1-(4-(1-propynyl)phenyl)-",CC#CC1=CC=C(C=C1)[Si]23OCCN(CCO2)CCO3,,,,,,
373,3080374,"2,8,9-Trioxa-5-aza-1-silabicyclo(3.3.3)undecane, 1-(4-((trimethylsilyl)ethynyl)phenyl)-",C[Si](C)(C)C#CC1=CC=C(C=C1)[Si]23OCCN(CCO2)CCO3,,,,,,
374,3080375,"L-Prolinamide, N-((hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-histidyl-N-methyl-, (S)-",CN1CCC[C@H]1C(=O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@@H]3CC(=O)N(C(=O)N3)C,,,,,,
375,3080376,"L-Prolinamide, N-((hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-histidyl-N,N-dimethyl-, hydrate (4:5)",CN1CCC[C@H]1C(=O)N(C)C(=O)[C@H](CC2=CN=CN2)NC(=O)C3CC(=O)N(C(=O)N3)C,,,,,,
376,3080377,"4-Pyrimidinecarboxamide, hexahydro-N-(2-(2-aminocarbonyl)-1-piperidinyl)-1-(1H-imidazol-4-ylmethyl-2-oxoethyl)-2,6-dioxo-1-methyl-, (4S-(4R*(R*(R*))))-, hemihydrate",CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCCC[C@H]3C(=O)N,,,,,,
377,3080378,"4-Pyrimidinecarboxamide, hexahydro-N-(2-(4-aminocarbonyl)-3-thiazolidinyl)-1-(1H-imidazol-4-ylmethyl)-2-oxoethyl)-2,6-dioxo-1-methyl-, (4S-(4R*(R*(S*))))-, hydrate (4:3)",CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CSC[C@H]3C(=O)N,,,,,,
378,3080379,"L-Histidine, N-((hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-, methyl ester, (S)-, dihydrate",CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)OC,,,,,,
379,3080380,"L-Prolinamide, N-((hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-norvalyl-, (S)-, hemihydrate",CCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N)NC(=O)[C@@H]2CC(=O)N(C(=O)N2)C,,,,,,
380,3080381,"L-Prolinamide, N-((hexahydro-1-ethyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-histidyl-, (S)-, hydrate",CCN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N,,,,,,
381,3080382,"L-Prolinamide, N-((hexahydro-2,6-dioxo-1-propyl-4-pyrimidinyl)carbonyl)-L-histidyl-, (S)-, hydrate (2:3)",CCCN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N,,,,,,
382,3080383,"L-Prolinamide, N-((hexahydro-1-(1-methylethyl)-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-histidyl-,(S)-, hydrate",CC(C)N1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N,,,,,,
383,3080384,"L-Prolinamide, N-((1-(2-fluoroethyl)hexahydro-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-histidyl-, (S)-, hydrate",C1C[C@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@@H]3CC(=O)N(C(=O)N3)CCF)C(=O)N,,,,,,
384,3080385,"L-Prolinamide, N-((hexahydro-1-butyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-histidyl-, hydrate",CCCCN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N,,,,,,
385,3080386,"L-Prolinamide, N-((hexahydro-2,6-dioxo-1-(phenylmethyl)-4-pyrimidinyl)carbonyl)-L-histidyl-, hydrate",C1C[C@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@@H]3CC(=O)N(C(=O)N3)CC4=CC=CC=C4)C(=O)N,,,,,,
386,3080387,"L-Prolinamide, N-((hexahydro-1-octadecyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-histidyl-, (S)-,monoacetate, hydrate (2:3)",CCCCCCCCCCCCCCCCCCN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N.CC(=O)O,,,,,,
387,3080388,"(4S)-N-[(2S)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-1-octadecyl-2,6-dioxo-1,3-diazinane-4-carboxamide",CCCCCCCCCCCCCCCCCCN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N,,,,,,
388,3080389,"L-Prolinamide, N-((1-(carboxymethyl)hexahydro-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-histidyl-, (S)-, hydrate (2:3)",C1C[C@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@@H]3CC(=O)N(C(=O)N3)CC(=O)O)C(=O)N,,,,,,
389,3080390,"L-Prolinamide, N-((hexahydro-3-methyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-histidyl-, (S)-, hydrate",CN1[C@@H](CC(=O)NC1=O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N,,,,,,
390,3080391,"L-Prolinamide, N-((hexahydro-2,6-dioxo-3-(phenylmethyl)-4-pyrimidinyl)carbonyl)-L-histidyl-, (S)-, hydrate",C1C[C@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@@H]3CC(=O)NC(=O)N3CC4=CC=CC=C4)C(=O)N,,,,,,
391,3080392,"L-Prolinamide, N-((hexahydro-1,3-dimethyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-histidyl-, (S)-, hemihydrate",CN1[C@@H](CC(=O)N(C1=O)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N,,,,,,
392,3080393,"7-(1,3-Oxathiolan-2-ylmethyl)theophylline",CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC3OCCS3,,,,,,
393,3080394,"L-Prolinamide, N-((hexahydro-2,6-dioxo-1-(2-propenyl)-4-pyrimidinyl)carbonyl)-L-histidyl-, (S)-, hydrate",C=CCN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N,,,,,,
394,3080395,"N-((Hexahydro-2,6-dioxo-1-pentyl-4-pyrimidinyl)carbonyl)-L-histidyl-L-prolinamide hydrate",CCCCCN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N,,,,,,
395,3080396,"D-Prolinamide, N-((hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-histidyl-, (S)-",CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@@H]3C(=O)N,,,,,,
396,3080397,"L-Prolinamide, N-((hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-D-histidyl-, (S)-, hydrate (4:3)",CN1C(=O)C[C@H](NC1=O)C(=O)N[C@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N,,,,,,
397,3080398,"L-Prolinamide, N-((hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-histidyl-, (R)-, hydrate",CN1C(=O)C[C@@H](NC1=O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N,,,,,,
398,3080399,"L-Prolinamide, N-((hexahydro-1-ethyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-histidyl-, (R)-, hydrate (2:3)",CCN1C(=O)C[C@@H](NC1=O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N,,,,,,
399,3080400,"1-Piperazinecarboximidamide, N-(3,4-dichlorophenyl)-4-(2-methoxyphenyl)-N'-(2-methylpropyl)-,monohydrochloride",CC(C)CN=C(NC1=CC(=C(C=C1)Cl)Cl)N2CCN(CC2)C3=CC=CC=C3OC.Cl,,,,,,
400,3080401,"N-(3,4-dichlorophenyl)-4-(2-methoxyphenyl)-N'-(2-methylpropyl)piperazine-1-carboximidamide",CC(C)CN=C(NC1=CC(=C(C=C1)Cl)Cl)N2CCN(CC2)C3=CC=CC=C3OC,,,,,,
401,3080402,"1-Piperazinecarboximidamide, N-(3-hydroxypropyl)-4-(2-methoxyphenyl)-N'-phenyl-, dihydrochloride",COC1=CC=CC=C1N2CCN(CC2)C(=NCCCO)NC3=CC=CC=C3.Cl.Cl,,,,,,
402,3080403,N'-(3-hydroxypropyl)-4-(2-methoxyphenyl)-N-phenylpiperazine-1-carboximidamide,COC1=CC=CC=C1N2CCN(CC2)C(=NCCCO)NC3=CC=CC=C3,,,,,,
403,3080404,"2-Pyrrolidinone, 1-(3,4-dihydro-3-hydroxy-2,2-dimethyl-6-(phenylsulfonyl)-2H-1-benzopyran-4-yl)-, trans-",CC1([C@@H]([C@H](C2=C(O1)C=CC(=C2)S(=O)(=O)C3=CC=CC=C3)N4CCCC4=O)O)C,,,,,,
404,3080405,CID 3080405,C1=CC(=C(C(=C1)Cl)C=NNC(=O)CN)Cl.Cl,,,,,,
405,3080406,CID 3080406,C1=CC(=C(C(=C1)Cl)C=NNC(=O)CN)Cl,,,,,,
406,3080407,"N-[(2,6-dichlorophenyl)methylideneamino]-2-methylsulfanylacetamide",CSCC(=O)NN=CC1=C(C=CC=C1Cl)Cl,,,,,,
407,3080408,CID 3080408,COCC(=O)NN=CC1=C(C=CC=C1Cl)Cl,,,,,,
408,3080409,"N-[1-(2,4-dichlorophenyl)ethylideneamino]-2-hydroxy-2-methylpropanamide",CC(=NNC(=O)C(C)(C)O)C1=C(C=C(C=C1)Cl)Cl,,,,,,
409,3080410,CID 3080410,C1=CC(=C(C=C1C=NNC(=O)CN)Cl)Cl.Cl,,,,,,
410,3080411,CID 3080411,C1=CC(=C(C=C1C=NNC(=O)CN)Cl)Cl,,,,,,
411,3080412,CID 3080412,C1=CC(=C(C=C1Cl)Cl)C=NNC(=O)CN.Cl,,,,,,
412,3080413,CID 3080413,C1=CC(=C(C=C1Cl)Cl)C=NNC(=O)CN,,,,,,
413,3080414,CID 3080414,CC(=NNC(=O)CN)C1=C(C=C(C=C1)Cl)Cl.Cl,,,,,,
414,3080415,CID 3080415,CC(=NNC(=O)CN)C1=C(C=C(C=C1)Cl)Cl,,,,,,
415,3080416,CID 3080416,CC(=NNC(=O)C(C)(C)O)C1=C(C=CC(=C1)Cl)Cl,,,,,,
416,3080417,ethyl N-[(2-chloro-6-nitrophenyl)methylideneamino]carbamate,CCOC(=O)NN=CC1=C(C=CC=C1Cl)[N+](=O)[O-],,,,,,
417,3080418,N-[(2-chloro-6-nitrophenyl)methylideneamino]pyridine-4-carboxamide,C1=CC(=C(C(=C1)Cl)C=NNC(=O)C2=CC=NC=C2)[N+](=O)[O-],,,,,,
418,3080419,"N-[1-(2,4-dichlorophenyl)ethylideneamino]acetamide",CC(=NNC(=O)C)C1=C(C=C(C=C1)Cl)Cl,,,,,,
419,3080420,"N-[1-(2,4-dichlorophenyl)ethylideneamino]-2-methylpropanamide",CC(C)C(=O)NN=C(C)C1=C(C=C(C=C1)Cl)Cl,,,,,,
420,3080421,"Benzeneacetic acid, alpha-hydroxy-4-methyl-alpha-(4-methylphenyl)-, 2-(chloroacetyl)hydrazide",CC1=CC=C(C=C1)C(C2=CC=C(C=C2)C)(C(=O)NNC(=O)CCl)O,,,,,,
421,3080422,"Benzeneacetic acid, 4-chloro-alpha-(4-chlorophenyl)-alpha-hydroxy-, 2-(chloroacetyl)hydrazide",C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)(C(=O)NNC(=O)CCl)O)Cl,,,,,,
422,3080423,"Benzeneacetic acid, alpha-hydroxy-3-methyl-alpha-(3-methylphenyl)-, 2-(2-bromo-1-oxopropyl)hydrazide",CC1=CC(=CC=C1)C(C2=CC=CC(=C2)C)(C(=O)NNC(=O)C(C)Br)O,,,,,,
423,3080424,"Benzeneacetic acid, alpha-hydroxy-4-methyl-alpha-(4-methylphenyl)-, 2-(2-bromo-1-oxopropyl)hydrazide",CC1=CC=C(C=C1)C(C2=CC=C(C=C2)C)(C(=O)NNC(=O)C(C)Br)O,,,,,,
424,3080425,"Benzeneacetic acid, 4-fluoro-alpha-(4-fluorophenyl)-alpha-hydroxy-, 2-(2-bromo-1-oxopropyl)hydrazide",CC(C(=O)NNC(=O)C(C1=CC=C(C=C1)F)(C2=CC=C(C=C2)F)O)Br,,,,,,
425,3080426,"Benzeneacetic acid, 4-chloro-alpha-(4-chlorophenyl)-alpha-hydroxy-, 2-(2-bromo-1-oxopropyl)hydrazide",CC(C(=O)NNC(=O)C(C1=CC=C(C=C1)Cl)(C2=CC=C(C=C2)Cl)O)Br,,,,,,
426,3080427,4-Methyl-1-piperazineacetic acid 2-(hydroxydiphenylacetyl)hydrazide,CN1CCN(CC1)CC(=O)NNC(=O)C(C2=CC=CC=C2)(C3=CC=CC=C3)O,,,,,,
427,3080428,"1-Piperazineacetic acid, 4-methyl-, 2-(bis(4-fluorophenyl)hydroxyacetyl)hydrazide",CN1CCN(CC1)CC(=O)NNC(=O)C(C2=CC=C(C=C2)F)(C3=CC=C(C=C3)F)O,,,,,,
428,3080429,"1-Piperazineacetic acid, 4-methyl-, 2-(bis(4-chlorophenyl)hydroxyacetyl)hydrazide",CN1CCN(CC1)CC(=O)NNC(=O)C(C2=CC=C(C=C2)Cl)(C3=CC=C(C=C3)Cl)O,,,,,,
429,3080430,alpha-Hydroxy-alpha-phenylbenzeneacetic acid 2-(2-(diethylamino)-1-oxopropyl)hydrazide,CCN(CC)C(C)C(=O)NNC(=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)O,,,,,,
430,3080431,"Benzeneacetic acid, alpha-hydroxy-3-methyl-alpha-(3-methylphenyl)-, 2-(2-(diethylamino)-1-oxopropyl)hydrazide",CCN(CC)C(C)C(=O)NNC(=O)C(C1=CC=CC(=C1)C)(C2=CC=CC(=C2)C)O,,,,,,
431,3080432,"Benzeneacetic acid, alpha-hydroxy-4-methyl-alpha-(4-methylphenyl)-, 2-(2-(diethylamino)-1-oxopropyl)hydrazide",CCN(CC)C(C)C(=O)NNC(=O)C(C1=CC=C(C=C1)C)(C2=CC=C(C=C2)C)O,,,,,,
432,3080433,"Benzeneacetic acid, 4-fluoro-alpha-(4-fluorophenyl)-alpha-hydroxy-, 2-(2-(diethylamino-1-oxopropyl)hydrazide",CCN(CC)C(C)C(=O)NNC(=O)C(C1=CC=C(C=C1)F)(C2=CC=C(C=C2)F)O,,,,,,
433,3080434,"Acetamide, N-(4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl)-, monohydrochloride",CCCC1=NC(=NC(=N1)N2CCOCC2)NC(=O)C.Cl,,,,,,
434,3080435,"1,3-Propanediamine, N,N-dimethyl-N'-(5-(2,4,6-trimethylphenyl)-1,3,4-thiadiazol-2-yl)-, dihydrochloride",CC1=CC(=C(C(=C1)C)C2=NN=C(S2)NCCCN(C)C)C.Cl.Cl,,,,,,
435,3080436,"N',N'-dimethyl-N-[5-(2,4,6-trimethylphenyl)-1,3,4-thiadiazol-2-yl]propane-1,3-diamine",CC1=CC(=C(C(=C1)C)C2=NN=C(S2)NCCCN(C)C)C,,,,,,
436,3080437,"(1)Benzothieno(2,3-d)pyrimidine-2(3H)-thione, 5,6,7,8-tetrahydro-3,4-diphenyl-",C1CCC2=C(C1)C3=C(N(C(=S)N=C3S2)C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
437,3080438,"(1)Benzothieno(2,3-d)pyrimidine-2(3H)-thione, 5,6,7,8-tetrahydro-4-phenyl-3-(phenylmethyl)-",C1CCC2=C(C1)C3=C(N(C(=S)N=C3S2)CC4=CC=CC=C4)C5=CC=CC=C5,,,,,,
438,3080439,"(1)Benzothieno(2,3-d)pyrimidine-2(3H)-thione, 5,6,7,8-tetrahydro-4-phenyl-3-(2-phenylethyl)-",C1CCC2=C(C1)C3=C(N(C(=S)N=C3S2)CCC4=CC=CC=C4)C5=CC=CC=C5,,,,,,
439,3080440,"(1)Benzothieno(2,3-d)pyrimidine-2(3H)-thione, 5,6,7,8-tetrahydro-3-(2-(4-morpholinyl)ethyl)-4-phenyl-",C1CCC2=C(C1)C3=C(N(C(=S)N=C3S2)CCN4CCOCC4)C5=CC=CC=C5,,,,,,
440,3080441,"(1)Benzothieno(2,3-d)pyrimidine-2(3H)-thione, 5,6,7,8-tetrahydro-3-(3-(4-morpholinyl)propyl)-4-phenyl-",C1CCC2=C(C1)C3=C(N(C(=S)N=C3S2)CCCN4CCOCC4)C5=CC=CC=C5,,,,,,
441,3080442,"3-Amino-4-phenyl-3,4,5,6,7,8-hexahydro-(1)benzothieno(2,3-d)pyrimidine-2(1H)-thione",C1CCC2=C(C1)C3=C(S2)NC(=S)N(C3C4=CC=CC=C4)N,,,,,,
442,3080443,"3,4-Diphenyl-3,4,5,6,7,8-hexahydro-(1)benzothieno(2,3-d)pyrimidine-2(1H)-thione",C1CCC2=C(C1)C3=C(S2)NC(=S)N(C3C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
443,3080444,"3,4,5,6,7,8-Hexahydro-4-phenyl-3-(phenylmethyl)-(1)benzothieno(2,3-d)pyrimidine-2(1H)-thione",C1CCC2=C(C1)C3=C(S2)NC(=S)N(C3C4=CC=CC=C4)CC5=CC=CC=C5,,,,,,
444,3080445,"(1)Benzothieno(2,3-d)pyrimidine-2(1H)-thione, 3,4,5,6,7,8-hexahydro-4-phenyl-3-(2-phenylethyl)-",C1CCC2=C(C1)C3=C(S2)NC(=S)N(C3C4=CC=CC=C4)CCC5=CC=CC=C5,,,,,,
445,3080446,"(1)Benzothieno(2,3-d)pyrimidine-2(1H)-thione, 3,4,5,6,7,8-hexahydro-3-(2-(4-morpholinyl)ethyl)-4-phenyl-",C1CCC2=C(C1)C3=C(S2)NC(=S)N(C3C4=CC=CC=C4)CCN5CCOCC5,,,,,,
446,3080447,"(1)Benzothieno(2,3-d)pyrimidine-2(1H)-thione, 3,4,5,6,7,8-hexahydro-3-(3-(4-morpholinyl)propyl)-4-phenyl-",C1CCC2=C(C1)C3=C(S2)NC(=S)N(C3C4=CC=CC=C4)CCCN5CCOCC5,,,,,,
447,3080448,"(1)Benzothieno(2,3-d)pyrimidine-2(1H)-thione, 3,4,5,6,7,8-hexahydro-4-phenyl-3-(2-(1-pyrrolidinyl)ethyl)-",C1CCC2=C(C1)C3=C(S2)NC(=S)N(C3C4=CC=CC=C4)CCN5CCCC5,,,,,,
448,3080449,alpha-((Aminocarbonyl)amino)-3-methyl-1H-indole-1-acetic acid,CC1=CN(C2=CC=CC=C12)C(C(=O)O)NC(=O)N,,,,,,
449,3080450,"4-Imidazolidinone, 5-((dimethylamino)methylene)-2-thioxo-",CN(C)/C=C\1/C(=O)NC(=S)N1,,,,,,
450,3080451,5-(1-(Dimethylamino)ethylidene)-2-thioxo-4-imidazolidinone,C/C(=C\1/C(=O)NC(=S)N1)/N(C)C,,,,,,
451,3080452,"5H-Pyrrolo(1,2-a)imidazole-2-thiol, 6,7-dihydro-",C1CC2=NC(=CN2C1)S,,,,,,
452,3080453,"5H-Pyrrolo(1,2-a)imidazole, 6,7-dihydro-2-(methylthio)-",CSC1=CN2CCCC2=N1,,,,,,
453,3080454,"6,7-Dihydro-2-(methylsulfinyl)-5H-pyrrolo(1,2-a)imidazole",CS(=O)C1=CN2CCCC2=N1,,,,,,
454,3080455,"5H-Pyrrolo(1,2-a)imidazole, 6,7-dihydro-2-(methylsulfonyl)-",CS(=O)(=O)C1=CN2CCCC2=N1,,,,,,
455,3080456,"(1)Benzothieno(2,3-d)pyrimidine-2(3H)-thione, 5,6,7,8-tetrahydro-4-phenyl-3-(2-pyrrolidinyl)ethyl)-",C1CCC2=C(C1)C3=C(N(C(=S)N=C3S2)CCN4CCCC4)C5=CC=CC=C5,,,,,,
456,3080457,CID 3080457,CON=C(C1=CSC(=N1)N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CSC=C4)C(=O)O.OS(=O)(=O)[O-],,,,,,
457,3080458,CID 3080458,CON=C(C1=CSC(=N1)N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CSC=C4)C(=O)O,,,,,,
458,3080459,CID 3080459,C1=CC=C(C=C1)NC(=C2C(=O)C3=CC=CC=C3C2=O)C4=CC=CS4,,,,,,
459,3080460,CID 3080460,COC1=CC=C(C=C1)NC(=C2C(=O)C3=CC=CC=C3C2=O)C4=CC=CS4,,,,,,
460,3080461,CID 3080461,COC1=CC=CC(=C1)NC(=C2C(=O)C3=CC=CC=C3C2=O)C4=CC=CS4,,,,,,
461,3080462,CID 3080462,COC1=CC=CC=C1NC(=C2C(=O)C3=CC=CC=C3C2=O)C4=CC=CS4,,,,,,
462,3080463,"7H-Indeno(2,1-c)quinolin-7-one, 6-(2-thienyl)-",C1=CC=C2C(=C1)C3=C(C2=O)C(=NC4=CC=CC=C43)C5=CC=CS5,,,,,,
463,3080464,"7H-Indeno(2,1-c)quinolin-7-one, 2-methoxy-6-(2-thienyl)-",COC1=CC2=C(C=C1)N=C(C3=C2C4=CC=CC=C4C3=O)C5=CC=CS5,,,,,,
464,3080465,"7H-Indeno(2,1-c)quinolin-7-one, 3-methoxy-6-(2-thienyl)-",COC1=CC2=C(C=C1)C3=C(C(=N2)C4=CC=CS4)C(=O)C5=CC=CC=C53,,,,,,
465,3080466,"7H-Indeno(2,1-c)quinolin-7-one, 4-methoxy-6-(2-thienyl)-",COC1=CC=CC2=C3C4=CC=CC=C4C(=O)C3=C(N=C21)C5=CC=CS5,,,,,,
466,3080467,"7H-Indeno(2,1-c)quinoline, 6-(2-thienyl)-",C1C2=CC=CC=C2C3=C1C(=NC4=CC=CC=C43)C5=CC=CS5,,,,,,
467,3080468,"7H-Indeno(2,1-c)quinoline, 2-methoxy-6-(2-thienyl)-",COC1=CC2=C(C=C1)N=C(C3=C2C4=CC=CC=C4C3)C5=CC=CS5,,,,,,
468,3080469,"7H-Indeno(2,1-c)quinoline, 3-methoxy-6-(2-thienyl)-",COC1=CC2=C(C=C1)C3=C(CC4=CC=CC=C43)C(=N2)C5=CC=CS5,,,,,,
469,3080470,"7H-Indeno(2,1-c)quinoline, 4-methoxy-6-(2-thienyl)-",COC1=CC=CC2=C3C(=C(N=C21)C4=CC=CS4)CC5=CC=CC=C53,,,,,,
470,3080471,"Acetamide, N-(4-chloro-2-(2-chlorobenzoyl)phenyl)-2-((4,5-dihydro-1H-imidazol-2-yl)thio)-N-methyl-, monohydrochloride",CN(C1=C(C=C(C=C1)Cl)C(=O)C2=CC=CC=C2Cl)C(=O)CSC3=NCCN3.Cl,,,,,,
471,3080472,"N-[4-chloro-2-(2-chlorobenzoyl)phenyl]-2-(4,5-dihydro-1H-imidazol-2-ylsulfanyl)-N-methylacetamide",CN(C1=C(C=C(C=C1)Cl)C(=O)C2=CC=CC=C2Cl)C(=O)CSC3=NCCN3,,,,,,
472,3080473,"Acetamide, N-(2-benzoyl-4-chlorophenyl)-2-((4,5-dihydro-1H-imidazol-2-yl)thio)-N-methyl-, monohydrochloride",CN(C1=C(C=C(C=C1)Cl)C(=O)C2=CC=CC=C2)C(=O)CSC3=NCCN3.Cl,,,,,,
473,3080474,"N-(2-benzoyl-4-chlorophenyl)-2-(4,5-dihydro-1H-imidazol-2-ylsulfanyl)-N-methylacetamide",CN(C1=C(C=C(C=C1)Cl)C(=O)C2=CC=CC=C2)C(=O)CSC3=NCCN3,,,,,,
474,3080475,"Acetamide, N-(4-chloro-2-(2-chlorobenzoyl)phenyl)-2-((4,5-dihydro-1H-imidazol-2-yl)thio)-, monohydrochloride",C1CN=C(N1)SCC(=O)NC2=C(C=C(C=C2)Cl)C(=O)C3=CC=CC=C3Cl.Cl,,,,,,
475,3080476,"N-[4-chloro-2-(2-chlorobenzoyl)phenyl]-2-(4,5-dihydro-1H-imidazol-2-ylsulfanyl)acetamide",C1CN=C(N1)SCC(=O)NC2=C(C=C(C=C2)Cl)C(=O)C3=CC=CC=C3Cl,,,,,,
476,3080477,"Acetamide, N-(4-chloro-2-(2-chlorobenzoyl)phenyl)-N-methyl-2-((1-methyl-1H-imidazol-2-yl)thio)-, monohydrochloride",CN1C=CN=C1SCC(=O)N(C)C2=C(C=C(C=C2)Cl)C(=O)C3=CC=CC=C3Cl.Cl,,,,,,
477,3080478,N-[4-chloro-2-(2-chlorobenzoyl)phenyl]-N-methyl-2-(1-methylimidazol-2-yl)sulfanylacetamide,CN1C=CN=C1SCC(=O)N(C)C2=C(C=C(C=C2)Cl)C(=O)C3=CC=CC=C3Cl,,,,,,
478,3080479,"Acetamide, N-(2-benzoyl-4-chlorophenyl)-2-(1H-imidazol-2-ylthio)-, monohydrochloride",C1=CC=C(C=C1)C(=O)C2=C(C=CC(=C2)Cl)NC(=O)CSC3=NC=CN3.Cl,,,,,,
479,3080480,N-(2-benzoyl-4-chlorophenyl)-2-(1H-imidazol-2-ylsulfanyl)acetamide,C1=CC=C(C=C1)C(=O)C2=C(C=CC(=C2)Cl)NC(=O)CSC3=NC=CN3,,,,,,
480,3080481,"Acetamide, N-(4-chloro-2-(2-chlorobenzoyl)phenyl)-2-(1H-imidazol-2-ylthio)-, monohydrochloride",C1=CC=C(C(=C1)C(=O)C2=C(C=CC(=C2)Cl)NC(=O)CSC3=NC=CN3)Cl.Cl,,,,,,
481,3080482,N-[4-chloro-2-(2-chlorobenzoyl)phenyl]-2-(1H-imidazol-2-ylsulfanyl)acetamide,C1=CC=C(C(=C1)C(=O)C2=C(C=CC(=C2)Cl)NC(=O)CSC3=NC=CN3)Cl,,,,,,
482,3080483,"Acetamide, N-(4-chloro-2-(2-chlorobenzoyl)phenyl)-2-(1H-imidazol-2-ylthio)-N-methyl-, monohydrochloride",CN(C1=C(C=C(C=C1)Cl)C(=O)C2=CC=CC=C2Cl)C(=O)CSC3=NC=CN3.Cl,,,,,,
483,3080484,N-[4-chloro-2-(2-chlorobenzoyl)phenyl]-2-(1H-imidazol-2-ylsulfanyl)-N-methylacetamide,CN(C1=C(C=C(C=C1)Cl)C(=O)C2=CC=CC=C2Cl)C(=O)CSC3=NC=CN3,,,,,,
484,3080485,"Methanone, (5-chloro-2-((2-(1H-imidazol-2-ylthio)ethyl)amino)phenyl)phenyl-",C1=CC=C(C=C1)C(=O)C2=C(C=CC(=C2)Cl)NCCSC3=NC=CN3,,,,,,
485,3080486,"Methanone, (5-chloro-2-((2-((4,5-dihydro-1H-imidazol-2-yl)thio)ethyl)amino)phenyl)phenyl-",C1CN=C(N1)SCCNC2=C(C=C(C=C2)Cl)C(=O)C3=CC=CC=C3,,,,,,
486,3080487,"Acetamide, N-(4-chloro-2-((2-chlorophenyl)hydroxymethyl)phenyl)-2-((4,5-dihydro-1H-imidazol-2-yl)thio)-N-methyl-",CN(C1=C(C=C(C=C1)Cl)C(C2=CC=CC=C2Cl)O)C(=O)CSC3=NCCN3,,,,,,
487,3080488,"Acetamide, N-(4-chloro-2-(phenylmethyl)phenyl)-2-((4,5-dihydro-1H-imidazol-2-yl)thio)-N-methyl-, monohydrochloride",CN(C1=C(C=C(C=C1)Cl)CC2=CC=CC=C2)C(=O)CSC3=NCCN3.Cl,,,,,,
488,3080489,"N-(2-benzyl-4-chlorophenyl)-2-(4,5-dihydro-1H-imidazol-2-ylsulfanyl)-N-methylacetamide",CN(C1=C(C=C(C=C1)Cl)CC2=CC=CC=C2)C(=O)CSC3=NCCN3,,,,,,
489,3080490,"Propanamide, N-(4-chloro-2-(2-chlorobenzoyl)phenyl)-2-((4,5-dihydro-1H-imidazol-2-yl)thio)-N-methyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)",CC(C(=O)N(C)C1=C(C=C(C=C1)Cl)C(=O)C2=CC=CC=C2Cl)SC3=NCCN3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,,,,,,
490,3080491,"N-[4-chloro-2-(2-chlorobenzoyl)phenyl]-2-(4,5-dihydro-1H-imidazol-2-ylsulfanyl)-N-methylpropanamide",CC(C(=O)N(C)C1=C(C=C(C=C1)Cl)C(=O)C2=CC=CC=C2Cl)SC3=NCCN3,,,,,,
491,3080492,"Acetamide, N-(2-benzoylphenyl)-2-(1H-imidazol-2-ylthio)-N-methyl-",CN(C1=CC=CC=C1C(=O)C2=CC=CC=C2)C(=O)CSC3=NC=CN3,,,,,,
492,3080493,"Acetamide, N-(2-benzoyl-4-chlorophenyl)-2-(1H-imidazol-2-ylthio)-N-methyl-, monohydrochloride",CN(C1=C(C=C(C=C1)Cl)C(=O)C2=CC=CC=C2)C(=O)CSC3=NC=CN3.Cl,,,,,,
493,3080494,N-(2-benzoyl-4-chlorophenyl)-2-(1H-imidazol-2-ylsulfanyl)-N-methylacetamide,CN(C1=C(C=C(C=C1)Cl)C(=O)C2=CC=CC=C2)C(=O)CSC3=NC=CN3,,,,,,
494,3080495,N-Methyl-2'-orthochlorobenzoyl-4'-chloro-2-isothioureidoacetanilide hydrochloride,CN(C1=C(C=C(C=C1)Cl)C(=O)C2=CC=CC=C2Cl)C(=O)CSC(=N)N.Cl,,,,,,
495,3080496,[2-[4-chloro-2-(2-chlorobenzoyl)-N-methylanilino]-2-oxoethyl] carbamimidothioate,CN(C1=C(C=C(C=C1)Cl)C(=O)C2=CC=CC=C2Cl)C(=O)CSC(=N)N,,,,,,
496,3080497,"Acetamide, N-(4-chloro-2-(2-chlorobenzoyl)phenyl)-N-methyl-2-(2-pyrimidinylthio)-",CN(C1=C(C=C(C=C1)Cl)C(=O)C2=CC=CC=C2Cl)C(=O)CSC3=NC=CC=N3,,,,,,
497,3080498,"Acetamide, N-(4-chloro-2-(2-chlorobenzoyl)phenyl)-2-((1-ethyl-1H-imidazol-2-yl)thio)-N-methyl-, monohydrochloride",CCN1C=CN=C1SCC(=O)N(C)C2=C(C=C(C=C2)Cl)C(=O)C3=CC=CC=C3Cl.Cl,,,,,,
498,3080499,N-[4-chloro-2-(2-chlorobenzoyl)phenyl]-2-(1-ethylimidazol-2-yl)sulfanyl-N-methylacetamide,CCN1C=CN=C1SCC(=O)N(C)C2=C(C=C(C=C2)Cl)C(=O)C3=CC=CC=C3Cl,,,,,,
499,3080500,"Propanamide, N-(4-chloro-2-(2-chlorobenzoyl)phenyl)-3-(1H-imidazol-2-ylthio)-N-methyl-",CN(C1=C(C=C(C=C1)Cl)C(=O)C2=CC=CC=C2Cl)C(=O)CCSC3=NC=CN3,,,,,,
500,3080501,"Acetamide, N-(2-benzoyl-4-nitrophenyl)-2-(1H-imidazol-2-ylthio)-N-methyl-, monohydrochloride",CN(C1=C(C=C(C=C1)[N+](=O)[O-])C(=O)C2=CC=CC=C2)C(=O)CSC3=NC=CN3.Cl,,,,,,
501,3080502,N-(2-benzoyl-4-nitrophenyl)-2-(1H-imidazol-2-ylsulfanyl)-N-methylacetamide,CN(C1=C(C=C(C=C1)[N+](=O)[O-])C(=O)C2=CC=CC=C2)C(=O)CSC3=NC=CN3,,,,,,
502,3080503,"Acetamide, N-(4-chloro-2-(2-fluorobenzoyl)phenyl)-2-(1H-imidazol-2-ylthio)-N-methyl-, monohydrochloride",CN(C1=C(C=C(C=C1)Cl)C(=O)C2=CC=CC=C2F)C(=O)CSC3=NC=CN3.Cl,,,,,,
503,3080504,N-[4-chloro-2-(2-fluorobenzoyl)phenyl]-2-(1H-imidazol-2-ylsulfanyl)-N-methylacetamide,CN(C1=C(C=C(C=C1)Cl)C(=O)C2=CC=CC=C2F)C(=O)CSC3=NC=CN3,,,,,,
504,3080505,"Acetamide, N-(2-benzoyl-4-methoxyphenyl)-2-(1H-imidazol-2-ylthio)-N-methyl-, monohydrobromide",CN(C1=C(C=C(C=C1)OC)C(=O)C2=CC=CC=C2)C(=O)CSC3=NC=CN3.Br,,,,,,
505,3080506,N-(2-benzoyl-4-methoxyphenyl)-2-(1H-imidazol-2-ylsulfanyl)-N-methylacetamide,CN(C1=C(C=C(C=C1)OC)C(=O)C2=CC=CC=C2)C(=O)CSC3=NC=CN3,,,,,,
506,3080507,3-((2-((Dimethylamino)methyl)phenyl)sulfinyl)phenol,CN(C)CC1=CC=CC=C1S(=O)C2=CC=CC(=C2)O,,,,,,
507,3080508,"Acetamide, N-(4-chloro-2-(2-chlorobenzoyl)phenyl)-2-((4,5-dihydro-1-methyl-1H-imidazol-2-yl)thio)-N-methyl-, monohydrochloride",CN1CCN=C1SCC(=O)N(C)C2=C(C=C(C=C2)Cl)C(=O)C3=CC=CC=C3Cl.Cl,,,,,,
508,3080509,"N-[4-chloro-2-(2-chlorobenzoyl)phenyl]-N-methyl-2-[(1-methyl-4,5-dihydroimidazol-2-yl)sulfanyl]acetamide",CN1CCN=C1SCC(=O)N(C)C2=C(C=C(C=C2)Cl)C(=O)C3=CC=CC=C3Cl,,,,,,
509,3080510,"1-Propanaminium, 3-carboxy-N-((ethylmethylphenylsilyl)methyl)-N,N-dimethyl-, bromide",CC[Si](C)(C[N+](C)(C)CCCC(=O)O)C1=CC=CC=C1.[Br-],,,,,,
510,3080511,3-Carboxypropyl-[(ethyl-methyl-phenylsilyl)methyl]-dimethylazanium,CC[Si](C)(C[N+](C)(C)CCCC(=O)O)C1=CC=CC=C1,,,,,,
511,3080512,"Thiosulfuric acid, S-(2-(((3-hydroxytricyclo(3.3.1.1(sup 3,7))dec-1-yl)methyl)amino)-2-iminoethyl) ester",C1C2CC3(CC1CC(C2)(C3)O)CN=C(CSS(=O)(=O)O)N,,,,,,
512,3080513,"Thiosulfuric acid, S-(2-((2-(3-hydroxytricyclo(3.3.1.1(sup 3,7))dec-1-yl)ethyl)amino)-2-iminoethyl ester",C1C2CC3(CC1CC(C2)(C3)O)CCN=C(CSS(=O)(=O)O)N,,,,,,
513,3080514,"Thiosulfuric acid, S-(2-((3-(3-hydroxytricyclo(3.3.1.1(sup 3,7))dec-1-yl)propyl)amino)-2-iminoethyl) ester, dihydrate",C1C2CC3(CC1CC(C2)(C3)O)CCCN=C(CSS(=O)(=O)O)N,,,,,,
514,3080515,"Thiosulfuric acid, S-(2-((1-(3-hydroxytricyclo(3.3.1.1(sup 3,7))dec-1-yl)ethyl)amino)-2-iminoethyl) ester, dihydrate",CC(C12CC3CC(C1)CC(C3)(C2)O)N=C(CSS(=O)(=O)O)N,,,,,,
515,3080516,"Thiosulfuric acid, S-(2-((5-hydroxytricyclo(3.3.1.1(sup 3,7))dec-2-yl)amino)-2-iminoethyl ester, hydrate (2:1)",C1C2CC3CC(C2)(CC1C3N=C(CSS(=O)(=O)O)N)O,,,,,,
516,3080517,"Thiosulfuric acid, S-(2-imino-2-((1-tricyclo(3.3.1.1(sup 3,7))dec-1-ylethyl)amino)ethyl ester,hemihydrate",CC(C12CC3CC(C1)CC(C3)C2)N=C(CSS(=O)(=O)O)N,,,,,,
517,3080518,"Acetamide, N-(2-(phenylamino)phenyl)-2-(4-pyridinylamino)-, hydrochloride",C1=CC=C(C=C1)NC2=CC=CC=C2NC(=O)CNC3=CC=NC=C3.Cl,,,,,,
518,3080519,N-(2-anilinophenyl)-2-(pyridin-4-ylamino)acetamide,C1=CC=C(C=C1)NC2=CC=CC=C2NC(=O)CNC3=CC=NC=C3,,,,,,
519,3080520,"3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-(5,5-dimethyl-1,3,2-dioxaphosphorinan-2-yl)-4-(3-nitrophenyl)-, 2-(phenylamino)ethyl ester, P-oxide",CC1=C(C(C(=C(N1)C)P2(=O)OCC(CO2)(C)C)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCNC4=CC=CC=C4,,,,,,
520,3080521,CID 3080521,C1=CC(=C(C=C1C(CNC=O)O)C2=C(C=CC(=C2)C(C(C(=O)[O-])NC=O)O)O)O.[Na+],,,,,,
521,3080522,"N,N-Dimethyl-N'-(2-nitrobenzo(b)thien-3-yl)-1,2-ethanediamine",CN(C)CCNC1=C(SC2=CC=CC=C21)[N+](=O)[O-],,,,,,
522,3080523,"N,N-Dimethyl-N'-(2-nitrobenzo(b)thien-3-yl)-1,3-propanediamine",CN(C)CCCNC1=C(SC2=CC=CC=C21)[N+](=O)[O-],,,,,,
523,3080524,"1,2-Ethanediamine, N,N-diethyl-N'-(2-nitrobenzo(b)thien-3-yl)-",CCN(CC)CCNC1=C(SC2=CC=CC=C21)[N+](=O)[O-],,,,,,
524,3080525,"N,N-Diethyl-N'-(2-nitrobenzo(b)thien-3-yl)-1,3-propanediamine",CCN(CC)CCCNC1=C(SC2=CC=CC=C21)[N+](=O)[O-],,,,,,
525,3080526,"Benzo(b)thiophen-3-amine, 2-nitro-N-(2-(1-pyrrolidinyl)ethyl)-",C1CCN(C1)CCNC2=C(SC3=CC=CC=C32)[N+](=O)[O-],,,,,,
526,3080527,"2-Pyrrolidinone, 1-(3-((2-nitrobenzo(b)thien-3-yl)amino)propyl)-",C1CC(=O)N(C1)CCCNC2=C(SC3=CC=CC=C32)[N+](=O)[O-],,,,,,
527,3080528,"1-Piperidineethanamine, N-(2-nitrobenzo(b)thien-3-yl)-",C1CCN(CC1)CCNC2=C(SC3=CC=CC=C32)[N+](=O)[O-],,,,,,
528,3080529,2-Methyl-N-(2-nitrobenzo(b)thien-3-yl)-1-piperidinepropanamine,CC1CCCCN1CCCNC2=C(SC3=CC=CC=C32)[N+](=O)[O-],,,,,,
529,3080530,"4-Morpholineethanamine, N-(2-nitrobenzo(b)thien-3-yl)-",C1COCCN1CCNC2=C(SC3=CC=CC=C32)[N+](=O)[O-],,,,,,
530,3080531,"4-Morpholinepropanamine, N-(2-nitrobenzo(b)thien-3-yl)-",C1COCCN1CCCNC2=C(SC3=CC=CC=C32)[N+](=O)[O-],,,,,,
531,3080532,"1,4-Benzenediamine, N,N-dimethyl-N'-(2-nitrobenzo(b)thien-3-yl)-",CN(C)C1=CC=C(C=C1)NC2=C(SC3=CC=CC=C32)[N+](=O)[O-],,,,,,
532,3080533,"1,4-Benzenediamine, N,N-diethyl-N'-(2-nitrobenzo(b)thien-3-yl)-",CCN(CC)C1=CC=C(C=C1)NC2=C(SC3=CC=CC=C32)[N+](=O)[O-],,,,,,
533,3080534,CID 3080534,C1=C(C(=C(C(=C1Br)C(=O)N)Br)CCC(=O)[O-])Br.[Na+],,,,,,
534,3080535,"3-(3-Carbamoyl-2,4,6-tribromophenyl)propionic acid",C1=C(C(=C(C(=C1Br)C(=O)N)Br)CCC(=O)O)Br,,,,,,
535,3080536,CID 3080536,CCCCC1C(C(CCC(CCCC(CCCC(C(=CC(C(CC(CC(CC(CC(CCCCC(=CC(C(C(C(OC1=O)CCCN=C(N)N)C)O)C)C)O)O)O)O)O)OC2C(C(C(O2)CO)O)O)C)O)O)O)C)O.CC(=O)O,,,,,,
536,3080537,CID 3080537,CCCCC1C(C(CCC(CCCC(CCCC(C(=CC(C(CC(CC(CC(CC(CCCCC(=CC(C(C(C(OC1=O)CCCN=C(N)N)C)O)C)C)O)O)O)O)O)OC2C(C(C(O2)CO)O)O)C)O)O)O)C)O,,,,,,
537,3080538,CID 3080538,CC(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)CSC4=CC=[N+](C=C4)C)C(=O)[O-],,,,,,
538,3080539,CID 3080539,CC(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)CSC4=CC=[N+](C=C4)C)C(=O)O,,,,,,
539,3080540,"alpha-(2-Hydroxyethyl)-2-methyl-N-(2-phenylethyl)-1,3-dioxolane-2-acetamide",CC1(OCCO1)C(CCO)C(=O)NCCC2=CC=CC=C2,,,,,,
540,3080541,"alpha-(2-Hydroxyethyl)-N-((4-methoxyphenyl)methyl)-2-methyl-1,3-dioxolane-2-acetamide",CC1(OCCO1)C(CCO)C(=O)NCC2=CC=C(C=C2)OC,,,,,,
541,3080542,"3(2H)-Pyridazinone, 2-(4-chlorophenyl)-5-((4-chlorophenyl)methoxy)-4-iodo-",C1=CC(=CC=C1COC2=C(C(=O)N(N=C2)C3=CC=C(C=C3)Cl)I)Cl,,,,,,
542,3080543,"3(2H)-Pyridazinone, 5-((4-chlorophenyl)methoxy)-2-(3,4-dichlorophenyl)-4-iodo-",C1=CC(=CC=C1COC2=C(C(=O)N(N=C2)C3=CC(=C(C=C3)Cl)Cl)I)Cl,,,,,,
543,3080544,CID 3080544,C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)N(CC2=CN=C3C(=N2)C(=O)N=C(N3)N)C=O,,,,,,
544,3080545,"2,3-dihydroxypropyl dihydrogen phosphate;(R)-[(2S,4R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol",COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@H]3C[C@H]4CCN3C[C@@H]4C=C)O.COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@H]3C[C@H]4CCN3C[C@@H]4C=C)O.C(C(COP(=O)(O)O)O)O,,,,,,
545,3080546,5alpha-Dihydrocorticosterone,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@H]4C(=O)CO)C)O,,,,,,
546,3080547,"L-Histidine, N-beta-alanyl-1-methyl-",CN1C=C(N=C1)C[C@@H](C(=O)OC(=O)CCN)N,,,,,,
547,3080548,"2,2,3,3-Tetrafluorobutane-1,4-diamine",C(C(C(CN)(F)F)(F)F)N,,,,,,
548,3080549,2-Amino-3-[methylthio]butyric acid,CC(C(C(=O)O)N)SC,,,,,,
549,3080550,"Olean-12-ene-3,16,28-triol",C[C@]12CC[C@@H](C(C1CC[C@@]3([C@@H]2CC=C4[C@]3(C[C@H]([C@@]5([C@@H]4CC(CC5)(C)C)CO)O)C)C)(C)C)O,,,,,,
550,3080551,Drimenol,CC1=CC[C@@H]2[C@@]([C@H]1CO)(CCCC2(C)C)C,,,,,,
551,3080552,"(1S,2S,4S,5'R,7S,8R,9S,12S,13R,14R,16R)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-14,16-diol",C[C@@H]1CCC2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5([C@@H](C[C@@H](C6)O)O)C)C)C)OC1,,,,,,
552,3080553,CID 3080553,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=CC(=O)C4=C(C=C(OC4=C3)C5=CC=C(C=C5)OC)O)O)O)O)O)O)O,,,,,,
553,3080554,Homoquinolinic acid,C1=CC(=C(N=C1)C(=O)O)CC(=O)O,,,,,,
554,3080555,"11-[(2S,3R)-3-pentyloxiran-2-yl]undec-9-enoic acid",CCCCC[C@@H]1[C@@H](O1)CC=CCCCCCCCC(=O)O,,,,,,
555,3080556,CID 3080556,C1C(=O)C=C(N1)O,,,,,,
556,3080557,Erysolin,CS(=O)(=O)CCCCN=C=S,,,,,,
557,3080558,Allopregnan-20alpha-ol-3-one,C[C@@H]([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CCC(=O)C4)C)C)O,,,,,,
558,3080559,Ergostan-3-ol,C[C@H](CC[C@H](C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4[C@@]3(CCC(C4)O)C)C,,,,,,
559,3080560,"3-Hydroxy-7,12-diketocholanoic acid",C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(C(=O)C[C@H]3[C@H]2C(=O)C[C@H]4[C@@]3(CC[C@H](C4)O)C)C,,,,,,
560,3080561,CID 3080561,COC1=CC2=CC=C(OC2=C(C1=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O,,,,,,
561,3080562,2-Aminohippuric acid,C1=CC=C(C(=C1)C(=O)NCC(=O)O)N,,,,,,
562,3080563,Isoretronecanol,C1C[C@H]2[C@H](CCN2C1)CO,,,,,,
563,3080564,"(1R,2R,9R,10S)-10-Prop-2-enyl-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one",C=CC[C@H]1[C@@H]2C[C@H](CN1)[C@H]3CCCC(=O)N3C2,,,,,,
564,3080565,6-Dehydrofluorocortisol acetate,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H](C3([C@H]2C=CC4=CC(=O)CC[C@@]43C)F)O)C)O,,,,,,
565,3080566,"1,2-Phenanthrenequinone",C1=CC=C2C(=C1)C=CC3=C2C=CC(=O)C3=O,,,,,,
566,3080567,Vital red,CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C4C=CC(=CC4=CC(=C3N)S(=O)(=O)[O-])S(=O)(=O)[O-])C)N=NC5=C(C=CC6=C5C=CC(=C6)S(=O)(=O)[O-])N.[Na+].[Na+].[Na+],,,,,,
567,3080568,Asterric acid,CC1=CC(=C(C(=C1)OC2=C(C=C(C=C2OC)O)C(=O)OC)C(=O)O)O,,,,,,
568,3080569,"9-Fluoro-11-hydroxy-3,20-dioxopregna-4,16-dien-21-yl acetate",CC(=O)OCC(=O)C1=CC[C@@H]2[C@@]1(C[C@@H](C3([C@H]2CCC4=CC(=O)CC[C@@]43C)F)O)C,,,,,,
569,3080570,9-beta-Xylofuranosyladenine 5'-triphosphate,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N,,,,,,
570,3080571,Hexamidine diisethionate,C1=CC(=CC=C1C(=N)N)OCCCCCCOC2=CC=C(C=C2)C(=N)N.C(CS(=O)(=O)O)O.C(CS(=O)(=O)O)O,,,['Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)'],,,
571,3080572,N-[4-(4-fluorophenyl)sulfonylphenyl]acetamide,CC(=O)NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(C=C2)F,,,,,,
572,3080573,CID 3080573,CN(CC1=NC2=C(NC(=NC2=NC1=O)N)N)C3=C(C=C(C=C3Cl)C(=O)N[C@@H](CCC(=O)O)C(=O)O)Cl,,,,,,
573,3080574,UpApU,C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CC([C@@H]3[C@H]([C@H]([C@@H](O3)N4C=CC(=O)NC4=O)O)O)OP(=O)(O)OP(=O)(O)OC[C@@H]5[C@H]([C@H]([C@@H](O5)N6C=NC7=C(N=CN=C76)N)O)O)O)O,,,,,,
574,3080575,Tetralysine,C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)N,,,,,,
575,3080576,Glycyllysine,C(CCN)C[C@@H](C(=O)O)NC(=O)CN,,,,,,
576,3080577,"3,5-Diiodo-tyrosyl-3,5-diiodo-tyrosine",C1=C(C=C(C(=C1I)O)I)C[C@@H](C(=O)N[C@@H](CC2=CC(=C(C(=C2)I)O)I)C(=O)O)N,,,,,,
577,3080578,Varanic acid,C[C@H](CCC(C(C)C(=O)O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,,,,,,
578,3080579,Resorufin acetate,CC(=O)OC1=CC2=C(C=C1)N=C3C=CC(=O)C=C3O2,,,,,,
579,3080580,CID 3080580,CC1=C(C(=O)C(=CC1=O)CC=C(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C,,,,,,
580,3080581,"2-[(3aR,5aR,6S,7S,9aR,9bS)-6-(2-methoxy-2-oxoethyl)-3a-methyl-3-(6-methylheptan-2-yl)-1,2,3,4,5,5a,6,7,8,9,9a,9b-dodecahydrocyclopenta[a]naphthalen-7-yl]acetic acid",CC(C)CCCC(C)C1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]([C@@H]3CC(=O)OC)CC(=O)O)C,,,,,,
581,3080582,2-Benzyl-3-chlorophenol,C1=CC=C(C=C1)CC2=C(C=CC=C2Cl)O,,,,,,
582,3080583,"Aluminum oxide, hydrate",O.[O-2].[O-2].[O-2].[Al+3].[Al+3],,,,,,
583,3080584,"8,11,14,17-Eicosatetraenoic acid",CCC=CCC=CCC=CCC=CCCCCCCC(=O)O,,,,,,
584,3080585,CID 3080585,CC(C)C1C(=O)C(=C(N1)O)C(=O)C,,,,,,
585,3080586,"5,6,8,14-Tetradehydro-3-hydroxy-2,4,6-trimethoxy-17-methyl-B-homomorphinan-7-one",CN1CCC23C=C(C(=O)C=C2[C@@H]1CCC4=CC(=C(C(=C34)OC)O)OC)OC,,,,,,
586,3080587,"17-Hydroxypregna-4,6-diene-3,20-dione",CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=CC4=CC(=O)CC[C@]34C)C)O,,,,,,
587,3080588,"Phosphorodithioic acid, O-methyl S-(2-(methylamino)-2-oxoethyl) ester",CNC(=O)CSP(=S)(O)OC,,,,,,
588,3080589,Azaperol,C1CN(CCN1CCCC(C2=CC=C(C=C2)F)O)C3=CC=CC=N3,,,,,,
589,3080590,"(2-oxo-2,3-dihydro-1H-indol-3-yl)acetic acid",C1=CC=C2C(=C1)C(C(=O)N2)CC(=O)O,,,,,,
590,3080591,10-Acetyl dithranol,CC(=O)C1C2=C(C(=CC=C2)O)C(=O)C3=C1C=CC=C3O,,,,,,
591,3080592,Chlormadinol acetate,CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=C[C@H](CC[C@]34C)O)Cl)C)OC(=O)C,,,,,,
592,3080593,tert-Butoxy,CC(C)(C)[O],,,,,,
593,3080594,3-Methoxyacetaminophen,CC(=O)NC1=CC(=C(C=C1)O)OC,,,,,,
594,3080595,Mitosene,CC1=CC(=O)C2=C(C1=O)N3CCCC3=C2COC(=O)N,,,,,,
595,3080596,Thyroxamine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CCN,,,,,,
596,3080597,Bigelovin,C[C@@H]1C[C@H]2[C@H]([C@@H]([C@]3([C@H]1C=CC3=O)C)OC(=O)C)C(=C)C(=O)O2,,,,,,
597,3080598,Chromium(3+) palmitate,CCCCCCCCCCCCCCCC(=O)[O-].CCCCCCCCCCCCCCCC(=O)[O-].CCCCCCCCCCCCCCCC(=O)[O-].[Cr+3],,,,,,
598,3080599,Betazine,C1=C(C=C(C(=C1I)O)I)C(CC(=O)O)N,,,,,,
599,3080600,Diodonmorpholide,C1COCCN1.C1=C(C(=O)C(=CN1CC(=O)O)I)I,,,,,,
600,3080601,Quateron,CCCCOC1=CC=C(C=C1)C(=O)OC(C)C(C)C[N+](CC)(CC)CC.[I-],,,,,,
601,3080602,[3-(4-Butoxybenzoyl)oxy-2-methylbutyl]-triethylazanium,CCCCOC1=CC=C(C=C1)C(=O)OC(C)C(C)C[N+](CC)(CC)CC,,,,,,
602,3080603,"5beta-Cholestane-3alpha,7alpha-diol",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,,,,,,
603,3080604,2-Methylthioadenosine,CSC1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,,,,,,
604,3080605,"Pregna-1,4-diene-11-ol-3,20-dione",CC(=O)[C@H]1CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C,,,,,,
605,3080606,CID 3080606,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)OP(=O)(O)OC[C@@H]3[C@H](C[C@@H](O3)N4C=NC5=C4NC(=NC5=O)N)O)CO,,,,,,
606,3080607,"2,4-Diaminopteridine-6-carbaldehyde",C1=C(N=C2C(=NC(=NC2=N1)N)N)C=O,,,,,,
607,3080608,"(2R,3S)-5-(4-aminopyrazolo[3,4-d]pyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-ol",C1[C@@H]([C@H](OC1N2C3=NC=NC(=C3C=N2)N)CO)O,,,,,,
608,3080609,Iminoacetic acid,C(=N)C(=O)O,,,,,,
609,3080610,"Butanedioic acid, compd. with (2,5-dioxo-4-imidazolidinyl)urea (1:1)",C(CC(=O)O)C(=O)O.C1(C(=O)NC(=O)N1)NC(=O)N,,,,,,
610,3080611,3-Deaza-4-deoxyuridine,C1=CC(=O)N(C=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
611,3080612,12-Ketolithocholic acid,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(C(=O)C[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C,,,,,,
612,3080613,"3alpha,7alpha,12alpha-Trihydroxy-5beta-cholest-24-enoic acid",C[C@H](CCC=C(C)C(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,,,,,,
613,3080614,N-Oxalylglycine,C(C(=O)O)NC(=O)C(=O)O,,,,,,
614,3080615,Chitintetraose,C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@H](CO)[C@H]([C@@H]([C@H](C=O)N)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)N)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)N)N)O)O)O,,,,,,
615,3080616,CID 3080616,C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C4NC(=NC5=O)N)O)O)O)[O-])C(=O)N,,,,,,
616,3080617,CID 3080617,C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C4NC(=NC5=O)N)O)O)O)O)C(=O)N,,,,,,
617,3080618,"4',5-Dimethylangelicin",CC1=CC2=C(C(=CO2)C)C3=C1C=CC(=O)O3,,,,,,
618,3080619,CID 3080619,C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CC3=C(C=C2)NC(=NC3=O)N,,,,,,
619,3080620,6-Methylergoline-8beta-carboxylic acid,CN1C[C@@H](CC2[C@H]1CC3=CNC4=CC=CC2=C34)C(=O)O,,,,,,
620,3080621,2'-O-L-Phenylalanyladenosine,C1=CC=C(C=C1)C[C@@H](C(=O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)O)N,,,,,,
621,3080622,"(1R,3R,6S,7R,8S)-2,2,6,8-tetramethyltricyclo[5.3.1.03,8]undecan-3-ol",C[C@H]1CC[C@@]2([C@@]3([C@@H]1C[C@H](C2(C)C)CC3)C)O,,,,,,
622,3080623,CID 3080623,C1=CC2=C(C=CC(=C2)S(=O)(=O)[O-])C=C1N=NC3=CC(=C(C=C3)O)C(=O)[O-].[Na+].[Na+],,,,,,
623,3080624,Dhpde,CCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCC,,,,,,
624,3080625,cis-2-Methylaconitate,C/C(=C(\CC(=O)O)/C(=O)O)/C(=O)O,,,,,,
625,3080626,N(4)-Methoxycytidine,CONC1=NC(=O)N(C=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
626,3080627,3-Deoxyfructose,C([C@@H]([C@@H](CO)O)O)C(=O)CO,,,,,,
627,3080628,Coenzyme A glutathione disulfide,CC(C)(CO)C(C(=O)NCCC(=O)NCCSSC[C@@H](C(=O)N(CC(=O)O)C(=O)CC[C@@H](C(=O)O)N)N)OP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O,,,,,,
628,3080629,Dibismuth tritartrate,[C@@H]([C@H](C(=O)[O-])O)(C(=O)[O-])O.[C@@H]([C@H](C(=O)[O-])O)(C(=O)[O-])O.[C@@H]([C@H](C(=O)[O-])O)(C(=O)[O-])O.[Bi+3].[Bi+3],,,,,,
629,3080630,Farnesylamine,CC(=CCCC(=CCCC(=CCN)C)C)C,,,,,,
630,3080631,CID 3080631,C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,,,,,,
631,3080632,Stigmast-7-en-3-ol,CC[C@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=CCC4[C@@]3(CC[C@@H](C4)O)C)C)C(C)C,,,,,,
632,3080633,Folienetriol,CC(=CCC[C@@](C)([C@H]1CC[C@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CCC4[C@@]3(CC[C@H](C4(C)C)O)C)C)O)C)O)C,,,,,,
633,3080634,Geigerinin,C[C@@H]1C[C@H]2[C@H](C[C@]3([C@H]1C[C@H]([C@@H]3O)O)C)C(=C)C(=O)O2,,,,,,
634,3080635,Atractylon,CC1=COC2=C1C[C@H]3C(=C)CCC[C@@]3(C2)C,,,,,,
635,3080636,Ammonium ferric citrate,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[NH4+].[Fe+3],,,,"[""The absorption and endogenous excretion of iron in man was studied by monitoring the fecal excretion of a stable iron isotope (58Fe). The study was carried out for 12 healthy volunteers who were divided into two groups. Group I received 58Fe-labeled ferric ammonium citrate (III) (58FeAC) equivalent to 6 mg of iron as a control, and group II received a combination of 500 mg of vitamin C and 58FeAC. A new formula was used to calculate the 58Fe absorption ratio reflecting the pool of iron in the intestinal cells, and the ratio was compared with that obtained from Janghorbani's formula, which has been used as one of the common methods. As a result, the 58Fe absorption ratio in group II was statistically significantly higher than that of group I (34.4 +/- 6.1% vs. 15.0 +/- 5.5%, M +/- SD) using Janghorbani's formula. The similar absorption ratio (34.1 +/- 6.0% vs. 14.8 +/- 5.5%) was also obtained by our new formula. Our results confirmed the previous findings that the availability of iron is stimulated by the supplementation of vitamin C. Both formulae agreed in the absorption of iron, indicating that the endogenous excretion of iron (caused by the desquamated cells) in the intestine does not disguise the iron absorption."", 'The absorption of a commercial brand of small-particle reduced iron was evaluated in 10 normal subjects. For each subject, the hemoglobin incorporation method was used to measure the true absorption of 60 mg of iron from either ferrous sulfate or ferric ammonium citrate. The iron tolerance test (ITT) was also studied for these two compounds and for reduced iron. This procedure consisted of measuring the area under the curve of plasma iron elevations at specified times for 6 hours, or the peak plasma iron, corrected by the plasma iron disappearance rate obtained from measuring plasma iron at specified times for 4 hours after the slow intravenous injection of 0.4 mg of iron as ferric citrate. Only the ITT was used to measure the absorption of 60 mg of reduced iron. Reference dose iron ascorbate absorption was measured in each subject. The absorption of ferric ammonium citrate and reduced iron was expressed as percent of dose and also as absorption percent of that of ferrous sulfate. Mean % geometric ""true absorptions"" were 39.0 for reference dose, 10.4 for FeSO4 and 2.4 for ferric ammonium citrate. The later was 23% that of FeSO4. By ITT the mean geometric % absorptions were 7.9, 3.7 and 3.2 for FeSO4, ferric ammonium citrate and reduced iron respectively, or 47 and 41% of that of FeSO4. We propose that the true absorption of the commercial brand of reduced iron tested was 20% that of FeSO4 based on the relation between the ITT results of reduced iron and the ITT and true absorption values of ferric ammonium citrate in relation to FeSO4.']",,
636,3080637,(2-Octadecanoyloxy-3-octadec-9-enoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate,CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C,,,,,,
637,3080638,2-[Hydroxy-(2-octadecanoyloxy-3-octadec-9-enoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCC[N+](C)(C)C,,,,,,
638,3080639,CID 3080639,C1=CC2=C(C=CC3=NN(N=C23)C4=CC(=C(C=C4)C=CC5=C(C=C(C=C5)N6N=C7C=CC8=C(C7=N6)C=CC=C8S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])C(=C1)S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
639,3080640,2-[3-Sulfo-4-[2-[2-sulfo-4-(6-sulfobenzo[e]benzotriazol-2-yl)phenyl]ethenyl]phenyl]benzo[e]benzotriazole-6-sulfonic acid,C1=CC2=C(C=CC3=NN(N=C23)C4=CC(=C(C=C4)C=CC5=C(C=C(C=C5)N6N=C7C=CC8=C(C7=N6)C=CC=C8S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)C(=C1)S(=O)(=O)O,,,,,,
640,3080641,Mercuric perchlorate,[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[Hg+2],,,,,,
641,3080642,"3-(4-Hydroxy-6-methoxy-3-methyl-11-oxo-5,6,6a,7-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl)prop-2-enamide",CC1=C(C2=C(C=C1)C(=O)N3C=C(CC3C(N2)OC)C=CC(=O)N)O,,,,,,
642,3080643,3alpha-Hydroxy-5alpha-pregnan-20-one sulfate,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@H](C4)OS(=O)(=O)O)C)C,,,,,,
643,3080644,"(3S,8R,9R,10R,12R,13R,14S,17S)-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol",CC(=CCC[C@](C)([C@H]1CC[C@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CCC4[C@@]3(CC[C@@H](C4(C)C)O)C)C)O)C)O)C,,,,,,
644,3080645,Cadmium tungsten oxide (CdWO4),[O-2].[O-2].[O-2].[O-2].[Cd+2].[W],,,,,,
645,3080646,Librax,CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O.C[N+]12CCC(CC1)C(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O.[Br-],,,"['Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)', 'Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists. (See all compounds classified as Cholinergic Antagonists.)', 'Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)']",,,
646,3080647,Ammifurin,COC1=C2C=CC(=O)OC2=CC3=C1C=CO3.COC1=C2C=COC2=C(C3=C1C=CC(=O)O3)OC,,,,,,
647,3080648,Ephedrine mixture with phenobarbital and theophylline,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2.C[C@@H]([C@@H](C1=CC=CC=C1)O)NC.CN1C2=C(C(=O)N(C1=O)C)NC=N2.Cl,,,,,,
648,3080649,CID 3080649,CCC1(C(=O)NC(=NC1=O)[O-])C2=CC=CC=C2.C[C@@H]([C@@H](C1=CC=CC=C1)O)NC.CN1C2=C(C(=O)N(C1=O)C)NC=N2.COC1=CC=CC=C1OCC(CO)O.O.[Na+],,,,,,
649,3080650,Perdormal,CCCC(C)C1(C(=O)NC(=O)N=C1[O-])CC=C.CCC1(C(=O)NC(=O)N=C1[O-])CCC(C)C.[Na+].[Na+],,,"['Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)', 'Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)']",,,
650,3080651,Sitrin,CCNC1=NC(=NC(=N1)Cl)NCC.CC(C)NC1=NC(=NC(=N1)SC)NC(C)C,,,,,,
651,3080652,Persteril,CC(=O)OO.OO.OS(=O)(=O)O,,,,,,
652,3080653,Instenon,CCN(CC)C(=O)C1=CC(=C(C=C1)O)OC.CN=C(CCC(=NC)CCOC(=O)C1=CC(=C(C(=C1)OC)OC)OC)CCOC(=O)C2=CC(=C(C(=C2)OC)OC)OC.CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCO,,,,,,
653,3080654,"[3,6-Bis(methylimino)-8-(3,4,5-trimethoxybenzoyl)oxyoctyl] 3,4,5-trimethoxybenzoate",CN=C(CCC(=NC)CCOC(=O)C1=CC(=C(C(=C1)OC)OC)OC)CCOC(=O)C2=CC(=C(C(=C2)OC)OC)OC,,,,,,
654,3080655,Aluminum;dimagnesium;oxygen(2-);silicon(4+);trihydroxide,[OH-].[OH-].[OH-].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Mg+2].[Mg+2].[Al+3].[Si+4].[Si+4].[Si+4],,,,,,
655,3080656,Biogest,CC(=O)[C@]1(C(=C)C[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)CC[C@]34C)Cl)C)OC(=O)C.C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC,,,,,,
656,3080657,"2-Propenoic acid, ethyl ester, polymer with ethene",CCOC(=O)C=C.C=C,,,,,,
657,3080658,Negatol,C=O.C1=CC=C(C(=C1)CO)S(=O)(=O)O,,,,,,
658,3080659,"2-Propenoic acid, 2-methyl-, methyl ester, polymer with diethenylbenzene",CC(=C)C(=O)OC.C=CC1=CC=CC=C1C=C,,,,,,
659,3080660,Carnitine bromoacetate,C[N+](C)(C)CC(CC(=O)[O-])OC(=O)CBr,,,,,,
660,3080661,[2-(2-Bromoacetyl)oxy-3-carboxypropyl]-trimethylazanium,C[N+](C)(C)CC(CC(=O)O)OC(=O)CBr,,,,,,
661,3080662,Sodium chromate CR-51,[O-][51Cr](=O)(=O)[O-].[Na+].[Na+],,,,,,
662,3080663,Chromate ion cr-51,[O-][51Cr](=O)(=O)[O-],,,,,,
663,3080664,Sebrin,CN(C)CCN(C1=CC=CC=N1)C2=CC=C([Se]2)Br,,,,,,
664,3080665,3-Hydroxydesmonomethylpromazine,CNCCCN1C2=C(C=C(C=C2)O)SC3=CC=CC=C31,,,,,,
665,3080666,"7-[(1R,2R,3R,5R)-3,5-dihydroxy-2-[(3S)-3-hydroxyoct-1-enyl]cyclopentyl]heptanoic acid",CCCCC[C@@H](C=C[C@H]1[C@@H](C[C@H]([C@@H]1CCCCCCC(=O)O)O)O)O,,,,,,
666,3080667,ppApA,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CC([C@@H]4[C@H]([C@H]([C@@H](O4)N5C=NC6=C(N=CN=C65)N)O)O)OP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N,,,,,,
667,3080668,"4,8,12,16-Tetramethylheptadecanoic acid",CC(C)CCCC(C)CCCC(C)CCCC(C)CCC(=O)O,,,,,,
668,3080669,"Mannonic acid 1,4-lactone",C([C@H](C1[C@@H]([C@@H](C(=O)O1)O)O)O)O,,,,,,
669,3080670,"2,4-Dinitrophenylornithine",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])NCCC[C@@H](C(=O)O)N,,,,,,
670,3080671,CID 3080671,C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)O[C@H]4[C@@H]([C@H](OC([C@H]4O)O)C(=O)O)O)O)O)NC(=NC2=O)N,,,,,,
671,3080672,7-Dehydrocholesterol-3-sulfate ester,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=CC=C4[C@@]3(CC[C@@H](C4)OS(=O)(=O)O)C)C,,,,,,
672,3080673,Cytidine 5'-tetraphosphate,C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O,,,,,,
673,3080674,Cedrone,C[C@@H]1CCC23C[C@@H]1C([C@@H]2CCC3=C)(C)C,,,,,,
674,3080675,CID 3080675,CCCCC1CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC3C(O3)C=CC(=O)O1)O)O)O)C(=O)O)O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)C)O)N)O,,,,,,
675,3080676,"(3S)-4-[[(2S)-1-[[(2S)-2-[[(2S)-2-acetamido-3-methylbutanoyl]amino]-3-methylbutanoyl]-[(3S,4S)-4-amino-3-hydroxy-6-methylheptanoyl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy-6-methylheptanoic acid",C[C@@H](C(=O)N(C(=O)C[C@@H]([C@H](CC(C)C)N)O)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)C)NC(CC(C)C)[C@H](CC(=O)O)O,,,,,,
676,3080677,Dynoram,CCC(C)C1=C(C(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-])O.C1=C(C=C(C(=C1C(=O)O)Cl)N)Cl,,,,,,
677,3080678,Amilon,CN(C(=O)NC1=CC(=C(C=C1)Cl)Cl)OC.C1=C(C=C(C(=C1C(=O)O)Cl)N)Cl,,,,,,
678,3080679,CID 3080679,CC(=C)[C@@H]1CC[C@]1(C)CCO.CC1(CCCC(=CCO)C1)C.CC1(CCCC(=CC=O)C1)C,,,,,,
679,3080680,Orthoclase,[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Al+3].[Si+4].[Si+4].[Si+4].[K+],,,,,,
680,3080681,"1,3-Oxathiole",C1OC=CS1,,,,,,
681,3080682,Calcium sucrose phosphate,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)CO)O)O)CO)O)O)O)O.OP(=O)([O-])[O-].[Ca+2],,,,,,
682,3080683,CID 3080683,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2CC=C(CCC=CC(C(C(C(C=CC=CC=CC=CC=CCCC(=O)OC(CC(CC(CC(CC=CC(CC(CC(CC(=O)C2C)O)O)O)O)O)O)C=CC[C@H](C=CC[C@@H](CCCN)O)O)C)O)C)O)CCC=C)O)O)O,,,,,,
683,3080684,"Dibenzo[c,e][1,2]oxazepine",C1=CC2=CON=C3C=CC=CC3=C2C=C1,,,,,,
684,3080685,Copper arsenate hydroxide (Cu2(AsO4)(OH)),[OH-].[O-][As](=O)([O-])[O-].[Cu+2].[Cu+2],,,,,"['Copper is mainly absorbed through the gastrointestinal tract, but it can also be inhalated and absorbed dermally. It passes through the basolateral membrane, possibly via regulatory copper transporters, and is transported to the liver and kidney bound to serum albumin. The liver is the critical organ for copper homoeostasis. In the liver and other tissues, copper is stored bound to metallothionein, amino acids, and in association with copper-dependent enzymes, then partitioned for excretion through the bile or incorporation into intra- and extracellular proteins. The transport of copper to the peripheral tissues is accomplished through the plasma attached to serum albumin, ceruloplasmin or low-molecular-weight complexes. Copper may induce the production of metallothionein and ceruloplasmin. The membrane-bound copper transporting adenosine triphosphatase (Cu-ATPase) transports copper ions into and out of cells. Physiologically normal levels of copper in the body are held constant by alterations in the rate and amount of copper absorption, compartmental distribution, and excretion. Arsenic is absorbed mainly by inhalation or ingestion, as to a lesser extent, dermal exposure. It is then distributed throughout the body, where it is reduced into arsenite if necessary, then methylated into monomethylarsenic (MMA) and dimethylarsenic acid (DMA) by arsenite methyltransferase. Arsenic and its metabolites are primarily excreted in the urine. Arsenic is known to induce the metal-binding protein metallothionein, which decreases the toxic effects of arsenic and other metals by binding them and making them biologically inactive, as well as acting as an antioxidant. (L20, L277, L279)']",
685,3080686,Kvartazin,CN(C)NCCCl.Cl,,,,,,
686,3080687,"2-(2-Chloroethyl)-1,1-dimethylhydrazine",CN(C)NCCCl,,,,,,
687,3080688,"N(4), O(2')-Dimethylcytidine",CNC1=NC(=O)N(C=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)OC,,,,,,
688,3080689,Propionine,CCCSCC[C@@H](C(=O)O)N,,,,,,
689,3080690,Cysteine-glutathione disulfide,C(CC(=O)N[C@H](C(=O)NCC(=O)O)C(=S)SC[C@@H](C(O)O)N)[C@@H](C(=O)O)N,,,,,,
690,3080691,Zanthoxylol,CC(=CCC1=C(C=CC(=C1)CCCO)O)C,,,,,,
691,3080692,Phosphoadenosine diphosphoribose,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)O)O)OP(=O)(O)OC[C@@H]4[C@H]([C@H](C(O4)O)O)O)N,,,['Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. (See all compounds classified as Hydroxymethylglutaryl-CoA Reductase Inhibitors.)'],,,
692,3080693,4-Aminobicyclo[2.2.2]octane-1-carboxylic acid,C1CC2(CCC1(CC2)C(=O)O)N,,,,,,
693,3080694,Carbonyl 3-chlorophenylhydrazone,C=NNC1=CC(=CC=C1)Cl,,,,,,
694,3080695,Sodium peroxocarbonate,C(=O)([O-])O[O-].[Na+],,,,,,
695,3080696,CID 3080696,C(=O)([O-])OO,,,,,,
696,3080697,Azanium;calcium;nitrate,[NH4+].[N+](=O)([O-])[O-].[Ca+2],,,,,,
697,3080698,1-Methyl-8-tridec-2-enylquinolin-4-one,CCCCCCCCCCC=CCC1=C2C(=CC=C1)C(=O)C=CN2C,,,,,,
698,3080699,5-Nitroso-salicylate,C1=CC(=C(C=C1N=O)C(=O)O)O,,,,,,
699,3080700,"1-Carbamimidoyl-1-(3,4-dichlorophenyl)-2-propan-2-ylguanidine;hydrochloride",CC(C)N=C(N)N(C1=CC(=C(C=C1)Cl)Cl)C(=N)N.Cl,,,,,,
700,3080701,"1-Carbamimidoyl-1-(3,4-dichlorophenyl)-2-propan-2-ylguanidine",CC(C)N=C(N)N(C1=CC(=C(C=C1)Cl)Cl)C(=N)N,,,,,,
701,3080702,2'-(5''-Phosphoribosyl)-5'-adenosine monophosphate,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O[C@H]4[C@@H]([C@@H]([C@H](O4)COP(=O)(O)O)O)O)N,,,,,,
702,3080703,2-Chloro-ADP,C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)O)O)O)Cl)N,,,,,,
703,3080704,"Bis(2,4-dinitrophenyl) oxalate",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])OC(=O)C(=O)OC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
704,3080705,Tubercidin 5'-monophosphate,C1=CN(C2=NC=NC(=C21)N)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O,,,,,,
705,3080706,"[(3S,5S,8R,9S,10S,13S,14S,16R,17R)-17-acetyl-17-hydroxy-10,13,16-trimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate",C[C@@H]1C[C@H]2[C@@H]3CC[C@H]4C[C@H](CC[C@@]4([C@H]3CC[C@@]2([C@]1(C(=O)C)O)C)C)OC(=O)C,,,,,,
706,3080707,CID 3080707,CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C,,,,,,
707,3080708,2-[(2-Hexadecanoyloxy-3-octadec-9-enoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCC[N+](C)(C)C,,,,,,
708,3080709,1-(5-Phospho-beta-D-arabinofuranosyl)-5-fluorouracil,C1=C(C(=O)NC(=O)N1[C@H]2[C@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)F,,,,,,
709,3080710,(2-Decanoyloxy-3-octadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate,CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCC,,,,,,
710,3080711,2-[(2-Decanoyloxy-3-octadecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCC,,,,,,
711,3080712,Aluminum sulfate hydrate,O.[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Al+3].[Al+3],,,"['Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)']",,,
712,3080713,Rubreserine,C[C@@]12CCN([C@@H]1N(C3=CC(=O)C(=O)C=C23)C)C,,,,,,
713,3080714,Pelargonidin-3-glucoside,C1=CC(=CC=C1C2=[O+]C3=CC(=CC(=C3C=C2O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)O.[Cl-],,,,,,
714,3080715,3'-Chloro-3'-deoxyuridine,C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)Cl)O,,,,,,
715,3080716,Quinespar,CCOC(=O)C[C@@H](C(=O)OCC)NC(=O)C1=CC=C(C=C1)NCC2=CC3=C(C=C2)N=C(N=C3N)N,,,,,,
716,3080717,"(2R,3R,4S,5R)-5-[[[[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxymethyl]-2-(3-carbamothioylpyridin-1-ium-1-yl)-4-hydroxyoxolan-3-olate",C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)OP(=O)(O)O)O)O)[O-])C(=S)N,,,,,,
717,3080718,7-Thionicotinamide-adenine-dinucleotide phosphate,C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)OP(=O)(O)O)O)O)O)C(=S)N,,,,,,
718,3080719,"1,3-Dideazaadenosine",C1=CC(=C2C(=C1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,,,,,,
719,3080720,5-Carboxymethyluridine,C1=C(C(=O)NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)CC(=O)O,,,,,,
720,3080721,7-Deazaadenosine-5'-Diphosphate,C1=CN(C2=NC=NC(=C21)N)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)O)O)O,,,,,,
721,3080722,"(2R,3R,4S,5R)-5-[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxymethyl]-2-(3-aminopyridin-1-ium-1-yl)-4-hydroxyoxolan-3-olate",C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O)O)[O-])N,,,,,,
722,3080723,Aminopyridine adenine dinucleotide,C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O)N,,,,,,
723,3080724,"[2-[(8S,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate",CC(=O)OCC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=CC4=CC(=O)CC[C@]34C)C,,,,,,
724,3080725,"Cholest-5-ene, 3-(hexadecyloxy)-, (3beta)-",CCCCCCCCCCCCCCCCO[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC[C@@H]4[C@H](C)CCCC(C)C)C)C,,,,,,
725,3080726,4-Ethylpyridine;rhodium(3+);trichloride,CCC1=CC=NC=C1.CCC1=CC=NC=C1.CCC1=CC=NC=C1.CCC1=CC=NC=C1.[Cl-].[Cl-].[Cl-].[Rh+3],,,,,,
726,3080727,2'-Deoxyadenylyl-(3'-5')-thymidine,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)(O)OC[C@@H]3[C@H](C[C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O,,,,,,
727,3080728,"S-(1-Ethyl-2,5-dioxopyrrolidin-3-yl)cysteinyl-N-gamma-glutamylglycine",CCN1C(=O)CC(C1=O)SC[C@@H](C(=O)N(CC(=O)O)C(=O)CC[C@@H](C(=O)O)N)N,,,,,,
728,3080729,"3-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]propanoic acid",CCCCC[C@@H](C=C[C@H]1[C@@H](CC(=O)[C@@H]1CCC(=O)O)O)O,,,,,,
729,3080730,"Glycine, N-(N-L-gamma-glutamyl-S-octyl-L-cysteinyl)-",CCCCCCC(C)N([C@@H](C(=O)CC[C@@H](C(=O)O)N)C(=O)O)C(=O)[C@H](CS)N,,,,,,
730,3080731,Barakol,CC1=CC2=C3C(=CC(=C2)O)OC(=CC3(O1)O)C,,,,,,
731,3080732,2-Ethylthymine,CCOC1=NC=C(C(=O)N1)C,,,,,,
732,3080733,"2-Aminooctadeca-4,14-diene-1,3-diol",CCCC=CCCCCCCCCC=CC(C(CO)N)O,,,,,,
733,3080734,"2-Propenoic acid, polymer with chloroethene",C=CC(=O)O.C=CCl,,,,,,
734,3080735,Bio acrylic resin,CC(=C)C(=O)OC.CC(=C)C(=O)OCCOC(=O)C(=C)C,,,,,,
735,3080736,7-Hydroxycholesterol-3-stearate,CCCCCCCCCCCCCCCCCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3[C@@H](C=C2C1)O)CC[C@@H]4[C@H](C)CCCC(C)C)C)C,,,,,,
736,3080737,"1,3-Isobenzofurandione, polymer with 2,5-furandione and 2,2'-oxybis(ethanol)",C1=CC=C2C(=C1)C(=O)OC2=O.C1=CC(=O)OC1=O.C(COCCO)O,,,,,,
737,3080738,"2-Propenoic acid, 2-methyl-, 2-(dimethylamino)ethyl ester, polymer with methyl 2-methyl-2-propenoate",CC(=C)C(=O)OC.CC(=C)C(=O)OCCN(C)C,,,,,,
738,3080739,CID 3080739,C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)NC(=NC2=O)Cl,,,,,,
739,3080740,Cholesterol glucoside,C[C@H](CCCC(C)C)C1CCC2[C@@]1(CCC3C2CC=C4[C@@]3(CCC(C4)OC5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)C,,,,,,
740,3080741,"Formaldehyde, polymer with 5,5-dimethyl-2,4-imidazolidinedione",CC1(C(=O)NC(=O)N1)C.C=O,,,,,,
741,3080742,Phenylone-2s,C1=CC(=CC(=C1)C(=O)O)C(=O)O.C1=CC(=CC(=C1)N)N.C1=CC(=CC=C1C(=O)O)C(=O)O,,,,,,
742,3080743,Lysine chloromethyl ketone,C(CCN)C[C@@H](C(=O)CCl)N,,,,,,
743,3080744,2'-O-methylcytidine 5'-monophosphate,CO[C@@H]1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)N)COP(=O)(O)O)O,,,,,,
744,3080745,2-Keto-3-deoxy-6-phosphogluconate,C([C@@H]([C@@H](COP(=O)(O)O)O)O)C(=O)C(=O)O,,,,,,
745,3080746,Poly-N(5)-(2-hydroxyethyl)glutamine,C(CC(=O)N)[C@@H](C(=O)O)NCCO,,,,,,
746,3080747,"1-Oleoyl-2,3-dipalmitoyl-rac-glycerol",CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC,,,,,,
747,3080748,"Ammonium, (m-acetylbenzyl)(2-aminoethyl)dimethyl-, chloride, hydrochloride",CC(=O)C1=CC=CC(=C1)C[N+](C)(C)CCN.Cl.[Cl-],,,,,,
748,3080749,(3-Acetylphenyl)methyl-(2-aminoethyl)-dimethylazanium,CC(=O)C1=CC=CC(=C1)C[N+](C)(C)CCN,,,,,,
749,3080750,Gardenin D,COC1=C(C=C(C=C1)C2=CC(=O)C3=C(C(=C(C(=C3O2)OC)OC)OC)O)O,,,,,,
750,3080751,"N-hydroxyoctadeca-9,12-dienamide",CCCCCC=CCC=CCCCCCCCC(=O)NO,,,,,,
751,3080752,Bis(3-hydroxypropyl)trisulfide,C(CO)CSSSCCCO,,,,,,
752,3080753,5-Methoxycarbonylmethyluridine,COC(=O)CC1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
753,3080754,5-Carbamoylmethyluridine,C1=C(C(=O)NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)CC(=O)N,,,,,,
754,3080755,Poly(epsilon-caprolactone-delta-valerolactone),C1CCC(=O)OCC1.C1CCOC(=O)C1,,,,,,
755,3080756,Ccris 9167,[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[K+].[K+].[K+].[K+].[Sb+3].[Sb+3],,,,,,
756,3080757,CID 3080757,C1=CC(=CC=C1C(=O)N(C(=O)CC[C@@H](C(=O)O)N)[C@](CCC(=O)O)(C(=O)CC[C@@H](C(=O)O)N)C(=O)OC(=O)CC[C@@H](C(=O)O)N)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,,,,,,
757,3080758,"[(1R,2R,3R)-2-(4,8-dimethylnona-3,7-dienyl)-2-methyl-3-(2,6,10-trimethylundeca-1,5,9-trienyl)cyclopropyl]methyl phosphono hydrogen phosphate",CC(=CCCC(=CCCC(=C[C@@H]1[C@H]([C@]1(C)CCC=C(C)CCC=C(C)C)COP(=O)(O)OP(=O)(O)O)C)C)C,,,,,,
758,3080759,Triiodothyronine glucuronide,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O,,,,,,
759,3080760,"2H-1,4-Benzothiazine-7-propanoic acid, alpha-amino-3-carboxy-3,4-dihydro-5-hydroxy-",C1C(NC2=C(C=C(C=C2S1)CC(C(=O)O)N)O)C(=O)O,,,,,,
760,3080761,"Methyl octadeca-2,9,12-trienoate",CCCCCC=CCC=CCCCCCC=CC(=O)OC,,,,,,
761,3080762,Adenosine 5'-phospho-2-methylimidazolide,CC1=NC=CN1P(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)O,,,,,,
762,3080763,CID 3080763,C/C(=C\1/C(=O)[C@@H]2[C@@H]3[C@@H](CC4=C5C3=CNC5=CC=C4)C(N2C1=O)(C)C)/N,,,,,,
763,3080764,CID 3080764,C1[C@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C4=C(C(=O)C=C(C4=C3)C5C(CC6=C(C=C(C=C6O5)O)O)O)OC(=O)C7=CC(=C(C(=C7)O)O)O)O)O)O,,,,,,
764,3080765,"8-Thioethyladenosine-3',5'-cyclic monophosphoric acid",C=CSC1=NC2=C(N=CN=C2N1[C@H]3[C@@H](C[C@H](O3)COP(=O)(O)O)O)N,,,,,,
765,3080766,L-Leucyl-Hydroxylamine,CC(C)C[C@@H](C(=O)NO)N,,,,,,
766,3080767,3-Methoxyphenylglyoxal,COC1=CC=CC(=C1)C(=O)C=O,,,,,,
767,3080768,Glycyl-prolyl-glutamic acid,C1C[C@H](N(C1)C(=O)CN)C(=O)N[C@@H](CCC(=O)O)C(=O)O,['Investigated for use/treatment in neurologic disorders.'],,,,,
768,3080769,2-(Bromomethyl)but-2-enedioic acid,C(C(=CC(=O)O)C(=O)O)Br,,,,,,
769,3080770,"(6R,7S)-6-(6-aminopurin-9-yl)-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol",C1C2C([C@@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)OP(=O)(O1)O,,,,,,
770,3080771,5-(2-Amino-1-hydroxyethyl)-2-methoxyphenol,COC1=C(C=C(C=C1)C(CN)O)O,,,,,,
771,3080772,4-Azido-L-phenylalanine,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N=[N+]=[N-],,,,,,
772,3080773,CID 3080773,C1[C@H]([C@H](OC2=CC(=CC(=C21)O)OC(=O)C3=CC(=C(C(=C3)O)O)O)C4=CC(=O)C(=C5C4=CC(=CC(=C5O)O)C6[C@@H](CC7=C(C=C(C=C7O6)O)O)O)OC(=O)C8=CC(=C(C(=C8)O)O)O)O,,,,,,
773,3080774,4-Amino-4-deoxyarabinose,C([C@H]([C@H]([C@@H](C=O)O)O)N)O,,,,,,
774,3080775,S-Methylthiocysteine,CSSC[C@@H](C(=O)O)N,,,,,,
775,3080776,"6-(2,2,6,6-Tetramethylpiperidine-1-oxyl)-adenosine triphosphate",CC1(CC(CC(N1[O])(C)C)NC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)C,,,,,,
776,3080777,Vitamin K1 chromenol,CC1=C(C2=CC=CC=C2C3=C1C=CC(O3)(C)CCCC(C)CCCC(C)CCCC(C)C)O,,,,,,
777,3080778,2-Methyl-2-nitro-1-phenylpropane,CC(C)(CC1=CC=CC=C1)[N+](=O)[O-],,,,,,
778,3080779,Erythrosamine,C([C@H]([C@H](C=O)N)O)O,,,,,,
779,3080780,alpha-Glucopyranosyl alpha-xylopyranoside,C1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)O,,,,,,
780,3080781,"N,N'-Bis(3-aminopropyl)cadaverine",C(CCNCCCN)CCNCCCN,,,,,,
781,3080782,"(8R,9S,10R,13S,14S)-10,13-dimethylspiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxirane]-3-one",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC45CO5)C,,,,,,
782,3080783,"(2R,3S,4R,5R)-5,6-dihydroxy-2,3,4-tris[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]hexanal",C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)O)O,,,,,,
783,3080784,5-Methyl-8-hydroxycoumarin,CC1=C2C=CC(=O)OC2=C(C=C1)O,,,,,,
784,3080785,5-(4-Hydroxy-3-methoxyphenyl)-5-phenylhydantoin,COC1=C(C=CC(=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3)O,,,,,,
785,3080786,Tempo carboxylic acid,CC1(CC(CC(N1[O])(C)C)C(=O)O)C,,,,,,
786,3080787,1-(4'-Nitrophenyl)prop-2-yn-1-one,C#CC(=O)C1=CC=C(C=C1)[N+](=O)[O-],,,,,,
787,3080788,"1,3-Benzodioxole-5,6-diamine",C1OC2=C(O1)C=C(C(=C2)N)N,,,,,,
788,3080789,Bis(4-nitrophenyl) phenyl phosphate,C1=CC=C(C=C1)OP(=O)(OC2=CC=C(C=C2)[N+](=O)[O-])OC3=CC=C(C=C3)[N+](=O)[O-],,,,,,
789,3080790,Halothane nitrous oxide,C(C(F)(F)F)(Cl)Br.[N-]=[N+]=O,,,,,,
790,3080791,Thymosterin,CC1CC(OC1(C)C)C(C)C2CCC3C2(C(CC4C3CC=C5C4(C(CC(C5)O)O)C)OC(=O)C)C,,,,,,
791,3080792,(R)-(-)-alpha-Methoxy-alpha-(trifluoromethyl)phenylacetyl chloride,CO[C@@](C1=CC=CC=C1)(C(=O)Cl)C(F)(F)F,,,,,,
792,3080793,"Ribavirin 2',3',5'-triacetate",CC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC(=N2)C(=O)N)OC(=O)C)OC(=O)C,,,,,,
793,3080794,2-Octyl-gamma-bromoacetoacetate,CCCCCCC(C)OC(=O)CC(=O)CBr,,,,,,
794,3080795,Dmpo-methyl,CC1CCC(N1[O])(C)C,,,,,,
795,3080796,"3-Oxazolidinyloxy, 2-(5-carboxypentyl)-4,4-dimethyl-2-undecyl-",CCCCCCCCCCCC1(N(C(CO1)(C)C)[O])CCCCCC(=O)O,,,,,,
796,3080797,Copoly(aspartic acid-glutamic acid),C(CC(=O)O)[C@@H](C(=O)O)N.C([C@@H](C(=O)O)N)C(=O)O,,,,,,
797,3080798,16-Diazoestrone,C[C@]12CC[C@H]3[C@H]([C@@H]1CC(=[N+]=[N-])C2=O)CCC4=C3C=CC(=C4)O,,,,,,
798,3080799,"(8R,9S,13S,14S)-3,17-dihydroxy-13-methyl-6,7,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthrene-16-diazonium",C[C@]12CC[C@H]3[C@H]([C@@H]1CC(=C2O)[N+]#N)CCC4=C3C=CC(=C4)O,,,,,,
799,3080800,"4-Azidoestra-1,3,5(10)-triene-3,17beta-diol",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4N=[N+]=[N-])O,,,,,,
800,3080801,Nonylthioacetic acid,CCCCCCCCCSCC(=O)O,,,,,,
801,3080802,"(2S,3R,4R,5R,6S)-2-[(2S,3R,4R,5R,6R)-4,5-Dihydroxy-2-[(4S,5'R,7S,8R,9S,13S)-16-hydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-14-yl]-6-methyl-2-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol",C[C@@H]1CCC2([C@H]([C@H]3[C@@H](O2)CC4[C@@]3(CCC5C4CC=C6[C@@]5(C(CC(C6)O)[C@@]7([C@@H]([C@@H]([C@H]([C@H](O7)C)O)O)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)O[C@H]9[C@@H]([C@H]([C@@H](CO9)O)O)O)C)C)C)OC1,,,,,,
802,3080803,6-Fluoropyridoxal,CC1=C(C(=C(C(=N1)F)CO)C=O)O,,,,,,
803,3080804,3-Guanidinobenzenesulfonic acid methyl ester,COS(=O)(=O)C1=CC=CC(=C1)N=C(N)N,,,,,,
804,3080805,CID 3080805,CC(=O)CC(C1=CC=C(C=C1)N)C2=C(OC3=CC=CC=C3C2=O)O,,,,,,
805,3080806,"17-Acetyloxy-21-hydroxypregna-1,4-diene-3,20-dione",CC(=O)O[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)C)C(=O)CO,,,,,,
806,3080807,10-Doxylstearic acid,CCCCCCCCC1(N(C(CO1)(C)C)[O])CCCCCCCCC(=O)O,,,,,,
807,3080808,Jatropham,CC1=C[C@H](NC1=O)O,,,,,,
808,3080809,"1-(3-Dimethylaminopropyl)pyrrole-2,5-dione; styrene",CN(C)CCCN1C(=O)C=CC1=O.C=CC1=CC=CC=C1,,,,,,
809,3080810,4-[[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobut-2-enoic acid,COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C=CC(=O)O,,,,,,
810,3080811,"Hex-1-ene;4-methylhexa-1,4-diene;5-methylhexa-1,4-diene",CCCCC=C.CC=C(C)CC=C.CC(=CCC=C)C,,,,,,
811,3080812,CID 3080812,C[C@H](C(=O)CCl)NC(=O)[C@@H](C)NC(=O)OCC1=CC=CC=C1,,,,,,
812,3080813,"(2S,3S,4S,5R,6R)-6-[[(6aR,6bS,8aS,12aR,14bR)-4,4,6a,6b,11,11,14b-heptamethyl-8a-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid",C[C@]12CCC(C(C1CC[C@@]3(C2CC=C4[C@]3(CC[C@@]5([C@@H]4CC(CC5)(C)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)(C)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O)O)O,,,,,,
813,3080814,Poly(lysyl-(leucyl-poly-alanine)),C[C@@H](C(=O)O)N.CC(C)C[C@@H](C(=O)O)N.C(CCN)C[C@@H](C(=O)O)N,,,,,,
814,3080815,4-Hydroxy-3-oxobutyl-1-phosphonic acid,C(CP(=O)(O)O)C(=O)CO,,,,,,
815,3080816,"4,5-Diaminophthalhydrazide",C1=C2C(=CC(=C1N)N)C(=O)NNC2=O,,,,,,
816,3080817,"3-(3,5-Dinitro-2-thienyl)thiazolidine",C1CSCN1C2=C(C=C(S2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
817,3080818,Tilnoprofenic acid,CC1=NC2=C(CC3=C(O2)C=CC(=C3)C(C)C(=O)O)C=C1,,,,,,
818,3080819,"3,6-Dihydroxy-4,5-dimethylphthalaldehyde",CC1=C(C(=C(C(=C1O)C=O)C=O)O)C,,,,,,
819,3080820,"3-Butyl-2-[5-(3-butyl-1,3-benzothiazol-2(3H)-ylidene)penta-1,3-dien-1-yl]-1,3-benzothiazol-3-ium iodide",CCCCN1C2=CC=CC=C2SC1=CC=CC=CC3=[N+](C4=CC=CC=C4S3)CCCC.[I-],,,,,,
820,3080821,"3-Butyl-2-[5-(3-butyl-1,3-benzothiazol-3-ium-2-yl)penta-2,4-dienylidene]-1,3-benzothiazole",CCCCN1C2=CC=CC=C2SC1=CC=CC=CC3=[N+](C4=CC=CC=C4S3)CCCC,,,,,,
821,3080822,"8,9,10,11-Tetrahydroxy-8,9,10,11-tetrahydrobenz(a)anthracene",C1=CC=C2C(=C1)C=CC3=CC4=C(C=C32)C(C(C(C4O)O)O)O,,,,,,
822,3080823,CID 3080823,C1=CN(C2=C1C(=O)N=CN2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O,,,,,,
823,3080824,"(-)-2-Amino-N-(2,6-dimethylphenyl)propanamide monohydrochloride",CC1=C(C(=CC=C1)C)NC(=O)[C@@H](C)N.Cl,,,,,,
824,3080825,Tonocard,CC1=C(C(=CC=C1)C)NC(=O)[C@@H](C)N,,,,,,
825,3080826,"(+)-2-Amino-N-(2,6-dimethylphenyl)propanamide monohydrochloride",CC1=C(C(=CC=C1)C)NC(=O)[C@H](C)N.Cl,,,,,,
826,3080827,"Propanamide, 2-amino-N-(2,6-dimethylphenyl)-, (S)-",CC1=C(C(=CC=C1)C)NC(=O)[C@H](C)N,,,,,,
827,3080828,"6-(2,2,6,6--Tetramethylpiperidine-1-oxyl)-adenosine monophosphate",CC1(CC(CC(N1[O])(C)C)NC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)COP(=O)(O)O)O)O)C,,,,,,
828,3080829,"1-[17-Hydroxy-19-norpregna-1,3,5(10)-trien-20-yn-3-yl]propane-2-sulfonic acid--3-oxo-19-norpregn-4-en-20-yn-17-yl acetate (1/1)",CC(CC1=CC2=C(C=C1)C3CC[C@]4(C(C3CC2)CCC4(C#C)O)C)S(=O)(=O)O.CC(=O)OC1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C)C#C,,,,,,
829,3080830,"1-[(13S)-17-ethynyl-17-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]propane-2-sulfonic acid",CC(CC1=CC2=C(C=C1)C3CC[C@]4(C(C3CC2)CCC4(C#C)O)C)S(=O)(=O)O,,,,,,
830,3080831,"3-Ethyl-3,5-dihydroxypentanoic acid",CCC(CCO)(CC(=O)O)O,,,,,,
831,3080832,Granular blue,C1=CC(=CC=C1C2=CC3=C(N2)C=C(C=C3)C(=N)N)OCCOC4=CC=C(C=C4)C(=N)N.Cl.Cl,,,,,,
832,3080833,2-[4-[2-(4-carbamimidoylphenoxy)ethoxy]phenyl]-1H-indole-6-carboximidamide,C1=CC(=CC=C1C2=CC3=C(N2)C=C(C=C3)C(=N)N)OCCOC4=CC=C(C=C4)C(=N)N,,,,,,
833,3080834,CID 3080834,C[C@H]1CCN[C@@H]1C(=O)N[C@@H]([C@@H](C)C=C)C(=O)N(C)[C@](C=O)(C(=O)C(CC=C)O)C(C)(C)C(=O)CCNC(=O)[C@@H](C)NC,,,,,,
834,3080835,Isopropyl-beta-galactopyranoside,CC(C)O[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O,,,,,,
835,3080836,Lysine clonixinate,CC1=C(C=CC=C1Cl)NC2=C(C=CC=N2)C(=O)O.C(CCN)C[C@@H](C(=O)O)N,,,,,,
836,3080837,CID 3080837,CCCCC1CCCCCCC2=CC1=C(N2)C=C3C(=CC(=C4C=CC=N4)N3)OC,,,,,,
837,3080838,N-Heptafluorobutyrylproline,C1C[C@H](N(C1)C(=O)C(C(C(F)(F)F)(F)F)(F)F)C(=O)Cl,,,,,,
838,3080839,"Androstane-2,3,17-triol",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@@H]4[C@@]3(C[C@H]([C@H](C4)O)O)C,,,,,,
839,3080840,"3',4'-Dihydroxy-2,4,6,2',6'-pentachlorobiphenyl",C1=C(C=C(C(=C1Cl)C2=C(C=C(C(=C2Cl)O)O)Cl)Cl)Cl,,,,,,
840,3080841,Pularyl,CNC(=O)OC1=CC=CC2=CC=CC=C21.C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl,,,,,,
841,3080842,CID 3080842,C[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)NC(=O)[C@H](CCCN=C(N)N)NC1=CC2=CC=CC=C2C(=C1)OC)NC(=O)OCC3=CC=CC=C3,,,,,,
842,3080843,CID 3080843,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]4[C@H]([C@H]([C@@H](O4)N5C=NC6=C5NC(=NC6=O)N)O)OP(=O)(O)OP(=O)(O)O)O)O)N,,,,,,
843,3080844,Cystathionamine,C(CN)CSCCN,,,,,,
844,3080845,Methyl prednisolonate,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)C(=O)OC)O)CCC4=CC(=O)C=C[C@]34C)O,,,,,,
845,3080846,Ethylphenidate,CCOC(=O)C(C1CCCCN1)C2=CC=CC=C2,,,"['Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake. (See all compounds classified as Dopamine Uptake Inhibitors.)', 'Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)', 'A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)']",,,
846,3080847,"2,3-Dicarboxyaziridine",[C@H]1([C@H](N1)C(=O)O)C(=O)O,,,,,,
847,3080848,Apernyl,CCCOC(=O)C1=CC=C(C=C1)O.CC(=O)OC1=CC=CC=C1C(=O)O,,,,,,
848,3080849,CID 3080849,C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)F)O)O)NC(=NC2=O)N,,,,,,
849,3080850,5-Mercaptouridine 5'-diphosphate,C1=C(C(=O)NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)O)O)O)S,,,,,,
850,3080851,CID 3080851,[B+3].C1=CC(=CC=C1C(=O)N)[N+]#N.[F-].[F-].[F-].[F-],,,,,,
851,3080852,Diflunisal glucuronide ether,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O,,,,,,
852,3080853,Stmpoc,CC1(CC(C(N1[O])(C)C)C(=O)ON2C(=O)CCC2=O)C,,,,,,
853,3080854,"6-(Butylphenylamino)-2,4(1H,3H)-pyrimidinedione",CCCCN(C1=CC=CC=C1)C2=CC(=O)NC(=O)N2,,,,,,
854,3080855,Chromozym PK,C1C[C@H](N(C1)C(=O)C2=CC=CC=C2)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)NC(=O)[C@H](CCCN=C(N)N)NC4=CC=C(C=C4)[N+](=O)[O-],,,,,,
855,3080856,alpha-[(4-Chlorobenzylideneamino)-oxy]-isobutyric acid,CC(C)(C(=O)O)ON=CC1=CC=C(C=C1)Cl,,,,,,
856,3080857,3-(5-oxoisoxazolin-2-yl)-L-alanine,C1=CN(OC1=O)C[C@@H](C(=O)O)N,,,,,,
857,3080858,L-Lysine monosalicylate,C1=CC=C(C(=C1)C(=O)O)O.C(CCN)C[C@@H](C(=O)O)N,,,,,,
858,3080859,Methyl 2-O-mannopyranosylmannopyranoside,CO[C@@H]1[C@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O[C@@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
859,3080860,3-[4-(Dimethylamino)phenyl]-1-imidazol-1-ylprop-2-en-1-one,CN(C)C1=CC=C(C=C1)C=CC(=O)N2C=CN=C2,,,,,,
860,3080861,"4-Nitrophenyl-2-diazo-3,3,3-trifluoropropionate",C1=CC(=CC=C1[N+](=O)[O-])OC(=O)C(=[N+]=[N-])C(F)(F)F,,,,,,
861,3080862,CID 3080862,C1=CC(=CC=C1[N+](=O)[O-])OC(=C(C(F)(F)F)[N+]#N)O,,,,,,
862,3080863,4-Biphenylylacetic acid methyl ester,COC(=O)CC1=CC=C(C=C1)C2=CC=CC=C2,,,,,,
863,3080864,Poly(1-methyl-6-thioinosinic acid),CN1C=NC2=C(C1=S)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O,,,,,,
864,3080865,Parstelin,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F.C1[C@H]([C@@H]1N)C2=CC=CC=C2.C1[C@H]([C@@H]1N)C2=CC=CC=C2.OS(=O)(=O)O.Cl.Cl,,,,,,
865,3080866,Anb-nos,C1CC(=O)N(C1=O)OC(=O)C2=C(C=CC(=C2)N=[N+]=[N-])[N+](=O)[O-],,,,,,
866,3080867,CID 3080867,C[74SeH],,,,,,
867,3080868,N-(4-acetamidobenzoyl)-L-glutamic acid,CC(=O)NC1=CC=C(C=C1)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
868,3080869,Benzyloxycarbonylphenylalanyl-alanine chloromethyl ketone,C[C@@H](C(=O)CCl)NC(=O)C(CC1=CC=CC=C1)NC(=O)OCC2=CC=CC=C2,,,,,,
869,3080870,Methionyltryptophan,CSCC[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N,,,,,,
870,3080871,"(2S)-N-[(2R)-1-[[2-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxo-3-sulfanylpropan-2-yl]-2-[[(2S,3R)-2-[[(2S,3S)-2-[[(2S)-2-[[(2R)-2-amino-3-sulfanylidenepropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]butanediamide",CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C=S)N,,,,,,
871,3080872,"1,2-Bis(5-ethoxy-2-benzimidazolyl)-1,2-ethanediol",CCOC1=CC2=C(C=C1)N=C(N2)C(C(C3=NC4=C(N3)C=C(C=C4)OCC)O)O,,,,,,
872,3080873,2-Methylselenobenzanilide,C[Se]C1=CC=CC=C1C(=O)NC2=CC=CC=C2,,,,,,
873,3080874,Phenylalanyl-leucyl-glutamyl-glutamyl-valine,CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N,,,,,,
874,3080875,CID 3080875,C[C@@H](C(=O)NC(=O)[C@H](CC1=CC=CC=C1)NC2=CC=C(C=C2)[N+](=O)[O-])NC(=O)[C@@H](C)NC(=O)OCC3=CC=CC=C3,,,,,,
875,3080876,CID 3080876,C[C@@H](C(=O)N[C@H](C)C(=O)NC(=O)[C@H](CC1=CC=CC=C1)NC2=CC=C(C=C2)[N+](=O)[O-])NC(=O)CCC(=O)O,,,,,,
876,3080877,Succinyl-alanine-4-nitroanilide,C[C@@H](C(=O)NC1=CC=C(C=C1)[N+](=O)[O-])NC(=O)CCC(=O)O,,,,,,
877,3080878,Succinyl-alanyl-alanine-4-nitroanilide,C[C@@H](C(=O)NC(=O)[C@H](C)NC(=O)CCC(=O)O)NC1=CC=C(C=C1)[N+](=O)[O-],,,,,,
878,3080879,Biocytinamide,C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)NCCCC[C@@H](C(=O)N)N)NC(=O)N2,,,,,,
879,3080880,"Enkephalin-met, des-tyr(1)-",CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CN,,,,,,
880,3080881,"N(6)-(2,2,6,6-Tetramethyl-1-oxypiperidin-4-yl)adenine",CC1(CC(CC(N1[O])(C)C)NC2=NC=NC3=C2NC=N3)C,,,,,,
881,3080882,"6-(2,2,6,6,-Tetramethylpiperidine-1-oxyl)-adenosine diphosphate",CC1(CC(CC(N1[O])(C)C)NC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)COP(=O)(O)OP(=O)(O)O)O)O)C,,,,,,
882,3080883,Mannopyranosyl-(1-4)-2-acetamido-2-deoxyglucopyranosyl-(1-4)-2-acetamido-2-deoxyglucopyranose,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O[C@H]([C@H](C=O)NC(=O)C)[C@@H]([C@@H](CO)O)O[C@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CO)O)O,,,,,,
883,3080884,CID 3080884,CC1=CC(=O)OC2=C1C=CC(=C2)N[C@H](C)C(=O)NC(=O)[C@@H]3CCCN3C(=O)[C@H](C)NC(=O)[C@@H](C)NC(=O)C,,,,,,
884,3080885,"8,15-Dihydroperoxyicosa-5,9,11,13-tetraenoic acid",CCCCCC(C=CC=CC=CC(CC=CCCCC(=O)O)OO)OO,,,,,,
885,3080886,"17-Hydroxy-19-norpregn-4-en-20-yn-3-one--estra-1(10),2,4-triene-3,17-diol (1/1)",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)O.C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2(C#C)O)CCC4=CC(=O)CC[C@H]34,,,,,,
886,3080887,17-epi-Norethindrone (Impurity G),C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2(C#C)O)CCC4=CC(=O)CC[C@H]34,,,,,,
887,3080888,Redta,CCCCCCCCCCCCCCCC[N+](C)(C)C.C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O.[Br-],,,,,,
888,3080889,"2,3,4-Tri-O-acetylarabinopyranosyl isothiocyanate",CC(=O)O[C@@H]1CO[C@@H]([C@H]([C@@H]1OC(=O)C)OC(=O)C)N=C=S,,,,,,
889,3080890,"Butanedioic acid, 2-(2-octen-1-yl)-",CCCCCC=CCC(CC(=O)O)C(=O)O,,,,,,
890,3080891,CID 3080891,CCCCC(C)(C)[C@@H](C=C[C@H]1[C@@H](CC(=O)[C@@H]1CC=CCCCC(=O)OC2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)NC(=O)C)O)O,,,,,,
891,3080892,Nelex,CC1=CC(=C(C=C1)S(=O)(=O)O)O.C=O,,,,,,
892,3080893,"2-N,4-N-diethyl-6-methylsulfinyl-1,3,5-triazine-2,4-diamine",CCNC1=NC(=NC(=N1)S(=O)C)NCC,,,,,,
893,3080894,Clinitest,C(C(=O)O)C(CC(=O)O)(C(=O)O)O.C(=O)(O)[O-].[OH-].[O-]S(=O)(=O)[O-].[Na+].[Na+].[Cu+2],,,,,,
894,3080895,"1,3,6,8,10,13,16,19-Octaazabicyclo-6,6,6-eicosanecobalt(II)",C1CNCN2CNCCNCN(CN1)CNCCNC2.[Co+2],,,,,,
895,3080896,"1,3,6,8,10,13,16,19-Octaazabicyclo[6.6.6]icosane",C1CNCN2CNCCNCN(CN1)CNCCNC2,,,,,,
896,3080897,Purin-6-yl 1-thio-beta-glucopyranosiduronic acid,C1=NC2=C(N1)C(=NC=N2)S[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O,,,,,,
897,3080898,"1,3-Selenazolidine-4-carboxylic acid",C1C(NC[Se]1)C(=O)O,,,,,,
898,3080899,Anethol sulfonic acid,CC=CC1=CC(=C(C=C1)OC)S(=O)(=O)O,,,,,,
899,3080900,"Pentanoic acid, 5-((iodoacetyl)amino)-",C(CCNC(=O)CI)CC(=O)O,,,,,,
900,3080901,H-Ala-gln-asp-phe-val-gln-trp-leu-met-asn-thr-OH,C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C)N)O,,,,,,
901,3080902,2-Ethylquinazoline,CCC1=NC2=CC=CC=C2C=N1,,,,,,
902,3080903,Glutamyl-glycyl-arginine chloromethyl ketone,C(C[C@@H](C(=O)CCl)NCC(=O)NC(=O)[C@H](CCC(=O)O)N)CN=C(N)N,,,,,,
903,3080904,Estrofem,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)O.C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]([C@@H]2O)O)CCC4=C3C=CC(=C4)O,,,,,,
904,3080905,N-Benzyloxycarbonylglycyl-glycyl-arginine-4-methylcoumarinyl-7-amide,CC1=CC(=O)OC2=C1C=CC(=C2)N[C@@H](CCCN=C(N)N)C(=O)NC(=O)CNC(=O)CNC(=O)OCC3=CC=CC=C3,,,,,,
905,3080906,"8,8-Difluoromyristic acid",CCCCCCC(CCCCCCC(=O)O)(F)F,,,,,,
906,3080907,Technetium oxine,C1=CC2=C(C(=C1)[O-])N=CC=C2.[Tc],,,,,,
907,3080908,CID 3080908,C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(OP(=O)(O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)S)O)O,,,,,,
908,3080909,"6,7-Dihydroxy-3-oxo-4-pregnene-21,17-carbolactone",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2(CCC(=O)O)O)C(CC4=CC(=O)C=C[C@]34C)O,,,,,,
909,3080910,CID 3080910,CC(C)CSC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C2NC=NC3=O)O)O,,,,,,
910,3080911,"3-Octadecyl-2-[5-(3-octadecyl-1,3-benzoxazol-3-ium-2-yl)penta-2,4-dienylidene]-1,3-benzoxazole;iodide",CCCCCCCCCCCCCCCCCCN1C2=CC=CC=C2OC1=CC=CC=CC3=[N+](C4=CC=CC=C4O3)CCCCCCCCCCCCCCCCCC.[I-],,,,,,
911,3080912,"3,3'-Dioctadecyloxacarbocyanine",CCCCCCCCCCCCCCCCCCN1C2=CC=CC=C2OC1=CC=CC=CC3=[N+](C4=CC=CC=C4O3)CCCCCCCCCCCCCCCCCC,,,,,,
912,3080913,Monothiopyrophosphoric acid,OP(=O)(O)OP(=S)(O)O,,,,,,
913,3080914,Phenoaldehyde,CC1=CC=CC=C1O.C=O.C1=CC(=CC(=C1)O)O,,,,,,
914,3080915,"Dapsone, methyluracil drug combination",CC1=CC(=O)NC(=O)N1.CC1=CC(=O)NC(=O)N1.C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,,,,,,
915,3080916,"1,2-Ditetradecylphosphatidylcholine",CCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OCCCCCCCCCCCCCC,,,,,,
916,3080917,"2-[2,3-Di(tetradecoxy)propoxy-hydroxyphosphoryl]oxyethyl-trimethylazanium",CCCCCCCCCCCCCCOCC(COP(=O)(O)OCC[N+](C)(C)C)OCCCCCCCCCCCCCC,,,,,,
917,3080918,alpha-Difluoromethyllysine,C(CCN)C[C@@](C(F)F)(C(=O)O)N.Cl,,,,,,
918,3080919,"(S)-2-(Difluoromethyl)-2,6-diaminohexanoic acid",C(CCN)C[C@@](C(F)F)(C(=O)O)N,,,,,,
919,3080920,Deoxyadenylyl-(3'-5')-deoxycytidylyl-(3'-5')-deoxyadenosine,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)N)C(C[C@@H]4[C@H](C[C@@H](O4)N5C=NC6=C(N=CN=C65)N)OP(=O)(O)O)OC[C@@H]7[C@H](C[C@@H](O7)N8C=CC(=NC8=O)N)OP(=O)(O)O)O,,,,,,
920,3080921,Dansylalanyllysine chloromethyl ketone,C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)CCl)NS(=O)(=O)C1=CC=CC2=C1C=CC=C2N(C)C,,,,,,
921,3080922,Poly(2-fluoroadenylic acid),C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)F)N,,,,,,
922,3080923,Methyl-O3-(alpha-D-mannose)-alpha-D-mannose,CO[C@@H]1[C@H]([C@H]([C@@H]([C@H](O1)CO)O)O[C@@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O,,,,,,
923,3080924,Utp-1-aminonaphthalene-5-sulfonate,C1=CC2=C(C=CC=C2S(=O)(=O)O)C(=C1)NP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=CC(=O)NC4=O)O)O,,,,,,
924,3080925,CID 3080925,C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)OCCC2=CN=C3C(=N2)C(=O)N=C(N3)N,,,,,,
925,3080926,"1H-Imidazole, 2-(2-benzofuranyl)-4,5-dihydro-",C1CN=C(N1)C2=CC3=CC=CC=C3O2,,,"['Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids. (See all compounds classified as Affinity Labels.)']",,,
926,3080927,"[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-[(2R,3R,4S,5S)-1-hydroxy-6-oxo-3,4,5-tris[[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]hexan-2-yl]oxyoxan-2-yl]methyl dihydrogen phosphate",C([C@@H]1[C@H]([C@@H]([C@@H]([C@H](O1)O[C@H](C=O)[C@H]([C@@H]([C@@H](CO)O[C@@H]2[C@H]([C@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)O)O[C@@H]3[C@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)O)O,,,,,,
927,3080928,"(R-(R*,S*))-3-(3-Cyclohexyl-3-hydroxypropyl)-2,5-dioxoimidazolidine-4-heptanoic acid",C1CCC(CC1)[C@@H](CCN2[C@H](C(=O)NC2=O)CCCCCCC(=O)O)O,,,,,,
928,3080929,"3-(2,6-Dimethylphenyl)-5-methylimidazolidine-2,4-dione",CC1C(=O)N(C(=O)N1)C2=C(C=CC=C2C)C,,,,,,
929,3080930,11-(9-Carbazolyl)undecanoic acid,C1=CC=C2C(=C1)C3=CC=CC=C3N2CCCCCCCCCCC(=O)O,,,,,,
930,3080931,Cyclex-2E,CNCC(=O)NCC(=O)N(C1(CCCCC1(CC2=CC=CC=C2)CC3=CC=CC=C3)C(=O)[C@H](CCC(=O)O)N)[C@@](C=O)(C(=O)C=NC(=O)CNC)C(=O)[C@H](CCC(=O)O)NC(=O)CNC4CCCCC4,,,,,,
931,3080932,N-((4-Azidophenyl)thio)phthalimide,C1=CC=C2C(=C1)C(=O)N(C2=O)SC3=CC=C(C=C3)N=[N+]=[N-],,,,,,
932,3080933,Dimethylaminonaphthalene-5-sulfonaminoethylmethylamine,CN(C)CCNS(=O)(=O)C1=CC=CC2=C1C=CC=C2N(C)C.Cl,,,,,,
933,3080934,N-[2-(Dimethylamino)ethyl]-5-(dimethylamino)-1-naphthalenesulfonamide,CN(C)CCNS(=O)(=O)C1=CC=CC2=C1C=CC=C2N(C)C,,,,,,
934,3080935,Thiamphenicol glycinate acetylcysteinate,CSC[C@@H](C=O)NC(=O)C(C(=O)OC[C@H]([C@@H](C1=CC=C(C=C1)S(=O)(=O)C)O)NC(=O)C(Cl)Cl)N,,,,,,
935,3080936,L-glutamic acid L-alanine,C[C@@H](C(=O)O)N.C(CC(=O)O)[C@@H](C(=O)O)N,,,,,,
936,3080937,Psyton,CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3.CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,,,,,,
937,3080938,"1,2-Bis(10,12-tricosadiynoyl)phosphatidylcholine",CCCCCCCCCCC#CC#CCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCC#CC#CCCCCCCCCCC,,,,,,
938,3080939,"1-O,2-O-Bis(1-oxo-10,12-tricosadiynyl)-L-glycero-3-phosphocholine",CCCCCCCCCCC#CC#CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCC#CC#CCCCCCCCCCC,,,,,,
939,3080940,Methacryloyl fluoride-methyl methacrylate copolymer,CC(=C)C(=O)OC.CC(=C)C(=O)F,,,,,,
940,3080941,"8-(2-Phenylethyl)-1-oxadiazaspiro(4,5)decan-2-one-2-thiophenecarboxylate",C1CN(CCC12CNC(=O)O2)CCC3=CC=CC=C3.C1=CSC(=C1)C(=O)O,,,,,,
941,3080942,Almagel,CCOC(=O)C1=CC=C(C=C1)N.[OH-].[OH-].[OH-].[OH-].[OH-].[Mg+2].[Al+3],,,,,,
942,3080943,CID 3080943,C1=CC2=C(C(=C1)NC(=O)C=CC(=O)OC(CC(=O)O)CN)C(=O)NNC2=O,,,,,,
943,3080944,CID 3080944,C1COC(O1)(COC2=CC=CC=C2)C=C[C@H]3[C@@H](C[C@@H]([C@@H]3CC=CCCCC(=O)O)O)O.C(C(CO)(CO)N)O,,,,,,
944,3080945,CID 3080945,C1COC(O1)(COC2=CC=CC=C2)C=C[C@H]3[C@@H](C[C@@H]([C@@H]3CC=CCCCC(=O)O)O)O,,,,,,
945,3080946,CID 3080946,CCCCCCCCCCCCCC=C[C@H]([C@H](COP(=O)([O-])OCC[N+](C)(C)C)NC(=O)CCCCCCCCCC=CC1=C2C=CC=CC2=CC3=CC=CC=C31)O,,,,,,
946,3080947,CID 3080947,CCCCCCCCCCCCCC=C[C@H]([C@H](COP(=O)(O)OCC[N+](C)(C)C)NC(=O)CCCCCCCCCC=CC1=C2C=CC=CC2=CC3=CC=CC=C31)O,,,,,,
947,3080948,Magurlit,CC1=NC=C(C(=C1O)CO)CO.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.C(C(=O)O)C(CC(=O)[O-])(C(=O)[O-])O.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+].[Mg+2].Cl.[K+].[K+].[K+],,,,,,
948,3080949,1-Octadecanoyl-2-decanoyl-sn-glycero-3-phosphocholine,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCC,,,,,,
949,3080950,[O-(1-O-Octadecanoyl-2-O-decanoyl-L-glycero-3-phospho)choline]anion,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCC,,,,,,
950,3080951,Esaft,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCC(=O)NCCCCCCNC(=S)NC4=CC5=C(C=C4)C6(C7=C(C=C(C=C7)O)OC8=C6C=CC(=C8)O)OC5=O)CCC9=C3C=CC(=C9)O,,,,,,
951,3080952,"(4R)-6-[2-[(1S,2S,6R,8aR)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]ethyl]-4-hydroxyoxan-2-one",C[C@@H]1CC[C@@H]2[C@H]([C@H](C=CC2=C1)C)CCC3C[C@H](CC(=O)O3)O,,,,,,
952,3080953,(2R)-2-amino-3-[(2-amino-2-carboxyethyl)disulfanyl]propanoic acid;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid,C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O.C([C@@H](C(=O)O)N)SSCC(C(=O)O)N,,,,,,
953,3080954,Poly(ribosylurea phosphate),C([C@@H]1[C@H]([C@H]([C@@H](O1)NC(=O)N)O)O)OP(=O)(O)O,,,,,,
954,3080955,4-O-Glucopyranosylmoranoline,C1CC(CNC1)O[C@@H]2[C@]([C@H](C([C@](O2)(CO)O)(O)O)O)(CO)O,,,['Compounds that inhibit or block the activity of GLYCOSIDE HYDROLASES such as ALPHA-AMYLASES and ALPHA-GLUCOSIDASES. (See all compounds classified as Glycoside Hydrolase Inhibitors.)'],,,
955,3080956,"beta-D-Glucopyranoside, (3alpha,12beta)-3-(beta-D-glucopyranosyloxy)-12-hydroxydammar-24-en-20-yl 6-O-beta-D-xylopyranosyl-",CC(=CCC[C@](C)(C1CC[C@]2(C1[C@H](CC3C2CCC4[C@@]3(CCC(C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)O)C)O[C@H]6[C@@H]([C@@H]([C@@H]([C@H](O6)CO[C@H]7[C@@H]([C@H]([C@@H](CO7)O)O)OC)O)O)O)C,,,,,,
956,3080957,Mannosyl(2)-N-acetyl(2)-glucose,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O[C@H]([C@H](C=O)NC(=O)C)[C@@H]([C@@H](CO)O[C@@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)CO)O)O,,,,,,
957,3080958,CID 3080958,CCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC([C@H](C(=O)O)N)C(=O)CC[C@@H](C(=O)O)N)C(=O)N[C@@H](C)C(=O)O,,,,,,
958,3080959,"6-[2-(2,6-Dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl)ethyl]-4-hydroxyoxan-2-one",C[C@@H]1CC[C@@H]2[C@H](C1)C=C[C@@H]([C@@H]2CC[C@@H]3C[C@H](CC(=O)O3)O)C,,,,,,
959,3080960,Labdane F2,C[C@@]12CCCC([C@H]1CC[C@]([C@@H]2CCC(=C)C=C)(C)O)(C)C,,,,,,
960,3080961,2-Methoxy-6-chloro-9-aminoacridinyl-N-pentamethylene tetrathymidylic acid,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)C[C@]3([C@@](C[C@@H](O3)N4C=C(C(=O)NC4=O)C)(CCCCCNC5=C6C=C(C=CC6=NC7=C5C=CC(=C7)Cl)OC)O)C(C[C@@H]8[C@H](C[C@@H](O8)N9C=C(C(=O)NC9=O)C)O)(C[C@@H]1[C@H](C[C@@H](O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OP(=O)(O)OP(=O)(O)O)OP(=O)(O)O)O,,,,,,
961,3080962,Penicillamine-glutathione mixed disulfide,CC(C)([C@H](C(=O)O)N)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N,,,,,,
962,3080963,Cyclo(val-pro-gly)4,CC(C)[C@@H](C(=O)N1CCC[C@H]1C=O)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@@H]3CCCN3C(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@H](C(C)C)NC(=O)C=N,,,,,,
963,3080964,Vinylpyridine-acrolein copolymer,C=CC=O.C=CC1=CC=CC=N1,,,,,,
964,3080965,Poly(N-isopropylacrylamide-N-tert-butylacrylamide)copolymer,CC(C)NC(=O)C=C.CC(C)(C)NC(=O)C=C,,,,,,
965,3080966,"(2S)-N-[(2R)-1-[(2S)-2-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-3-sulfanylpropan-2-yl]-2-[[(2R,3R)-3-methyl-2-[[(2S)-2-[[(2S,3S)-3-methyl-2-[[2-(2-sulfanylidenecyclohexyl)acetyl]amino]pentanoyl]amino]-3-phenylpropanoyl]amino]pentanoyl]amino]butanediamide",CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N)NC(=O)CC3CCCCC3=S,,,,,,
966,3080967,Daaccal,CC(C)C[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)[C@@H](C=S)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)NC(=O)[C@H](CCCN=C(N)N)NC,,,,,,
967,3080968,4-Nitro-tpala-dynorphin,CCN([C@H](CC(C)C)C(=O)N(C(=O)[C@H](CCCN=C(N)N)NC)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(C=C1)[N+](=O)[O-])N)C(=O)CNC(=O)CNC(=O)[C@H](CC2=CC=C(C=C2)O)NC,,,,,,
968,3080969,1-Methyl-5-(4-benzoyl)pyrrole-2-acetic acid 2-(theophylline-7-yl)ethyl ester,CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)OCCN3C=NC4=C3C(=O)N(C(=O)N4C)C,,,,,,
969,3080970,Dilipoyl lipid,C[N+](C)(C)CCOP(=O)([O-])OCC(COC(=O)CCCCCCCCCCCOC(=O)CCCCC1CSSC1)OC(=O)CCCCCCCCCCCOC(=O)CCCCC2CSSC2,,,,,,
970,3080971,"2-[2,3-Bis[12-[5-(dithiolan-4-yl)pentanoyloxy]dodecanoyloxy]propoxy-hydroxyphosphoryl]oxyethyl-trimethylazanium",C[N+](C)(C)CCOP(=O)(O)OCC(COC(=O)CCCCCCCCCCCOC(=O)CCCCC1CSSC1)OC(=O)CCCCCCCCCCCOC(=O)CCCCC2CSSC2,,,,,,
971,3080972,CID 3080972,CC1=CC=CC=C1OC(=O)[C@@H](C2=CSC=C2)C(=O)N[C@]3([C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-])OC.[Na+],,,,,,
972,3080973,CID 3080973,CC1=CC=CC=C1OC(=O)[C@@H](C2=CSC=C2)C(=O)N[C@]3([C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O)OC,,,,,,
973,3080974,7-Amino-8-iodoketanserin,C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=C(C(=C(C=C4)N)[125I])NC3=O,,,,,,
974,3080975,CID 3080975,C[C@@H]1[C@H](CC=CC=CC=C[C@@H](CC(=O)NC2=CC(=CC(=C2)CCC=C([C@@H]1O)C)O)OC)OC(=O)[C@H](C)NC(=O)CCC(C)C,,,,,,
975,3080976,Antho-rfamide,C1CC(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N,,,,,,
976,3080977,CID 3080977,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O.C1CN(CCN1CC=CC2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
977,3080978,"1-Cyclopropyl-7-(2,5-diazabicyclo[2.2.1]heptan-2-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid",C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CC5C[C@H]4CN5)F)C(=O)O,,,,,,
978,3080979,"N,N-Dimethyl-4-iodophentermine",CC(C)(CC1=CC=C(C=C1)I)N(C)C,,,,,,
979,3080980,Florical,C(=O)(O)[O-].C(=O)(O)[O-].[F-].[Na+].[Ca+2],,,,,,
980,3080981,Arizonin A1,CC1C2=C(C3[C@H](O1)CC(=O)O3)C(=O)C4=C(C2=O)C(=C(C=C4)O)OC,,,,,,
981,3080982,"2-[[(2S)-2-[[2-Acetamido-3-(4-hydroxyphenyl)prop-2-enoyl]amino]-3-(4-hydroxyphenyl)propyl]amino]-3-(3,4-dihydroxyphenyl)prop-2-enoic acid",CC(=O)NC(=CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)CNC(=CC3=CC(=C(C=C3)O)O)C(=O)O,,,,,,
982,3080983,CID 3080983,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2[C@H]([C@H](O[C@@H]([C@@H]2O[C@H]3[C@@H]([C@@H]([C@H]([C@@H](O3)C)O)O)O)OC4=C(OC5=CC(=O)C=C(C5=C4O)O)C6=CC=C(C=C6)O)CO)O)O)O)O,,,,,,
983,3080984,CID 3080984,C[C@@H](CCC(=O)C[C@@H](C(=O)O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)O,,,,,,
984,3080985,CID 3080985,CCCCC[C@@H](C=C[C@H]1[C@@H](C[C@H]2[C@@H]1CC(=C2)C(=C)CCCC(=O)O)O)O,,,,,,
985,3080986,N-butan-2-yl-1-(2-chlorophenyl)-N-(2-isothiocyanatoethyl)isoquinoline-3-carboxamide,CCC(C)N(CCN=C=S)C(=O)C1=CC2=CC=CC=C2C(=N1)C3=CC=CC=C3Cl,,,,,,
986,3080987,5-Methylcoumarin-4-gentiobioside,CC1=C2C(=CC=C1)OC(=O)C=C2O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)O,,,,,,
987,3080988,16-Acetoxy-7alpha-methoxyroyleanone,CC(COC(=O)C)C1=C(C2=C(C(=O)C1=O)[C@]3(CCCC([C@@H]3CC2OC)(C)C)C)O,,,,,,
988,3080989,CID 3080989,CCCC[C@@](C)(CC=C[C@H]1[C@@H](CC(=O)[C@@H]1CCC=C(CCC(=O)OC)F)O)O,,,,,,
989,3080990,CID 3080990,CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OC1[C@H]([C@H](C([C@H]([C@@H]1O)O)O)O)O)OC(=O)CCCCCNC2=CC=C(C3=NON=C23)N(O)O,,,,,,
990,3080991,Methyl (3-((hydroxymethyl)amino)-2-methyl-3-oxopropyl)methylphosphinate,CC(CP(=O)(C)OC)C(=O)NCO,,,,,,
991,3080992,21-Fluoroprednisone,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)C[18F])O)CCC4=CC(=O)C=C[C@]34C,,,,,,
992,3080993,Tiamdipine,CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)CSCCN,,,,,,
993,3080994,Arginyl-glycyl-aspartyl-phenylalanine,C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)N,,,,,,
994,3080995,"(2S)-N-[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[2-[[(4S)-8,9-diamino-2-methyl-6-methylsulfonyl-5,9-dioxononan-4-yl]amino]-2-oxoethyl]-methylamino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,5-dioxopentan-2-yl]-2-(3-aminopropanoylamino)pentanediamide",CC(C)C[C@@H](C(=O)C(CC(C(=O)N)N)S(=O)(=O)C)NC(=O)CN(C)C(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)NC(=O)CCN,,,,,,
995,3080996,CID 3080996,CC(=O)OC1=C(C=C(C=C1)C=CC(=O)N2CCCC2=O)OC(=O)C,,,,,,
996,3080997,"4-[3-(3,4-Dihydroxyphenyl)prop-2-enoylamino]butanoic acid",C1=CC(=C(C=C1C=CC(=O)NCCCC(=O)O)O)O,,,,,,
997,3080998,CID 3080998,C[C@@H]([C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@@H](CCC3=C)O)C)[C@H](CCC(C)C)O,,,,,,
998,3080999,4-(3-Chloropropyl)-2-piperazin-1-ylquinoline,C1CN(CCN1)C2=NC3=CC=CC=C3C(=C2)CCCCl,,,,,,
999,3081000,Tetrakis(3-aminopropyl)ammonium,C(CN)C[N+](CCCN)(CCCN)CCCN,,,,,,
1000,3081001,"5,5'-Dibromo-bapta",C1=CC(=C(C=C1Br)OCCOC2=C(C=CC(=C2)Br)N(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,,,,,,
1001,3081002,N-(8-benzyl-8-azabicyclo[3.2.1]octan-3-yl)-N-phenylpropanamide,CCC(=O)N(C1CC2CCC(C1)N2CC3=CC=CC=C3)C4=CC=CC=C4,,,,,,
1002,3081003,8-Peabomp,CCC(=O)N(C1CC2CCC(C1)N2CCC3=CC=CC=C3)C4=CC=C(C=C4)C,,,,,,
1003,3081004,8-N-(2-Ethylmorpholinyl)-8-azabicyclo(3.2.1)octane-3-propionanilide,CCC(=O)N(C1CC2CCC(C1)N2CCN3CCOCC3)C4=CC=CC=C4,,,,,,
1004,3081005,Aaphg-tfa,C1C[C@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)N)C(=O)C(CCN=C(N)N)[C@@](C(=O)CNC(=O)[C@@H]2C[C@H](CN2)O)(C(=O)O)N(C(=O)[C@H](CC3=CC=CS3)N)C(=O)[C@@H](CC4=CC=CC=C4)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CC=CS5)N.C(=O)(C(F)(F)F)O,,,,,,
1005,3081006,"(7-Chloro-6-fluoro-2-methyl-3,4-dihydro-2H-1-benzopyran-4-yl)ethaneperoxoic acid",C[C@@H]1C[C@@H](C2=CC(=C(C=C2O1)Cl)F)CC(=O)OO,,,,,,
1006,3081007,5-Hydroxyisoavrainvilleol,C1=C(C=C(C(=C1O)O)Br)CC2=C(C(=C(C=C2CO)O)O)Br,,,,,,
1007,3081008,Fluorovinylglycine,C=C(C(C(=O)O)N)F,,,,,,
1008,3081009,Fluoromethyl 2-methoxy-2-fluoro-1-(trifluoromethyl)vinyl ether,CO/C(=C(/C(F)(F)F)\OCF)/F,,,,,,
1009,3081010,CID 3081010,C[C@H](C(=O)N[C@@H](C)C(=O)NC(=O)[C@@H]1CCCN1[C@@H](C)C(=O)CCl)NC(=O)CCC(=O)OC,,,,,,
1010,3081011,"2,6-Bis(carboxymethyl)-4,4-dimethylmorpholinium",C[N+]1(C[C@@H](O[C@@H](C1)CC(=O)[O-])CC(=O)O)C,,,,,,
1011,3081012,"2-[(2S,6R)-6-(carboxymethyl)-4,4-dimethylmorpholin-4-ium-2-yl]acetic acid",C[N+]1(C[C@@H](O[C@@H](C1)CC(=O)O)CC(=O)O)C,,,,,,
1012,3081013,5-(2-Aminohexafluoroprop-2-yl)-2'-deoxyuridine,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)C(C(F)(F)F)(C(F)(F)F)N)CO)O,,,,,,
1013,3081014,CID 3081014,CC[C@@H](C1CC[C@@H]([C@@H](O1)C(=CC=C[C@H]2C=C[C@@H]3CCC[C@H]3[C@@H]2C(=O)C4=CC=CN4)CC)C)C(=O)O,,,,,,
1014,3081015,CID 3081015,C[C@H](CCC=C(C)C(=O)O)[C@H]1C[C@@H]([C@@]2([C@@]1(CC=C3C2=CCC4[C@@]3(CC[C@@H](C4(C)C)OC(=O)C)C)C)C)OC(=O)C,,,,,,
1015,3081016,Piperolactam A,COC1=C(C2=C3C(=C1)C(=O)NC3=CC4=CC=CC=C42)O,,,,,,
1016,3081017,N-(N-(Phenyl)butyryl-L-prolyl)pyrrolidine,C1CCN(C1)C(=O)[C@@H]2CCCN2C(=O)CCCC3=CC=CC=C3,,,,,,
1017,3081018,"(2R,3S,5R)-2-[[2-aminooxyethyl(methyl)amino]oxymethyl]-5-(6-aminopurin-9-yl)oxolan-3-ol",CN(CCON)OC[C@@H]1[C@H](C[C@@H](O1)N2C=NC3=C(N=CN=C32)N)O,,,,,,
1018,3081019,"N'-[(13S,17S)-3-methoxy-13-methyl-1,4,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-N,N,N'-trimethylpropane-1,3-diamine",C[C@]12CCC3C(C1CC[C@@H]2N(C)CCCN(C)C)CCC4=C3CC=C(C4)OC,,,,,,
1019,3081020,"4-Amino-N-(2-(diethylamino)ethyl)-3,5-dimethylbenzamide",CCN(CC)CCNC(=O)C1=CC(=C(C(=C1)C)N)C,,,,,,
1020,3081021,Bis-azo PC,CCCCC1=CC=C(C=C1)N=NC2=CC=C(C=C2)CCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCC3=CC=C(C=C3)N=NC4=CC=C(C=C4)CCCC,,,,,,
1021,3081022,"[O-[1-O,2-O-Bis[4-[4-(4-butylphenylazo)phenyl]butyryl]-L-glycero-3-phospho]choline]anion",CCCCC1=CC=C(C=C1)N=NC2=CC=C(C=C2)CCCC(=O)OC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCC3=CC=C(C=C3)N=NC4=CC=C(C=C4)CCCC,,,,,,
1022,3081023,"1-Propanesulfonic acid, 3-(cyclohexyl(dithiocarboxy)amino)-2-hydroxy-, disodium salt",C1CCC(CC1)N(CC(CS(=O)(=O)[O-])O)C(=S)[S-].[Na+].[Na+],,,,,,
1023,3081024,3-[Cyclohexyl(dithiocarboxy)amino]-2-hydroxypropane-1-sulfonic acid,C1CCC(CC1)N(CC(CS(=O)(=O)O)O)C(=S)S,,,,,,
1024,3081025,Peptide T amide,C[C@H]([C@@H](C(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](C)N)O,,,,,,
1025,3081026,"10-(3-Chlorophenyl)-6,8,9,10-tetrahydrobenzo(b)(1,8)-naphthyridine-5(7H)-one",C1CCC2=C(C1)C3=C(N=CC=C3)N(C2=O)C4=CC(=CC=C4)Cl,,,,,,
1026,3081027,4-[2-(4-Isopropylbenzamido)ethoxy]benzoic acid,CC(C)C1=CC=C(C=C1)C(=O)NCCOC2=CC=C(C=C2)C(=O)O,,,,,,
1027,3081028,8-Methyl-3-(4-methyl-1-piperazinyl)-2(1H)-quinolinone,CC1=C2C(=CC=C1)C=C(C(=O)N2)N3CCN(CC3)C.Cl,,,,,,
1028,3081029,8-methyl-3-(4-methylpiperazin-1-yl)-1H-quinolin-2-one,CC1=C2C(=CC=C1)C=C(C(=O)N2)N3CCN(CC3)C,,,,,,
1029,3081030,7-Amino-4-chloro-3-(3-isothiureidopropoxy)isocoumarin,C1=CC2=C(C=C1N)C(=O)OC(=C2Cl)OCCCSC(=N)N,,,,,,
1030,3081031,"4-Hydroxy-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline",CN1CC2=CC=CC=C2C(C1)(C3=CC=CC=C3)O,,,,,,
1031,3081032,Glutamic acid-arginine-alanine polymer,C[C@@H](C(=O)O)N.C(C[C@@H](C(=O)O)N)CN=C(N)N.C(CC(=O)O)[C@@H](C(=O)O)N,,,,,,
1032,3081033,"1-(3-Chloro-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone",CCCCCC(=O)C1=C(C(=C(C=C1O)OC)Cl)O,,,,,,
1033,3081034,Hmdra,C1[C@@H]2COCC(C23C=CC(=O)C=C3)C4=CC(=C(C=C41)O)O,,,,,,
1034,3081035,(S)-N-(2-((2-Amino-3-methyl-1-oxobutyl)amino)-2-deoxy-beta-D-glucopyranosyl)-N-octadecyldodecanamide,CCCCCCCCCCCCCCCCCCN([C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)NC(=O)[C@H](C(C)C)N)C(=O)CCCCCCCCCCC,,,,,,
1035,3081036,Dhmdr,C1C2C3=CC(=C(C=C3C[C@@](C24C=CC(=O)C=C4)(CO1)O)O)O,,,,,,
1036,3081037,N-Allyl-3-quinuclidinol,C=CC[N+]12CCC(CC1)C(C2)O,,,,,,
1037,3081038,Tyrosyl-prolyl-leucyl-glycine,CC(C)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC2=CC=C(C=C2)O)N,,,,,,
1038,3081039,"[1-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)ethylideneamino] acetate;hydrochloride",CC(=NOC(=O)C)C1=CCCN(C1)C.Cl,,,,,,
1039,3081040,"[1-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)ethylideneamino] acetate",CC(=NOC(=O)C)C1=CCCN(C1)C,,,,,,
1040,3081041,Heptyl phosphinate,CCCCCCCC(CP(=O)(C(C)N)O)C(=O)O,,,,,,
1041,3081042,N(4)-Chloroacetylcytarabine,C1=CN(C(=O)N=C1NC(=O)CCl)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
1042,3081043,Perimed,C=CN1CCCC1=O.OO.II,,,,,,
1043,3081044,"1-(2,4-Dihydroxyphenyl)-3-[2-(3,7-dimethylocta-2,6-dienyl)-3,4-dihydroxyphenyl]propan-1-one",CC(=CCCC(=CCC1=C(C=CC(=C1O)O)CCC(=O)C2=C(C=C(C=C2)O)O)C)C,,,,,,
1044,3081045,"(3R,5R)-3-(4-chlorophenyl)-3-(imidazol-1-ylmethyl)-2-methyl-5-[(4-methylphenyl)sulfanylmethyl]-1,2-oxazolidine",CC1=CC=C(C=C1)SC[C@H]2C[C@](N(O2)C)(CN3C=CN=C3)C4=CC=C(C=C4)Cl,,,,,,
1045,3081046,"2,3-dibromo-N-methoxypropan-1-imine",CON=CC(CBr)Br,,,,,,
1046,3081047,Ota-vasotocin,CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C=S)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC2=CC=C(C=C2)OC)C(=O)N)NC(=O)[C@H](CC3=CC=C(C=C3)O)NC(=O)CC4(CCCCC4)S,,,,,,
1047,3081048,2-Amino-3-chlorobut-3-enoic acid,C=C(C(C(=O)O)N)Cl,,,,,,
1048,3081049,3-Phenyl-3-(N-piperidinyl)bicyclo(3.1.0)hexane,C1CCN(CC1)C2(C[C@H]3C[C@H]3C2)C4=CC=CC=C4,,,,,,
1049,3081050,"Neurokinin B (4-10), beta-asp(4)-Me-phe(7)-",CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N(C(=O)C[C@@H](C(=O)O)N)C(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC2=CC=CC=C2)N)NC(=O)CNC(=O)[C@H](CC3=CC=CC=C3)NC,,,,,,
1050,3081051,"(3R,5R)-5-[(4-chlorophenoxy)methyl]-3-(4-chlorophenyl)-3-(imidazol-1-ylmethyl)-2-methyl-1,2-oxazolidine",CN1[C@@](C[C@@H](O1)COC2=CC=C(C=C2)Cl)(CN3C=CN=C3)C4=CC=C(C=C4)Cl,,,,,,
1051,3081052,Triethoxycholesterol galactose,C[C@H](CCCC(C)C)C1CCC2[C@@]1(CCC3C2CC=C4[C@@]3(CC[C@@H](C4)OCCOCCOCCO[C@H]5[C@@H]([C@H]([C@H]([C@H](O5)CO)O)O)O)C)C,,,,,,
1052,3081053,CID 3081053,CCCCCCCCCCCCCCC=COC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)C,,,,,,
1053,3081054,CID 3081054,CCCCCCCCCCCCCCC=COC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)C,,,,,,
1054,3081055,"1D-myo-inositol 3,4,6-trisphosphate",[C@H]1([C@@H]([C@@H]([C@H]([C@@H]([C@H]1OP(=O)(O)O)O)OP(=O)(O)O)OP(=O)(O)O)O)O,,,,,,
1055,3081056,5-Chloro-4-oxo-2-hexendioic acid,C(=CC(=O)O)C(=O)C(C(=O)O)Cl,,,,,,
1056,3081057,1-[4-(Hydroxyamino)phenoxy]-3-(propan-2-ylamino)propan-2-ol; oxalic acid,CC(C)NCC(COC1=CC=C(C=C1)NO)O.C(=O)(C(=O)O)O,,,,,,
1057,3081058,"2-Propanol, 1-[4-(hydroxyamino)phenoxy]-3-[(1-methylethyl)amino]-",CC(C)NCC(COC1=CC=C(C=C1)NO)O,,,,,,
1058,3081059,"4,8-Dimethyl-5'-acetylpsoralen",CC1=CC(=O)OC2=C1C=C3C=C(OC3=C2C)C(=O)C,,,,,,
1059,3081060,CID 3081060,C[C@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CO)NC(=O)[C@H](CO)N,,,,,,
1060,3081061,CID 3081061,CCCCC[C@H]1C(=CC=CCCCCCCCC(=O)O)O1,,,,,,
1061,3081062,"3-(Glutathion-S-yl)-1,4-naphthoquinone",C1=CC=C2C(=C1)C(=CC(=C2O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)O)N)O,,,,,,
1062,3081063,"Guanidine, N-(3-(3,4-difluorophenyl)-3-(2-pyridinyl)propyl)-N'-(3-(1H-imidazol-4-yl)propyl)-",C1=CC=NC(=C1)C(CCNC(=NCCCC2=CN=CN2)N)C3=CC(=C(C=C3)F)F,,,,,,
1063,3081064,"1-[3-(3,5-difluorophenyl)-3-pyridin-2-ylpropyl]-2-[3-(1H-imidazol-5-yl)propyl]guanidine",C1=CC=NC(=C1)C(CCNC(=NCCCC2=CN=CN2)N)C3=CC(=CC(=C3)F)F,,,,,,
1064,3081065,"3-Quinolinecarboxylic acid, 7-(4-amino-2-methyl-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-, monohydrochloride, (2S-trans)-",C[C@H]1C[C@@H](CN1C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=C(C=C(C=C4)F)F)F)N.Cl,,,,,,
1065,3081066,"4-[Bis(3,3-dimethylbutan-2-yloxy)phosphoryl]aniline",CC(C(C)(C)C)OP(=O)(C1=CC=C(C=C1)N)OC(C)C(C)(C)C,,,,,,
1066,3081067,"6-(2-Chlorophenyl)-8,9-dihydro-1-methyl-N,N-dipropyl-4H,7H-cyclopenta(4,5)thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine-8-carboxamide",CCCN(CCC)C(=O)C1CC2=C(C1)SC3=C2C(=NCC4=NN=C(N43)C)C5=CC=CC=C5Cl,,,,,,
1067,3081068,N-Chenodeoxycholyl-2-fluoro-beta-alanine,C[C@H](CCC(=O)NCC(C(=O)O)F)[C@H]1CCC2[C@@]1(CCC3C2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,,,,,,
1068,3081069,"4-Chloro-2-[2-hydroxy-3-[[2-methyl-1-[4-(4-methyl-6-oxo-4,5-dihydro-1H-pyridazin-3-yl)anilino]propan-2-yl]amino]propoxy]benzonitrile,(Z)-4-ethoxy-4-oxobut-2-enoic acid",CCOC(=O)C=CC(=O)O.CC1CC(=O)NN=C1C2=CC=C(C=C2)NCC(C)(C)NCC(COC3=C(C=CC(=C3)Cl)C#N)O,,,,,,
1069,3081070,"Argipressin, beta mercapto-beta,beta-cyclopentamethylenepropionic acid(1)-O-methyl-tyr(2)-tyrnh2(9)-",COC1=CC=C(C=C1)C[C@@H](C(=O)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C=S)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)CC5(CCCCC5)S,,,,,,
1070,3081071,Nnnnpbc,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)NC(=O)C)O[C@@H]3[C@H](O[C@H]([C@@H]([C@H]3O)NC(=O)C)OC4[C@H](O[C@H]([C@@H]([C@H]4O)NC(=O)C)O[C@@H]5[C@H](O[C@H]([C@@H]([C@H]5O)NC(=O)C)OC6=CC=C(C=C6)[N+](=O)[O-])CO)CO)CO)CO)CO)O)O,,,,,,
1071,3081072,"3-[(3R,4R)-4-(3-hydroxyphenyl)hexan-3-yl]phenol",CC[C@@H](C1=CC(=CC=C1)O)[C@@H](CC)C2=CC(=CC=C2)O,,,,,,
1072,3081073,"2-Chloro-2'-deoxy-3,7-dideazaadenosine",C1[C@@H]([C@H](O[C@@H]1N2C=CC3=C(N=C(C=C32)Cl)N)CO)O,,,,,,
1073,3081074,"2'-Deoxy-3,7-dideazaadenosine",C1[C@@H]([C@H](O[C@@H]1N2C=CC3=C2C=CN=C3N)CO)O,,,,,,
1074,3081075,Dspc-8B,CCCCCCCCCCC(CCCC)CCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC(CCCC)CCCCCCCCCC,,,,,,
1075,3081076,"2-[2,3-Bis(8-butyloctadecanoyloxy)propoxy-hydroxyphosphoryl]oxyethyl-trimethylazanium",CCCCCCCCCCC(CCCC)CCCCCCC(=O)OCC(COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCC(CCCC)CCCCCCCCCC,,,,,,
1076,3081077,"N-(2 (N-Methyl-3,4-dichlorophenylacetamido)-3-methylbutyl)pyrrolidine",CC(C)[C@@H](CN1CCCC1)N(C)C(=O)CC2=CC(=C(C=C2)Cl)Cl.Cl,,,,,,
1077,3081078,"1-[(2S)-2-[Methyl[(3,4-dichlorophenyl)acetyl]amino]-3-methylbutyl]pyrrolidine",CC(C)[C@@H](CN1CCCC1)N(C)C(=O)CC2=CC(=C(C=C2)Cl)Cl,,,,,,
1078,3081079,"7-[(4S)-5-[(1R)-1-hydroxyhepta-2,4,6-triynyl]-2-oxo-1,3-dioxolan-4-yl]heptanoic acid",C#CC#CC#C[C@H](C1[C@@H](OC(=O)O1)CCCCCCC(=O)O)O,,,,,,
1079,3081080,N(alpha)-((Acetylthio)acetyl)-phenylalanyl-prolyl-arginine chloromethyl ketone,CC(=O)SCC(=O)N[C@H](CC1=CC=CC=C1)C(=O)NC(=O)[C@@H]2CCCN2[C@@H](CCCN=C(N)N)C(=O)CCl,,,,,,
1080,3081081,CID 3081081,CCCC[C@@H](C(=O)N[C@@H](CC(=O)OS(=O)(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NC(=O)[C@@H](CC(=O)O)NC(=O)OC(C)(C)C)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@@H](CCCCN)NC[C@H](C=CC=C)NC(=O)[C@H](CC4=CC=C(C=C4)O)N,,,,,,
1081,3081082,"2-[(5S,8S,8aS)-3,8-dimethyl-2-oxo-4,5,6,7,8,8a-hexahydro-1H-azulen-5-yl]prop-2-enoic acid",C[C@H]1CC[C@@H](CC2=C(C(=O)C[C@@H]12)C)C(=C)C(=O)O,,,,,,
1082,3081083,"8,9-Dihydroxy-1-methylcoumestan",CC1=C2C(=CC=C1)OC(=O)C3=C2OC4=CC(=C(C=C43)O)O,,,,,,
1083,3081084,"3beta,7alpha-Dihydroxy-5-cholestenoate",C[C@H](CCCC(C)C(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C=C4[C@@]3(CC[C@@H](C4)O)C)O)C,,,,,,
1084,3081085,7alpha-Hydroxy-3-oxo-4-cholestenoic acid,C[C@H](CCCC(C)C(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](CC4=CC(=O)CC[C@]34C)O)C,,,,,,
1085,3081086,CID 3081086,C[C@H](C=C[C@H](C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@@H](CCC3=C)O)C.[O-][As](=O)([O-])[O-].[Na+].[Na+].[Na+],,,,,,
1086,3081087,3-Butyryl-4-(2-methylphenylamino)-8-methoxyquinoline,CCCC(=O)C1=CN=C2C(=C1NC3=CC=CC=C3C)C=CC=C2OC,,,,,,
1087,3081088,"(5S,12R)-5,12-Dihydroxy-20-oxoicosa-6,8,10,14-tetraenoic acid",C(CCC=O)CC=CC[C@H](C=CC=CC=C[C@H](CCCC(=O)O)O)O,,,,,,
1088,3081089,"(3-acetyloxy-2-hydroxypropyl) (1R,2S,4aS,4bS,10aS)-2,4a,8,8,10a-pentamethyl-2,3,4,4b,5,6,7,10-octahydro-1H-phenanthrene-1-carboxylate",C[C@H]1CC[C@]2([C@@H]3CCCC(C3=CC[C@]2([C@@H]1C(=O)OCC(COC(=O)C)O)C)(C)C)C,,,,,,
1089,3081090,CID 3081090,CC1=C(C=C(N=C1)C=CC2=CC=CC3=CC=CC=C32)N4CCCCC4.Cl,,,,,,
1090,3081091,5-Methyl-2-(2-naphthalen-1-ylethenyl)-4-piperidin-1-ylpyridine,CC1=C(C=C(N=C1)C=CC2=CC=CC3=CC=CC=C32)N4CCCCC4,,,,,,
1091,3081092,"5-((2-(Diethylamino)ethyl)amino)-7-methoxy-5,11-dihydro(1)benzoxepino(3,4-b)pyridine",CCN(CC)CCNC1C2=C(COC3=C1C=C(C=C3)OC)N=CC=C2,,,,,,
1092,3081093,CID 3081093,CCC1=C(C(=CC=C1)OC)OCCNCCCC2=C(C(=C(C=C2CC#N)OC)OC)OC.C(=CC(=O)O)C(=O)O,,,,,,
1093,3081094,"2-[2-[3-[2-(2-Ethyl-6-methoxyphenoxy)ethylamino]propyl]-3,4,5-trimethoxyphenyl]acetonitrile",CCC1=C(C(=CC=C1)OC)OCCNCCCC2=C(C(=C(C=C2CC#N)OC)OC)OC,,,,,,
1094,3081095,Sodium iodide I-124,[Na+].[124I-],,,,,,
1095,3081096,CID 3081096,C1C[C@@H]2[C@H]([C@@H]([C@@H]1O2)CC=CCCCC(=O)O)C=CC(COC3=CC=C(C=C3)F)O,,,,,,
1096,3081097,2-(3-Aminopropylamino)ethaneperthiol,C(CN)CNCCSS,,,,,,
1097,3081098,Mhptca,COC(=O)[C@@H]1CSC(=N1)C2=CC=CC=C2O,,,,,,
1098,3081099,Paphnr,CC1(CC(=NNC(=O)[C@H]2[C@@H]([C@H](C3=CC4=C(C=C3[C@H]2C5=CC(=C(C(=C5)OC)OC)OC)OCO4)O)CO)CC(N1[O])(C)C)C,,,,,,
1099,3081100,"Methyl 7-phenyldibenz(a,j)anthracene-14-carboxylate",COC(=O)C1=C2C(=C(C3=C1C4=CC=CC=C4C=C3)C5=CC=CC=C5)C=CC6=CC=CC=C62,,,,,,
1100,3081101,8-Pentanoylneosolaniol,CCCCC(=O)O[C@H]1C[C@]2([C@@H](C=C1C)O[C@@H]3[C@@H]([C@H]([C@]2(C34CO4)C)OC(=O)C)O)COC(=O)C,,,,,,
1101,3081102,App-MP,C1=NC2=C(C(=N1)N)N=CN=C2N[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O,,,,,,
1102,3081103,Appchcl-ppa,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OC[C@@H]4[C@H]([C@H]([C@@H](O4)N5C=NC6=C(N=CN=C65)N)O)OP(=O)(C(P(=O)(O)O)Cl)O)O)O)N,,,,,,
1103,3081104,Aglycone C,COC1=CC=CC2=C1C(=O)C3=C(C4=C(CC(CC4)(C(CO)O)O)C(=C3C2=O)O)O,,,,,,
1104,3081105,"4-[2-Hydroxy-3-[[2-methyl-1-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]propan-2-yl]amino]propoxy]-1,3-dihydrobenzimidazol-2-one",CC(C)(CNC1=CC=C(C2=NON=C12)[N+](=O)[O-])NCC(COC3=CC=CC4=C3NC(=O)N4)O,,,,,,
1105,3081106,Bssda,CC1(COC(N1[O])(CCCC(=O)ON2C(=O)CC(C2=O)S(=O)(=O)O)CCCC(=O)ON3C(=O)CC(C3=O)S(=O)(=O)O)C,,,,,,
1106,3081107,CID 3081107,C[C@@H](C(=O)N[C@H](C)C(=O)NC(=O)[C@H](CC1=CC=CC=C1)NC2=CC=C(C=C2)C(=O)O)NC(CCC3=CC=CC=C3)C(=O)O,,,,,,
1107,3081108,1-(N2-Nicotinoyl-L-lysyl-gamma-D-glutamyl)octahydro-1H-indole-2-carboxylic acid,C1CC[C@H]2[C@@H](C1)C[C@H](N2C(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)C3=CN=CC=C3)C(=O)O,,,,,,
1108,3081109,CID 3081109,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=C(C(=O)NC2=O)F)O)O)OC(=O)CCCCCCCCCCCCCCC.[Na+],,,,,,
1109,3081110,"Inositol 1,4-bisphosphate 5-phosphorothioate",[C@@H]1([C@H]([C@@H]([C@H]([C@@H]([C@H]1OP(=O)(O)O)O)OP(=S)(O)O)OP(=O)(O)O)O)O,,,,,,
1110,3081111,Fluorescein isothiocyanate-phenylglyoxal,C1=CC(=CC=C1C(=O)C=O)NC(=S)NC2=CC3=C(C=C2)C4(C5=C(C=C(C=C5)O)OC6=C4C=CC(=C6)O)OC3=O,,,,,,
1111,3081112,3-Benzylglycidol,C1=CC=C(C=C1)C[C@@H]2[C@H](O2)CO,,,,,,
1112,3081113,"2-(2-Dimethylaminoethyl)5-benzylidene-6-methyl-(2h,4h)-3-pyridazinone",CC1=NN(C(=O)CC1=CC2=CC=CC=C2)CCN(C)C,,,,,,
1113,3081114,"12-[Methyl-(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]octadecanoic acid",CCCCCCC(CCCCCCCCCCC(=O)O)N(C)C1=CC=C(C2=NON=C12)[N+](=O)[O-],,,,,,
1114,3081115,CID 3081115,C1=CC(=C(C=C1C2=COC3=C(C(=O)C=CC3=C2O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O,,,,,,
1115,3081116,3-Hydroxybutanoic acid;4-hydroxybutanoic acid,CC(CC(=O)O)O.C(CC(=O)O)CO,,,,,,
1116,3081117,3-Methoxy-4-hydroxyclomiphene,CCN(CC)CCOC1=CC=C(C=C1)/C(=C(\C2=CC=CC=C2)/Cl)/C3=CC(=C(C=C3)O)OC,,,,,,
1117,3081118,1-(Phenyl)-1-(4-(2-(diethylamino)-ethoxy)phenyl)-2-(4-hydroxyphenyl)-2-chloroethane,CCN(CC)CCOC1=CC=C(C=C1)/C(=C(\C2=CC=C(C=C2)O)/Cl)/C3=CC=CC=C3,,,,,,
1118,3081119,1-(4-(2-(Diethylamino)ethoxy)-phenyl)-1-(phenyl)-2-(3-methoxy-4-hydroxyphenyl)-2-chloroethane,CCN(CC)CCOC1=CC=C(C=C1)/C(=C(\C2=CC(=C(C=C2)O)OC)/Cl)/C3=CC=CC=C3,,,,,,
1119,3081120,tert-Butyloxycarbonyl-leucyl-glycyl-arginine-4-trifluoromethylcoumarin-7-amide,CC(C)C[C@@H](C(=O)NCC(=O)NC(=O)[C@H](CCCN=C(N)N)NC1=CC2=C(C=C1)C(=CC(=O)O2)C(F)(F)F)NC(=O)OC(C)(C)C,,,,,,
1120,3081121,"14,15-Setyo",C[C@@]1(CC[C@H]2[C@H](C1)CCC3=C2C=CC(=C3)O)[C@H]([13C]#[13CH])O,,,,,,
1121,3081122,8-Azido-p3A3,C1=NC(=C2C(=N1)N(C(N2)(N=[N+]=[N-])N=[N+]=[N-])[C@H]3[C@@H]([C@@H]([C@H](O3)C(C[C@@H]4[C@H]([C@H]([C@@H](O4)N5C6=NC=NC(=C6N=C5N=[N+]=[N-])N)O)O)(C[C@@H]7C(=C([C@@H](O7)N8C=NC9=C(N=CN=C98)N)O)O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N,,,,,,
1122,3081123,"2'-Deoxy-8,5'-cycloadenosine",C1[C@@H]([C@H]2[C@H](C3=NC4=C(N=CN=C4N3[C@@H]1O2)N)O)O,,,,,,
1123,3081124,Tyrosyl-prolyl-arginine,C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O,,,,,,
1124,3081125,"2-Methyl-4-carboxy-5-hydroxy-3,4,5,6-tetrahydropyrimidine",CC1=NCC(C(N1)C(=O)O)O,,,,,,
1125,3081126,"12(r)-Hydroxy-5,8,14-eicosatrienoic acid",CCCCCC=CC[C@@H](CCC=CCC=CCCCC(=O)O)O,,,,,,
1126,3081127,CID 3081127,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CC(C[C@@H]3[C@H](C[C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)([C@@H]6[C@H](C[C@@H](O6)N7C=NC8=C7NC(=NC8=O)N)O)OC[C@@H]9[C@H](C[C@@H](O9)N1C=CC(=NC1=O)N)O)OP(=O)(O)OP(=O)(O)OP(=O)(O)O,,,,,,
1127,3081128,"Pyridine-2,4-dicarboxylic-diethylamide",CCNC(=O)C1=CC(=NC=C1)C(=O)NCC,,,,,,
1128,3081129,3-(Methylamino)pyridyl salicylate,CNC1=CN=CC=C1.C1=CC=C(C(=C1)C(=O)O)O,,,,,,
1129,3081130,"1,2-Diundecanoylphosphatidylethanolamine",CCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC,,,,,,
1130,3081131,1-Methyl-4-(2-naphthalen-1-ylethenyl)piperidine;hydrochloride,CN1CCC(CC1)C=CC2=CC=CC3=CC=CC=C32.Cl,,,,,,
1131,3081132,1-Methyl-4-(2-naphthalen-1-ylethenyl)piperidine,CN1CCC(CC1)C=CC2=CC=CC3=CC=CC=C32,,,,,,
1132,3081133,"(2S)-2-[[2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S,3S)-2-[[(2S)-2-[[(2S,3R)-3-hydroxy-2-[[(2S)-pyrrolidine-2-carbonyl]amino]butanoyl]amino]-3-(4H-imidazol-4-yl)propanoyl]amino]-3-methylpentanoyl]amino]hexanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]acetyl]amino]butanedioic acid",CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC3C=NC=N3)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]4CCCN4,,,,,,
1133,3081134,CID 3081134,C1[C@@H]([C@@H]([C@H]([C@@H]1O)C=CC(CCC2=CC=C(C=C2)N=[N+]=[N-])O)CC=CCCCC(=O)O)O,,,,,,
1134,3081135,"2',3',5'-Trichloro-2',3',5'-trideoxy-2',3'-secouridine",C1=CN(C(=O)NC1=O)[C@@H](CCl)OC(CCl)CCl,,,,,,
1135,3081136,"2',3',5'-Trichloro-2',3'-5'-trideoxy-5-fluoro-2',3'-secouridine",C1=C(C(=O)NC(=O)N1[C@@H](CCl)OC(CCl)CCl)F,,,,,,
1136,3081137,4-Hydroxy-3-methoxymethamphetamine,CC(CC1=CC(=C(C=C1)O)OC)NC,,,,,,
1137,3081138,"15-Hydroxy-14-iodoicosa-5,8,11-trienoic acid",CCCCCC(C(CC=CCC=CCC=CCCCC(=O)O)I)O,,,,,,
1138,3081139,CID 3081139,C1CCC(CC1)C(C=CC2C(CC(C2CC=CCCCC(=O)O)Cl)O)O,,,,,,
1139,3081140,CID 3081140,C1CCC(CC1)C(C=CC2C(CC(C2CC=CCCCC(=O)O)F)O)O,,,,,,
1140,3081141,"N-(4-Hydroxyphenyl)-N-(1,1,1-trifluoro-2-propyl)-4-hydroxybenzamide",CC(C(F)(F)F)N(C1=CC=C(C=C1)O)C(=O)C2=CC=C(C=C2)O,,,,,,
1141,3081142,26-Thiacholesterol,C[C@H](CCC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)CS,,,,,,
1142,3081143,N-(3-Iodo-4-azidophenylpropionamido)-S-(2-thiopyridyl)cysteine,C1=CC=NC(=C1)SSC[C@@H](C(=O)O)NC(=O)CCC2=CC(=C(C=C2)N=[N+]=[N-])I,,,,,,
1143,3081144,"1-Benzoyl-7-chloro-1,2-dihydro-3-aminoquinoxaline",C1C(=NC2=C(N1C(=O)C3=CC=CC=C3)C=C(C=C2)Cl)N,,,,,,
1144,3081145,Preparation B 100,CC1=C(CCCC1)C(C)C.CC1=C(CC=CC1)C(C)C.CC1=CC=CC=C1C(C)C,,,,,,
1145,3081146,"1,2-Di-(heptacosadiynoyl)-sn-glycero-3-phosphocholine",CCCCCCCCCCCCCC#CC#CCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCC#CC#CCCCCCCCCCCCCC,,,,,,
1146,3081147,"2-[[(2R)-2,3-di(heptacosa-11,13-diynoyloxy)propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium",CCCCCCCCCCCCCC#CC#CCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCC#CC#CCCCCCCCCCCCCC,,,,,,
1147,3081148,"4-Acetamido-4'-maleimidylstilbene-2,2'-disulfonic acid",CC(=O)NC1=CC(=C(C=C1)C=CC2=C(C=C(C=C2)N3C(=O)C=CC3=O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
1148,3081149,8-Hexanoylneosolaniol,CCCCCC(=O)O[C@H]1C[C@]2([C@@H](C=C1C)O[C@@H]3[C@@H]([C@H]([C@]2(C34CO4)C)OC(=O)C)O)COC(=O)C,,,,,,
1149,3081150,"2,2,3,3,5,5-Hexamethyl-1-pyrrolidinyloxyl",CC1(CC(N(C1(C)C)[O])(C)C)C,,,,,,
1150,3081151,"But-2-enedioic acid;[4-(3-phenylpropyl)piperazin-1-yl]-(2-pyridin-3-yl-1,3-thiazolidin-4-yl)methanone",C1CN(CCN1CCCC2=CC=CC=C2)C(=O)C3CSC(N3)C4=CN=CC=C4.C(=CC(=O)O)C(=O)O,,,,,,
1151,3081152,1-(3-Phenylpropyl)-4-[2-(3-pyridyl)thiazolidin-4-ylcarbonyl]piperazine,C1CN(CCN1CCCC2=CC=CC=C2)C(=O)C3CSC(N3)C4=CN=CC=C4,,,,,,
1152,3081153,2'-Demethylpiritrexim,CC1=C2C(=NC(=NC2=NC=C1CC3=C(C=CC(=C3)OC)O)N)N,,,,,,
1153,3081154,5'-Demethylpiritrexim,CC1=C2C(=NC(=NC2=NC=C1CC3=C(C=CC(=C3)O)OC)N)N,,,,,,
1154,3081155,"5-[[4-[(3,4-Dichlorophenyl)sulfonylamino]phenyl]sulfonylamino]-2-[2-[4-[[4-[(3,4-dichlorophenyl)sulfonylamino]phenyl]sulfonylamino]-2-sulfophenyl]ethenyl]benzenesulfonic acid",C1=CC(=CC=C1NS(=O)(=O)C2=CC(=C(C=C2)Cl)Cl)S(=O)(=O)NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)NS(=O)(=O)C5=CC=C(C=C5)NS(=O)(=O)C6=CC(=C(C=C6)Cl)Cl)S(=O)(=O)O)S(=O)(=O)O,,,,,,
1155,3081156,Methyl 3-(2-quinolinylmethoxy)benzeneacetohydroxamate,CONC(=O)CC1=CC(=CC=C1)OCC2=NC3=CC=CC=C3C=C2,,,,,,
1156,3081157,"Diisopropyl 2,3-dimercaptosuccinate",CC(C)OC(=O)[C@@H]([C@@H](C(=O)OC(C)C)S)S,,,,,,
1157,3081158,Bis(maleimidoethoxy)propane,CC(C)(OCCN1C(=O)C=CC1=O)OCCN2C(=O)C=CC2=O,,,,,,
1158,3081159,"Benzenesulfonic acid, 2-amino-4-chloro-5-fluoro-",C1=C(C(=CC(=C1Cl)F)S(=O)(=O)O)N,,,,,,
1159,3081160,Adodatad,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CSC(CCCCCNCCCN)CCN)O)O)N,,,,,,
1160,3081161,Cordil,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3CC[C@]5([C@@]4(CC[C@@H]5C(=O)OC)N)C)C)O)O)O,,,,,,
1161,3081162,5'-Deoxy-5'-((monofluoromethyl)thio)adenosine,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CSCF)O)O)N,,,,,,
1162,3081163,Levomecol,CC1=CNC(=O)NC1=O.C1=CC(=CC=C1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],,,,,,
1163,3081164,CID 3081164,CC1=CC(=C(C=C1)CNNC=NC(=O)C2=C(N=C(C(=N2)Cl)NCC3=CC=C(C=C3)Cl)N)C,,,,,,
1164,3081165,5-(3-Aminopropyl)-2'-deoxyuridine,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)CCCN)CO)O,,,,,,
1165,3081166,"1,2-Epoxy-3-(paranitrophenyl)propane",CCC[C@@H]1[C@H](O1)C2=CC=C(C=C2)[N+](=O)[O-],,,,,,
1166,3081167,"2-Pyrrolidinone, 1-(4-((2-chloroethyl)methylamino)-2-butynyl)-5-methyl-, monohydrochloride",CC1CCC(=O)N1CC#CCN(C)CCCl.Cl,,,,,,
1167,3081168,N-(4-((2-Chloroethyl)methylamino)-2-butynyl)-5-methyl-2-pyrrolidone,CC1CCC(=O)N1CC#CCN(C)CCCl,,,,,,
1168,3081169,1-[4-[2-Bromoethyl(methyl)amino]but-2-ynyl]-5-methylpyrrolidin-2-one;oxalic acid,CC1CCC(=O)N1CC#CCN(C)CCBr.C(=O)(C(=O)O)O,,,,,,
1169,3081170,N-(4-((2-Bromoethyl)methylamino)-2-butynyl)-5-methyl-2-pyrrolidone,CC1CCC(=O)N1CC#CCN(C)CCBr,,,,,,
1170,3081171,Bis(sulfosuccinimidyl)tartrate,C1C(C(=O)N(C1=O)OC(=O)C(C(C(=O)ON2C(=O)CC(C2=O)S(=O)(=O)O)O)O)S(=O)(=O)O,,,,,,
1171,3081172,CID 3081172,C1=CC(=CC=C1C(=O)N[C@@H](CCCN)C(=O)O)NCC2=CC3=C(C=C2)NC(=NC3=O)N,,,,,,
1172,3081173,1-O-(N-Dansyl-11-amino-1-undecyl)-2-O-decanoylphosphatidylcholine,CCCCCCCCCC(=O)O[C@H](COCCCCCCCCCCCNS(=O)(=O)C1=CC=CC2=C1C=CC=C2N(C)C)COP(=O)([O-])OCC[N+](C)(C)C,,,,,,
1173,3081174,2-[[(2R)-2-decanoyloxy-3-[11-[[5-(dimethylamino)naphthalen-1-yl]sulfonylamino]undecoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCC(=O)O[C@H](COCCCCCCCCCCCNS(=O)(=O)C1=CC=CC2=C1C=CC=C2N(C)C)COP(=O)(O)OCC[N+](C)(C)C,,,,,,
1174,3081175,Azido-N-(4-aminophenethyl)spiperone,C1CN(CCC12CN(CN2C3=CC=CC=C3)CCC4=CC=C(C=C4)N=[N+]=[N-])CCCC(=O)C5=CC=C(C=C5)F,,,,,,
1175,3081176,CID 3081176,C1[C@H](C[C@@H]([C@H]1COP(=O)(O)O)O)N2C=NC3=C2NC(=NC3=O)N,,,,,,
1176,3081177,Di-(isobutyl)dimercaptosuccinate,CC(C)COC(=O)[C@@H]([C@@H](C(=O)OCC(C)C)S)S,,,,,,
1177,3081178,Di-(isoamyl)dimercaptosuccinate,CC(C)CCOC(=O)[C@@H]([C@@H](C(=O)OCCC(C)C)S)S,,,,,,
1178,3081179,CID 3081179,C1=NC(=O)C2=C(N1)N=CN2O,,,,,,
1179,3081180,Sapriparaquinone,CC1=C(C2=C(C=C1)C(=C(C(=O)C2=O)C(C)C)O)CCCC(C)C,,,,,,
1180,3081181,Bbdoaed,CCCCCCCC[N+](C)(C)CCSSCC[N+](C)(C)CCCCCCCC.[Br-].[Br-],,,,,,
1181,3081182,2-[2-[Dimethyl(octyl)azaniumyl]ethyldisulfanyl]ethyl-dimethyl-octylazanium,CCCCCCCC[N+](C)(C)CCSSCC[N+](C)(C)CCCCCCCC,,,,,,
1182,3081183,2-N-Carboxamidonormianserin,C1CN2C(CN1C(=O)N)C3=CC=CC=C3CC4=CC=CC=C42,,,,,,
1183,3081184,Degrck,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)N[C@@H](C(CC(=O)O)CCl)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)O,,,,,,
1184,3081185,Nerispirdine,CCCN(C1=C(C=NC=C1)F)N2C=C(C3=CC=CC=C32)C,,,,,,
1185,3081186,N-(4-pyridinyl)-1H-indol-1-amine,C1=CC=C2C(=C1)C=CN2NC3=CC=NC=C3,,,,,,
1186,3081187,"(6R,8S,10S,11S,13S,14S)-9-fluoro-6,11-dihydroxy-10,13-dimethyl-17-methylsulfonyl-7,8,11,12,14,15-hexahydro-6H-cyclopenta[a]phenanthren-3-one",C[C@]12C[C@@H](C3([C@H]([C@@H]1CC=C2S(=O)(=O)C)C[C@H](C4=CC(=O)C=C[C@@]43C)O)F)O,,,,,,
1187,3081188,"N-(3,5-Difluorophenyl)-2-pyridinecarbothioamide",C1=CC=NC(=C1)C(=S)NC2=CC(=CC(=C2)F)F,,,,,,
1188,3081189,"6-Carboxymethyl-2-hydroxy-2-pentadecyl-5,5-dimethylmorpholinium",CCCCCCCCCCCCCCC[C@]1(C[N+](C[C@@H](O1)CC(=O)O)(C)C)O.[Br-],,,,,,
1189,3081190,"2-[(2S,6S)-6-hydroxy-4,4-dimethyl-6-pentadecylmorpholin-4-ium-2-yl]acetic acid",CCCCCCCCCCCCCCC[C@]1(C[N+](C[C@@H](O1)CC(=O)O)(C)C)O,,,,,,
1190,3081191,"Pentanoic acid, 5-(dipentylamino)-5-oxo-4-((3-quinolinylcarbonyl)amino)-, (R)-",CCCCCN(CCCCC)C(=O)[C@@H](CCC(=O)O)NC(=O)C1=CC2=CC=CC=C2N=C1,,,,,,
1191,3081192,"1-Methyl-3-phenyl-1,2,3,6-tetrahydropyridine",CN1CC=CC(C1)C2=CC=CC=C2,,,,,,
1192,3081193,Dpsgtc,C[N+](C)(C)CCN([C@@H](CC1=CC=C(C=C1)O)C(=O)NC(=O)CN)C(=O)CCSSCCC(=O)ON2C(=O)CC(C2=O)S(=O)(=O)O.[Cl-],,,,,,
1193,3081194,"2-[[(2S)-1-[(2-aminoacetyl)amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-[3-[[3-(2,5-dioxo-3-sulfopyrrolidin-1-yl)oxy-3-oxopropyl]disulfanyl]propanoyl]amino]ethyl-trimethylazanium",C[N+](C)(C)CCN([C@@H](CC1=CC=C(C=C1)O)C(=O)NC(=O)CN)C(=O)CCSSCCC(=O)ON2C(=O)CC(C2=O)S(=O)(=O)O,,,,,,
1194,3081195,Preussin,CCCCCCCCCC1CC(C(N1C)CC2=CC=CC=C2)O,,,,,,
1195,3081196,"(5S)-6-[6-[(3R)-3-hydroxyundeca-1,5-dienyl]pyridin-2-yl]hexane-1,5-diol",CCCCCC=CC[C@H](C=CC1=CC=CC(=N1)C[C@H](CCCCO)O)O,,,,,,
1196,3081197,N-((4-Methylphenyl)sulfonyl)-3-(2-quinolinylmethoxy)benzamide,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)C2=CC(=CC=C2)OCC3=NC4=CC=CC=C4C=C3,,,,,,
1197,3081198,Thiogar,C([C@@H]1[C@H]([C@H]([C@@H](O1)NC(=O)CS)O)O)OP(=O)(O)O,,,,,,
1198,3081199,"2'-O-Triflyl-2,3'-anhydroxylosyluracil",C1=CN2[C@H]3[C@@H]([C@H]([C@@H](O3)CO)OC2=NC1=O)OS(=O)(=O)C(F)(F)F,,,,,,
1199,3081200,N-Benzyloxycarbonyl-leucyl-valyl-glycine diazomethane,CC(C)C[C@@H](C(=O)NC(=O)[C@H](C(C)C)NCC(=O)C=[N+]=[N-])NC(=O)OCC1=CC=CC=C1,,,,,,
1200,3081201,CID 3081201,CC(C)C[C@@H](C(=O)NC(=O)[C@H](C(C)C)NCC(=C[N+]#N)O)NC(=O)OCC1=CC=CC=C1,,,,,,
1201,3081202,1-O-(12-(2-Iodophenyl)dodecyl)-2-O-methylglycero-3-phosphocholine,C[N+](C)(C)CCOP(=O)([O-])OCC(COCCCCCCCCCCCCC1=CC(=CC=C1)[125I])OC,,,,,,
1202,3081203,2-[hydroxy-[3-[12-(3-(125I)iodanylphenyl)dodecoxy]-2-methoxypropoxy]phosphoryl]oxyethyl-trimethylazanium,C[N+](C)(C)CCOP(=O)(O)OCC(COCCCCCCCCCCCCC1=CC(=CC=C1)[125I])OC,,,,,,
1203,3081204,Luffolide,CC(=O)O[C@H](C[C@@H]1[C@H](CC[C@H]2[C@]1(CC[C@@H]3[C@@]2(CCCC3(C)C)C)C)C=O)C4=CC(=O)O[C@H]4O,,,,,,
1204,3081205,CID 3081205,C1=CC(=C(C=C1C[C@H](C(=O)O)OC(=O)C=CC2=C3[C@@H]([C@H](OC3=C(C=C2)O)C4=CC(=C(C=C4)O)O)C(=O)OC(CC5=CC(=C(C=C5)O)O)C(=O)O)O)O,,,,,,
1205,3081206,"2',5'-Dideoxyadenosine 3'-(4-(fluorosulfonyl)benzoate)",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)N)CO)C4=C(C=CC(=C4)S(=O)(=O)F)C(=O)O,,,,,,
1206,3081207,Fioricet,CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C.CC(=O)NC1=CC=C(C=C1)O.CN1C=NC2=C1C(=O)N(C(=O)N2C)C,,,"['Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)']",,,
1207,3081208,Ursometh,CC1CCC(C(C1)O)C(C)C.C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,,,,,,
1208,3081209,CID 3081209,CCCCCC[C@H](C=C[C@@H]1[C@H](C[C@@H]2[C@H]1CC(=C2)CCCCC(=O)O)O)O,,,,,,
1209,3081210,Acetyl-arginyl-glycyl-aspartyl-serinamide,CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N,,,,,,
1210,3081211,"1-(2-Methylphenyl)-4-methylamino-6-methyl-2,3-dihydropyrrolo(3,2-c)quinoline",CC1=C2C(=CC=C1)C3=C(CCN3C4=CC=CC=C4C)C(=N2)NC,,,['Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX. (See all compounds classified as Proton Pump Inhibitors.)'],,,
1211,3081212,Fulvotomentoside A,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@H](CO[C@H]2O[C@H]3CC[C@@]4([C@H]5CC=C6[C@H]7CC(CC[C@@]7(CC[C@]6([C@@]5(CCC4C3(C)CO)C)C)C(=O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O)O)O)(C)C)C)O)O[C@@H]1[C@@H]([C@H]([C@@H](CO1)O)O)O)O)O)O,,,,,,
1212,3081213,CID 3081213,C([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)O[C@@H]([C@@H]([C@@H](CO)O)O)[C@H](C(=O)[O-])O[C@@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O)O)O)O.[K+],,,,,,
1213,3081214,"(2R,3S,4R,5R)-4,5,6-trihydroxy-2,3-bis[[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]hexanoic acid",C([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)O[C@@H]([C@@H]([C@@H](CO)O)O)[C@H](C(=O)O)O[C@@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O)O)O)O,,,,,,
1214,3081215,"3-(4-(2-((Methoxycarbonyl)oxy)-3-(((octadecylamino)carbonyl)oxy)propoxy)-4-oxobutyl)-, hydroxide, (R)-thiazolium",CCCCCCCCCCCCCCCCCCNC(=O)OC[C@@H](COC(=O)CCC[N+]1=CSC=C1)OC(=O)OC.[OH-],,,,,,
1215,3081216,"[(2R)-2-methoxycarbonyloxy-3-(octadecylcarbamoyloxy)propyl] 4-(1,3-thiazol-3-ium-3-yl)butanoate",CCCCCCCCCCCCCCCCCCNC(=O)OC[C@@H](COC(=O)CCC[N+]1=CSC=C1)OC(=O)OC,,,,,,
1216,3081217,"1,2-Di-O-tetradecyl-3-O-(6-O-glucopyranosyl-glucopyranosyl)glycerol",CCCCCCCCCCCCCCO[C@@]1([C@@H]([C@H](O[C@H]([C@@]1(O)OCCCCCCCCCCCCCC)OCCC)CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O,,,,,,
1217,3081218,N2LL Poly(amido-amine)-polyurethane copolymer,CNCCCCNC.C=CC(=O)N1CCN(CC1)C(=O)C=C.C(CCCN=C=O)CCN=C=O,,,,,,
1218,3081219,"(8R,9S,10R,13S,14S)-17-hydroxy-17-(6-(125I)iodanylhex-1-ynyl)-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2(C#CCCCC[125I])O)CCC4=CC(=O)CC[C@H]34,,,,,,
1219,3081220,6-(5-Hydroxy-2-pyridylmethylamino)-9-beta-ribofuranosylpurine,C1=CC(=NC=C1O)CNC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O,,,,,,
1220,3081221,Vanillal S 10026,CCOC1=C(C=CC(=C1)C=O)O.C1=CC=C(C=C1)CO,,,,,,
1221,3081222,CID 3081222,C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NC(=O)[C@H](CC1=CN=CN1)N[C@H](CC(C)C)CN[C@@H](CC2=CC=CC=C2)C(=O)N)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H](CC5=CC=CC6=CC=CC=C65)N,,,,,,
1222,3081223,Fadgg,C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H](O[C@@H]([C@@H]2O)CO)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)NC(=O)C)NC(=O)C)O)O)O,,,,,,
1223,3081224,4-Nitrophenyl O-beta-galactopyranosyl-(1-4)-O-(2-acetamido-2-deoxy-beta-glucopyranosyl)-(1-3)-beta-galactopyranoside,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O[C@]2([C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)C3=CC=C(C=C3)[N+](=O)[O-])CO)O)O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O,,,,,,
1224,3081225,CID 3081225,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](C(=O)O)NC(=O)C1=C(C(=C(C=C1)N=[N+]=[N-])I)O)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
1225,3081226,Phosphoglyceroyl-ATP,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)OP(=O)(O)OCCOC(=O)O)O)N,,,,,,
1226,3081227,Lasilacton,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CCC([C@]4(CC3)C)(CCC(=O)O)O)C.C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,,,,,,
1227,3081228,CID 3081228,C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)SC=C=CC(=O)Br)N,,,,,,
1228,3081229,i-Pr-Tfm,CC1(O[C@@H]2[C@H]([C@H](O[C@@H]2O1)C3=CC(=O)NC3=O)O)C,,,,,,
1229,3081230,"8,11-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-6-methoxy-1,2,3,4-tetrahydro-7,12-benz(a)anthraquinone",COC1=C2C(=C3CCCCC3=C1)C(=O)C4=C(C=CC(=C4C2=O)NCCNCCO)NCCNCCO,,,,,,
1230,3081231,S-(2-Aldehydoethyl)glutathione,C(CSC[C@@H](C(=O)N(CC(=O)O)C(=O)CC[C@@H](C(=O)O)N)N)C=O,,,,,,
1231,3081232,14-O-Palmitoylhydroxyrubicin,CCCCCCCCCCCCCCCC(=O)OCC(=O)[C@]1(C[C@@H](C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)O[C@@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)O)O,,,,,,
1232,3081233,Shiraiachrome A,CC(=O)C1C2=C(C(=C(C3=CC(=C4C(=CC(=O)C5=C4C3=C2C6=C(C1(C)O)C=C(C(=O)C65)OC)OC)OC)O)O)OC,,,,,,
1233,3081234,"3-Acetylimino-6-[3,6-bis(dimethylamino)xanthen-9-ylidene]cyclohexa-1,4-diene-1-carboxylic acid",CC(=O)N=C1C=CC(=C2C3=C(C=C(C=C3)N(C)C)OC4=C2C=CC(=C4)N(C)C)C(=C1)C(=O)O,,,,,,
1234,3081235,"(2aR-(2aalpha,4beta,4abeta,5alpha,6beta,9alpha,11beta,12alpha,12aalpha,12balpha))-3,4,4a,5,6,9,10,11,12,12a-Decahydro-4a,8,13,13-tetramethyl-7,14-methano-1H-cyclodeca(3,4)benz(1,2-b)oxete-4,5,6,9,12,12b(2aH)-hexol 4,5,6,9,12b-pentaacetate 12-benzoate",CC1=C2[C@H]([C@@H]([C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@H](C2(C)C)C[C@@H]1OC(=O)C)OC(=O)C5=CC=CC=C5)(CO4)OC(=O)C)OC(=O)C)C)OC(=O)C)OC(=O)C,,,,,,
1235,3081236,"[(2R,3R,4R,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[2-(dimethylaminomethylideneamino)purin-9-yl]-3-hydroxyoxolan-2-yl]methoxy-N-ethenyl-N-ethylphosphonamidic acid",CCN(C=C)P(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=CN=C(N=C32)N=CN(C)C)O[Si](C)(C)C(C)(C)C)O,,,,,,
1236,3081237,CID 3081237,CC=CCOP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=CN=C(N=C32)N=CN(C)C)O[Si](C)(C)C(C)(C)C)O,,,,,,
1237,3081238,"(1R,2R,4aS,6aR,8R,9R,10aS,12aS)-9-acetyloxy-2,4a,7,7,10a,12a-hexamethyl-2-(3-methylbutan-2-yl)-3-oxo-8-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4,5,6,6a,8,9,10,11,12-decahydrochrysene-1-carboxylic acid",CC(C)C(C)[C@@]1([C@@H]([C@@]2(CCC3=C([C@]2(CC1=O)C)CC[C@@H]4[C@@]3(C[C@H]([C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)OC(=O)C)C)C)C(=O)O)C,,,,,,
1238,3081239,CID 3081239,CN1CC(=O)N=C1N.C1=C2C(=CNC2=C(C(=C1O)O)F)CCN.OS(=O)(=O)O,,,,,,
1239,3081240,"3-(2-aminoethyl)-7-fluoro-1H-indole-5,6-diol",C1=C2C(=CNC2=C(C(=C1O)O)F)CCN,,,,,,
1240,3081241,"3-(2-aminoethyl)-4-fluoro-1H-indole-5,6-diol;2-amino-3-methyl-4H-imidazol-5-one;sulfuric acid",CN1CC(=O)N=C1N.C1=C2C(=C(C(=C1O)O)F)C(=CN2)CCN.OS(=O)(=O)O,,,,,,
1241,3081242,"3-(2-aminoethyl)-4-fluoro-1H-indole-5,6-diol",C1=C2C(=C(C(=C1O)O)F)C(=CN2)CCN,,,,,,
1242,3081243,"N-[(1S)-1-amino-3-[(2S)-2-[(E,6S)-6-amino-2-[(4R)-4-amino-2-(4-hydroxyphenyl)-3-oxo-5-phenylpentanimidoyl]-9-(diaminomethylideneamino)-3-formyl-4,5-dioxonon-2-enoyl]pyrrolidin-1-yl]-3-oxopropyl]formamide",C1C[C@H](N(C1)C(=O)C[C@@H](N)NC=O)C(=O)/C(=C(\C=O)/C(=O)C(=O)[C@H](CCCN=C(N)N)N)/C(=N)C(C2=CC=C(C=C2)O)C(=O)[C@@H](CC3=CC=CC=C3)N,,,,,,
1243,3081244,Methyl green-platinum complex,CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)[N+](C)(C)C.[Cl-].[Cl-].[Cl-].[Cl-].[Pt+2],,,,,,
1244,3081245,Galp-glcpnac-manp-(glcpnac)-(galp-glpnac-manp)-manp-glcnac,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)NC(=O)C)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)O[C@H]5[C@@H]([C@H]([C@H]([C@H](O5)CO)O)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)NC(=O)C)O[C@@H]7[C@H]([C@H]([C@@H]([C@H](O7)CO)O)O[C@H]8[C@@H]([C@H]([C@H]([C@H](O8)CO)O)O)O)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)NC(=O)C)CO)O)O,,,,,,
1245,3081246,CID 3081246,CCCCCCCCCCCCCCCCOCC(COP(=O)O)OCCCCCCCCCCCCCCCC.CCN(CC)CC,,,,,,
1246,3081247,CID 3081247,CCCCCCCCCCCCCCCCOCC(COP(=O)O)OCCCCCCCCCCCCCCCC,,,,,,
1247,3081248,CID 3081248,CCC#CC[C@H](C)[C@@H](C=C[C@H]1[C@@H](C[C@H]2[C@@H]1CC(=C2)C=CCCC(=O)O)O)O,,,,,,
1248,3081249,CID 3081249,C1C[C@H](N(C1)C(=O)CNC(=O)[C@H](C=CCN=C(N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N,,,,,,
1249,3081250,Arg(hyp(3)-thi(5)-tic(7)-tic(8))-bradykinin,C1C[C@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)N)C(=O)[C@@](C(O)O)([C@](CCN=C(N)N)(C(C2=NC=CC3=CC=CC=C32)O)C(=O)C4C5=CC=CC=C5CCN4)N(C(=O)CNC(=O)[C@@H]6C[C@H](CN6)O)C(=O)[C@H](CO)NC(=O)[C@H](CC7=CC=CS7)N,,,,,,
1250,3081251,Acmptn,CP(=S)(O)OC[C@@H]1C(=C[C@@H](O1)N2C=NC3=C(N=CN=C32)N)O,,,,,,
1251,3081252,CID 3081252,CC(C)C[C@H]([C@@H](CSC1=CC=CC=C1)C(=O)NO)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)NC,,,,,,
1252,3081253,"N-[(2S,3R,4R,5S,6R)-4-[(2R,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-methoxyoxan-2-yl]oxy-5-hydroxy-6-(hydroxymethyl)-2-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-methyloxan-2-yl]oxyoxan-3-yl]acetamide",CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O[C@]2([C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)C)CO)O)O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)OC,,,,,,
1253,3081254,CID 3081254,C[C@H](C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC1C=NC=N1)C(=O)N[C@@H](CC(C)C)C(=O)OC)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H](CC4=CC=CC=C4)N,,,,,,
1254,3081255,7-Methyl-10-bromoacetamidomethylcamptothecin,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=CC5=C4C)CNC(=O)CBr)O,,,,,,
1255,3081256,"3-Azido-4-[2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-enyl]benzoic acid",CC(=CC1=C(C=C(C=C1)C(=O)O)N=[N+]=[N-])C2=CC3=C(C=C2)C(CCC3(C)C)(C)C,,,,,,
1256,3081257,Peptide 78,C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O,,,,,,
1257,3081258,CID 3081258,CC1COC2(CC1OC(=O)C=CC3=CC=CC=C3)C(C4CCC(CC4O2)C(=O)OC5C(C(C(C(O5)C)O)O)OC6C(C(C(C(O6)C)O)O)O)(CO)O,,,,,,
1258,3081259,CID 3081259,C[C@H]1[C@@H](C[C@@H]([C@]2(CO2)[C@H](C[C@@H]3CC=C[C@H](O3)C[C@H]([C@H](C=C(C=CC(=O)O[C@@H]1[C@@H](C)[C@H]([C@@H](C)CCC(=O)[C@H](C)[C@@H]([C@H](C)C=CN(C)C=O)OC)O)C)O)O)OC)OC)OC,,,,,,
1259,3081260,Kapurimycin A2,CCC1C(O1)(C)C2=CC(=O)C3=C(C=C4C=C5C(CCC(=O)C5=C(C4=C3O2)O)OC(=O)C)CC(=O)O,,,,,,
1260,3081261,"1,10-dihydroxy-8-methyl-12-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxynaphtho[1,2-c]isochromen-6-one",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=C3C(=C4C(=C2)C5=C(C=C(C=C5O)C)C(=O)O4)C=CC=C3O)O)O)O,,,,,,
1261,3081262,CID 3081262,CC(C(=O)O)O.C1CSS[C@@H]1CCCCC(=O)O,,,,,,
1262,3081263,1-(3-(2-Methoxy-3-(2-methylpropylamino)propoxy)-4-methyl-2-thienyl)-3-phenyl-1-propanone hydrochloride,CC1=CSC(=C1OCC(CNCC(C)C)OC)C(=O)CCC2=CC=CC=C2.Cl,,,,,,
1263,3081264,1-[3-[2-Methoxy-3-[(2-methylpropyl)amino]propoxy]-4-methyl-2-thienyl]-3-phenyl-1-propanone,CC1=CSC(=C1OCC(CNCC(C)C)OC)C(=O)CCC2=CC=CC=C2,,,,,,
1264,3081265,CID 3081265,C[C@H](C(=O)C1=CC=C(C=C1)C[C@@H](C(=O)N)NC2=CC3=CC=CC=C3C(=C2)OC)NC(=O)[C@@H](C)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)CCCC(=O)O,,,,,,
1265,3081266,"3-(2-aminoethyl)-4,7-difluoro-1H-indole-5,6-diol;2-amino-3-methyl-4H-imidazol-5-one;sulfuric acid",CN1CC(=O)N=C1N.C1=C(C2=C(N1)C(=C(C(=C2F)O)O)F)CCN.OS(=O)(=O)O,,,,,,
1266,3081267,"3-(2-aminoethyl)-4,7-difluoro-1H-indole-5,6-diol",C1=C(C2=C(N1)C(=C(C(=C2F)O)O)F)CCN,,,,,,
1267,3081268,Nicotinamide 8-azidoadenine dinucleotide,C1C=CN(C=C1C(=O)N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C5=NC=NC(=C5N=C4N=[N+]=[N-])N)O)O)O)O,,,,,,
1268,3081269,"Adipokinetic hormone, beetle",CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CO)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N)NC(=O)[C@@H]5CCC(=O)N5,,,,,,
1269,3081270,CID 3081270,C[C@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NC(=O)[C@H](CC4=CN=CN4)N[C@H](CC(C)C)CN[C@@H](CC(C)C)C(=O)N)N,,,,,,
1270,3081271,Flurbiprofen N-(3-(3-(1-piperidinylmethyl)phenoxy)propyl)-2-(2-hydroxyethylthio)acetamide,CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)OCCSCC(=O)NCCCOC3=CC=CC(=C3)CN4CCCCC4,,,,,,
1271,3081272,(2S)-2-[[(2S)-2-[(2-amino-4-methylpentyl)-methylamino]-4-methylpentanoyl]amino]-N-[(2S)-3-(1H-indol-3-yl)-1-oxo-1-[[(2S)-1-oxo-1-(2-oxoethylideneamino)-3-phenylpropan-2-yl]amino]propan-2-yl]pentanediamide,CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N=CC=O)N(C)CC(CC(C)C)N,,,,,,
1272,3081273,CID 3081273,C[C@]1(CC[C@H]2[C@]1(CCCC2=CC=C3COC(OCC3=C)(C)C)C)CCCCC(C)(C)O,,,,,,
1273,3081274,N-Myristoyl-arginyl-lysyl-arginyl-threonyl-leucyl-arginyl-arginyl-leucine,CCCCCCCCCCCCCCN[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)O,,,,,,
1274,3081275,6-Aipp-fsk,CC(=O)O[C@H]1[C@H]([C@@H]2[C@]([C@H](CCC2(C)C)O)([C@@]3([C@@]1(O[C@@](CC3=O)(C)C=C)C)O)C)OC(=O)NCCNC(=O)CCC4=CC(=C(C=C4)N=[N+]=[N-])[125I],,,,,,
1275,3081276,"[(6S,8S,10S,11S,13S,14S,16R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate;2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol",CCC(=O)OC1([C@@H](C[C@@H]2[C@@]1(C[C@@H](C3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF.C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,,,,,,
1276,3081277,"[(6S,8S,10S,11S,13S,14S,16R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1([C@@H](C[C@@H]2[C@@]1(C[C@@H](C3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF,,,,,,
1277,3081278,CID 3081278,C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2C[C@H]([C@]4(C3(CC[C@@H]4C5=CC(=O)OC5)O)C)O)OCC(=O)NCCCCCC(=O)NCC=CC6=CN(C(=O)NC6=O)[C@H]7CCC(O7)COP(=O)(O)OP(=O)(O)OP(=O)(O)O,,,,,,
1278,3081279,5-Azido-udp-glucuronic acid,C1=C(C(=O)NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O[32P](=O)(O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O)O)O)N=[N+]=[N-],,,,,,
1279,3081280,1-Vinyl-3-methylimidazole-maleic acid diethyl ester copolymer,CC/C(=C(\CC)/C(=O)O)/C(=O)O.C[N+]1=CN(C=C1)C=C.[I-],,,,,,
1280,3081281,Diethylmaleic acid,CC/C(=C(\CC)/C(=O)O)/C(=O)O,,,,,,
1281,3081282,CID 3081282,C1=CC=C(C=C1)C[C@H](C(=O)N[C@@H](C=CCN=C(N)N)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CCCCN)C(=O)N)NC(=O)[C@H](CC4C=NC=N4)NC(=O)[C@H](CC=O)N,,,,,,
1282,3081283,4-(125I)Iododexetimide,C1CN(CCC1C2(C(CC(=O)NC2=O)[125I])C3=CC=CC=C3)CC4=CC=CC=C4,,,,,,
1283,3081284,Spiroprop,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O.CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CCC([C@]4(CC3)C)(CCC(=O)O)O)C,,,,,,
1284,3081285,Phenylalanyl-cysteinyl-tyrosyl-tryptophyl-lysyl-threonyl-cysteinyl-N-naphthylalanine amide,C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)NC(=O)[C@H](CC1=CC2=CC=CC=C2C=C1)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CC=C(C=C5)O)NC(=O)[C@H](CS)NC(=O)[C@@H](CC6=CC=CC=C6)N)O,,,,,,
1285,3081286,CID 3081286,CCCCCC=CCC=CCCCCCCCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H](C3=CCC2C1)CC[C@@H]4[C@H](C)C=C[C@H](C)C(C)C)C)C,,,,,,
1286,3081287,CID 3081287,C[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)N,,,,,,
1287,3081288,Cyclo(glycyl-arginyl-glycyl-aspartyl-seryl-aspartyl-alanyl),C[C@@H](C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C=O)C(=O)N[C@@H](CC(=O)O)C=O)N,,,,,,
1288,3081289,4-Ethyl-2-propyl-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methylimidazole-5-carboxylic acid,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)CC,,,,,,
1289,3081290,"Di-2',8'-O-di-5',5'-N,N-methylstreptonigrone",CC1=C(C(=C(N=C1OC)C2=NC3=C(C=C2)C(=O)C(=C(C3=O)N)OC)N(C)C)C4=C(C(=C(C=C4)OC)OC)OC,,,,,,
1290,3081291,Hipdsha,CC/C(=C(/CC)\C1=CC=C(C=C1)OCCCCCC(=O)NCCC2=CC(=C(C=C2)O)[125I])/C3=CC=C(C=C3)O,,,,,,
1291,3081292,CID 3081292,CCCCCC=CCCCNP(=O)(O)OC[C@@H]1C[C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O,,,,,,
1292,3081293,CID 3081293,C1[C@@H]2C=C(C[C@@H]2[C@H]([C@@H]1O)C=C[C@H](CCCCC3=CC(=CC=C3)N=[N+]=[N-])O)CCCCC(=O)O,,,,,,
1293,3081294,"(1R,3R)-1-N,3-N-bis(7-chloroquinolin-4-yl)cyclohexane-1,3-diamine",C1C[C@H](C[C@@H](C1)NC2=C3C=CC(=CC3=NC=C2)Cl)NC4=C5C=CC(=CC5=NC=C4)Cl,,,,,,
1294,3081295,CID 3081295,C1=CC=C(C=C1)[C@@H](C=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](C=CCN=C(N)N)N,,,,,,
1295,3081296,CID 3081296,CC(C)C[C@@H](CP(=O)(CN1C(=C2C=C(C(=O)C3=CC=CC(=C32)C1=O)Br)O)O)C(=O)N[C@H]4CCCCCCCCCCNC4=O,,,,,,
1296,3081297,Glucosyl-O-galactosyl-(1-4)glucoside,C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)CO)O)O)O)O)O)O,,,,,,
1297,3081298,"[2-[(1S,2S,4S,6R,8S,9S,11S,12S,13R)-6-cyclohexyl-11-hydroxy-9,13-dimethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] 2-methylpropanoate",CC(C)C(=O)OCC(=O)[C@@]12[C@H](C[C@@H]3[C@@]1(C[C@@H]([C@H]4[C@H]3CCC5=CC(=O)C=C[C@]45C)O)C)O[C@H](O2)C6CCCCC6,,,,,,
1298,3081299,Protactin,CC1CC[C@H](N1C(=O)[C@@H](C(=C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)C2=C(C(=C(C=C2)C)O)N)C(=O)N(C)CC(=O)N(C)[C@H](C=O)C(C)C,,,,,,
1299,3081300,N-Methyl-N-(1-phenyl-2-(3-hydroxypyrrolidine-1-yl)ethyl)-2-aminophenylacetamide dihydrochloride,CN([C@H](CN1CC[C@@H](C1)O)C2=CC=CC=C2)C(=O)CC3=CC=CC=C3N,,,,,,
1300,3081301,"[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] N,N-dipropylcarbamate",CCCN(CCC)C(=O)OC1=CC2=C(C=C1)[C@H]3CC[C@]4([C@H]([C@@H]3CC2)CCC4=O)C,,,,,,
1301,3081302,"Benz(g)isoquinoline-5,10-dione, 6,9-bis((2-aminoethyl)amino)-, (2Z)-2-butenedioate (1:2)",C1=CC(=C2C(=C1NCCN)C(=O)C3=C(C2=O)C=NC=C3)NCCN.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,,,,,,
1302,3081303,1-Hydroxy-2-(N-acetylcysteinyl)-3-butene,CC(=O)N[C@@H](CSC(CO)C=C)C(=O)O,,,,,,
1303,3081304,Diclosulam,CCOC1=NC(=CC2=NC(=NN21)S(=O)(=O)NC3=C(C=CC=C3Cl)Cl)F,,,,,,
1304,3081305,"[(2R,5S)-5-(6-amino-5-fluoro-2,4-dioxo-1H-pyrimidin-3-yl)-1,3-oxathiolan-2-yl]methyl-[hydroxy(phosphonooxy)phosphoryl]oxyphosphinic acid",C1[C@H](O[C@H](S1)CP(=O)(O)OP(=O)(O)OP(=O)(O)O)N2C(=O)C(=C(NC2=O)N)F,,,,,,
1305,3081306,2-(4-Hydroxyphenoxy)acetic acid-formaldehyde polymer,C=O.C1=CC(=CC=C1O)OCC(=O)O.N,,,,,,
1306,3081307,"beta-Alanine, N-((6-((4-acetyl-2-ethyl-5-hydroxyphenoxy)methyl)-2-pyridinyl)carbonyl)-N-ethyl-",CCC1=CC(=C(C=C1OCC2=NC(=CC=C2)C(=O)N(CC)CCC(=O)O)O)C(=O)C,,,,,,
1307,3081308,Arg-arg-pro-hyp-gly-phe-ser-hype (transpropyl)-oic-arg,CCCO[C@H]1C[C@@H](NC1)C(=O)N(C(=O)C2C[C@@H]3CCCC[C@@H]3N2)[C@@](C(CCN=C(N)N)C(=O)[C@@H]4CCCN4C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)N)(C(=O)[C@H](CO)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)CNC(=O)[C@@H]6CC(CN6)O)C(=O)O,,,,,,
1308,3081309,"(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2R,3R,4R,5R)-3,5-dihydroxy-2,4-dimethyloctadecanoyl]amino]-3,3-dimethylpent-4-enoyl]amino]-3-hydroxybutanoyl]amino]-3-oxopropanoic acid",CCCCCCCCCCCCC[C@H]([C@@H](C)[C@H]([C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C=O)C(=O)O)C(C)(C)C=C)O)O,,,,,,
1309,3081310,CID 3081310,CCCCCC=CCCCCCC[C@H]([C@@H](C)[C@H]([C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N([C@@H](COS(=O)(=O)O)C=O)C(=O)[C@H]([C@@H](C)OC(=O)C)N)O)O,,,,,,
1310,3081311,"1,2-Bis(12-methoxydodecanoyl)-sn-glycero-3-phosphocholine",C[N+](C)(C)CCOP(=O)([O-])OC[C@@H](COC(=O)CCCCCCCCCCCOC)OC(=O)CCCCCCCCCCCOC,,,,,,
1311,3081312,"(2S)-2-amino-N-[(2S)-1-[[(4S,5R,7S)-7-[[(2R)-1-[[(2S)-2-aminopropanoyl]amino]-1-oxopropan-2-yl]amino]-5,6-dihydroxy-2,9-dimethyldecan-4-yl]amino]-1-oxopropan-2-yl]propanamide",C[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@H](C([C@H](CC(C)C)N[C@H](C)C(=O)NC(=O)[C@H](C)N)O)O)N,,,,,,
1312,3081313,"[(2S,3S,5R)-3-azido-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl (8S,9S,10R,13S,14S)-11-hydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-17-carboxylate",CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COC(=O)C3CC[C@@H]4[C@@]3(CC([C@H]5[C@H]4CCC6=CC(=O)CC[C@]56C)O)C)N=[N+]=[N-],,,,,,
1313,3081314,Choad-azt,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COC(=O)C3C(C[C@@H]4[C@@]3(CC([C@H]5[C@H]4CCC6=CC(=O)C=C[C@]56C)O)C)C#N)N=[N+]=[N-],,,,,,
1314,3081315,Morpholine urea-phenylalanyl-homophenylalanine methyl fluoride,C1COCCN1C(=O)NC(CC2=CC=CC=C2)C(=O)N[C@@H](CCC3=CC=CC=C3)C(=O)CF,,,,,,
1315,3081316,CID 3081316,C1=CC(=CC=C1C=CS(=O)C2=NC3=C(N2[C@H]4C=C([C@H](O4)COP(=O)(O)O)O)NC(=NC3=O)N)N=[N+]=[N-],,,,,,
1316,3081317,"N-[1-cyclohexyl-5-(2,2-dimethylpropylcarbamoyl)-3-hydroxy-6-methylheptan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide",CC(C)C(CC(C(CC1CCCCC1)NC(=O)C(CC(=O)N)NC(=O)C2=NC3=CC=CC=C3C=C2)O)C(=O)NCC(C)(C)C,,,,,,
1317,3081318,6-[3-[(N'-tert-butyl-N-cyanocarbamimidoyl)amino]phenyl]-6-pyridin-3-ylhex-5-enoic acid,CC(C)(C)N=C(NC#N)NC1=CC=CC(=C1)C(=CCCCC(=O)O)C2=CN=CC=C2,,,,,,
1318,3081319,6-(Mercaptomethyl)-5-oxo-1-thia-4-azacyclotridecane-3-carboxylic acid,C1CCC[C@@H](C(=O)N[C@@H](CSCCC1)C(=O)O)CS,,,,,,
1319,3081320,"2-[3-(Diethylamino)-6-diethylazaniumylidenexanthen-9-yl]-5-[3-[3-[4-(1-methylindol-3-yl)-2,5-dioxopyrrol-3-yl]indol-1-yl]propylsulfamoyl]benzenesulfonate",CCN(CC)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](CC)CC)C=C3O2)C4=C(C=C(C=C4)S(=O)(=O)NCCCN5C=C(C6=CC=CC=C65)C7=C(C(=O)NC7=O)C8=CN(C9=CC=CC=C98)C)S(=O)(=O)[O-],,,,,,
1320,3081321,"[6-(Diethylamino)-9-[4-[3-[3-[4-(1-methylindol-3-yl)-2,5-dioxopyrrol-3-yl]indol-1-yl]propylsulfamoyl]-2-sulfophenyl]xanthen-3-ylidene]-diethylazanium",CCN(CC)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](CC)CC)C=C3O2)C4=C(C=C(C=C4)S(=O)(=O)NCCCN5C=C(C6=CC=CC=C65)C7=C(C(=O)NC7=O)C8=CN(C9=CC=CC=C98)C)S(=O)(=O)O,,,,,,
1321,3081322,"6-(alpha,alpha-Diphenylacetylpiperazinyl)phenyl-5-methyl-4,5-dihydro-3(2H)-pyridazinone",CC1CC(=O)NN=C1C2=CC=C(C=C2)N3CCN(CC3)C(=O)C(C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
1322,3081323,CID 3081323,C1N=C2C(=C(N1[C@H]3C(=C([C@H](O3)CO)O)O)N)N=C(N2[C@H]4C(=C[C@H](O4)COP(=O)(O)OP(=O)(O)O)O)N,,,,,,
1323,3081324,Poly(N-isopropylacrylamide-co-methacrylic acid),CC(C)NC(=O)C=C.CC(=C)C(=O)O,,,,,,
1324,3081325,Dipsacus saponin B,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@@H]([C@H]([C@@H](O[C@H]2O[C@@H]3[C@H]([C@H](CO[C@H]3O[C@H]4CC[C@@]5([C@H]6CC=C7[C@H]8CC(CC[C@@]8(CC[C@]7([C@@]6(CCC5C4(C)CO)C)C)C(=O)O)(C)C)C)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O)O[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)C)O)O)O)O)O,,,,,,
1325,3081326,"1-((2-Hydroxyethoxy)methyl)-5-(phenylselanyl)pyrimidine-2,4(1H,3H)-dione",C1=CC=C(C=C1)[Se]C2=CN(C(=O)NC2=O)COCCO,,,,,,
1326,3081327,"2',6'-Difluoroamodiaquine",CCN(CC)CC1=C(C(=CC(=C1O)F)NC2=C3C=CC(=CC3=NC=C2)Cl)F,,,,,,
1327,3081328,3-(8-Methyl-8-azabicyclo[3.2.1]octan-3-yl)-2-phenylsulfanylpropanoic acid,CN1C2CCC1CC(C2)CC(C(=O)O)SC3=CC=CC=C3,,,,,,
1328,3081329,Boc-F-psi(HE)-F,CC(C)(C)OC(=O)N[C@@H](CC1=CC=CC=C1)C[C@@H]([C@@H](CC2=CC=CC=C2)C(=O)O)O,,,,,,
1329,3081330,CID 3081330,COC1=C(C=CC(=C1)C=CC(=O)OC[C@@H]2[C@H]([C@@H]([C@H]([C@H](O2)O[C@@]3([C@H]([C@@H]([C@H](O3)COC(=O)C=CC4=CC=C(C=C4)O)O)OC(=O)C=CC5=CC=C(C=C5)O)COC(=O)C=CC6=CC=C(C=C6)O)O)O)O)O,,,,,,
1330,3081331,CID 3081331,CC(=O)O[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1O[C@@]2([C@H]([C@@H]([C@H](O2)COC(=O)C=CC3=CC=C(C=C3)O)O)OC(=O)C=CC4=CC=C(C=C4)O)COC(=O)C=CC5=CC=C(C=C5)O)COC(=O)C=CC6=CC(=C(C=C6)O)OC)O)O,,,,,,
1331,3081332,CID 3081332,CCCC[C@H](C(=O)[O-])N(C(=O)[C@@H](CC1=CN(C2=CC=CC=C21)C(=O)OC)N)C(=O)[C@H](CC(C)(C)C)NC(=O)N3[C@@H](CCC[C@@H]3C)C.[Na+],,,,,,
1332,3081333,"(2R)-2-[[(2R)-2-amino-3-(1-methoxycarbonylindol-3-yl)propanoyl]-[(2S)-2-[[(2R,6S)-2,6-dimethylpiperidine-1-carbonyl]amino]-4,4-dimethylpentanoyl]amino]hexanoic acid",CCCC[C@H](C(=O)O)N(C(=O)[C@@H](CC1=CN(C2=CC=CC=C21)C(=O)OC)N)C(=O)[C@H](CC(C)(C)C)NC(=O)N3[C@@H](CCC[C@@H]3C)C,,,,,,
1333,3081334,"1-(3-(2,3-Dihydroxypropyl)-3,4-dihydro-2,6-dimethoxy-5-nitro-4-pyrimidinyl)-2-propanone",CC(=O)CC1C(=C(N=C(N1CC(CO)O)OC)OC)[N+](=O)[O-],,,,,,
1334,3081335,CID 3081335,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@H]([C@H](CC3=CC=CC=C3)NC(=O)O[C@H]4COC5[C@H]4CCO5)O,,,,,,
1335,3081336,"6,7-Dimethoxy-8-(3-tert-butylamino-2-hydroxypropoxy)-2H-1-benzopyran-2-one",CC(C)(C)NCC(COC1=C2C(=CC(=C1OC)OC)C=CC(=O)O2)O,,,,,,
1336,3081337,CID 3081337,C[C@H](CCCC(C)C)[C@H]1CCC2[C@@]1(CCC3C2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)NC5=C6C(=CC(=C5)S(=O)(=O)O)C=C(C=C6O)S(=O)(=O)[O-])C)C.[Na+],,,,,,
1337,3081338,"4-[[(3S,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]-5-hydroxynaphthalene-2,7-disulfonic acid",C[C@H](CCCC(C)C)[C@H]1CCC2[C@@]1(CCC3C2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)NC5=C6C(=CC(=C5)S(=O)(=O)O)C=C(C=C6O)S(=O)(=O)O)C)C,,,,,,
1338,3081339,"N-(3-Bromopropyl)-N,N,N',N',N'-pentamethyl-1,3-propanediaminium dibromide",C[N+](C)(C)CCC[N+](C)(C)CCCBr.[Br-].[Br-],,,,,,
1339,3081340,3-Bromopropyl-dimethyl-[3-(trimethylazaniumyl)propyl]azanium,C[N+](C)(C)CCC[N+](C)(C)CCCBr,,,,,,
1340,3081341,"(2R)-3-[(2S)-1-[(2S,3R)-2-[[(2S)-5-amino-2-(hexadecanoylamino)-4-hydroxy-5-oxopentanoyl]amino]-3-hydroxybutanoyl]-4-hydroxypyrrolidine-2-carbonyl]-2-[(2S,3R)-2-amino-3-hydroxybutanoyl]-1-[(2S)-2,5-diamino-3-hydroxy-5-oxopentanoyl]-3-hydroxy-4-methyl-4-(3-sulfooxyphenyl)pyrrolidine-2-carboxylic acid",CCCCCCCCCCCCCCCC(=O)N[C@@H](CC(C(=O)N)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CC(C[C@H]1C(=O)C2([C@@](N(CC2(C)C3=CC(=CC=C3)OS(=O)(=O)O)C(=O)[C@H](C(CC(=O)N)O)N)(C(=O)[C@H]([C@@H](C)O)N)C(=O)O)O)O,,,,,,
1341,3081342,"Lamivudine sulfoxide, (3RS)-",C1[C@H](O[C@H](S1=O)CO)N2C=CC(=NC2=O)N,,,,,,
1342,3081343,"N,N'-Bis(2-(4-(3-aminopropylcarbamoyl)-2,4'-bithiazol-2'-yl)ethyl)ethylenediamine",C1=C(NC(S1)(CCN=CCN=CCC2(NC(=CS2)C(=O)NCCCN)C3=CSC=N3)C4=CSC=N4)C(=O)NCCCN.Cl.Cl.Cl.Cl,,,,,,
1343,3081344,"N-(3-aminopropyl)-2-[2-[2-[2-[4-(3-aminopropylcarbamoyl)-2-(1,3-thiazol-4-yl)-3H-1,3-thiazol-2-yl]ethylideneamino]ethylideneamino]ethyl]-2-(1,3-thiazol-4-yl)-3H-1,3-thiazole-4-carboxamide",C1=C(NC(S1)(CCN=CCN=CCC2(NC(=CS2)C(=O)NCCCN)C3=CSC=N3)C4=CSC=N4)C(=O)NCCCN,,,,,,
1344,3081345,CID 3081345,CC1=C(C(=C(C=C1O)O)CS)C(=O)OC(=O)[C@@H](C)N(C(=O)[C@H](C)N)C(=O)[C@H](C=S)NC(=O)[C@H](CO)NC(=O)[C@@H]2[C@@H](CCN2)O,,,,,,
1345,3081346,"1-(11-(dodecylamino)-10-hydroxyundecyl)-3,7-dihydro-3,7-dimethyl-1H-purine-2,6-dione",CCCCCCCCCCCCNCC(CCCCCCCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C)O,,,,,,
1346,3081347,FP-21399 (Sodium),COC1=CC(=C(C=C1N=NC2=C(C3=C(C=C(C=C3C=C2S(=O)(=O)[O-])S(=O)(=O)[O-])NC(=O)C4=C(C(=CC=C4)Cl)Cl)O)OC)N=NC5=C(C6=C(C=C(C=C6C=C5S(=O)(=O)[O-])S(=O)(=O)[O-])NC(=O)C7=C(C=C(C=C7)Cl)Cl)O.[Na+].[Na+].[Na+].[Na+],,,,,,
1347,3081348,FP-21399 free acid,COC1=CC(=C(C=C1N=NC2=C(C3=C(C=C(C=C3C=C2S(=O)(=O)O)S(=O)(=O)O)NC(=O)C4=C(C(=CC=C4)Cl)Cl)O)OC)N=NC5=C(C6=C(C=C(C=C6C=C5S(=O)(=O)O)S(=O)(=O)O)NC(=O)C7=C(C=C(C=C7)Cl)Cl)O,,,,,,
1348,3081349,Laromustine,CNC(=O)N(N(CCCl)S(=O)(=O)C)S(=O)(=O)C,"['Investigated for use/treatment in brain cancer, cancer/tumors (unspecified), colorectal cancer, leukemia (lymphoid), leukemia (myeloid), lung cancer, myelodysplastic syndrome, pediatric indications, and solid tumors.']",,,,,
1349,3081350,Boc-ypgflt(O-tbu),C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](CC3=CC=C(C=C3)O)NC(=O)OC(C)(C)C)OC(C)(C)C,,,,,,
1350,3081351,"Sulfamic acid, 4-(2-((1-oxotetradecyl)amino)ethyl)phenyl ester",CCCCCCCCCCCCCC(=O)NCCC1=CC=C(C=C1)OS(=O)(=O)N,,,,,,
1351,3081352,"1-Piperidinepropanoic acid, 4-(8-fluoro(1)benzoxepino(4,3-b)pyridin-11(5H)-ylidene)-, dihydrate",C1CN(CCC1=C2C3=C(C=C(C=C3)F)OCC4=C2N=CC=C4)CCC(=O)O.O.O,,,,,,
1352,3081353,"3-[4-(8-fluoro-5H-[1]benzoxepino[4,3-b]pyridin-11-ylidene)piperidin-1-yl]propanoic acid",C1CN(CCC1=C2C3=C(C=C(C=C3)F)OCC4=C2N=CC=C4)CCC(=O)O,,,,,,
1353,3081354,N-Methoxy-2-propylpentanamide,CCCC(CCC)C(=O)NOC,,,,,,
1354,3081355,"(1S-endo)-5-(4-Chloro-3-methylphenyl)-1-((4-methylphenyl)methyl)-N-(1,3,3-trimethylbicyclo(2.2.1)hept-2-yl)-1H-pyrazole-3-carboxamide",CC1=CC=C(C=C1)CN2C(=CC(=N2)C(=O)N[C@H]3[C@]4(CC[C@H](C4)C3(C)C)C)C5=CC(=C(C=C5)Cl)C,,,,,,
1355,3081356,"(2R,3S)-2-[(3,4-dihydroxyphenyl)methyl]-2-hydroxy-3-[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyloxy]butanedioic acid",COC1=C(C=CC(=C1)C=CC(=O)O[C@H](C(=O)O)[C@](CC2=CC(=C(C=C2)O)O)(C(=O)O)O)O,,,,,,
1356,3081357,"(2R,3S)-2-[(3,4-dihydroxyphenyl)methyl]-2-hydroxy-3-[3-(3-hydroxy-4-methoxyphenyl)prop-2-enoyloxy]butanedioic acid",COC1=C(C=C(C=C1)C=CC(=O)O[C@H](C(=O)O)[C@](CC2=CC(=C(C=C2)O)O)(C(=O)O)O)O,,,,,,
1357,3081358,Rubrobramide,CC(C)C[C@]12[C@H]3[C@](C(=O)C[C@](O3)(O1)C)(C(=O)N2)O,,,,,,
1358,3081359,"3H-1,2,4-Triazol-3-one, 4-(4-(4-((1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl)-1-piperazinyl)phenyl)-2,4-dihydro-2-((4-(trifluoromethoxy)phenyl)methyl)-",C[C@H]([C@](CN1C=NC=N1)(C2=C(C=C(C=C2)F)F)O)N3CCN(CC3)C4=CC=C(C=C4)N5C=NN(C5=O)CC6=CC=C(C=C6)OC(F)(F)F,,,,,,
1359,3081360,Tattoo C,CCCOC(=O)NCCCN(C)C.C(#N)C1=C(C(=C(C(=C1Cl)Cl)Cl)C#N)Cl.Cl,,,,,,
1360,3081361,Vandetanib,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,"['Vandetanib is currently approved as an alternative to local therapies for both unresectable and disseminated disease. Because Vandetanib can prolong the Q-T interval, it is contraindicated for use in patients with serious cardiac complications such as congenital long QT syndrome and uncompensated heart failure.']",['Mean IC50 of approximately 2.1 μg/mL.'],,"['Slow- peak plasma concentrations reached at a median 6 hours. On multiple dosing, Vandetanib accumulates about 8 fold with steady state reached after around 3 months.', 'About 69% was recovered following 21 days after a single dose of vandentanib. 44% was found in feces and 25% in urine.', 'Vd of about 7450 L.', 'Vandetanib binds to human serum albumin and a1-acid-glycoprotein with in vitro protein binding being approximately 90%. In ex vivo plasma samples from colorectal cancer patients at steady state exposure after 300 mg once daily, the mean percentage protein binding was 94%.', 'Within a 21-day collection period after a single dose of (14)C-vandetanib, approximately 69% was recovered with 44% in feces and 25% in urine. Excretion of the dose was slow and further excretion beyond 21 days would be expected based on the plasma half-life.  Vandetanib was not a substrate of hOCT2 expressed in HEK293 cells. Vandetanib inhibits the uptake of the selective OCT2 marker substrate 14C-creatinine by HEK-OCT2 cells, with a mean IC50 of 2.1 ug/mL. This is higher than vandetanib plasma concentrations (0.81 ug/mL) observed after multiple dosing at 300 mg. Inhibition of renal excretion of creatinine by vandetanib provides an explanation for increases in plasma creatinine seen in human subjects receiving vandetanib.', 'Following oral administration of Caprelsa, absorption is slow with peak plasma concentrations typically achieved at a median of 6 hours, range 4-10 hours, after dosing. Vandetanib accumulates approximately 8-fold on multiple dosing with steady state achieved in approximately 3 months.  Exposure to vandetanib is unaffected by food.', 'The protein binding of (14)C-Vandetanib in plasma of mice, rats, rabbits dogs and human was moderate, from 83 to 90%. The tissue distribution of vandetanib and/or metabolites in pigmented and non pigmented male rats after single oral dosing was slow but extensive, and consistent with the distribution pattern of a lipophilic compound. Highest concentrations of vandetanib and/or its metabolites were seen in the majority of tissues at 6-8 hours after administration. The distribution of radioactivity to brain was evident. Retention of radioactivity was seen in pigmented tissues indicating melanin affinity. A significant distribution of radioactivity was seen in milk of lactating rats and further on in the plasma of suckling pups.', 'For more Absorption, Distribution and Excretion (Complete) data for Vandetanib (8 total), please visit the HSDB record page.']","['Unchanged vandentanib and metabolites vandetanib N-oxide and N-desmethyl vandetanib were detected in plasma, urine and feces.  N-desmethyl-vandetanib is primarily produced by CYP3A4, and vandetanib-N-oxide is primarily produced by flavin–containing monooxygenase enzymes FMO1 and FMO3.', 'The metabolism of vandetanib seemed to be similar in the toxicology species, rat and dog, as well as in mouse and human. The 2 major metabolites identified in excreta, were N-desmethyl-vandetanib and vandetanib-N-oxide. In mouse, a minor metabolite was also identified as O-desalkyl-vandetanib glucuronid. A glucuronide conjugate was also detected in human urine. Metabolism as well as biliary excretion appears to be most important for the elimination of vandetanib in preclinical species. CYP identification studies in vitro, suggest that CYP3A4 is involved in the formation of N-desmethyl-Vandetanib. vandetanib-N-oxide is formed via FMO1 and FMO3 (FMO=flavine mono-oxygenase). Both these enzymes are also found in kidney indicating that renal excretion might be contributed to the clearance of vandetanib.', 'Following oral dosing of (14)C-vandetanib, unchanged vandetanib and metabolites vandetanib N-oxide and N-desmethyl vandetanib were detected in plasma, urine and feces. A glucuronide conjugate was seen as a minor metabolite in excreta only. N-desmethyl-vandetanib is primarily produced by CYP3A4 and vandetanib-N-oxide by flavin-containing monooxygenase enzymes FMO1 and FMO3. N-desmethyl-vandetanib and vandetanib-N-oxide circulate at concentrations of approximately 7-17% and 1.4-2.2%, respectively, of those of vandetanib.', '... In plasma, concentrations of total radioactivity were higher than vandetanib concentrations at all time points, indicating the presence of circulating metabolites. Unchanged vandetanib and 2 anticipated metabolites (N-desmethylvandetanib and vandetanib N-oxide) were detected in plasma, urine, and feces. A further trace minor metabolite (glucuronide conjugate) was found in urine and feces. ... Unchanged vandetanib and N-desmethyl and N-oxide metabolites were detected in plasma, urine, and feces.']","['Median half life of 19 days.', '... Caprelsa at the 300 mg dose in medullary thyroid cancer (MTC) patients /is/ characterized by a ... median plasma half-life of 19 days.', '... Vandetanib was absorbed and eliminated slowly with a half life of approximately 10 days after single oral doses. ...']"
1361,3081362,Telavancin,CCCCCCCCCCNCCN[C@]1(C[C@@H](O[C@H]([C@H]1O)C)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C(=C(C=C9[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)CNCP(=O)(O)O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)C,"['For the treatment of complicated skin and skin structure infections (cSSSI) caused by gram-positive bacteria like methicillin-susceptible or -resistant Staphylococcus aureus, vancomycin-susceptible Enterococcus faecalis, and Streptococcus pyogenes, Streptococcus agalactiae, or Streptococcus anginosus group. Also for the treatment of adult patients with hospital-acquired bacterial pneumonia (HAP) and ventilator-associated bacterial pneumonia (VAP), known or suspected to be caused by susceptible isolates of Staphylococcus aureus (including methicillin-susceptible and methicillin-resistant S. aureus).']","['Telavancin is a semi-synthetic derivative of vancomycin, therefore the mode of bactericidal action is similar to vancomycin in which both antibiotics inhibit cell wall synthesis. Not only that, it displays concentration-dependent bactericidal action. Furthermore, telavancin is a more potent inhibitor (10-fold) of peptidoglycan synthesis and, unlike vancomycin, disrupts cell membrane integrity via its interaction with lipid II. AUC/MIC ratio best predicts the extent of in-vivo response in which the higher the ratio, the greater the bactericidal activity. The smallest ratio in which one would be able to observe no bacterial growth at 24 hours is 50. Maximal bactericidal activity is observed at a AUC/MIC ratio of 404.']",['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)'],"['Telavancin demonstrates linear pharmacokinetics at doses between 1 and 12.5 mg/kg. Furthermore, 24 hours post-infusion of a dose of 7.5 to 15 mg/kg, activity against MRSA and penicillin-resistant Streptococcus pneumonia can still be observed. The trough concentration at this point of time is approximately 10 μg/mL. Telavancin also has poor bioavailability and must be administered over 30-120 minutes IV.  Cmax, healthy subjects, 10 mg/kg = 93.6 ± 14.2 μg/mL; AUC (0- ∞), healthy subjects, 10 mg/kg = 747 ± 129 μg · h/mL; AUC (0-24h), healthy subjects, 10 mg/kg = 666± 107 μg · h/mL; Time to steady state = 3 days;', 'Urine with >80% as unchanged drug and <20% as hydroxylated metabolites (with dose of 10mg/kg); Feces (<1%)', 'Vss, healthy subjects, 10 mg/kg  = 0.14 L/kg', 'Cl, healthy subjects, 10 mg/kg = 13.9 ± 2.9 mL/h/kg', 'Telavancin is primarily eliminated by the kidney. In a mass balance study, approximately 76% of the administered dose was recovered from urine and <1% of the dose was recovered from feces (collected up to 216 hours) based on total radioactivity.', 'Telavancin binds to human plasma proteins, primarily to serum albumin, in a concentration-independent manner. The mean binding is approximately 90% and is not affected by renal or hepatic impairment.  Concentrations of telavancin in skin blister fluid were 40% of those in plasma (AUC0-24hr ratio) after 3 daily doses of 7.5 mg/kg VIBATIV in healthy young adults.', 'The mass balance and pharmacokinetics of telavancin, a semisynthetic lipoglycopeptide antimicrobial agent, were characterized in an open-label, phase 1 study of six healthy male subjects. After a single 1-h intravenous infusion of 10 mg/kg (14)C-telavancin (0.68 uCi/kg), blood, urine, and feces were collected at regular intervals up to 216 hr postdose. Whole blood, plasma, urine, and fecal samples were assayed for total radioactivity using scintillation counting; plasma and urine were also assayed for parent drug and metabolites using liquid chromatography with tandem mass spectrometry. The concentration-time profiles for telavancin and total radioactivity in plasma were comparable from 0 to 24 hr after the study drug administration. Telavancin accounted for >95% and 83% of total radioactivity in plasma at 12 hr and 24 hr, respectively. By 216 hr, approximately 76% of the total administered dose was recovered in urine while only 1% was collected in feces. Unchanged telavancin accounted for most (83%) of the eliminated dose. Telavancin metabolite THRX-651540 along with two other hydroxylated metabolites (designated M1 and M2) accounted for the remaining radioactivity recovered from urine. The mean concentrations of total radioactivity in whole blood were lower than the concentration observed in plasma, and mean concentrations of THRX-651540 in plasma were minimal relative to mean plasma telavancin concentrations. These observations demonstrate that most of an administered telavancin dose is eliminated unchanged via the kidneys. ...', 'The aim of this study was to assess the steady-state pharmacokinetic parameters of telavancin, an investigational bactericidal lipoglycopeptide, after intravenous (iv) administration to healthy male and female subjects. In a randomized, double-blind, parallel-group, gender-stratified, two-dose study, 79 adult subjects received three daily 60 min iv infusions of telavancin at 7.5 mg/kg (n = 40) or 15 mg/kg (n = 39). Blood and urine samples were collected for pharmacokinetic analyses at admission, on day 3 pre-infusion and up to 48 hr after the start of the day 3 infusion for 73 subjects (45 males and 28 females). Pharmacokinetic parameters were estimated by non-compartmental analysis. Following the day 3 telavancin dose (7.5 or 15 mg/kg), dose-proportional increases in mean peak plasma concentrations (C(max), 88 versus 186 mg/L for low and high doses, respectively) and total systemic exposures (AUC(0-24), 599 versus 1282 mg.h/L for low and high doses, respectively) were observed. Trough concentrations at steady state were 6 mg/L at 7.5 mg/kg/day and 16 mg/L at 15 mg/kg/day. The elimination half-life was dose-independent; the mean +/- SD ranged from 6.0 +/- 0.6 to 7.5 +/- 1.3 hr for low and high doses, respectively. Approximately two-thirds of the total telavancin dose was excreted unchanged in urine over 48 hr. Pharmacokinetic parameters were similar in males and females. Telavancin displayed linear plasma pharmacokinetics over the dose range 7.5-15 mg/kg/day and was primarily cleared via urinary excretion. No gender-related differences in the pharmacokinetic disposition of telavancin were observed. These data further characterize the pharmacokinetic profile of telavancin, a once-daily therapy targeted for the treatment of serious Gram-positive infections.', 'For more Absorption, Distribution and Excretion (Complete) data for Telavancin (8 total), please visit the HSDB record page.']","['Metabolism of telavancin does not involve the cytochrome P450 enzyme system. Primary metabolite is called THRX-651540, but the metabolite pathway has not been identified.', 'In a mass balance study in male subjects using radiolabeled telavancin, 3 hydroxylated metabolites were identified with the predominant metabolite (THRX-651540) accounting for <10% of the radioactivity in urine and <2% of the radioactivity in plasma. The metabolic pathway for telavancin has not been identified.', 'No metabolites of telavancin were detected in in vitro studies using human liver microsomes, liver slices, hepatocytes, and kidney S9 fraction. None of the following recombinant CYP 450 isoforms were shown to metabolize telavancin in human liver microsomes: CYP 1A2, 2C9, 2C19, 2D6, 3A4, 3A5, 4A11.', 'Telavancin was not extensively metabolized in rats, dogs and monkeys after IV administration. Unchanged telavancin was the predominant component in the serum (99, 89 and 94 % of total AUC for rats, dogs and monkeys, respectively) while 7-OH-telavancin (AMI-11352), telavancin des-phosphonate (AMI-999) and other OH-metabolites were identified. Telavancin accounted for more than 60% (dogs) and 86% (monkeys) of the urinary recoveries. AMI-11352 represented about 17% (dogs) and 5% (monkeys) of total urinary recovery while AMI-999 represented about 1.2% (dogs) and 1.8% (monkeys) and other OH-metabolites represented about 17% (dogs) and 6% (monkey). There was no significant gender-related difference observed for metabolism profiles. Of the three OH-metabolites of the 2-(decylamino) ethyl side chain of telavancin identified in human urine 7-OH-telavancin (AMI-11352) was the most abundant. The plasma AUC of 7-OH-telavancin (which is much less active against bacteria than telavancin) was about 2-3% of the AUC of telavancin and accounted for 50% of total peak areas of the three hydroxylated metabolites. AMI-11355 (8-OH metabolite) and AMI-11353 (9-OH metabolite) accounted for 24.2% and 25.3% of the total peak areas of the three hydroxylated metabolites, respectively. Plasma concentrations of AMI-11352 were low in the rat and increases in Cmax and AUC0-24 were less than dose-proportional. Systemic exposure to AMI-11352 was larger in dogs compared to rats. According to the applicant, saturation of the metabolic pathway at higher doses may be anticipated as the AUC0-t metabolite/telavancin ratio decreased at high doses in both rats and dogs. Systemic exposures to telavancin, AMI-999 and AMI-11352 in rats and/or dogs at steady state exceeded human systemic exposure at the proposed clinical dose of 10 mg/kg/day.', 'The main metabolite of telavancin, 7-OH-Telavancin (AMI-11352), has antibacterial activity but is 10-fold less potent than telavancin. Due to the low antibacterial activity of AMI-11352 and the low human exposure, this metabolite is not considered to have a relevant contribution to the overall activity of telavancin in vivo.']","['Terminal elimination half-life = 8 ± 1.5 hours (with normal renal function)', 'Following single doses of 10 mg/kg telavancin (IV bolus injection or infusion) the serum or plasma concentrations of telavancin declined in all species with half life ranging from 1.2 hours in mice to 2.3 hours in monkeys.', 'In a randomized, double-blind, parallel-group, gender-stratified, two-dose study, 79 adult subjects received three daily 60 min iv infusions of telavancin at 7.5 mg/kg (n = 40) or 15 mg/kg (n = 39). Blood and urine samples were collected for pharmacokinetic analyses at admission, on day 3 pre-infusion and up to 48 hr after the start of the day 3 infusion for 73 subjects (45 males and 28 females). ... The elimination half-life was dose-independent; the mean +/- SD ranged from 6.0 +/- 0.6 to 7.5 +/- 1.3 hr for low and high doses, respectively. ...', 'In the pigmented rat quantitative whole body autoradiography (QWBA) study the highest levels of radioactivity at 168 hours post dose were observed in liver, spleen and kidney and at 336 hours post dose were observed in spleen, adrenal gland and kidney. The half-life estimated for liver and kidney were 4 and 5 days, respectively. The high levels of radioactivity observed in the bone at all time points appeared to be mainly located in the growth plates and also in the bone marrow with an estimated half-life of 332 hours (approximately 14 days). Penetration into the CNS was minimal.']"
1362,3081363,Fentrazamide,CCN(C1CCCCC1)C(=O)N2C(=O)N(N=N2)C3=CC=CC=C3Cl,,,,,,
1363,3081364,Dicyclanil,C1CC1NC2=NC(=C(C(=N2)N)C#N)N,,,"['Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)']",,,
1364,3081365,Isazophos-methyl,CC(C)N1C(=NC(=N1)OP(=S)(OC)OC)Cl,,,,,,
1365,3081366,CID 3081366,CN1C(=NN(C1=O)C(=NS(=O)(=O)C2=CC=CC=C2OC(F)(F)F)[O-])OC.[Na+],,,,,,
1366,3081367,Flucarbazone,CN1C(=NN(C1=O)C(=O)NS(=O)(=O)C2=CC=CC=C2OC(F)(F)F)OC,,,,,,
1367,3081368,Aldehydo-ascarylose,C[C@@H]([C@@H](C[C@H](C=O)O)O)O,,,,,,
1368,3081369,Ascarylose,C[C@H]([C@H](C[C@@H](C=O)O)O)O,,,,,,
1369,3081370,"5-O-(3,4,5-Trihydroxybenzoyl)-2-C-{[(3,4,5-trihydroxybenzoyl)oxy]methyl}pentose",C1=C(C=C(C(=C1O)O)O)C(=O)OCC(C(C(COC(=O)C2=CC(=C(C(=C2)O)O)O)(C=O)O)O)O,,,,,,
1370,3081371,Cladinose,C[C@H]([C@H]([C@](C)(CC=O)OC)O)O,,,,,,
1371,3081372,Angiotensin I,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC5=CC=C(C=C5)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N,,,,,,
1372,3081373,"(2S,3R,4S,5S,6R)-2-[[(2R,3S,4R)-4-hydroxy-2-(hydroxymethyl)-3,4-dihydro-2H-pyran-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol",C1=CO[C@@H]([C@H]([C@@H]1O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CO,,,,,,
1373,3081374,Leukoefdin,C1=C(C=C(C(=C1O)O)O)C2C(C(C3=C(C=C(C=C3O2)O)O)O)O,,,,,,
1374,3081375,CID 3081375,C[C@H]1C[C@H](C(=O)C=C[C@H](C(OC(=O)[C@@H]([C@H]1O[C@H]2[C@@H]([C@H](C[C@H](O2)C)N(C)C)O)C)[C@@H](C)O)C)C,,,,,,
1375,3081376,"10,18-Epoxyros-15-ene-7,18-dione",CC1(CCC2(C(C1)C(=O)CC3C24CCCC3(C(=O)O4)C)C)C=C,,,,,,
1376,3081377,Simarolide,C[C@@H]1C[C@@H](C(=O)[C@]2([C@H]1C[C@@H]3[C@@]4([C@@H]2[C@@H](C[C@@]([C@@H]4CC(=O)O3)(C)C(=O)[C@@H]5CC(=O)OC5)OC(=O)C)C)C)O,,,,,,
1377,3081378,Copper;iron;sulfane,S.S.[Fe].[Cu],,,,,,
1378,3081379,"Ruthenocene, acetyl-",CC(=C1C=CC=C1)[O-].[CH-]1C=CC=C1.[Ru+2],,,,,,
1379,3081380,"Cytidine 3',5'-diphosphate",C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)OP(=O)(O)O)O,,,,,,
1380,3081381,Dlpts,CCCCCCCCCCCC(=O)OCC(COP(=O)(O)OC[C@@H](C(=O)O)N)OC(=O)CCCCCCCCCCC,,,,,,
1381,3081382,Dipalmitoylphosphatidylserine,CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OC[C@@H](C(=O)O)N)OC(=O)CCCCCCCCCCCCCCC,,,,,,
1382,3081383,glutaryl-CoA,CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)[C@H](C(=O)NCCC(=O)NCCSC(=O)CCCC(=O)O)O,,,,,,
1383,3081384,6-Thioxanthine 5'-monophosphate,C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)NC(=O)NC2=S,,,,,,
1384,3081385,"Cyclic 3',5'-uridine monophosphate",C1[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC(=O)NC3=O)O)OP(=O)(O1)O,,,,,,
1385,3081386,Thio-NAD,C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O)O)[O-])C(=S)N,,,,,,
1386,3081387,Thionicotinamide-adenine-dinucleotide,C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O)C(=S)N,,,,,,
1387,3081388,CID 3081388,C[N+]1(CC[C@]23[C@@H]4[C@H](C=CC2[C@@H]1CC5=C3C(=C(C=C5)O)O4)O)CC=C,,,,,,
1388,3081389,"4,5-Dihydrotestolactone",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC(=O)O2)CC[C@H]4[C@@]3(C=CC(=O)C4)C,,,,,,
1389,3081390,N(6)-Methyl-3'-deoxy-5'-adenylic acid,CNC1=C2C(=NC=N1)N(C=N2)[C@H]3[C@@H](C[C@H](O3)COP(=O)(O)O)O,,,,,,
1390,3081391,Fructosyl-glycine,C([C@H]([C@H]([C@@H](C(=O)CNCC(=O)O)O)O)O)O,,,,,,
1391,3081392,N(6)-Methyldeoxyadenosine 5'-triphosphate,CNC1=C2C(=NC=N1)N(C=N2)[C@H]3[C@@H](C[C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,,,,,,
1392,3081393,CID 3081393,CC(=O)OC1=C2C3=C(C[C@H]4C5[C@]3(CCN4C)[C@@H](O2)[C@H](C=C5)O)C=C1,,,,,,
1393,3081394,"7,8-Diethyl-10-(1'-D-ribityl)isoalloxazine",CCC1=CC2=C(C=C1CC)N(C3=NC(=O)NC(=O)C3=N2)C[C@@H]([C@@H]([C@@H](CO)O)O)O,,,,,,
1394,3081395,"(1S,9R,10S)-17-prop-2-enyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol",C=CCN1CC[C@@]23CCCC[C@@H]2[C@H]1CC4=C3C=C(C=C4)O,,,,,,
1395,3081396,Stibosamine,CCNCC.C1=CC(=CC=C1N)[Sb](=O)(O)O,,,,,,
1396,3081397,"(2S,3R,4S,5R,6S)-6-[(2S,3R,4R,5R,6S)-2-Carboxy-6-[(2S,3R,4R,5R)-2-carboxy-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid",C(=O)[C@@H]([C@H]([C@H]([C@@H](C(=O)O)O)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)C(=O)O)O[C@@H]2[C@@H]([C@H]([C@H]([C@H](O2)C(=O)O)O)O)O)O)O)O)O,,,,,,
1397,3081398,"Thymidine, 5'-deoxy-5'-oxo-",CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)C=O)O,,,,,,
1398,3081399,"2H,8H-Benzo[1,2-b:5,4-b']dipyran-2-one",C1C=CC2=C(O1)C=C3C(=C2)C=CC(=O)O3,,,,,,
1399,3081400,"(2R,3S,4R,5R)-6-hydroxy-2,3,4,5-tetrakis[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]hexanal",C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@H](CO)[C@H]([C@@H]([C@H](C=O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)O)O,,,,,,
1400,3081401,N(6)-Methyl-3'-amino-3'-deoxyadenosine,CNC1=C2C(=NC=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)N)O,,,,,,
1401,3081402,"(2R,3S,4R,5R)-2-[(2R,3R,4S,5R,6R)-6-(hydroxymethyl)-3,4,5-tris[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]oxy-3,4,5,6-tetrakis[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]hexanal",C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)OC[C@H]([C@H]([C@@H]([C@H](C=O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O[C@@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O[C@@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O[C@@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O)O)O,,,,,,
1402,3081403,Isomaltoheptaose,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)OC[C@H]([C@H]([C@@H]([C@H](C=O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O[C@@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O)O)O)O,,,,,,
1403,3081404,"(2R,3S,4R,5R,6R)-5-amino-6-[[(2R,3S,4R,5R,6S)-5-amino-6-[(2S,3R,4R,5S,6R)-3-amino-4-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-bis[[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]methoxy]-2-(hydroxymethyl)oxane-3,4-diol",C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)N)N)N)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)N)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)N)N)O)O)O,,,,,,
1404,3081405,Phellodendrine,C[N@@+]12CCC3=CC(=C(C=C3[C@@H]1CC4=CC(=C(C=C4C2)OC)O)O)OC,,,,,,
1405,3081406,"[(2R,3S,5S)-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3-hexadecanoyloxyoxolan-2-yl]methyl hexadecanoate",CCCCCCCCCCCCCCCC(=O)OC[C@@H]1[C@H](C[C@H](O1)N2C=C(C(=O)NC2=O)F)OC(=O)CCCCCCCCCCCCCCC,,,,,,
1406,3081407,CID 3081407,CC1=CC(=C2C3=C1C(=O)C4C(C3(COC2=O)C5C4(C6=C7C(=COC(=C7C(=O)C=C6C)O)C5=O)OC)O)O,,,,,,
1407,3081408,"N-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[(2R,3S,4R,5R)-6-hydroxy-1-oxo-2,4-bis[[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]-5-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyhexan-3-yl]oxyoxan-3-yl]acetamide",C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)O[C@H](CO)[C@H]([C@@H]([C@H](C=O)O[C@@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)NC(=O)C)O[C@@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)O)O)O,,,,,,
1408,3081409,"(9,19-Dihydroxy-11,17-dimethyl-3,5,7,15,21-pentaoxo-6,22-dioxaheptacyclo[12.9.1.11,16.14,8.02,13.012,26.020,25]hexacosa-2(13),8,10,12(26),16(25),17,19-heptaen-24-yl) acetate",CC1=CC(=C2C3=C1C4=C(C(=O)C3C(=O)OC2=O)C56COC(=O)C7=C(C=C(C(=C75)C(=O)C4C6OC(=O)C)C)O)O,,,,,,
1409,3081410,Gibberellic Acid Acetate,CC(=O)O[C@H]1C=CC23[C@@H]4CC[C@]5(CC4(CC5=C)[C@H]([C@@H]2[C@]1(C(=O)O3)C)C(=O)O)O,,,,,,
1410,3081411,Supronal,CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N.C1=CC(=CC=C1CN)S(=O)(=O)N.C1=CC(=CC=C1N)S(=O)(=O)NC(=S)N,,,,,,
1411,3081412,CID 3081412,C[C@H]1C[C@H]([C@H]([C@H](O1)O[C@@H]2[C@@H](C[C@@]3(CO3)C(=O)[C@H]([C@H]([C@H]([C@@H](OC(=O)[C@H]([C@H]([C@H]2C)O[C@@H]4C[C@H]([C@H]([C@@H](O4)C)O)OC)C)C)C)O)C)C)O)N(C)C.C[C@@]1([C@H]2C[C@@H]3[C@@H](C(=O)C(=C(N)O)C(=O)[C@@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,,,,,,
1412,3081413,CID 3081413,CCCCCCCCCCCCOS(=O)(=O)O.CC[C@H]1[C@]([C@@H]([C@@H](C(=O)[C@H](C[C@@]([C@@H]([C@@H]([C@@H]([C@@H](C(=O)O1)C)O[C@@H]2C[C@@]([C@@H]([C@@H](O2)C)O)(C)OC)C)O[C@@H]3[C@@H]([C@@H](C[C@@H](O3)C)N(C)C)OC(=O)CC)(C)O)C)C)O)(C)O.C[C@@]1([C@H]2[C@H]([C@H]3[C@@H](C(=O)C(=C(N)O)C(=O)[C@@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O)O,,,,,,
1413,3081414,CID 3081414,CC(C1=CC=CC(=C1)C2CC3CCC(C2)N3C)C(=O)OO.CC(C1=CC=CC(=C1)C2CC3CCC(C2)N3C)C(=O)OO.C[N+]1=CC=CC(=C1)C=NO.COP(=O)(C(C(Cl)(Cl)Cl)O)OC.OS(=O)(=O)O.[I-],,,,,,
1414,3081415,2-[3-(8-Methyl-8-azabicyclo[3.2.1]octan-3-yl)phenyl]propaneperoxoic acid,CC(C1=CC=CC(=C1)C2CC3CCC(C2)N3C)C(=O)OO,,,,,,
1415,3081416,Ascorbigen,C1[C@@H]([C@@H]2[C@](O1)(C(C(=O)O2)(CC3=CNC4=CC=CC=C43)O)O)O,,,,,,
1416,3081417,Uridylyl-(2'-5')-adenosine,C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)OP(=O)(O)O)O)O)O,,,,,,
1417,3081418,CID 3081418,CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](C)NC(=O)[C@H](CC(=O)O)N,,,,,,
1418,3081419,Nitroxinil meglumate,CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.C1=C(C=C(C(=C1[N+](=O)[O-])O)I)C#N,,,,,,
1419,3081420,Ferrocenium,[CH-]1C=CC=C1.[CH-]1C=CC=C1.[Fe+3],,,,,,
1420,3081421,Lizardite,O.[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[Mg+2].[Mg+2].[Mg+2],,,,,,
1421,3081422,Rhabdophane,O.[O-]P(=O)([O-])[O-].[La].[Ce],,,,,,
1422,3081423,Staurolite,O.[O-2].[O-][Si]([O-])([O-])[O-].[Mg+2].[Al+3].[Fe].[Zn],,,,,,
1423,3081424,Molybdenocene dichloride,[CH-]1C=CC=C1.[CH-]1C=CC=C1.[Cl-].[Cl-].[Mo+4],,,,,,
1424,3081425,Procion Brown MX 5BR,[H+].C1=CC=C(C(=C1)C(=O)[O-])N=NC2=C(C=C3C=C(C=CC3=C2[O-])NC4=NC(=NC(=N4)Cl)Cl)S(=O)(=O)[O-].C1=CC=C(C(=C1)C(=O)[O-])N=NC2=C(C=C3C=C(C=CC3=C2[O-])NC4=NC(=NC(=N4)Cl)Cl)S(=O)(=O)[O-].[Na+].[Na+].[Cr+3],,,,,,
1425,3081426,"2-[6-[(4,6-Dichloro-1,3,5-triazine-2-yl)amino]-1-hydroxy-3-sulfo-2-naphthylazo]benzoic acid",C1=CC=C(C(=C1)C(=O)O)N=NC2=C(C=C3C=C(C=CC3=C2O)NC4=NC(=NC(=N4)Cl)Cl)S(=O)(=O)O,,,,,,
1426,3081427,Barium hydroxyapatite,[O-2].[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[Ba+2].[Ba+2].[Ba+2].[Ba+2].[Ba+2],,,,,,
1427,3081428,Molybdenum sodium oxide,[O-2].[O-2].[O-2].[O-2].[Na+].[Na+].[Mo],,,,,,
1428,3081429,CID 3081429,CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC\4(C(C5C6(C(C(C(=N6)/C(=C\7/C(C(C(=N7)C=C8C(C(C(=N8)/C(=C4\[N-]5)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[OH-].[Co+3],,,,,,
1429,3081430,Cupric ferrocyanide,[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[Fe+2].[Cu+2].[Cu+2],,,,,,
1430,3081431,21-Deacetyldeflazacort,CC1=N[C@@]2([C@H](O1)C[C@@H]3[C@@]2(C[C@@H]([C@H]4[C@H]3CCC5=CC(=O)C=C[C@]45C)O)C)C(=O)CO,,,,,,
1431,3081432,Aquapentacyanoferrate,[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.O.[Na+].[Na+].[Na+].[Fe+2],,,,,,
1432,3081433,Copper(II)-iminodiacetate,C(C(=O)[O-])NCC(=O)[O-].[Cu+2],,,,,,
1433,3081434,Bottromycin,CC1CCN2C1C(=O)NC(C(=O)NC(C(=NCC2=O)NC(C(=O)NC(C(C)C3=CC=CC=C3)C(=O)NC(CC(=O)OC)C4=NC=CS4)C(C)(C)C)C(C)(C)C)C(C)C,,,,,,
1434,3081435,Ferric dtpa,[H+].[H+].[H+].C(CN(CC(=O)[O-])CC(=O)[O-])N(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Fe+2],,,,,,
1435,3081436,"5-[3-[5,8-Bis[3-[(4-carboxy-3-methylbut-2-enoyl)-oxidoamino]propyl]-11,14-bis(hydroxymethyl)-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]propyl-oxidoamino]-3-methyl-5-oxopent-3-enoic acid;iron(3+)",CC(=CC(=O)N(CCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)N1)CO)CO)CCCN(C(=O)C=C(C)CC(=O)O)[O-])CCCN(C(=O)C=C(C)CC(=O)O)[O-])[O-])CC(=O)O.[Fe+3],,,,,,
1436,3081437,"5-[3-[5,8-Bis[3-[(4-carboxy-3-methylbut-2-enoyl)-oxidoamino]propyl]-11,14-bis(hydroxymethyl)-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]propyl-oxidoamino]-3-methyl-5-oxopent-3-enoic acid",CC(=CC(=O)N(CCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)N1)CO)CO)CCCN(C(=O)C=C(C)CC(=O)O)[O-])CCCN(C(=O)C=C(C)CC(=O)O)[O-])[O-])CC(=O)O,,,,,,
1437,3081438,Dimethylhemin,CC1=C(C2=CC3=C(C(=C([N-]3)C=C4C(=C(C(=N4)C=C5C(=C(C(=N5)C=C1[N-]2)C)C=C)C)C=C)C)CCC(=O)OC)CCC(=O)OC.[Cl-].[Fe+3],,,,,,
1438,3081439,Eicosanoyl-CoA,CCCCCCCCCCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O,,,,,,
1439,3081440,4-O-(beta-D-Xylo-hexopyranosyl-3-ulose)-D-glucopyranose,C([C@@H]1[C@@H](C(=O)[C@H]([C@@H](O1)O[C@H]([C@@H](CO)O)[C@@H]([C@H](C=O)O)O)O)O)O,,,,,,
1440,3081441,Reineckate,C(#N)[S-].C(#N)[S-].C(#N)[S-].C(#N)[S-].N.N.[Cr+3],,,,,,
1441,3081442,Cobaltous chloride Co 57,[Cl-].[Cl-].[57Co+2],,,,,,
1442,3081443,"5-Acetamido-3,5-dideoxygalactosylheptulosonic acid",CC(=O)N[C@H]([C@H](CC(=O)C(=O)O)O)[C@H](CO)O,,,,,,
1443,3081444,"1,5-Anhydroglucitol-6-phosphate",C1[C@@H]([C@H]([C@@H]([C@H](O1)COP(=O)(O)O)O)O)O,,,,,,
1444,3081445,CID 3081445,CC1=C(C(C[C@@H](C1)O)(C)C)C#CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=C[C@]23[C@](O2)(C[C@H](CC3(C)C)O)C)C)C,,,,,,
1445,3081446,Cholecystokinin pentapeptide,CSCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)CN,,,,,,
1446,3081447,Methyl daunosamine,C[C@H]1[C@H]([C@H](C[C@@H](O1)OC)N)O,,,,,,
1447,3081448,Etiohemin,CCC1=C(C2=CC3=C(C(=C([N-]3)C=C4C(=C(C(=N4)C=C5C(=C(C(=N5)C=C1[N-]2)C)CC)C)CC)C)CC)C.[Cl-].[Fe+3],,,,,,
1448,3081449,6-Anilinonaphthalene-2-sulfonate,C1=CC=C(C=C1)NC2=CC3=C(C=C2)C=C(C=C3)S(=O)(=O)[O-],,,,,,
1449,3081450,palladium(2+);7H-purine-6-thiolate,C1=NC2=C(N1)C(=NC=N2)[S-].C1=NC2=C(N1)C(=NC=N2)[S-].[Pd+2],,,,,,
1450,3081451,Praseodymium dtpa,C(CN(CC(=O)[O-])CC(=O)[O-])N(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Pr+3],,,,,,
1451,3081452,N(3)-Methyl-2'-deoxycytidine,CNC1=NC(=O)N(C=C1)[C@H]2C[C@@H]([C@H](O2)CO)O,,,,,,
1452,3081453,Arg-pro-pro-gly-phe,C1C[C@H](N(C1)C(=O)[C@@H]2CCCN2C(=O)[C@H](CCCN=C(N)N)N)C(=O)NCC(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O,,,,,,
1453,3081454,Chlorocruoroporphyrin,CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=CO)C(=N5)C=C1N2)C)C(=C4CCC(=O)O)C)C(=C3C)CCC(=O)O)C=C,,,,,,
1454,3081455,"Angiotensin I, des-leu(10)-",CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](CC5=CN=CN5)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N,,,,,,
1455,3081456,Scoytr,CC12CCC3C(C1CCC2=O)CC#CCC(=O)CCC3=O,,,,,,
1456,3081457,Glycerophosphoserine,C([C@@H](C(=O)O)N)OP(=O)(O)OCC(CO)O,,,,,,
1457,3081458,"Tris(2,2'-bipyridine)ruthenium III",C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Cl-].[Cl-].[Cl-].[Ru+3],,,,,,
1458,3081459,Nitrilotriacetate,C(C(=O)[O-])N(CC(=O)[O-])CC(=O)[O-],,,,,,
1459,3081460,"(2R,3R,4R,5R)-4-fluoro-2,3,5,6-tetrahydroxyhexanal",C([C@H]([C@H]([C@@H]([C@H](C=O)O)O)F)O)O,,,,,,
1460,3081461,"5-Acetamido-3,5-dideoxygalactosyloctulosonic acid",CC(=O)N[C@H]([C@H](CC(=O)C(=O)O)O)[C@H]([C@@H](CO)O)O,,,,,,
1461,3081462,Harderoporphyrin,CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5C(=C(C(=N5)C=C1N2)CCC(=O)O)C)C=C)C)C(=C3CCC(=O)O)C)CCC(=O)O,,,,,,
1462,3081463,CID 3081463,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)(O)O)O.C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O.C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)N.C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)NC(=NC2=O)N,,,,,,
1463,3081464,CID 3081464,CC(=CC(=O)N(CCCC1C(=O)NC(C(=O)N1)CCCN(C(=O)C=C(C)CCOC(=O)C(CCCN(C(=O)C=C(C)CCO)[O-])NC(=O)C)[O-])[O-])CCO.[Fe+3],,,,,,
1464,3081465,CID 3081465,CC(=CC(=O)N(CCCC1C(=O)NC(C(=O)N1)CCCN(C(=O)C=C(C)CCOC(=O)C(CCCN(C(=O)C=C(C)CCO)[O-])NC(=O)C)[O-])[O-])CCO,,,,,,
1465,3081466,1-Deoxyfructose,CC(=O)[C@H]([C@@H]([C@@H](CO)O)O)O,,,,,,
1466,3081467,Chloroacetyl coa,CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCSC(=O)CCl)O,,,,,,
1467,3081468,Strychnobrasiline,C[C@@H]1/C/2=C/N(CCC34[C@H]([C@@H]([C@H]2CC3=O)CO1)N(C5=CC=CC=C45)C(=O)C)C,,,,,,
1468,3081469,"Miliiamine C 20-Ac, (or positional isomer)",CC1CC2C(C2(C)C)C3C=C(C(C4(C1(C3=O)C=C(C4OC(=O)C5=CC=CC=C5NC(=O)C6=C(C(=CC=C6)O)NC(=O)C7=CC=CC=C7N(C)C)C)O)O)COC(=O)C,,,,,,
1469,3081470,Acetoxycholestenone,C[C@H](CCCC(C)C)[C@H]1CC(=O)C2=C3CC[C@H]4C[C@H](CC[C@@]4([C@H]3CC[C@]12C)C)OC(=O)C,,,,,,
1470,3081471,"2',5'-Dichloro-2',5'-dideoxyuridine",C1C[C@@H](O[C@@H]1C(OCl)Cl)N2C=CC(=O)NC2=O,,,,,,
1471,3081472,Dtpdt ethylphosphotriester,CCOP(=O)(OC[C@@H]1[C@H](C[C@@H](O1)N2C=C(C(=O)NC2=O)C)O)O[C@H]3C[C@@H](O[C@@H]3CO)N4C=C(C(=O)NC4=O)C,,,,,,
1472,3081473,LHRH (free acid),CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)NC(=O)CNC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6,,,,,,
1473,3081474,Pressinoic acid,C1[C@@H](C(=O)N[C@H](C(=O)NC(C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSS1)C(=O)O)CC(=O)N)CCC(=O)N)CC2=CC=CC=C2)CC3=CC=C(C=C3)O)N,,,,,,
1474,3081475,CID 3081475,C1=CC(=CC=C1C=CC(=O)C2=C(C(=CC3=C(C(=C(C=CC4=CC=C(C=C4)O)O)C(=O)[C@](C3=O)([C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O)C(=O)[C@](C2=O)([C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O)O)O,,,,,,
1475,3081476,Potassium;azanylidyneoxidanium;iron;trisulfide,N#[O+].N#[O+].N#[O+].N#[O+].N#[O+].N#[O+].N#[O+].[S-2].[S-2].[S-2].[K+].[Fe].[Fe].[Fe].[Fe],,,,,,
1476,3081477,"LHRH, Des-gly(10)-",CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N)NC(=O)CNC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6,,,,,,
1477,3081478,CID 3081478,CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC\4(C(C5C6(C(C(C(=N6)/C(=C\7/C(C(C(=N7)C=C8C(C(C(=N8)/C(=C4\[N-]5)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)O)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3],,,,,,
1478,3081479,"3-[(5Z)-2,7,18-tris(2-amino-2-oxoethyl)-8,13-bis(3-amino-3-oxopropyl)-17-[3-[2-[[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxypropylamino]-3-oxopropyl]-1,2,5,7,12,12,15,17-octamethyl-3,8,13,18,19,22-hexahydrocorrin-3-yl]propanoic acid",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)/C(=C\7/C(C(C(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)N7)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)O)(C)CC(=O)N)C)CC(=O)N)C)O,,,,,,
1479,3081480,(2S)-1-[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]-N-(2-amino-2-oxoethyl)pyrrolidine-2-carboxamide,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)CNC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)N,,,,,,
1480,3081481,"[[5-(6-Aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] hydrogen phosphate",CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)OP(=O)(O)OCC4C(C(C(O4)N5C=NC6=C(N=CN=C65)N)O)OP(=O)(O)O)O)O)O,,,,,,
1481,3081482,N-Butyryldaunorubicin,CCCC(=O)N[C@H]1C[C@@H](O[C@H]([C@H]1O)C)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O,,,,,,
1482,3081483,"(2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-2-[(1S,4S,5'R,6R,7S,8R,9S,12S,13R,14R,16R)-16-hydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-14-yl]oxy-6-methyloxan-3-yl]oxy-6-methyloxane-3,4,5-triol",C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)CC4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5([C@@H](C[C@@H](C6)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C)O)O)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)C)C)C)OC1,,,,,,
1483,3081484,CID 3081484,COC1=C(C=CC(=C1)C(=O)OC2C3C=COC(C3C4(C2O4)CO)OC5C(C(C(C(O5)CO)O)O)O)O,,,,,,
1484,3081485,Chenodeoxycholate 3-sulphate,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C.OS(=O)(=O)O,,,,,,
1485,3081486,CID 3081486,[Cu].[Cu].[Zn].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2],,,,,,
1486,3081487,Immobilon,CCC[C@](C)([C@H]1CC23C=C[C@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)C)OC)O.C[C@@H](CN1C2=CC=CC=C2SC3=C1C=C(C=C3)OC)CN(C)C,,,,,,
1487,3081488,"(2S,6R,14R,15S,19R)-19-[(2R)-2-hydroxypentan-2-yl]-15-methoxy-5-methyl-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11,16-tetraen-11-ol",CCC[C@](C)([C@H]1CC23C=C[C@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)C)OC)O,,,,,,
1488,3081489,"Methyl 4-(acetyloxy)-15-[11-(acetyloxy)-1a-ethyl-3-oxo-1a,2,3,4,5,10,11,12,13,13a-decahydro-3,13-methano-3lambda~5~-oxireno[9,10]azacycloundecino[5,4-b]indol-11-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate",CCC12C[N+]3(CCC4=C(C(CC(C3)C1O2)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)OC(=O)C)NC1=CC=CC=C41)[O-],,,,,,
1489,3081490,"(3aR-(3aalpha,4alpha,4abeta,5beta,8alpha,8abeta,8balpha,10S*))-Decahydro-8-methyl-5-(1-methylethyl)-8a-propyl-4,8,3a-(1,2,4)butanetriylcyclopent(b)indole",CCCC12[C@@H]3CCCC34CC[C@@H]5C1(CC[C@@H]([C@@H]2N4C5)C(C)C)C,,,"['Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)', 'Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)']",,,
1490,3081491,3-Chloroacetylpyridine-adenine dinucleotide,C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O)O)[O-])C(=O)CCl,,,,,,
1491,3081492,3-(Chloroacetyl) Pyridine Adenine Dinucleotide,C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O)C(=O)CCl,,,,,,
1492,3081493,2-Fluoro-2-deoxyglucose 6-phosphate,C([C@H]([C@H]([C@@H]([C@H](C=O)F)O)O)O)OP(=O)(O)O,,,,,,
1493,3081494,cis-Pt(II)(Benzothiazole)2Cl2,C1=CC=C2C(=C1)N=CS2.C1=CC=C2C(=C1)N=CS2.[Cl-].[Cl-].[Pt+2],,,,,,
1494,3081495,1-(beta-D-Ribofuranosyl)-2-thio-uracil-5'-phosphate,C1=CN(C(=S)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O,,,,,,
1495,3081496,"2,3-Bis(3,7,11,15-tetramethylhexadecoxy)propyl 2,3-dihydroxypropyl hydrogen phosphate",CC(C)CCCC(C)CCCC(C)CCCC(C)CCOCC(COP(=O)(O)OCC(CO)O)OCCC(C)CCCC(C)CCCC(C)CCCC(C)C,,,,,,
1496,3081497,"(2S,6R,14R,15S,19R)-19-(2-hydroxy-5-methylhexan-2-yl)-15-methoxy-5-methyl-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11,16-tetraen-11-ol",CC(C)CCC(C)([C@H]1CC23C=C[C@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)C)OC)O,,,,,,
1497,3081498,CID 3081498,CC(C)[N+](C)(CCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)N)C(C)C.CC(C(C1=CC=CC=C1)O)N.CN(C)CCCC1=CC=CC=N1.C1=CC(=CC=C1OC(=O)C=CC(=O)O)Cl.Cl.[I-],,,,,,
1498,3081499,"3beta,17beta-Diacetoxy-4-estrene",[H][C@@]1(C[C@@H]2[C@H]3CC[C@]4([C@H]([C@@H]3CCC2=C[C@H]1OC(=O)C)CC[C@@H]4OC(=O)C)C)[3H],,,,,,
1499,3081500,6-D-Ala-gonadorelin,C[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6,,,,,,
1500,3081501,CID 3081501,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=NC2=O)N)Br)COP(=O)(O)O[C@H]3C[C@@H](O[C@@H]3COP(=O)(O)O)N4C=NC5=C4NC=NC5=O)O,,,,,,
1501,3081502,Nitinol,[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni],,,,,,
1502,3081503,"LHRH, Des-tyr(5)-",CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CN=CN4)NC(=O)[C@@H]5CCC(=O)N5,,,,,,
1503,3081504,CID 3081504,CC(C)CC(C)C=CCC1CC(=O)OC1=O.C1CC2C(O2)CC1C3CO3.C1C(O1)COCCCOCC2CO2,,,,,,
1504,3081505,"Oxirane, 2,2'-[1,3-propanediylbis(oxymethylene)]bis-",C1C(O1)COCCCOCC2CO2,,,,,,
1505,3081506,"3-(4,6-Dimethylhept-2-enyl)oxolane-2,5-dione",CC(C)CC(C)C=CCC1CC(=O)OC1=O,,,,,,
1506,3081507,CID 3081507,CCNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6,,,,,,
1507,3081508,alpha-Glucopyranosyl-(1-4)-2-deoxy-D-glucose,C(C=O)[C@H](C([C@@H](CO)O)O[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)O,,,,,,
1508,3081509,Antibiotic A447 B,CCC1(CC(C2=C(C1OC3CC(C(C(O3)C)OC4CCC(C(O4)C)OC5CCC(C(O5)C)O)N(C)C)C(=C6C(=C2O)C(=O)C7=C(C6=O)C=CC=C7O)O)OC8CC(C(C(O8)C)OC9CC(C(C(O9)C)OC1CCC(C(O1)C)O)O)N(C)C)O,,,,,,
1509,3081510,Lacto-N-fucoheptaose,CC1C(C(C(C(O1)OC2(CC(C(OC2CO)OC3C(C(OC(C3O)OC(C(CO)O)C(C(C=O)O)O)COC4C(C(C(C(O4)CO)OC5C(C(C(C(O5)CO)O)O)O)O)NC(=O)C)O)NC(=O)C)OC6C(C(C(C(O6)CO)O)O)O)O)O)O,,,,,,
1510,3081511,"[(2R)-2-[(3aR,5R,6S,6aS)-6-fluoro-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]-2-hydroxyethyl] benzoate",CC1(O[C@@H]2[C@H]([C@H](O[C@@H]2O1)[C@@H](COC(=O)C3=CC=CC=C3)O)F)C,,,,,,
1511,3081513,"3,7,12-Trihydroxy-5beta-cholestanoyl-CoA",C[C@H](CCCC(C)C(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O)[C@H]4CC[C@@H]5[C@@]4(C(C[C@H]6[C@H]5C(CC7[C@@]6(CCC(C7)O)C)O)O)C,,,,,,
1512,3081514,Icdxg,CC1(O[C@@H]2[C@H]([C@H](O[C@@H]2O1)[C@@H](CCl)O)O)C,,,,,,
1513,3081515,Jenicillin A,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C,,,,,,
1514,3081516,CID 3081516,[CH3-].CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC\4(C(C5C6(C(C(C(=N6)/C(=C\7/C(C(C(=N7)C=C8C(C(C(=N8)/C(=C4\[N-]5)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Cl-].[Cl-].[Cl-].[Co+3].[Pd+2],,,,,,
1515,3081517,5-Mercaptouridylic acid,C1=C(C(=O)NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)S,,,,,,
1516,3081518,CID 3081518,C[C@H](C(C1=CC=CC=C1)O)N.CNC[C@@H](C1=CC(=CC=C1)O)O.CN(C)CCCC1=CC=CC=N1.C1=CC(=CC=C1OC(=O)C=CC(=O)O)Br.Cl.Cl,,,,,,
1517,3081519,CID 3081519,C1=CC(=CC=C1OC(=O)C=CC(=O)O)Br,,,,,,
1518,3081520,CID 3081520,C[C@@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C[C@@H]2[C@H]([C@@H](C[C@@](O2)(C[C@@H](C[C@H]([C@@H](CC[C@H](C[C@@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@@H]3[C@@H]([C@@H]([C@H]([C@@H](O3)C)O)N)O.CNC[C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O,,,,,,
1519,3081522,"Methyl 3,4-bis(acetyloxy)-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate",CC[C@@]12C=CCN3[C@@H]1C4(CC3)[C@H]([C@]([C@@H]2OC(=O)C)(C(=O)OC)OC(=O)C)N(C5=C4C=CC(=C5)OC)C,,,,,,
1520,3081523,Papyriogenin A,C[C@]12CCC(=O)C([C@@H]1CC[C@@]3([C@@H]2C=CC4=C5CC(C(=O)C[C@@]5(CC[C@]43C)C(=O)O)(C)C)C)(C)C,,,,,,
1521,3081524,"LHRH, lys(6)-N-Et-pronh2(9)-",CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6,,,,,,
1522,3081525,beta-Endorphin (1-9),C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)[C@H](CC2=CC=C(C=C2)O)N)O,,,,,,
1523,3081526,CID 3081526,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)OC(C(C(=O)N1)NC)C(C)CC=CC)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,,,,,,
1524,3081527,N-Formylmethionyl tryptophan,CSCC[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC=O,,,,,,
1525,3081528,"GNRH (1-9)nonapeptide ethylamide, penicillamine-(tert-butyl)(6)-",CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C(C)(C)SC(C)(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6,,,,,,
1526,3081529,Dineca,CCNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O[N+](=O)[O-])O[N+](=O)[O-],,,,,,
1527,3081530,3-Deoxy-C(3)-methyleneglucose,C=C([C@H](C=O)O)[C@@H]([C@@H](CO)O)O,,,,,,
1528,3081531,CID 3081531,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)OC)OC3C(C(C(C(O3)C)O)NC(=O)C)O,,,,,,
1529,3081532,13-Dihydrocarminomycinone,C[C@@H]([C@]1(C[C@@H](C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4O)O)O)O)O,,,,,,
1530,3081533,CID 3081533,[H+].[H+].[H+].C1C(C(=O)OCC(C(=O)OCC(C(=O)O1)NC(=O)C2=C(C(=CC=C2)[O-])[O-])NC(=O)C3=C(C(=CC=C3)[O-])[O-])NC(=O)C4=C(C(=CC=C4)[O-])[O-].[Fe+3],,,,,,
1531,3081534,CID 3081534,CC1CC2(C(C1O)C3C(O3)(CCC4C(C4(C)C)C=C(C2=O)CO)C)OC(=O)C=CC5=CC=CC=C5,,,,,,
1532,3081535,"(16-Hydroxy-4,8,8,11,15-pentamethyl-12-oxo-3-oxatetracyclo[11.3.0.02,4.07,9]hexadec-10-en-13-yl) 3-phenylprop-2-enoate",CC1CC2(C(C1O)C3C(O3)(CCC4C(C4(C)C)C=C(C2=O)C)C)OC(=O)C=CC5=CC=CC=C5,,,,,,
1533,3081536,"3,8-Diamino-6-phenyl-phenanthridine",[H+].C1=CC=C(C=C1)C2=C3C=C(C=CC3=C4C=CC(=CC4=N2)N)N,,,,,,
1534,3081537,Mixogen,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C.CC(C)CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C.C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCC4=CC=CC=C4)CCC5=CC(=O)CC[C@]35C.C[C@]12CCC3C(C1CC[C@@H]2O)CCC4=C3C=CC(=C4)OC(=O)C5=CC=CC=C5.C[C@]12CCC3C(C1CC[C@@H]2OC(=O)CCC4=CC=CC=C4)CCC5=C3C=CC(=C5)O,,,,,,
1535,3081538,"[(13S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] 3-phenylpropanoate",C[C@]12CCC3C(C1CC[C@@H]2OC(=O)CCC4=CC=CC=C4)CCC5=C3C=CC(=C5)O,,,,,,
1536,3081539,CID 3081539,[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2],,,,,,
1537,3081540,Dpvdavp,CC(C)C1C(=O)NC(C(=O)NC(CSSC(CC(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)O)(C)C)C(=O)N4CCCC4C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N,,,,,,
1538,3081541,Ruthenium bis(bipyridine)dicarboxybipyridine,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.C1=CN=C(C=C1C(=O)[O-])C2=NC=CC(=C2)C(=O)[O-].[Ru+2],,,,,,
1539,3081542,CID 3081542,[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[InH3].[InH3].[InH3].[InH3].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2],,,,,,
1540,3081543,14-Bromodaunorubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CBr)O)N)O,,,,,,
1541,3081544,Apramycin sulfate,CN[C@H]1[C@H]([C@@H]2[C@H](C[C@H]([C@H](O2)O[C@@H]3[C@H](C[C@H]([C@@H]([C@H]3O)O)N)N)N)O[C@@H]1O[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)N)O)O)O.OS(=O)(=O)O,,,['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)'],,,
1542,3081545,Apramycin,CN[C@H]1[C@H]([C@@H]2[C@H](C[C@H]([C@H](O2)O[C@@H]3[C@H](C[C@H]([C@@H]([C@H]3O)O)N)N)N)O[C@@H]1O[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)N)O)O)O,['For the treatment of bacterial infections in animals.'],,['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)'],,,
1543,3081546,bismuth;7H-purine-6-thiolate,C1=NC2=C(N1)C(=NC=N2)[S-].C1=NC2=C(N1)C(=NC=N2)[S-].C1=NC2=C(N1)C(=NC=N2)[S-].[Bi+3],,,,,,
1544,3081547,Hyp(9)-LHRH,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1C[C@@H](C[C@H]1C(=O)NCC(=O)N)O)NC(=O)CNC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6,,,,,,
1545,3081548,Kuwanon D,CC1(C2CCC3(C2C1C4=C(O3)C=C(C(=C4)C5CC(=O)C6=C(C=C(C=C6O5)O)O)O)C)C,,,,,,
1546,3081549,CID 3081549,C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)O[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)F)O)O)NC(=NC2=O)N,,,,,,
1547,3081550,CID 3081550,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6,,,,,,
1548,3081551,DG-Gluc,CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4C3CC(C5(C4(CCC5C6=CC(=O)OC6)O)C)O)C)O)OC7CC(C(C(O7)C)OC8CC(C(C(O8)C)OC9C(C(C(C(O9)C(=O)O)O)O)O)O)O,,,,,,
1549,3081552,CID 3081552,CN(C)C(=NN=CC=NN=C(N(C)C)[S-])[S-].[Cu+2],,,,,,
1550,3081553,Nmanchol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OCCCCCCS[C@@H]5[C@H]([C@H]([C@@H]([C@H](O5)CN)O)O)O)C)C,,,,,,
1551,3081554,CID 3081554,C1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)N)COP(=O)(O)O[C@H]3C[C@@H](O[C@@H]3COP(=O)(O)O[C@H]4C[C@@H](O[C@@H]4COP(=O)(O)O[C@H]5C[C@@H](O[C@@H]5COP(=O)(O)O)N6C=NC7=C6NC(=NC7=O)N)N8C=CC(=NC8=O)N)N9C=NC1=C9NC(=NC1=O)N)O,,,,,,
1552,3081555,"1,6-Dichloro-1,6-dideoxyfructose",C([C@H]([C@H]([C@@H](C(=O)CCl)O)O)O)Cl,,,,,,
1553,3081556,Pt-Plant,C1=C(SC(=N1)N)[N+](=O)[O-].C1=C(SC(=N1)N)[N+](=O)[O-].[Cl-].[Cl-].[Pt+2],,,,,,
1554,3081557,Bis-NAD,C1C[C@@H](O[C@@H]1COP(=O)(O)OP(=O)(O)O)N2CNC3=C(N=C(N=C32)C(N=N)OC[C@@H]4[C@H]([C@H]([C@@H](O4)[N+]5=CC=CC(=C5)C(=O)N)[O-])O)NCC(=O)C(CC(=O)OC[C@@H]6[C@H]([C@H]([C@@H](O6)[N+]7=CC=CC(=C7)C(=O)N)[O-])O)(C(=O)CNC8=C9C(=NC(=N8)C(=O)NN)N(CN9)[C@H]1CC[C@H](O1)COP(=O)(O)OP(=O)(O)O)C(=O)O,,,,,,
1555,3081558,"2-[2-[[2-[[(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-diazenylmethyl]-9-[(2R,5S)-5-[[hydroxy(phosphonooxy)phosphoryl]oxymethyl]oxolan-2-yl]-7,8-dihydropurin-6-yl]amino]acetyl]-2-[2-[[(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-2-oxoethyl]-4-[[2-(hydrazinecarbonyl)-9-[(2R,5S)-5-[[hydroxy(phosphonooxy)phosphoryl]oxymethyl]oxolan-2-yl]-7,8-dihydropurin-6-yl]amino]-3-oxobutanoic acid",C1C[C@@H](O[C@@H]1COP(=O)(O)OP(=O)(O)O)N2CNC3=C(N=C(N=C32)C(N=N)OC[C@@H]4[C@H]([C@H]([C@@H](O4)[N+]5=CC=CC(=C5)C(=O)N)O)O)NCC(=O)C(CC(=O)OC[C@@H]6[C@H]([C@H]([C@@H](O6)[N+]7=CC=CC(=C7)C(=O)N)O)O)(C(=O)CNC8=C9C(=NC(=N8)C(=O)NN)N(CN9)[C@H]1CC[C@H](O1)COP(=O)(O)OP(=O)(O)O)C(=O)O,,,,,,
1556,3081559,Cobalt tetracarboxyphthalocyanine,[H+].[H+].[H+].[H+].C1=CC2=C(C=C1C(=O)[O-])C3=NC4=NC(=NC5=NC(=NC6=C7C=CC(=C([O-])[O-])C=C7C(=N6)N=C2[N-]3)C8=C5C=CC(=C8)C(=O)[O-])C9=C4C=CC(=C9)C(=O)[O-].[Co+2],,,,,,
1557,3081560,"Substance P (6-11), glp(6)-iodo-tyr(8)-",CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)CNC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H]3CCC(=O)N3,,,,,,
1558,3081561,Mannosyl(9)-N-acetylglucosamine,CC(=O)N[C@@H](C=O)[C@H]([C@@H]([C@@H](CO[C@@H]1[C@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O[C@@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O[C@@H]3[C@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)O[C@@H]5[C@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O[C@@H]6[C@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O[C@H]7[C@H]([C@H]([C@@H]([C@H](O7)CO)O)O[C@@H]8[C@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O[C@@H]9[C@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O,,,,,,
1559,3081562,Mannosyl(5)-N-acetyl(2)-glucose,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O[C@H]([C@H](C=O)NC(=O)C)[C@@H]([C@@H](CO[C@@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O[C@@H]3[C@H]([C@H]([C@@H]([C@H](O3)CO)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O[C@@H]5[C@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O[C@H]6[C@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)CO)O)O,,,,,,
1560,3081563,CID 3081563,CC1=C(C(=CC2=C(C(=C(N2)C=C3C(=C(C(=CC4=NC(=O)C(=C4C)C=C)N3)C)C=C)C)CCC(=O)O)NC1=O)CCC(=O)O,,,,,,
1561,3081564,"1,4,5,8-Tetramethylhemin",[H+].[H+].CC1=C(C2=CC3=C(C(=C([N-]3)C=C4C(=C(C(=N4)C=C5C(=C(C(=N5)C=C1[N-]2)C)C=C)C=C)C)C)CCC(=O)[O-])CCC(=O)[O-].[Cl-].[Fe+3],,,,,,
1562,3081565,Protoporphyrin III,CC1=C(C2=CC3=C(C(=C(N3)C=C4C(=C(C(=N4)C=C5C(=C(C(=N5)C=C1N2)C)CCC(=O)O)CCC(=O)O)C)C)C=C)C=C,,,,,,
1563,3081566,CID 3081566,CC1=C(C(=O)NC1=CC2=C(C(=C(N2)C=C3C(=C(C(=CC4=NC(=O)C(=C4C)CCC(=O)O)N3)C=C)C)C)C=C)CCC(=O)O,,,,,,
1564,3081567,Naloxazine,C=CCN1CCC23C4C(CCC2(C1CC5=C3C(=C(C=C5)O)O4)O)NN,,,,,,
1565,3081568,Papyriogenin C,C[C@]12CC[C@H](C([C@@H]1CC[C@@]3([C@@H]2C=CC4=C5CC(C(=O)C[C@@]5(CC[C@]43C)C(=O)O)(C)C)C)(C)C)O,,,,,,
1566,3081569,Chromium adenosine diphosphate,C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)([O-])OP(=O)([O-])[O-])O)O)N.O.O.O.O.[Cr+3],,,,,,
1567,3081570,CID 3081570,C[C@H]1C[C@@H]([C@@H]([C@@H]2[C@@H]1[C@]3([C@@H](C=C2)C(=CC[C@@H](C(=C[C@@H]4[C@H](CC(=CC45C(=O)C(=C(O5)O)C3=O)C=O)O)C)O[C@H]6C[C@]([C@H]([C@H](O6)C)NC(=O)OC)(C)[N+](=O)[O-])C)C)O[C@H]7C[C@H]([C@H]([C@@H](O7)C)OC(=O)C)O[C@H]8CC[C@H]([C@@H](O8)C)O[C@H]9C[C@H]([C@H]([C@@H](O9)C)O[C@H]1CC[C@H]([C@@H](O1)C)O)O)C,,,,,,
1568,3081571,Perhydrohexestrol,CCC(C1CCC(CC1)O)C(CC)C2CCC(CC2)O,,,,,,
1569,3081572,CID 3081572,C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O.C1=NC(=O)C2=C(N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O.C1=NC(=O)C2=C(N1)N(C(=N2)N=[N+]=[N-])[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O,,,,,,
1570,3081573,"Msh, beta, (9-18), tyr(9)-",C1C[C@H](N(C1)C(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H](CC6=CC=C(C=C6)O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O,,,,,,
1571,3081574,CID 3081574,CC1(C=COC2=C(O1)C=CC3=C2NC(=O)[C@@]34CC56CN7CCCCC7(C[C@H]5C4(C)C)C(=O)N6C)C,,,,,,
1572,3081575,CID 3081575,CC1CC(C(C2C1C3(C(C=C2)C(=CCC(C(=CC4C(C=C(CC45C(=O)C(=C(O5)O)C3=O)C=O)O)C)OC6CC(C(C(O6)C)NC(=O)OC)(C)[N+](=O)[O-])C)C)OC7CC(C(C(O7)C)OC(=O)C)OC8CC(C(OC8)C)OC9CC(C(C(O9)C)O)O)C,,,,,,
1573,3081576,CID 3081576,[Cd].[Cd].[Cd].[Cd].[Cd].[Cd].[Cd].[Cd].[Cd].[Cd].[Cd].[Cd].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[PbH2].[PbH2].[PbH2].[PbH2].[PbH2].[PbH2].[PbH2].[PbH2].[PbH2].[PbH2].[PbH2].[PbH2].[PbH2].[PbH2].[PbH2].[PbH2].[PbH2].[PbH2].[PbH2].[PbH2].[PbH2].[PbH2].[PbH2].[PbH2].[PbH2].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3].[BiH3],,,,,,
1574,3081577,CID 3081577,CCC1(C(=O)NC(=O)NC1=O)CC=CC.CC[N+](C)(CC)CCOC(C)(C1CC2CC1C=C2)C3=CC=CC=C3.CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)[O-].CN1CC[C@]23[C@@H]4[C@@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O.OP(=O)(O)O.[Na+].[Br-],,,,,,
1575,3081578,Dynorphin A (1-9),CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)[C@H](CC2=CC=C(C=C2)O)N,,,,,,
1576,3081579,"(L-Histidinato-N,N3,O)copper(1+)",C1=C(NC=N1)C[C@H](C(=O)[O-])N.[Cu+2],,,,,,
1577,3081580,"Oxytocin, 1-desamino-(O-Et-tyr)(2)-",CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)OCC)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,,,,,,
1578,3081581,FAMan,C([C@H]([C@H]([C@@H]([C@@H](C=O)NC(=O)CF)O)O)O)O,,,,,,
1579,3081582,CID 3081582,C[C@@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C[C@@H]2[C@H]([C@@H](C[C@@](O2)(C[C@@H](C[C@H]([C@@H](CC[C@H](C[C@@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@@H]3[C@@H]([C@@H]([C@H]([C@@H](O3)C)O)NCC(=O)[C@H]([C@H]([C@@H](CO)O)O)O)O,,,,,,
1580,3081583,CID 3081583,CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](C2=CN=CN2)O)C(=O)N[C@@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC3=NC(=CS3)C4=NC(=CS4)C(=O)NCCCCN=C(N)N)O,,,,,,
1581,3081584,Mannosyl(6)-N-acetylglucosamine(2),CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O[C@H]([C@@H](CO[C@@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)O[C@@H]3[C@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O[C@H]5[C@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)[C@@H]([C@H](C=O)NC(=O)C)O[C@@H]6[C@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O[C@@H]7[C@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)CO)O)O,,,,,,
1582,3081585,CID 3081585,CC1C=CC=C(C(=O)N=C2C(=CNN=C3N(C4=CC=CC=C4S3)C)C(=C5C(=C2O)C(=C(C6=C5C(=O)C(O6)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C,,,,,,
1583,3081586,CID 3081586,C[C@H]1C[C@@H]([C@@H]([C@@H]2[C@@H]1[C@]3([C@@H](C=C2)C(=CC[C@@H](C(=C[C@@H]4C=C([C@@H](CC45C(=O)C(=C(O5)O)C3=O)C)CO)C)O[C@H]6C[C@]([C@H]([C@H](O6)C)NC(=O)OC)(C)[N+](=O)[O-])C)C)O[C@H]7C[C@H]([C@H]([C@@H](O7)C)O)O[C@H]8C[C@H]([C@H]([C@@H](O8)C)O[C@@H]9C[C@H]([C@H]([C@@H](O9)C)OC)O)O[C@H]1C[C@H]([C@H]([C@@H](O1)C)O)O)C,,,,,,
1584,3081587,"Amaninamide, deoxy-ile(3)-ala(7)-",CCC(C)C1C(=O)NC(C(=O)NC2CSC3=C(CC(C(=O)NCC(=O)N1)NC(=O)C(NC(=O)C4CC(CN4C(=O)C(NC2=O)CC(=O)N)O)C(C)CC)C5=CC=CC=C5N3)C,,,,,,
1585,3081588,Magnesium;hydron;2-oxidooxycarbonylbenzoate,[H+].[H+].C1=CC=C(C(=C1)C(=O)[O-])C(=O)O[O-].C1=CC=C(C(=C1)C(=O)[O-])C(=O)O[O-].[Mg+2],,,,,,
1586,3081589,CID 3081589,C1=CC=C(C(=C1)C(=O)[O-])C(=O)OO,,,,,,
1587,3081590,1-Hydroxyauramycin B,CC1C2C(CC(O1)OC3C(OC(CC3N(C)C)OC4CC(C(C5=CC6=C(C(=C45)O)C(=O)C7=C(C=CC(=C7C6=O)O)O)C(=O)OC)(C)O)C)OC8CC(=O)C(OC8O2)C,,,,,,
1588,3081591,"5-Hydroxy-8,12,12-trimethyl-4-methylidene-2,10-dioxatetracyclo[7.4.0.01,5.09,11]tridecan-3-one",CC1CCC2(C(=C)C(=O)OC23C14C(O4)C(C3)(C)C)O,,,,,,
1589,3081592,CID 3081592,C[C@H](C(C1=CC=CC=C1)O)N.CNC[C@@H](C1=CC(=CC=C1)O)O.CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)C4=CC=CC=C4C(CO)C(=O)O.CN1C2CCC1CC(C2)C3=CC(=CC=C3)C(CO)C(=O)O.CN1C2CCC1CC(C2)C3=CC(=CC=C3)C(CO)C(=O)O.CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O.Cl.Cl.Br,,,,,,
1590,3081593,"3-hydroxy-2-[2-[(1R,2R,4S,5S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl]phenyl]propanoic acid",CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)C4=CC=CC=C4C(CO)C(=O)O,,,,,,
1591,3081594,Pyridoxal(5')diphospho(1)-glucose,CC1=NC=C(C(=C1O)C=O)COP(=O)([O-])OP(=O)([O-])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O.[Na+].[Na+],,,,,,
1592,3081595,"[(4-formyl-5-hydroxy-6-methylpyridin-3-yl)methoxy-hydroxyphosphoryl] [(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate",CC1=NC=C(C(=C1O)C=O)COP(=O)(O)OP(=O)(O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
1593,3081596,CID 3081596,C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O[C@@H]3[C@H](O[C@H]([C@@H]3F)N4C=NC5=C4NC(=NC5=O)N)CO)O)O,,,,,,
1594,3081597,"methyl (2R,4S,5R,6R)-2-[[(3aR,4R,6R,6aR)-4-(5-fluoro-2,4-dioxopyrimidin-1-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methoxy]-5-acetamido-4-acetyloxy-6-[(1S,2R)-1,2,3-triacetyloxypropyl]oxane-2-carboxylate",CC(=O)N[C@@H]1[C@H](C[C@@](O[C@H]1[C@@H]([C@@H](COC(=O)C)OC(=O)C)OC(=O)C)(C(=O)OC)OC[C@@H]2[C@@H]3[C@H]([C@@H](O2)N4C=C(C(=O)NC4=O)F)OC(O3)(C)C)OC(=O)C,,,,,,
1595,3081598,"(7S,9S)-9-acetyl-7-[(2R,4S,5R,6S)-4-(dibenzylamino)-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N(CC6=CC=CC=C6)CC7=CC=CC=C7)O,,,,,,
1596,3081599,Cholecystokinin (26-33),CSCC[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)[C@H](CC(=O)O)N,,,,,,
1597,3081600,CID 3081600,[H+].C1C(C(OC1N2C=NC3=C2NC(=NC3=O)N)COP(=O)([O-])OC4CC(OC4OCP(=O)([O-])[O-])N5C=NC6=C5NC(=NC6=O)N)O.N.N.[Pt+2],,,,,,
1598,3081601,CID 3081601,C1C(C(OC1N2C=NC3=C2NC(=NC3=O)N)COP(=O)(O)OC4CC(OC4OCP(=O)(O)O)N5C=NC6=C5NC(=NC6=O)N)O,,,,,,
1599,3081602,"7,14,20-Trihydroxykaur-16-ene-11,15-dione",CC1(CCC[C@@]2([C@@H]1C[C@H](C34[C@H]2C(=O)CC([C@@H]3O)C(=C)C4=O)O)CO)C,,,,,,
1600,3081603,"Arginine vasopressin, 1-(beta-mercapto-beta,beta-diethylpropionic acid)-",CCC1(CC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSS1)C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)CC,,,,,,
1601,3081604,Tnp-cap-dppe,CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCNC(=O)CCCCCNC1=C(C=C(C=C1[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-])OC(=O)CCCCCCCCCCCCCCC,,,,,,
1602,3081605,Octaethylverdohemochrome,CCC1=C(C2=NC1=CC3=C(C(=C([N-]3)OC4=NC(=CC5=NC(=C2)C(=C5CC)CC)C(=C4CC)CC)CC)CC)CC.C1=CC=NC=C1.C1=CC=NC=C1.[Fe+2],,,,,,
1603,3081606,"4,5,9,10,14,15,19,20-Octaethyl-2-oxa-21,22,23,24-tetrazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1(21),3(24),4,6,8,10,12,14,16(22),17,19-undecaene",CCC1=C(C2=NC1=CC3=C(C(=C(N3)C=C4C(=C(C(=N4)OC5=NC(=C2)C(=C5CC)CC)CC)CC)CC)CC)CC,,,,,,
1604,3081607,De-tyr-dynorphin(2-13),CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)CNC(=O)CN,,,,,,
1605,3081608,CID 3081608,CC1C(C(CC(O1)OC2CC(CC3=CC4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5O)(C(=NN=C6CCCCC6)C)O)N)O,,,,,,
1606,3081609,CID 3081609,[AlH3].[AlH3].[AlH3].[AlH3].[AlH3].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Mo].[Mo].[Mo].[Mo].[Mo].[Mo].[Mo].[Mo],,,,,,
1607,3081610,Demethylolivomycin A,CC1C(C(CC(O1)OC2CC(OC(C2OC(=O)C)C)OC3=CC(=C4C(=C3)C=C5CC(C(C(=O)C5=C4O)OC6CC(C(C(O6)C)O)OC7CC(C(C(O7)C)O)OC8CC(C(C(O8)C)OC(=O)C(C)C)(C)O)C(C(=O)C(C(C)O)O)OC)O)O)O,,,,,,
1608,3081611,Demethylchromomycin A2,CC1C(C(CC(O1)OC2CC(OC(C2OC(=O)C)C)OC3=CC4=CC5=C(C(=O)C(C(C5)C(C(=O)C(C(C)O)O)OC)OC6CC(C(C(O6)C)O)OC7CC(C(C(O7)C)O)OC8CC(C(C(O8)C)OC(=O)C(C)C)(C)O)C(=C4C(=C3C)O)O)O)O,,,,,,
1609,3081612,Demethylolivomycin B,CC1C(C(CC(O1)OC2CC(OC(C2OC(=O)C)C)OC3=CC(=C4C(=C3)C=C5CC(C(C(=O)C5=C4O)OC6CC(C(C(O6)C)O)OC7CC(C(C(O7)C)O)OC8CC(C(C(O8)C)OC(=O)C)(C)O)C(C(=O)C(C(C)O)O)OC)O)O)O,,,,,,
1610,3081613,Demethylchromomycin A3,CC1C(C(CC(O1)OC2CC(OC(C2OC(=O)C)C)OC3=CC4=CC5=C(C(=O)C(C(C5)C(C(=O)C(C(C)O)O)OC)OC6CC(C(C(O6)C)O)OC7CC(C(C(O7)C)O)OC8CC(C(C(O8)C)OC(=O)C)(C)O)C(=C4C(=C3C)O)O)O)O,,,,,,
1611,3081614,Ablsp,CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)CNC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C3CCCN3C(=O)C(CCCCN)NC(=O)CCCCC4C5C(CS4)NC(=O)N5,,,,,,
1612,3081615,Bbpp-Ru,C1=CC=C2C(=C1)N=C3C4=C(C5=C(C3=N2)C=CC=N5)N=CC=C4.C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Ru+2],,,,,,
1613,3081616,"Dipyrido[3,2-a:2',3'-c]phenazine",C1=CC=C2C(=C1)N=C3C4=C(C5=C(C3=N2)C=CC=N5)N=CC=C4,,,,,,
1614,3081617,CID 3081617,C[C@H](C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]3CCC(=O)N3,,,,,,
1615,3081618,CID 3081618,C[C@H](C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]4CCC(=O)N4,,,,,,
1616,3081619,CID 3081619,CCC[C@H]([C@@H](C)[C@@H]([C@@H](CC)C=C[C@H]([C@@H](C)[C@H]1CC=C([C@H]([C@H]([C@@H](C[C@H]([C@@H]([C@@H](CC2C[C@H]([C@H]([C@@](O2)(C[C@H]([C@@H](CC[C@H](C[C@@H](CC=C(C(=O)O1)CC)O)O)C)O[C@@H]3[C@@H]([C@@H]([C@H]([C@@H](O3)C)O)O[C@@H]4C[C@H]([C@H]([C@@H](O4)C)O)N)O[C@@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)O)O)O)O)O)O)O)C)O)O[C@@H]6[C@@H]([C@@H]([C@H]([C@@H](O6)CO)O)O)O)C)O)C)O)O)O[C@@H]7C[C@@]([C@@H]([C@@H](O7)C)O)(C)N,,,,,,
1617,3081620,Manganese bleomycin,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCCCN=C(N)N)O)[O-].[Mn+3],,,,,,
1618,3081621,CID 3081621,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)C(C[C@@H]3[C@H](C[C@@H](O3)N4C=NC5=C4NC(=NC5=O)N)O)(C[C@@H]6[C@H](C[C@@H](O6)N7C=NC8=C(N=CN=C87)N)O)OC[C@@H]9[C@H](C[C@@H](O9)N1C=CC(=NC1=O)N)O)OP(=O)(O)OP(=O)(O)OP(=O)(O)O,,,,,,
1619,3081622,Nonoxynol-9 iodine,CCCCCCCCCC1=CC=C(C=C1)OCCOCCOCCOCCOCCOCCOCCOCCOCCO.II,,,,,,
1620,3081623,"(2S)-N-[(2S)-1-[[(2S)-1-[(2S)-2-[[2-[[(2S)-1-[[2-[[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]carbamoyl]pyrrolidin-1-yl]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-[[(2S)-3-methyl-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]butanoyl]amino]butanediamide",C[C@H]([C@@H](C(=O)N)NC(=O)CNC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)CNC(=O)[C@@H]3CCCN3C(=O)[C@H](CO)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]5CCC(=O)N5)O,,,,,,
1621,3081624,CID 3081624,C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2)O,,,,,,
1622,3081625,CID 3081625,CC=CC=C[C@@H]1[C@H]([C@@H](C[C@@](O1)([C@@H](C)[C@@H](C(C)[C@@H]2[C@H](C=CC=C(C[C@@H]([C@@H]([C@@H](C=C(C=C(C(=O)O2)OC)C)C)O)C)C)OC)O)O)O[C@@H]3C[C@H]([C@@H]([C@H](O3)C)O)O)C,,,,,,
1623,3081626,CID 3081626,CC(=NN=C1CCC2(C3CC4=C5C2([C@@H]1OC5=C(C=C4)O)CCN3CC6CC6)O)[C@@H]7CC[C@H]8[C@]7(CC[C@@H]9[C@H]8CC=C1[C@]9(CC[C@@H](C1)O)C)C,,,,,,
1624,3081627,CID 3081627,C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C4NC(=NC5=O)N)N)OP(=O)(O)O)OP(=O)(O)O)N,,,,,,
1625,3081628,CID 3081628,C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C4NC(=NC5=O)N)OP(=O)(O)O)N)OP(=O)(O)O)N,,,,,,
1626,3081629,1'-Ethylascorbigen,C=CN1C=C(C2=CC=CC=C21)C[C@@](C(=O)O)([C@@]3(C[C@H](CO3)O)O)O,,,,,,
1627,3081630,(N-(2-((4-((2-((4-(9-Acridinylamino)phenyl)amino)-2-oxoethyl)amino)-4-oxobutyl)amino)-1-(1H-imidazol-4-ylmethyl)-1-oxoethyl)-6-(((-2-aminoethyl)amino)methyl)-2-pyridinecarboxamidato) iron(1+),C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C=C4)NC(=O)CNC(=O)CCCNC(=O)C(CC5=CN=CN5)N=C(C6=CC=CC(=N6)CNCCN)[O-].[Fe+2],,,,,,
1628,3081631,N-[1-[[4-[[2-[4-(acridin-9-ylamino)anilino]-2-oxoethyl]amino]-4-oxobutyl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-6-[(2-aminoethylamino)methyl]pyridine-2-carboxamide,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C=C4)NC(=O)CNC(=O)CCCNC(=O)C(CC5=CN=CN5)NC(=O)C6=CC=CC(=N6)CNCCN,,,,,,
1629,3081632,"Bis-(N,N'-uracil-1-yl)selenoxomethane",C1=CN(C(=O)NC1=O)C(=[Se])N2C=CC(=O)NC2=O,,,,,,
1630,3081633,5-(2-Trifluoroacetylaminohexafluoroprop-2-yl)-2'-deoxyuridine,C1=C(C=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(C(F)(F)F)(C(F)(F)F)NC(=O)C(F)(F)F,,,,,,
1631,3081634,Nafenopin-coenzyme A,CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)[C@H](C(=O)NCCC(=O)NCCSC(=O)C(C)(C)OC4=CC=C(C=C4)C5CCCC6=CC=CC=C56)O,,,,,,
1632,3081635,CID 3081635,C1COC2=C([C@]13C(=O)NC(=N3)[O-])C=C(C=C2)F.[Na+],,,,,,
1633,3081636,Tnrnflrfamide,C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N)N)O,,,,,,
1634,3081637,"(2R,3R,4S,5R)-2-(2-anilinopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol",C1=CC=C(C=C1)NC2=NC=C3C(=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O,,,,,,
1635,3081638,CID 3081638,CCCCCCC=CCC(=O)NC1COC(=O)CNC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC1=O)CCCN(C(=O)C)[O-])C(C)C)CO)CCCN(C(=O)C)[O-])C)CCCN(C(=O)C)[O-].[Fe+3],,,,,,
1636,3081639,CID 3081639,CCCCCCC=CCC(=O)NC1COC(=O)CNC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC1=O)CCCN(C(=O)C)[O-])C(C)C)CO)CCCN(C(=O)C)[O-])C)CCCN(C(=O)C)[O-],,,,,,
1637,3081640,CID 3081640,[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Pd].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2],,,,,,
1638,3081641,Uridine diphosphate-2-fluoro-2-deoxy-D-galactose,C1=CN(C(=NC1=O)C2[C@@]([C@H]([C@H]([C@H](O2)CO)O)O)(O)[18F])[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)O)O)O,,,,,,
1639,3081642,"2-Acetamido-2,4-dideoxy-4-fluoro-3-O-galactopyranosylglucopyranose",CC(=O)N[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)F)O[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O,,,,,,
1640,3081643,"Benzyl 2-acetamido-6-O-(2-acetamido-2,4-dideoxy-4-fluoroglucopyranosyl)-2-deoxygalactopyranoside",CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@H]1OCC2=CC=CC=C2)CO[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)F)O)NC(=O)C)O)O,,,,,,
1641,3081644,Me Pbdqc,COC(=O)C1=C2C(=C(C3=C1C4=C(C=CC=N4)C=C3)C5=CC=CC=C5)C=CC6=C2N=CC=C6,,,,,,
1642,3081645,"[(2S,3R,4R,5S,6S)-3,5-diacetyloxy-2-[[(1S,2S,4S,5S,6R,10S)-2-(hydroxymethyl)-10-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,9-dioxatricyclo[4.4.0.02,4]dec-7-en-5-yl]oxy]-6-methyloxan-4-yl] 3-(4-methoxyphenyl)prop-2-enoate",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2[C@@H]3C=CO[C@H]([C@@H]3[C@@]4([C@H]2O4)CO)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)OC(=O)C)OC(=O)C=CC6=CC=C(C=C6)OC)OC(=O)C,,,,,,
1643,3081646,"4,5-Dihydroxy-2,6,13-trimethyl-8-oxatricyclo[4.4.3.01,5]tridecane-9,12-dione",CC1CC(C2(C13CC(=O)C(C2(COC(=O)C3)C)C)O)O,,,,,,
1644,3081647,CID 3081647,CCC(C(C=C(C)C=C1C=CC2=NCCC3C12O3)OC4CCC(C(O4)C)O)O,,,,,,
1645,3081648,CID 3081648,CC[C@@](C(=O)N[C@H]1[C@@H](OC(=O)[C@H](NC(=O)[C@@H]2CCCNN2C(=O)[C@H](N(C(=O)[C@@H](N(C(=O)[C@H]3CCCNN3C1=O)O)C)C)C)[C@H](C)O)C(C)C)([C@]4(CC[C@@H]([C@H](O4)C(=C[C@H](C)C(=O)C(=CC)C)C)C)O)O,,,,,,
1646,3081649,"(1R,6R,10S,12S,14R,15S)-3,7,7,10,14-pentamethyl-16-oxatetracyclo[10.4.0.01,15.06,10]hexadec-2-ene-4,9,11-trione",C[C@@H]1C[C@@H]2C(=O)[C@]3([C@H](CC(=O)C(=C[C@]24[C@H]1O4)C)C(CC3=O)(C)C)C,,,,,,
1647,3081650,"Angiotensin II, sar(1)-aza-val(3)-ile(8)-",CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC3=CC=C(C=C3)O)NC(=O)N(C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC,,,,,,
1648,3081651,CID 3081651,C1=CC=C(C=C1)P(C=CP(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4.C1=CC=C(C=C1)P(C=CP(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4.[Au+],,,,,,
1649,3081652,"Bis(1,2-bis(diphenylphosphino)propane)gold (I)",C1=CC=C(C=C1)P(CCCP(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4.C1=CC=C(C=C1)P(CCCP(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4.[Au+],,,,,,
1650,3081653,"Methyl 3-[8-[1-[1-[8,12-bis(3-methoxy-3-oxopropyl)-3,7,13,18-tetramethyl-21,24-dihydroporphyrin-2-yl]ethoxy]ethyl]-18-(3-methoxy-3-oxopropyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoate",CC1=CC2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C(C)OC(C)C6=C7C=C8C(=CC(=CC9=NC(=CC1=NC(=CC(=C6C)N7)C(=C1CCC(=O)OC)C)C(=C9C)CCC(=O)OC)N8)C)C)C(=C4CCC(=O)OC)C)C(=C3C)CCC(=O)OC,,,,,,
1651,3081654,Periplocoside D,CC1C=C(C(=O)C(O1)OC2CCC3(C4CCC5(C(C4CC=C3C2)CCC5(C(C)OC6CC7C(C(O6)C)OOC8(CC(C(C(O8)C)OC9CC(C(C(O9)C)OC1CC(C(C(O1)C)OC1CC(C(C(O1)C)OC1C(C(C(C(O1)C)O)OC)O)OC)OC)OC)OC)CO7)O)C)C)OC,,,,,,
1652,3081655,Bis(14-thiadaunomycin),CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CSCCNC(=O)CCC(=O)NCCSCC(=O)C6(CC(C7=C(C6)C(=C8C(=C7O)C(=O)C9=C(C8=O)C=CC=C9OC)O)OC1CC(C(C(O1)C)O)N)O)O)N)O,,,,,,
1653,3081656,"10-[3-(dimethylamino)-4,6-dihydroxy-3,6-dimethyloxan-2-yl]-8-[4-(dimethylamino)-3-hydroxy-2-methyl-3,4-dihydro-2H-pyran-6-yl]-2-[3-(3,3-dimethyloxiran-2-yl)-2-methyloxiran-2-yl]-11-hydroxy-5-methylnaphtho[2,3-h]chromene-4,7,12-trione",CC1C(C(C=C(O1)C2=C3C(=C(C(=C2)C4C(C(CC(O4)(C)O)O)(C)N(C)C)O)C(=O)C5=C(C3=O)C=C(C6=C5OC(=CC6=O)C7(C(O7)C8C(O8)(C)C)C)C)N(C)C)O,,,,,,
1654,3081657,"methyl (1R,2R,4S)-4-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-2,5,7,10,12-pentahydroxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate",CC[C@]1(C[C@@H](C2=C([C@H]1C(=O)OC)C(=C3C(=C2O)C(=O)C4=C(C=CC(=C4C3=O)O)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)N)O,,,,,,
1655,3081658,Arg-pro-hyp-gly-phe-ser-phe-phe-arg-trifluoroacetic acid,C1C[C@H](N(C1)C(=O)[C@H](CCCN=C(N)N)N)C(=O)N2C[C@@H](C[C@H]2C(=O)NCC(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)NC(CCCN=C(N)N)C(=O)C(F)(F)F)O,,,,,,
1656,3081659,"2,3,4,6-Tetra-O-benzylgalactopyranosyl phenyl sulfoxide",C1=CC=C(C=C1)COC[C@@H]2[C@@H]([C@@H]([C@H]([C@@H](O2)S(=O)C3=CC=CC=C3)OCC4=CC=CC=C4)OCC5=CC=CC=C5)OCC6=CC=CC=C6,,,,,,
1657,3081660,3-phenylpropanoyl-CoA,CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)[C@H](C(=O)NCCC(=O)NCCSC(=O)CCC4=CC=CC=C4)O,,,,,,
1658,3081661,"Bradykinin, leu-ile-ser-",CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N2CCC[C@H]2C(=O)NCC(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CO)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC(C)C)N,,,,,,
1659,3081662,"2',3'-Dideoxy-uridine-5'-monophosphate",C1C[C@@H](O[C@@H]1COP(=O)(O)O)N2C=CC(=O)NC2=O,,,,,,
1660,3081663,CID 3081663,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(CNC(=O)C2=CC=C(C=C2)N=[N+]=[N-])C3=CC(=C(C=C3)OC)OC,,,,,,
1661,3081664,CID 3081664,CC1=NC=C(C(=C1O)C=O)COP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C3NC(=NC4=O)N)O)O,,,,,,
1662,3081665,Iminodiacetic acid-ruthenium (III) complex,[H+].[H+].[H+].[H+].C(C(=O)[O-])NCC(=O)[O-].C(C(=O)[O-])NCC(=O)[O-].O.[Cl-].[Cl-].[Cl-].[Ru+3],,,,,,
1663,3081666,"2-[3,4-dihydroxy-4,6-dimethyl-5-(methylamino)oxan-2-yl]oxy-8-propylidene-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-11-one",CCC=C1CC2C=NC3=C(C=C(C=C3)OC4C(C(C(C(O4)C)NC)(C)O)O)C(=O)N2C1,,,,,,
1664,3081667,"1-Hydroxy-3,4-diaminocyclohexanedichloroplatinum(II)",C1CC(C(CC1O)N)N.[Cl-].[Cl-].[Pt+2],,,,,,
1665,3081668,"Cyclohexanol, 3,4-diamino-",C1CC(C(CC1O)N)N,,,,,,
1666,3081669,Bolton hunter-cholecystokinin nonapeptide,CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N)NC(=O)[C@H](CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCN=C(N)N)N,,,,,,
1667,3081670,"(11-Chloro-21-hydroxy-12,15,20-trimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl) 2-methylpropanoate",CC1C2CC(C(C=CC=C(C(C3=CC(=C(C(=C3)OC)Cl)N(C(=O)CC(C4(C1O4)C)OC(=O)C(C)C)C)OC)C)OC)(NC(=O)O2)O,,,,,,
1668,3081671,"(1R,9S,10S)-17-(cyclopropylmethyl)-3,10-dimethoxy-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-13-one",COC1=CC=CC2=C1[C@]34CCN([C@@H](C2)[C@@]3(CCC(=O)C4)OC)CC5CC5,,,,,,
1669,3081672,7-O-Ethyl fangchinoline,CCOC1=C(C=C2CCN([C@@H]3C2=C1OC4=C(C=C5CCN([C@H](C5=C4)CC6=CC=C(C=C6)OC7=C(C=CC(=C7)C3)OC)C)OC)C)OC,,,,,,
1670,3081673,2-FM-Daunorubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C=CC(=C5)F)O)(C(=O)C)O)N)O,,,,,,
1671,3081674,3-FD-Daunomycin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C=C(C=C5)F)O)(C(=O)C)O)N)O,,,,,,
1672,3081675,"(5R,8S,11R,15S,18S,19S,22R)-8,15-bis[3-(diaminomethylideneamino)propyl]-18-[(5S,6S)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dienyl]-5,19-dimethyl-2-methylidene-3,6,9,13,16,20,25-heptaoxo-1,4,7,10,14,17,21-heptazacyclopentacosane-11,22-dicarboxylic acid",C[C@H]1[C@@H](NC(=O)[C@@H](NC(=O)C[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)C(=C)NC(=O)CC[C@@H](NC1=O)C(=O)O)C)CCCN=C(N)N)C(=O)O)CCCN=C(N)N)C=CC(=C[C@H](C)[C@H](CC2=CC=CC=C2)OC)C,,,,,,
1673,3081676,CID 3081676,CC1=C(C=C(C(=C1CC2=C(C(=CC(=C2C)Cl)C(C)C)O)O)C(C)C)Cl.CN1CC[C@]23[C@@H]4[C@@H]1CC5=C2C(=C(C=C5)OCCN6CCOCC6)O[C@H]3[C@H](C=C4)O.CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.COC1=CC=CC=C1OCC(CO)O.C(=CC(=O)O)C(=O)O,,,,,,
1674,3081677,CID 3081677,CN1C=NC2=C1NC(=NC2=O)N.CN1C=NC2=C1NC(=NC2=O)N.C1CCC(C(C1)N)N.[Cl-].[Cl-].[Cl-].[Cl-].[Pt+2],,,,,,
1675,3081678,CID 3081678,CN1C=NC2=C1NC(=NC2=O)N.CN1C=NC2=C1NC(=NC2=O)N.C1CCC(C(C1)N)N.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[Pt+2],,,,,,
1676,3081679,5'-Octanoyl-5-fluoro-2'-deoxyuridine,CCCCCCCC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=C(C(=O)NC2=O)F)O)O,,,,,,
1677,3081680,"8-((3-(4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl)propyl)oxy)-8-azaspiro(4.5)decane-7,9-dione",C1CCC2(C1)CC(=O)N(C(=O)C2)OCCCN3CCN(CC3)C4=NSC5=CC=CC=C54.Cl,,,,,,
1678,3081681,"8-[3-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]propyloxy]-8-azaspiro[4.5]decane-7,9-dione",C1CCC2(C1)CC(=O)N(C(=O)C2)OCCCN3CCN(CC3)C4=NSC5=CC=CC=C54,,,,,,
1679,3081682,Hematoporphyrin dicyclohexanyl ether,CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C(C)OC6CCCCC6)C)C(=C4CCC(=O)O)C)C(=C3C)CCC(=O)O)C(C)OC7CCCCC7,,,,,,
1680,3081683,Hematoporphyrin diphenyl ether,CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C(C)OC6=CC=CC=C6)C)C(=C4CCC(=O)O)C)C(=C3C)CCC(=O)O)C(C)OC7=CC=CC=C7,,,,,,
1681,3081684,Indium(111)-atn-2,[H+].[H+].[H+].CC1=C(C2=CC3=C(C(=C([N-]3)C=C4C(=C(C(=N4)C=C5C(=C(C(=N5)C=C1[N-]2)C)C=C)C)C(C)OCCOC(=O)CN(CCN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])C)CCC(=O)[O-])CCC(=O)[O-].O.[OH-].[Ga+3].[111In+3],,,,,,
1682,3081685,"3-[13-[1-[2-[2-[2-[2-[Bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetyl]oxyethoxy]ethyl]-18-(2-carboxyethyl)-8-ethenyl-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid",CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C=C)C)C(=C4CCC(=O)O)C)C(=C3C)CCC(=O)O)C(C)OCCOC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O,,,,,,
1683,3081686,"7-Nitro-2-phenyl-1,2-benzoselenazol-3-one",C1=CC=C(C=C1)N2C(=O)C3=C([Se]2)C(=CC=C3)[N+](=O)[O-],,,,,,
1684,3081687,"(6R,8S,9R,10S,11S,13S,14S)-9-fluoro-6,11-dihydroxy-10,13-dimethyl-17-methylsulfinyl-7,8,11,12,14,15-hexahydro-6H-cyclopenta[a]phenanthren-3-one",C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1CC=C2S(=O)C)C[C@H](C4=CC(=O)C=C[C@@]43C)O)F)O,,,,,,
1685,3081688,"7(O)-(3-Amino-2,3,6-trideoxy-2-fluorotalopyranosyl)adriamycinone",C[C@H]1[C@H]([C@H]([C@H]([C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)F)N)O.Cl,,,,,,
1686,3081689,"(8S,10S)-8-Hydroxyacetyl-10-[(2-fluoro-3-amino-2,3,6-trideoxy-alpha-L-talo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione",C[C@H]1[C@H]([C@H]([C@H]([C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)F)N)O,,,,,,
1687,3081690,2-Vinyl-4-hydroxymethyldeuteroporphyrin,CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C=C)C)C(=C4C)CO)C(=C3CCC(=O)O)C)CCC(=O)O,,,,,,
1688,3081691,Rh(Phi)2(bpy)3+,C1=CC=C2C(=C1)C3=CC=CC=C3C(=C2[NH-])[NH-].C1=CC=C2C(=C1)C3=CC=CC=C3C(=C2[NH-])[NH-].C1=CC=NC(=C1)C2=CC=CC=N2.[Cl-].[Cl-].[Cl-].[Rh],,,,,,
1689,3081692,"3-[(4aR,7R,8R,8aS)-6,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-7-yl]-1-methyl-1-nitrosourea",CC1OC[C@@H]2[C@@H](O1)[C@@H]([C@H](C(O2)O)NC(=O)N(C)N=O)O,,,,,,
1690,3081693,CID 3081693,CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCNCC)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
1691,3081694,"2-Methoxyethyl 2,2,2-trifluoroethanesulfonate",COCCOS(=O)(=O)CC(F)(F)F,,,,,,
1692,3081695,Gadolinium-mcta,[H+].CC1CN(CCN(CCN(CCN1CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],,,,,,
1693,3081696,"1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, 2-methyl-",CC1CN(CCN(CCN(CCN1CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O,,,,,,
1694,3081697,Schistoflrfamide,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](CC3=CN=CN3)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]4CCCN4,,,,,,
1695,3081698,"33-(1,6-Dihydroxy-2-methylhexyl)-30-ethyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone",CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CCCCO)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,,,,,,
1696,3081699,CID 3081699,COC1=CC(=CC(=C1[O-])C=NNC(=S)N)N=NC2=CC=CC=C2.COC1=CC(=CC(=C1[O-])C=NNC(=S)N)N=NC2=CC=CC=C2.[Cu+2],,,,,,
1697,3081700,1'-O-Acetylpaxilline,CC(=O)OC(C)(C)[C@@H]1C(=O)C=C2[C@@H](O1)CC[C@]3([C@]2(CC[C@@H]4[C@@]3(C5=C(C4)C6=CC=CC=C6N5)C)O)C,,,,,,
1698,3081701,Polyoxyethylene (2-methyl-2-propenyl) methyl diether-maleic anhydride copolymer,CC(=C)COCCOC.C1=CC(=O)OC1=O,,,,,,
1699,3081702,"Poly(oxy-1,2-ethanediyl), alpha-methyl-omega-[(2-methyl-2-propen-1-yl)oxy]-",CC(=C)COCCOC,,,,,,
1700,3081703,N-Acetylneuraminyl(2-3)galactosyl(1-3)-N-acetylglucosyl(1-6)-N-acetylgalactose,CC(=O)N[C@@H]1[C@H](C[C@@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O[C@H]2[C@H]([C@H](O[C@H]([C@@H]2O)O[C@H]([C@H](C=O)NC(=O)C)[C@H]([C@@H](CO[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)NC(=O)C)O)O)CO)O)O,,,,,,
1701,3081704,CID 3081704,C(C(C(C(=CF)C(C=O)O)O)O)O,,,,,,
1702,3081705,3-Modchp,CN1C(=O)C=C(N=C1[O-])C(=O)[O-].C1CCC(C(C1)N)N.[Pd+2],,,,,,
1703,3081706,CID 3081706,CC1=C[C@@H]2[C@](CC1)([C@@]3([C@@H](C[C@@H](C3=C)O2)OC(=O)C=CC=C[C@@H]([C@H](C)O)O)C)COC(=O)C=C(C)CCO,,,,,,
1704,3081707,CID 3081707,CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C=C(F)F)C)C(=C4CCC(=O)OC)C)C(=C3C)CCC(=O)OC)C=C(F)F,,,,,,
1705,3081708,CID 3081708,CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C=C)C)C(=C4CCC(=O)OC)C)C(=C3C)CCC(=O)OC)C=C(F)F,,,,,,
1706,3081709,CID 3081709,CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C=C(F)F)C)C(=C4CCC(=O)OC)C)C(=C3C)CCC(=O)OC)C=C,,,,,,
1707,3081710,"3-Acetyl-6-amino-3,12-dihydroxy-10-methoxy-11-oxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxyhexopyranoside",CC1C(C(CC(O1)OC2CC(CC3=CC4=C(C(=C23)O)C(=O)C5=C(C4N)C=CC=C5OC)(C(=O)C)O)N)O,,,,,,
1708,3081711,CID 3081711,CCOC(=O)C(=CC)N=C1C2=C(C(=CC=C2)OC)C(=O)C3=C(C4=C(CC(CC4OC5CC(C(C(O5)C)O)N)(C(=O)C)O)C(=C31)O)O,,,,,,
1709,3081712,11-Oxotetrodotoxin,C12C3C(C4C(C1(C(C(O3)(O4)O)O)NC(=NC2O)N)O)(C(O)O)O,,,,,,
1710,3081713,CID 3081713,C[C@H](C=CC(CO)(C(C)(C)O)O)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@H](CCC3=C)O)C,,,,,,
1711,3081714,Etomoxir-coa,CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)[C@H](C(=O)NCCC(=O)NCCSC(=O)C4(CO4)CCCCCCOC5=CC=C(C=C5)Cl)O,,,,,,
1712,3081715,Papa-apec,CCNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=C(N=C32)NCCC4=CC=C(C=C4)CCC(=O)NCCNC(=O)CC5=CC=C(C=C5)N)N)O)O,,,,,,
1713,3081716,"(8S-cis)-8-Acetyl-10-((6-deoxy-2-O-methyl-alpha-L-talopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione",CC1C(C(C(C(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)OC)O)O,,,,,,
1714,3081717,"(8S-cis)-10-((6-Deoxy-2-O-methyl-alpha-L-talopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione",CC1C(C(C(C(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)OC)O)O,,,,,,
1715,3081718,"7-O-(3-Amino-2,3,6-trideoxy-2-fluorotalopyranosyl)daunomycinone",C[C@H]1[C@H]([C@H]([C@H]([C@@H](O1)O[C@H]2C[C@@]([C@@H](C3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)O)(C(=O)C)O)F)N)O.Cl,,,,,,
1716,3081719,"(7S,9R,10R)-9-acetyl-7-[(2R,3R,4R,5S,6S)-4-amino-3-fluoro-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,10,11-tetrahydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",C[C@H]1[C@H]([C@H]([C@H]([C@@H](O1)O[C@H]2C[C@@]([C@@H](C3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)O)(C(=O)C)O)F)N)O,,,,,,
1717,3081720,"21,24,28-Triacetyloxy-7-methoxy-19,26-dioxo-3-oxa-16-azaheptacyclo[15.12.0.02,4.02,8.04,15.018,27.020,25]nonacosa-1(29),6,17,20,22,24,27-heptaen-9,13-diyne-6-carboxylic acid",CC(=O)OC1=C2C(=C(C=C1)OC(=O)C)C(=O)C3=C4C(=CC(=C3C2=O)OC(=O)C)C56C7C#CCCC#CC(C5(O6)CC(=C7OC)C(=O)O)N4,,,,,,
1718,3081721,(Pt(DACH)(MePhSO)Cl),CS(=O)C1=CC=CC=C1.C1CCC(C(C1)N)N.[N+](=O)([O-])[O-].[Cl-].[Pt+2],,,,,,
1719,3081722,"6-[[3,5-Bis(trifluoromethyl)phenyl]methyl-[2,3,5,6-tetrahydroxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexyl]amino]-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexane-1,2,4,5-tetrol",C1=C(C=C(C=C1C(F)(F)F)C(F)(F)F)CN(CC(C(C(C(CO)O)OC2C(C(C(C(O2)CO)O)O)O)O)O)CC(C(C(C(CO)O)OC3C(C(C(C(O3)CO)O)O)O)O)O,,,,,,
1720,3081723,"Amaninamide, S-deoxy-(gamma-hydroxy-ile(3))-",CCC(C)C1C(=O)NCC(=O)NC2CSC3=C(CC(C(=O)NCC(=O)N1)NC(=O)C(NC(=O)C4CC(CN4C(=O)C(NC2=O)CC(=O)N)O)C(C)C(C)O)C5=CC=CC=C5N3,,,,,,
1721,3081724,CID 3081724,CC(C1=CC=CC=C1[N+](=O)[O-])OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C3NC(=NC4=O)N)O)O,,,,,,
1722,3081725,"(2R,3R,4S,6S)-3-Methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaene-16,18-dione",C[C@]12[C@@H]([C@H](C[C@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)C(=O)NC6=O)NC)OC,,,,,,
1723,3081726,3-(2-Methoxyethoxy)propanal,COCCOCCC=O,,,,,,
1724,3081727,"2-[2-Hydroxy-6-[[2-[5-[5-(6-hydroxy-4-methoxy-3,5,6-trimethyloxan-2-yl)oxolan-2-yl]oxolan-2-yl]-3,7-dimethoxy-2,4,6-trimethyl-1,10-dioxaspiro[4.5]decan-9-yl]methyl]-4-methoxy-5-(5-methoxy-6-methyloxan-2-yl)oxy-3,5-dimethyloxan-2-yl]propanoic acid",CC1C(OC(C(C1OC)C)(C)O)C2CCC(O2)C3CCC(O3)C4(C(C(C5(O4)C(C(CC(O5)CC6C(C(C(C(O6)(C(C)C(=O)O)O)C)OC)(C)OC7CCC(C(O7)C)OC)OC)C)C)OC)C,,,,,,
1725,3081728,Pt(II)Clda,C(CCCN)CCN.N.N.N.N.[Cl-].[Cl-].[Cl-].[Cl-].[Pt+2].[Pt+2],,,,,,
1726,3081729,Europium(III) trisbipyridine cryptate,C1C2=NC(=CC=C2)C3=CC=CC(=N3)CN4CC5=NC(=CC=C5)C6=CC=CC(=N6)CN1CC7=NC(=CC(=C7)C(=O)NCCN)C8=CC(=CC(=N8)C4)C(=O)NCCN.[Eu+3],,,,,,
1727,3081730,"N,N'-(2,2'-Bipyridine-6,6'-diylbismethylene)-N,N'-(2,2'-bipyridine-6,6'-diylbismethylene)-4,4'-bis(2-aminoethylcarbamoyl)-2,2'-bipyridine-6,6'-dimethaneamine",C1C2=NC(=CC=C2)C3=CC=CC(=N3)CN4CC5=NC(=CC=C5)C6=CC=CC(=N6)CN1CC7=NC(=CC(=C7)C(=O)NCCN)C8=CC(=CC(=N8)C4)C(=O)NCCN,,,,,,
1728,3081731,laTTP,CC1=CN(C(=O)NC1=O)[C@H]2[C@@H]3[C@@H](O3)[C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O,,,,,,
1729,3081732,Lysodektose,CN(C1C(C(C(OC1OCC2C(C(C(C(O2)OC3C(C(C(C(O3)CO)O)O)O)O)O)O)CO)O)O)O,,,,,,
1730,3081733,Ph3SnCh2 Carbohydrate,CC1(OC[C@@H](O1)[C@@H]2[C@@]([C@@H]3[C@H](O2)OC(O3)(C)C)(C[Sn](C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6)O)C,,,,,,
1731,3081734,Ph3Sn Carbohydrate,CC1(OC[C@@H](O1)[C@@H]2[C@]([C@@H]3[C@H](O2)OC(O3)(C)C)(O)[Sn](C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6)C,,,,,,
1732,3081735,"2-[3-[7,12-Bis(ethenyl)-3,8,13,17-tetramethyl-18-[3-oxo-3-[2-(trimethylazaniumyl)ethoxy]propyl]-22,23-dihydroporphyrin-2-yl]propanoyloxy]ethyl-trimethylazanium",CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C=C)C)C(=C4CCC(=O)OCC[N+](C)(C)C)C)C(=C3C)CCC(=O)OCC[N+](C)(C)C)C=C,,,,,,
1733,3081736,Napavin,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)NCCNC1=C(C=C(C=C1)N=[N+]=[N-])[N+](=O)[O-])O)O)CC)OC)C(=O)OC)O,,,,,,
1734,3081737,CID 3081737,CCCCCCCCCCCCCC=C[C@H]([C@H](CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O[C@@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O)O)O)O)O)N)O,,,,,,
1735,3081738,"5-(4-Aminopiperidyl-1-carbonyl)-L-2,6-phenylalanyl-beta-alanyl-(4S-amino-3S-hydroxy-5-cyclohexyl)-pentancarbonyl-L-isoleucyl-aminomethyl-4-amino-2-methylpyrimidine citrate",CC[C@H](C)[C@@H](C(=O)N(C(=O)CCNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)N2CCC(CC2)N)C(=O)CC([C@H](CC3CCCCC3)N)O)NCC4=CN=C(N=C4N)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,,,,,,
1736,3081739,"4-amino-N-[(2S)-1-[[3-[[(4S)-4-amino-5-cyclohexyl-3-hydroxypentanoyl]-[(2S,3S)-2-[(4-amino-2-methylpyrimidin-5-yl)methylamino]-3-methylpentanoyl]amino]-3-oxopropyl]amino]-1-oxo-3-phenylpropan-2-yl]piperidine-1-carboxamide",CC[C@H](C)[C@@H](C(=O)N(C(=O)CCNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)N2CCC(CC2)N)C(=O)CC([C@H](CC3CCCCC3)N)O)NCC4=CN=C(N=C4N)C,,,,,,
1737,3081740,"(2S,3S)-N-[(3-amino-5,6-dimethylpyrazin-2-yl)methyl]-2-[[(3S,4S)-4-[[2-[[(2S)-2-(6-aminohexanoylamino)-3-phenylpropanoyl]amino]acetyl]amino]-5-cyclohexyl-3-hydroxypentanoyl]amino]-3-methylpentanamide",CC[C@H](C)[C@@H](C(=O)NCC1=NC(=C(N=C1N)C)C)NC(=O)C[C@@H]([C@H](CC2CCCCC2)NC(=O)CNC(=O)[C@H](CC3=CC=CC=C3)NC(=O)CCCCCN)O,,,,,,
1738,3081741,"(2S,3S,4R,5R)-5-[6-amino-2-[2-[4-[3-(2-aminoethylamino)-3-oxopropyl]phenyl]ethylamino]purin-9-yl]-N-ethyl-3,4-dihydroxyoxolane-2-carboxamide",CCNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=C(N=C32)NCCC4=CC=C(C=C4)CCC(=O)NCCN)N)O)O,,,,,,
1739,3081742,CID 3081742,CN1CCC[C@H]1C2=CN=CC=C2.CN1CC[C@]23[C@@H]4[C@@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O.CN1CC[C@]23[C@@H]4[C@@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O.CN1[C@@H]2CC(C[C@H]1[C@@H]3[C@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4.COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC,,,,,,
1740,3081743,"[(1S,2R,4S,5R)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate",CN1[C@@H]2CC(C[C@H]1[C@@H]3[C@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4,,,,,,
1741,3081744,CID 3081744,CCCCCC=CCC(C(C=CC(CC=CCCCC(=O)O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)O)N)O,,,,,,
1742,3081745,3-amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methylpentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid,CC(C)C[C@@H](CN[C@@H](CC(C)C)C(=O)N)NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CO)NC(=O)C(CC(=O)O)N,,,,,,
1743,3081746,"2-[(5S,6R,7R,9R,15R,16R)-6-[(2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-16-ethyl-15-(hydroxymethyl)-5,9,13-trimethyl-2,10-dioxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde",CC[C@@H]1[C@H](C=C(C=CC(=O)[C@@H](C[C@@H]([C@@H]([C@H](CCC(=O)O1)C)O[C@H]2[C@@H]([C@H](C[C@H](O2)C)N(C)C)O)CC=O)C)C)CO,,,,,,
1744,3081747,4-O-Methylbetaclamycin T,CCC1(CC(C2=C(C1O)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5CC(C(C(O5)C)O)N(C)C)O,,,,,,
1745,3081748,Nickel lapachol,CC(=CCC1=C(C2=CC=CC=C2C(=O)C1=O)[O-])C.CC(=CCC1=C(C2=CC=CC=C2C(=O)C1=O)[O-])C.[Ni+2],,,,,,
1746,3081749,"6-O-(3-Ethoxypropionyl)-3',4'-O-exo-benzylidenechartreusin",CCOCCC(=O)OC1=C2C3=C(C4=C1C=CC(=C4)OC5C(C6C(C(O5)C)OC(O6)C7=CC=CC=C7)OC8C(C(C(C(O8)C)O)OC)O)OC(=O)C9=C(C=CC(=C93)OC2=O)C,,,,,,
1747,3081750,CID 3081750,C[C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H]([C@H]([C@H](O[C@H]2OC3=CC=CC4=C3C5=C6C7=C(C=CC(=C7C(=O)O5)C)OC(=C6C4=O)O)C)O)O)O)O)O,,,,,,
1748,3081751,Diamminechloro(glutathionato-S)platinum(II),[H+].[H+].C(CC(=O)NC(C[S-])C(=O)NCC(=O)[O-])C(C(=O)[O-])N.N.N.[Cl-].[Pt+2],,,,,,
1749,3081752,Schumanniofioside B,CC1=CC(=O)C2=C(C=C(C=C2O1)OC3C(C(C(C(O3)CO)O)O)OC4C(C(CO4)(CO)O)O)O,,,,,,
1750,3081753,Epoxytocopherone,CC1=C(C2(C3(CCC(O2)(C)CCCC(C)CCCC(C)CCCC(C)C)C(C1=O)(O3)C)OO)C,,,,,,
1751,3081754,Variapeptin,CCC(C)CC1CCC(OC1C)(C(C)(C(=O)NC2C(OC(=O)C(NC(=O)C3CCCNN3C(=O)C(N(C(=O)C(N(C(=O)C4CCCNN4C2=O)O)C)C)CC5=CC=CC=C5)CO)C(C)C)O)O,,,,,,
1752,3081755,"9-(1,2-dihydroxyethyl)-7-[(2R,3R,4R,5S,6S)-3-fluoro-4,5-dihydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",C[C@H]1[C@H]([C@H]([C@H]([C@@H](O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(CO)O)O)F)O)O,,,,,,
1753,3081756,Goreishic acid I,C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(C[C@H]([C@@H](C5(C)C)O)O)C)C)C2=C1C)C)C(=O)O,,,,,,
1754,3081757,"10,11-Dihydroxy-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,9,10,11,12,13-tetradecahydropicene-4a-carboxylic acid",CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5C)O)O)C)C)C2=C1C)C)C(=O)O,,,,,,
1755,3081758,"5-N-Acetyl-9-(4-azidosalicoylamido)-2-deoxy-2,3-didehydroneuraminic acid",CC(=O)N[C@@H]1[C@H](C=C(O[C@H]1[C@@H]([C@@H](CNC(=O)C2=C(C=C(C=C2)N=[N+]=[N-])O)O)O)C(=O)O)O,,,,,,
1756,3081759,Triamminechromium pyrophosphate,[H+].N.N.N.O.O.O.[O-]P(=O)([O-])OP(=O)([O-])[O-].[Cr+3],,,,,,
1757,3081760,Basic fuchsin-platinum complex,[H+].[H+].CC1=CC(=C(C2=CC=C(C=C2)N)C3=CC=C(C=C3)N)C=CC1=N.CC1=CC(=C(C2=CC=C(C=C2)N)C3=CC=C(C=C3)N)C=CC1=N.[Cl-].[Cl-].[Cl-].[Cl-].[Pt+2],,,,,,
1758,3081761,16-(9-Anthroyloxy)palmitoyl-coenzyme A,CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCSC(=O)CCCCCCCCCCCCCCCOC(=O)C4=C5C=CC=CC5=CC6=CC=CC=C64)O,,,,,,
1759,3081762,CID 3081762,CCCCOC1=C2C(=C(C=C1)OCCCC)C3=NC4=NC(=NC5=NC(=NC6=C7C(=CC=C(C7=C([N-]6)N=C2[N-]3)OCCCC)OCCCC)C8=C(C=CC(=C85)OCCCC)OCCCC)C9=C(C=CC(=C94)OCCCC)OCCCC.CC[Si](CC)(CC)[O-].CC[Si](CC)(CC)[O-].[GeH4],,,,,,
1760,3081763,"12,13-Didehydro-2,3-dimethoxy-12,24-secostrychnidin-10-one",COC1=C(C=C2C(=C1)C34CCN5[C@H]3C[C@@H](C(=CCO)C5)C6=CCC(=O)N2[C@H]46)OC,,,,,,
1761,3081764,"2,3,5,6,7-Norbornanepentol",[C@H]1([C@@H](C2[C@H]([C@H](C1C2O)O)O)O)O,,,,,,
1762,3081765,Phosphotyrosylangiotensin II,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)OP(=O)(O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N,,,,,,
1763,3081766,"2,4-Bis(1-decyloxyethyl)deuteroporphyrinyl-6,7-bisaspartic acid",CCCCCCCCCCOC(C)C1=C(C2=CC3=C(C(=C(N3)C=C4C(=C(C(=N4)C=C5C(=C(C(=N5)C=C1N2)C)CCC(=O)N[C@@H](CC(=O)O)C(=O)O)CCC(=O)N[C@@H](CC(=O)O)C(=O)O)C)C)C(C)OCCCCCCCCCC)C,,,,,,
1764,3081767,"5-Acetamido-3-(18F)fluoranyl-4,6,7,8,9-pentahydroxy-2-oxononanoic acid",CC(=O)NC(C(C(C(CO)O)O)O)C(C(C(=O)C(=O)O)[18F])O,,,,,,
1765,3081768,"Gadolinium-1,7,13-triaza-4,10,16-trioxacyclooctadecane-N,N',N''-triacetic acid",C1COCCN(CCOCCN(CCOCCN1CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],,,,,,
1766,3081769,HP2Ddc,CN1C=CCC(=C1)C(=O)NC2=NC(=O)N(C=C2)C3CCC(O3)COC(=O)C4=CN(C=CC4)C,,,,,,
1767,3081770,CID 3081770,C[C@@]1([C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C(N)O)C(=O)[C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O)O.C1N2CN3CN1CN(C2)C3.C1=CC=C(C=C1)CC2=NC3=CC=CC=C3N2,,,,,,
1768,3081771,Calixarene,CC(C)(C)C1=CC2=C(C(=C1)CC3=CC(=CC(=C3OCC(=O)OC)CC4=CC(=CC(=C4OCC(=O)OC)CC5=C(C(=CC(=C5)C(C)(C)C)C2)OCC(=O)OC)C(C)(C)C)C(C)(C)C)OCC(=O)OC,,,,,,
1769,3081772,"3-Hydroxy-10,11-dihydroquinidine",CC[C@]1(CN2CC[C@@H]1C[C@@H]2[C@H](C3=C4C=C(C=CC4=NC=C3)OC)O)O.OS(=O)(=O)O,,,,,,
1770,3081773,"(3S,4R,6R)-3-ethyl-6-[(S)-hydroxy-(6-methoxyquinolin-4-yl)methyl]-1-azabicyclo[2.2.2]octan-3-ol",CC[C@]1(CN2CC[C@@H]1C[C@@H]2[C@H](C3=C4C=C(C=CC4=NC=C3)OC)O)O,,,,,,
1771,3081774,CID 3081774,CC(=O)OC1=CC=CC=C1C(=O)O.CN1CC[C@]23[C@@H]4[C@@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O,,,,,,
1772,3081775,"(3S)-3-[[(5S,8S,23S)-23-[[(2S)-2-acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-5-(1H-indol-3-ylmethyl)-3,6,14,17,24-pentaoxo-1,4,7,13,18-pentazacyclotetracosane-8-carbonyl]amino]-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid",CC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@H]2CCCCNC(=O)CCC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)CNC2=O)CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N,,,,,,
1773,3081776,"9-(2-Deoxy-5-O-triphospho-beta-ribofuranosyl)-N(6),N(6)-ethano-2,6-diaminopurine",C1CN1C2=NC(=NC3=C2N=CN3[C@H]4C[C@@H]([C@H](O4)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)N,,,,,,
1774,3081777,"2-[[1,6,9,14-Tetrahydroxy-5-[3-hydroxy-6-methyl-5-(methylamino)-4-(3,4,5-trihydroxyoxan-2-yl)oxyoxan-2-yl]oxy-11-methoxy-3-methyl-8,13-dioxo-5,6-dihydrobenzo[a]tetracene-2-carbonyl]amino]acetic acid",CC1C(C(C(C(O1)OC2C(C3=CC4=C(C(=C3C5=C2C=C(C(=C5O)C(=O)NCC(=O)O)C)O)C(=O)C6=C(C4=O)C(=CC(=C6)OC)O)O)O)OC7C(C(C(CO7)O)O)O)NC,,,,,,
1775,3081778,[5-Hydroxy-6-[[5-hydroxy-6-(hydroxymethyl)-3-(3-hydroxytetradecanoylamino)-4-(3-hydroxytetradecanoyloxy)oxan-2-yl]oxymethyl]-3-(3-hydroxytetradecanoylamino)-4-(3-hydroxytetradecanoyloxy)oxan-2-yl]phosphonic acid,CCCCCCCCCCCC(CC(=O)NC1C(C(C(OC1OCC2C(C(C(C(O2)P(=O)(O)O)NC(=O)CC(CCCCCCCCCCC)O)OC(=O)CC(CCCCCCCCCCC)O)O)CO)O)OC(=O)CC(CCCCCCCCCCC)O)O,,,,,,
1776,3081779,4-Nitrophenyl O-(2-acetamido-2-deoxyglucopyranosyl)-(1-2)-O-(4-O-methylmannopyranosyl)-(1-6)-glucopyranoside,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O[C@H]2[C@H]([C@@H]([C@H](O[C@@H]2O[C@]3([C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C4=CC=C(C=C4)[N+](=O)[O-])CO)OC)O)CO)O)O,,,,,,
1777,3081780,Efrapeptin F,CC[C@@](C)(C(=O)N[C@@H](CC(C)C)CN1CCC[N+]2=C1CCC2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C(C)(C)NC(=O)[C@@H]3CCCCN3C(=O)C(C)(C)NC(=O)C(C)(C)NC(=O)CNC(=O)CCNC(=O)[C@H](CC(C)C)NC(=O)C(C)(C)NC(=O)C(C)(C)NC(=O)[C@@H]4CCCCN4C(=O)C(C)(C)NC(=O)[C@@H]5CCCCN5C(=O)C,,,,,,
1778,3081781,Contortumine,CCN1CC2CCC(C34C2CC(C31)C5(CC(C6CC4C5C6OC(=O)C7=CC=C(C=C7)OC)OC)O)OC,,,,,,
1779,3081782,"2-((6-carboxy-4,5-dihydroxy-3-methoxytetrahydro-2H-pyran-2-yl)oxy)-14-hydroxy-8a,10a-bis(hydroxymethyl)-14-(3-methoxy-3-oxopropyl)-1,4,4a,6,6a,17b,19b,21b-octamethyl-16-oxo-2,3,4,4a,4b,5,6,6a,6b,7,8,8a,8b,9,10,10a,14,16,17,17a,17b,18,19,19a,19b,20,21,21a,21b,22,23,23a-dotriacontahydro-1H-benzo[9,10]piceno[3,4-a]furo[3,4-j]xanthene-1-carboxylic acid",CC1CC2C(CCC3C2(C(CC(C3(C)C(=O)O)OC4C(C(C(C(O4)C(=O)O)O)O)OC)C)C)(C5C1(C6CCC7(C(C6(CC5)C)CCC8(C7CCC9(C8CC1=C(O9)C=CC2=C1C(=O)OC2(CCC(=O)OC)O)CO)C)CO)C)C,,,,,,
1780,3081783,Rhhwe,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2OC(=O)CC(C3=CC=CC=C3)O)NC(=O)C(C)(C)C)O[C@H]4C[C@]5([C@@H]6CC[C@@]7(CC6(CC[C@@H]5C(C4)(C(=O)O)C(=O)O)[C@H](C7=C)O)O)C)CO)O)O)O,,,,,,
1781,3081784,CID 3081784,CCCC1CC23C(C=C1)C=C(C(CC=CC4C(=CC5C(C4(C(=O)C(=C(O2)O)C3=O)C)C(CC(C5O)O)C)CC)OC6CC(C(C(O6)C)NC(=O)C7=C(C=CC(=C7C)Cl)O)N(C)C)C,,,,,,
1782,3081785,3'-p-Hydroxypaclitaxel,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=C(C=C5)O)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,,,,,,
1783,3081786,Ddp-Cr,[H+].N.N.O.O.O.O.[O-]P(=O)([O-])OP(=O)([O-])[O-].[Cr+3],,,,,,
1784,3081787,Aaabd,C1=CC(=C[N+](=C1)CCCCOP(=O)([O-])OP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)NCCC5=CC=C(C=C5)N=[N+]=[N-])O)O)N=[N+]=[N-],,,,,,
1785,3081788,"[[(2R,3S,4R,5R)-5-[6-[2-(4-azidophenyl)ethylamino]purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 4-(3-azidopyridin-1-ium-1-yl)butyl hydrogen phosphate",C1=CC(=C[N+](=C1)CCCCOP(=O)(O)OP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)NCCC5=CC=C(C=C5)N=[N+]=[N-])O)O)N=[N+]=[N-],,,,,,
1786,3081789,CID 3081789,CC1COC2(CC1OC(=O)C=CC3=CC=CC=C3)C4(CO4)C5CCC(CC5O2)C(=O)OC6C(C(C(C(O6)CO)O)O)OC7C(C(C(C(O7)C)O)O)O,,,,,,
1787,3081790,2-Demethylsteffimycin D,CC1C(C(C(C(O1)OC2C(C(CC3=CC4=C(C(=C23)O)C(=O)C5=C(C4=O)C=C(C=C5O)O)(C)O)OC)OC)O)O,,,,,,
1788,3081791,CID 3081791,C[C@H]1[C@@H](C[C@@H]([C@@H]([C@H](C[C@@H]2CC=C[C@@H](O2)C[C@H](CC=C(C=CC(=O)O[C@@H]1[C@@H](C)[C@H]([C@@H](C)CCC(=O)[C@H](C)[C@@H]([C@H](C)C=CN(C)C=O)OC)O)C)O)OC)C)OC)O,,,,,,
1789,3081792,3-Modcpl,CN1C(=O)C=C(N=C1[O-])C(=O)[O-].C1CCC(C(C1)N)N.[Pt+2],,,,,,
1790,3081793,H-Asp-Arg-Val-D-Ala(Unk)-Ile-His-Pro-Phe-His-Leu-OH,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@@H](CC5=CC=[N+](C=C5)[O-])NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N,,,,,,
1791,3081794,"3-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)decahydro-2H-6,7,9-(epimethanetriyl)pentaleno[1,2-d]azepine-2,4(3H)-dione",C1CN(CCN1CCCCN2C(=O)CC3C(CC2=O)C4C5C3C6C4C6C5)C7=NC=CC=N7,,,,,,
1792,3081795,"2,3-Bis[2,6-dimethyl-8-(2,6,6-trimethylcyclohexen-1-yl)octa-1,3,5,7-tetraenyl]oxirane",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC2C(O2)C=C(C)C=CC=C(C)C=CC3=C(CCCC3(C)C)C)C)C,,,,,,
1793,3081796,Dynemicin S,C[C@H]1C(=C([C@@H]2C3=CC=CC=C3[C@H]4[C@]1([C@@]2(C5=CC(=C6C(=C5N4)C(=O)C7=C(C=CC(=C7C6=O)O)O)O)SCC(=O)OC)O)OC)C(=O)O,,,,,,
1794,3081797,"(3aR,4R,5S,6S,6aS)-4-(hydroxymethyl)-2-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-3a,5,6,6a-tetrahydrocyclopenta[d][1,3]oxazole-4,5,6-triol",C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)NC2=N[C@@H]3[C@H](O2)[C@H]([C@@H]([C@@]3(CO)O)O)O)O)O)O)O,,,,,,
1795,3081798,In-Ehpg,C1=CC=C(C(=C1)C(C(=O)[O-])NCCNC(C2=CC=CC=C2[O-])C(=O)[O-])[O-].[111In+3],,,,,,
1796,3081799,CID 3081799,CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCNC1=CC=C(C2=NON=C12)N(O)O,,,,,,
1797,3081800,Qqfgp,CC1=CC(=O)C2=C(O1)C=C3C(=C(C=C(C3=C2O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO[C@H]5[C@@H]([C@](CO5)(CO)O)O)O)O)O)OC)C,,,,,,
1798,3081801,"3,13,15,25,35,37-Hexahydroxy-11-[3-hydroxy-6-(4-hydroxy-6-methyloxan-2-yl)-4-methylhexan-2-yl]-33-[3-hydroxy-6-(4-methoxy-6-methyloxan-2-yl)-4-methylhexan-2-yl]-17,39-dimethoxy-6,12,16,28,34,38-hexamethyl-10,32,45,46-tetraoxatricyclo[39.3.1.119,23]hexatetraconta-5,7,21,27,29,43-hexaene-9,31-dione",CC1CC(CC(O1)CCC(C)C(C(C)C2C(C(CC(C(C(CC3CC=CC(O3)CC(CC=C(C=CC(=O)OC(C(C(CC(C(C(CC4CC=CC(O4)CC(CC=C(C=CC(=O)O2)C)O)OC)C)O)O)C)C(C)C(C(C)CCC5CC(CC(O5)C)OC)O)C)O)OC)C)O)O)C)O)O,,,,,,
1799,3081802,"1,10-Phenanthroline-glycine palladium(II)",C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1.C(C(=O)[O-])N.[Cl-].[Pd+2],,,,,,
1800,3081803,"2-[2-[Bis(carboxylatomethyl)amino]ethyl-[2-[carboxylatomethyl-[2-[(3-hydroxy-3,3-diphosphonatopropyl)amino]-2-oxoethyl]amino]ethyl]amino]acetate;gadolinium(3+);hydron",[H+].[H+].[H+].[H+].[H+].C(CNC(=O)CN(CCN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])C(O)(P(=O)([O-])[O-])P(=O)([O-])[O-].[Gd+3],,,,,,
1801,3081804,"2-[2-[Bis(carboxymethyl)amino]ethyl-[2-[carboxymethyl-[2-[(3-hydroxy-3,3-diphosphonopropyl)amino]-2-oxoethyl]amino]ethyl]amino]acetic acid",C(CNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O)C(O)(P(=O)(O)O)P(=O)(O)O,,,,,,
1802,3081805,Gddtpa-bdp,[H+].[H+].[H+].[H+].[H+].C(CC(P(=O)([O-])[O-])P(=O)([O-])[O-])CNC(=O)CN(CCN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],,,,,,
1803,3081806,"2-[2-[Bis(carboxymethyl)amino]ethyl-[2-[carboxymethyl-[2-(4,4-diphosphonobutylamino)-2-oxoethyl]amino]ethyl]amino]acetic acid",C(CC(P(=O)(O)O)P(=O)(O)O)CNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O,,,,,,
1804,3081807,"Bis(di-isobutyloctadecylsiloxy)silicon 2,3-naphthalocyanine",CCCCCCCCCCCCCCCCCC[Si](CC(C)C)(CC(C)C)[O-].CCCCCCCCCCCCCCCCCC[Si](CC(C)C)(CC(C)C)[O-].C1=CC=C2C=C3C(=CC2=C1)C4=NC5=C6C=C7C=CC=CC7=CC6=C([N-]5)N=C8C9=CC1=CC=CC=C1C=C9C(=N8)N=C1C2=CC5=CC=CC=C5C=C2C(=N1)N=C3[N-]4.[Si+4],,,,,,
1805,3081808,Bisisobutyloctadecylsilanol,CCCCCCCCCCCCCCCCCC[Si](CC(C)C)(CC(C)C)O,,,,,,
1806,3081809,Vanadyl-chlorophyl-a complex,CCC1=C(C2=CC3=NC(=CC4=NC(=C(C5=NC(=C(C5=C([O-])[O-])C)C=C1[N-]2)CC(=O)[O-])C(C4C)CCC(=O)[O-])C(=C3C=C)C)C.[Na+].[Na+].[Na+].[V+2],,,,,,
1807,3081810,Argipressin (4-8),C1C[C@H](N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O,,,,,,
1808,3081811,Fe-Pgdf,[H+].CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CC(CC(=O)[O-])C1=CC=CC=C1)[O-])[O-])[O-].[Fe+3],,,,,,
1809,3081812,5-[5-[[4-[5-[[4-[5-[Acetyl(oxido)amino]pentylamino]-4-oxobutanoyl]-oxidoamino]pentylamino]-4-oxobutanoyl]-oxidoamino]pentylamino]-5-oxo-3-phenylpentanoic acid,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CC(CC(=O)O)C1=CC=CC=C1)[O-])[O-])[O-],,,,,,
1810,3081813,7-N-(4-O-Sialosylphenyl)-9-methoxymitosane methyl ester,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)NC5=CC=C(C=C5)OC6(CC(C(C(O6)C(C(CO)O)O)NC(=O)C)O)C(=O)OC,,,,,,
1811,3081814,111In-Atn-10,[H+].[H+].[H+].[H+].[H+].[H+].CC1=C(C2=CC3=C(C(=C([N-]3)C=C4C(=C(C(=N4)C=C5C(=C(C(=N5)C=C1[N-]2)C)C=C)C)C(C)OCCOC(=O)CN(CCN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])C)CCC(=O)[O-])CCC(=O)[O-].O.[OH-].[Mn+3],,,,,,
1812,3081815,Azane;methylsulfinylmethane;ruthenium(3+);trichloride,CS(=O)C.CS(=O)C.N.[Cl-].[Cl-].[Cl-].[Ru+3],,,,,,
1813,3081816,Bis(6-aminoquinoline)dichloroplatinum(II),C1=CC2=C(C=CC(=C2)N)N=C1.C1=CC2=C(C=CC(=C2)N)N=C1.[Cl-].[Cl-].[Pt+2],,,,,,
1814,3081817,"[(2R,3R,4R,5R,6R)-4-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-3-yl] 3-(3,4-dihydroxyphenyl)prop-2-enoate",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OCCC3=CC(=C(C=C3)O)O)O)O[C@H]4[C@@H]([C@](CO4)(CO)O)O)OC(=O)C=CC5=CC(=C(C=C5)O)O)O)O)O,,,,,,
1815,3081818,"S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (2S)-2-(4-tert-butylphenyl)propanethioate",C[C@@H](C1=CC=C(C=C1)C(C)(C)C)C(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)OP(=O)(O)O)O,,,,,,
1816,3081819,6-I-Hpp-fsk,CC(=O)O[C@H]1[C@H]([C@@H]2[C@]([C@H](CCC2(C)C)O)([C@@]3([C@@]1(O[C@@](CC3=O)(C)C=C)C)O)C)OC(=O)NCCNC(=O)CCC4=CC(=C(C=C4)O)[125I],,,,,,
1817,3081820,CID 3081820,C1=CC(=C[N+](=C1)CC=NO)OCCCOC2=C[N+](=CC=C2)CC=NO.[I-].[I-],,,,,,
1818,3081821,CID 3081821,C1=CC(=C[N+](=C1)CC=NO)OCCCOC2=C[N+](=CC=C2)CC=NO,,,,,,
1819,3081822,"4-[6-[4-Amino-6-[4-amino-6-[[23-(dimethylamino)-10-[5-(dimethylamino)-4-hydroxy-3-methyloxan-2-yl]oxy-8,12,15,22-tetrahydroxy-1,12-dimethyl-6,17-dioxo-20,25-dioxahexacyclo[19.3.1.02,19.05,18.07,16.09,14]pentacosa-2(19),3,5(18),7,9(14),15-hexaen-24-yl]oxy]-2,4-dimethyloxan-3-yl]oxy-2,4-dimethyloxan-3-yl]oxy-4-methoxy-2-methyloxan-3-yl]oxy-4-oxobutanoic acid",CC1C(C(COC1OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C=CC6=C5OC7C(C(C(C6(O7)C)OC8CC(C(C(O8)C)OC9CC(C(C(O9)C)OC1CC(C(C(O1)C)OC(=O)CCC(=O)O)OC)(C)N)(C)N)N(C)C)O)O)(C)O)N(C)C)O,,,,,,
1820,3081823,Isonicotinoylhydrazine glucuronide,C1=CN=CC=C1C(=O)NN[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O,,,,,,
1821,3081824,Sbgmg,CCCCCCCCCCCCCCCCCCCCCCOC(COCCCCCCCCCCCCCCCCCC)C(=O)N(C)CC(C(C(C(CO)O)O)O)O,,,,,,
1822,3081825,CID 3081825,C1[C@@H]([C@H](O[C@H]1N2C=CC3=C2NC=NC3=O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,,,,,,
1823,3081826,"Titanium alloy, Ti,Ta (TiTa30)",[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ta].[Ta].[Ta],,,,,,
1824,3081827,"5-O-(oxan-2-ylmethyl) 3-O-[2-(1,1,3-trioxo-1,2-benzothiazol-2-yl)ethyl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate",CC1=C(C(C(=C(N1)C)C(=O)OCC2CCCCO2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCN4C(=O)C5=CC=CC=C5S4(=O)=O,,,,,,
1825,3081828,Tkbma-Rh2,CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].CN1C=NC2=C(C1=N)N=CN2C3C(C(C(O3)CO)O)O.CN1C=NC2=C(C1=N)N=CN2C3C(C(C(O3)CO)O)O.O.[Rh+2].[Rh+2],,,,,,
1826,3081829,CID 3081829,CN1C2=C(C(=O)N=C1[O-])NC(=S)N2.C1=CC=C(C=C1)P(C2=CC=CC=C2)C3=CC=CC=C3.[Au+],,,,,,
1827,3081830,"3-Methyl-8-sulfanylidene-7,9-dihydropurine-2,6-dione",CN1C2=C(C(=O)NC1=O)NC(=S)N2,,,,,,
1828,3081831,Tripbromolide,CC(C)[C@@]1([C@@H]([C@H]2[C@@]3(O2)[C@]4(CCC5=C([C@@H]4C[C@H]6[C@]3([C@@H]1O)O6)COC5=O)C)Br)O,,,,,,
1829,3081832,Spinorphin,C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N)O,,,,,,
1830,3081833,Mastoparan B,CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC(C)C)N,,,,,,
1831,3081834,"[(2R,3S,6S,7S,9R,10S,11S,12R,13S,14R)-2,6,9,11,13,14-hexahydroxy-3,7,10-trimethyl-11-propan-2-yl-15-oxapentacyclo[7.5.1.01,6.07,13.010,14]pentadecan-12-yl] pyridine-3-carboxylate",C[C@H]1CC[C@@]2([C@@]3(C[C@@]4([C@]5([C@]([C@H]([C@@]3([C@]5(C2([C@@H]1O)O4)O)O)OC(=O)C6=CN=CC=C6)(C(C)C)O)C)O)C)O,,,,,,
1832,3081835,"1-N-[4-(3-aminobutylamino)butyl]butane-1,3-diamine",CC(CCNCCCCNCCC(C)N)N,,,,,,
1833,3081836,"cis-Pt-O(6),9-Dimeg complex",CN1C=NC2=C1N=C(N=C2OC)N.CN1C=NC2=C1N=C(N=C2OC)N.N.N.[Cl-].[Cl-].[Pt+2],,,,,,
1834,3081837,Flammacerium,C1=CC=C(C=C1)S(=O)(=O)[N-]C2=NC=CC=N2.[N+](=O)([O-])[O-].[Ag+].[Ce+3],,,,,,
1835,3081838,CID 3081838,CCCCCC=CCC=CCCCCCCCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@@]4([C@H](CC[C@H]4C35C=CC2(C1)OO5)[C@H](C)C=C[C@H](C)C(C)C)C)C,,,,,,
1836,3081839,CID 3081839,C[C@H]([C@H](C1=CC=CC=C1)O)N.CC(=O)OC1=CC=CC=C1C(=O)O.CN1C=NC2=C1C(=O)N(C(=O)N2C)C.CN(C)CCCC1=NC(=CC=C1)C2=CC=C(C=C2)Cl.C(=CC(=O)O)C(=O)O.Cl,,,,,,
1837,3081840,"3-[6-(4-chlorophenyl)pyridin-2-yl]-N,N-dimethylpropan-1-amine",CN(C)CCCC1=NC(=CC=C1)C2=CC=C(C=C2)Cl,,,,,,
1838,3081841,CID 3081841,CCO.C1CN=C2C3=C1C=NC3=C(C4=C2C56C[C@H](N4)S[C@@H]5CC(=O)C(=C6)Br)O,,,,,,
1839,3081842,CID 3081842,C1CN=C2C3=C1C=NC3=C(C4=C2C56C[C@H](N4)S[C@@H]5CC(=O)C(=C6)Br)O,,,,,,
1840,3081843,"N-(1-azabicyclo(2.2.2)-oct-3-yl)-5-chlorospiro(benzofuran-2(3H),1'-cyclohexane)-7-carboxamide",C1CCC2(CC1)CC3=C(O2)C(=CC(=C3)Cl)C(=O)N[C@@H]4CN5CCC4CC5,,,,,,
1841,3081844,"2-[18-(4-Aminobutyl)-15,24-bis(2-aminoethyl)-21-(carboxymethyl)-3-(2-chloro-1-hydroxyethyl)-27-(3,4-dihydroxytetradecanoylamino)-9-ethylidene-12-(1-hydroxyethyl)-2,5,8,11,14,17,20,23,26-nonaoxo-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-6-yl]-2-hydroxyacetic acid",CCCCCCCCCCC(C(CC(=O)NC1COC(=O)C(NC(=O)C(NC(=O)C(=CC)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC(=O)O)CCCCN)CCN)C(C)O)C(C(=O)O)O)C(CCl)O)O)O,,,,,,
1842,3081845,"2,5-Diaminohexanedioate;platinum(2+);2-pyridin-2-ylpyridine;dichloride",C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.C(CC(C(=O)[O-])N)C(C(=O)[O-])N.[Cl-].[Cl-].[Pt+2].[Pt+2],,,,,,
1843,3081846,Pd(II)(Bipy)2(daa)Cl2,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.C(CC(C(=O)[O-])N)C(C(=O)[O-])N.[Cl-].[Cl-].[Pd+2].[Pd+2],,,,,,
1844,3081847,Bds-Pt,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.C(CCC(C(=O)[O-])N)CC(C(=O)[O-])N.[Cl-].[Cl-].[Pt+2].[Pt+2],,,,,,
1845,3081848,BP-DS-Pdcl2,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.C(CCC(C(=O)[O-])N)CC(C(=O)[O-])N.[Cl-].[Cl-].[Pd+2].[Pd+2],,,,,,
1846,3081849,Mn(III) Uroporphyrin I,[H+].[H+].[H+].[H+].[H+].[H+].[H+].C1=C2C(=C(C(=CC3=NC(=CC4=NC(=CC5=C(C(=C1[N-]5)CC(=O)[O-])CCC(=O)[O-])C(=C4CCC(=O)[O-])CC(=O)[O-])C(=C3CCC(=O)[O-])CC(=O)[O-])[N-]2)CC(=O)[O-])CCC(=O)[O-].[Mn+3],,,,,,
1847,3081850,H-Lys-Pro-Asn-DL-Pro-Glu-Arg-Phe-Tyr-Gly-Leu-Met-NH2,CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)CNC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)C3CCCN3C(=O)[C@H](CC(=O)N)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)N,,,,,,
1848,3081851,CID 3081851,CC1CC=CCC(CC=CC=CCC2C=C(C(CC23C(=O)C(=C(O3)O)C(=O)C4C1C(SC4)C(=O)C(=O)O)C)C)O,,,,,,
1849,3081852,CID 3081852,CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC1CCC(O1)N2C=CC(=NC2=O)N)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
1850,3081853,CID 3081853,CCC(C)C1C2=NC(C(O2)C)C(=O)NC(C3=NC(=CS3)C(=O)NC(C4=NC(C(O4)C)C(=O)NC(C5=NC(=CS5)C(=O)N1)C(C)C)C(C)C)CC6=CC=CC=C6,,,,,,
1851,3081854,3-Dimethylheptyl-11-hydroxyhexahydrocannabinol,[H][C@@]1(C[C@@H]2[C@@H](C[C@]1([3H])CO)C3=C(C=C(C=C3OC2(C)C)C(C)(C)CCCCCC)O)[3H],,,,,,
1852,3081855,"Thymidine 5'-(alpha,beta-imido)triphosphate",CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OP(=N)(O)O)O,,,,,,
1853,3081856,Aztmppnp,CC1=CN(C(=O)NC1=O)[C@H]2C[C@]([C@H](O2)COP(=N)(O)OP(=O)(O)OP(=O)(O)O)(N=[N+]=[N-])O,,,,,,
1854,3081857,"Substance P, N-spermine-gln(5)-",CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)CNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)NCCCNCCCCNCCCN)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CCCCN)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCN=C(N)N)N,,,,,,
1855,3081858,Dfftp-daunomycinone,CC1C(C(C(C(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)F)O)OC6C(CCCO6)F,,,,,,
1856,3081859,CID 3081859,C1C[C@]2([C@@H]3CC4=C5[C@@]2(CCN3CC6CC6)[C@H]([C@H]1I)OC5=C(C=C4)O)O,,,,,,
1857,3081860,"alpha-L-Galactopyranoside, (3beta,4beta,5beta)-3-hydroxypregn-20-en-4-yl 6-deoxy-3-O-methyl-, 2-acetate",CC1C(C(C(C(O1)OC2C3CCC4C5CCC(C5(CCC4C3(CCC2O)C)C)C=C)OC(=O)C)OC)O,,,,,,
1858,3081861,Trichlorobis(dimethylsulfoxide)imidazoleruthenium(III),CS(=O)C.CS(=O)C.C1=CN=CN1.[Cl-].[Cl-].[Cl-].[Ru+3],,,,,,
1859,3081862,CID 3081862,C1=CC(=C2C(=C1)OC3=CC(=O)C4=C(C3=N2)C(=CC(=C(O)O)N4)O)C(=O)CC(C(=O)O)N,,,,,,
1860,3081863,CID 3081863,CCN[C@H]1CO[C@H](C[C@@H]1OC)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2O[C@H]3C#CC=CC#C[C@]4(CC(=O)C(=C3C4=CCSSSC)NC(=O)OC)O)C)NO)O,,,,,,
1861,3081864,"3'-Azido-3',5'-dideoxythymidine-5'-methylphosphonic acid diphosphate",CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CCP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])N=[N+]=[N-].[NH4+].[NH4+].[NH4+].[NH4+],,,,,,
1862,3081865,"3'-Azido-5'-[[[[(phosphonooxy)phosphonyl]oxy]phosphonyl]methyl]-3',5'-dideoxythymidine",CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CCP(=O)(O)OP(=O)(O)OP(=O)(O)O)N=[N+]=[N-],,,,,,
1863,3081866,CID 3081866,CC=C1[C@H](C(=O)NC1=CC2=C(C(=C(N2)C=C3C(=C(C(=CC4=NC(=O)C(=C4C)C=C)N3)C)CCC(=O)O)C)CCC(=O)O)C,,,,,,
1864,3081867,Betaclamycin B,CCC1(CC(C2=C(C1O)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4O)O)OC5CC(C(C(O5)C)OC6CC7C(C(O6)C)OC8C(O7)CC(=O)C(O8)C)N(C)C)O,,,,,,
1865,3081868,3-Amino-5-C-(3-carboxy-4-(carboxymethyl)-2-oxo-3-cyclohexen-1-yl)altrofuranose,CC(C1C(C(C(O1)O)O)N)(C2C(=O)CCC(=C2C(=O)O)CC(=O)O)O,,,,,,
1866,3081869,ZINC histidinate,C1=C(NC=N1)CC(C(=O)[O-])N.C1=C(NC=N1)CC(C(=O)[O-])N.[Zn+2],,,,,,
1867,3081870,3-Indolepropionyl-coenzyme A,CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)[C@H](C(=O)NCCC(=O)NCCSC(=O)CCC4=CNC5=CC=CC=C54)O,,,,,,
1868,3081871,CID 3081871,CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)[C@H](C(=O)NCCC(=O)NCCSC(=O)C=CC4=CNC5=CC=CC=C54)O,,,,,,
1869,3081872,CID 3081872,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O.C(=CC(=O)O)C(=O)O,,,,,,
1870,3081873,Cap-mla,CCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(=O)OC1C(C(OC(C1OP(=O)(O)O)COC(=O)CCCCCN)OCC(C(C(C(C=O)NC(=O)CC(CCCCCCCCCCC)O)OC(=O)CC(CCCCCCCCCCC)O)O)O)NC(=O)CCCCCCCCCCCCCOC(=O)CCCCCCCCCCC,,,,,,
1871,3081874,Cyclo(glycyl-prolyl-phenylalanyl-valyl-phenylalanyl-phenylalanyl),CC(C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N1)CC3=CC=CC=C3)CC4=CC=CC=C4)CC5=CC=CC=C5,,,,,,
1872,3081875,"(14-Acetyloxy-4,8,12-trimethyl-16-methylidene-17-oxo-3,18-dioxatricyclo[13.3.0.02,4]octadeca-7,11-dien-10-yl) acetate",CC1=CCCC2(C(O2)C3C(C(CC(=CC(C1)OC(=O)C)C)OC(=O)C)C(=C)C(=O)O3)C,,,,,,
1873,3081876,1-Hydroxy-13-deoxocarminomycin,CCC1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C=CC(=C4C3=O)O)O)O)OC5CC(C(C(O5)C)O)N)O,,,,,,
1874,3081877,CID 3081877,CCC1C(C=C(C=CC(=NOCC2=CC=C(C=C2)[N+](=O)[O-])C(CC(C(C(C(CC(=O)O1)O)C)OC3C(C(C(C(O3)C)OC4CC(C(C(O4)C)O)(C)O)N(C)C)O)CC=O)C)C)COC5C(C(C(C(O5)C)O)OC)OC,,,,,,
1875,3081878,"Spiro(9H-fluorene-9,4'-imidazolidine)-2',5'-dione, 2,7-difluoro-4-methoxy-, (S)-",COC1=CC(=CC2=C1C3=C([C@@]24C(=O)NC(=O)N4)C=C(C=C3)F)F,,,,,,
1876,3081879,Phyllactone A,CCC(CC(=O)O[C@@H]1C[C@@H]2[C@]3(CCC[C@]([C@@H]3CC[C@]2([C@H]4[C@]1(C5=C([C@H](OC5=O)C)[C@@H](C4)O)C)C)(C)CC)C)O,,,,,,
1877,3081880,Desalaninebenanomicin A,CC1C(C(C(C(O1)OC2C(C3=CC4=C(C(=C3C5=C2C=C(C(=C5O)C(=O)O)C)O)C(=O)C6=C(C4=O)C(=CC(=C6)OC)O)O)O)OC7C(C(C(CO7)O)O)O)O,,,,,,
1878,3081881,N-(3-Pyridylmethyl)dihydroepidoxorubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(CO)O)O)NCC6=CN=CC=C6)O,,,,,,
1879,3081882,CID 3081882,CCC[C@@H](C)C=C(C)C(=O)O[C@@H]1[C@@H](O[C@H](C[C@@]1(C)O)O[C@H]2CC[C@@H](O[C@@H]2C)O[C@@H]3C(=O)C(=C([C@@]4([C@]3(CC5=C(C6=C(C(=O)C=C(C6=O)OC)C(=C5C4=O)O)C)O)O)O)C(=O)C)C,,,,,,
1880,3081883,Dibutyltin 3-hydroxyflavone,CCC[CH2-].CCC[CH2-].C1=CC=C(C=C1)C2=C(C(=O)C3=CC=CC=C3O2)[O-].[Br-].[Sn+4],,,,,,
1881,3081884,Glatiramer acetate,C[C@@H](C(=O)O)N.CC(=O)O.C1=CC(=CC=C1C[C@@H](C(=O)O)N)O.C(CCN)C[C@@H](C(=O)O)N.C(CC(=O)O)[C@@H](C(=O)O)N,,,"['Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)', 'Drugs that are used to treat RHEUMATOID ARTHRITIS. (See all compounds classified as Antirheumatic Agents.)', 'Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)']",,,
1882,3081885,CID 3081885,CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OC[C@@H]1CCC(O1)N2C=CC(=NC2=O)N)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
1883,3081886,"methyl 4-[4-(dimethylamino)-6-methyl-5-[6-methyl-5-[(6-methyl-5-oxo-2H-pyran-2-yl)oxy]oxan-2-yl]oxyoxan-2-yl]oxy-2-ethyl-2,5,7,10-tetrahydroxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate",CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C=CC(=C4C3=O)O)O)O)OC5CC(C(C(O5)C)OC6CCC(C(O6)C)OC7C=CC(=O)C(O7)C)N(C)C)O,,,,,,
1884,3081887,9-Dihydrotaxol,CC1=C2[C@H]([C@@H]([C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)O)OC(=O)C,,,,,,
1885,3081888,"[2-(decanoylamino)-3-hydroxy-3-phenylpropyl] N-[2-[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methylamino]-2-oxoethyl]carbamate",CCCCCCCCCC(=O)NC(COC(=O)NCC(=O)NC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=O)NC2=O)O)O)C(C3=CC=CC=C3)O,,,,,,
1886,3081889,"[5-[[18-[6-[2-(9-Aminodecyl)-1,3-thiazol-4-yl]-3-methyloxan-2-yl]-5,7,9,13,15,17-hexahydroxy-2,4-dimethyloctadec-2-enoyl]amino]-12,16,18,26,30,32-hexahydroxy-24-methoxy-4,7,21-trimethyl-2-oxo-3,37-dioxa-39-azabicyclo[34.2.1]nonatriaconta-1(38),22,36(39)-trien-6-yl] hydrogen sulfate",CC1CCC(CC(CCCC(CCCCC(C(C(C(OC(=O)C2=COC(=N2)CCCC(CC(CCCC(CC(C=C1)OC)O)O)O)C)NC(=O)C(=CC(C)C(CC(CC(CCCC(CC(CC(CC3C(CCC(O3)C4=CSC(=N4)CCCCCCCCC(C)N)C)O)O)O)O)O)O)C)OS(=O)(=O)O)C)O)O)O,,,,,,
1887,3081890,MNPAM cpd,C1CNCCNCCNCCNCCN1.[Cl-].[Cl-].[Mn+2],,,,,,
1888,3081891,CID 3081891,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@@H]2CC6=C4C(=C(C=C6)O)O5)NC(=O)CBr,,,,,,
1889,3081892,CID 3081892,CC1=CC(=O)C(=CC2=C1CC3CC(C4(C(CC5=C(O4)C=C(C(=O)C=C5C)O)CC(C=CCC3(O2)C)(C)C)C)O)O,,,,,,
1890,3081893,Phenylalanyl-valyl-phenylalanyl-psi(methylamino)leucyl-glutamyl-isoleucineamide,CC[C@H](C)[C@@H](C(=O)N)NC[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC2=CC=CC=C2)N,,,,,,
1891,3081894,rtTTP,CC1=CN(C(=O)NC1=O)[C@H]2[C@@H]3[C@@H](S3)[C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O,,,,,,
1892,3081895,"2-[(3S,6S,9S,12R,15S,18R,21R,24R,30R,33R)-6,9-bis[(2S)-butan-2-yl]-3-(carboxymethyl)-37-heptyl-27-[(1S)-1-hydroxyethyl]-12,18-bis(hydroxymethyl)-15,21,24,33-tetrakis(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32,35-dodecaoxo-1-oxa-4,7,10,13,16,19,22,25,28,31,34-undecazacycloheptatriacont-30-yl]acetic acid",CCCCCCCC1CC(=O)N[C@@H](C(=O)N[C@@H](C(=O)NC(C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O1)CC(=O)O)[C@@H](C)CC)[C@@H](C)CC)CO)CC(C)C)CO)CC(C)C)CC(C)C)[C@H](C)O)CC(=O)O)CC(C)C,,,,,,
1893,3081896,"fluoro-[[(2R,3R,5R)-3-fluoro-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphinic acid",CC1=CN(C(=O)NC1=O)[C@H]2C[C@H]([C@H](O2)COP(=O)(O)F)F,,,,,,
1894,3081897,CID 3081897,CC1=CCCC(C1=CC=C(C)C=CC=C(C)C(CO)O)(C)C,,,,,,
1895,3081898,Taxcultine,CCCC(=O)N[C@@H](C1=CC=CC=C1)[C@H](C(=O)O[C@H]2C[C@]3([C@H]([C@H]4[C@@]([C@H](C[C@@H]5[C@]4(CO5)OC(=O)C)O)(C(=O)[C@@H](C(=C2C)C3(C)C)OC(=O)C)C)OC(=O)C6=CC=CC=C6)O)O,,,,,,
1896,3081899,"Bis(dimethylthexylsiloxy)silicon 2,3-naphthalocyanine",CC(C)C(C)(C)[Si](C)(C)[O-].CC(C)C(C)(C)[Si](C)(C)[O-].C1=CC=C2C=C3C(=CC2=C1)C4=NC5=C6C=C7C=CC=CC7=CC6=C([N-]5)N=C8C9=CC1=CC=CC=C1C=C9C(=N8)N=C1C2=CC5=CC=CC=C5C=C2C(=N1)N=C3[N-]4.[Si+4],,,,,,
1897,3081900,Azidotaxol,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=C(C=C6)N=[N+]=[N-])O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,,,,,,
1898,3081901,Taxapu,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)N(C)C6=CC=C(C=C6)N=[N+]=[N-])O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,,,,,,
1899,3081902,"2-(4-(4-(3-(1,2-Benzisothiazolyl))-1-piperazinyl)butyl)-4a,5,6,7,8,8a-hexahydro-1(2H)-phthalazinone",C1CC[C@@H]2[C@@H](C1)C=NN(C2=O)CCCCN3CCN(CC3)C4=NSC5=CC=CC=C54,,,,,,
1900,3081903,"1-Hydroxy-3-((4-hydroxybenzoyl)oxy)-D-friedoolean-14-en-28-oic acid (1beta,3beta)-",C[C@@]12CC[C@@H]3[C@@]([C@H]1CC[C@@]4(C2=CC[C@@]5([C@H]4CC(CC5)(C)C)C(=O)O)C)([C@@H](C[C@@H](C3(C)C)OC(=O)C6=CC=C(C=C6)O)O)C,,,,,,
1901,3081904,"2alpha-Hydroxymaprounic acid 2,3-bis-p-hydroxybenzoate",C[C@@]12CC[C@@H]3[C@@]([C@H]1CC[C@@]4(C2=CC[C@@]5([C@H]4CC(CC5)(C)C)C(=O)O)C)(C[C@H]([C@@H](C3(C)C)OC(=O)C6=CC=C(C=C6)O)OC(=O)C7=CC=C(C=C7)O)C,,,,,,
1902,3081905,Woodrosin I,CCCCCC1CCCCCCCCCC(=O)OC2C(C(C(OC2OCC3C(C(C(C(O3)OC4C(C(OC(C4OC5C(C(C(C(O5)C)OC(=O)C(C)CC)O)OC(=O)C(C)CC)OC6C(C(C(OC6O1)CO)O)O)CO)O)O)OC(=O)C(C)CC)OC(=O)C(C)CC)CO)O)O,,,,,,
1903,3081906,Woodrosin II,CCCCCC1CCCCCCCCCC(=O)OC2C(C(C(OC2OCC3C(C(C(C(O3)OC4C(C(OC(C4OC5C(C(C(C(O5)C)OC(=O)C(C)CC)O)OC(=O)C(C)CC)OC6C(C(C(OC6O1)CO)O)O)CO)O)O)OC(=O)C(C)C)OC(=O)C(C)CC)CO)O)O,,,,,,
1904,3081907,Motexafin lutetium,CCC1=C(C2=CC3=NC(=CN=C4C=C(C(=CC4=NC=C5C(=C(C(=N5)C=C1[N-]2)CCCO)C)OCCOCCOCCOC)OCCOCCOCCOC)C(=C3CCCO)C)CC.CC(=O)[O-].CC(=O)[O-].O.[Lu+3],,,['Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. (See all compounds classified as Photosensitizing Agents.)'],,,
1905,3081908,"[3-[[[[3-Azido-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-octadecanoyloxypropyl] octadecanoate",CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OP(=O)(O)OP(=O)(O)OCC1C(CC(O1)N2C=C(C(=O)NC2=O)C)N=[N+]=[N-])OC(=O)CCCCCCCCCCCCCCCCC,,,,,,
1906,3081909,Dodecyl laminarapentaoside peracetate,CCCCCCCCCCCCO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COC(=O)C)OC(=O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)COC(=O)C)OC(=O)C)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COC(=O)C)OC(=O)C)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)COC(=O)C)OC(=O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
1907,3081910,Ggpl-I,CCCCCCCCCCCCCCCC(=O)OC[C@H](CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COP(=O)([O-])OCC[N+](C)(C)C)O)O)O)OC(=O)CCCCCCCCCCCCCCC,,,,,,
1908,3081911,"3-O-[6-O-[[2-(Trimethylaminio)ethoxy]phosphonyl]-alpha-D-glucopyranosyl]-L-glycerol 1,2-dipalmitate",CCCCCCCCCCCCCCCC(=O)OC[C@H](CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COP(=O)(O)OCC[N+](C)(C)C)O)O)O)OC(=O)CCCCCCCCCCCCCCC,,,,,,
1909,3081912,"Indate(1-), (N-(2-((2-(bis(carboxymethyl)amino)ethyl)(carboxymethyl)amino)ethyl)-N-(carboxymethyl)glycyl-D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (3-8)-disulfidato(4-))-, hydrogen, (R-(R*,R*))-",[H+].CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)NC(=O)CN(CCN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])C(=O)NC(CO)C(C)O)O.[In+3],,,,,,
1910,3081913,Fenozan 50F,C1CCC2(C1)O[C@H]3C=C(C[C@]3(OO2)C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,,,,,,
1911,3081914,"4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-(3-(3,4-methylenedioxyphenylcarbamoyloxy)propyl)piperidine",C1CN(CCC1C2=NOC3=C2C=CC(=C3)F)CCCOC(=O)NC4=CC5=C(C=C4)OCO5.Cl,,,,,,
1912,3081915,"3-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]propyl N-(1,3-benzodioxol-5-yl)carbamate",C1CN(CCC1C2=NOC3=C2C=CC(=C3)F)CCCOC(=O)NC4=CC5=C(C=C4)OCO5,,,,,,
1913,3081916,CID 3081916,C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)O[C@](C)(CCC=C(C)C(=O)O[C@H]2[C@@H](O[C@@H]([C@@H]([C@@H]2O)O)O[C@](C)(CCC=C(CO)C(=O)O[C@@H]3C[C@]4([C@@H](C[C@@]5(C(=CC[C@H]6[C@@]5(CC[C@@H]7[C@]6(CC[C@H](C7(C)C)O[C@@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)CO[C@@H]9[C@@H]([C@@H]([C@@H](CO9)O)O)O[C@@H]1[C@@H]([C@@H]([C@@H](CO1)O)O)O)O)O)O)C)C)[C@@H]4CC3(C)C)C)O)C(=O)O[C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)CO)O)O)O[C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O[C@@H]1[C@@H]([C@H]([C@@H](O1)CO)O)O)O[C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)CO)O)O)O)O)C=C)C)C=C)O)O)O,,,,,,
1914,3081917,"Manganese(2+);2,5,12,15,18-pentazatricyclo[17.4.0.06,11]tricosane;dichloride",C1CCC2C(C1)NCCNCCNC3CCCCC3NCCN2.[Cl-].[Cl-].[Mn+2],,,,,,
1915,3081918,"2,5,12,15,18-Pentazatricyclo[17.4.0.06,11]tricosane",C1CCC2C(C1)NCCNCCNC3CCCCC3NCCN2,,,,,,
1916,3081919,Lasofoxifene tartrate,C1CCN(C1)CCOC2=CC=C(C=C2)[C@H]3[C@H](CCC4=C3C=CC(=C4)O)C5=CC=CC=C5.[C@H]([C@@H](C(=O)O)O)(C(=O)O)O,['Fablyn is indicated for the treatment of osteoporosis in postmenopausal women at increased risk of fracture. A significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated (see section 5. 1).'],,,,,
1917,3081920,CID 3081920,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC(=C(C=C7)O)OS(=O)(=O)[O-])O)O)C(CC(=O)N)O)C)O)O)O.[Na+],,,,,,
1918,3081921,CID 3081921,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)C(CC(=O)N)O)C)O)O)O,,,"['Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)']",,,
1919,3081922,Trethocanic acid,CC(C)CCCC(C)CCCC(C)(CC(=O)O)O,,,,,,
1920,3081923,"D,D-Neotame",CC(C)(C)CCN[C@H](CC(=O)O)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)OC,,,,,,
1921,3081924,Oxapyrazon,C1=CC=C(C=C1)N2C(=O)C(=C(C=N2)NC(=O)C(=O)O)Br,,,,,,
1922,3081925,Thionisoxetine,CNCCC(C1=CC=CC=C1)OC2=CC=CC=C2SC,,,,,,
1923,3081926,Perophoramidine,CN1CCC23C1=NCC[C@]24C5=C(C(=CC(=C5)Cl)Cl)N=C4NC6=C3C=CC(=C6)Br,,,,,,
1924,3081927,Pactimibe,CCCCCCCCN1CCC2=C(C(=C(C(=C21)NC(=O)C(C)(C)C)C)CC(=O)O)C,,,,,,
1925,3081928,Pleiadene,C1=CC2=CC3=CC=CC4=C3C(=CC=C4)C=C2C=C1,,,,,,
1926,3081929,CID 3081929,CCCCCCCCCCCCCCCCCC=CCCC#CCC(=O)O[C@@H](C)C[C@@H](CCC[C@@](C)(CC(=O)NCCS(=O)(=O)O)O)OC(=O)C,,,,,,
1927,3081930,"4(5H)-Benzofuranone, 6-ethenyl-6,7-dihydro-3,6-dimethyl-5-(1-methylethenyl)-, trans-",CC1=COC2=C1C(=O)[C@@H]([C@@](C2)(C)C=C)C(=C)C,,,,,,
1928,3081931,Smenospongine,C[C@H]1CC[C@]2([C@H]([C@]1(C)CC3=C(C(=CC(=O)C3=O)N)O)CCCC2=C)C,,,,,,
1929,3081932,"Isocyanic acid, ammonium salt",C(#N)O.N,,,,,,
1930,3081933,CID 3081933,C1=CC(=C(C=C1C2=C(C=C3C(=C2[AsH2])N=C(O3)SCCC(=O)O)[AsH2])N(CC(CO)O)CC(=O)CO)O,,,,,,
1931,3081934,Lauroguadine hydrochloride,CCCCCCCCCCCCOC1=C(C=C(C=C1)N=C(N)N)N=C(N)N.Cl.Cl,,,,,,
1932,3081935,3-Hydroxy-3-methyl-2-phenylpentanoic acid,CCC(C)(C(C1=CC=CC=C1)C(=O)O)O,,,,,,
1933,3081936,7-chloro-L-tryptophan,C1=CC2=C(C(=C1)Cl)NC=C2C[C@@H](C(=O)O)N,,,,,,
1934,3081937,Spiro-oxazolidine,C1CCC2(CC1)CNCO2,,,,,,
1935,3081938,"(6Z,12Z)-4a,5,10a,11-tetrahydrobenzo[c][1,5]benzodiazocine",C1=CC/2N/C=C/3\C(N/C=C2/C=C1)C=CC=C3,,,,,,
1936,3081939,6beta-Hydroxydoc,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)CO)C[C@H](C4=CC(=O)CC[C@]34C)O,,,,,,
1937,3081940,9alpha-Fluorocorticosterone,C[C@]12CCC(=O)C=C1CC[C@@H]3C2([C@H](C[C@]4([C@H]3CC[C@@H]4C(=O)CO)C)O)F,,,,,,
1938,3081941,CID 3081941,C[C@H](C(=O)O)NC1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])F,,,,,,
1939,3081942,4-Fluorobenzenesulfonyl fluoride,C1=CC(=CC=C1F)S(=O)(=O)F,,,,,,
1940,3081943,epsilon-Aminocaproic acid hexyl ester,CCCCCCOC(=O)CCCCCN,,,,,,
1941,3081944,Perfluoronon-1-ene,C(=C(F)F)(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)F,,,,,,
1942,3081945,CID 3081945,[B+3].C1=CC=C2C(=C1)C=C(C=N2)[N+]#N.[F-].[F-].[F-].[F-],,,,,,
1943,3081946,Quinoline-3-diazonium,C1=CC=C2C(=C1)C=C(C=N2)[N+]#N,,,,,,
1944,3081947,"8-(4-Oxo-3,3-diphenylhexyl)-1-phenyl-1,3,8-triazaspiro(4.5)decan-4-one",CCC(=O)C(CCN1CCC2(CC1)C(=O)NCN2C3=CC=CC=C3)(C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
1945,3081948,6-Bromoamiloride,C1(=C(N=C(C(=N1)Br)N)N)C(=O)N=C(N)N,,,,,,
1946,3081949,5-(N-tert-Butyl)amiloride,CC(C)(C)NC1=NC(=C(N=C1Cl)C(=O)N=C(N)N)N,,,,,,
1947,3081950,5-(N-Butyl-N-methyl)amiloride,CCCCN(C)C1=NC(=C(N=C1Cl)C(=O)N=C(N)N)N,,,,,,
1948,3081951,"3,12-Bis(2-chloroethyl)-3,12-diaza-6,9-diazoniadispiro[5.2.5.2]hexadecane dichloride",C1C[N+]2(CCN1CCCl)CC[N+]3(CCN(CC3)CCCl)CC2.[Cl-].[Cl-],,,,,,
1949,3081952,"3,12-Bis(2-chloroethyl)-3,12-diaza-6,9-diazoniadispiro[5.2.59.26]hexadecane",C1C[N+]2(CCN1CCCl)CC[N+]3(CCN(CC3)CCCl)CC2,,,,,,
1950,3081953,Gibberellin-A-12,C[C@@]12CCC[C@@]([C@H]1[C@@H](C34[C@H]2CCC(C3)C(=C)C4)C(=O)O)(C)C(=O)O,,,,,,
1951,3081954,"1-(4-Hydroxyphenyl)-2-phenyl-4-(2-phenylsulfanylethyl)pyrazolidine-3,5-dione",C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=C(C=C3)O)CCSC4=CC=CC=C4,,,,,,
1952,3081955,Bephedon,CCC1=CC=C(C=C1)C(=O)CC(C2C(=O)C3=CC=CC=C3C2=O)C4=CC=CC=C4,,,,,,
1953,3081956,Phenylmaltoside,C1=CC=C(C=C1)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O,,,,,,
1954,3081957,Cannabidiol dimethyl ether,CCCCCC1=CC(=C(C(=C1)OC)[C@@H]2C=C(CC[C@H]2C(=C)C)C)OC,,,,,,
1955,3081958,"7alpha,12alpha-Dihydroxycholest-4-en-3-one",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](CC4=CC(=O)CC[C@]34C)O)O)C,,,,,,
1956,3081959,Glycoyl-coenzyme A,CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCSC(=O)CO)O,,,,,,
1957,3081960,"Chloromercury;cyclopenta-1,3-diene;iron(2+)",[CH-]1C=CC=C1.[CH-]1C=CC=C1.Cl[Hg].[Fe+2],,,,,,
1958,3081961,Malachite (Cu2(CO3)(OH)2),C(=O)(O)O.O.O.[Cu].[Cu],,,,,,
1959,3081962,"Thiazole, aminonitro-",C1=C(N=C(S1)N)[N+](=O)[O-],,,,,,
1960,3081963,"[(2R,3S,4S,5S,6S,8S,13S,16S,17S)-11-ethyl-3,8,9-trihydroxy-4,6,16-trimethoxy-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-13-yl] 2-acetamidobenzoate",CCN1C[C@@]2(CC[C@@H](C34[C@@H]2CC(C31)([C@]5(C[C@@H]([C@@H]6C[C@H]4[C@@]5([C@H]6OC)O)OC)O)O)OC)OC(=O)C7=CC=CC=C7NC(=O)C,,,,,,
1961,3081964,2-Fluoro-ADP,C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)O)O)O)F)N,,,,,,
1962,3081965,GW-Amide,C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N)NC(=O)CN,,,,,,
1963,3081966,N-Desmethylquazepam,C1C(=S)NC2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F,,,,,,
1964,3081967,8-Fluoro-8-demethylriboflavin,CC1=CC2=C(C=C1F)N(C3=NC(=O)NC(=O)C3=N2)C[C@@H]([C@@H]([C@@H](CO)O)O)O,,,,,,
1965,3081968,CID 3081968,[Be+2].C1=CC(=C(C=C1S(=O)(=O)[O-])C(=O)[O-])O,,,,,,
1966,3081969,CID 3081969,C([C@@H]1[C@H]([C@H]([C@](O1)(CO)O[C@@H]2[C@@H](C(=O)[C@@H]([C@H](O2)CO)O)O)O)O)O,,,,,,
1967,3081970,Lactyl-coa,CC(C(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O)O,,,,,,
1968,3081971,20-Azacholesterol,CC(C)CCCN(C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
1969,3081972,CID 3081972,C1CC1CN2CC[C@]34[C@@H]5[C@@H]2CC6=C3C(=C(C=C6)O)O[C@H]4[C@H](C=C5)O,,,,,,
1970,3081973,4-Dimethylamino-L-phenylalanine,CN(C)C1=CC=C(C=C1)C[C@@H](C(=O)O)N,,,,,,
1971,3081974,Spiro-3-oxiranylandrostan-17-ol,C[C@]12CCC3(C[C@@H]1CC[C@@H]4[C@@H]2CC[C@]5([C@H]4CC[C@@H]5O)C)CO3,,,,,,
1972,3081975,CID 3081975,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CC([C@@H]4[C@H]([C@H]([C@@H](O4)N5C=NC6=C5NC(=NC6=O)N)OP(=O)(O)O)O)OC[C@@H]7[C@H]([C@H]([C@@H](O7)N8C=NC9=C(N=CN=C98)N)O)OP(=O)(O)O)O)O)N,,,,,,
1973,3081976,CID 3081976,C([C@@H]1[C@H]([C@H]([C@@H](O1)N2C3=C(C(=O)N=C(N3)N)N=C2Cl)O)O)O,,,,,,
1974,3081977,N-Cyclopentyldeisopropylpropranolol,C1CCC(C1)NCC(COC2=CC=CC3=CC=CC=C32)O.Cl,,,,,,
1975,3081978,1-(Cyclopentylamino)-3-naphthalen-1-yloxypropan-2-ol,C1CCC(C1)NCC(COC2=CC=CC3=CC=CC=C32)O,,,,,,
1976,3081979,Ambunol,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)CN(CCO)CCO.Cl,,,,,,
1977,3081980,"1-(4-Hydroxyphenyl)ethane-1,2-diol",C1=CC(=CC=C1C(CO)O)O,,,,,,
1978,3081981,4-(1-Amino-2-hydroxypropan-2-yl)phenol,CC(CN)(C1=CC=C(C=C1)O)O,,,,,,
1979,3081982,"Oxytocin, phe(2)-orn(8)-",CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)NCC(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](C=S)N,,,,,,
1980,3081983,Lincomycin B,CCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)O,,,,,,
1981,3081984,"7-chloro-1-methyl-5-phenyl-4,5-dihydro-3H-1,4-benzodiazepin-2-one",CN1C(=O)CNC(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,,,,,,
1982,3081985,Janus Red,CC1=C(C=CC(=C1)N=NC2=C(C=CC3=CC=CC=C32)O)N=NC4=CC(=CC=C4)[N+](C)(C)C.[Cl-],,,,,,
1983,3081986,1-Allylnorantifeine,CNC(=O)C1=C(N(C=N1)CC=C)C(=O)NC,,,,,,
1984,3081987,"2,3-Bis(3,7,11,15-tetramethylhexadecoxy)propyl (2-hydroxy-3-phosphonooxypropyl) hydrogen phosphate",CC(C)CCCC(C)CCCC(C)CCCC(C)CCOCC(COP(=O)(O)OCC(COP(=O)(O)O)O)OCCC(C)CCCC(C)CCCC(C)CCCC(C)C,,,,,,
1985,3081988,"N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4R,5R)-5-acetamido-3,4-bis[[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]-1-hydroxy-6-oxohexan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide",CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O[C@H](CO)[C@H]([C@@H]([C@H](C=O)NC(=O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)NC(=O)C)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)NC(=O)C)CO)O)O,,,,,,
1986,3081989,"(8S,9S,13S,14S)-17-ethynyl-10-fluoro-17-hydroxy-13-methyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2(C#C)O)CCC4=CC(=O)CCC34F,,,,,,
1987,3081990,Cannabinolic acid,CCCCCC1=CC2=C(C3=C(C=CC(=C3)C)C(O2)(C)C)C(=C1C(=O)O)O,,,,,,
1988,3081991,CID 3081991,C1=NC2=C(N=CN(C2=N1)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)N,,,,,,
1989,3081992,(3R)-4-(dimethylamino)-3-hydroxybutanoic acid,CN(C)C[C@@H](CC(=O)O)O,,,,,,
1990,3081993,alpha-Tocopheronolactone,CC1=C(C(=O)C(=C(C1=O)C)CCC2(CCC(=O)O2)C)C,,,,,,
1991,3081994,Citryl-coa,CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCSC(=O)CC(CC(=O)O)(C(=O)O)O)O,,,,,,
1992,3081995,CID 3081995,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC(=NC3=O)N)C(OP(=O)(O)O)OP(=O)(O)O)O,,,,,,
1993,3081996,19-Norcholest-4-en-3-one,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C,,,,,,
1994,3081997,d-Arabinosone,C([C@H]([C@H](C(=O)C=O)O)O)O,,,,,,
1995,3081998,Succinyl phosphate,C1CC(=O)OC1=O.OP(=O)(O)O,,,,,,
1996,3081999,"(2Z)-6-methyl-2-[(4S,8S,9R,10S,13R,14R,16S)-4,10,14-trimethyl-3,11-dioxo-16-propanoyloxy-1,2,4,5,6,7,8,9,12,13,15,16-dodecahydrocyclopenta[a]phenanthren-17-ylidene]hept-5-enoic acid",CCC(=O)O[C@H]\1C[C@@]2([C@H]3CCC4[C@@H](C(=O)CC[C@@]4([C@@H]3C(=O)C[C@H]2/C1=C(\CCC=C(C)C)/C(=O)O)C)C)C,,,,,,
1997,3082000,Uridylyl-(3'-5')-uridylyl-(3'-5')-3'-uridylic acid,C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)C(C[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=CC(=O)NC4=O)OP(=O)(O)O)O)(C[C@@H]5[C@H]([C@H]([C@@H](O5)N6C=CC(=O)NC6=O)OP(=O)(O)O)O)OP(=O)(O)O)O)O,,,,,,
1998,3082001,(2S)-1-[(2S)-1-[(2S)-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pent-4-enoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]-N-[2-[[(2S)-1-[[(2S)-3-hydroxy-1-oxo-1-[(2S)-2-[[(2S)-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]propan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]pyrrolidine-2-carboxamide,C1C[C@H](N(C1)C(=O)[C@@H]2CCCN2C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC=CN=C(N)N)N)C(=O)NCC(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CO)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CC5=CC=CC=C5)C=O,,,,,,
1999,3082002,Thallium thiocyanate,C(#N)[S-].[Tl+],,,,,,
2000,3082003,(2-Hydroxy-3-octadec-9-enoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate,CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)O,,,,,,
2001,3082004,Heptadecanoyl-coa,CCCCCCCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O,,,,,,
2002,3082005,Dehydrogriseofulvin,CC1=CC(=O)C=C([C@]12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC,,,,,,
2003,3082006,"1,3,5-Trimethyl-4-trimethylammoniopyrazole iodide",CC1=C(C(=NN1C)C)[N+](C)(C)C.[I-],,,,,,
2004,3082007,"Trimethyl-(1,3,5-trimethylpyrazol-4-yl)azanium",CC1=C(C(=NN1C)C)[N+](C)(C)C,,,,,,
2005,3082008,"(2R,3S,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-3-hydroxy-2-(hydroxymethyl)-5,6-bis[[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol",C([C@@H]1[C@H]([C@@H]([C@@H]([C@H](O1)O[C@H]2[C@@H]([C@H](O[C@@H]([C@H]2O[C@@H]3[C@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)CO)O)O)O)O)O,,,,,,
2006,3082009,3alpha-Hydroxy-5beta-chol-6-en-24-oic acid,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C[C@H]4[C@@]3(CC[C@H](C4)O)C)C,,,,,,
2007,3082010,"Oxytocin, mephe(2)-",CC[C@H](C)C1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)C)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,,,,,,
2008,3082011,"(8S,10S,13S,14S,17S)-9-fluoro-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-one",C[C@]12CCC3([C@H]([C@@H]1CC[C@@H]2C(=O)CO)CCC4=CC(=O)CC[C@@]43C)F,,,,,,
2009,3082012,Uridine diphosphate-N-acetylgalactosamine 4-sulfate,CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC(=O)NC3=O)O)O)CO)OS(=O)(=O)O)O,,,,,,
2010,3082013,"2,6-Dideoxy-4-O-methylhexopyranose",C[C@H]([C@@H]([C@@H](CC=O)O)OC)O,,,,,,
2011,3082014,22-Azacholesterol,C[C@@H]([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)NCCC(C)C,,,,,,
2012,3082015,"2,5,7,8-Tetramethyl-2-(2'-carboxyethyl)-6-hydroxychroman",CC1=C(C2=C(CCC(O2)CCC(=O)OC)C(=C1O)C)C,,,,,,
2013,3082016,Desoleandomycin,CC1CC(C(C(O1)OC2C(CC3(CO3)C(=O)C(C(C(C(OC(=O)C(C(C2C)O)C)C)C)O)C)C)O)N(C)C,,,,,,
2014,3082017,Hexaaquaaluminum(III) bromate,[O-]Br(=O)=O.[O-]Br(=O)=O.[O-]Br(=O)=O.[Al+3],,,,,,
2015,3082018,"1,3-Hexadien-1-ol",CCC=CC=CO,,,,,,
2016,3082019,"9-[2-carboxy-5-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-oxalooxyoxan-2-yl]oxy-4-hydroxy-10-oxo-9H-anthracen-9-yl]-4-hydroxy-10-oxo-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9H-anthracene-2-carboxylic acid",C1=CC2=C(C(=C1)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C(=O)C4=C(C2C5C6=C(C(=CC=C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)OC(=O)C(=O)O)C(=O)C8=C5C=C(C=C8O)C(=O)O)C=C(C=C4O)C(=O)O,,,,,,
2017,3082020,CID 3082020,S.S.S.S.[Fe].[Cu].[Cu].[SnH2],,,,,,
2018,3082021,CID 3082021,O.[O-][Si](=O)[O-].[NaH].[AlH3].[Ca+2],,,,,,
2019,3082022,Rhodocene,[CH-]1C=CC=C1.[CH-]1C=CC=C1.[Rh+2],,,,,,
2020,3082023,Tin fluoride phosphate,[O-]P(=O)([O-])[O-].[F-].[F-].[F-].[Sn+4].[Sn+4].[Sn+4],,,,,,
2021,3082024,"3,7,11,15,19,23,27,31,35,39,43-Undecamethyltetratetraconta-6,10,14,18,22,26,30,34,38,42-decaen-1-ol",CC(CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)CCO,,,,,,
2022,3082025,Dryocrassin ABBA,CCCC(=O)C1=C(C(=C(C(=C1O)CC2=C(C(C(=O)C(=C2O)C(=O)C)(C)C)O)O)CC3=C(C(=C(C(=C3O)C(=O)CCC)O)CC4=C(C(C(=O)C(=C4O)C(=O)C)(C)C)O)O)O,,,,,,
2023,3082026,8-Methylpterin,CN1C=CN=C2C1=NC(=NC2=O)N,,,,,,
2024,3082027,Lincosamine,C[C@H]([C@H]([C@@H]1[C@@H]([C@@H]([C@H](C(O1)O)O)O)O)N)O,,,,,,
2025,3082028,CID 3082028,C1=NC(=C2C(=N1)N(C=N2)[C@H](C=O)O[C@H](COP(=O)(O)O)C=O)N,,,,,,
2026,3082029,Adenosine 5'-(O-methylphosphate),COP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O,,,,,,
2027,3082030,"2-(Ethylamino)ethyl 2,2-diphenylpentanoate",CCCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)OCCNCC,,,,,,
2028,3082031,3-Hydroxymethylaminopyrine,CN1C(=C(C(=O)N1C2=CC=CC=C2)N(C)C)CO,,,,,,
2029,3082032,formyl-CoA,CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)[C@H](C(=O)NCCC(=O)NCCSC=O)O,,,,,,
2030,3082033,Palptglm,CC(C)C[C@@H](C(=O)NC(CCSC)C(=O)N)NC(=O)CNC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N)NC(=O)[C@@H]3CCCN3,,,,,,
2031,3082034,N-Acetylglucosamine hexasaccharide 1-4,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)NC(=O)C)NC(=O)C)NC(=O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)NC(=O)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)NC(=O)C)CO)O)O,,,,,,
2032,3082035,"(2R,3S,4R,5R)-4,5,6-trihydroxy-2,3-bis[[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]hexanal",C([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)O[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O[C@@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O)O)O)O,,,,,,
2033,3082036,Glycyl-aspartyl-glycine,C([C@@H](C(=O)NCC(=O)NCC(=O)O)N)C(=O)O,,,,,,
2034,3082037,3-O-Methylascorbic acid,COC1=C(C(=O)OC1[C@H](CO)O)O,,,,,,
2035,3082038,"Cholestane-3,6-dione",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC(=O)C4[C@@]3(CCC(=O)C4)C)C,,,,,,
2036,3082039,CID 3082039,CC(C)[C@H]1C(=O)O[C@@H](C(=O)N[C@@H](C(=O)O[C@H](C(=O)N[C@H](C(=O)O[C@@H](C(=O)N[C@@H](C(=O)O[C@H](C(=O)N[C@@H](C(=O)O[C@@H](C(=O)N[C@H](C(=O)O[C@H](C(=O)N1)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C,,,,,,
2037,3082040,N-Acetylhyalobiuronic acid,CC(=O)N[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)C(=O)O)O)O)O,,,,,,
2038,3082041,Trimethyl-[(5-methyl-4-oxooxolan-2-yl)methyl]azanium,CC1C(=O)CC(O1)C[N+](C)(C)C,,,,,,
2039,3082042,Angiotensin III,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)N,,,,,,
2040,3082043,"Alanine, N,N-bis(carboxymethyl)-2-methyl-",CC(C)(C(=O)O)N(CC(=O)O)CC(=O)O,,,,,,
2041,3082044,"N-hydroxy-N,2-diphenylacetamide",C1=CC=C(C=C1)CC(=O)N(C2=CC=CC=C2)O,,,,,,
2042,3082045,"(1,1'-Biphenyl)-4,4'-diethanaminium, N,N'-bis(2,2-diethoxyethyl)-N,N,N',N'-tetramethyl-beta,beta'-dioxo-, dibromide",CCOC(C[N+](C)(C)CC(=O)C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)C[N+](C)(C)CC(OCC)OCC)OCC.[Br-].[Br-],,,,,,
2043,3082046,"2,2'-[1,1'-Biphenyl-4,4'-diyl]bis[N-(2,2-diethoxyethyl)-N,N-dimethyl-2-oxoethanaminium]",CCOC(C[N+](C)(C)CC(=O)C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)C[N+](C)(C)CC(OCC)OCC)OCC,,,,,,
2044,3082047,Amminepentacyanoferrate(III),[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.N.[Fe+2],,,,,,
2045,3082048,"6-(4-Methoxyphenyl)-2,4-diphenylverdazyl",COC1=CC=C(C=C1)C2=NN(CN([N]2)C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
2046,3082049,Tacaco,N.N.N.N.O.[Cl-].[Cl-].[Cl-].[Co+3],,,,,,
2047,3082050,CID 3082050,[H+].[H+].CC1=C(C2=CC3=NC(=CC4=NC(=CC5=NC(=C(C5=C[O-])C)C=C1[N-]2)C(=C4C=C)C)C(=C3CCC(=O)[O-])C)CCC(=O)[O-].[Fe+2],,,,,,
2048,3082051,Ornithokinin,C[C@H]([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)CNC(=O)[C@@H]3CCCN3C(=O)[C@@H]4CCCN4C(=O)[C@H](CCCN=C(N)N)N)O,,,,,,
2049,3082052,Phosphoribosylamine,C([C@@H]1[C@H]([C@H](C(O1)N)O)O)OP(=O)(O)O,,,,,,
2050,3082053,"4,4'-Disuccinoylaminodiphenyl sulfone",C1=CC(=CC=C1NC(=O)CCC(=O)[O-])S(=O)(=O)C2=CC=C(C=C2)NC(=O)CCC(=O)[O-].[Na+].[Na+],,,,,,
2051,3082054,Gaxilose,C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H](CO)[C@@H]([C@H](C=O)O)O)O)O)O)O,,,,,,
2052,3082055,"2-[(3R,3aR,5aS,6S,7S,9aR,9bS)-6-(2-hydroxyethyl)-3a,6-dimethyl-3-[(2R)-6-methylheptan-2-yl]-2,3,4,5,5a,7,8,9,9a,9b-decahydro-1H-cyclopenta[a]naphthalen-7-yl]ethanol",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]([C@]3(C)CCO)CCO)C,,,,,,
2053,3082056,N-Acetylperosamine,C[C@@H]1[C@H]([C@@H]([C@@H](C(O1)O)O)O)NC(=O)C,,,,,,
2054,3082057,4-Trimethylamino-1-butanol,C[N+](C)(C)CCCCO.[I-],,,,,,
2055,3082058,Trimethyl(4-hydroxybutyl)aminium,C[N+](C)(C)CCCCO,,,,,,
2056,3082059,"Oxytocin, 1,6-alpha-asu-",CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCCC(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,,,,,,
2057,3082060,Silver-107,[107Ag],,,,,,
2058,3082061,Pentaammineaquocobalt(III),N.N.N.N.N.O.[Co+3],,,,,,
2059,3082062,Trimethionine,CSCC[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)O)N,,,,,,
2060,3082063,"cobalt(3+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(4Z,14Z)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate;1-hydroxyethenolate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC\4(C(C5C6(C(C(C(=N6)/C(=C\7/C(C(C(=N7)C=C8C(C(C(=N8)/C(=C4\[N-]5)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.C=C(O)[O-].[Co+3],,,,,,
2061,3082064,CID 3082064,CC1=NC=C(C(=C1O)C=NNC(=O)CC[C@@H](C(=O)O)N)COP(=O)(O)O,,,,,,
2062,3082065,"3,5-Dihydroxy-4-(3,7,11-trimethyldodeca-2,6,10-trienoxy)phthalaldehyde",CC(=CCCC(=CCCC(=CCOC1=C(C=C(C(=C1O)C=O)C=O)O)C)C)C,,,,,,
2063,3082066,N-Acetylarterenone,CC(=O)NCC(=O)C1=CC(=C(C=C1)O)O,,,,,,
2064,3082067,Hexaaquacopper(II) bromate,[O-]Br(=O)=O.[O-]Br(=O)=O.[Cu+2],,,,,,
2065,3082068,Propizepine hydrochloride,CC(CN1C2=CC=CC=C2NC3=C(C1=O)C=CC=N3)N(C)C.Cl,,,,,,
2066,3082069,Kaur-15-en-17-ol,C[C@@]12CCCC([C@H]1CCC34[C@H]2CC[C@@H](C3)C(=C4)CO)(C)C,,,,,,
2067,3082070,Uridine diphosphate arabinose,C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)C(C3[C@@H]([C@H]([C@@H](O3)CO)O)O)OP(=O)(O)OP(=O)(O)O)O)O,,,,,,
2068,3082071,CID 3082071,C/C/1=C/2\C(C(C([N-]2)C3(C(C(C(=N3)/C(=C\4/C(C(C(=N4)C=C5C(C(C1=N5)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)(C)CCC(=O)NCC(C)OP(=O)([O-])OC6C(OC(C6O)N7C=NC8=C7C=CC(=C8)O)CO.[C-]#N.[Co+3],,,,,,
2069,3082072,"[4-hydroxy-5-(5-hydroxybenzimidazol-1-yl)-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(14Z)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-1,2,7,12,17,23-hexahydrocorrin-3-yl]propanoylamino]propan-2-yl hydrogen phosphate",CC1=C2C(C(C(=N2)C=C3C(C(/C(=C(/C4=NC(C5C(C(C1=N5)(C)CCC(=O)NCC(C)OP(=O)(O)OC6C(OC(C6O)N7C=NC8=C7C=CC(=C8)O)CO)CC(=O)N)(C(C4CCC(=O)N)(C)CC(=O)N)C)\C)/N3)(C)CC(=O)N)CCC(=O)N)(C)C)CCC(=O)N,,,,,,
2070,3082073,4-Heptylpyrazole,CCCCCCCC1=CNN=C1,,,,,,
2071,3082074,"(3S,9R,10R,13R,14S,17R)-3-hydroxy-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,5,6,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-14-carbaldehyde",C[C@H](CCCC(C)C)[C@H]1CC[C@@]2([C@@]1(CC[C@H]3C2=CCC4[C@@]3(CC[C@@H](C4(C)C)O)C)C)C=O,,,,,,
2072,3082075,Dithionate,[O-]S(=O)(=O)S(=O)(=O)[O-],,,,,,
2073,3082076,2-(2'-Carboxyphenyl)benzoyl-6-aminopenicillanic acid,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C3=CC=CC=C3C4=CC=CC=C4C(=O)O)C(=O)O)C,,,,,,
2074,3082077,1-Hydroxypropan-2-yl dihydrogen phosphate,CC(CO)OP(=O)(O)O,,,,,,
2075,3082078,"1-Propanaminium, 3-carboxy-N,N,N-trimethyl-2-((1-oxohexyl)oxy)-, chloride",CCCCCC(=O)OC(CC(=O)O)C[N+](C)(C)C.[Cl-],,,,,,
2076,3082079,DL-Hexanoylcarnitine,CCCCCC(=O)OC(CC(=O)O)C[N+](C)(C)C,,,,,,
2077,3082080,"Vasopressin, N-(N-gly-gly)-8-lys-",C1C[C@H](N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N,,,,,,
2078,3082081,Cyclo(L-leucyl-L-tryptophyl),CC(C)C[C@H]1C(=O)N[C@H](C(=O)N1)CC2=CNC3=CC=CC=C32,,,,,,
2079,3082082,Pbpban,C1=C[N-]C(=C1)C=NCCCN=CC2=CC=C[N-]2.[Ni+2],,,,,,
2080,3082083,"N~1~,N~3~-Bis[(2H-pyrrol-2-ylidene)methyl]propane-1,3-diamine",C1=CNC(=C1)C=NCCCN=CC2=CC=CN2,,,,,,
2081,3082084,Nitrogen tribromide,N(Br)(Br)Br,,,,,"['Bromine is mainly absorbed via inhalation, but may also enter the body through dermal contact. Bromine salts can be ingested. Due to its reactivity, bromine quickly forms bromide and may be deposited in the tissues, displacing other halogens. (L626)']",
2082,3082085,24-Norlithocholic acid,C[C@H](CC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
2083,3082086,Guanidinospermidine,C(CCNCCCN=C(N)N)CN,,,,,,
2084,3082087,Chromium triethylenediamine,C(CN)N.C(CN)N.C(CN)N.[Cr+3],,,,,,
2085,3082088,Hexamminecobalt(III) tricarbonatocobaltate(III),C(=O)([O-])[O-].C(=O)([O-])[O-].C(=O)([O-])[O-].N.N.N.N.N.N.[Co+3].[Co+3],,,,,,
2086,3082089,"5beta-Cholestane-3alpha,7alpha,26-triol",C[C@H](CCCC(C)CO)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,,,,,,
2087,3082090,Hexaaquairon(II),O.O.O.O.O.O.[Fe+2],,,,,,
2088,3082091,Nickel(II) protoporphyrin IX,[H+].[H+].CC1=C(C2=CC3=C(C(=C([N-]3)C=C4C(=C(C(=N4)C=C5C(=C(C(=N5)C=C1[N-]2)C)C=C)C)C=C)C)CCC(=O)[O-])CCC(=O)[O-].[Ni+2],,,,,,
2089,3082092,S-(2-acetamidoethyl) dec-3-enethioate,CCCCCCC=CCC(=O)SCCNC(=O)C,,,,,,
2090,3082093,Arginyl adenylate,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OC(=O)[C@H](CCCN=C(N)N)N)O)O)N,,,,,,
2091,3082094,S-(2-acetamidoethyl) dec-2-enethioate,CCCCCCCC=CC(=O)SCCNC(=O)C,,,,,,
2092,3082095,"11-Hydroxyicosa-8,12,14-trienoic acid",CCCCCC=CC=CC(CC=CCCCCCCC(=O)O)O,,,,,,
2093,3082096,CID 3082096,CC1C(=NC2=C(N1)NC(=NC2=O)N)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],,,,,,
2094,3082097,CID 3082097,CC1C(=NC2=C(N1)NC(=NC2=O)N)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
2095,3082098,Hematohemin IX,[H+].[H+].CC1=C(C2=CC3=C(C(=C([N-]3)C=C4C(=C(C(=N4)C=C5C(=C(C(=N5)C=C1[N-]2)C)C(C)O)C)C(C)O)C)CCC(=O)[O-])CCC(=O)[O-].[Cl-].[Fe+3],,,,,,
2096,3082099,"Carbonic acid, compd. with N,N-diethylethanamine (1:1)",CCN(CC)CC.C(=O)(O)O,,,,,,
2097,3082100,"9-Methyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizine",CC1=CC2=C(C=C1)NC3=C2CCN4C3CCCC4,,,,,,
2098,3082101,"3,3-Dimethylbutyl alpha-hydroxy-alpha-phenylbenzeneacetate",CC(C)(C)CCOC(=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)O,,,,,,
2099,3082102,"7-(Hydroxymethyl)-8,9-dihydrobenzo[a]anthracene-8,9-diol",C1=CC=C2C(=C1)C=CC3=C2C=C4C=CC(C(C4=C3CO)O)O,,,,,,
2100,3082103,CID 3082103,C1=CC(=CC=C1NN=C2C(=CC3=C(C2=O)C(=O)C(=NNC4=CC=C(C=C4)[As](=O)(O)O)C(=C3)S(=O)(=O)O)S(=O)(=O)O)[As](=O)(O)O,,,,,,
2101,3082104,"[[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-[(3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl] phosphono hydrogen phosphate",C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)C(C3[C@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)OP(=O)(O)OP(=O)(O)O)O)O,,,,,,
2102,3082105,"5-Phenyloxolane-2,3,4-trione",C1=CC=C(C=C1)C2C(=O)C(=O)C(=O)O2,,,,,,
2103,3082106,"Oxytocin, tri-gly-",CC[C@H](C)C1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)NC(=O)CNC(=O)CNC(=O)CN)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,,,,,,
2104,3082107,"[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hexadec-9-enoate",CCCCCCC=CCCCCCCCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC[C@@H]4[C@H](C)CCCC(C)C)C)C,,,,,,
2105,3082108,"(2Z)-2-[(3R,4S,8S,9R,10S,13R,14R,16S)-3-hydroxy-4,10,14-trimethyl-11-oxo-16-propanoyloxy-2,3,4,5,6,7,8,9,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoic acid",CCC(=O)O[C@H]\1C[C@@]2([C@H]3CCC4[C@@H]([C@@H](CC[C@@]4([C@@H]3C(=O)C[C@H]2/C1=C(\CCC=C(C)C)/C(=O)O)C)O)C)C,,,,,,
2106,3082109,Lacto-N-difucohexaose,C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)O[C@@H]2[C@H]([C@H]([C@H](O[C@@H]2O[C@H]([C@@H](CO)O[C@H]3[C@H]([C@@H]([C@@H]([C@@H](O3)C)O)O)O)[C@@H]([C@H](C=O)O[C@@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)NC(=O)C)CO)O)O)O)O)O,,,,,,
2107,3082110,"D-2,5-Hexodiulose 1-phosphate",C(C(=O)[C@H]([C@@H](C(=O)COP(=O)(O)O)O)O)O,,,,,,
2108,3082111,"Cholesta-4,7-dien-3-one",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=CCC4=CC(=O)CC[C@]34C)C,,,,,,
2109,3082112,"(4R,9R,10R,13S,14R)-14-(hydroxymethyl)-5,5,9-trimethyltetracyclo[11.2.1.01,10.04,9]hexadecan-14-ol",C[C@@]12CCCC([C@H]1CCC34[C@H]2CC[C@@H](C3)[C@](C4)(CO)O)(C)C,,,,,,
2110,3082113,Diamminesilver(1+),N.N.[Ag+],,,,,,
2111,3082114,O-Seryl-beta-N-acetylglucosaminide,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC[C@@H](C(=O)O)N)CO)O)O,,,,,,
2112,3082115,"2-amino-4-[[[(2S,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]-hydroxymethyl]-methylsulfonio]butanoate",C[S+](CCC(C(=O)[O-])N)C([C@@H]1[C@H](C[C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O,,,,,,
2113,3082116,"(3-amino-3-carboxypropyl)-[[(2S,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]-hydroxymethyl]-methylsulfanium",C[S+](CCC(C(=O)O)N)C([C@@H]1[C@H](C[C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O,,,,,,
2114,3082117,N-Benzoylnormethylecgonine,COC(=O)C1[C@H]2CCC(N2C(=O)C3=CC=CC=C3)CC1O,,,,,,
2115,3082118,"2,13,15,17-Tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25-heptaene-6,23,27,29-tetrone",CC1C=CC=C(C(=O)NC2=CC(=O)C3=C(C2=O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)O)C)OC)C)C)O)C,,,,,,
2116,3082119,"N,N-Dimethyl-O-glucopyranuronosyl-5-hydroxytryptamine",CN(C)CCC1=CNC2=C1C=C(C=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O,,,,,,
2117,3082120,"Tris(2,2'-bipyridyl)chromium(II)",C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Cr+2],,,,,,
2118,3082121,Hexacyanocobaltate (III),[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[60Co+3],,,,,,
2119,3082122,Photolumazine C,CC1=NC2=C(NC(=O)NC2=O)N(C1=O)CC(C(C(CO)O)O)O,,,,,,
2120,3082123,"(3R,3aS,10S,11aR)-3,6,10-trimethyl-3,3a,4,5,8,10,11,11a-octahydrocyclodeca[b]furan-2,9-dione",C[C@H]1C[C@@H]2[C@@H](CCC(=CCC1=O)C)[C@H](C(=O)O2)C,,,,,,
2121,3082124,N-(Ethoxycarbonylmethyl)-6-methoxyquinolinium,CCOC(=O)C[N+]1=CC2=CC=CC=C2C=C1.[Br-],,,,,,
2122,3082125,"(9R,10S,13R,14R,17R)-17-[(2R,5S)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-1,2,4,5,6,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one",CC[C@@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=CCC4[C@@]3(CCC(=O)C4)C)C)C(C)C,,,,,,
2123,3082126,CID 3082126,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@H](C)C(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N,,,,,,
2124,3082127,"5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione",C1=CC(=CC=C1C2=CC(=S)SS2)O,,,,,,
2125,3082128,2-Methyl-3-amylpyrrole,CCCCCC1=C(NC=C1)C,,,,,,
2126,3082129,5-Butylisatin,CCCCC1=CC2=C(C=C1)NC(=O)C2=O,,,,,,
2127,3082130,"3-Hydroxyandrost-4-ene-6,17-dione",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=O)C4=C[C@H](CC[C@]34C)O,,,,,,
2128,3082131,"1,2-Dihydro-alpha-santonin",C[C@H]1[C@@H]2CC[C@]3(CCC(=O)C(=C3[C@H]2OC1=O)C)C,,,,,,
2129,3082132,"N1,N2-Didodecyl-N1,N1,N2,N2-tetramethylethane-1,2-diaminium bromide",CCCCCCCCCCCC[N+](C)(C)CC[N+](C)(C)CCCCCCCCCCCC.[Br-].[Br-],,,,,,
2130,3082133,"1,2-Ethanediaminium, N,N'-didodecyl-N,N,N',N'-tetramethyl-",CCCCCCCCCCCC[N+](C)(C)CC[N+](C)(C)CCCCCCCCCCCC,,,,,,
2131,3082134,Cyclanoline,C[N@@+]12CCC3=CC(=C(C=C3[C@@H]1CC4=C(C2)C(=C(C=C4)OC)O)O)OC,,,,,,
2132,3082135,Bddhd,CCCCCCCCCC[N+](C)(C)CCCCCC[N+](C)(C)CCCCCCCCCC.[Br-].[Br-],,,,,,
2133,3082136,Cobalt triethylene tetramine complex,C(CNCCN)N.C(CNCCN)N.[Co+3],,,,,,
2134,3082137,Acetylquinine,CC(=O)O[C@@H]([C@@H]1C[C@H]2CCN1C[C@@H]2C=C)C3=C4C=C(C=CC4=NC=C3)OC,,,,,,
2135,3082138,7-Hydroxydigitoxin,C[C@@H]1[C@H]([C@H](C[C@H](O1)O[C@H]2C[C@H](O[C@@H]([C@H]2O[C@@H]3C[C@@H]([C@@H]([C@H](O3)C)O)O)C)O[C@H]4CC[C@@]5([C@H]6CC[C@@]7([C@H](CCC7([C@@H]6[C@H](C[C@@H]5C4)O)O)C8=CC(=O)OC8)C)C)O)O,,,,,,
2136,3082139,Ttcep,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)C(CCC#N)OC[C@@H]3[C@H](C[C@@H](O3)N4C=C(C(=O)NC4=O)C)OP(=O)(O)O)O,,,,,,
2137,3082140,pimeloyl-CoA,CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)[C@H](C(=O)NCCC(=O)NCCSC(=O)CCCCCC(=O)O)O,,,,,,
2138,3082141,4-Nitrophenylrhamnoside,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=CC=C(C=C2)[N+](=O)[O-])O)O)O,,,,,,
2139,3082142,Bis(oxalato)chromate(III),C(=O)(C(=O)[O-])[O-].C(=O)(C(=O)[O-])[O-].O.O.[Cr+3],,,,,,
2140,3082143,2-(4-Methoxyphenyl)Cyclopropanamine,COC1=CC=C(C=C1)C2CC2N,,,,,,
2141,3082144,"3,3'-Methylenebis(tyrosine)",C1=CC(=C(C=C1C[C@@H](C(=O)O)N)CC2=C(C=CC(=C2)C[C@@H](C(=O)O)N)O)O,,,,,,
2142,3082145,2-(1H-imidazol-2-yl)ethanamine,C1=CN=C(N1)CCN,,,,,,
2143,3082146,CID 3082146,C[C@H](C(=O)OC)O[C@@H]1[C@H]([C@H](O[C@@H]([C@H]1O)CO)OC)NC(=O)C,,,,,,
2144,3082147,"3beta,7alpha-Dihydroxychol-5-en-24-oic Acid",C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C=C4[C@@]3(CC[C@@H](C4)O)C)O)C,,,,,,
2145,3082148,O-Methyl-di-N-acetyl beta-chitobioside,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)NC(=O)C)OC)CO)CO)O)O,,,,,,
2146,3082149,Malaben,C1=CC(=CC=C1C(=O)[O-])NC(=O)CC(=O)NC2=CC=C(C=C2)C(=O)[O-].[Na+].[Na+],,,,,,
2147,3082150,"16-Methylene-17-hydroxypregna-1,4,9(11)-triene-3,20-dione",CC(=O)[C@]1(C(=C)C[C@@H]2[C@@]1(CC=C3[C@H]2CCC4=CC(=O)C=C[C@@]43C)C)O,,,,,,
2148,3082151,[2-(4-Formyl-5-Hydroxy-6-Methylpyridin-3-Yl)ethyl]phosphonic Acid,CC1=NC=C(C(=C1O)C=O)CCP(=O)(O)O,,,,,,
2149,3082152,3-Oxohexanoyl-CoA,CCCC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O,,,,,,
2150,3082153,"(4S,6R,9S,10R,13S,14R)-14-(hydroxymethyl)-5,5,9-trimethyltetracyclo[11.2.1.01,10.04,9]hexadecane-6,14-diol",C[C@@]12CC[C@H](C([C@H]1CCC34[C@H]2CC[C@@H](C3)[C@](C4)(CO)O)(C)C)O,,,,,,
2151,3082154,N(2)-Succinylarginine,C(C[C@@H](C(=O)O)N)CN=C(N)N.C(CC(=O)O)C(=O)O,,,,,,
2152,3082155,CID 3082155,CCOC(C)C(=CN=NC(=NC)[S-])NNC(=NC)[S-].[Cu+2],,,,,,
2153,3082156,CID 3082156,CCOC(C)C(=CN=NC(=S)NC)NNC(=S)NC,,,,,,
2154,3082157,"3,7-Dimethyl-9-(2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-4-en-1-yl)nona-2,4,6,8-tetraenal",CC(=CC=O)C=CC=C(C)C=CC12C(CC=CC1(O2)C)(C)C,,,,,,
2155,3082158,"2,2,5a,9-Tetramethyloctahydro-2H-3,9a-methano-1-benzoxepine",C[C@H]1CCC[C@@]2(C13C[C@@H](CC2)C(O3)(C)C)C,,,,,,
2156,3082159,Cobalt tetraammine phosphate,N.N.N.N.[O-]P(=O)([O-])[O-].[Co+3],,,,,,
2157,3082160,Trimethylamine hydriodide,CN(C)C.I,,,,,,
2158,3082161,Hydroxydocosanoic acid sophoroside,CCCCCCCCCC(CCCCCCCCCCCC(=O)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COC(=O)C)O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)COC(=O)C)O)O)O,,,,,,
2159,3082162,Dipalmitoyllysine,CCCCCCCCCCCCCCCC(=O)NCCCC[C@@H](C(=O)O)NC(=O)CCCCCCCCCCCCCCC,,,,,,
2160,3082163,1-Stearoyl-2-myristoyl-sn-glycero-3-phosphocholine,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC,,,,,,
2161,3082164,2-[hydroxy-[(2R)-3-octadecanoyloxy-2-tetradecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC,,,,,,
2162,3082165,4-Methylumbelliferyl caprylate,CCCCCCCC(=O)OC1=CC2=C(C=C1)C(=CC(=O)O2)C,,,,,,
2163,3082166,Permethylsorbitol,COC[C@H]([C@H]([C@@H]([C@H](COC)OC)OC)OC)OC,,,,,,
2164,3082167,"2,3-Didehydrobutyrine",CC=C(C(=O)O)N,,,,,,
2165,3082168,"3-Benzoyloxycholesta-8,14-diene",C[C@H](CCCC(C)C)[C@H]1CC=C2[C@@]1(CCC3=C2CCC4[C@@]3(CC[C@@H](C4)OC(=O)C5=CC=CC=C5)C)C,,,,,,
2166,3082169,"(2R,3S,4R,5R)-2-{[(2R,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-4,5,6-trihydroxy-3-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexanal",C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)O[C@@H]2[C@H]([C@H]([C@H](O[C@@H]2O[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O[C@H]3[C@H]([C@@H]([C@@H]([C@@H](O3)C)O)O)O)CO)O)O)O)O)O,,,,,,
2167,3082170,10-(Carboxyethyl)flavin,CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CCC(=O)O,,,,,,
2168,3082171,Bis(3'-5')cyclic(uridylyl-adenosine monophosphate),C1=CN(C(=O)N=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COC[C@@H]3C(=C([C@@H](O3)N4C=NC5=C(N=CN=C54)N)OP(=O)(O)O)O)OP(=O)(O)O)O,,,,,,
2169,3082172,"Methyl 4-azido-4,6-dideoxymannopyranoside",C[C@@H]1[C@H]([C@@H]([C@@H]([C@H](O1)OC)O)O)N=[N+]=[N-],,,,,,
2170,3082173,CID 3082173,CC1=C(C(=O)N=C1C=C2C(=C(C(=CC3=C(C(=C(N3)C=C4C(=C(C(=O)N4)C)CCC(=O)O)C)C=C)N2)C)C=C)CCC(=O)O,,,,,,
2171,3082174,"20-Methylpregn-5-ene-3,20-diol",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(C)(C)O)CC=C4[C@@]3(CC[C@@H](C4)O)C,,,,,,
2172,3082175,"Cholecystokinin (27-33), t-butyloxycarbonyl-",CC(C)(C)OC(=O)N[C@@H](CC1=CC=C(C=C1)OS(=O)(=O)O)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](CC(=O)N)C4=CC=CC=C4,,,,,,
2173,3082176,Cerulein 7,C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N)NC(=O)[C@H](CC4=CC=C(C=C4)OS(=O)(=O)O)N)O,,,,,,
2174,3082177,Deuteroferriheme,[H+].[H+].CC1=CC2=CC3=C(C(=C([N-]3)C=C4C(=C(C(=CC5=NC(=CC1=N2)C=C5C)[N-]4)C)CCC(=O)[O-])CCC(=O)[O-])C.[Cl-].[Fe+3],,,,,,
2175,3082178,Secretin (1-6),C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC2=CN=CN2)N)O,,,,,,
2176,3082179,3'-O-Methylpyridoxal 5'-phosphate,CC1=NC=C(C(=C1OC)C=O)COP(=O)(O)O,,,,,,
2177,3082180,"1,2-Bis(2-aminoethylthio)ethane",C(CSCCSCCN)N,,,,,,
2178,3082181,Methanohexohydroisoindoline ethylguanidine hemisulfate,C1C[C@H]2C[C@@H]1[C@@H]3[C@H]2CN(C3)CCN=C(N)N.C1C[C@H]2C[C@@H]1[C@@H]3[C@H]2CN(C3)CCN=C(N)N.OS(=O)(=O)O,,,,,,
2179,3082182,"2-[2-[(1S,2S,6R,7R)-4-azatricyclo[5.2.1.02,6]decan-4-yl]ethyl]guanidine",C1C[C@H]2C[C@@H]1[C@@H]3[C@H]2CN(C3)CCN=C(N)N,,,,,,
2180,3082183,9-(beta-D-ribofuranosyl)uric acid,C([C@@H]1[C@H]([C@H]([C@@H](O1)N2C3=C(C(=O)NC(=O)N3)NC2=O)O)O)O,,,,,,
2181,3082184,"2-Propanol, 1-(7-benzofuranyloxy)-3-((1-methylethyl)amino)-",CC(C)NCC(COC1=CC=CC2=C1OC=C2)O,,,,,,
2182,3082185,Cholecystokinin hexapeptide,CSCC[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N)N,,,,,,
2183,3082186,CID 3082186,CC(C1C(=O)N=C(O1)NC)C2=CNC3=CC=CC=C32,,,,,,
2184,3082187,Benzo(a)pyrene-6-carboxamide,C1=CC=C2C(=C1)C3=C4C(=C2C(=O)N)C=CC5=CC=CC(=C54)C=C3,,,,,,
2185,3082188,"1-Allyl-4,5-di(N-methylcarbamoyl)pyrazole",CNC(=O)C1=C(N(N=C1)CC=C)C(=O)NC,,,,,,
2186,3082189,Isomaltosylfructoside,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@]2([C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)[C@@]3([C@H]([C@@H]([C@H](O3)CO)O)O)CO)O)O)O)O,,,,,,
2187,3082190,N(3)-Benzylthymidine,CC1=CN(C(=O)N(C1=O)CC2=CC=CC=C2)[C@H]3C[C@@H]([C@H](O3)CO)O,,,,,,
2188,3082191,Quaternary ammonium sulfanilamide,C[N+](C)(C)CC1=CC=C(C=C1)S(=O)(=O)N,,,,,,
2189,3082192,"2-(4-Aminophenyl)-4,5,6-trichloro-3(2H)-pyridazinone",C1=CC(=CC=C1N)N2C(=O)C(=C(C(=N2)Cl)Cl)Cl,,,,,,
2190,3082193,CID 3082193,CC(=CCO)CNC1=NC=NC2=C1NC=N2,,,,,,
2191,3082194,"[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-2-[[hydroxy(phosphonooxy)phosphoryl]oxymethyl]oxolan-3-yl] (2S,3S,4R,5R)-5-acetamido-3,4,6-trihydroxyoxane-2-carboxylate",CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](OC1O)C(=O)O[C@@H]2[C@H](O[C@H]([C@@H]2O)N3C=CC(=O)NC3=O)COP(=O)(O)OP(=O)(O)O)O)O,,,,,,
2192,3082195,"Lanosta-7,24-dien-3-one, 16-hydroxy-, (13alpha,14beta,16beta,17alpha)-",C[C@H](CCC=C(C)C)[C@@H]1[C@H](C[C@]2([C@]1(CC[C@H]3C2=CCC4[C@@]3(CCC(=O)C4(C)C)C)C)C)O,,,,,,
2193,3082196,Cyclo(seryltyrosyl),C1=CC(=CC=C1C[C@H]2C(=O)N[C@H](C(=O)N2)CO)O,,,,,,
2194,3082197,"(8R,9S,10R,14S)-13-ethyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-dione",CCC12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=CC(=O)CC[C@H]34,,,,,,
2195,3082198,"Dimethyl 4-(2-aminophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate",CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2N)C(=O)OC,,,,,,
2196,3082199,"2-Butanol, 3-((1-methylethyl)amino)-1-(1-naphthalenyloxy)-",CC(C)NC(C)C(COC1=CC=CC2=CC=CC=C21)O,,,,,,
2197,3082200,CID 3082200,C1=NC(=O)C2=C(N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=S)(O)O)O)O,,,,,,
2198,3082201,1-(2'-Deoxyribosyl)-2-pyrimidinone,C1[C@@H]([C@H](O[C@@H]1N2C=CC=NC2=O)CO)O,,,,,,
2199,3082202,"1-[(2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidin-2-one",CC1=CN(C(=O)N=C1)[C@@H]2C[C@@H]([C@H](O2)CO)O,,,,,,
2200,3082203,2-Oxophytanic acid,CC(C)CCCC(C)CCCC(C)CCCC(C)C(=O)C(=O)O,,,,,,
2201,3082204,2-(3-Chloro-4-pyrrol-1-ylphenyl)propanoic acid,CC(C1=CC(=C(C=C1)N2C=CC=C2)Cl)C(=O)O,,,,,,
2202,3082205,"(13S)-17-[(1S)-1-hydroxypropyl]-1,5,10-triazabicyclo[11.4.0]heptadec-14-en-11-one",CC[C@@H](C1CC=C[C@H]2N1CCCNCCCCNC(=O)C2)O,,,,,,
2203,3082206,N-Acetylneuraminlactose sulfate,CC(=O)N[C@@H]1[C@H](C[C@@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O[C@H]2[C@H]([C@H](O[C@H]([C@@H]2O)O[C@@H]3[C@H](OC([C@@H]([C@H]3O)O)O)CO)COS(=O)(=O)O)O)O,,,,,,
2204,3082207,"(3S,5R,10S,13R,17R)-4,4,10,13,14-pentamethyl-17-propan-2-yl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol",CC(C)[C@H]1CCC2([C@@]1(CCC3=C2CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)C,,,,,,
2205,3082208,"methyl (4aS,6aR,6aS,6bR,10R,11R,12aR,14bR)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate",C[C@@]12CCC3[C@@]([C@H]1CC=C4[C@]2(CC[C@@]5([C@@H]4CC(CC5)(C)C)C(=O)OC)C)(C[C@H]([C@@H](C3(C)C)O)O)C,,,,,,
2206,3082209,Laminaribiose octaacetate,CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@H]2[C@@H]([C@H](O[C@H]([C@@H]2OC(=O)C)OC(=O)C)COC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
2207,3082210,Bacitracin F,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCCCC(C(=O)NC(C(=O)N1)CCCN)NC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2=CSC(=N2)C(=O)C(C)CC)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,,,,,,
2208,3082211,3-Hydroxyhalazepam,C1=CC=C(C=C1)C2=NC(C(=O)N(C3=C2C=C(C=C3)Cl)CC(F)(F)F)O,,,,,,
2209,3082212,"N-[(3S,14S,15S)-15-benzyl-10-[(2S)-butan-2-yl]-14-hydroxy-7,13,13-trimethyl-2,5,9,12-tetraoxo-3-propan-2-yl-1,4,8,11-tetraoxacyclopentadec-6-yl]-3-formamido-2-hydroxybenzamide",CC[C@H](C)C1C(=O)OC(C(C(=O)O[C@H](C(=O)O[C@H]([C@H](C(C(=O)O1)(C)C)O)CC2=CC=CC=C2)C(C)C)NC(=O)C3=C(C(=CC=C3)NC=O)O)C,,,,,,
2210,3082213,3-Hydroxyglibenclamide,COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCC(C3)O,,,,,,
2211,3082214,4-Hydroxyglibenclamide,COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)O,,,,,['4-cis-hydroxycyclohexyl glyburide is a known human metabolite of Glyburide.'],
2212,3082215,8-Bromoguanosine triphosphate,C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N=C(N(C2=O)Br)N,,,,,,
2213,3082216,L-Arginine pantothenate,CC(C)(CO)[C@H](C(=O)NCCC(=O)O)O.C(C[C@@H](C(=O)O)N)CN=C(N)N,,,,,,
2214,3082217,"[[(2R,3S,4R,5R)-5-(2-amino-8-bromopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate",C1=C2C(=NC(=N1)N)N(C(=N2)Br)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O,,,,,,
2215,3082218,"Tris(2,2'-bipyridine)osmium(II)",C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Os+2],,,,,,
2216,3082219,20-Hydroperoxycholesterol,CC(C)CCC[C@@](C)([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)OO,,,,,,
2217,3082220,CID 3082220,C[C@H](C=CC=C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
2218,3082221,Sultopride hydrochloride,CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)CC)OC.Cl,,,"['Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)', 'Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)', 'A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. (See all compounds classified as Antidepressive Agents, Second-Generation.)']",,,
2219,3082222,alpha-Codeimethine,CN(C)CC[C@@]12[C@H]3C=C[C@@H]([C@@H]1OC4=C(C=CC(=C24)C=C3)OC)O,,,,,,
2220,3082223,CID 3082223,CC1=C[C@H](CC(C1C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=C[C@H]2C(=CC(=O)CC2(C)C)C)C)C)(C)C)O,,,,,,
2221,3082224,CID 3082224,C[C@H](CCCC(C)C)[C@H]1CCC2[C@@]1(CCCC2=CC=C3CC(CCC3=C)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O)C,,,,,,
2222,3082225,CID 3082225,CC1=CC=C(C=C1)S(=O)(=O)[O-].CC1=CC2=C(C=C1)OC(=CC3=[N+](C4=C(O3)C=CC(=C4)C)C)N2C,,,,,,
2223,3082226,"2-(2,3-Dihydro-3,5-dimethylbenzoxazole-2-ylidenemethyl)-3,5-dimethylbenzoxazole-3-ium",CC1=CC2=C(C=C1)OC(=CC3=[N+](C4=C(O3)C=CC(=C4)C)C)N2C,,,,,,
2224,3082227,Tetracosanoyl-CoA,CCCCCCCCCCCCCCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O,,,,,,
2225,3082228,p-Aminophenethyltrimethylammonium,C[N+](C)(C)CCC1=CC=C(C=C1)N,,,,,,
2226,3082229,(2S)-3-Ethylideneazetidine-2-carboxylic acid,CC=C1CN[C@@H]1C(=O)O,,,,,,
2227,3082230,Fucosamine,C[C@H]([C@@H]([C@@H]([C@H](C=O)N)O)O)O,,,,,,
2228,3082231,2-chloro-N-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide,CC(C)NCC(COC1=CC=C(C=C1)NC(=O)CCl)O,,,,,,
2229,3082232,"Glycine, N-(N-(1-(N2-(N-(N-(N2-(N-(N-L-alpha-glutamyl-L-histidyl)-L-phenylalanyl)-L-arginyl)-L-tryptophyl)glycyl)-L-lysyl)-L-prolyl)-L-valyl)-",CC(C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CC5C=NC=N5)NC(=O)[C@H](CCC(=O)O)N,,,,,,
2230,3082233,"Oxytocin, (4-ethyl-phe)(2)-",CCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)N2)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N)C(C)CC,,,,,,
2231,3082234,3-Ketotrehalose,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@@H](C(=O)[C@@H]([C@H](O2)CO)O)O)O)O)O)O,,,,,,
2232,3082235,"Angiotensin II, des-asp(1)-Me-tyr(4)-",CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)OC)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N,,,,,,
2233,3082236,"2,2,6,6-Tetramethyl-4-(dichlorotriazin)aminopiperidine-1-oxyl",CC1(CC(CC(N1[O])(C)C)NC2=NC(=NC(=N2)Cl)Cl)C,,,,,,
2234,3082237,"4-[Cyclohexyl(methyl)amino]naphthalene-1,2-dione",CN(C1CCCCC1)C2=CC(=O)C(=O)C3=CC=CC=C32,,,,,,
2235,3082238,Dapdapda,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)N)CC([C@@H]4[C@H](C[C@@H](O4)N5C=NC6=C(N=CN=C65)N)OP(=O)(O)O)OC[C@@H]7[C@H](C[C@@H](O7)N8C=NC9=C(N=CN=C98)N)OP(=O)(O)O)O,,,,,,
2236,3082239,N-Phospho-L-lombricine,C(COP(=O)(O)OC[C@@H](C(=O)O)N)N=C(N)NP(=O)(O)O,,,,,,
2237,3082240,"3-(3,7-Dimethylocta-2,6-dienyl)-2,4-dihydroxy-6-pentylbenzoic acid",CCCCCC1=CC(=C(C(=C1C(=O)O)O)CC=C(C)CCC=C(C)C)O,,,,,,
2238,3082241,CID 3082241,C[C@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N,,,,,,
2239,3082242,Desulfated benzyloxycarbonyl cholecystokinin (26-33),CC(C)(C)OC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N,,,,,,
2240,3082243,Xyron,CC1=C(C(=CC=C1)C)O.C=CC1=CC=CC=C1,,,,,,
2241,3082244,Sodium;ethylidene(dioxido)azanium,C/C=[N+](\[O-])/[O-].[Na+],,,,,,
2242,3082245,1-Nitroethan-1-ide,CC=[N+](O)[O-],,,,,,
2243,3082246,"1,6-Anhydrolactose hexaacetate",CC(=O)O[C@H]1[C@H]2CC[C@H](O2)[C@H]([C@@H]1OC(=O)C)O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)OOC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
2244,3082247,Dabuavp,CCC(C(=O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C=S)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC3=CC=C(C=C3)O)NC(=O)CCS)N,,,,,,
2245,3082248,Poly(vinyl alcohol-co-N-vinyl-2-pyrrolidone),C=CN1CCCC1=O.C=CO,,,,,,
2246,3082249,Pyridoxal 5'-methylenephosphonate,CC1=NC=C(C(=C1O)C=O)CP(=O)(O)O,,,,,,
2247,3082250,CID 3082250,CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC\4(C(C5C6(C(C(C(=N6)/C(=C\7/C(C(C(=N7)C=C8C(C(C(=N8)/C(=C4\[N-]5)/C)CCC(=O)O)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3],,,,,,
2248,3082251,"3-[(14Z)-2,13,18-tris(2-amino-2-oxoethyl)-12,17-bis(3-amino-3-oxopropyl)-3-[3-[2-[[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxypropylamino]-3-oxopropyl]-3,5,8,8,13,15,18,19-octamethyl-1,2,7,12,17,23-hexahydrocorrin-7-yl]propanoic acid",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)/C(=C\7/C(C(C(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)O)N7)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O,,,,,,
2249,3082252,Pyridoxal methyloxime,CC1=NC=C(C(=C1OC)C=NO)CO,,,,,,
2250,3082253,Hydroxyethyl methacrylate-ethyl methacrylate,CCOC(=O)C(=C)C.CC(=C)C(=O)OCCO,,,,,,
2251,3082254,Formaldehyde-hydroquinone polymer,C=O.C1=CC(=CC=C1O)O,,,,,,
2252,3082255,"5-Isoxazolol, 3-(aminomethyl)-",C1=C(NOC1=O)CN,,,,,,
2253,3082256,"1,2,3,3a,4,5-Hexahydrocanthin-6-one",C1CC(=O)N2C3=CC=CC=C3C4=C2C1NCC4,,,,,,
2254,3082257,1-[3-(2-Aminopropoxy)propoxy]propan-2-amine,CC(COCCCOCC(C)N)N,,,,,,
2255,3082258,CID 3082258,C1=CC=C(C=C1)C[C@@H](C(=O)O)OC(=O)C=CC2=CC=CC=C2,,,,,,
2256,3082259,Allylestriol,C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]([C@]2(CC=C)O)O)CCC4=C3C=CC(=C4)O,,,,,,
2257,3082260,Glycine-proline-proline polymer,C1C[C@H](N(C1)C(=O)CN)C(=O)N2CCC[C@H]2C(=O)O,,,,,,
2258,3082261,Erythronolide A,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O)C)O)(C)O)C)C)O)(C)O,,,,,,
2259,3082262,"Methyl 2,3-4,5-di-O-isopropylidine-glucoseptanoside",CC1(OC2CO[C@@H](C3C(C2O1)OC(O3)(C)C)OC)C,,,,,,
2260,3082263,Apogalanthamine,CN1CCC2=CC=CC=C2C3=C(C1)C=CC(=C3O)O,,,,,,
2261,3082264,Dithiobisacetylcholine,C[N+](C)(C)CCOC(=O)CSSCC(=O)OCC[N+](C)(C)C,,,,,,
2262,3082265,tert-Butyloxycarbonylcholecystokinin-8,CC(C)(C)OC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=C(C=C1)OS(=O)(=O)O)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N,,,,,,
2263,3082266,Gentisohydroxamic acid,C1=CC(=C(C=C1O)C(=O)NO)O,,,,,,
2264,3082267,2'(3')-O-Bromoacetyluridine,C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COC(=O)CBr)O)O,,,,,,
2265,3082268,CID 3082268,C[C@@H](C1[C@H]([C@H]([C@@H](O1)OC2=CC(=O)C3=C(C(=C(OC3=C2)C4=CC=C(C=C4)O)O[C@H]5[C@@H]([C@H]([C@@H](O5)CO)O)O)O)O)O)O,,,,,,
2266,3082269,4-O-Methylcryptochlorophaeic acid,CCCCCC1=CC(=C(C(=C1C(=O)O)O)OC(=O)C2=C(C=C(C=C2OC)OC)CCCCC)O,,,,,,
2267,3082270,N-Acetylprocaineamide ethobromide,CC[N+](CC)(CC)CCNC(=O)C1=CC=C(C=C1)NC(=O)C,,,,,,
2268,3082271,"Benzenepropanoic acid, 4-(((4-(aminomethyl)cyclohexyl)carbonyl)oxy)-, phenylmethyl ester, hydrochloride, trans-",C1CC(CCC1CN)C(=O)OC2=CC=C(C=C2)CCC(=O)OCC3=CC=CC=C3.Cl,,,,,,
2269,3082272,Pressinamide,C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](C=S)N,,,,,,
2270,3082273,CID 3082273,C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(C=C=C)O,,,,,,
2271,3082274,"1,2-Dinonanoyl-sn-glycero-3-phosphocholine",CCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC,,,,,,
2272,3082275,"[O-(1-O,2-O-Dinonanoyl-L-glycero-3-phospho)choline]anion",CCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC,,,,,,
2273,3082276,7-Phenylacetamidodeacetoxycephalosporanic acid,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)C(C3=CC=CC=C3)OC(=O)C)SC1)C(=O)O,,,,,,
2274,3082277,"5alpha-Pregnan-3beta,20beta-diol disulfate",C[C@H]([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@H](C4)OS(=O)(=O)O)C)C)OS(=O)(=O)O,,,,,,
2275,3082278,Acetiamine hydrochloride,CC1=NC=C(C(=N1)N)CN(C=O)/C(=C(/CCOC(=O)C)\SC(=O)C)/C.Cl,,,,,,
2276,3082279,Dihydrospectinomycin,C[C@@H]1C[C@H]([C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)NC)O)NC)O)O)O,,,,,,
2277,3082280,"[(2R,3S,4R,5S)-5-[(2R,3R,4R,5R)-2-(6-aminopurin-9-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]oxy-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O[C@H]4[C@@H]([C@@H]([C@H](O4)COP(=O)(O)O)O)O)N,,,,,,
2278,3082281,Methyl 3-isobutyryloxy-1-oxomeliac-8(30)-enate,CC(C)C(=O)O[C@@H]1[C@H]2C=C3[C@H](CC[C@@]4([C@H]3CC(=O)O[C@H]4C5=COC=C5)C)[C@](C2=O)([C@H](C1(C)C)CC(=O)OC)C,,,,,,
2279,3082282,3-Acetylstrophanthin,CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@@]4([C@H](CC[C@@]4([C@@H]3CC[C@@]2(C1)O)O)C5=COC(=O)C5O)C)C=O,,,,,,
2280,3082283,"L-Cysteine, S-(3-carboxy-3-hydroxypropyl)-",C(CSC[C@@H](C(=O)O)N)C(C(=O)O)O,,,,,,
2281,3082284,D-Mannose-O-beta-D-mannopyranosyl-(1-4)-O-beta-D-mannopyranosyl-(1-4)-,C([C@@H]1[C@H]([C@@H]([C@@H]([C@@H](O1)O[C@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O[C@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)O)O,,,,,,
2282,3082285,CID 3082285,CC=CC1O[C@@]2(CCC3([C@@]2(C[C@@H]([C@H]4[C@H]3CCC5=CC(=O)CC[C@]45C)O)C)O1)C(=O)COC(=O)C,,,,,,
2283,3082286,Ribosyl-ribosyladenine,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N,,,,,,
2284,3082287,CID 3082287,CCCCCCCCC=CCC=CCCCCC(=O)O,,,,,,
2285,3082288,"3,7-Dioxocholan-24-oic acid",C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C(=O)CC4[C@@]3(CCC(=O)C4)C)C,,,,,,
2286,3082289,4-(Hydroxybutyl)dichloroarsine,C(CC[As](Cl)Cl)CO,,,,,,
2287,3082290,3-Methylriboflavin,CC1=CC2=C(C=C1C)N(C3=NC(=O)N(C(=O)C3=N2)C)C[C@@H]([C@@H]([C@@H](CO)O)O)O,,,,,,
2288,3082291,Thiofedrine,CC(C(C1=CC=CC=C1)O)NCCC(=O)C2=CC=CS2,,,,,,
2289,3082292,Ac-Lys-D-Ala-D-Ala-OH,C[C@H](C(=O)N[C@H](C)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)C,,,,,,
2290,3082293,Iso-fmn,CC1=C(C2=C(C=C1)N(C3=NC(=O)NC(=O)C3=N2)C[C@@H]([C@@H]([C@@H](COP(=O)(O)O)O)O)O)C,,,,,,
2291,3082294,Vinylidene fluoride-trifluoroethylene copolymer,C=C(F)F.C(=C(F)F)F,,,,,,
2292,3082295,2-Thio-fmn,CC1=CC2=C(C=C1C)N(C3=NC(=S)NC(=O)C3=N2)C[C@@H]([C@@H]([C@@H](COP(=O)(O)O)O)O)O,,,,,,
2293,3082296,"1H-Pyrazole-4-carboxylic acid, 3-((2-hydroxy-1-naphthalenyl)azo)-",C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=NN3)C(=O)O)O,,,,,,
2294,3082297,1-Methoxyberberine,COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=C(C5=C(C=C4CC3)OCO5)OC)OC.[Cl-],,,,,,
2295,3082298,1-Methoxyberberinium,COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=C(C5=C(C=C4CC3)OCO5)OC)OC,,,,,,
2296,3082299,CID 3082299,C1=NC(=O)C2=C(N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)OS(=O)(=O)O)O,,,,,,
2297,3082300,CID 3082300,CCCCC=CCCCCCCCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC[C@@H]4[C@H](C)CCCC(C)C)C)C,,,,,,
2298,3082301,Genipin 1-gentiobioside,COC(=O)C1=CO[C@H]([C@H]2[C@@H]1CC=C2CO)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)O,,,,,,
2299,3082302,4-(1-Hydroxy-2-aminoethyl)-2-aminoimidazoline-5-carboxylic acid,C([C@H](C1[C@H](N=C(N1)N)C(=O)O)O)N,,,,,,
2300,3082303,CID 3082303,C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O[C@H]2[C@@H]([C@H]([C@H]([C@@H](O2)OC3=C(OC4=CC(=O)C=C(C4=C3O)O)C5=CC(=C(C=C5)O)O)O)O)O)O,,,,,,
2301,3082304,Glutamic acid-5-ethyl glutamate copolymer,CCOC(=O)CC[C@@H](C(=O)O)N.C(CC(=O)O)[C@@H](C(=O)O)N,,,,,,
2302,3082305,L-Glutamic acid 5-ethyl ester,CCOC(=O)CC[C@@H](C(=O)O)N,,,,,,
2303,3082306,D-Pantothenic acid 4'-O-beta-glucoside,CC(C)(CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)C(C(=O)NCCC(=O)O)O,,,,,,
2304,3082307,"Methylfructose-1,6-diphosphate",CC(C1([C@H]([C@@H]([C@H](O1)COP(=O)(O)O)O)O)O)OP(=O)(O)O,,,,,,
2305,3082308,CID 3082308,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO[C@@H]2[C@@H]([C@@H]([C@H]([C@@H](O2)CO)O)O)O)C)C,,,,,,
2306,3082309,"[[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-[(3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]methyl] phosphono hydrogen phosphate",C[C@H]1[C@@H]([C@H]([C@H](C(O1)C([C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC(=O)NC3=O)O)O)OP(=O)(O)OP(=O)(O)O)O)O)O,,,,,,
2307,3082310,"6-[[6-[2-(Dimethylamino)ethyl]-1,3-benzodioxol-5-yl]methylidene]-[1,3]dioxolo[4,5-g]isoindol-8-one",CN(C)CCC1=CC2=C(C=C1C=C3C4=C(C5=C(C=C4)OCO5)C(=O)N3)OCO2,,,,,,
2308,3082311,11-Hydroxycannabinol,CCCCCC1=CC(=C2C(=C1)OC(C3=C2C=C(C=C3)CO)(C)C)O,,,,,,
2309,3082312,"4-(9-Hydroxy-3-{5'-[6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-2,3'-dimethyl[2,2'-bioxolan]-5-yl}-3,8-dimethyl-1,6-dioxaspiro[4.5]decan-7-yl)-3-methoxy-2-methylpentanoic acid",CC1CC(C(OC1C2CC(C(O2)C3(CCC(O3)C4(CC5(CC(C(C(O5)C(C)C(C(C)C(=O)O)OC)C)O)OC4)C)C)C)(CO)O)C,,,,,,
2310,3082313,Adenosine triphosphate uridine,C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O)OP(=O)(O)OP(=O)(O)O)O)O,,,,,,
2311,3082314,Phenypressin,C1CC(N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=CC=C4)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N,,,,,,
2312,3082315,N-Acetylglucosamine trimer,CC(=O)N[C@@H](CO)[C@H]([C@@H]([C@@H](CO)O)O)O.CC(=O)N[C@@H](CO)[C@H]([C@@H]([C@@H](CO)O)O)O.CC(=O)N[C@@H](CO)[C@H]([C@@H]([C@@H](CO)O)O)O,,,,,,
2313,3082316,"2-Methylimino-3-(2,6-dichlorophenyl)-4-methylthiazolidine",CC1CSC(=NC)N1C2=C(C=CC=C2Cl)Cl,,,,,,
2314,3082317,"2-(3-(4-Fluorobenzoyl)-1-propyl)-5alpha,9 alpha-dimethyl-2'-hydroxy-6,7-benzomorphan",CC1C2CC3=C(C1(CCN2CCCC(=O)C4=CC=C(C=C4)F)C)C=C(C=C3)O,,,,,,
2315,3082318,"2H-1,4-Benzodiazepin-2-one, 5-(2-fluorophenyl)-1,3-dihydro-7-iodo-",C1C(=O)NC2=C(C=C(C=C2)I)C(=N1)C3=CC=CC=C3F,,,,,,
2316,3082319,Bis(hexafluoroacetonyl)acetone,C(=C(C(F)(F)F)C(F)(F)F)C(=O)C=C(C(F)(F)F)C(F)(F)F,,,,,,
2317,3082320,beta-Deaminocystathionine-oxytocin,CC[C@H](C)C1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCSCCC(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,,,,,,
2318,3082321,N-Acetylnorepinephrine,CC(=O)NC[C@@H](C1=CC(=C(C=C1)O)O)O,,,,,,
2319,3082322,2-Nitrophenylmaltoside,C1=CC=C(C(=C1)[N+](=O)[O-])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O,,,,,,
2320,3082323,Strontium titanium fluoride,[F-].[F-].[F-].[F-].[F-].[F-].[Ti+4].[Sr+2],,,,,,
2321,3082324,Propyl-delta(8)-tetrahydrocannabinol,CCCC1=CC(=C2[C@@H]3CC(=CC[C@H]3C(OC2=C1)(C)C)C)O,,,,,,
2322,3082325,1-Oxoestazolam,C1C2=NNC(=O)N2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,,,,,,
2323,3082326,"[(2R,3S,5R)-5-[6-amino-8-(benzylideneamino)purin-9-yl]-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate",C1[C@@H]([C@H](O[C@H]1N2C3=NC=NC(=C3N=C2N=CC4=CC=CC=C4)N)CO)OP(=O)(O)O,,,,,,
2324,3082327,Poly-L-lysyltyrosine,C1=CC(=CC=C1C[C@@H](C(=O)O)N)O.C(CCN)C[C@@H](C(=O)O)N,,,,,,
2325,3082328,4-Amino-1-guanylpiperidine-4-carboxylic acid,C1CN(CCC1(C(=O)O)N)C(=N)N,,,,,,
2326,3082329,Bromoacetylarginine,C(C[C@H](C(=O)O)NC(=O)CBr)CN=C(N)N,,,,,,
2327,3082330,"2',3,5,7-Tetrahydroxyflavanone",C1=CC=C(C(=C1)[C@@H]2[C@H](C(=O)C3=C(C=C(C=C3O2)O)O)O)O,,,,,,
2328,3082331,CID 3082331,CC[C@H](C(=O)[C@H]([C@@H](O)[C@@H](CCC\1=C(C(=O)C(=C/C1=[N+](/[O-])\[O-])C)[N+](=O)[O-])C)C)C2O[C@@](C[C@@H]2C)(C3O[C@H]([C@@](CC3)(O)CC)C)CC.[Na+],,,,,,
2329,3082332,"(3R,5S,6S,7R)-3-[(3S,5S)-5-ethyl-5-[(5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-3-methyloxolan-2-yl]-6-hydroxy-9-(3-hydroxy-4-methyl-2,6-dinitrophenyl)-5,7-dimethylnonan-4-one",CC[C@H](C1[C@H](C[C@@](O1)(CC)C2CC[C@@]([C@@H](O2)C)(CC)O)C)C(=O)[C@@H](C)[C@H]([C@H](C)CCC3=C(C=C(C(=C3[N+](=O)[O-])O)C)[N+](=O)[O-])O,,,,,,
2330,3082333,Tryptophyl adenylate,C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O[C@@H]3[C@H](O[C@H]([C@@H]3O)N4C=NC5=C(N=CN=C54)N)COP(=O)(O)O)N,,,,,,
2331,3082334,2-((2-Chloroethyl)methylamino)ethyl-4-ethoxybenzoate,CCOC1=CC=C(C=C1)C(=O)OCCN(C)CCCl,,,,,,
2332,3082335,Gma edma,CC(=C)C(=O)OCCOC(=O)C(=C)C.CC(=C)C(=O)OCC1CO1,,,,,,
2333,3082336,Benzylarginine ethyl ester,CCOC(=O)[C@H](CCCN=C(N)N)NCC1=CC=CC=C1,,,,,,
2334,3082337,"8-[2-(2-Carboxyethyl)-3,5-dihydroxycyclopentyl]-6-oxooctanoic acid",C1C(C(C(C1O)CCC(=O)O)CCC(=O)CCCCC(=O)O)O,,,,,,
2335,3082338,"(2S,3S)-2-amino-N-hydroxy-3-methylpentanamide",CC[C@H](C)[C@@H](C(=O)NO)N,,,,,,
2336,3082339,"6-(4-Nitrophenyl)-2,4-diphenylverdazyl",C1N(N=C([N]N1C2=CC=CC=C2)C3=CC=C(C=C3)[N+](=O)[O-])C4=CC=CC=C4,,,,,,
2337,3082340,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O.C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)N,,,,,,
2338,3082341,"(1S,6R)-1,6-dihydroxycyclohexa-2,4-dienecarboxylic acid",C1=C[C@H]([C@@](C=C1)(C(=O)O)O)O,,,,,,
2339,3082342,"6,7-Dimethoxy-2,3-dimethylquinoxaline",CC1=NC2=CC(=C(C=C2N=C1C)OC)OC,,,,,,
2340,3082343,"1-Propanaminium, N,N-diethyl-3-hydroxy-N-methyl-, chloride",CC[N+](C)(CC)CCCO.[Cl-],,,,,,
2341,3082344,"1-Propanaminium, N,N-diethyl-3-hydroxy-N-methyl-",CC[N+](C)(CC)CCCO,,,,,,
2342,3082345,CID 3082345,C[C@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N,,,,,,
2343,3082346,N-Acetylleucyl-tyrosine methyl ester,CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)OC)NC(=O)C,,,,,,
2344,3082347,Amp-4-(N-2-chloroethyl-N-methylamino)benzylamidate,CN(CCCl)C1=CC=C(C=C1)CNP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)O,,,,,,
2345,3082348,fluoro 2-(5-oxo-2H-furan-2-yl)acetate,C1=CC(=O)OC1CC(=O)OF,,,,,,
2346,3082349,Alumichrome,CC(=O)N(CCCC1C(=O)NC(C(=O)NC(C(=O)NCC(=O)NCC(=O)NCC(=O)N1)CCCN(C(=O)C)[O-])CCCN(C(=O)C)[O-])[O-].[Al+3],,,,,,
2347,3082350,"1H-Pyrazol-5-amine, 3-methyl-4-((1-methylpropyl)thio)-1-phenyl-",CCC(C)SC1=C(N(N=C1C)C2=CC=CC=C2)N,,,,,,
2348,3082351,"1H-Pyrazol-5-amine, 1-methyl-4-((1-methylpropyl)thio)-3-phenyl-",CCC(C)SC1=C(N(N=C1C2=CC=CC=C2)C)N,,,,,,
2349,3082352,1-Methyl-3-phenyl-4-(3'-methyl)butylthio-5-aminopyrazole,CC(C)CCSC1=C(N(N=C1C2=CC=CC=C2)C)N,,,,,,
2350,3082353,5-(2-Phosphonoethyl)pyridoxal,CC1=NC=C(C(=C1O)C=O)CCOP(=O)(O)O,,,,,,
2351,3082354,O-Glucopyranosyl-(1-4)-O-glucopyranosyl-(1-6)glucopyranose,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)O)O,,,,,,
2352,3082355,1-Phenyl-3-methyl-4-benzylthio-5-aminopyrazole,CC1=NN(C(=C1SCC2=CC=CC=C2)N)C3=CC=CC=C3,,,,,,
2353,3082356,"2-Mercaptoquinoline-N-oxide, sodium salt",C1=CC=C2C(=C1)C=CC(=S)N2[O-].[Na+],,,,,,
2354,3082357,1-Oxidoquinoline-2-thione,C1=CC=C2C(=C1)C=CC(=S)N2[O-],,,,,,
2355,3082358,1-Naphthalenylacetylaspartic acid,COC(=O)C[C@@H](C(=O)O)NC(=O)C1=CC=CC2=CC=CC=C21,,,,,,
2356,3082359,Phthalexon S,C1=CC=C2C(=C1)C(OS2(=O)=O)(C3(C4C=C3C=CC4O)N(CC(=O)O)CC(=O)O)C5(C6C=C5C=CC6O)N(CC(=O)O)CC(=O)O,,,,,,
2357,3082360,"Difluoromethyl-1-bromo-2,2,2-trifluoroethyl ether",C(C(F)(F)F)(OC(F)F)Br,,,,,,
2358,3082361,Poly(methyl methacrylate)-poly(gamma-benzylglutamate) copolymer,CC(=C)C(=O)OC.C1=CC=C(C=C1)COC(=O)CC[C@@H](C(=O)O)N,,,,,,
2359,3082362,"3-(2,6-Dimethylphenyl)-1-ethyl-2-methylimidazolidin-4-one",CCN1CC(=O)N(C1C)C2=C(C=CC=C2C)C,,,,,,
2360,3082363,"Benzeneethanamine, N-(2-(diphenylmethoxy)ethyl)-3-methoxy-N,alpha-dimethyl-, hydrochloride",CC(CC1=CC(=CC=C1)OC)N(C)CCOC(C2=CC=CC=C2)C3=CC=CC=C3.Cl,,,,,,
2361,3082364,N-(2-benzhydryloxyethyl)-1-(3-methoxyphenyl)-N-methylpropan-2-amine,CC(CC1=CC(=CC=C1)OC)N(C)CCOC(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
2362,3082365,2-Bromopalmitoylcarnitine,CCCCCCCCCCCCCCC(C(=O)OC(CC(=O)[O-])C[N+](C)(C)C)Br,,,,,,
2363,3082366,[2-(2-Bromohexadecanoyloxy)-3-carboxypropyl]-trimethylazanium,CCCCCCCCCCCCCCC(C(=O)OC(CC(=O)O)C[N+](C)(C)C)Br,,,,,,
2364,3082367,N-3-Tolyl-4-chlorobenzohydroxamic acid,CC1=CC(=CC=C1)N(C(=O)C2=CC=C(C=C2)Cl)O,,,,,,
2365,3082368,"[2,4-Bis(diaminomethylideneamino)-5-[3-[4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-3,6-dihydroxycyclohexyl] dihydrogen phosphate",CC1C(C(C(O1)OC2C(C(C(C(C2O)OP(=O)(O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(CO)O,,,,,,
2366,3082369,"2-(Chlorodifluoromethoxy)-1,1,1-trifluoroethane",C(C(F)(F)F)OC(F)(F)Cl,,,,,,
2367,3082370,"Pyrimido(5,4-g)pteridinetetrone 5-oxide, 1,3,7,9-tetrabutyl",CCCCN1C2=C(C(=O)N(C1=O)CCCC)[N+](=C3C(=N2)N(C(=O)N(C3=O)CCCC)CCCC)[O-],,,,,,
2368,3082371,Poly(glutamyl-tyrosyl-alanyl-glycine),C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCC(=O)O)N,,,,,,
2369,3082372,CID 3082372,C[C@@]12CC[C@H]3[C@]([C@@]14[C@H](O4)C(=O)O[C@H]2C5=COC=C5)([C@H](C(=O)[C@H]6C37COC(=O)C[C@@H]7OC6(C)C)O)C,,,,,,
2370,3082373,Digitoxigenin-galactose,C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4(C3(CC[C@@H]4C5=CC(=O)OC5)O)C)O[C@H]6[C@@H]([C@H]([C@H]([C@H](O6)CO)O)O)O,,,,,,
2371,3082374,3-Methyllactose,COC1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O)O,,,,,,
2372,3082375,4-Phenylalanyl-6-valine-antamanide,CC(C)[C@H]1C(=O)N2CCCC2C(=O)N3CCC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N4CCCC4C(=O)N5CCC[C@H]5C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC6=CC=CC=C6)CC7=CC=CC=C7)C(C)C)CC8=CC=CC=C8)CC9=CC=CC=C9,,,,,,
2373,3082376,Tauropine,C[C@H](C(=O)O)NCCS(=O)(=O)O,,,,,,
2374,3082377,5-Aminomethylpyrazolin-5-one,C1=C(NNC1=O)CN,,,,,,
2375,3082378,CID 3082378,C/C/1=C/2\C(C(C([N-]2)C3(C(C(C(=N3)/C(=C\4/C(C(C(=N4)C=C5C(C(C1=N5)CCC(=O)O)(C)C)CCC(=O)O)(C)CC(=O)O)/C)CCC(=O)O)(C)CC(=O)O)C)CC(=O)O)(C)CCC(=O)O.[Co+3],,,,,,
2376,3082379,4-Dibutylaminobenzenediazonium fluoroborate,CCCCN(CCCC)C1=CC=C(C=C1)[N+]#N,,,,,,
2377,3082380,"Methyl 2,3,6-trideoxy-alpha-glycero-hex-2-enopyranosid-4-ulose",C[C@@H]1C(=O)C=C[C@H](O1)OC,,,,,,
2378,3082381,"(3R,5R,8R,9R,10R,13S,14R)-3-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-10,13-dimethyl-17-[(1S)-1-[(2R,5S,6R)-5-methyl-6-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]ethyl]-1,2,3,4,5,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-6-one",C[C@H]1CC[C@@H](O[C@@H]1O[C@H]2[C@@H]([C@@H]([C@H]([C@@H](O2)C)O)O)O)[C@@H](C)C3CC[C@H]4[C@@]3(CC[C@@H]5[C@@H]4CC(=O)[C@H]6[C@@]5(CC[C@H](C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)C)C,,,,,,
2379,3082382,Tetrakis(1H-imidazol-1-yl)copper(2+) dinitrate,C1=CNN=C1.C1=CN=CN1.C1=CN=CN1.C1=CN=CN1.[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[Cu+2],,,,,,
2380,3082383,Perhydroantamanide,C[C@@H](C(=O)C1CN([C@@](C1(C(=O)[C@@H]2CCCN2C(=O)[C@@H]3CCCN3C(=O)[C@H](CC4CCCCC4)N)C(=O)[C@H](CC5CCCCC5)N)(C=O)C(=O)[C@H](CC6CCCCC6)N)C(=O)[C@@H]7CC=CN7C(=O)[C@H](C(C)C)NC(=O)[C@H](CC8CCCCC8)N)N,,,,,,
2381,3082384,CID 3082384,CC1=C(C(CC(C1)O)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC(C2(CC(CC2(C)C)O)C)O)C)C,,,,,,
2382,3082385,"3,17,20-Trihydroxypregnane",CC([C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4[C@@]3(CCC(C4)O)C)C)O)O,,,,,,
2383,3082386,Quinoline-8-thiol hydrochloride,C1=CC2=C(C(=C1)S)N=CC=C2.Cl,,,,,,
2384,3082387,"(+)-2,3,4,4abeta,8,9,13balpha,14-Octahydro-3alpha-isopropyl-1H-benzo(6,7)cyclohepta(1,2,3-de)pyrido(2,1-a)isochinolin-3-ol",CC(C)C1(CCN2CC3C4=CC=CC=C4CCC5=C3C(=CC=C5)C2C1)O,,,,,,
2385,3082388,CID 3082388,C([C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O)O.[Na+].[Fe+3],,,,,,
2386,3082389,"N(4),N(4),O(2')-Trimethylcytidine",CN(C)C1=NC(=O)N(C=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)OC,,,,,,
2387,3082390,S-Methylpenicillamine,CC(C)([C@@H](C(=O)O)N)SC,,,,,,
2388,3082391,S-Methyl-N-acetylpenicillamine,CC(=O)N[C@H](C(=O)O)C(C)(C)SC,,,,,,
2389,3082392,Lactose-lysine,C(CCNCC(=O)C(C(C(CO)O)OC1C(C(C(C(O1)CO)O)O)O)O)CC(C(=O)O)N,,,,,,
2390,3082393,Tocinoic acid,CC[C@H](C)C1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)O)CC(=O)N)CCC(=O)N,,,,,,
2391,3082394,CID 3082394,CC(C)(C)OC1=C2C3=C(C[C@H]4[C@H]5[C@]3(CCN4C)[C@@H](O2)[C@H](C=C5)O)C=C1,,,,,,
2392,3082395,N-Acetylphenylalanylglycine 4-nitroanilide,CC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NC(=O)CNC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
2393,3082396,Allobarbital mixture with propyphenazone,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)C(C)C.C=CCC1(C(=O)NC(=O)NC1=O)CC=C,,,,,,
2394,3082397,(2S)-2-amino-N-[2-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-5-(diaminomethylideneamino)pentanamide,C1=CC=C(C=C1)C[C@@H](C(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)N,,,,,,
2395,3082398,"1,6-Anhydrolactose",C1[C@H]2[C@H]([C@@H]([C@H]([C@@H](O1)O2)O)O)O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O,,,,,,
2396,3082399,"N-[3-(2-acetamido-2-oxoethyl)-5-nitro-1,3-thiazol-2-ylidene]-2,2-dimethylpropanamide",CC(=O)NC(=O)CN1C=C(SC1=NC(=O)C(C)(C)C)[N+](=O)[O-],,,,,,
2397,3082400,1-[3-[[(3S)-3-amino-3-carboxypropyl]amino]-3-carboxypropyl]azetidine-2-carboxylic acid,C1CN(C1C(=O)O)CCC(C(=O)O)NCC[C@@H](C(=O)O)N,,,,,,
2398,3082401,"1,6-Dihydro-6-oxo-2-pyrazinecarboxylic acid 4-oxide",C1=C(NC(=O)C=[N+]1[O-])C(=O)O,,,,,,
2399,3082402,Butaphosphone,CCCCNC(C)(C)P(=O)(O)O,,,,,,
2400,3082403,CID 3082403,C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@@H]1CC5=C3C(=C(C=C5)OS(=O)(=O)O)O4)O,,,,,,
2401,3082404,"Sodium;2-amino-3-methyl-3-sulfidobutanoate;antimony(3+);2,3-dioxidobutanedioate;hydron",[H+].[H+].CC(C)(C(C(=O)[O-])N)[S-].C(C(C(=O)[O-])[O-])(C(=O)[O-])[O-].[Na+].[Sb+3],,,,,,
2402,3082405,5C-aglycone,CC1=C(C(=O)C2=CC=CC=C2C1=O)CCC(C)C(=O)O,,,,,,
2403,3082406,N-[3-(1H-imidazol-4-yl)propyl]-N'-methylthiourea,CNC(=S)NCCCC1=CN=CN1,,,,,,
2404,3082407,6-Deoxy-alpha-gluco-heptopyranosyluronic acid,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O)O)O)O)C(=O)O,,,,,,
2405,3082408,2'-O-(N-Acetylphenylalanyl)adenosine,CC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)O,,,,,,
2406,3082409,Tetradecyl-4-ethylpyridinium,CCCCCCCCCCCCCC[N+]1=CC=C(C=C1)CC.[Cl-],,,,,,
2407,3082410,4-Ethyl-1-tetradecylpyridinium,CCCCCCCCCCCCCC[N+]1=CC=C(C=C1)CC,,,,,,
2408,3082411,Cyclopropanecarbonylcarnitine,C[N+](C)(C)CC(CC(=O)[O-])OC(=O)C1CC1,,,,,,
2409,3082412,[3-Carboxy-2-(cyclopropanecarbonyloxy)propyl]-trimethylazanium,C[N+](C)(C)CC(CC(=O)O)OC(=O)C1CC1,,,,,,
2410,3082413,"5,11,14-Eicosatriynoic acid",CCCCCC#CCC#CCCCCC#CCCCC(=O)O,,,,,,
2411,3082414,3-Hydroxyhexadecanoyl-coenzyme A,CCCCCCCCCCCCCC(CC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O)O,,,,,,
2412,3082415,18-Hydroxy-11-deoxycortisol,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)CO,,,,,,
2413,3082416,3-Ethylhistidine,CCN1C=NC=C1C[C@@H](C(=O)O)N,,,,,,
2414,3082417,3-Hydroxyglutaryl-coenzyme A,CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)[C@H](C(=O)NCCC(=O)NCCSC(=O)CC(CC(=O)O)O)O,,,,,,
2415,3082418,1-Hydroxyfluromidine,C1=C(C=NC2=C1N(C(=N2)C(F)(F)F)O)Cl,,,,,,
2416,3082419,CID 3082419,CCOC(=O)CN.C[C@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N,,,,,,
2417,3082420,Poly(beta-benzyl-L-aspartate-co-L-leucine),CC(C)C[C@@H](C(=O)O)N.C1=CC=C(C=C1)COC(=O)C[C@@H](C(=O)O)N,,,,,,
2418,3082421,Oxoprolintane,CCCC(CC1=CC=CC=C1)N2CCCC2=O,,,,,,
2419,3082422,Nicr perchlorate,CC1=NCCCNCCCN=C(C2=CC=CC1=N2)C.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[Ni+2],,,,,,
2420,3082423,"2,6-[Iminobis(trimethylenenitriloethylidyne)]pyridine",CC1=NCCCNCCCN=C(C2=CC=CC1=N2)C,,,,,,
2421,3082424,3-Bromopyruvamide,C(C(=O)C(=O)N)Br,,,,,,
2422,3082425,Schizokinen,CC(=O)N(CCCNC(=O)CC(CC(=O)NCCCN(C(=O)C)O)(C(=O)O)O)O,,,,,,
2423,3082426,CID 3082426,CCC(=O)O[C@@H]1CC(=O)O[C@@H](CC=CC=C[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]1OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC)(C)O)N(C)C)O)CC=O)C)OC(=O)C)C,,,,,,
2424,3082427,Fucosterol epoxide,CC1[C@](O1)(CC[C@@H](C)[C@H]2CC[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4(CC[C@@H](C5)O)C)C)C(C)C,,,,,,
2425,3082428,Istanbulin A,C[C@@H]1CCC(=O)[C@H]2[C@]1(CC3=C(C(=O)O[C@]3(C2)O)C)C,,,,,,
2426,3082429,"LHRH, Lys(8)-",CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)CNC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6,,,,,,
2427,3082430,CID 3082430,C1=CC(=C(C=C1C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@@H](O4)[C@@H](CO)O)O)O)O)O,,,,,,
2428,3082431,"4,6-Dideoxy-3-C-methyl-4-(methylamino)mannose",CC(C(C(C)(C(C=O)O)O)NC)O,,,,,,
2429,3082432,Dichlorobis(cytosine)copper(II),C1=C(NC(=O)N=C1)N.C1=C(NC(=O)N=C1)N.[Cl-].[Cl-].[Cu+2],,,,,,
2430,3082433,"gamma-Glutamyl-(S-4-nitrobenz-2-oxa-1,3-diazole)cysteinylglycine",C1=C(C2=NON=C2C(=C1)SC[C@@H](C(=O)N(CC(=O)O)C(=O)CC[C@@H](C(=O)O)N)N)[N+](=O)[O-],,,,,,
2431,3082434,3-(4-Phenylphenyl)propanoic acid,C1=CC=C(C=C1)C2=CC=C(C=C2)CCC(=O)O,,,,,,
2432,3082435,Z-Phe-ome,COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)OCC2=CC=CC=C2,,,,,,
2433,3082436,t-Butyloxycarbonyl-asparaginylproline benzyl ester,CC(C)(C)OC(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@H]1C(=O)OCC2=CC=CC=C2,,,,,,
2434,3082437,Thymidylyl(3'-5')-5'-thio-5'-deoxythymidine,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)(O)SC[C@@H]3[C@H](C[C@@H](O3)N4C=C(C(=O)NC4=O)C)O)O,,,,,,
2435,3082438,CID 3082438,CCCCCCCCC=CCCCCCCCC(=O)O[C@@]1([C@H]([C@H](O[C@H](C1(O)O)OCCC)CO[C@@H]2[C@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O)O,,,,,,
2436,3082439,3-Furylmethylpenicillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=COC=C3)C(=O)O)C,,,,,,
2437,3082440,"[(8R,9S,10R,13S,14S)-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate",CC(=O)OC1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CCCC[C@H]34)C)C#C,,,,,,
2438,3082441,"3-(4-Hydroxy-1-naphthoxy)propane-1,2-diol",C1=CC=C2C(=C1)C(=CC=C2OCC(CO)O)O,,,,,,
2439,3082442,Heptacos-9-ene,CCCCCCCCCCCCCCCCCC=CCCCCCCCC,,,,,,
2440,3082443,Glycyl-asparaginyl-glycine,C([C@@H](C(=O)NCC(=O)O)NC(=O)CN)C(=O)N,,,,,,
2441,3082444,"6',7'-Epoxyrotenone",CC1(CO1)C2CC3=C(O2)C=CC4=C3OC5COC6=CC(=C(C=C6C5C4=O)OC)OC,,,,,,
2442,3082445,O-Methyl-delta-9 tetrahydrocannabinol,CCCCCC1=CC2=C([C@@H]3C=C(CC[C@H]3C(O2)(C)C)C)C(=C1)OC,,,,,,
2443,3082446,Polydeoxyinosinic-polydeoxy-(5-methylcytidylic)acid,CC1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O.C1=C2C(=NC=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O,,,,,,
2444,3082447,Dithiodiphosphoric acid,OP(=S)(O)OP(=S)(O)O,,,,,,
2445,3082448,CID 3082448,C[C@@H]1C[C@H]([C@]2([C@@H](O1)O[C@H]3C[C@]4([C@@H](CC[C@@H]5[C@@H]4CC[C@]6(C5(CC[C@@H]6C7=CC(=O)OC7)O)C)C[C@@H]3O2)C)O)O,,,,,,
2446,3082449,N-Trifluoroacetylprolyl chloride,C1C[C@H](N(C1)C(=O)C(F)(F)F)C(=O)Cl,,,,,,
2447,3082450,CID 3082450,CCCCCC=CCC=CCCCCCCCC(=O)O[C@H](CC(=O)[O-])C[N+](C)(C)C,,,,,,
2448,3082451,"[(2R)-3-carboxy-2-octadeca-9,12-dienoyloxypropyl]-trimethylazanium",CCCCCC=CCC=CCCCCCCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C,,,,,,
2449,3082452,5-Isoxazolidinecarboxylic acid,C1CNOC1C(=O)O,,,,,,
2450,3082453,"4-Piperidinol, 1-((5-chloro-2-oxo-3(2H)-benzothiazolyl)acetyl)-",C1CN(CCC1O)C(=O)CN2C3=C(C=CC(=C3)Cl)SC2=O,,,,,,
2451,3082454,1-(4-Chlorophenyl)sulfonyl-3-(2-hydroxypropyl)urea,CC(CNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl)O,,,,,,
2452,3082455,Asparaginol,C([C@@H](CO)N)C(=O)N,,,,,,
2453,3082456,CID 3082456,C(CN(COP(=O)O)COP(=O)O)N(CCN(COP(=O)O)COP(=O)O)COP(=O)O,,,,,,
2454,3082457,Platinum-iridium alloy,[Ir].[Pt],,,,,,
2455,3082458,"Ammonium, magnesium, manganese, sodium bicarbonate, zinc sulfate drug combination",C(=O)(O)[O-].[NH4+].[NH4+].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Na+].[Mg+2].[Mn+2],,,,,,
2456,3082459,"1-hydroxy-6,6,9-trimethyl-3-pentyl-6a,10a-dihydro-4H-benzo[c]chromene-4a-carboxylic acid",CCCCCC1=CC(=C2C3C=C(C=CC3C(OC2(C1)C(=O)O)(C)C)C)O,,,,,,
2457,3082460,Invert sugar,C([C@H]([C@H]([C@@H]([C@H](C=O)O)O)O)O)O.C([C@H]([C@H]([C@@H](C(=O)CO)O)O)O)O,"['Invert sugar presents a large variety of uses. It can be used therapeutically for parenteral hyperalimentation or to be used as an excipient with a known effect. Invert sugar is also approved for its use in food products as a humectant, crystallization modifier, and liquid and nutritive sweetener.']","['Intravenous administration of invert sugar has been proven to be favorable. These reports indicate a temporary rise, within physiological levels, of lactate, pyruvate, and insulin in the blood plasma whereas the level of free fatty acids was declined.']","['Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed) (See all compounds classified as Sweetening Agents.)', 'Substances that promote DENTAL CARIES. (See all compounds classified as Cariogenic Agents.)']","['It has been reported that administration of 10-15% of intravenous invert sugar solution is rapidly absorbed in the intestine and distributed in blood without exceeding the renal threshold. The absorption of invert sugar happens mainly as monosaccharides. Glucose is absorbed into the portal vein by the transporter GLUT2 while fructose is absorbed by the transporter GLUT5.', 'Reports have indicated that after intravenous administration of invert sugar present a reduced content or carbohydrates in urine when compared to the intravenous administration of glucose. This response indicates a reduced diuresis of invert sugar. It has also been reported a reduced diuresis in the presence of invert diuresis.', 'LESS THAN 2% OF SUGAR IS EXCRETED IN URINE WHEN 1 L OF 10% INVERT SUGAR SOLN IS INFUSED IN 1 HR. WHEN GIVEN OVER A LONGER PERIOD OF TIME INVERT SUGAR IS COMPLETELY UTILIZED AND NONE IS EXCRETED IN URINE.']","['The metabolism of invert sugar and other fructose-glucose sweeteners is not meaningfully different. Once absorbed, the fructose monosaccharides are taken up by the liver and bypass a key step regulatory step in glycolysis. Both of the monosaccharides first step metabolism is marked by its phosphorylation to glucose-6-phosphate by glucokinase or fructose-1-phosphate by fructokinase. After this step, the glycolysis continues its pathway until the obtention of pyruvic acid. The metabolism of fructose is more rapid than the one of glucose and thus, it is possible to administer at the same speed than a glucose dose correspondent to 55% of the invert sugar dose.']","['The glucose half-life following intravenous administration of invert sugar is of approximately 30 min. In the same report, the half-life of fructose after the intravenous administration is reported to be 16 min.']"
2458,3082461,Maltosylsucrose,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@H]([C@@H](CO)O)[C@@H]([C@H](C=O)O)O)O)O)O)O.C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@]2([C@H]([C@@H]([C@H](O2)CO)O)O)CO)O)O)O)O,,,,,,
2459,3082462,gamma-Benzylglutamate-alanine copolymer,C[C@@H](C(=O)O)N.C1=CC=C(C=C1)COC(=O)CC[C@@H](C(=O)O)N,,,,,,
2460,3082463,Cyclo(prolyl-N-methylphenylalanyl),CN1[C@H](C(=O)N2CCC[C@H]2C1=O)CC3=CC=CC=C3,,,,,,
2461,3082464,N-Trifluoroacetyl-4-fluorophenylalanine,C1=CC(=CC=C1C[C@H](C(=O)O)NC(=O)C(F)(F)F)F,,,,,,
2462,3082465,4-(2-Nitroethyl)phenol,C1=CC(=CC=C1CC[N+](=O)[O-])O,,,,,,
2463,3082466,"2,3-O-Isopropylideneerythrose",CC1(O[C@H]([C@H](O1)C=O)CO)C,,,,,,
2464,3082467,"(1R,12R)-16-Methoxy-20-methyl-5,7-dioxa-20-azapentacyclo[10.7.1.02,10.04,8.013,18]icosa-2,4(8),9,13,15,17-hexaen-15-ol",CN1[C@@H]2CC3=CC4=C(C=C3[C@H]1CC5=CC(=C(C=C25)O)OC)OCO4,,,,,,
2465,3082468,CID 3082468,CCCCC[C@@H](C=C[C@H]1CC[C@@H]([C@@H]1CCCCCCC(=O)O)O)O,,,,,,
2466,3082469,"Prostan-1-oic acid, 15-hydroxy-9-oxo-, (15S)-",CCCCC[C@@H](CC[C@H]1CCC(=O)[C@@H]1CCCCCCC(=O)O)O,,,,,,
2467,3082470,CID 3082470,CCCCCCCCCCCC(=O)N[C@@H](C(C)C)C(=O)[O-].[Na+],,,,,,
2468,3082471,3-Methoxybutyl 2-cyanoprop-2-enoate,CC(CCOC(=O)C(=C)C#N)OC,,,,,,
2469,3082472,"Ethanethiol, 2-((phenylmethyl)amino)-, hydrochloride",C1=CC=C(C=C1)CNCCS.Cl,,,,,,
2470,3082473,"Oxytocin, trp(2)-",CC[C@H](C)C1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CNC3=CC=CC=C32)N)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,,,,,,
2471,3082474,CID 3082474,CC1=C(C2=CC3=C(C4=C5C(C3)OCOC5=C6C(=C(C7=C(O6)C(CCC7O)OC)O)C4=O)C(=O)C2=C(N1N)O)Cl,,,,,,
2472,3082475,"D-Alanine, N-methylglycyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-",CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@H](C)C(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC,,,,,,
2473,3082476,CID 3082476,CC(=CCO)CNC1=C2C(=NC=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
2474,3082477,"1-(2,4-Dichlorophenoxy)-1-imidazol-1-yl-3,3-dimethylbutan-2-one",CC(C)(C)C(=O)C(N1C=CN=C1)OC2=C(C=C(C=C2)Cl)Cl,,,,,,
2475,3082478,"5-Chloro-2-(3-methyl-5-((methylamino)methyl)-4H-1,2,4-triazole-4-yl)benzophenone",CC1=NN=C(N1C2=C(C=C(C=C2)Cl)C(=O)C3=CC=CC=C3)CNC,,,,,,
2476,3082479,"5-Chloro-2-(3-((diethylamino)methyl)-5-methyl-4H-1,2,4-triazol-4-yl)benzophenone",CCN(CC)CC1=NN=C(N1C2=C(C=C(C=C2)Cl)C(=O)C3=CC=CC=C3)C,,,,,,
2477,3082480,N(6)-Aminohexyladenosine monophosphate,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)NCCCCCCN,,,,,,
2478,3082481,"5-(N,N-Diethylamino)pentyl-3,4,5-trimethoxybenzoate",CCN(CC)CCCCCOC(=O)C1=CC(=C(C(=C1)OC)OC)OC.Cl,,,,,,
2479,3082482,"3,4,5-Trimethoxybenzoic acid 5-(diethylamino)pentyl ester",CCN(CC)CCCCCOC(=O)C1=CC(=C(C(=C1)OC)OC)OC,,,,,,
2480,3082483,1-(5'-O-Benzoyl-3'-deoxypentofuran-2'-ulosyl)uracil,C1[C@H](O[C@H](C1=O)N2C=CC(=O)NC2=O)COC(=O)C3=CC=CC=C3,,,,,,
2481,3082484,"3alpha-Hydroxy-5alpha-pregna-9(11),16-diene-20-one",CC(=O)C1=CC[C@@H]2[C@@]1(CC=C3[C@H]2CC[C@@H]4[C@@]3(CC[C@H](C4)O)C)C,,,,,,
2482,3082485,3-(4-Hydroxy-3-methoxyphenyl)-1-(piperidin-1-yl)prop-2-en-1-one,COC1=C(C=CC(=C1)C=CC(=O)N2CCCCC2)O,,,,,,
2483,3082486,Leucyl-arginyl-prolyl-glycinamide,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)N,,,,,,
2484,3082487,Catecholine,C[N+](C)(C)CC(C1=CC(=C(C=C1)O)O)O.[I-],,,,,,
2485,3082488,cis-3-Aminocyclohexanecarboxylic acid,C1C[C@H](C[C@H](C1)N)C(=O)O,,,,,,
2486,3082489,"2-tert-Butyl-4,4,5,5-tetramethylimidazoline-3-oxide 1-oxyl",CC1(C([N+](=C(N1[O])C(C)(C)C)[O-])(C)C)C,,,,,,
2487,3082490,Dopamine glucuronide,C1=CC(=C(C=C1CCN)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O,,,,,,
2488,3082491,Leucyl-phenylalanine amide,CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)N,,,,,,
2489,3082492,8-Arg-1-(3-mercaptopropanoic acid)vasotocin,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)C(=O)N3CCCC3C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,,,,,,
2490,3082493,Serratenediol-21-acetate,CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@H]4[C@@](CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)O)C)(CC3=CC[C@H]2C1(C)C)C)C,,,,,,
2491,3082494,"Tetrandrine metabolite, N'-nor-D-",CN1CCC2=CC(=C(C3=C2[C@@H]1CC4=CC(=C(C=C4)OC)OC5=CC=C(C[C@H]6C7=CC(=C(C=C7CCN6)OC)O3)C=C5)OC)OC,,,,,,
2492,3082495,(Man)5(glcnac)2Asn,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1N[C@@H](CC(=O)N)C(=O)O)CO[C@@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)O[C@@H]3[C@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O[C@H]5[C@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O[C@@H]7[C@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)NC(=O)C,,,,,,
2493,3082496,"1-(4'-Carboxybutyl)-3,7-dimethylxanthine",CN1C=NC2=C1C(=O)N(C(=O)N2C)CCCCC(=O)O,,,,,,
2494,3082497,3-Iodo-1-hydroxypropan-2-one,C(C(=O)CI)O,,,,,,
2495,3082498,Macedonic acid methyl ester,C[C@@]12CC[C@@]3(C(=C1C[C@]([C@@H](C2)O)(C)C(=O)OC)C=C[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)O)C)C)C,,,,,,
2496,3082499,CID 3082499,CC(=O)N(CCCC1C(=O)NC(C(=O)NC(C(=O)NCC(=O)NCC(=O)NCC(=O)N1)CCCN(C(=O)C)[O-])CCCN(C(=O)C)[O-])[O-].[Ga+3],,,,,,
2497,3082500,"(3R,6S,8S,10R,13R,14S)-6,14-Dihydroxy-5,5,14-trimethyl-9-methylidenetetracyclo[11.2.1.01,10.03,8]hexadecan-4-one",C[C@@]1(CC23C[C@H]1CC[C@H]2C(=C)[C@H]4C[C@@H](C(C(=O)[C@@H]4C3)(C)C)O)O,,,,,,
2498,3082501,5beta-Ketodiol (ecdysone),C[C@H](CCCC(C)C)[C@H]1CCC2([C@@]1(CC[C@H]3C2=CC(=O)[C@H]4[C@@]3(CC[C@@H](C4)O)C)C)O,,,,,,
2499,3082502,CID 3082502,CCCCC[C@@H](C=C[C@@H]1[C@@H](CC(=O)[C@H]1CC=CCCCC(=O)O)O)O,,,,,,
2500,3082503,CID 3082503,CC1=C2CCN3C(=C(C4=C3C=C5C(C=C4)(C(=C(N5)O)CCC(=O)O)C)C)C=C2NC1=CC6=NC(=O)C(=C6C)CCC(=O)O,,,,,,
2501,3082504,CID 3082504,[O-2].[O-2].[Mg+2].[Ti+4],,,,,,
2502,3082505,CID 3082505,O.[O-2].[Mg+2].[SiH4],,,,,,
2503,3082506,"[(1S,9S,10S)-9-hydroxy-3,7-dimethyl-10-propan-2-ylcyclodeca-3,7-dien-1-yl] 4-hydroxy-3-methoxybenzoate",CC1=C[C@@H]([C@@H]([C@H](CC(=CCC1)C)OC(=O)C2=CC(=C(C=C2)O)OC)C(C)C)O,,,,,,
2504,3082507,"3-[(7R,8R,9S,10R,13S,14S)-7-acetylsulfanyl-17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoic acid;6-chloro-3-(2-methylpropyl)-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide",CC(C)CC1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl.CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CCC([C@]4(CC3)C)(CCC(=O)O)O)C,,,,,,
2505,3082508,Multifugin,CC(C1=CC=CC=C1)N2CCC(CC2)NC3=CC=CC=C3.C1=CC=C(C(=C1)C(=O)O)O.C1=CC(=CC=C1NC(=O)C2=C(C=CC(=C2)Br)O)Cl,,,,,,
2506,3082509,N-phenyl-1-(1-phenylethyl)piperidin-4-amine,CC(C1=CC=CC=C1)N2CCC(CC2)NC3=CC=CC=C3,,,,,,
2507,3082510,Sulfaton,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N.COC1=NC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N,,,,,,
2508,3082511,d(T-A-T-A),CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COC(C[C@@H]3[C@H](C[C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)(C[C@@H]6[C@H](C[C@@H](O6)N7C=C(C(=O)NC7=O)C)OP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H]8[C@H](C[C@@H](O8)N9C=NC1=C(N=CN=C19)N)O)O,,,,,,
2509,3082512,CID 3082512,C1=CC=C2C(=C1)C(=C3C=CC(=O)C(=C3O2)O)O,,,,,,
2510,3082513,Bismuth potassium iodide,[K+].[I-].[I-].[I-].[I-].[Bi+3],,,,,,
2511,3082514,"2-Deoxy-2,3-didehydro-N-glycoloylneuraminic acid",C1=C(O[C@H]([C@@H]([C@H]1O)NC(=O)CO)[C@@H]([C@@H](CO)O)O)C(=O)O,,,,,,
2512,3082515,N-(3-Methyl-iosothiazolyl-4)methyl-guanidine hemi-sulfate,CC1=NSC=C1CN=C(N)N.CC1=NSC=C1CN=C(N)N.OS(=O)(=O)O,,,,,,
2513,3082516,1-[(3-Methylisothiazol-4-yl)methyl]guanidine,CC1=NSC=C1CN=C(N)N,,,,,,
2514,3082517,4-Amino-7-iodoquinoline,C1=CC2=C(C=CN=C2C=C1I)N,,,,,,
2515,3082518,2'-Chloro-2'-deoxyuridine 5'-diphosphate,C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)O)O)Cl,,,,,,
2516,3082519,Ptcl2-Pr-sulfoxide,CCCS(=O)CCC.CCCS(=O)CCC.[Cl-].[Cl-].[Pt+2],,,,,,
2517,3082520,2-Methyl-6-amino-4-nitropyridine N-oxide,CC1=CC(=CC(=N)N1O)[N+](=O)[O-],,,,,,
2518,3082521,Deoxylincomycin,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(CC(O2)SC)O)O)C(C)O.Cl,,,,,,
2519,3082522,"N-[1-(3,4-dihydroxy-6-methylsulfanyloxan-2-yl)-2-hydroxypropyl]-1-methyl-4-propylpyrrolidine-2-carboxamide",CCCC1CC(N(C1)C)C(=O)NC(C2C(C(CC(O2)SC)O)O)C(C)O,,,,,,
2520,3082523,"2-Acetamido-2,6-dideoxyglucose",C[C@H]([C@H]([C@@H]([C@H](C=O)NC(=O)C)O)O)O,,,,,,
2521,3082524,6-Deoxy-manno-heptopyranose,C(CO)[C@H]([C@H]([C@@H]([C@@H](C=O)O)O)O)O,,,,,,
2522,3082525,CID 3082525,C1[C@@H]([C@@H]([C@H]([C@H]1O)C=CC(COC2=CC(=CC=C2)Cl)O)CC=CCCCC(=O)O)O,,,,,,
2523,3082526,Glucose-1-(1-naphthalene)acetate,C1=CC=C2C(=C1)C=CC=C2CC(=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
2524,3082527,"[(3Ar,4R,5R,6aS)-2-oxo-4-(3-oxooct-1-enyl)-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-5-yl] benzoate",CCCCCC(=O)C=C[C@H]1[C@@H](C[C@H]2[C@@H]1CC(=O)O2)OC(=O)C3=CC=CC=C3,,,,,,
2525,3082528,CID 3082528,C[C@@H]1CCCCCCCCCCCCCC[C@H](C[C@@H]2[C@H]([C@@H](C[C@@](O2)(C[C@@H](C[C@H]([C@@H](CC[C@H](C[C@@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@@H]3[C@@H]([C@@H]([C@H]([C@@H](O3)C)O)N)O,,,,,,
2526,3082529,"3-[(7R,8S,9S,10R,13R,14S)-7-methoxycarbonyl-10,13-dimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]propanoic acid",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2CCC(=O)O)[C@@H](CC4=CC(=O)C=C[C@]34C)C(=O)OC,,,,,,
2527,3082530,N-Acetylglutamate 4-nitroanilide,CC(=O)N[C@H](CCC(=O)O)C(=O)NC1=CC=C(C=C1)[N+](=O)[O-],,,,,,
2528,3082531,L-Arginyl-D-allo-threonyl-L-phenylalanine,C[C@H]([C@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O,,,,,,
2529,3082532,6-(Dimethylamino)-4-(4-hydroxyphenyl)-4-phenylheptan-3-one,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=C(C=C2)O,,,,,,
2530,3082533,5-Hydroxybenzimidazole,C1=CC2=C(C=C1O)NC=N2,,,,,,
2531,3082534,2-Ferrocenylethylamine,[CH-]1C=CC=C1.[CH-]1C=CC(=C1)CCN.[Fe+2],,,,,,
2532,3082535,"Pyrano(3,4-b)indole-1-acetic acid, 1-butyl-1,3,4,9-tetrahydro-",CCCCOC(=O)CC1C2=C(CCO1)C3=CC=CC=C3N2,,,,,,
2533,3082536,"Carbonothioic dihydrazide, ((2-hydroxyphenyl)methylene)-",C1=CC=C(C(=C1)C=NNC(=S)NN)O,,,,,,
2534,3082537,"1,3,4-Trimethyl-delta(3)-phospholene-1,1-dichloride",CC1=C(CP(C1)(C)(Cl)Cl)C,,,,,,
2535,3082538,Dimercuriomethylmercury;hexahydrate,C([Hg])([Hg])[Hg].C([Hg])([Hg])[Hg].C([Hg])([Hg])[Hg].O.O.O.O.O.O,,,,,,
2536,3082539,CID 3082539,CC1=C(C[C@@H](C[C@H]1O)O)C=CC2=CCC[C@]3([C@H]2CC[C@@H]3[C@H](C)CCCC(C)C)C,,,,,,
2537,3082540,Thioinosine triphosphate disulfide,C1=NC2=C(C(=N1)SSC3=NC=NC4=C3N=CN4[C@H]5[C@@H]([C@@H]([C@H](O5)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N=CN2[C@H]6[C@@H]([C@@H]([C@H](O6)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O,,,,,,
2538,3082541,Rupicolin A,CC1=CC[C@@]2([C@H]1[C@@H]3[C@@H]([C@H](C=C2C)O)C(=C)C(=O)O3)O,,,,,,
2539,3082542,Rupicolin B,CC1=CC[C@@]2([C@H]1[C@@H]3[C@@H]([C@H](CC2=C)O)C(=C)C(=O)O3)O,,,,,,
2540,3082543,Sugereoside,CC1(C2CCC34CC(CCC3C2(CCC1=O)C)C(C4)(COC5C(C(C(C(O5)CO)O)O)O)O)C,,,,,,
2541,3082544,"Spirostan-3,6-diol",C[C@@H]1CCC2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4C[C@H]([C@@H]6[C@@]5(CC[C@@H](C6)O)C)O)C)C)OC1,,,,,,
2542,3082545,Cryptosporin,C[C@@H]1[C@@H]([C@@H](C2=C(O1)C(=O)C3=C(C2=O)C=CC=C3O)O)O,,,,,,
2543,3082546,Desialylated human cad antigenic determinant,CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@H]1O[C@@H]([C@@H](CO)O)[C@@H]([C@H](C=O)NC(=O)C)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)CO)O)O,,,,,,
2544,3082547,Aminophenylacetylleucine,CC(C)C[C@@H](C(=O)O)NC(=O)[C@@H](C1=CC=CC=C1)N,,,,,,
2545,3082548,"[5-Hydroxy-2-methyl-6-[[3,4,5-trihydroxy-6-[2-(4-hydroxyphenyl)ethoxy]oxan-2-yl]methoxy]-4-(3,4,5-trihydroxyoxan-2-yl)oxyoxan-3-yl] 3-phenylprop-2-enoate",CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OCCC3=CC=C(C=C3)O)O)O)O)O)OC4C(C(C(CO4)O)O)O)OC(=O)C=CC5=CC=CC=C5,,,,,,
2546,3082549,"2,3-Methylene penam",C[C@@]12C[C@@]1(N3[C@H](S2)[C@@H](C3=O)NC(=O)CC4=CC=CC=C4)C(=O)O,,,,,,
2547,3082550,CID 3082550,C1=CC(=CC=C1[N+](=O)[O-])OP(=O)([O-])OC[C@@H](CO)O[C@@H](CO)N2C=CC(=O)NC2=O.[NH4+],,,,,,
2548,3082551,CID 3082551,C1=CC(=CC=C1[N+](=O)[O-])OP(=O)(O)OC[C@@H](CO)O[C@@H](CO)N2C=CC(=O)NC2=O,,,,,,
2549,3082552,CID 3082552,COC1=CC(=CC(=C1O)OC)C=CC(=O)O[C@H]2[C@H](C[C@](C[C@@H]2OC(=O)C=CC3=CC(=C(C=C3)O)O)(C(=O)O)O)O,,,,,,
2550,3082553,"[5-Hydroxy-2-methyl-6-[[3,4,5-trihydroxy-6-[2-(4-hydroxyphenyl)ethoxy]oxan-2-yl]methoxy]-4-(3,4,5-trihydroxyoxan-2-yl)oxyoxan-3-yl] 3-(4-methoxyphenyl)prop-2-enoate",CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OCCC3=CC=C(C=C3)O)O)O)O)O)OC4C(C(C(CO4)O)O)O)OC(=O)C=CC5=CC=C(C=C5)OC,,,,,,
2551,3082554,"9-Methoxy-4-benzyl-1,2,3,4,4a,5,6,10b-octahydrobenzo(f)quinoline",COC1=CC2=C(CC[C@@H]3[C@@H]2CCCN3CC4=CC=CC=C4)C=C1,,,,,,
2552,3082555,Selodenoson,CCNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)NC4CCCC4)O)O,,,,,,
2553,3082556,8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin,CCCN(CCC)[C@H]1CCC2=C([C@H]1C)C(=CC=C2)O.Cl,,,,,,
2554,3082557,"7-Dipropylamino-8-methyl-5,6,7,8-tetrahydro-naphthalen-1-ol; hydrochloride",CCCN(CCC)[C@H]1CCC2=C([C@H]1C)C(=CC=C2)O,,,,,,
2555,3082558,CID 3082558,CN1CCC23C4C(=NN=C5CCC6(C7CC8=C9C6(C5OC9=C(C=C8)O)CCN7CC5CC5)O)CCC2(C1CC1=C3C(=C(C=C1)O)O4)O,,,,,,
2556,3082559,"7-[[3-(cyclopropylmethyl)-4a-hydroxy-9-methoxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ylidene]hydrazinylidene]-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol",CN1CCC23C4C(=NN=C5CCC6(C7CC8=C9C6(C5OC9=C(C=C8)OC)CCN7CC5CC5)O)CCC2(C1CC1=C3C(=C(C=C1)O)O4)O,,,,,,
2557,3082560,Gdpflrfamide,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CC(=O)O)NC(=O)CN,,,,,,
2558,3082561,Sdpflrfamide,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)N,,,,,,
2559,3082562,2-Acetamido-2-deoxy-3-O-(gluco-4-enepyranosyluronic acid)glucose,CC(=O)N[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O[C@H]1[C@@H]([C@H](C=C(O1)C(=O)O)O)O,,,,,,
2560,3082563,CID 3082563,C[C@H](C(=O)N1CCC[C@H]1C(=O)O)N[C@@H](CCC(=O)NC2=CC=CC=C2)C(=O)O,,,,,,
2561,3082564,"2-((3-Bromo-2-oxopropyl)thio)adenosine 2',5'-bisphosphate",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=C(N=C32)SCC(=O)CBr)N)C(OP(=O)(O)O)OP(=O)(O)O)O,,,,,,
2562,3082565,Oxalyl phosphate,C(=O)(C(=O)OP(=O)(O)O)O,,,,,,
2563,3082566,CID 3082566,C[C@H](C(=O)NC(=O)[C@@H]1CCCN1C(C(C)C)C(=O)C(F)(F)F)NC(=O)[C@@H](C)NC(=O)OCC2=CC=CC=C2,,,,,,
2564,3082567,3-(4-(1-Hydroxy-2-methoxyethyl)phenoxy)-1-(isopropylamino)-2-propanol,CC(C)NC[C@H](COC1=CC=C(C=C1)C(COC)O)O,,,,,['Alpha-Hydroxymetoprolol is a known human metabolite of (r)-metoprolol.'],
2565,3082568,"Hexadecanamide, N-(3-(hexadecyloxy)-2-hydroxypropyl)-N-(2-hydroxyethyl)-",CCCCCCCCCCCCCCCCOCC(CN(CCO)C(=O)CCCCCCCCCCCCCCC)O,,,,,,
2566,3082569,"N-[1-[[1-[[1-[[1-[[1-[[1-[[1-[[3-(1-aminopropan-2-ylamino)-3-oxopropyl]amino]-2-methyl-1-oxopropan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]amino]-3-hydroxy-4-methyl-1-oxopentan-2-yl]amino]-6-hydroxy-4-methyl-1,8-dioxodecan-2-yl]-4-methyl-1-(4-methylhex-2-enoyl)pyrrolidine-2-carboxamide",CCC(C)C=CC(=O)N1CC(CC1C(=O)NC(CC(C)CC(CC(=O)CC)O)C(=O)NC(C(C(C)C)O)C(=O)NC(C)(C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C)(C)C(=O)NC(C)(C)C(=O)NCCC(=O)NC(C)CN)C,,,,,,
2567,3082570,[2-Methyl-2-(4-methylpent-3-enyl)cyclopropyl]methyl phosphono hydrogen phosphate,CC(=CCCC1(CC1COP(=O)(O)OP(=O)(O)O)C)C,,,,,,
2568,3082571,CID 3082571,C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@H]1C(=O)OC(=O)[C@H](CC(=O)N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(=O)N)NC(=O)[C@@H](C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CC(=O)N)NC(=O)[C@@H](C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CS)NC(=O)C)N,,,,,,
2569,3082572,"Cholestane-3,7,12,24,25,26-hexol",C[C@H](CC[C@@H](C(C)(CO)O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,,,,,,
2570,3082573,CID 3082573,C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)OC2=C(OC3=C(C(=CC(=O)C3=C2O)O[C@@H]4[C@@H]([C@@H]([C@H]([C@@H](O4)CO)O)O)O)CC=C(C)C)C5=CC=C(C=C5)OC)O[C@@H]6[C@@H]([C@@H]([C@@H](CO6)O)O)O)O)O,,,,,,
2571,3082574,CID 3082574,C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)O[C@@H]2[C@@H]([C@H]([C@@H](O[C@@H]2OC3=C(OC4=C(C(=CC(=O)C4=C3O)O[C@@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)CO)O)O)O)CC=C(C)C)C6=CC=C(C=C6)OC)C)O)O)O)O)O,,,,,,
2572,3082575,Suriclone N-oxide,C[N+]1(CCN(CC1)C(=O)OC2C3=C(C(=O)N2C4=NC5=C(C=C4)C=CC(=N5)Cl)SCCS3)[O-],,,,,,
2573,3082576,Leucinamide-beta-carboline-3-carboxylate methyl ester,CC(C)C[C@@H](C(=O)OC)NC(=O)C1=NC=C2C(=C1)C3=CC=CC=C3N2,,,,,,
2574,3082577,"6-Chloro-2-cyclohexyl-3'-[3-(dimethylamino)propyl]spiro[2,3-dihydrochromene-4,5'-imidazolidine]-2',4'-dione",CN(C)CCCN1C(=O)C2(CC(OC3=C2C=C(C=C3)Cl)C4CCCCC4)NC1=O,,,,,,
2575,3082578,Bz(2)Epsilon ADP,C1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)C(=O)OP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C4N=CN6C5=NC=C6)O)O,,,,,,
2576,3082579,"1-Cyclopropyl-6-fluoro-3-formyl-1,4-dihydro-4-oxo-7-piperazinylquinoline",C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C=O,,,,,,
2577,3082580,"1-Ethyl-6-fluoro-3-formyl-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxoquinoline",CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C=O,,,,,,
2578,3082581,CID 3082581,CC(C)C(C(=O)OC)NC(=O)C(=CC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)OC(C)(C)C,,,,,,
2579,3082582,2-[[(2R)-2-acetyloxy-3-hexadecoxypropoxy]-oxidophosphinothioyl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCCOC[C@H](COP(=S)([O-])OCC[N+](C)(C)C)OC(=O)C,,,,,,
2580,3082583,CID 3082583,CCCCCCCCCCCCCCCCOC[C@H](COP(=O)(OCC[N+](C)(C)C)S)OC(=O)C,,,,,,
2581,3082584,Isoleucyl-arginyl-isoleucyl-cysteinyl-arginyl-lysyl-glycine ethyl ester,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)OCC)N,,,,,,
2582,3082585,Technetium Tc 99m dea,[H+].CCN(CC)CC(C[N-]CC(C)(C)[S-])[N-]CC(C)(C)[S-].O=[99Tc+3],,,,,,
2583,3082586,1-[[3-(Diethylamino)-2-[(2-methyl-2-sulfanylpropyl)amino]propyl]amino]-2-methylpropane-2-thiol,CCN(CC)CC(CNCC(C)(C)S)NCC(C)(C)S,,,,,,
2584,3082587,"2-(4-Hydroxyphenyl)-N,N-di-n-propylcyclopropylamine",CCCN(CCC)[C@@H]1C[C@H]1C2=CC=C(C=C2)O,,,,,,
2585,3082588,C-Fiau,C1C(C(C(C1N2C=C(C(=O)NC2=O)I)F)O)CO,,,,,,
2586,3082589,S-3'-Deoxy-7-deazaadenosylhomocysteine,C1[C@H](O[C@H]([C@@H]1O)N2C=CC3=C(N=CN=C32)N)CSCC[C@@H](C(=O)O)N,,,,,,
2587,3082590,"Substance P, pro(9)-met(O2)(11)-",CC(C)C[C@@H](C(=O)N[C@@H](CCS(=O)(=O)C)C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)[C@@H]5CCCN5C(=O)[C@H](CCCN=C(N)N)N,,,,,,
2588,3082591,"2-[(1S,2R)-2-(dipropylamino)cyclopropyl]phenol",CCCN(CCC)[C@@H]1C[C@H]1C2=CC=CC=C2O,,,,,,
2589,3082592,"3-[(1S,2R)-2-(dipropylamino)cyclopropyl]phenol",CCCN(CCC)[C@@H]1C[C@H]1C2=CC(=CC=C2)O,,,,,,
2590,3082593,CID 3082593,CCOP(=O)(CC=CC=O)OCC,,,,,,
2591,3082594,"2,6-Aemtgmh",C[CH2-].CC(=O)OCC1C(C(C(C(O1)C[S-])OC(=O)C)OC(=O)C)OC(=O)C.[Hg+2],,,,,,
2592,3082595,"6-Amino-1-(2-deoxypentofuranosyl)-1H-pyrrolo(3,2-c)pyridin-4(5H)-one",C1[C@@H]([C@H](O[C@@H]1N2C=CC3=C2C=C(NC3=O)N)CO)O,,,,,,
2593,3082596,"6-Amino-1-arabinofuranosyl-1H-pyrrolo(3,2-c)pyridin-4(5H)-one",C1=CN(C2=C1C(=O)NC(=C2)N)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
2594,3082597,5-Methoxy-3-(di-n-propylamino)chroman,CCCN(CCC)C1CC2=C(C=CC=C2OC)OC1,,,,,,
2595,3082598,"(1S,5R,6S,9S,11R,13S,15S,16S,17R,19S,21S)-6,21-dimethyl-21-(4-methyl-3-methylidenepentyl)-14,18,20-trioxaheptacyclo[15.4.1.02,16.02,19.05,15.06,11.013,15]docosan-9-ol",CC(C)C(=C)CC[C@]1([C@H]2C[C@@H]3[C@@H]4C2(CC[C@H]5[C@@]46[C@@H](O6)C[C@@H]7[C@@]5(CC[C@@H](C7)O)C)[C@@H](O3)O1)C,,,,,,
2596,3082599,Progesterone 12-succinyltyrosine methyl ester,CC(=O)[C@H]1CCC2[C@@]1([C@H](CC3C2CCC4=CC(=O)CC[C@]34C)OC(=O)CCC(=O)N[C@@H](CC5=CC=C(C=C5)O)C(=O)OC)C,,,,,,
2597,3082600,"1H-Pyrido(2,1-b)quinazoline-8-carboxamide, N-(1-methyl-4-(3-pyridinyl)butyl)-1-oxo-",CC(CCCC1=CN=CC=C1)NC(=O)C2=CN3C=C4C(=O)C=CC=C4N=C3C=C2,,,,,,
2598,3082601,"(9S)-9-hydroperoxyoctadeca-10,12,15-trienoic acid",CCC=CCC=CC=C[C@H](CCCCCCCC(=O)O)OO,,,,,,
2599,3082602,Cyclo(phenylalanyl-tryptophyl-lysyl-threonyl-4-(aminomethyl)phenylacetic acid),C[C@H]([C@@H](C=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)CC4=CC=C(C=C4)CN)O,,,,,,
2600,3082603,CID 3082603,COC(=O)CCCCCS[C@@H]1[C@H]([C@@H](CC1=O)O)C=CC(CCC2CCCCC2)O,,,,,,
2601,3082604,5-(Benzyloxycarbonylphenylalanylarginylthioamido)isophthalic acid dimethyl ester,COC(=O)C1=CC(=CC(=C1)SN[C@@H](CCCN=C(N)N)C(=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CC=CC=C3)C(=O)OC.Br,,,,,,
2602,3082605,"dimethyl 5-[[(2S)-5-(diaminomethylideneamino)-1-oxo-1-[[(2S)-3-phenyl-2-(phenylmethoxycarbonylamino)propanoyl]amino]pentan-2-yl]amino]sulfanylbenzene-1,3-dicarboxylate",COC(=O)C1=CC(=CC(=C1)SN[C@@H](CCCN=C(N)N)C(=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CC=CC=C3)C(=O)OC,,,,,,
2603,3082606,CID 3082606,CCCCC1CCC(C1)[C@@H](C=C[C@H]2[C@@H](CC(=O)C2CC(=O)CCCCC(=O)N[C@@H](CC(C)C)C(=O)O)O)O,,,,,,
2604,3082607,Sadopine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2C(F)(F)F)C(=O)OCCNC(=O)C(CCSC)NC(=O)OC(C)(C)C)C)C,,,,,,
2605,3082608,CID 3082608,CCCC1=C(C=CC(=C1O)C(=O)C)OCCCOC2=C(C=C(C(=C2)N=C(C3=NNN=N3)[O-])C)Cl.[Na+],,,,,,
2606,3082609,N-[5-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-4-chloro-2-methylphenyl]-2H-tetrazole-5-carboxamide,CCCC1=C(C=CC(=C1O)C(=O)C)OCCCOC2=C(C=C(C(=C2)NC(=O)C3=NNN=N3)C)Cl,,,,,,
2607,3082610,CID 3082610,CCCC1=C(C=CC(=C1O)C(=O)C)OCCCOC2=C(C=C(C(=C2)N=C(C3=NNN=N3)[O-])C)Br.[Na+],,,,,,
2608,3082611,N-[5-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-4-bromo-2-methylphenyl]-2H-tetrazole-5-carboxamide,CCCC1=C(C=CC(=C1O)C(=O)C)OCCCOC2=C(C=C(C(=C2)NC(=O)C3=NNN=N3)C)Br,,,,,,
2609,3082612,Uralenolide,C[C@]12CC[C@@H]([C@]([C@@H]1CC[C@@]3([C@@H]2C=CC4=C5C[C@]6(C[C@@H]([C@@]5(CC[C@]43C)C)OC6=O)C)C)(C)CO)O,,,,,,
2610,3082613,CID 3082613,CCC1C(C2C(O2)(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC3C(C(C(C(O3)C)OC4CC(C(C(O4)C)O)(C)O)N(C)C)O)CC=O)C)C)C,,,,,,
2611,3082614,"7-[(1R,2R,3R)-3-Hydroxy-2-[(3S)-3-hydroxyocta-1,7-dienyl]-5-oxocyclopentyl]hept-5-enoic acid",C=CCCC[C@@H](C=C[C@H]1[C@@H](CC(=O)[C@@H]1CC=CCCCC(=O)O)O)O,,,,,,
2612,3082615,4-Chloro-N-(2-((2-hydroxyethyl)amino)ethyl)benzamide,C1=CC(=CC=C1C(=O)NCCNCCO)Cl,,,,,,
2613,3082616,Acetazolamide adipate ethyl ester,CCOC(=O)CCCCC(=O)NS(=O)(=O)C1=NN=C(S1)NC(=O)C,,,,,,
2614,3082617,"2-(((5-Methyl-2-pyridinyl)methyl)sulfinyl)-1H-thieno(3,4-d)imidazole",CC1=CN=C(C=C1)CS(=O)C2=NC3=CSC=C3N2,,,['Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX. (See all compounds classified as Proton Pump Inhibitors.)'],,,
2615,3082618,"3-(((2-Phenyl-2-cyclohexen-1-yl)carbonyl)oxy)-8,8-diethyl-8-azoniabicyclo(3.2.1)octane iodide",CC[N+]1(C2CCC1CC(C2)OC(=O)C3CCCC=C3C4=CC=CC=C4)CC.[I-],,,,,,
2616,3082619,"(8,8-Diethyl-8-azoniabicyclo[3.2.1]octan-3-yl) 2-phenylcyclohex-2-ene-1-carboxylate",CC[N+]1(C2CCC1CC(C2)OC(=O)C3CCCC=C3C4=CC=CC=C4)CC,,,,,,
2617,3082620,(2S)-N-[(2S)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-2-[[(2S)-1-[(2R)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2R)-3-(4-ethoxyphenyl)-2-[[2-(1-sulfanylcyclohexyl)acetyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]-4-oxobutanoyl]amino]-3-sulfanylidenepropanoyl]pyrrolidine-2-carbonyl]amino]pentanediamide,CCOC1=CC=C(C=C1)C[C@H](C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C=S)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N)NC(=O)CC4(CCCCC4)S,,,,,,
2618,3082621,"1-(3-Aminopropyl)-4-methyl-1,4,8,11-tetraazacyclotetradecane",CN1CCCNCCNCCCN(CC1)CCCN,,,,,,
2619,3082622,1-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-3-(2-hydroxyethyl)-2-methyl-4-nitroimidazolium,CC1=NC=C(C(=N1)N)C[N+]2=C(N(C(=C2)[N+](=O)[O-])CCO)C,,,,,,
2620,3082623,CID 3082623,CCCCCCCCCC(=O)O[C@H](COCCCCCCCCCCC=CC1=CC2=CC=CC=C2C=C1)COP(=O)([O-])OCC[N+](C)(C)C,,,,,,
2621,3082624,CID 3082624,CCCCCCCCCC(=O)O[C@H](COCCCCCCCCCCC=CC1=CC2=CC=CC=C2C=C1)COP(=O)(O)OCC[N+](C)(C)C,,,,,,
2622,3082625,11-Hydroxy-10-methylaporphine,CC1=C(C2=C(C[C@@H]3C4=C(CCN3C)C=CC=C42)C=C1)O,,,,,,
2623,3082626,2-Hydroxyglutaryl-1-coenzyme A,CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)[C@H](C(=O)NCCC(=O)NCCSC(=O)[C@@H](CCC(=O)O)O)O,,,,,,
2624,3082627,"Angiotensin II, sar(1)-phe(8)-",CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@H](C3=CC=CC=C3)C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC,,,,,,
2625,3082628,(S)-2-Amino-4-(hydroxyamino)butanoic acid,C(CNO)[C@@H](C(=O)O)N,,,,,,
2626,3082629,"2,4-Dihydroxyphenylacetyl-L-asparagine",C1=CC(=C(C=C1O)O)CC(=O)N[C@@H](CC(=O)N)C(=O)O,,,,,,
2627,3082630,p-Hydroxyketorolac,C1CN2C(=CC=C2C(=O)C3=CC=C(C=C3)O)C1C(=O)O,,,,,,
2628,3082631,Poly(N-isopropylacrylamide-co-butyl methacrylate),CCCCOC(=O)C(=C)C.CC(C)NC(=O)C=C.CC(=C)C(=O)OCCOC(=O)C(=C)C,,,,,,
2629,3082632,CID 3082632,C[C@@H]1C[C@@H](C(=O)C=CC=C[C@H]([C@@H](OC(=O)C=C[C@H]([C@H]1O[C@@H]2[C@H](C3(C[C@@H](O2)C)[C@@H](OC(=O)O3)C)O)C)C)CO[C@@H]4[C@@H]([C@@H]([C@H]([C@@H](O4)C)O)OC)OC)C,,,,,,
2630,3082633,"2,6-Dichloro-4-nitrophenyl phosphate",C1=C(C=C(C(=C1Cl)OP(=O)(O)O)Cl)[N+](=O)[O-],,,,,,
2631,3082634,Succinyl-tyrosyl-methionyl-glycyl-tryptophyl-methionyl-aspartyl-phenethylamide,CSCC[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCSC)C(=O)N(CCC3=CC=CC=C3)[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)CCC(=O)O,,,,,,
2632,3082635,Preprosomatostatin (25-34),C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)N,,,,,,
2633,3082636,CID 3082636,CC(C)CC1C(=O)NC(=CC2=CC=CC=C2)C(=O)N3CCCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(=CC4=CC=CC=C4)C(=O)N5CCCC5C(=O)NC(C(=O)NC(C(=O)N1)CCCN)C(C)C)CC(C)C)CCCN)C(C)C,,,,,,
2634,3082637,"1,2-Ditricosanoyl-sn-glycero-3-phosphocholine",CCCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCCC,,,,,,
2635,3082638,"2-[[(2R)-2,3-di(tricosanoyloxy)propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium",CCCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCCC,,,,,,
2636,3082639,"2-(Ethoxymethyl)-3,5-dihydroxypyran-4-one",CCOCC1=C(C(=O)C(=CO1)O)O,,,,,,
2637,3082640,5-(7-(5-Hydro-4-ethyl-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole,CC[C@H]1COC(=N1)C2=CC=C(C=C2)OCCCCCCCC3=CC(=NO3)C,,,,,,
2638,3082641,Benzoyl-beta-alanyl-glycyl-arginine-4-nitroanilide acetate,CC(=O)O.C1=CC=C(C=C1)C(=O)NCCC(=O)NCC(=O)NC(=O)[C@H](CCCN=C(N)N)NC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
2639,3082642,N-[3-[[2-[[(2S)-5-(diaminomethylideneamino)-2-(4-nitroanilino)pentanoyl]amino]-2-oxoethyl]amino]-3-oxopropyl]benzamide,C1=CC=C(C=C1)C(=O)NCCC(=O)NCC(=O)NC(=O)[C@H](CCCN=C(N)N)NC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
2640,3082643,"2-[6-[[2-[5-[3-(3,5-Dichloro-2-hydroxy-6-methylbenzoyl)oxy-1-hydroxy-2-methoxybutyl]-5-methyloxolan-2-yl]-7-methoxy-2,4,6-trimethyl-1,10-dioxaspiro[4.5]decan-9-yl]methyl]-3,5-dimethyloxan-2-yl]propanoic acid",CC1CC(C(OC1CC2CC(C(C3(O2)C(CC(O3)(C)C4CCC(O4)(C)C(C(C(C)OC(=O)C5=C(C(=CC(=C5O)Cl)Cl)C)OC)O)C)C)OC)C(C)C(=O)O)C,,,,,,
2641,3082644,Paridiformoside,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O[C@H]5CC[C@@]6([C@H]7CCC89[C@H]1C[C@](CCC1(CO8)[C@@H](C[C@]9([C@@]7(CCC6C5(C)C)C)C)O)(C)C=O)C)CO)O)O)O,,,,,,
2642,3082645,Taxifolin 6-C-glucoside,C1=CC(=C(C=C1[C@@H]2[C@H](C(=O)C3=C(O2)C=C(C(=C3O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)O)O,,,,,,
2643,3082646,"3-(5-Fluoro-2,4-dinitroanilino)-1-oxyl-2,2,5,5-tetramethyl-3-pyrrolidine",CC1(C=C(C(N1[O])(C)C)NC2=CC(=C(C=C2[N+](=O)[O-])[N+](=O)[O-])F)C,,,,,,
2644,3082647,Saroaspidin B,CCC(C)C(=O)C1=C(C(=C(C(=C1O)CC2=C(C(C(=O)C(=C2O)C(=O)C(C)C)(C)C)O)O)C)O,,,,,,
2645,3082648,Saroaspidin A,CC1=C(C(=C(C(=C1O)C(=O)C(C)C)O)CC2=C(C(C(=O)C(=C2O)C(=O)C(C)C)(C)C)O)O,,,,,,
2646,3082649,Saroaspidin C,CCC(C)C(=O)C1=C(C(=C(C(=C1O)CC2=C(C(C(=O)C(=C2O)C(=O)C(C)CC)(C)C)O)O)C)O,,,,,,
2647,3082650,Annonidin B,CC(=CCC1=C2C(=CC=C1)C(=CN2)C(C=C(C)C)C3=CNC4=CC=CC=C43)C,,,,,,
2648,3082651,CID 3082651,C1=CC(=NCCS(=O)(=O)O)C(=CC1=N)N(O)O,,,,,,
2649,3082652,Toquipidine,CC1=CC=C(C=C1)C2C3=CC=CC=C3C=CN2C(C)(N4CCCCC4)O,,,,,,
2650,3082653,"Methanesulfonamide, N-[4-[1-hydroxy-2-[4-(4-pyridinyl)-1-piperazinyl]ethyl]phenyl]-",CS(=O)(=O)NC1=CC=C(C=C1)C(CN2CCN(CC2)C3=CC=NC=C3)O,,,,,,
2651,3082654,N-Acetyl-leucyl-phenylalanyl trifluoromethyl ketone,CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)C(F)(F)F)NC(=O)C,,,,,,
2652,3082655,"1-(2-(4-Chlorophenyl)ethyl)-4-(3,5-dimethoxybenzoyl)piperazine monohydrochloride",COC1=CC(=CC(=C1)C(=O)N2CCN(CC2)CCC3=CC=C(C=C3)Cl)OC.Cl,,,,,,
2653,3082656,"Piperazine, 1-[2-(4-chlorophenyl)ethyl]-4-(3,5-dimethoxybenzoyl)-",COC1=CC(=CC(=C1)C(=O)N2CCN(CC2)CCC3=CC=C(C=C3)Cl)OC,,,,,,
2654,3082657,2-Methyl-N-(2-(4-morpholinyl)ethyl)-4-(3-nitrophenyl)-6-phenylnicotinamide,CC1=C(C(=CC(=N1)C2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)NCCN4CCOCC4,,,,,,
2655,3082658,"6-Chlorocholest-7-en-3-ol benzoate, (3beta,5alpha,6alpha)-",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4)OC(=O)C5=CC=CC=C5)C)Cl)C,,,,,,
2656,3082659,"Enkephalin, met(2)-pronh2(5)(N(1.5)-glucopyranosyl)",CSCC[C@H](C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NC(=O)[C@@H]2CCCN2[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)N,,,,,,
2657,3082660,"1-(2-Phenylethyl) N-(N-(N-(N-(N-(N-((1,1-dimethylethoxy)carbonyl)-O-sulfo-L-tyrosyl)-L-methionyl)glycyl)-L-tryptophyl)-L-norleucyl)-L-aspartate",CCCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)OCCC1=CC=CC=C1)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)OC(C)(C)C,,,,,,
2658,3082661,"Enkephalinamide, met(2)-pro(5)-(N(1,5))-galactopyranosyl-",CSCC[C@H](C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NC(=O)[C@@H]2CCCN2[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)N,,,,,,
2659,3082662,"(2-Aminoethyl)-10,12-tricosadiynamide",CCCCCCCCCCC#CC#CCCCCCCCCC(=O)NCCN,,,,,,
2660,3082663,CID 3082663,C[C@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)O)NC(=O)C2=CC=CC=C2,,,,,,
2661,3082664,Nitro-paps,CCCN(CCCS(=O)(=O)[O-])C1=CC(=C(C=C1)N=NC2=NC=C(C=C2)[N+](=O)[O-])O.[Na+],,,,,,
2662,3082665,"3-[[4-[(5-Nitropyridin-2-yl)hydrazinylidene]-3-oxocyclohexa-1,5-dien-1-yl]-propylamino]propane-1-sulfonic acid",CCCN(CCCS(=O)(=O)O)C1=CC(=C(C=C1)N=NC2=NC=C(C=C2)[N+](=O)[O-])O,,,,,,
2663,3082666,"(1R,2S)-2-(4-fluorophenyl)cyclopropan-1-amine",C1[C@H]([C@@H]1N)C2=CC=C(C=C2)F,,,,,,
2664,3082667,N-(Cyclohexylacetyl)-L-phenylalanyl-L-arginyl-L-seryl-L-valyl-L-glutamamide,CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CC2CCCCC2,,,,,,
2665,3082668,2-Amino-4-methylpent-2-enoic acid,CC(C)C=C(C(=O)O)N,,,,,,
2666,3082669,N-Pivaloyloxymethylchlorpromazine,CC(C)(C)C(=O)OC[N+](C)(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl.[Cl-],,,,,,
2667,3082670,"3-(2-Chlorophenothiazin-10-yl)propyl-(2,2-dimethylpropanoyloxymethyl)-dimethylazanium",CC(C)(C)C(=O)OC[N+](C)(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,,,,,,
2668,3082671,CID 3082671,C[C@@H]([C@@H](C(=O)N(C(=O)[C@H](CCSC)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CC3=CC=C(C=C3)OS(=O)(=O)O)NC(=O)C)C(=O)[C@H](CC4=CC=CC=C4)NC)N)OS(=O)(=O)O,,,,,,
2669,3082672,Mecaot,CC[C@H](C)C1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC2(CCC(CC2)C)CC(=O)N[C@H](C(=O)N1)CC3=CC=C(C=C3)O)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,,,,,,
2670,3082673,Mepaot,CC[C@H](C)C1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC2(CCN(CC2)C)CC(=O)N[C@H](C(=O)N1)CC3=CC=C(C=C3)O)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,,,,,,
2671,3082674,"Benzeneacetic acid, alpha-hydroxy-, compd. with 1-(4-(3-(4-(bis(4-fluorophenyl)methyl)-1-piperidinyl)propoxy)-3-methoxphenyl)ethanone (1:1)",CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F)OC.C1=CC=C(C=C1)C(C(=O)O)O,,,,,,
2672,3082675,1-[4-[3-[4-[Bis(4-fluorophenyl)methyl]-1-piperidinyl]propoxy]-3-methoxyphenyl]ethanone,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F)OC,,,,,,
2673,3082676,"1-(1-Phenylcyclohexyl)-2,3-dihydro-4-pyridone",C1CCC(CC1)(C2=CC=CC=C2)N3CCC(=O)C=C3,,,,,,
2674,3082677,2-((3-((Phenyl)(phenylmethyl)amino)-2-(1-pyrrolidinyl)propoxy)methyl)-2-propanol,CC(C)(COCC(CN(CC1=CC=CC=C1)C2=CC=CC=C2)N3CCCC3)O,,,,,,
2675,3082678,CID 3082678,[H+].C1=NC2=C(N1C3C(C(C(O3)COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O)O)NC(=NC2=O)N.O.O.O.O.[Cr+3],,,,,,
2676,3082679,Acetyldithio-coenzyme A,CC(=S)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O,,,,,,
2677,3082680,CID 3082680,C[N+]1(CCN(CC1)C(=S)N=C2C=CC(=NC3=CC=C(C=C3)N(O)O)C=C2)[O-],,,,,,
2678,3082681,"1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8-Heptadecafluorooctadec-9-ene",CCCCCCCCC=CC(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
2679,3082682,5-(Dodecyldithio)-2-nitrobenzoic acid,CCCCCCCCCCCCSSC1=CC(=C(C=C1)[N+](=O)[O-])C(=O)O,,,,,,
2680,3082683,Antho-rwamide I,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N)NC(=O)[C@H](CO)NC(=O)[C@@H]3CCC(=O)N3,,,,,,
2681,3082684,Benzyltetrahydropalmatine,COC1=C(C2=C(CC3C4=CC(=C(C=C4CCN3C2CC5=CC=CC=C5)OC)OC)C=C1)OC,,,,,,
2682,3082685,"(6S,8S,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-17-[(1S)-1-hydroxyethyl]-6,10,13-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one",C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H](C2([C@@]4(C1=CC(=O)C=C4)C)F)O)C)([C@H](C)O)O,,,,,,
2683,3082686,Levitide,CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@@H]1CCC(=O)N1,,,,,,
2684,3082687,CID 3082687,C1=C(N=C2C(=N1)NC(=NC2=O)N)C([C@@H](CO[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)N)O)O,,,,,,
2685,3082688,Sbmet,CC(=CCC1=C(C(=CC(=C1)[C@@H]2CC(=O)C3=C(C=C(C=C3O2)O)O)O)OC)C,,,,,,
2686,3082689,"2,3-Dihydro-2,2-dimethyl-5-phenyl-8-(trifluoromethyl)-1H-pyrimido(1,2-a)quinoxaline 6-oxide, monohydrochloride",CC1(CN=C2C(=[N+](C3=C(N2C1)C=CC(=C3)C(F)(F)F)[O-])C4=CC=CC=C4)C.Cl,,,,,,
2687,3082690,"2,3-dihydro-2,2-dimethyl-5-phenyl-8-trifluoromethyl-1H-pyrimido[1,2-a]quinoxaline 6-oxide",CC1(CN=C2C(=[N+](C3=C(N2C1)C=CC(=C3)C(F)(F)F)[O-])C4=CC=CC=C4)C,,,,,,
2688,3082691,Urodiolenone,C[C@@H]1CC(=O)C=C2[C@]1(CC(CC2)[C@](C)(CO)O)C,,,,,,
2689,3082692,"7-[5-[8-[[2-[2,3-Dihydroxy-5,5-dimethyl-6-penta-1,3-dienyl-4-(2-phenylacetyl)oxyoxan-2-yl]-3-[5-[5-(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxypropanoyl]amino]-3-methoxy-4-methylocta-4,6-dien-2-yl]-3-hydroxyoxolan-2-yl]hepta-2,4,6-trienoic acid",CC=CC=CC1C(C(C(C(O1)(C(COC2CC(C(C(O2)C)OC3CC(C(C(O3)C)OC4CC(C(C(O4)C)O)OC)OC)OC)C(=O)NCC=CC=C(C)C(C(C)C5CC(C(O5)C=CC=CC=CC(=O)O)O)OC)O)O)OC(=O)CC6=CC=CC=C6)(C)C,,,,,,
2690,3082693,"5-(4-Aminophenyl)-8-chloro-3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-ol",CN1CCC2=CC(=C(C=C2C(C1)C3=CC=C(C=C3)N)O)Cl,,,,,,
2691,3082694,"Pyridinium, 2,2'-(dithiobis(methylene))bis(1-(1H-benzimidazol-2-yl)-3-methyl-4-(2,2,2-trifluoroethoxy)-, dichloride",CC1=C(C=C[N+](=C1CSSCC2=[N+](C=CC(=C2C)OCC(F)(F)F)C3=NC4=CC=CC=C4N3)C5=NC6=CC=CC=C6N5)OCC(F)(F)F.[Cl-].[Cl-],,,,,,
2692,3082695,AG-1812 free base,CC1=C(C=C[N+](=C1CSSCC2=[N+](C=CC(=C2C)OCC(F)(F)F)C3=NC4=CC=CC=C4N3)C5=NC6=CC=CC=C6N5)OCC(F)(F)F,,,,,,
2693,3082696,Sitophilate,CC[C@H]([C@H](C)C(=O)OC(CC)CC)O,,,,,,
2694,3082697,"LHRH, phe(5)-delta-ala(6)-",CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)C(=C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6,,,,,,
2695,3082698,"LHRH, phe(5)-delta-ala(6)-N-Et-pronh2(9)-",CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6,,,,,,
2696,3082699,"2-(4-Acetoxy-3-chloro-1-butyn-1-yl)-5-(1,3-butadiyn-1-yl)thiophene",CC(=O)OCC(C#CC1=CC=C(S1)C#CC#C)Cl,,,,,,
2697,3082700,CID 3082700,C1=NC2=C(N1OCCCO)NC(=NC2=O)N,,,,,,
2698,3082701,[4-[2-(Methylamino)propyl]phenyl] hydrogen sulfate,CC(CC1=CC=C(C=C1)OS(=O)(=O)O)NC,,,,,,
2699,3082702,3-(2-Phenylethyl)-4-methylsydnone,CN1C(=NOC1=O)CCC2=CC=CC=C2,,,,,,
2700,3082703,3-Iodo-4-azidophenpyramine,CN(CCCCCNC(=O)CC1=CC(=C(C=C1)N=[N+]=[N-])[125I])CCN(CC2=CC=C(C=C2)OC)C3=CC=CC=N3,,,,,,
2701,3082704,"3,7,8-Tri-O-methylellagic acid 4-glucoside",COC1=C(C2=C3C(=C1)OC(=O)C4=C3C(=CC(=C4O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)OC)OC2=O)OC,,,,,,
2702,3082705,1-[3-[Fluoro(methyl)phosphoryl]oxypropyl]pyrene,CP(=O)(OCCCC1=C2C=CC3=CC=CC4=C3C2=C(C=C4)C=C1)F,,,,,,
2703,3082706,4-(Chloromethyl)benzoylformate,C1=CC(=CC=C1CCl)C(=O)C(=O)O,,,,,,
2704,3082707,Cyclo(aaap)(2),CC1C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3CCCC3C(=O)NC(C(=O)N1)C)CCCCCCC=C)C)C)CCCCCCC=C,,,,,,
2705,3082708,"1-(3,6-Dihydropyrazin-1(2H)-yl)-1-(naphthalen-1-yl)ethan-1-ol--hydrogen chloride (1/1)",CC(C1=CC=CC2=CC=CC=C21)(N3CCN=CC3)O.Cl,,,,,,
2706,3082709,"1-(3,5-dihydro-2H-pyrazin-4-yl)-1-naphthalen-1-ylethanol",CC(C1=CC=CC2=CC=CC=C21)(N3CCN=CC3)O,,,,,,
2707,3082710,3-Carboxy-4-methyl-5-ethyl-2-furanpropionic acid,CCC1=C(C(=C(O1)CCC(=O)O)C(=O)O)C,,,,,,
2708,3082711,14-Methylcholesterol,C[C@H](CCCC(C)C)[C@H]1CCC2([C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)C,,,,,,
2709,3082712,Bio-ahx-aii,CCC(C)C(C(=O)NC(CC1=NC=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)NC(=O)CCCCCNC(=O)CCCCC5C6C(CS5)NC(=O)N6,,,,,,
2710,3082713,"2-Methyl-2,3,3a,4,5,9b-hexahydro-6,7-dihydroxy-1H-benz(e)isoindole",CN1CC2CCC3=C(C2C1)C=CC(=C3O)O,,,,,,
2711,3082714,"(2,5-dioxopyrrolidin-1-yl) 2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[(9R)-9-phenylmethoxycarbonyloxy-9H-fluoren-4-yl]propanoate",C1CC(=O)N(C1=O)OC(=O)C(CC2=C3C(=CC=C2)[C@@H](C4=CC=CC=C43)OC(=O)OCC5=CC=CC=C5)NC(=O)OCC6C7=CC=CC=C7C8=CC=CC=C68,,,,,,
2712,3082715,CID 3082715,CCC1C(=O)N(C2CCCN(C2=O)C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C,,,,,,
2713,3082716,"(5S,12R)-20,20,20-Trifluoro-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid",C(CCC(F)(F)F)CC=CC[C@H](C=CC=CC=C[C@H](CCCC(=O)O)O)O,,,,,,
2714,3082717,"2-(3,4-Dichlorophenyl)-N-methyl-N-[(1S)-1-phenyl-2-(1-pyrrolidinyl)ethyl]acetamide hydrochloride",CN([C@H](CN1CCCC1)C2=CC=CC=C2)C(=O)CC3=CC(=C(C=C3)Cl)Cl.Cl,,,,,,
2715,3082718,"2-(3,4-dichlorophenyl)-N-methyl-N-[(1S)-1-phenyl-2-(1-pyrrolidinyl)ethyl]acetamide",CN([C@H](CN1CCCC1)C2=CC=CC=C2)C(=O)CC3=CC(=C(C=C3)Cl)Cl,,,,,,
2716,3082719,"N-(2-(N-Methyl-3,4-dichlorophenylacetamido)-2-(3,4-dimethyloxyphenyl)ethyl)pyrrolidine",CN(C(CN1CCCC1)C2=CC(=C(C=C2)OC)OC)C(=O)CC3=CC(=C(C=C3)Cl)Cl.Cl,,,,,,
2717,3082720,"2-(3,4-Dichloro-phenyl)-N-[1-(3,4-dimethoxy-phenyl)-2-pyrrolidin-1-yl-ethyl]-N-methyl-acetamide",CN(C(CN1CCCC1)C2=CC(=C(C=C2)OC)OC)C(=O)CC3=CC(=C(C=C3)Cl)Cl,,,,,,
2718,3082721,"2-(1H-indol-3-ylmethyl)-1,3-thiazolidine-4-carboxylic acid",C1C(NC(S1)CC2=CNC3=CC=CC=C32)C(=O)O,,,,,,
2719,3082722,"N,N'-Bis(3-maleimidepropionyl)-2-hydroxy-1,3-propanediamine",C1=CC(=O)N(C1=O)CCC(=O)NCC(CNC(=O)CCN2C(=O)C=CC2=O)O,,,,,,
2720,3082723,Bis((1-naphthyl)methyl)acetyl-histidyl-statyl-leucyl-episilon-lysinol,CC(C)C[C@@H](C(=O)NCCCC[C@@H](CO)N)NC(=O)C[C@@H](C(CC(C)C)NC(=O)C(CC1=CN=CN1)NC(=O)C(CC2=CC=CC3=CC=CC=C32)CC4=CC=CC5=CC=CC=C54)O.Cl.Cl,,,,,,
2721,3082724,"Unk-DL-His-Sta(3S,4xi)-Leu-(1).H-Lys(1)-ol",CC(C)C[C@@H](C(=O)NCCCC[C@@H](CO)N)NC(=O)C[C@@H](C(CC(C)C)NC(=O)C(CC1=CN=CN1)NC(=O)C(CC2=CC=CC3=CC=CC=C32)CC4=CC=CC5=CC=CC=C54)O,,,,,,
2722,3082725,Methoxyadiantifoline,CN1CCC2=C3[C@@H]1CC4=CC(=C(C=C4C3=C(C(=C2OC)OC)OC)OC)OC5=CC(=C(C=C5C[C@H]6C7=CC(=C(C(=C7CCN6C)OC)OC)OC)OC)OC,,,,,,
2723,3082726,Neohyacinthoside,C[C@H]1CC[C@@H]2[C@H]([C@H]3[C@@H](N2C1)C[C@@H]4[C@@]3(CCC5[C@H]4CC=C6[C@@]5(CCC(C6)[C@]7([C@@H]([C@@H]([C@@H]([C@H](O7)CO)O)O)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)C)C)C,,,,,,
2724,3082727,dGVTA,CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)OC)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)CC3CCCCC3=S,,,,,,
2725,3082728,Wushanicariin,CC(=CCC1=CC2=C(C=C1O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)OC(=CC2=O)C4=CC(=C(C(=C4)O)OC)O)C,,,,,,
2726,3082729,S-Phosphocysteine,C([C@@H](C(=O)O)N)SP(=O)(O)O,,,,,,
2727,3082730,Copper(II)-cimetidine-alanine complex,CC1=C(N=CN1)CSCCNC(=NC)NC#N.CC(C(=O)[O-])N.[OH-].[Cu+2],,,,,,
2728,3082731,Merremoside B,CCCCCC1CCCCCCCCCC(=O)OC2C(C(OC(C2OC3C(C(C(C(O3)C)OC4C(C(C(C(O4)C)OC(=O)C(C)C)O)O)O)OC(=O)C(C)C)C)OC5C(OC(O1)C(C5O)O)C)O,,,,,,
2729,3082732,"[[(2R,3S,4R,5R)-5-[6-amino-8-(4-bromo-2,3-dioxobutyl)sulfanylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate",C1=NC(=C2C(=N1)N(C(=N2)SCC(=O)C(=O)CBr)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N,,,,,,
2730,3082733,2-Sulfanyl-3-[(2-sulfanyl-3-sulfopropyl)disulfanyl]propane-1-sulfonic acid,C(C(CS(=O)(=O)O)S)SSCC(CS(=O)(=O)O)S,,,,,,
2731,3082734,Ala-argipressin,C[C@@H](C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CC2=CC=C(C=C2)O)CC3=CC=CC=C3)CCC(=O)N)CC(=O)N)C(=O)N4CCCC4C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N)N,,,,,,
2732,3082735,Succinylglutaminyl-valyl-valyl-alanyl-alanine-4-nitroanilide,C[C@@H](C(=O)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)N)NC(=O)CCC(=O)O)NC1=CC=C(C=C1)[N+](=O)[O-],,,,,,
2733,3082736,N-Hydroxy-beta-oxo-gamma-phenylbenzenebutanamide,C1=CC=C(C=C1)C(C2=CC=CC=C2)C(=O)CC(=O)NO,,,,,,
2734,3082737,CID 3082737,C[C@H]([C@@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)N)O,,,,,,
2735,3082738,"4-(2-aminopropanoylamino)-N-[1-[5-[3,4-dihydroxy-6-methyl-5-(methylamino)oxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]-2-oxopyrimidin-4-yl]benzamide",CC1C(C(C(C(O1)OC2C(OC(CC2O)N3C=CC(=NC3=O)NC(=O)C4=CC=C(C=C4)NC(=O)C(C)N)C)O)O)NC,,,,,,
2736,3082739,"3-[2-[(1R,4aS,8aS)-5,5,8a-trimethylspiro[3,4,4a,6,7,8-hexahydro-1H-naphthalene-2,2'-oxirane]-1-yl]ethylidene]oxolan-2-one",C[C@]12CCCC([C@@H]1CCC3([C@@H]2CC=C4CCOC4=O)CO3)(C)C,,,,,,
2737,3082740,Napadg,C1=CC(=C(C=C1N=[N+]=[N-])[N+](=O)[O-])NCCC(=O)NCCCCCCCCCC[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
2738,3082741,Dihydroergocristine mixture with 5-hydroxytryptophan,CC(C)[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C.C1=CC2=C(C=C1O)C(=CN2)C[C@@H](C(=O)O)N,,,,,,
2739,3082742,CID 3082742,CC1=NC2=NC(=NN2C(=C1)SCC3=C(N4[C@@H]([C@@H](C4=O)NC(=O)C(=NOC(C)(C)C(=O)NNC(=O)C5=CC(=C(C=C5)O)O)C6=CSC(=N6)N)SC3)C(=O)[O-])C(=O)[O-].[Na+].[Na+],,,,,,
2740,3082743,CID 3082743,CC1=NC2=NC(=NN2C(=C1)SCC3=C(N4[C@@H]([C@@H](C4=O)NC(=O)C(=NOC(C)(C)C(=O)NNC(=O)C5=CC(=C(C=C5)O)O)C6=CSC(=N6)N)SC3)C(=O)O)C(=O)O,,,,,,
2741,3082744,"9-Ethyl-9,10-dihydro-9-methyl-6-phenyl-8H-pyrido(3',4':5,6)pyrazino(1,2-a)pyrimidine 5-oxide",CCC1(CN=C2C(=[N+](C3=C(N2C1)C=CN=C3)[O-])C4=CC=CC=C4)C,,,,,,
2742,3082745,2-Bromoporphobilinogen,C(CC(=O)O)C1=C(NC(=C1CC(=O)O)CN)Br,,,,,,
2743,3082746,"methyl (6R,6aS,14aR)-11-amino-1,6,8,14a-tetrahydroxy-6a-methoxy-3-methyl-7,9,12,14-tetraoxo-5,6-dihydrobenzo[a]tetracene-2-carboxylate",CC1=CC2=C(C(=C1C(=O)OC)O)[C@@]3(C(=O)C4=C(C(=C5C(=C4)C(=O)C(=CC5=O)N)O)C(=O)[C@@]3([C@@H](C2)O)OC)O,,,,,,
2744,3082747,"Methyl 1,8,14a-trihydroxy-11-[(4-hydroxy-3,5-dimethoxy-6-methyloxan-2-yl)amino]-6a-methoxy-3-methyl-7,9,12,14-tetraoxo-5,6-dihydrobenzo[a]tetracene-2-carboxylate",CC1C(C(C(C(O1)NC2=CC(=O)C3=C(C4=C(C=C3C2=O)C(=O)C5(C6=C(CCC5(C4=O)OC)C=C(C(=C6O)C(=O)OC)C)O)O)OC)O)OC,,,,,,
2745,3082748,Baishouwubenzophenone,CC1=C(C=CC(=C1C(=O)C2=C(C=CC(=C2O)C(=O)C)O)O)O,,,,,,
2746,3082749,"Guanidine 1,5-diazabicyclo(5.3.0)decane",C1CC2CN(CCCN2C1)CCN=C(N)N,,,,,,
2747,3082750,"Guanidine 1,5-diazabicyclo(5.4.0)undecane",C1CCN2CCCN(CC2C1)CCN=C(N)N,,,,,,
2748,3082751,Bamads,C1CCN2CCCN(CC2C1)CCCN=C(N)N,,,,,,
2749,3082752,4-Nitrophenyl-O-(6-O-benzyl)-glucopyranosyl(1--4)-O-glucopyranosyl(1--4)-O-glucopyranosyl(1--4)-O-glucopyranosyl(1--4)-glucopyranoside,C1=CC=C(C=C1)COC[C@@H]2[C@H]([C@@H]([C@H]([C@H](O2)O[C@@H]3[C@H](O[C@]([C@@H]([C@H]3O[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)(C6=CC=C(C=C6)[N+](=O)[O-])O[C@@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)CO)O)O)O,,,,,,
2750,3082753,CID 3082753,CC(C)C[C@@H]([C@H]([C@@H]([C@H](C(C)C)C(=O)O)O)O)N,,,,,,
2751,3082754,Iodopride,CCN1CCC[C@@H]1CNC(=O)C2=C(C=CC(=C2)I)OC,,,,,,
2752,3082755,"1-(1H-indol-4-yloxy)-3-[[2-methyl-2-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]propyl]amino]propan-2-ol",CC(C)(CNCC(COC1=CC=CC2=C1C=CN2)O)NC3=CC=C(C4=NON=C34)[N+](=O)[O-],,,,,,
2753,3082756,"1-hydroxy-3,6-dimethoxy-1,2-dimethyl-9H-carbazol-4-one",CC1=C(C(=O)C2=C(C1(C)O)NC3=C2C=C(C=C3)OC)OC,,,,,,
2754,3082757,"1-hydroxy-3-methoxy-1,2-dimethyl-9H-carbazol-4-one",CC1=C(C(=O)C2=C(C1(C)O)NC3=CC=CC=C32)OC,,,,,,
2755,3082758,"Androsta-4,6,8(9)-triene-3,17-dione",C[C@]12CCC3=C([C@@H]1CCC2=O)C=CC4=CC(=O)CC[C@]34C,,,,,,
2756,3082759,Npbgd,C1=C(C=C(C=C1NC(=O)CCCC(=O)O)[N+](=O)[O-])NC(=O)CCCC(=O)O,,,,,,
2757,3082760,Cpe-penicillin,CC1([C@@H](N2[C@H](S1)C3(C2=O)[C@](O3)(C(=O)NC4=CC=CC=C4)Cl)C(=O)O)C,,,['Endogenous substances and drugs that inhibit or block the activity of BETA-LACTAMASES. (See all compounds classified as beta-Lactamase Inhibitors.)'],,,
2758,3082761,"(8S,9S,10R,14S,17S)-17-acetyl-10-methyl-13-prop-2-enyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one",CC(=O)[C@H]1CC[C@@H]2C1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)CC=C,,,,,,
2759,3082762,Mesihc,C[N+]1(CCN(CC1)C[Si](C2CCCCC2)(C3=CC=CC=C3OC)O)C.COS(=O)(=O)[O-],,,,,,
2760,3082763,o-Methoxysilahexocyclium,C[N+]1(CCN(CC1)C[Si](C2CCCCC2)(C3=CC=CC=C3OC)O)C,,,,,,
2761,3082764,"(1S,2S,4S,5R)-6-fluorocyclohexane-1,2,3,4,5-pentol",[C@H]1([C@H](C([C@H]([C@H](C1O)O)O)F)O)O,,,,,,
2762,3082765,Dehydromiltirone,CC(C)C1=CC2=C(C3=C(C=C2)C(CC=C3)(C)C)C(=O)C1=O,,,,,,
2763,3082766,"Septide, acetyl-arg(6)-",CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CCCN=C(N)N)NC(=O)C,,,,,,
2764,3082767,"2-amino-N-[1-[[6-(2-amino-1-hydroxy-2-oxoethyl)-18-[3-(diaminomethylideneamino)propyl]-12-(1-hydroxyethyl)-3-(hydroxymethyl)-24-(1-hydroxy-2-methylpropyl)-21-(2-methylpropyl)-2,5,8,11,14,17,20,23,26-nonaoxo-28-phenyl-15-propan-2-yl-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-27-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide",CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)OC(C(C(=O)NC(C(=O)N1)C(C(C)C)O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)N)C2=CC=CC=C2)CO)C(C(=O)N)O)C(C)O)C(C)C)CCCN=C(N)N,,,,,,
2765,3082768,2-[5-Hydroxyimino-3-(oxolan-2-yloxy)-2-[3-(oxolan-2-yloxy)oct-1-enyl]cyclopentyl]acetic acid,CCCCCC(C=CC1C(CC(=NO)C1CC(=O)O)OC2CCCO2)OC3CCCO3,,,,,,
2766,3082769,4'-O-(Glucosyl)-5'-O-(cellobiosyl)pyridoxine,CC1=NC=C(C(=C1O)CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CO[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O,,,,,,
2767,3082770,"(2S,3R,4S,5S,6R)-2-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-2-[[5-hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methyl]-6-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol",CC1=NC=C(C(=C1O)CO)C[C@@]2([C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,,,,,,
2768,3082771,"(4aR,4bS,6aS,6bS,7S,10aR,11aS,11bR)-6b-acetyl-4a,6a,7-trimethyl-4,4b,5,6,7,8,9,10,10a,11,11a,11b,12,13-tetradecahydro-3H-indeno[2,1-a]phenanthren-2-one",C[C@H]1CCC[C@H]2[C@@]1([C@]3(CC[C@H]4[C@H]([C@@H]3C2)CCC5=CC(=O)CC[C@]45C)C)C(=O)C,,,,,,
2769,3082772,N-Normethylskytanthine,C[C@@H]1CC[C@@H]2[C@H]1CNC[C@@H]2C,,,,,,
2770,3082773,HP-Fortimicin A,CN(C1C(C(C(C(C1OC)O)N)OC2C(CCC(O2)C(CCCCO)N)N)O)C(=O)CN,,,,,,
2771,3082774,3-[[(2S)-1-[(2-aminoacetyl)amino]-4-methyl-1-oxopentan-2-yl]amino]prop-1-en-2-ylphosphonic acid,CC(C)C[C@@H](C(=O)NC(=O)CN)NCC(=C)P(=O)(O)O,,,,,,
2772,3082775,CID 3082775,CC1C2CC=C3C2(COC14C(CC(O4)(C)C)O)C(=O)CC5(C3CCC6C5(CC7=NC8=C(CC9(C(C8)CCC1C9CC(C2(C1=CC1C2(C(C2(O1)C(CC(O2)(C)CO)O)C)O)C)O)C)N=C7C6)C)O,,,,,,
2773,3082776,CID 3082776,CC1C2CC=C3C2(COC14C(C(C(O4)(C)C)C)O)C(=O)CC5(C3CCC6C5(CC7=NC8=C(CC9(C(C8)CCC1C9CC(C2(C1=CC1C2(C(C2(O1)C(CC(O2)(C)CO)O)C)O)C)O)C)N=C7C6)C)O,,,,,,
2774,3082777,"7-Iodo-8-hydroxy-3-methyl-1-(4-azidophenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine",CN1CCC2=CC(=C(C=C2C(C1)C3=CC=C(C=C3)N=[N+]=[N-])O)I,,,,,,
2775,3082778,"17-Cyano-9,17-dihydroxyandrost-4-ene-3-one",C[C@]12CCC3([C@H]([C@@H]1CCC2(C#N)O)CCC4=CC(=O)CC[C@@]43C)O,,,,,,
2776,3082779,"(8S,10S,13S,14S)-17-ethynyl-9,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one",C[C@]12CCC3([C@H]([C@@H]1CCC2(C#C)O)CCC4=CC(=O)CC[C@@]43C)O,,,,,,
2777,3082780,N-Desmethyleclanamine,CCC(=O)N([C@@H]1CCC[C@H]1NC)C2=CC(=C(C=C2)Cl)Cl,,,,,,
2778,3082781,"N-[(1R,2R)-2-aminocyclopentyl]-N-(3,4-dichlorophenyl)propanamide",CCC(=O)N([C@@H]1CCC[C@H]1N)C2=CC(=C(C=C2)Cl)Cl,,,,,,
2779,3082782,"N-(6-Azido-2-methoxy-9-acridinyl)-N'-(9-acridinyl)octane-1,8-diamine",COC1=CC2=C(C3=C(C=C(C=C3)N=[N+]=[N-])N=C2C=C1)NCCCCCCCCNC4=C5C=CC=CC5=NC6=CC=CC=C64,,,,,,
2780,3082783,Senecioyldithranol,CC(=CC(=O)C1C2=C(C(=CC=C2)O)C(=O)C3=C1C=CC=C3O)C,,,,,,
2781,3082784,"1-[11-(3,5,9,11,13,17,27,29,31,40-Decahydroxy-6,10,14,18,22,28-hexamethyl-19,35,37-trioxo-2,20,34,38-tetraoxatricyclo[31.8.1.03,39]dotetraconta-15,23,25-trien-21-yl)-9-methyldodec-4-enyl]-2-methylguanidine;propanedioic acid",CC1CCC(C(C(CC(C(C=CC(C(C(=O)OC(C(C=CC=CC(C(C(CC(CC2CC3CC(C(C(O3)(CC1O)O)OC(=O)CC(=O)O2)O)O)O)C)O)C)C(C)CC(C)CCCC=CCCCNC(=NC)N)C)O)C)O)O)C)O.C(C(=O)O)C(=O)O,,,,,,
2782,3082785,"1-[11-(3,5,9,11,13,17,27,29,31,40-Decahydroxy-6,10,14,18,22,28-hexamethyl-19,35,37-trioxo-2,20,34,38-tetraoxatricyclo[31.8.1.03,39]dotetraconta-15,23,25-trien-21-yl)-9-methyldodec-4-enyl]-2-methylguanidine",CC1CCC(C(C(CC(C(C=CC(C(C(=O)OC(C(C=CC=CC(C(C(CC(CC2CC3CC(C(C(O3)(CC1O)O)OC(=O)CC(=O)O2)O)O)O)C)O)C)C(C)CC(C)CCCC=CCCCNC(=NC)N)C)O)C)O)O)C)O,,,,,,
2783,3082786,"5-cyclohexyl-3-hydroxy-N-(2-morpholin-4-ylethyl)-4-[[2-[[4-morpholin-4-yl-2-(naphthalen-1-ylmethyl)-4-oxobutanoyl]amino]-3-(1,3-thiazol-4-yl)propanoyl]amino]pentanamide",C1CCC(CC1)CC(C(CC(=O)NCCN2CCOCC2)O)NC(=O)C(CC3=CSC=N3)NC(=O)C(CC4=CC=CC5=CC=CC=C54)CC(=O)N6CCOCC6,,,,,,
2784,3082787,CID 3082787,C1[C@@H](C(=O)N2[C@H](CSC[C@H]2C(=O)O)C3=CC=CC=C31)N[C@H](CCC4=CC=CC=C4)C(=O)O,,,,,,
2785,3082788,2-[hydroxy(methyl)amino]-N-[4-[(3-methyl-2-nitroimidazol-4-yl)methoxy]phenyl]propanamide,CC(C(=O)NC1=CC=C(C=C1)OCC2=CN=C(N2C)[N+](=O)[O-])N(C)O,,,,,,
2786,3082789,3-(3-Iodo-4-amino)phenethyl-1-propyl-8-cyclopentylxanthine,CCCN1C(=O)C2=C(N=C(N2)C3CCCC3)N(C1=O)CCC4=CC(=C(C=C4)N)[125I],,,,,,
2787,3082790,3-(3-Iodo-4-azido)phenethyl-1-propyl-8-cyclopentylxanthine,CCCN1C(=O)C2=C(N=C(N2)C3CCCC3)N(C1=O)CCC4=CC(=C(C=C4)N=[N+]=[N-])[125I],,,,,,
2788,3082791,CID 3082791,CCCC[C@@H](C(=O)N[C@H](CCCN)C(=O)N[C@@H](CC1C=NC=N1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)NCC(=O)N[C@@H](CC=CC=N)CN)NC(=O)C,,,,,,
2789,3082792,Acetylalanyl-prolyl-valyl-trifluoromethyl ketone,C[C@@H](C(=O)NC(=O)[C@@H]1CCCN1[C@@H](C(C)C)C(=O)C(F)(F)F)NC(=O)C,,,,,,
2790,3082793,"14-Hydroxy-3-[(3-C-methyl-3-O-methylpentopyranosyl)oxy]-4,5-epoxybufa-20,22-dienolide",CC12CCC(C3C1(O3)CCC4C2CCC5(C4(CCC5C6=COC(=O)C=C6)O)C)OC7C(C(C(CO7)O)(C)OC)O,,,,,,
2791,3082794,Knqdk peptide,C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N,,,,,,
2792,3082795,3-(N(epsilon)-Lysino)lactic acid,C(CCNCC(C(=O)O)O)C[C@@H](C(=O)O)N,,,,,,
2793,3082796,S-(N-Monomethoxytritylaminoethyl)-O-(2-chlorophenyl)phosphorothioate,COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)NCCSP(=O)(O)OC4=CC=CC=C4Cl,,,,,,
2794,3082797,2-Methoxyequilin,C[C@]12CC[C@H]3C(=CCC4=CC(=C(C=C34)OC)O)[C@@H]1CCC2=O,,,,,,
2795,3082798,4-Methoxyequilenin,C[C@]12CCC3=C([C@@H]1CCC2=O)C=CC4=C3C=CC(=C4OC)O,,,,,,
2796,3082799,2-Methoxyequilenin,C[C@]12CCC3=C([C@@H]1CCC2=O)C=CC4=CC(=C(C=C34)OC)O,,,,,,
2797,3082800,"12a-Methyl-2,3,3a,3b,4,5,9,10,10b,11,12,12a-dodecahydro-1H-8,10a-methanocyclohepta[a]cyclopenta[f]naphthalene-1,7(8H)-dione",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=CC(=O)[C@H]5CCC34C5,,,,,,
2798,3082801,"6,9-Dimethoxy-4-propyl-2,3,4a,5,10,10a-hexahydro-4H-naphtho(2,3-b)(1,4)thiazine",CCCN1CCS[C@H]2[C@H]1CC3=C(C=CC(=C3C2)OC)OC,,,,,,
2799,3082802,Dpohbq,CCCN1CCN[C@@H]2[C@@H]1CC3=C(C=CC(=C3C2)OC)OC,,,,,,
2800,3082803,1-(N(2)-Benzyloxycarbonylornithyl-gamma-glutamyl)octahydro-1H-indole-2-carboxylic acid,C1CCC2C(C1)CC(N2C(=O)CC[C@H](C(=O)O)NC(=O)[C@H](CCCN)NC(=O)OCC3=CC=CC=C3)C(=O)O,,,,,,
2801,3082804,"But-2-enedioic acid; methyl 2-methylprop-2-enoate; propane-1,2-diol",CC(CO)O.CC(=C)C(=O)OC.C(=CC(=O)O)C(=O)O,,,,,,
2802,3082805,"N-((2,3-Dihydro-1,4-benzodioxin-2-yl)methyl)-5-methoxy-1H-indole-3-ethanamine",COC1=CC2=C(C=C1)NC=C2CCNCC3COC4=CC=CC=C4O3,,,,,,
2803,3082806,"(2R,3S,4S,5R,6S)-2-[[(2S,3R,4S,5S,6R)-6-[[(2S,3R,4S,5S,6S)-6-(fluoromethyl)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxymethyl]-6-methoxyoxane-3,4,5-triol",CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CF)O)O)O)O)O)O)O)O)O,,,,,,
2804,3082807,(2S)-2-[[(2S)-1-[(2S)-5-(diaminomethylideneamino)-2-(3-phenothiazin-10-ylpropanoylamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid,C1C[C@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)CCN2C3=CC=CC=C3SC4=CC=CC=C42)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)O,,,,,,
2805,3082808,Tryptophyl-leucyl-glutamic acid,CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N,,,,,,
2806,3082809,12-Iodooctadec-9-enoic acid,CCCCCCC(CC=CCCCCCCCC(=O)O)I,,,,,,
2807,3082810,"2-(2-Furanyl)-8,9-dihydro-7H-cyclopenta(e)(1,2,4)triazolo(1,5-c)pyrimidin-5-amine",C1CC2=C(C1)N=C(N3C2=NC(=N3)C4=CC=CO4)N,,,,,,
2808,3082811,CID 3082811,CCC1C[C@H]2[C@]([C@@H]1CCCC[C@H](CC)O)(CCCC2(C)C=CC3=C(C=C[C@H](C3)O)C)C,,,,,,
2809,3082812,CID 3082812,[3H]CC(=O)NC1C(CC(OC1C(C(CO)O)O)(C(=O)O)OC2C(C(OC(C2OC3C(C(C(C(O3)CO)O)OC4C(C(C(C(O4)CO)O)O)O)NC(=O)C)CO)OC5C(OC(C(C5O)O)OCC(C(C=CCCCCCCCCCCCCC)O)NC(=O)CCCCCCCCCCCNC6=C(C=C(C=C6)N=[N+]=[N-])[N+](=O)[O-])CO)O)O,,,,,,
2810,3082813,"1-(4-Hydroxy-3,5-ditert-butylbenzoyl)homopiperazine",CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C(=O)N2CCCNCC2,,,,,,
2811,3082814,"2-(4-(3,4-Dichlorophenylureido)phenoxy)-2-methylpropionic acid",CC(C)(C(=O)O)OC1=CC=C(C=C1)NC(=O)NC2=CC(=C(C=C2)Cl)Cl,,,,,,
2812,3082815,Hmeeb,C[C@H]1[C@H]2[C@@H]3C4=C([C@]1(CCN2CCO3)C)C=C(C=C4)O.Cl,,,,,,
2813,3082816,"(1S,8S,15S,16R)-8,16-dimethyl-14-oxa-11-azatetracyclo[6.6.2.02,7.011,15]hexadeca-2(7),3,5-trien-5-ol",C[C@H]1[C@H]2[C@@H]3C4=C([C@]1(CCN2CCO3)C)C=C(C=C4)O,,,,,,
2814,3082817,"(2R,3R,4S,5S,6R)-2-hex-2-enoxy-6-(hydroxymethyl)oxane-3,4,5-triol",CCCC=CCO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O,,,,,,
2815,3082818,oNADH,C1=CC(=C[N+](=C1)C(C=O)OC(COP(=O)([O-])OP(=O)(O)OCC2C(C(C(O2)N3C=NC4=C(N=CN=C43)N)O)O)C=O)C(=O)N,,,,,,
2816,3082819,"[[5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [2-[1-(3-carbamoylpyridin-1-ium-1-yl)-2-oxoethoxy]-3-oxopropyl] hydrogen phosphate",C1=CC(=C[N+](=C1)C(C=O)OC(COP(=O)(O)OP(=O)(O)OCC2C(C(C(O2)N3C=NC4=C(N=CN=C43)N)O)O)C=O)C(=O)N,,,,,,
2817,3082820,CID 3082820,CC1=C(NC2=C1CCN3C(=C2)C(=C(C3=CC4=NC(=O)C(=C4CCC(=O)OC)C)CCC(=O)OC)C)C=C5C(=C(C(=O)N5)C)C=C,,,,,,
2818,3082821,"[(2R,3S,4R,5R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-5-[5-methyl-2-oxo-4-[2-[6-[(2,2,2-trifluoroacetyl)amino]hexylideneamino]ethylamino]pyrimidin-1-yl]oxolan-3-yl]oxy-N-tert-butyl-N-propan-2-ylphosphonamidic acid",CC1=CN(C(=O)N=C1NCCN=CCCCCCNC(=O)C(F)(F)F)[C@H]2[C@@H]([C@@H]([C@H](O2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)OP(=O)(N(C(C)C)C(C)(C)C)O)O,,,,,,
2819,3082822,"21,21-Dichloroprogesterone",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)C(Cl)Cl)CCC4=CC(=O)CC[C@]34C,,,,,,
2820,3082823,"21,21-Dichloropregnenolone",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)C(Cl)Cl)CC=C4[C@@]3(CC[C@@H](C4)O)C,,,,,,
2821,3082824,"4-Benzofurazanamine, N,N-dihexadecyl-7-nitro-",CCCCCCCCCCCCCCCCN(CCCCCCCCCCCCCCCC)C1=CC=C(C2=NON=C12)[N+](=O)[O-],,,,,,
2822,3082825,Tyrosyl-arginyl-glycyl-phenylalanine ethyl ester,CCOC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)N,,,,,,
2823,3082826,Valine thiazole,CCOC(=O)C1=CSC(=N1)[C@@H](C(C)C)NC(=O)OCC2=CC=CC=C2,,,,,,
2824,3082827,"(2S)-1-[(2S)-6-amino-2-[hydroxy(4-phenylbutyl)phosphoryl]oxyhexanoyl]-2,3-dihydroindole-2-carboxylic acid",C1[C@H](N(C2=CC=CC=C21)C(=O)[C@H](CCCCN)OP(=O)(CCCCC3=CC=CC=C3)O)C(=O)O,,,,,,
2825,3082828,"[[5-(2,4-Dioxopyrimidin-1-yl)-3-oxooxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate",C1C(OC(C1=O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)N2C=CC(=O)NC2=O,,,,,,
2826,3082829,N-(alpha-Carboxy-2-nitrobenzyl)carbamoylcholine,C[N+](C)(C)CCOC(=O)NC(C1=CC=CC=C1[N+](=O)[O-])C(=O)O.C(=O)(C(F)(F)F)O,,,,,,
2827,3082830,(2-Nitrophenyl)[2-(trimethylaminio)ethoxycarbonylamino]acetic acid,C[N+](C)(C)CCOC(=O)NC(C1=CC=CC=C1[N+](=O)[O-])C(=O)O,,,,,,
2828,3082831,"(2S,3R,4R)-2,3,4-trihydroxy-6-oxoheptanedioic acid",C([C@H]([C@H]([C@@H](C(=O)O)O)O)O)C(=O)C(=O)O,,,,,,
2829,3082832,CID 3082832,CC(=O)S[C@@H]1C=C[C@H]2[C@@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)O)CCN3C,,,,,,
2830,3082833,CID 3082833,C1C[C@H](N(C1)C(=O)C=NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)N)NCC(=O)O)C(=O)NCC(=O)N[C@@H](CC=CC=N)C(=O)N3CCC[C@H]3C(=O)NCC(=O)N4CCC[C@@]4(CCN)C=O,,,,,,
2831,3082834,N-Acetyl-9-deoxyneuraminic acid,C[C@H]([C@H]([C@H]1[C@@H]([C@H](C[C@](O1)(C(=O)O)O)O)NC(=O)C)O)O,,,,,,
2832,3082835,"N-Acetyl-4,7-dideoxyneuraminic acid",CC(=O)N[C@H]1CC[C@](O[C@@H]1CC(CO)O)(C(=O)O)O,,,,,,
2833,3082836,2-(Trimethylsilyl)ethyl beta-galactopyranoside,C[Si](C)(C)CCO[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O,,,,,,
2834,3082837,2-Dimethylaminomethylcyclohexyl benzoate,CN(C)C[C@@H]1CCCC[C@@H]1OC(=O)C2=CC=CC=C2,,,,,,
2835,3082838,CID 3082838,CC(=O)NCC=C1C=CC(=O)C(=C1)O,,,,,,
2836,3082839,4-Chlorobenzoyl-CoA,CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)[C@H](C(=O)NCCC(=O)NCCSC(=O)C4=CC=C(C=C4)Cl)O,,,,,,
2837,3082840,"2,2'-(4-Methacryloxydiethoxyphenyl)propane",CCOC1=C(C=CC(=C1OCC)OC(=O)C(=C)C)C(C)(C)C2=C(C(=C(C=C2)OC(=O)C(=C)C)OCC)OCC.CC(C)(C(COC=C)OC(COC=C)C(C)(C)C(=O)O)C(=O)O,,,,,,
2838,3082841,"3-(3-Carboxy-1-ethenoxy-3-methylbutan-2-yl)oxy-4-ethenoxy-2,2-dimethylbutanoic acid",CC(C)(C(COC=C)OC(COC=C)C(C)(C)C(=O)O)C(=O)O,,,,,,
2839,3082842,"[4-[2-[2,3-Diethoxy-4-(2-methylprop-2-enoyloxy)phenyl]propan-2-yl]-2,3-diethoxyphenyl] 2-methylprop-2-enoate",CCOC1=C(C=CC(=C1OCC)OC(=O)C(=C)C)C(C)(C)C2=C(C(=C(C=C2)OC(=O)C(=C)C)OCC)OCC,,,,,,
2840,3082843,L-Tyrosylglycylglycyl-L-phenylalanyl-L-leucylglycyl-L-prolyl-L-lysyl-2-methylalanyl-L-leucyl-2-methylalanyl-L-lysyl-2-methylalanyl-L-leucyl-2-methylalanine methyl ester,CC(C)C[C@@H](C(=O)C(C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)[C@H](CC3=CC=C(C=C3)O)N)[C@@](C)(C(=O)OC)N(C(=O)[C@H](CCCCN)NC(=O)C(C)(C)N)C(=O)[C@H](CC(C)C)NC(=O)C(C)(C)N)NC(=O)C(C)(C)N,,,,,,
2841,3082844,"Enkephalin-leu, gly-pro-(lys-pro-pro-pro)2-ome-",CC(C)C[C@@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N3CCC[C@H]3C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCCN)C(=O)N5CCC[C@H]5C(=O)N6CCC[C@H]6C(=O)N7CCC[C@H]7C(=O)OC)NC(=O)[C@H](CC8=CC=CC=C8)NC(=O)CNC(=O)CNC(=O)[C@H](CC9=CC=C(C=C9)O)N,,,,,,
2842,3082845,"Enkephalin-leu, gly-pro-(lys-sar-sar-sar)(2)-ome-",CC(C)C[C@@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)C(C(=O)CNC)(C(=O)CNC)N(C(=O)CNC)[C@](C(=O)CNC)(C(=O)[C@H](CCCCN)NC(=O)CNC)C(=O)OC)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)[C@H](CC3=CC=C(C=C3)O)N,,,,,,
2843,3082846,"1,1-Diethoxytetradecane",CCCCCCCCCCCCCC(OCC)OCC,,,,,,
2844,3082847,3-Azi-1-methoxybutylgalactopyranoside,CCO[C@]1([C@]([C@H]([C@H]([C@H](O1)CO)O)O)(C2(N=N2)C)O)OC,,,,,,
2845,3082848,Rh(H2O)4ATP,[H+].C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O)O)N.O.O.O.O.[Rh+3],,,,,,
2846,3082849,Rh(H2O)3ATP,[H+].C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O)O)N.O.O.O.[Rh+3],,,,,,
2847,3082850,Cdhppg,C1CCC(CC1)P(C2CCCCC2)C3=CC=CC=C3.C1CCC(CC1)P(C2CCCCC2)C3=CC=CC=C3.[Cl-].[Au+],,,,,,
2848,3082851,"3'-O-(5-Fluoro-2,4-dinitrophenyl)ATP ether",C1=C(C(=CC(=C1[N+](=O)[O-])F)O[C@@H]2[C@H](O[C@H]([C@@H]2O)N3C=NC4=C(N=CN=C43)N)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[N+](=O)[O-],,,,,,
2849,3082852,"3'-O-(5-Fluoro-2,4-dinitrophenyl)ADP ether",C1=C(C(=CC(=C1[N+](=O)[O-])F)O[C@@H]2[C@H](O[C@H]([C@@H]2O)N3[14CH]=NC4=C(N=CN=C43)N)COP(=O)(O)OP(=O)(O)O)[N+](=O)[O-],,,,,,
2850,3082853,Caudoxirene,C=C[C@@H]1CC=C[C@H]1[C@@H]2[C@H](O2)C=C,,,,,,
2851,3082854,Nickel(II) perbromate,O.O.O.O.O.O.[O-]Br(=O)(=O)=O.[O-]Br(=O)(=O)=O.[Ni+2],,,,,,
2852,3082855,Drosulfakinin 0,C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)N)O,,,,,,
2853,3082856,Sesamoside,C[C@@]12[C@H]3[C@@H](OC=C([C@]3([C@@H]([C@@H]1O2)O)O)C(=O)OC)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,,,,,,
2854,3082857,Isoleucylcysteine,CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)N,,,,,,
2855,3082858,H-Tyrosyl-cyclo(cysteinyl-phenylalanyl-penicillaminyl)-OH,CC(C)([C@H](C(=O)OC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](CS)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)N)S,,,,,,
2856,3082859,"2,6-Dibromospirost-4-en-3-one",C[C@@H]1CCC2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4C[C@H](C6=CC(=O)[C@@H](C[C@]56C)Br)Br)C)C)OC1,,,,,,
2857,3082860,"(1-Carboxy-4-hydroxy-2,5-cyclohexadiene-1-yl)lactic acid",C1=CC(C=CC1O)(CC(C(=O)O)O)C(=O)O,,,,,,
2858,3082861,Ginsenol,C[C@]12CCC[C@@]3([C@]1(CC([C@@H]3CC2)(C)C)O)C,,,,,,
2859,3082862,Thcad,C1C(C(C(C(C1OC2C(C(C(C(O2)CO)O)O)N)O)O)O)CO,,,,,,
2860,3082863,CID 3082863,[H+].C1=NC2=C(N1C3C(C(C(O3)COP(=O)([O-])OP(=O)(NP(=O)([O-])[O-])[O-])O)O)NC(=NC2=O)N.O.O.O.O.[Cr+3],,,,,,
2861,3082864,CID 3082864,C[C@H](CCCC=CC[C@H](C=CC=CC=C[C@H](CCCC(=O)O)O)O)O,,,,,,
2862,3082865,Benzyloxycarbonyl-leucyl-methionine-H,CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C=O)NC(=O)OCC1=CC=CC=C1,,,,,,
2863,3082866,CID 3082866,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@H]([C@H](O[C@H]2OC3=C(OC4=CC(=O)C=C(C4=C3O)O)C5=CC(=C(C=C5)O)O)CO)O)O)O)O)O,,,,,,
2864,3082867,Dddmcdd,CCOC(=O)C12C3C4C5C1C6=C(C5C2(C4C7=C3CCC7=O)C(=O)OCC)CCC6=O,,,,,,
2865,3082868,CID 3082868,CCCCCC=CCC=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(=O)C(=O)O,,,,,,
2866,3082869,Leucyl-valyl-isoleucinamide,CC[C@H](C)[C@@H](C(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N,,,,,,
2867,3082870,Momc acid,CC[C@H](C)C(=O)OC[C@H]1CCCC[C@@H]1CCC(=O)C[C@H](CC(=O)O)O,,,['Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. (See all compounds classified as Hydroxymethylglutaryl-CoA Reductase Inhibitors.)'],,,
2868,3082871,8-Azido-2'-deoxyadenosine-5'-triphosphate,C1[C@@H]([C@H](O[C@H]1N2C3=NC=NC(=C3N=C2N=[N+]=[N-])N)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,,,,,,
2869,3082872,Spermexatin,CN(C(=O)CCC(=O)N(CCCCNC(=O)CCC(=O)NCO)CCCNC(=O)CCC(=O)NCO)O,,,,,,
2870,3082873,Spermexatol,CN(C(=O)CCC(=O)N(CCCCNC(=O)C1=C(C(=CC=C1)O)O)CCCNC(=O)C2=C(C(=CC=C2)O)O)O,,,,,,
2871,3082874,Hmb-cimu,C1CCC(CC1)N=C(N2CCOCC2)N(C3CCCCC3)C(=O)NCCCCCCNC(=O)N(C4CCCCC4)C(=NC5CCCCC5)N6CCOCC6,,,,,,
2872,3082875,Tris(2-pyridylmethyl)amine triperchlorate,C1=CC=NC(=C1)CN(CC2=CC=CC=N2)CC3=CC=CC=N3.OCl(=O)(=O)=O.OCl(=O)(=O)=O.OCl(=O)(=O)=O,,,,,,
2873,3082876,Ningpeisine,C[C@H]1CC[C@@H](N(C1)C)[C@@H](C)[C@@H]2CC[C@@H]3[C@H]([C@H]2C)C[C@H]4[C@H]3CC(=O)[C@@H]5[C@@]4(CC[C@@H](C5)O)C,,,,,,
2874,3082877,CID 3082877,C[C@H](C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N(C2=CC=C(C=C2)[N+](=O)[O-])[C@@H](CC(=O)N)C(=O)O)NC(=O)OC(C)(C)C,,,,,,
2875,3082878,"[6-[[10-formyl-5,14-dihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-2-methyloxan-3-yl] 4-[2-(4-azido-3-iodophenyl)ethylamino]-4-oxobutanoate",CC1C(C(CC(O1)OC2CCC3(C4CCC5(C(CCC5(C4CCC3(C2)O)O)C6=CC(=O)OC6)C)C=O)OC)OC(=O)CCC(=O)NCCC7=CC(=C(C=C7)N=[N+]=[N-])I,,,,,,
2876,3082879,"2-Amino-3-(pyrazolo(1,5-a)pyridin-3-yl)propionic acid",C1=CC2=C(C=NN2C=C1)CC(C(=O)O)N,,,,,,
2877,3082880,1-Glucopyranosylpyrid-2(1H)-one-6-acetic acid,C1=CC(=O)N(C(=C1)CC(=O)O)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
2878,3082881,3-(4-hydroxy-3-methoxyphenyl)-N-(2-hydroxy-5-oxocyclopenten-1-yl)prop-2-enamide,COC1=C(C=CC(=C1)C=CC(=O)NC2=C(CCC2=O)O)O,,,,,,
2879,3082882,O-Bromoacetylthiamine,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOC(=O)CBr,,,,,,
2880,3082883,APGPR Enterostatin,C[C@@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N,['Investigated for use/treatment in ulcerative colitis.'],"['Patients with UC have reduced AP levels and activity in the inflamed tissue in the intestines. A short treatment with AP helps to restore the intestinal mucosal barrier in UC patients, which can be classified as a disease modifying antiinflammatory effect.']",,,,
2881,3082884,CID 3082884,CC(=CC(=O)N(CCCC(C(=O)OCCC(=CC(=O)N(CCCC1C(=O)NC(C(=O)N1)CCCN(C(=O)C)[O-])[O-])C)N(C)C)[O-])CCO.[Fe+3],,,,,,
2882,3082885,CID 3082885,CC(=CC(=O)N(CCCC(C(=O)OCCC(=CC(=O)N(CCCC1C(=O)NC(C(=O)N1)CCCN(C(=O)C)[O-])[O-])C)N(C)C)[O-])CCO,,,,,,
2883,3082886,CID 3082886,CC(=CC(=O)N(CCCC1C(=O)NC(C(=O)N1)CCCN(C(=O)C=C(C)CCOC(=O)C(CCCN(C(=O)C)[O-])N(C)C)[O-])[O-])CCO.[Fe+3],,,,,,
2884,3082887,CID 3082887,CC(=CC(=O)N(CCCC1C(=O)NC(C(=O)N1)CCCN(C(=O)C=C(C)CCOC(=O)C(CCCN(C(=O)C)[O-])N(C)C)[O-])[O-])CCO,,,,,,
2885,3082888,CID 3082888,CC(=CC(=O)N(CCCC1C(=O)NC(C(=O)N1)CCCN(C(=O)C=C(C)CCOC(=O)C(CCCN(C(=O)C=C(C)CCO)[O-])N(C)C)[O-])[O-])CCO.[Fe+3],,,,,,
2886,3082889,CID 3082889,CC(=CC(=O)N(CCCC1C(=O)NC(C(=O)N1)CCCN(C(=O)C=C(C)CCOC(=O)C(CCCN(C(=O)C=C(C)CCO)[O-])N(C)C)[O-])[O-])CCO,,,,,,
2887,3082890,Cefazolin delta-3-methyl ester,CC1=NN=C(S1)SCC2=CS[C@@H]3[C@@H](C(=O)N3C2C(=O)OC)NC(=O)CN4C=NN=N4,,,,,,
2888,3082891,Trisgalactosylglycine,C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)OCC(CO[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)(CO[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O)NC(=O)CN)O)O)O)O,,,,,,
2889,3082892,N-Octanoyl-asparaginyl-tyrosyl-threoninamide,CCCCCCCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N,,,,,,
2890,3082893,"N-[1-[[1-[(5-azido-1-cyclohexyl-3,4-dihydroxypentan-2-yl)amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-methylpropanamide",CC(C)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC2=CN=CN2)C(=O)NC(CC3CCCCC3)C(C(CN=[N+]=[N-])O)O,,,,,,
2891,3082894,"Dopamine, N-benzyloxycarboxyl-lys-pro-amide-",C1C[C@H](N(C1)C(=O)CC2=CC(=C(C=C2)O)O)C(=O)NC(=O)[C@H](CCCCN)NC(=O)OCC3=CC=CC=C3,,,,,,
2892,3082895,"Dopamine, lys-pro-amide-",C1C[C@H](N(C1)C(=O)CC2=CC(=C(C=C2)O)O)C(=O)NC(=O)[C@H](CCCCN)N,,,,,,
2893,3082896,"Dopamine, gly-pro-amide-",C1C[C@H](N(C1)C(=O)CC2=CC(=C(C=C2)O)O)C(=O)NC(=O)CN,,,,,,
2894,3082897,"3-[4beta-(Piperidin-2alpha-yl)-2beta-ethyl-1,3-dioxolan-2-yl]phenyl isothiocyanate",CC[C@@]1(OC[C@@H](O1)[C@@H]2CCCCN2)C3=CC(=CC=C3)N=C=S,,,,,,
2895,3082898,CID 3082898,CCCCCCCCCCCCCCCCC=CCC=CCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCC=CCC=CCCCCCCCCCCCCCCCC,,,,,,
2896,3082899,CID 3082899,CCCCCCCCCCCCCCCCC=CCC=CCCCCC(=O)OC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCC=CCC=CCCCCCCCCCCCCCCCC,,,,,,
2897,3082900,CID 3082900,CC[C@H](C(=O)NCC=CC=C(C)[C@H]([C@@H](C)C([C@H](C=CC=CC=CC=C(C)C(=O)C1=C(N(C=CC1=O)C)O)O)O)OC)[C@@]2(C[C@@H](C([C@@H](O2)C=CC=CC)(C)C)O[C@H]3[C@@H]([C@@H]([C@@H]([C@H](O3)C)O[C@H]4[C@@H]([C@@H]([C@H]([C@@H](O4)C)O)O)OC)OC)O)O,,,,,,
2898,3082901,3-Benzoylcholic acid,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)OC(=O)C5=CC=CC=C5)C)O)O)C,,,,,,
2899,3082902,Methoxyacetylcarbamide,COCC(=O)NC(=O)N,,,,,,
2900,3082903,"Bradykinin, phe(8)-psi-CH2NH-arg(9)-",C1C[C@H](N(C1)C(=O)[C@@H]2CCCN2C(=O)[C@H](CCCN=C(N)N)N)C(=O)NCC(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CO)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CC5=CC=CC=C5)CN[C@@H](CCCN=C(N)N)C(=O)O,,,,,,
2901,3082904,"4'-Mat-3,4-adduct",CC1=COC2=C1C3=C(C=C2)C4C(C(=O)O3)C5(C4NC(=O)NC5=O)C,,,,,,
2902,3082905,"3-O-(4-O-Galactopyranosyl-glucopyranosyl)-1,2-di-O-tetradecyl-sn-glyceryol",CCCCCCCCCCCCCCO[C@@]1([C@@H]([C@H](O[C@H]([C@@]1(O)OCCCCCCCCCCCCCC)OCCC)CO[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O)O,,,,,,
2903,3082906,Tdo-HT,C1=CC(=C(C2=C1NC=C2CCN)C3=C(C4=C(N3)C=CC(=C4C5=CC(=O)C(=O)C6=C5NC=C6CCN)O)CCN)O,,,,,,
2904,3082907,CID 3082907,C[C@@H](C=C[C@@H](C)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3C2=CCC4[C@@]3(CCC(=O)C4)C)C)O)C(C)C,,,,,,
2905,3082908,2-Isothiocyanato-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)benzeneacetamide,CN([C@H]1CCCC[C@@H]1N2CCCC2)C(=O)CC3=CC=CC=C3N=C=S,,,,,,
2906,3082909,2-Methylthiocarbapenem,C[C@H]([C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)O)SC)O,,,,,,
2907,3082910,"(2R,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-(2-chloro-4-nitrophenyl)-4,5-dihydroxy-6-(hydroxymethyl)-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol",C1=CC(=C(C=C1[N+](=O)[O-])Cl)[C@]2([C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,,,,,,
2908,3082911,Sulfoenolpyruvate,C=C(C(=O)O)OS(=O)(=O)O,,,,,,
2909,3082912,4-Trifluoroacetamidophenyl-1-O-glucopyranosylribitol-1'-phosphate,C1=CC(=CC=C1NC(=O)C(F)(F)F)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)OC[C@@H]([C@@H]([C@@H](COP(=O)(O)O)O)O)O)O,,,,,,
2910,3082913,Chloroorienticin C,CC1C(C(CC(O1)OC2C3C(=O)NC(C4=C(C(=CC(=C4)O)O)C5=C(C=CC(=C5)C(C(=O)N3)NC(=O)C6C7=CC(=C(C(=C7)OC8=C(C=C2C=C8)Cl)O)OC9=C(C=C(C=C9)C(C(C(=O)NC(C(=O)N6)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)O)C(=O)O)(C)N)O,,,,,,
2911,3082914,Chloroorienticin D,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C7C(=O)NC(C8=C(C(=CC(=C8)O)O)C9=C(C=CC(=C9)C(C(=O)N7)NC(=O)C5NC(=O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC(=O)C(CC(C)C)N(C)C)CC(=O)N)O)C(=O)O)OC1CC(C(C(O1)C)O)(C)N)Cl)CO)O)O)(C)N)O,,,,,,
2912,3082915,Chloroorienticin E,CC1C(C(CC(O1)OC2C3C(=O)NC(C4=C(C(=CC(=C4)O)O)C5=C(C=CC(=C5)C(C(=O)N3)NC(=O)C6C7=CC(=C(C(=C7)OC8=C(C=C2C=C8)Cl)OC9C(C(C(C(O9)CO)O)O)O)OC1=C(C=C(C=C1)C(C(C(=O)NC(C(=O)N6)CC(=O)N)NC(=O)C(CC(C)C)N(C)C)O)Cl)O)C(=O)O)(C)N)O,,,,,,
2913,3082916,N-(N-Maleoylglycyl)-2-amino-2-deoxyglucopyranose,C1=CC(=O)N(C1=O)CC(=O)N[C@@H]2[C@H]([C@@H]([C@H](OC2O)CO)O)O,,,,,,
2914,3082917,CID 3082917,CCCCC1=NC(=C(N1CC2=CC=CC=C2Cl)CC(=O)[O-])Cl.[Na+],,,,,,
2915,3082918,[2-Butyl-5-chloro-3-(2-chloro-benzyl)-3H-imidazol-4-yl]-acetic acid,CCCCC1=NC(=C(N1CC2=CC=CC=C2Cl)CC(=O)O)Cl,,,,,,
2916,3082919,B-Tapp,C1=CC=C(C(=C1)CCN)CSSCC2=CC=CC=C2CCN.Cl.Cl,,,,,,
2917,3082920,2-[2-[[[2-(2-Aminoethyl)phenyl]methyldisulfanyl]methyl]phenyl]ethanamine,C1=CC=C(C(=C1)CCN)CSSCC2=CC=CC=C2CCN,,,,,,
2918,3082921,Bispyridoxal tetraphosphate,CC1=NC=C(C(=C1O)C=O)COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OCC2=CN=C(C(=C2C=O)O)C,,,,,,
2919,3082922,Dmatu,C[C@]12[C@@H]3CC[C@H]1C(=O)N([C@H]2C=CC3)C(C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
2920,3082923,Poly(N-isopropylacrylamide-N-n-butylacrylamide-N-acryloxysuccinimide),CCCCNC(=O)C=C.CC(C)NC(=O)C=C.C=CC(=O)ON1C(=O)CCC1=O,,,,,,
2921,3082924,8-O-(4-Amino-4-deoxyarabinopyranosyl)-3-deoxyoctulosonic acid,C1[C@@H]([C@@H]([C@H]([C@H](O1)OC[C@H]([C@H]([C@@H]([C@@H](CC(=O)CO)O)O)O)O)O)O)N,,,,,,
2922,3082925,Butyloxycarbonyl-lysinyl-tryptophyl-glycyl-lysine,CC(C)(C)OC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O,,,,,,
2923,3082926,4-Chlorophenoxyisobutyric acid hydrazide,CC(COC1=CC=C(C=C1)Cl)C(=O)NN,,,,,,
2924,3082927,CID 3082927,CCC(C)C(=O)OC(C)C1(C(OC(CC1OC)OC2C(C(OC(C2OC(=O)C3C(SC(=S)N3)C)COC(=O)C)C4(CC(=O)C(=C(C4=O)C(=O)O)N)O)O)C)O,,,,,,
2925,3082928,"myo-Inositol 1,4-bisphosphothioate",[C@H]1([C@@H](C([C@H]([C@@H](C1OP(=S)(O)O)O)O)OP(=S)(O)O)O)O,,,,,,
2926,3082929,CID 3082929,CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)C4=CC(=C(C=C4)O)O)C(=O)O,,,,,,
2927,3082930,CID 3082930,CC1=CC=C[C@@H](CC2N3C(CO2)C(C34CCC=C4C(=O)O[C@H](C(=C)C=CC(=O)N=CN=C1)C(C)C)O)O,,,,,,
2928,3082931,"2-(4-Chlorophenyl)-3H-imidazo(4,5-b)pyridine-3-acetamide",C1=CC2=C(N=C1)N(C(=N2)C3=CC=C(C=C3)Cl)CC(=O)N,,,,,,
2929,3082932,"Methyl 9,12-bis[[dimethyl(1-methylethyl)silyl]oxy]-8-[1-[[dimethyl(1-methylethyl)silyl]oxy]-3-oxo-3-(propylamino)propyl]-5,10-heptadecadienoate",CCCCCC(C=CC(C(CC=CCCCC(=O)OC)C(CC(=O)NCCC)O[Si](C)(C)C(C)C)O[Si](C)(C)C(C)C)O[Si](C)(C)C(C)C,,,,,,
2930,3082933,Dansyl-platelet activating factor,CC(=O)O[C@H](COCCCCCCCCCCCNS(=O)(=O)C1=CC=CC2=C1C=CC=C2N(C)C)COP(=O)([O-])OCC[N+](C)(C)C,,,,,,
2931,3082934,2-[[(2R)-2-acetyloxy-3-[11-[[5-(dimethylamino)naphthalen-1-yl]sulfonylamino]undecoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium,CC(=O)O[C@H](COCCCCCCCCCCCNS(=O)(=O)C1=CC=CC2=C1C=CC=C2N(C)C)COP(=O)(O)OCC[N+](C)(C)C,,,,,,
2932,3082935,msADP,C1=C(N=CN=C1N)CC2C(C(C(O2)COP(=O)(O)OP(=O)(O)O)O)O,,,,,,
2933,3082936,2-Hydroxyethyl 2-methylprop-2-enoate--hydroxymethyl 2-methylprop-2-enoate (1/1),CC(=C)C(=O)OCCO.CC(=C)C(=O)OCO,,,,,,
2934,3082937,"4',5'-Dimethylfluorescein",CC1=C(C=CC2=C1OC3=C(C24C5=CC=CC=C5C(=O)O4)C=CC(=C3C)O)O,,,,,,
2935,3082938,"1-[6-[3-(4-Hydroxybutyl)oxiran-2-yl]pyridin-2-yl]undeca-1,5-dien-3-ol",CCCCCC=CCC(C=CC1=NC(=CC=C1)C2C(O2)CCCCO)O,,,,,,
2936,3082939,Dmt-tdmtt,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)(C(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)O[C@H]6C[C@@H](O[C@@H]6COC(C7=CC=CC=C7)(C8=CC=C(C=C8)OC)C9=CC=C(C=C9)OC)N1C=C(C(=O)NC1=O)C)O,,,,,,
2937,3082940,Dimethyldiazaperopyrenium,C[N+]1=CC2=C3C(=C1)C=CC4=C5C=CC6=C[N+](=CC7=C6C5=C(C=C7)C(=C43)C=C2)C,,,,,,
2938,3082941,"N-Isopropyl-3-amino-2-(3,4-dihydroxyphenyl)-2-hydroxybicyclo(2.2.1)heptane",CC(C)NC1C2CCC(C2)C1(C3=CC(=C(C=C3)O)O)O,,,,,,
2939,3082942,Antho-rwamide II,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N)NC(=O)CNC(=O)[C@@H]3CCC(=O)N3,,,,,,
2940,3082943,CID 3082943,CCCCC[C@@H](C=C[C@H]1[C@@H](C([C@@H]2C1CC(=CCCC(C(=O)O)(F)F)O2)(F)F)O)O,,,,,,
2941,3082944,10-Thiaprostanoic acid,CCCCCCCC[C@H]1CSC[C@@H]1CCCCCCC(=O)O,,,,,,
2942,3082945,"(Morpholinyl-2-methoxy)-8-tetrahydro-1,2,3,4-quinoline",C1CC2=C(C(=CC=C2)OCC3CNCCO3)NC1,,,,,,
2943,3082946,Viscumneoside VI,CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)OC2=CC(=C3C(=O)C[C@H](OC3=C2)C4=CC(=C(C=C4)O)OC)O)O)O)O,,,,,,
2944,3082947,"22,26-Epiminocholest-5-ene-3,16,20-triol",C[C@H]1CCC(NC1)[C@@](C)([C@H]2[C@H](C[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4(CC[C@@H](C5)O)C)C)O)O,,,,,,
2945,3082948,CID 3082948,CC(=CCCC(=CCC1=C(C(=O)C2=CC=CC=C2C1=O)C(F)(F)F)C)C,,,,,,
2946,3082949,Magau,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1NC(=O)N)CO)O[C@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O,,,,,,
2947,3082950,2-(4-Chlorophenoxy)-2-phenylacetic acid,C1=CC=C(C=C1)C(C(=O)O)OC2=CC=C(C=C2)Cl,,,,,,
2948,3082951,4-[(1-amino-1-oxo-3-phenylpropan-2-yl)amino]-3-[2-[[3-(1H-indol-3-yl)-2-[[5-[[2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(4-sulfooxyphenyl)propanoyl]amino]-4-oxononanoyl]amino]propanoyl]amino]hexanoylamino]-4-oxobutanoic acid,CCCCC(C(=O)CCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCCC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)OC(C)(C)C,,,,,,
2949,3082952,3-Pentynoyl-S-pantetheine-11-pivalate,CC#CCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COC(=O)C(C)(C)C)O,,,,,,
2950,3082953,Ncmaeo,C[C@]12CC[C@H]3[C@H]([C@@H]1CC(=O)N(C2)Cl)CCC4=C3C=CC(=C4)OC,,,,,,
2951,3082954,Somnium,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,,,,,,
2952,3082955,Dcadc,CC(C)N(C(C)C)C(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CCC(=C4)C(=O)O)C)C,,,,,,
2953,3082956,"[4-(6-oxo-4,5-dihydro-1H-pyridazin-3-yl)phenyl]methyl 2,6-dimethyl-5-nitro-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate",CC1=C(C(C(=C(N1)C)[N+](=O)[O-])C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCC3=CC=C(C=C3)C4=NNC(=O)CC4,,,,,,
2954,3082957,Dphpdpg,CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(CC(COP(=O)(CC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)O)O)O)OC(=O)CCCCCCCCCCCCCCC,,,,,,
2955,3082958,CID 3082958,C([C@@H](C(=O)O)NC=CC=O)O,,,,,,
2956,3082959,"10-(3',5'-Dimethylphenyl)-3-methylflavin",CC1=CC(=CC(=C1)N2C3=C(C=C(C(=C3)C)C)N=C4C2=NC(=O)N(C4=O)C)C,,,,,,
2957,3082960,Kliostom,CC1=NC=C(N1CCOC(=O)C2=CC=CC=C2)[N+](=O)[O-].C1=CC(=C(C=C1Cl)O)OC2=C(C=C(C=C2)Cl)Cl,,,,,,
2958,3082961,"N(6)-(N((4-Azido-3,5,6-trifluoro)pyridin-2-yl)-2-aminoethyl)adenosine 5'-monophosphate",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)NCCNC4=NC(=C(C(=C4F)N=[N+]=[N-])F)F,,,,,,
2959,3082962,Ditc-xac,CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC=C(C=C3)OCC(=O)NCCNC(=O)SNC4=CC(=CC=C4)N=C=S,,,,,,
2960,3082963,"S-[4-[(2-aminoethylamino)sulfanylcarbonylamino]anilino] N-[2-[[2-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenoxy]acetyl]amino]ethyl]carbamothioate",CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC=C(C=C3)OCC(=O)NCCNC(=O)SNC4=CC=C(C=C4)NC(=O)SNCCN,,,,,,
2961,3082964,Enp maltoheptaoside,CC1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@H](O2)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)OC4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)O)O[C@@H]7[C@H](O[C@@H]([C@@H]([C@H]7O)O)OC8=CC=C(C=C8)[N+](=O)[O-])CO)CO)CO)CO)CO)O)O,,,,,,
2962,3082965,CID 3082965,CCCOC1=CC=CC=C1C2=NC(=O)C3=C(N2)N=CN3,,,,,,
2963,3082966,12-Hydroxy-16-heptadecynoic acid,C#CCCCC(CCCCCCCCCCC(=O)O)O,,,,,,
2964,3082967,"[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methyl dihydroxyphosphinimyl hydrogen phosphate",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)OP(=N)(O)O)O,,,,,,
2965,3082968,1-Iodo-MK 801,CC12C3=C(CC(N1)C4=CC=CC=C24)C(=CC=C3)I,,,,,,
2966,3082969,"Argipressin, (1-mercapto-4-methylcyclohexaneacetic acid)(1)-",CC1CCC2(CC1)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSS2)C(=O)N3CCC[C@H]3C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N)CC4=CC=CC=C4)CC5=CC=C(C=C5)O,,,,,,
2967,3082970,"Argipressin, (4-tert-butyl-1-mercaptocyclohexaneacetic acid)(1)-",CC(C)(C)C1CCC(CC1)(CC(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C=S)C(=O)N4CCC[C@H]4C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N)S,,,,,,
2968,3082971,"Argipressin, (1-mercapto-4-phenylcyclohexaneacetic acid)(1)-",C1C[C@H](N(C1)C(=O)[C@@H]2CSSC3(CCC(CC3)C4=CC=CC=C4)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC5=CC=CC=C5)CC6=CC=C(C=C6)O)C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N,,,,,,
2969,3082972,3-Isocyano-4-methoxybutanoic acid,COCC(CC(=O)O)[N+]#[C-],,,,,,
2970,3082973,CID 3082973,CCCCC=CCC(=O)NCCNC(=O)CSSCC(=O)NCCNC(=O)CC=CCCCC,,,,,,
2971,3082974,CID 3082974,CC1=CC=C(C=C1)OC2C(C(C(O2)CO)OP(=O)([O-])OC(C)CNC(=O)CCC\3(C(C4C5C(C(C(=N5)/C(=C\6/C(C(C(=N6)C=C7C(C(C(=N7)/C(=C3\[N-]4)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CCC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)CC(=O)N)C)O.[C-]#N.[C-]#N.[Co+3],,,,,,
2972,3082975,"1-[3-[(14Z)-2,18-bis(2-amino-2-oxoethyl)-7,12,13,17-tetrakis(3-amino-3-oxopropyl)-3,5,8,8,13,15,18-heptamethyl-2,7,12,17,19,23-hexahydro-1H-corrin-3-yl]propanoylamino]propan-2-yl [4-hydroxy-2-(hydroxymethyl)-5-(4-methylphenoxy)oxolan-3-yl] hydrogen phosphate",CC1=CC=C(C=C1)OC2C(C(C(O2)CO)OP(=O)(O)OC(C)CNC(=O)CCC3(C(C4C5C(C(C(=N5)/C(=C\6/C(C(C(=CC7=NC(=C(C3=N4)C)C(C7(C)C)CCC(=O)N)N6)CCC(=O)N)(C)CCC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)CC(=O)N)C)O,,,,,,
2973,3082976,"(2R,3R,11R,12R)-1,4,7,10,13,16-Hexaoxacyclooctadecane-2,3,11,12-tetracarboxylic acid",C1CO[C@H]([C@@H](OCCOCCO[C@H]([C@@H](OCCO1)C(=O)O)C(=O)O)C(=O)O)C(=O)O,,,,,,
2974,3082977,5-(3-Dimethylaminomethyl-4-hydroxyphenylsulfonyl)thiophene-2-sulfonamide,CN(C)CC1=C(C=CC(=C1)S(=O)(=O)C2=CC=C(S2)S(=O)(=O)N)O.Cl,,,,,,
2975,3082978,5-[3-[(Dimethylamino)methyl]-4-hydroxyphenyl]sulfonylthiophene-2-sulfonamide,CN(C)CC1=C(C=CC(=C1)S(=O)(=O)C2=CC=C(S2)S(=O)(=O)N)O,,,,,,
2976,3082979,CID 3082979,C[C@@H](C(=O)NC(=O)[C@H](CCCCN)N[C@H](CCCN=C(N)N)C(=O)C[S+](C)C)N,,,,,,
2977,3082980,6-Chlorofructos-1-yl-glutathione,C(CC(=O)NC(CSCC(=O)C(C(C(CCl)O)O)O)C(=O)NCC(=O)O)C(C(=O)O)N,,,,,,
2978,3082981,4-Bromohomoibotenic acid,C(C1=C(C(=O)NO1)Br)[C@H](C(=O)O)N,,,,,,
2979,3082982,Udp-glcnac-mannaca,CC(=O)NC1C(C(C(OC1OC2C(OC(C(C2O)NC(=O)C)OP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)N4C=CC(=O)NC4=O)O)O)CO)C(=O)O)O)O,,,,,,
2980,3082983,7-(Bromoethoxyphenyl)tetrahydropalmatine,COC1=C(C2=C(CC3C4=CC(=C(C=C4CC[N+]3(C2)C5=CC=CC=C5OCCBr)OC)OC)C=C1)OC,,,,,,
2981,3082984,"5alpha-Dihydrotestosterone 3,17-bromoacetate",C[C@]12CC[C@@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4OC(=O)CBr)C)OC(=O)CBr,,,,,,
2982,3082985,"L-Tyrosine, N-(N-(N-(N-(N-(1-acetyl-L-prolyl)-L-phenylalanyl)-L-histidyl)-L-leucyl)-L-valyl)-",CC(C)C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@@H]4CCCN4C(=O)C,,,,,,
2983,3082986,"(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-acetamido-3-methylpentanoyl]amino]-3-(1H-imidazol-2-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoic acid",CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=NC=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)C,,,,,,
2984,3082987,21-Chloro-6-dehydrodanazol,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#CCl)O)C=CC4=CC5C(=C[C@]34C)C=NO5,,,,,,
2985,3082988,"5-Amino-8-vinylphthalazine-1,4(2H,3H)-dione-methyl methacrylate copolymer",CC(=C)C(=O)OC.C=CC1=C2C(=C(C=C1)N)C(=O)NNC2=O,,,,,,
2986,3082989,"5-Amino-8-ethenyl-2,3-dihydrophthalazine-1,4-dione",C=CC1=C2C(=C(C=C1)N)C(=O)NNC2=O,,,,,,
2987,3082990,CID 3082990,CCCC=CCC=CCC=CCC=CCC=CCCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O,,,,,,
2988,3082991,4-Fluoro-3-tyrosine,C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)F,,,,,,
2989,3082992,Dansyl-arginyl-phenylalaninamide,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N,,,,,,
2990,3082993,CID 3082993,CCC1C(C2C(O2)(C=CC(=O)C(CC(C(C(C(CC(=O)O1)OC(=O)C)C)OC3C(C(C(C(O3)C)OC4CC(C(C(O4)C)OC(=O)CC(C)C)(C)O)N(C)C)OC(=O)C)CC=O)C)C)COC(=O)C,,,,,,
2991,3082994,Papaverine hydrochloride mixture with phentolamine mesylate,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O.COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC.CS(=O)(=O)O.Cl,,,,,,
2992,3082995,CID 3082995,CCC1(C(=O)NC(=O)NC1=O)CC.CCOC1=C2C3=C(C[C@H]4[C@H]5[C@]3(CCN4C)[C@@H](O2)[C@H](C=C5)O)C=C1.CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N.Cl,,,,,,
2993,3082996,"[(2S,3S,4S,5R,6R)-5-hydroxy-2-methyl-6-[[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[2-(4-hydroxyphenyl)ethoxy]oxan-2-yl]methoxy]-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-3-yl] 3-(3,4-dimethoxyphenyl)prop-2-enoate",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OCCC3=CC=C(C=C3)O)O)O)O)O)O[C@H]4[C@@H]([C@H]([C@@H](CO4)O)O)O)OC(=O)C=CC5=CC(=C(C=C5)OC)OC,,,,,,
2994,3082997,CID 3082997,C[C@H]1C[C@H]([C@@H]2[C@H](C1)C=CC([C@H]2C(=O)C3=C(N([C@H](C3=O)C(C)C)C)O)[C@]4([C@@H](O4)C)C)C,,,,,,
2995,3082998,Dphgpt,CC(C)CCCC(C)CCCC(C)CCCC(C)CC(=O)OCC(COP(=O)(O)OCCCOP(=O)(O)O)OC(=O)CC(C)CCCC(C)CCCC(C)CCCC(C)C,,,,,,
2996,3082999,9-Ethoxyaristolactone,CCOC1=C2C3=C(C4=C1C(=CC=C4)OC)C5=C(C=C3C(=O)O2)OCO5,,,,,,
2997,3083000,Trichloro(cyclopentylamine)platinate(0),C1CCC(C1)N.C1CCC(C1)N.O.[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[K+].[K+].[Pt+2].[Pt+2],,,,,,
2998,3083001,"2-[[(2S)-2-[[1-[(4R,7S,10S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetic acid",CC[C@H](C)C1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)O)CC(=O)N)CCC(=O)N,,,,,,
2999,3083002,CID 3083002,C1C(C(OP(=O)(O1)O)C(=O)C2=CN=C3C(=N2)C(=O)N=C(N3)N)O,,,,,,
3000,3083003,Kalmagin,C(=O)(O)[O-].C(=O)([O-])[O-].C(=O)([O-])[O-].C(=O)([O-])[O-].[OH-].[OH-].[OH-].[OH-].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Ca+2],,,,,,
3001,3083004,(Galactopyranosyl(1-4)-fucopyranosyl(1-3))-N-acetylglucosamine 1-phosphate,C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)O[C@H]2C[C@H](O[C@]([C@@H]2NC(=O)C)(O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O)OP(=O)(O)O)CO)O)O)O,,,,,,
3002,3083005,CID 3083005,CN(CCN(C)C(=O)C(C(C(C(COS(=O)(=O)[O-])OS(=O)(=O)[O-])OC1C(C(C(C(O1)COS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])C(=O)C(C(C(C(COS(=O)(=O)[O-])OS(=O)(=O)[O-])OC2C(C(C(C(O2)COS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,,,,,
3003,3083006,"[2-[6-[Methyl-[2-[methyl-[2,3,5,6-tetrasulfooxy-4-[3,4,5-trisulfooxy-6-(sulfooxymethyl)oxan-2-yl]oxyhexanoyl]amino]ethyl]amino]-6-oxo-1,2,4,5-tetrasulfooxyhexan-3-yl]oxy-3,5-disulfooxy-6-(sulfooxymethyl)oxan-4-yl] hydrogen sulfate",CN(CCN(C)C(=O)C(C(C(C(COS(=O)(=O)O)OS(=O)(=O)O)OC1C(C(C(C(O1)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)C(=O)C(C(C(C(COS(=O)(=O)O)OS(=O)(=O)O)OC2C(C(C(C(O2)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O,,,,,,
3004,3083007,Ala-pro-ser-gly-ala-gln-arg-leu-tyr-gly-phe-gly-leu-NH2,C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)NCC(=O)N[C@@H](CC3=CC=CC=C3)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N)N,,,,,,
3005,3083008,Seldane-D,C[C@@H]([C@H](C1=CC=CC=C1)O)NC.CC(C)(C)C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O.Cl,,,,,,
3006,3083009,"1,5-Dimethyl-2-phenyl-4-propan-2-ylpyrazol-3-one;1,3,7-trimethylpurine-2,6-dione",CC1=C(C(=O)N(N1C)C2=CC=CC=C2)C(C)C.CN1C=NC2=C1C(=O)N(C(=O)N2C)C,,,,,,
3007,3083010,"2-[6-[[amino-[[amino-(4-chloroanilino)methylidene]amino]methylidene]amino]hexyl]-1-[amino-(4-chloroanilino)methylidene]guanidine;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoic acid",C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl.C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O.C([C@H]([C@H]([C@@H]([C@H](C(=O)O)O)O)O)O)O.C([C@H]([C@H]([C@@H]([C@H](C(=O)O)O)O)O)O)O,,,,,,
3008,3083011,Dccem,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)CC5SCCS5,,,,,,
3009,3083012,Antimony(V) phosphate,O.[OH-].[O-2].OP(=O)(O)O.[Sb+3],,,,,,
3010,3083013,CID 3083013,CC(=CCCC(=CCCC(=CCCC=C(C)CCC=C(C)CCC=NC)C)C)C,,,,,,
3011,3083014,Ashimycin A,CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)OC4C(C(C(O4)CO)O)(C(=O)O)O)O)NC)(C=O)O,,,,,,
3012,3083015,Ashimycin B,CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)N(C)C(=O)CO)(C=O)O,,,,,,
3013,3083016,Histamine-releasing peptide,CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)O)N,,,,,,
3014,3083017,Nomilin glucoside,CC(=O)O[C@@H]1CC(=O)OC([C@H]2[C@]1([C@H]3CC[C@@](C4([C@@]3(C(=O)C2)C)[C@@H](O4)C(=O)O)(C)C(C5=COC=C5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)(C)C,,,,,,
3015,3083018,CID 3083018,C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC3=CC=C(C=C3)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)N,,,,,,
3016,3083019,Cicatrol,CC(C)(CO)C(C(=O)NCCC(=O)[O-])O.CC(C)(CO)C(C(=O)NCCC(=O)[O-])O.COC1=CN=C(N=C1)[N-]S(=O)(=O)C2=CC=C(C=C2)N.[Ca+2].[Ag+],,,,,,
3017,3083020,Geneseroline,C[C@@]12CCN(O[C@@H]1N(C3=C2C=C(C=C3)O)C)C,,,,,,
3018,3083021,"2-[5-Methyl-6-(3,5,7,13-tetrahydroxy-4,6,12,14,16-pentamethylnonadeca-10,14,18-trien-2-yl)oxan-2-yl]propanoic acid",CC1CCC(OC1C(C)C(C(C)C(C(C)C(CCC=CC(C)C(C(=CC(C)CC=C)C)O)O)O)O)C(C)C(=O)O,,,,,,
3019,3083022,"11,18-Epoxy-6-hydroxy-3-oxoandrost-4-ene-17,18-carbolactone",C[C@]12C=CC(=O)C=C1[C@@H](C[C@@H]3[C@@H]2[C@@H]4CC5([C@H]3CC[C@@H]5C(=O)O)CO4)O,,,,,,
3020,3083023,Arsenous carbonate,C1(=O)O[As]2OC(=O)O[As](O1)OC(=O)O2,,,,,,
3021,3083024,CID 3083024,C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)SC=C=CBr)N,,,,,,
3022,3083025,Mn(5-Cl-Salahp)2,CO.C1=CC(=C(C=C1Cl)C=NCCC[O-])[O-].C1=CC(=C(C=C1Cl)C=NCCC[O-])[O-].[Mn],,,,,,
3023,3083026,"4-Chloro-6-[(3-hydroxypropylamino)methylidene]cyclohexa-2,4-dien-1-one",C1=CC(=C(C=C1Cl)C=NCCCO)O,,,,,,
3024,3083027,"2-[[2-Chloro-3-(2,2-dicyanoethenyl)cyclopent-2-en-1-ylidene]methyl]propanedinitrile;pyridine",C1CC(=C(C1=CC(C#N)C#N)Cl)C=C(C#N)C#N.C1=CC=NC=C1,,,,,,
3025,3083028,"2-[[2-Chloro-3-(2,2-dicyanoethenyl)cyclopent-2-en-1-ylidene]methyl]propanedinitrile",C1CC(=C(C1=CC(C#N)C#N)Cl)C=C(C#N)C#N,,,,,,
3026,3083029,Hdtat,CCCCCCCCCCCCCCCC[N+](CCCC)(CCCC)CCCC.C[C@H](CCC(=O)NCCS(=O)(=O)[O-])[C@H]1CCC2[C@@]1([C@H](CC3C2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,,,,,,
3027,3083030,"2-[[(4R)-4-[(3R,5S,7R,10S,12S,13R,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid",C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CCC2[C@@]1([C@H](CC3C2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,,,,,,
3028,3083031,Cetyltributylaminium,CCCCCCCCCCCCCCCC[N+](CCCC)(CCCC)CCCC,,,,,,
3029,3083032,CID 3083032,CC(=O)N(CCC[C@@H](C(=O)N(C1[C@H]2CCC(=C(N2C1=O)C(=O)O)Cl)[C@H](C3=CC=C(C=C3)O)C(=O)N(C(=O)[C@H](CCCN(C(=O)C)O)N)C(=O)[C@H](CCCN(C(=O)C)O)N)N)O,,,,,,
3030,3083033,CID 3083033,CC(=O)N(CCC[C@@H](C(=O)N(C1[C@H]2CCC(=C(N2C1=O)C(=O)O)Cl)[C@H](C3=CC=CC=C3)C(=O)N(C(=O)[C@H](CCCN(C(=O)C)O)N)C(=O)[C@H](CCCN(C(=O)C)O)N)N)O,,,,,,
3031,3083034,CID 3083034,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)COC(=O)CCCNC(=O)C2=CC=C(C=C2)C3(N=N3)C(F)(F)F)C)CC(C)C)C)C(C)C)CC(C)C)C)C,,,,,,
3032,3083035,3-Tolylacetyl-coa,CC1=CC(=CC=C1)CC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)OP(=O)(O)O)O,,,,,,
3033,3083036,4-Tolylacetyl-coenzyme A,CC1=CC=C(C=C1)CC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)OP(=O)(O)O)O,,,,,,
3034,3083037,"Hypotrehalosemic hormone, tabanus atratus",C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)NCC(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)NCC(=O)N[C@@H](CC5=CC=C(C=C5)O)C(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]6CCC(=O)N6)O,,,,,,
3035,3083038,Pgitn,CC[C@H](C)[C@@H](C(=O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NCC3=CC=CC=C3)NP(=O)(CN4C(=O)C5=CC=CC=C5C4=O)OCC6=CC=CC=C6,,,['Compounds that inhibit the enzyme activity or activation of MATRIX METALLOPROTEINASES. (See all compounds classified as Matrix Metalloproteinase Inhibitors.)'],,,
3036,3083039,3-Iodotyrosyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide,CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)N)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N)NC(=O)[C@H](CC4=CC(=C(C=C4)O)[125I])N,,,,,,
3037,3083040,Thienyl-gbr 13119,C1CN(CCN1CCCC2=CC=CC=C2)CCOC(C3=CC=C(C=C3)[18F])C4=CC=CS4,,,,,,
3038,3083041,CID 3083041,CC(=O)O[C@@H](CC(=O)O)[C@@]1([C@@H]2CC[C@@](C3([C@]2(C(=O)C[C@H]1C(C)(C)O)C)[C@H](O3)C(=O)O)(C)[C@@H](C4=COC=C4)O[C@@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)CO)O)O)O)C,,,,,,
3039,3083042,12-((5-Iodo-4-azido-2-hydroxybenzoyl)amino)dodecanoate,C1=C(C(=CC(=C1[125I])N=[N+]=[N-])O)C(=O)NCCCCCCCCCCCC(=O)O,,,,,,
3040,3083043,12-((4-Azido-5-iodo-2-hydroxybenzoyl)amino)dodecanoate-coenzyme A,CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)[C@H](C(=O)NCCC(=O)NCCSC(=O)CCCCCCCCCCCNC(=O)C4=CC(=C(C=C4O)N=[N+]=[N-])[125I])O,,,,,,
3041,3083044,"3,8-Dihydroxy-4-methoxy-2-oxochromene-5-carboxylic acid",COC1=C(C(=O)OC2=C(C=CC(=C21)C(=O)O)O)O,,,,,,
3042,3083045,CID 3083045,C[C@H](C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NC(=O)[C@H](CC1=CN=CN1)N[C@H](CC(C)C)CO[C@@H](CC(C)C)C(=O)N)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CN=CN4)NC(=O)C,,,,,,
3043,3083046,"[2,13-Dioxo-16-(2-phenylacetyl)oxy-8-oxa-22,23,24,25-tetrathia-3,14-diazahexacyclo[10.9.4.01,14.03,12.04,10.015,20]pentacosa-6,9,17,19-tetraen-5-yl] 2-hydroxy-2-phenylacetate",C1C2=CC=CC(C2N3C14C(=O)N5C6C(C=COC=C6CC5(C3=O)SSSS4)OC(=O)C(C7=CC=CC=C7)O)OC(=O)CC8=CC=CC=C8,,,,,,
3044,3083047,Emethallicin C,C1C2=COC=CC(C2N3C14C(=O)N5C6C(C=COC=C6CC5(C3=O)SSSS4)OC(=O)C(C7=CC=CC=C7)O)OC(=O)C(C8=CC=CC=C8)O,,,,,,
3045,3083048,"(3S)-4-[[(2S)-1-[[(2S)-3-(1H-indol-3-yl)-2-[[2-oxo-3-[[(1R)-1-[[(2S)-2-(2,2,3,3,3-pentatritiopropanoylamino)-3-(4-sulfooxyphenyl)propanoyl]amino]pentyl]amino]propanoyl]amino]propanoyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2S)-2-(methylamino)hexanoyl]amino]-4-oxobutanoic acid",[3H]C([3H])([3H])C([3H])([3H])C(=O)N[C@@H](CC1=CC=C(C=C1)OS(=O)(=O)O)C(=O)N[C@H](CCCC)NCC(=O)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCC)NC,,,,,,
3046,3083049,2-Aminoacetic acid; 2-hydroxypropanoic acid,CC(C(=O)O)O.C(C(=O)O)N,,,,,,
3047,3083050,Uridine 5'-diphosphate chloroacetol,C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COCC(=O)CCl)OP(=O)(O)OP(=O)(O)O)O,,,,,,
3048,3083051,Uridine 5'-diphosphate bromoacetol,C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)OP(=O)(O)OP(=O)(O)OCC(=O)CBr)O,,,,,,
3049,3083052,Methyl 3-O-galactopyranosyl-2-O-(glucopyranosyluronic acid)mannopyranoside,COC1C(C(C(C(O1)CO)O)OC2C(C(C(C(O2)CO)O)O)O)OC3C(C(C(C(O3)C(=O)O)O)O)O,,,,,,
3050,3083053,"(2R,4S,5R,6R)-5-acetamido-2-[[(2R,3S,4S,5S,6S)-6-[(2R,3S,4R,5R)-5-acetamido-1,2,4-trihydroxy-6-oxohexan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid",CC(=O)N[C@@H]1[C@H](C[C@@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)OC[C@@H]2[C@H]([C@@H]([C@@H]([C@@H](O2)O[C@H]([C@@H](CO)O)[C@@H]([C@H](C=O)NC(=O)C)O)O)O)O)O,,,,,,
3051,3083054,Dmmtgd-argipressin,CCN(CC)CC(=O)N(C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C=S)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)N)N(CC)CC)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC3=CC=C(C=C3)OC)NC(=O)CC4(CCCCC4)S,,,,,,
3052,3083055,Gonyauline,C[S+](C)[C@@H]1C[C@@H]1C(=O)[O-],,,,,,
3053,3083056,"[(1R,2R)-2-carboxycyclopropyl]-dimethylsulfanium",C[S+](C)[C@@H]1C[C@@H]1C(=O)O,,,,,,
3054,3083057,CID 3083057,CC1C(C(CC(O1)OC2(C3CC4(C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C5=C2C(=C(C=C5O)OC)Cl)O)O)N(C)C)O)C)(C)[N+](=O)[O-])OC,,,,,,
3055,3083058,"Oxytocin, mpa(1)-cyclo(glu(4)-lys(8))-",CC[C@H](C)[C@H]1C(=O)NCC2CC(=O)NCCCC[C@H](NC(=O)C3CCCN3C(=O)C(CSSCCC(=O)N[C@H](C(=O)N1)CC4=CC=C(C=C4)O)NC(=O)[C@@H](NC2=O)CC(=O)N)C(=O)NCC(=O)N,,,,,,
3056,3083059,"Adipokinetic hormone, tabanus atratus",C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)NCC(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]5CCC(=O)N5)O,,,,,,
3057,3083060,"[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] (2R,3S,4S,5S)-5-acetamido-3,4,6-trihydroxyoxane-2-carboxylate",CC(=O)N[C@H]1[C@@H]([C@@H]([C@@H](OC1O)C(=O)OP(=O)(O)OP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC(=O)NC3=O)O)O)O)O,,,,,,
3058,3083061,CID 3083061,CCNC(=O)CNC(=O)C(=CC1=CC=CC=C1)NC(=O)[C@@H]2CCCN2C(=O)OC(C)(C)C,,,,,,
3059,3083062,CID 3083062,C[C@H]1[C@H](CC[C@@H](O1)O[C@]23C(=O)C[C@](C[C@]2(C=CC4=C3C5=C6C(=C(O5)C7=CC=C(C=C7)O)C=C(C(=C6C4=O)O)[C@H]8C[C@H]([C@@H]([C@H](O8)C)O)O[C@H]9CC[C@@H]([C@@H](O9)C)O[C@H]1C[C@H]([C@@H]([C@H](O1)C)O)O)O)(C)O)O,,,,,,
3060,3083063,Kalten,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O.C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl.C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N.Cl,,,,,,
3061,3083064,CID 3083064,C[C@H](C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CN=CN4)NC(=O)[C@H](CC(=O)N)NC(=O)CN,,,,,,
3062,3083065,Emethallicin D,C1C2=CC=CC(C2N3C14C(=O)N5[C@@H]6[C@H](C=COC=C6CC5(C3=O)SSS4)OC(=O)[C@@H](C7=CC=CC=C7)O)OC(=O)CC8=CC=CC=C8,,,,,,
3063,3083066,Violdelphin,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=CC4=C(C=C(C=C4[O+]=C3C5=CC(=C(C(=C5)O)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)COC(=O)C7=CC=C(C=C7)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)COC(=O)C9=CC=C(C=C9)O)O)O)O)O)O)O)O)O)O)O)O)O)O,,,,,,
3064,3083067,CID 3083067,C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)OC[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)OC3=C(OC4=CC(=CC(=O)C4=C3)O[C@@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)COC(=O)C6=CC=C(C=C6)O[C@@H]7[C@@H]([C@@H]([C@H]([C@@H](O7)COC(=O)C8=CC=C(C=C8)O)O)O)O)O)O)O)C9=CC(=C(C(=C9)O)O)O)O)O)O)O)O)O,,,,,,
3065,3083068,Cyclo(glycyl-tyrosyl-glycyl-prolyl-leucyl-prolyl),CC(C)C[C@H]1C(=O)N2CCCC2C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N3CCC[C@H]3C(=O)N1)CC4=CC=C(C=C4)O,,,,,,
3066,3083069,Cionin,CSCC[C@@H](C(=O)NC(CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)CNC(=O)[C@H](CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)[C@H](CC5=CC=C(C=C5)OS(=O)(=O)O)NC(=O)[C@H](CC(=O)N)N,,,,,,
3067,3083070,Dioxicol,CCN(CC)CC(=O)NC1=C(C=C(C=C1C)C)C.CC1=CC(=O)NC(=O)N1.C1=CC=C2C(=C1)N(C(=C([N+]2=O)CO)CO)[O-],,,,,,
3068,3083071,N-Acetyl-4-deoxy-4-acetamidoneuraminic acid,CC(=O)N[C@H]1C[C@](O[C@H]([C@@H]1NC(=O)C)[C@@H]([C@@H](CO)O)O)(C(=O)O)O,,,,,,
3069,3083072,CID 3083072,CCC(=CN=NC(=NC)[S-])NNC(=NC)[S-].[Cu+2],,,,,,
3070,3083073,CID 3083073,CCC(=CN=NC(=S)NC)NNC(=S)NC,,,,,,
3071,3083074,"N-[1-[(2-amino-2-oxoethyl)amino]-6-[[5-(dimethylamino)naphthalen-1-yl]sulfonylamino]-1-oxohexan-2-yl]-1-[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide",CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NCCCCC(C(=O)NCC(=O)N)NC(=O)C3CCCN3C(=O)C4CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4)CC(=O)N)CCC(=O)N)CC5=CC=CC=C5)CC6=CC=C(C=C6)O,,,,,,
3072,3083075,CID 3083075,C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)OC)NC(=O)[C@H](C(C)C)NC(=O)C(C)(C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@H](C(C)C)NC(=O)OC(C)(C)C.C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)OC)NC(=O)[C@H](C(C)C)NC(=O)C(C)(C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@H](C(C)C)NC(=O)OC(C)(C)C.O,,,,,,
3073,3083076,CID 3083076,C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)OC)NC(=O)[C@H](C(C)C)NC(=O)C(C)(C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@H](C(C)C)NC(=O)OC(C)(C)C,,,,,,
3074,3083077,2-[[2-[(3-Aminophenyl)methyl-[2-[(2-hydroxyphenyl)methylamino]ethyl]amino]ethylamino]methyl]phenol,C1=CC=C(C(=C1)CNCCN(CCNCC2=CC=CC=C2O)CC3=CC(=CC=C3)N)O,,,,,,
3075,3083078,Decarestrictine B,C[C@@H]1C[C@H]2[C@H](O2)[C@H](CC(=O)CC(=O)O1)O,,,,,,
3076,3083079,Dimethyltrimethylene carbonate-trimethylene carbonate copolymer,CC1(COC(=O)OC1)C.C1COC(=O)OC1,,,,,,
3077,3083080,"3-tert-Butyldiphenylsiloxy-2,3,3a,7a-tetrahydrobenzo(b)thiophen-5(4H)-one 1,1-dioxide",CC(C)(C)[Si](C1=CC=CC=C1)(C2=CC=CC=C2)O[C@H]3CS(=O)(=O)[C@H]4[C@@H]3CC(=O)C=C4,,,,,,
3078,3083081,CID 3083081,C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)C(C)(C)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CN=CN2)N)O,,,,,,
3079,3083082,CID 3083082,CC[C@H](C)[C@@H](C(=O)N[C@H](C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(C)C)C(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](C)N,,,,,,
3080,3083083,"N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-13-benzyl-10-(3-hydrazinyl-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide",C1CC(N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)NN)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N,,,,,,
3081,3083084,"(2S)-N-[(2S,3S)-2-amino-3-methylpentanoyl]-N-[(2R)-1-(1H-indol-3-yl)-3-oxopropan-2-yl]-1-[(2R)-2-(methylamino)-3-[(6R)-6-(piperazine-1-carbonyl)-6-(2H-pyridine-1-carbonyl)cyclohexa-1,3-dien-1-yl]propanoyl]pyrrolidine-2-carboxamide",CC[C@H](C)[C@@H](C(=O)N([C@H](CC1=CNC2=CC=CC=C21)C=O)C(=O)[C@@H]3CCCN3C(=O)[C@@H](CC4=CC=CC[C@@]4(C(=O)N5CCNCC5)C(=O)N6CC=CC=C6)NC)N,,,,,,
3082,3083085,"1-(Myristoyl)-2-(7,7-difluoromyristoyl)glycero-3-phosphocholine",CCCCCCCCCCCCCC(=O)O[C@@H](CCOP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCC(CCCCCCC)(F)F,,,,,,
3083,3083086,"2-[[(3R)-3-(7,7-difluorotetradecanoyloxy)-3-tetradecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium",CCCCCCCCCCCCCC(=O)O[C@@H](CCOP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCC(CCCCCCC)(F)F,,,,,,
3084,3083087,"Substance P (6-11), glu(glc)(6)-",CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)CNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCC(=O)N)N[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
3085,3083088,"Benzene-1,2,5,6,7,8,11,12-octachloro-N, N'-dimethylperylene-3,4-9,10-bis(dicarboximide)",CN1C(=O)C2=C3C4=C(C5=C6C7=C(C(=C5Cl)Cl)C(=O)N(C(=O)C7=C(C(=C6C4=C(C(=C3C1=O)Cl)Cl)Cl)Cl)C)C(=C2Cl)Cl.C1=CC=CC=C1.C1=CC=CC=C1,,,,,,
3086,3083089,"10,11,14,15,21,22,25,26-Octachloro-7,18-dimethyl-7,18-diazaheptacyclo[14.6.2.22,5.03,12.04,9.013,23.020,24]hexacosa-1(23),2,4,9,11,13,15,20(24),21,25-decaene-6,8,17,19-tetrone",CN1C(=O)C2=C3C4=C(C5=C6C7=C(C(=C5Cl)Cl)C(=O)N(C(=O)C7=C(C(=C6C4=C(C(=C3C1=O)Cl)Cl)Cl)Cl)C)C(=C2Cl)Cl,,,,,,
3087,3083090,Cyclo(leucyl-phenylalanyl-glycyl-phenylalanyl-leucyl-glycyl),CC(C)C[C@@H](C=O)NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C=NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(C)C)NC(=O)CN.O.O.O,,,,,,
3088,3083091,H-Gly-Leu-Phe-Unk-D-Phe-Leu-al,CC(C)C[C@@H](C=O)NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C=NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(C)C)NC(=O)CN,,,,,,
3089,3083092,Cyclo(phenylalanyl-leucyl-glycyl-leucyl-phenylalanyl-glycyl),CC(C)C[C@@H](C=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C=NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](CC(C)C)NC(=O)CN.O.O.O,,,,,,
3090,3083093,H-Gly-D-Leu-Phe-Unk-Phe-Leu-al,CC(C)C[C@@H](C=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C=NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](CC(C)C)NC(=O)CN,,,,,,
3091,3083094,Fqvvcg-NH2,CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)NC(=O)CNC(=O)[C@H](CSSC1=C(C=CC=N1)[N+](=O)[O-])N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)N,,,,,,
3092,3083095,"2-[4,5-Dihydroxy-6-[5-hydroxy-4-[5-hydroxy-6-(hydroxymethyl)-3,4-bis[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl]oxy-6-(hydroxymethyl)-2-(5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-yl)oxyoxan-3-yl]oxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol",CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)OC7C(C(C(C(O7)CO)O)OC8C(C(C(C(O8)CO)O)OC9C(C(C(CO9)O)O)O)OC2C(C(C(CO2)O)O)O)OC2C(C(C(C(O2)CO)OC2C(C(C(CO2)O)O)O)O)O)C)C)C)OC1,,,,,,
3093,3083096,Agaveside B,CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)OC7C(C(C(C(O7)CO)O)OC8C(C(C(C(O8)CO)O)OC9C(C(C(CO9)O)O)O)OC2C(C(C(CO2)O)O)O)OC2C(C(C(C(O2)CO)O)O)O)C)C)C)OC1,,,,,,
3094,3083097,CID 3083097,CCCCCCC=CCCCCCC=CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)NC(=O)C)O[C@@H]3[C@H](O[C@H]([C@@H]([C@H]3O)NC(=O)C)O[C@H]([C@@H](COS(=O)(=O)O)O)[C@@H]([C@H](C=O)NC(=O)C)O)CO)CO)CO)O)O,,,,,,
3095,3083098,Meraboin,CC1CC2=C(CN1)C3=C(C=CC=C3N2)CCC4=CN=C(C=C4)C.OS(=O)(=O)O.OS(=O)(=O)O,,,,,,
3096,3083099,"Cyclon(alpha6),C(delta11)-beta-endorphin (6-17)",C[C@H]([C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NC(CC(C)C)C(=O)O)CO)CCCCN)CCC(=O)O)CO)O,,,,,,
3097,3083100,CID 3083100,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@@H]([C@@H]([C@H]([C@@H](O2)OC3=C(OC4=CC(=O)C=C(C4=C3O)O)C5=CC(=C(C=C5)O)OC)O)O)O)O)O)OC(=O)C=CC6=CC=C(C=C6)O,,,,,,
3098,3083101,3-O-(Methylthiomethyl)apiitol tetraacetate,CC(=O)OCC(C(COC(=O)C)(COC(=O)C)OCSC)OC(=O)C,,,,,,
3099,3083102,Methyl oligobiosaminide,CC1C(C(C(C(O1)OC)O)O)NC2C(C(C(C(C2O)O)O)CO)O,,,,,,
3100,3083103,Methyl 2-acetamido-2-deoxy-3-O-(beta-glucopyranosyluronic acid)-4-O-sulfo-beta-galactopyranoside,CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@H]1OC)CO)OS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)[O-])O)O)O.[Na+].[Na+],,,,,,
3101,3083104,GlcA(b1-3)GalNAc4S(b)-O-Me,CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@H]1OC)CO)OS(=O)(=O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O,,,,,,
3102,3083105,Yemuoside YM(9),CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OCC3C(C(C(C(O3)OC(=O)C45CCC(=C)CC4C6=CCC7C8(CCC(C(C8CCC7(C6(CC5)C)C)(C)C)OC9C(C(C(CO9)O)O)OC1C(C(C(C(O1)C)O)OC1C(C(C(C(O1)CO)O)O)O)O)C)O)O)O)CO)O)O)O,,,,,,
3103,3083106,"Ribavirin 3',5'-phosphate pentadecamer homoribopolymer",CCN(CC)CC.C1=NC(=NN1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)C(=O)N,,,,,,
3104,3083107,N-Laurylbiotinamide,CCCCCCCCCCCCNC(=O)CCCC[C@@H]1[C@H]2[C@@H](CS1)NC(=O)N2,,,,,,
3105,3083108,"3,4,5-Trihydroxy-6-[[3,4,5-trihydroxy-6-[5-hydroxy-2-methoxy-6-methyl-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxyoxan-2-yl]methoxy]oxane-2-carboxylic acid",CC1C(C(C(C(O1)OC)OC2C(C(C(C(O2)COC3C(C(C(C(O3)C(=O)O)O)O)O)O)O)O)OC4C(C(C(C(O4)CO)O)O)O)O,,,,,,
3106,3083109,CID 3083109,C1=CC(=CC=C1[N+](C2=CC=C(C=C2)Br)(C3=CC=C(C=C3)Br)C4=CC=C(C=C4)Br)Br.[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[SbH3],,,,,,
3107,3083110,Tetrakis(4-bromophenyl)azanium,C1=CC(=CC=C1[N+](C2=CC=C(C=C2)Br)(C3=CC=C(C=C3)Br)C4=CC=C(C=C4)Br)Br,,,,,,
3108,3083111,Org 5222 glucuronide,C1C2C(CN1C(=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O)C4=C(C=CC(=C4)Cl)OC5=CC=CC=C25,,,,,,
3109,3083112,"[4-[4,5-Dihydroxy-6-methyl-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-(hydroxymethyl)oxan-3-yl] 3-(3,4-dihydroxyphenyl)prop-2-enoate",CC1C(C(C(C(O1)OC2C(C(OC(C2OC(=O)C=CC3=CC(=C(C=C3)O)O)CO)OCCC4=CC(=C(C=C4)O)O)O)OC5C(C(C(C(O5)CO)O)O)O)O)O,,,,,,
3110,3083113,CID 3083113,C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)OC2=C(OC3=C(C(=CC(=O)C3=C2O)O[C@@H]4[C@@H]([C@@H]([C@H]([C@@H](O4)CO)O)O)O)CC=C(C)C)C5=CC=C(C=C5)OC)O)O[C@@H]6[C@@H]([C@@H]([C@H]([C@@H](O6)CO)O)O)O)O,,,,,,
3111,3083114,Citreamicin beta,CC(C)C(=O)OCC1(C(=O)OC2(N1C(=O)C3=C(C2)C=C4C=CC5=C(C4=C3O)C(=O)C6=C(C5=O)OC7=CC(=C(C=C7C6=O)OC)OC)C)C,,,,,,
3112,3083115,tert-butyl N-[1-[[1-[[1-cyclohexyl-3-hydroxy-5-[[3-methyl-1-oxo-1-(tetrazol-2-ylmethylamino)pentan-2-yl]amino]-5-oxopentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]carbamate,CCC(C)C(C(=O)NCN1N=CN=N1)NC(=O)CC(C(CC2CCCCC2)NC(=O)C(CC3=CN=CN3)NC(=O)C(CC4=CC=CC=C4)NC(=O)OC(C)(C)C)O,,,,,,
3113,3083116,"[(2R,3R,4R,5R,6R)-4-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-(hydroxymethyl)oxan-3-yl] 3-(3,4-dihydroxyphenyl)prop-2-enoate",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H](O[C@@H]([C@H]2OC(=O)C=CC3=CC(=C(C=C3)O)O)CO)OCCC4=CC(=C(C=C4)O)O)O)O[C@H]5[C@@H]([C@H]([C@@H](CO5)O)O)O)O)O,,,,,,
3114,3083117,CID 3083117,CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)NC(=CC2=CC=CC=C2)C(=O)NCC(=O)O,,,,,,
3115,3083118,CID 3083118,CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC\4(C(C5C6(C(C(C(=N6)/C(=C\7/C(C(C(=N7)C=C8C(C(C(=N8)/C(=C4\[N-]5)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.C(CC(=O)NC(C[S-])C(=O)NCC(=O)O)C(C(=O)O)N.[Co+3],,,,,,
3116,3083119,CID 3083119,C[C@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CO)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N)NC(=O)CN,,,,,,
3117,3083120,Dakh peptide,C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]5CCC(=O)N5)O,,,,,,
3118,3083121,CID 3083121,CC(=O)S[C@@H]1C=C[C@H]2[C@@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)O)CCN3CC6CC6,,,,,,
3119,3083122,CID 3083122,CC[C@H]1C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@H](C(=O)NC3CC4=C(NC5=CC=CC=C45)SC[C@H](C(=O)N1)NC(=O)CNC(=O)[C@@H](NC(=O)CNC3=O)[C@@H](C)CC)[C@@H](C)CC)O,,,,,,
3120,3083123,"DL-Arginine, butanedioate (2:1), tetrahydrate",C(C[C@@H](C(=O)O)N)CN=C(N)N.C(C[C@@H](C(=O)O)N)CN=C(N)N.C(CC(=O)O)C(=O)O.O.O.O.O,,,,,,
3121,3083124,CID 3083124,C1CC(CCC1C(=O)O)([C@H](C=CCCCCCCCCC2=CC=CC=C2)SCCC(=O)O)O,,,,,,
3122,3083125,CID 3083125,C1=CC(=CC=C1NC(=O)[C@H](CC2=CC(=C(C=C2)O)I)NP(=O)(O)OP(=O)(OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C4NC(=NC5=O)N)O)O)OP(=O)(O)O)N=[N+]=[N-],,,,,,
3123,3083126,S-(2-Ornithylamino-4-methoxy-5-(1'-methyl-4'-piperidylamino)carboxyphenyl)glutathione,CN1CCC(CC1)NC(=O)C2=CC(=C(C=C2OC)NC(=O)[C@H](CCCN)N)SC[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)O)N,,,,,,
3124,3083127,Tem-hrth,CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N)NC(=O)[C@@H]5CCC(=O)N5,,,,,,
3125,3083128,"2,3-Di(icosa-8,11,14-trienoyloxy)propyl icosa-8,11,14-trienoate",CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC,,,,,,
3126,3083129,3-Hydroxy-1-p-sulfonatophenyl-3-phenyltriazene Cu (II) complex,[H+].[H+].C1=CC=C(C=C1)N(N=NC2=CC=C(C=C2)S(=O)(=O)[O-])[O-].C1=CC=C(C=C1)N(N=NC2=CC=C(C=C2)S(=O)(=O)[O-])[O-].[Cu+2],,,,,,
3127,3083130,4-[(N-oxidoanilino)diazenyl]benzenesulfonic acid,C1=CC=C(C=C1)N(N=NC2=CC=C(C=C2)S(=O)(=O)O)[O-],,,,,,
3128,3083131,"1-Benzyloxy-4,8,11,11-tetramethyl-6-phenylthiobicyclo(5.3.1)undec-7-en-3-one",C[C@H]1C[C@@H](C2=C(CC[C@](C2(C)C)(CC1=O)OCC3=CC=CC=C3)C)SC4=CC=CC=C4,,,,,,
3129,3083132,"2,4,6-Trinitrophenyl-uridine diphosphate galactose",C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)O[C@@H]3[C@@H]([C@H]([C@H]([C@H](O3)COC4=C(C=C(C=C4[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-])O)O)O)O)O,,,,,,
3130,3083133,"(3R,4R,5S)-2-[(1R)-1,2-dihydroxyethyl]-5-[(2R,3R,4S)-5-[(1R)-1,2-dihydroxyethyl]-2-[(2S,3R,4R)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy-4-hydroxyoxolan-3-yl]oxyoxolane-3,4-diol",C([C@H](C1[C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](C(O[C@@H]2O[C@H]3[C@@H]([C@H](C(O3)[C@@H](CO)O)O)O)[C@@H](CO)O)O)O)O)O)O,,,,,,
3131,3083134,6-Deoxy-gluco-heptopyranosyl 6-deoxy-gluco-heptopyranoside,C(CO)[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CCO)O)O)O)O)O)O,,,,,,
3132,3083135,2-(4-(2-(2-((4-Azidophenyl)methylcarbonylamino)ethylaminocarbonyl)ethyl)phenyl)ethylamino-5'-N-ethylcarboxamidoadenosine,CCNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=C(N=C32)NCCC4=CC=C(C=C4)CCC(=O)NCCNC(=O)CC5=CC=C(C=C5)N=[N+]=[N-])N)O)O,,,,,,
3133,3083136,"Flrlamide, manduca",CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CO)NC(=O)[C@H](CC3C=NC=N3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]4CCC(=O)N4,,,,,,
3134,3083137,Ysdspstst peptide,C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)O,,,,,,
3135,3083138,epsilon-Biotinamidocaproyl-beta-ala-beta-ala-lisinopril,C1C[C@H](N(C1)C(=O)[C@H](CCCCNC(=O)CCNC(=O)CCNC(=O)CCCCCNC(=O)CCCC[C@H]2[C@@H]3[C@H](CS2)NC(=O)N3)NC(CCC4=CC=CC=C4)C(=O)O)C(=O)O,,,,,,
3136,3083139,Taurizine,C(CS(=O)(=O)O)N.C(C(C(=O)[O-])N)C(=O)[O-].O.O.O.[Zn+2],,,,,,
3137,3083140,"(2R)-2-[[(2S)-2-aminopropanoyl]amino]propanoic acid;(2S)-2,6-diaminohexanoic acid",C[C@@H](C(=O)N[C@H](C)C(=O)O)N.C(CCN)C[C@@H](C(=O)O)N,,,,,,
3138,3083141,CID 3083141,C[C@@H](C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)O)N.C(CCN)C[C@@H](C(=O)O)N,,,,,,
3139,3083142,CID 3083142,CCCCN1CCC=C(C1)C2=C(SC(=N2)N)Cl.C(=CC(=O)O)C(=O)O,,,,,,
3140,3083143,"5-Chloro-4-(1-butyl-1,2,5,6-tetrahydropyridin-3-yl)-thiazole-2-amine",CCCCN1CCC=C(C1)C2=C(SC(=N2)N)Cl,,,,,,
3141,3083144,"6-Methyl-3,20-dioxo-1,4,9(11)-pregnatrien-17-acetate",C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(CC=C2[C@@]4(C1=CC(=O)C=C4)C)C)(C(=O)C)OC(=O)C,,,,,,
3142,3083145,"Oxytocin, beta-mercapto-beta,beta-cyclopentamethylenepropionic acid-trp(2)-phe(3)-ile(4)-arg(8)-",CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C=S)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](CC3=CNC4=CC=CC=C43)NC(=O)CC5(CCCCC5)S,,,,,,
3143,3083146,CID 3083146,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)NCCN3CCOCC3)OC4C(C(C(C(O4)C)O)N)O.C([C@@H](C(=O)O)N)C(=O)O.C([C@@H](C(=O)O)N)C(=O)O,,,,,,
3144,3083147,CID 3083147,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)NCCN3CCOCC3)OC4C(C(C(C(O4)C)O)N)O,,,,,,
3145,3083148,CID 3083148,C[N+](C)(CCC=C1C2=CC=CC=C2CC(C3=CC=CC=C31)O)[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O)O)O,,,,,,
3146,3083149,CID 3083149,C[N+](C)(CCC=C1C2=CC=CC=C2CC(C3=CC=CC=C31)O)[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O,,,,,,
3147,3083150,"D-Glucose, O-D-xylosyl-",C1[C@H]([C@@H]([C@H](C(O1)O[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O)O)O)O,,,,,,
3148,3083151,Ziebeimine,C[C@@H]1CC[C@H]2[C@@H](C3=C(CN2C1)[C@@H]4C[C@H]5[C@H]([C@@H]4CC3)C[C@H]([C@@H]6[C@@]5(CC[C@H](C6)O)C)O)C,,,,,,
3149,3083152,Esculentoside K,C[C@]1(CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CCC5[C@@]4(CC[C@@H]([C@@]5(C)CO)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O[C@H]8[C@@H]([C@H]([C@@H](CO8)O)O)O)C)C)[C@H]2C1)C)C(=O)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O)C(=O)OC,,,,,,
3150,3083153,O-alpha-Glucopyranosyl-(1-4)-O-alpha-xylopyranosyl-(1-4)-O-alpha-xylopyranosyl-(1-4)-glucopyranose,C1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H](CO3)O)O)O)O)O)O,,,,,,
3151,3083154,"methyl (2S)-1-[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S,3S)-2-[[2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-acetamido-3-(1H-indol-3-yl)propanoyl]amino]-3-methylpentanoyl]amino]propanoyl]amino]-2-methylpropanoyl]amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]-2-methylpropanoyl]amino]-4-methylpentanoyl]amino]-2-methylpropanoyl]pyrrolidine-2-carboxylate",CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)NC(C)(C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N1CCC[C@H]1C(=O)OC)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)C,,,,,,
3152,3083155,8-Thiocyanatoriboflavin,CC1=CC2=C(C=C1SC#N)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(CO)O)O)O,,,,,,
3153,3083156,11-Hydroxy-N-allylnoraporphine,C=CCN1CCC2=C3[C@H]1CC4=C(C3=CC=C2)C(=CC=C4)O.Br,,,,,,
3154,3083157,"(6aR)-6-prop-2-enyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-11-ol",C=CCN1CCC2=C3[C@H]1CC4=C(C3=CC=C2)C(=CC=C4)O,,,,,,
3155,3083158,CID 3083158,CCC1CC23C(=O)C(=C(O2)O)OC(=O)C4(C5CCC(C(C5C=C(C4CCCCC3(C=C1C(=O)O)C)C)OC6C(C(C(C(O6)C)OC(=O)C7=C(C=CC=C7OC)C)OC8CC(C(C(O8)C)OC)O)O)O)C,,,,,,
3156,3083159,12-(4'-Azido-2'-nitrophenoxy)dodecanoyl-coenzyme A,CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)[C@H](C(=O)NCCC(=O)NCCSC(=O)CCCCCCCCCCCOC4=C(C=C(C=C4)N=[N+]=[N-])[N+](=O)[O-])O,,,,,,
3157,3083160,"(2,9-Dimethyl-1,10-phenanthroline)(thiophenolato)copper(I)",CC1=NC2=C(C=C1)C=CC3=C2N=C(C=C3)C.C1=CC=C(C=C1)[S-].[Cu+],,,,,,
3158,3083161,"2-[[6-[2,3-Dihydroxy-6-(hydroxymethyl)-4-[[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]cyclohexyl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol",C1C(C(C(C(C1NC2C=C(C(C(C2O)O)O)CO)O)O)OC3C(C(C(C(O3)COC4C(C(C(C(O4)CO)O)O)O)O)O)O)CO,,,,,,
3159,3083162,"9,10-Dioxoindano(2',3'-4,3)cyclobuta(1,2-b)indan-4b,4c-diyl diacetate",CC(=O)O[C@@]12[C@@H]([C@@H]3[C@]1(C4=CC=CC=C4C3=O)OC(=O)C)C(=O)C5=CC=CC=C25,,,,,,
3160,3083163,2-Hydroxypropyl-cmh,C[C@@H](CO[C@@H]1[C@H]([C@H]2[C@H](O[C@@H]1O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)O)O[C@@H]7[C@H](O[C@@H]([C@@H]([C@H]7O)O)O[C@@H]8[C@H](O[C@H](O2)[C@@H]([C@H]8O)O)CO)CO)CO)CO)CO)CO)CO)O)O,,,,,,
3161,3083164,Boc-phe-pro-boroarg-OH,B1(O[C@@H]2C[C@H]3C[C@@H]([C@@]2(O1)C)C3(C)C)C(CCCN=C(N)N)N4CCC[C@@]4(C(=O)[C@@H](CC5=CC=CC=C5)NC(=O)OC(C)(C)C)C(=O)N,,,,,,
3162,3083165,CID 3083165,CC(C=CCCCCCCCCCCCC=O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COC(=O)C)O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)COC(=O)C)O)O)O,,,,,,
3163,3083166,"Adenosine, 5'-deoxy-5',5'-difluoro-",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)C(F)F)O)O)N,,,,,,
3164,3083167,Ggapga,C1C[C@H](N(C1)C(=O)[C@H](CC(=O)N)N[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C(=O)O,,,,,,
3165,3083168,"(6R,7R)-7-[[2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carbonyl)oxymethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CON=C(C1=CSC(=N1)N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)C4=CN(C5=CC(=C(C=C5C4=O)F)N6CCNCC6)C7CC7)C(=O)O,,,,,,
3166,3083169,"(2R,3R,4S,5S,6R)-2-[(2R,3S,4S,5S,6R)-6-[(1R)-1,2-dihydroxyethyl]-3-[(2S,3S,4S,5S,6R)-6-[(1R)-1,2-dihydroxyethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-2,5-dihydroxy-2-methyloxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol",C[C@@]1([C@H]([C@H]([C@@H]([C@H](O1)[C@@H](CO)O)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)[C@@H](CO)O)O)O)O)O,,,,,,
3167,3083170,Brianolide,CC1C2C(C3(C(C(=O)OC3C(C(=C)C4C(O4)C(C2(C5C(C1OC(=O)C)O5)C)O)Cl)C)O)OC(=O)C,,,,,,
3168,3083171,"N-[5-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxopentan-2-yl]-1-[7-(2-amino-2-oxoethyl)-13-benzyl-16-[(4-ethoxyphenyl)methyl]-6,9,12,15,18-pentaoxo-10-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide",CCOC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)N2)C(=O)N3CCCC3C(=O)NC(CCCN)C(=O)NCC(=O)N)CC(=O)N)C(C)C)CC4=CC=CC=C4,,,,,,
3169,3083172,CID 3083172,C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)O[C@@H]2[C@H]([C@@H](O[C@@H]([C@@H]2O[C@@H]3[C@@H]([C@@H]([C@@H](CO3)O)O)O)OC4=C(OC5=CC(=O)C=C(C5=C4O)O)C6=CC=C(C=C6)O)CO)O)O)O)O,,,,,,
3170,3083173,CID 3083173,CC(CC(=O)O)(CC(=O)OCC1C(C(C(C(O1)OC2=C(OC3=CC(=CC(=O)C3=C2O)OC)C4=CC(=C(C=C4)O)OC)OC5C(C(CO5)(CO)O)O)O)O)O,,,,,,
3171,3083174,"4-(9,10-Didehydroergolin-8-yl)methylpiperazine-2,6-dione",C1[C@@H]2C(=C[C@H](CN2)CN3CC(=O)NC(=O)C3)C4=C5C1=CNC5=CC=C4,,,,,,
3172,3083175,Gafquat HS 100,CC(=C)C(=O)NCCC[N+](C)(C)C.C=CN1CCCC1=O.[Cl-],,,,,,
3173,3083176,N-Diazirinyl-lyso-G(M1),CCCCCCCCCCCCCCCC(C(NC(=O)CCCCC1=CC=C(C=C1)C2(N=N2)C(F)(F)F)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)CO)OC5C(C(C(C(O5)CO)O)OC6C(C(C(C(O6)CO)O)O)O)NC(=O)C)OC7(CC(C(C(O7)C(C(CO)O)O)NC(=O)C)O)C(=O)O)O)O)O)O,,,,,,
3174,3083177,2-Methacryloxyethyl D-glucopyranoside,CC(=C)C(=O)OCCOC1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O,,,,,,
3175,3083178,CID 3083178,CC1C=CC=CC=CC=CC=CC=CC=CC(CC(C(C(CC(=NOC)CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O,,,,,,
3176,3083179,Thymidylylacetamido-(3'(O)-5'(C))-5'-deoxythymidine,CC1=CN(C(=O)NC1=O)[C@@H]2C[C@@H]([C@H](O2)OC(=O)NC[C@@H]3[C@H](C[C@@H](O3)N4C=C(C(=O)NC4=O)C)O)CN,,,,,,
3177,3083180,CID 3083180,CC(=CCCC(=CCCC(=CCCC=C(C)CCC=C(C)CCC=C(C)C)C)C)C.C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl.C1(C(=O)NC(=O)N1)NC(=O)N,,,,,,
3178,3083181,"9-(4-Azido-2-nitrophenyl)-5-acetamido-2,6-anhydro-2,3,5,9-tetradeoxy-9-thioglycerogalactonon-2-enoic acid",[3H]C1=CC(=C(C(=C1N=[N+]=[N-])[3H])[N+](=O)[O-])SC[C@H]([C@H]([C@H]2[C@@H]([C@H](C=C(O2)C(=O)O)O)NC(=O)C)O)O,,,,,,
3179,3083182,23-Epidihydrocalysterol,C[C@@H]1[C@H]([C@H]1C(C)C)C[C@@H](C)[C@H]2CC[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4(CC[C@@H](C5)O)C)C,,,,,,
3180,3083183,CID 3083183,CCCCCCCCCC=CC=CC=CC=CC=CC=CC(=O)OCC.CCCCCCCCCC=CC=CC=CC=CC=CC(=O)OCC,,,,,,
3181,3083184,Dynorphin B (5-9),CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N,,,,,,
3182,3083185,"[(2R,3R,4R,5R)-2-[[(3R)-2,2-difluoro-3-hydroxytetradecanoyl]amino]-5,6-dihydroxy-1-oxo-4-phosphonooxyhexan-3-yl] (3R)-3-tetradecanoyloxytetradecanoate",CCCCCCCCCCCCCC(=O)O[C@H](CCCCCCCCCCC)CC(=O)O[C@H]([C@H](C=O)NC(=O)C([C@@H](CCCCCCCCCCC)O)(F)F)[C@@H]([C@@H](CO)O)OP(=O)(O)O,,,,,,
3183,3083186,"2-Dipropylamino-1-oxa-2,3-dihydro-1H-phenalene",CCCN(CCC)C1CC2=CC=CC3=C2C(=CC=C3)O1,,,,,,
3184,3083187,"Methylcarrabioside 2,4'-disulfate",CO[C@@H]1[C@@H]([C@H]2C([C@@H](O1)CO2)O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)OS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-].[K+].[K+],,,,,,
3185,3083188,"[(2R,3R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[[(1S,3S,4R,5R)-3-methoxy-4-sulfooxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]oxan-3-yl] hydrogen sulfate",CO[C@@H]1[C@@H]([C@H]2C([C@@H](O1)CO2)O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)OS(=O)(=O)O)O)O)OS(=O)(=O)O,,,,,,
3186,3083189,Uridine-3'-(5-bromo-4-chloroindol-3-yl)-phosphate,CCCC[N+](CCCC)(CCCC)CCCC.C1=CC(=C(C2=C1NC=C2OP(=O)([O-])OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=CC(=O)NC4=O)O)O)Cl)Br,,,,,,
3187,3083190,"(5-bromo-4-chloro-1H-indol-3-yl) [(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate",C1=CC(=C(C2=C1NC=C2OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=CC(=O)NC4=O)O)O)Cl)Br,,,,,,
3188,3083191,"Argipressin, 1-(4-thio-4-tetrahydropyranoacetic acid)-O-Et-tyr(2)-val(4)-",CCOC1=CC=C(C=C1)C[C@@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC3(CCOCC3)CC(=O)N2)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N)C(C)C)CC5=CC=CC=C5,,,,,,
3189,3083192,"Argipressin, 1-(4-thio-4-tetrahydrothiopyranoacetic acid)-O-Et-tyr(2)-val(4)-",CCOC1=CC=C(C=C1)C[C@@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC3(CCSCC3)CC(=O)N2)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N)C(C)C)CC5=CC=CC=C5,,,,,,
3190,3083193,"(4S)-5-amino-4-[[(2S)-1-[(2S,5S)-2-(4-aminobutyl)-5-[[(2S)-2-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]propanoyl]amino]-6-(4-hydroxyphenyl)-4-oxohexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoic acid",CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)C[C@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)O)C(=O)N)N,,,,,,
3191,3083194,CID 3083194,C[C@H]([C@@H](C(=O)N[C@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)C(CC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)CN)O,,,,,,
3192,3083195,6-Oppcpd,C1=CC=C(C=C1)OP2(=NP(=NP(=O)(N2)OC3=CC=CC=C3)(OC4=CC=CC=C4)OC5=CC=CC=C5)OC6=CC=CC=C6,,,,,,
3193,3083196,CID 3083196,CC(CCNC(=O)OCCOC(=O)C(=C)C)CC(C)(C)CNC(=O)OCCOC(=O)C(=C)C.CC(=C)C(=O)OCCOC(=O)C1=CC2=C(C=C1)C(=O)OC2=O,,,,,,
3194,3083197,CID 3083197,C[C@](CCCCN(C(=O)C=CC1=CC=CC=C1)O)(C(=O)O)NC(=O)CC(CC(=O)N[C@@](C)(CCCCN(C(=O)C=CC2=CC=CC=C2)O)C(=O)O)(C(=O)O)O,,,,,,
3195,3083198,"Oxytocin, beta mercapto-beta,beta-cyclopentamethylenepropionic acid-trp(2)-arg(8)-",CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C=S)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)CC4(CCCCC4)S,,,,,,
3196,3083199,"6-[2-[4,5-Dihydroxy-2-(hydroxymethyl)-6-[(3,4,5,6-tetrahydroxyoxan-2-yl)methoxy]oxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2-carboxylic acid",C(C1C(C(C(C(O1)OC2C(C(OC(C2OC3C(C(C(C(O3)C(=O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O)OC5C(OC(C(C5O)O)OCC6C(C(C(C(O6)O)O)O)O)CO)CO)O)O)O)O)O,,,,,,
3197,3083200,18-Ethylenedithioprogesterone,CC(=O)[C@H]1CC[C@@H]2C13CCC4[C@H]2CCC5=CC(=O)C(CC(C3)S)(C[C@]45C)S,,,,,,
3198,3083201,(2S)-2-amino-N-[(2S)-1-[[(2S)-1-[[2-[[(2R)-2-amino-3-[(3-nitropyridin-2-yl)disulfanyl]propanoyl]amino]acetyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]pentanediamide,CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)NC(=O)CNC(=O)[C@H](CSSC1=C(C=CC=N1)[N+](=O)[O-])N)NC(=O)[C@H](CCC(=O)N)N,,,,,,
3199,3083202,"4-Amino-2-[4,6-diamino-3-[6-(aminomethyl)-4-fluoro-3-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol",C1C(OC(C(C1F)O)OC2C(CC(C(C2O)OC3C(C(C(C(O3)CO)O)N)O)N)N)CN,,,,,,
3200,3083203,"(1S,2S,3S,6S,7R,9R)-9-[tert-butyl(dimethyl)silyl]oxy-1,4,4-trimethyl-11-oxatricyclo[5.3.1.02,6]undecan-3-ol",C[C@@]12C[C@@H](C[C@@H](O1)[C@@H]3[C@H]2[C@@H](C(C3)(C)C)O)O[Si](C)(C)C(C)(C)C,,,,,,
3201,3083204,CID 3083204,CC1=COC(=O)C2=C1C=CC(=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O)O)NC(=O)C.[K+],,,,,,
3202,3083205,"[(2R,3S,4R,5R,6S)-5-acetamido-3,4-dihydroxy-6-(4-methyl-1-oxoisochromen-7-yl)oxyoxan-2-yl]methyl hydrogen sulfate",CC1=COC(=O)C2=C1C=CC(=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)O)O)O)NC(=O)C,,,,,,
3203,3083206,Albuminamide,CC[C@H](C)[C@@H](C(=O)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC1C=NC=N1)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(=O)O)N,,,,,,
3204,3083207,Gbvscp,CC(=O)N[C@@H]1[C@H](C[C@@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O[C@H]2[C@H]([C@H](O[C@H]([C@@H]2O)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)NC(=O)C)OC[C@@H]4[C@H]([C@@H]([C@H]([C@H](O4)O[C@H]5[C@H](O[C@H]([C@@H]([C@H]5O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O)O[C@@H]7[C@H](O[C@H]([C@@H]([C@H]7O)O)O)CO)CO)O)O)O)CO)CO)O)O,,,,,,
3205,3083208,Diiodo-philanthotoxin-343-lysine,CCCC(=O)N[C@@H](CC1=CC(=C(C(=C1)[125I])O)[125I])C(=O)NCCCNCCCCNCCCNC(=O)[C@H](CCCCN)N,,,,,,
3206,3083209,Glykenin IV,CCCCC[C@H](CCC[C@@H]([C@@H](CCCCCCCCCCCCC[C@@H](C(=O)O)O)O)O)O[C@H]1[C@@H]([C@H]([C@@H](CO1)OC(=O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)COC(=O)C)O)O)O)O[C@H]3[C@@H]([C@H]([C@@H](CO3)O)O)O,,,,,,
3207,3083210,"11,17-Bbbhb",C[C@@]12CCCC([C@H]1C[C@@H](C34[C@]2(CC[C@](C3)(C=C4)COC(=O)C5=CC=C(C=C5)Br)O)OC(=O)C6=CC=C(C=C6)Br)(C)C,,,,,,
3208,3083211,17-Bbehb,C[C@@]12CCCC([C@H]1C[C@@H](C34[C@@]25[C@@H](O5)C[C@](C3)(C=C4)COC(=O)C6=CC=C(C=C6)Br)O)(C)C,,,,,,
3209,3083212,CID 3083212,C[C@@H]1CC23[C@@H](C=CCCCC[C@@H]4C=C[C@H]5[C@H]([C@@]4(C(=O)OC(=C(O2)O)C3=O)C)CCC[C@@H]5O[C@@H]6C[C@H]([C@@H]([C@H](O6)C)O[C@@H]7C[C@H]([C@@H]([C@H](O7)C)OC(=O)C8=C(C=CC(=C8C)Cl)O)O)O)C=C1C(=O)O,,,,,,
3210,3083213,1-[3-(3-Azidophenyl)propyl]-4-(2-benzhydryloxyethyl)piperazine,C1CN(CCN1CCCC2=CC(=CC=C2)N=[N+]=[N-])CCOC(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
3211,3083214,"(6R,7S)-3-chloro-7-[[4-[4-[(2,3-dihydroxybenzoyl)amino]butyl-[3-[(2,3-dihydroxybenzoyl)amino]propyl]amino]-4-oxobutanoyl]amino]-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C1CC(=C(N2[C@H]1[C@@H](C2=O)NC(=O)CCC(=O)N(CCCCNC(=O)C3=C(C(=CC=C3)O)O)CCCNC(=O)C4=C(C(=CC=C4)O)O)C(=O)O)Cl,,,,,,
3212,3083215,"5-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyldisulfanyl]-3-hydroxy-3-methyl-5-oxopentanoic acid",CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)[C@H](C(=O)NCCC(=O)NCCSSC(=O)CC(C)(CC(=O)O)O)O,,,,,,
3213,3083216,"(4S)-5-[(2S)-2-[[(2S)-4-amino-1-[[(2S)-6-imino-1-oxohexan-2-yl]amino]-1,4-dioxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-methyl-4-[(2-methylpropan-2-yl)oxycarbonylamino]-5-oxopentanoic acid",CC(C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCC=N)C=O)NC(=O)OC(C)(C)C)C(=O)O,,,,,,
3214,3083217,CID 3083217,CCCCCCCCCCCCCC(=O)CC1=CC=CC(=C1)CC(C(=O)NC(C(C)OC2C(C(C(C(O2)O)O)OC3C(C(C(C(O3)C)O)OC4C(C(C(C(O4)C)O)OC5C(C(C(C(O5)C)OC)OC)OC)OC(=O)CCCC=CCCCCCC)O)O)C(=O)OC)NC(=O)C(CO)NC(=O)C(COC6C(C(C(C(O6)C)O)OC)O)NC(=O)CCCCCCCCCCC,,,,,,
3215,3083218,Adipate-adipic acid,C(CCC(=O)[O-])CC(=O)[O-].C(CCC(=O)[O-])CC(=O)[O-].C(CCC(=O)[O-])CC(=O)[O-].O.O.[Na+].[Na+],,,,,,
3216,3083219,Poly(3-hydroxyvalerate)-(3-hydroxyheptanoate)-(3-hydroxynonanoate)-(3-hydroxyundecanoate) copolymer,CCCCCCCCC(CC(=O)O)O.CCCCCCC(CC(=O)O)O.CCCCC(CC(=O)O)O.CCC(CC(=O)O)O,,,,,,
3217,3083220,3-hydroxyheptanoic Acid,CCCCC(CC(=O)O)O,,,,,,
3218,3083221,3-Hydroxyundecanoic acid,CCCCCCCCC(CC(=O)O)O,,,,,,
3219,3083222,CID 3083222,C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)O[C@@H]2[C@@H]([C@H]([C@@H](O[C@@H]2OC3=C(OC4=CC(=O)C=C(C4=C3O)O)C5=CC=C(C=C5)O)CO)O)O[C@@H]6[C@@H]([C@@H]([C@H]([C@@H](O6)CO)O)O)O)O)O)O,,,,,,
3220,3083223,"5-(dimethylamino)-N-[30-ethyl-34-hex-4-en-2-yl-4,7,10,12,15,19,25,28-octamethyl-6,9,18,24-tetrakis(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-3,21-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22,25,28,31-decazacyclotetratriacont-33-yl]-N-methylnaphthalene-1-sulfonamide",CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)OC(C(C(=O)N1)N(C)S(=O)(=O)C2=CC=CC3=C2C=CC=C3N(C)C)C(C)CC=CC)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,,,,,,
3221,3083224,2-Meimpiig,CC1=NC=CN1P(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C4=C(C(=NC3=O)N)NC=N4)O)O,,,,,,
3222,3083225,CID 3083225,CC[C@@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)N,,,,,,
3223,3083226,CID 3083226,C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)O[C@@H]2[C@H]([C@@H](O[C@@H]([C@@H]2O[C@@H]3[C@@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)O)OC4=C(OC5=CC(=O)C=C(C5=C4O)O)C6=CC=C(C=C6)O)CO)O)O)O)O,,,,,,
3224,3083227,"2-[(2R,3S,4S,5R)-6-[(1R)-1-[(2S,7S,8R)-7-Hydroxy-2-[(5S)-5-[(3S,5R)-5-[(3S,5R,6S)-6-hydroxy-3,5,6-trimethyloxan-2-yl]-3-[(2S,5S,6R)-5-methoxy-6-methyloxan-2-yl]oxyoxolan-2-yl]-5-methyloxolan-2-yl]-2,8-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]ethyl]-4-[(2S,5S,6R)-5-hydroxy-6-methyloxan-2-yl]oxy-5-methoxy-3-methyloxan-2-yl]ethaneperoxoic acid",C[C@H]1C[C@H]([C@@](OC1[C@H]2C[C@@H](C(O2)[C@@]3(CCC(O3)[C@@]4(CCC5(O4)C[C@@H]([C@H](C(O5)[C@@H](C)C6[C@H]([C@H]([C@H]([C@H](O6)CC(=O)OO)C)O[C@H]7CC[C@@H]([C@H](O7)C)O)OC)C)O)C)C)O[C@H]8CC[C@@H]([C@H](O8)C)OC)(C)O)C,,,,,,
3225,3083228,Yiyeliangwanoside I,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2[C@@H]([C@H](O[C@@H]([C@@H]2O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)OC(=O)[C@@]45CC[C@@]6(C(=CC[C@H]7[C@]6(CCC8[C@@]7(CC[C@@H](C8(C)C)O[C@H]9[C@@H]([C@H]([C@H](CO9)OC(=O)C)OC(=O)C)O)C)C)[C@H]4CC(CC5)(C)C(=O)O)C)CO)O)O)O)O,,,,,,
3226,3083229,"4-[2-(1-methylpyridin-1-ium-4-yl)ethenyl]-N,N-di(pentadecyl)aniline;iodide",CCCCCCCCCCCCCCCN(CCCCCCCCCCCCCCC)C1=CC=C(C=C1)C=CC2=CC=[N+](C=C2)C.[I-],,,,,,
3227,3083230,1-Methyl-4-[2-[4-(dipentadecylamino)phenyl]ethenyl]pyridinium,CCCCCCCCCCCCCCCN(CCCCCCCCCCCCCCC)C1=CC=C(C=C1)C=CC2=CC=[N+](C=C2)C,,,,,,
3228,3083231,Cyclo(atsptpal),C[C@H]([C@@H](C(=O)N[C@@H](C=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N2CCC[C@H]2C=O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)N)O,,,,,,
3229,3083232,"[6-[4-(Dimethylamino)-6-[[10-(dimethylamino)-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-oxacyclohexadec-6-yl]oxy]-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] 3-methylbutanoate",CC1CCCCCC(C(CC(C(C(C(CC(=O)O1)O)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C)N(C)C,,,,,,
3230,3083233,CID 3083233,CC(=CC(=O)N(CCCC1C(=O)NC(C(=O)N1)CCCN(C(=O)C=C(C)CCOC(=O)C(CCCN(C(=O)C=C(C)C(CO)O)[O-])NC(=O)C)[O-])[O-])CCO.[Fe+3],,,,,,
3231,3083234,CID 3083234,CC(=CC(=O)N(CCCC1C(=O)NC(C(=O)N1)CCCN(C(=O)C=C(C)CCOC(=O)C(CCCN(C(=O)C=C(C)C(CO)O)[O-])NC(=O)C)[O-])[O-])CCO,,,,,,
3232,3083235,"Argipressin, beta-mercapto-beta, beta-cyclopentamethylenepropionic acid(1)-O-methyl-tyr(2)-lysnh2(9)-",COC1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C=S)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N)NC(=O)CC4(CCCCC4)S,,,,,,
3233,3083236,"Iron,[5-[[3-[5-[3-(acetylhydroxyamino)propyl]-3,6-dioxo-2-piperazinyl]propyl]hydroxyamino]-3-methyl-5-oxo-3-pentenylN2-acetyl-N5-(4,5-dihydroxy-3-methyl-1-oxo-2-pentenyl)-N5-hydroxy-L-ornithinato(3-)]-(9CI)",CC(=CC(=O)N(CCCC1C(=O)NC(C(=O)N1)CCCN(C(=O)C)[O-])[O-])CCOC(=O)C(CCCN(C(=O)C=C(C)C(CO)O)[O-])NC(=O)C.[Fe+3],,,,,,
3234,3083237,"[5-[3-[5-[3-[Acetyl(oxido)amino]propyl]-3,6-dioxopiperazin-2-yl]propyl-oxidoamino]-3-methyl-5-oxopent-3-enyl] 2-acetamido-5-[(4,5-dihydroxy-3-methylpent-2-enoyl)-oxidoamino]pentanoate",CC(=CC(=O)N(CCCC1C(=O)NC(C(=O)N1)CCCN(C(=O)C)[O-])[O-])CCOC(=O)C(CCCN(C(=O)C=C(C)C(CO)O)[O-])NC(=O)C,,,,,,
3235,3083238,"Iron,[5-[[3-[5-[3-[(4,5-dihydroxy-3-methyl-1-oxo-2-pentenyl)hydroxyamino]propyl]-3,6-dioxo-2-piperazinyl]propyl]hydroxyamino]-3-methyl-5-oxo-3-pentenylN2,N5-diacetyl-N5-hydroxy-L-ornithinato(3-)]-(9CI)",CC(=CC(=O)N(CCCC1C(=O)NC(C(=O)N1)CCCN(C(=O)C=C(C)C(CO)O)[O-])[O-])CCOC(=O)C(CCCN(C(=O)C)[O-])NC(=O)C.[Fe+3],,,,,,
3236,3083239,"[5-[3-[5-[3-[(4,5-Dihydroxy-3-methylpent-2-enoyl)-oxidoamino]propyl]-3,6-dioxopiperazin-2-yl]propyl-oxidoamino]-3-methyl-5-oxopent-3-enyl] 2-acetamido-5-[acetyl(oxido)amino]pentanoate",CC(=CC(=O)N(CCCC1C(=O)NC(C(=O)N1)CCCN(C(=O)C=C(C)C(CO)O)[O-])[O-])CCOC(=O)C(CCCN(C(=O)C)[O-])NC(=O)C,,,,,,
3237,3083240,"6-[[14b-Formyl-9-(4-hydroxy-3,5-dimethoxybenzoyl)oxy-11-(hydroxymethyl)-4,4,6a,6b,8a,11-hexamethyl-1,2,3,4a,5,6,6a,7,8,9,10,13,14,14a-tetradecahydropicen-3-yl]oxy]-5-[4,5-dihydroxy-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxy-3,4-dihydroxyoxane-2-carboxylic acid",CC1C(C(C(C(O1)OC2C(C(COC2OC3C(C(C(OC3OC4CCC5(C6CCC7C8=CC(CC(C8(CCC7(C6(CCC5C4(C)C)C)C)C)OC(=O)C9=CC(=C(C(=C9)OC)O)OC)(C)CO)C=O)C(=O)O)O)O)O)O)O)O)O,,,,,,
3238,3083241,Ersilan,CC(C)[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C.CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCO,,,,,,
3239,3083242,Aaphgpspla,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)N)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)CNC(=O)[C@@H]4C[C@H](CN4)O,,,,,,
3240,3083243,CID 3083243,CC(C1=CN=C2C(=NC(=NC2=O)N)N1)NC3=C(C=C(C(=C3)O)CC(C(C(COC4C(C(C(O4)COP(=O)(O)OC(CCC(=O)O)C(=O)NC(CC(=O)O)C(=O)O)O)O)O)O)O)O,,,,,,
3241,3083244,Cyclo-bis(alanyl-glycyl-prolyl-phenylalanyl),C[C@@H](C(=O)N=CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](C)C(=O)NCC(=O)N3CCC[C@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C=O)N.O.O.O.O,,,,,,
3242,3083245,H-Ala-Unk-Pro-Phe-Ala-Gly-Pro-Phe-al,C[C@@H](C(=O)N=CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](C)C(=O)NCC(=O)N3CCC[C@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C=O)N,,,,,,
3243,3083246,Copper dichlorate tetrahydrate,O.O.O.O.[O-]Cl(=O)=O.[O-]Cl(=O)=O.[Cu+2],,,,,,
3244,3083247,Zervamicin Z-L,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@](C)(CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N1C[C@@H](C[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)NC(C)(C)C(=O)N2C[C@@H](C[C@H]2C(=O)NC(C)(C)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC4=CC=CC=C4)CO)O)O)NC(=O)[C@H](CC(C)C)NC(=O)C,,,,,,
3245,3083248,N-(3-(4-Azido-3-iodophenyl)-propionamide)-7-aminoethylcarbamyl-7-desacetylforskolin,C[C@@]1(CC(=O)[C@@]2([C@]3([C@H](CCC([C@@H]3[C@@H]([C@@H]([C@]2(O1)C)OC(=O)NCCNC(=O)CCC4=CC(=C(C=C4)N=[N+]=[N-])I)O)(C)C)O)C)O)C=C,,,,,,
3246,3083249,"(2S)-1-[(2S)-2-[[(2S)-1-(2-aminoacetyl)pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]-N-[2-[(2S)-2-[[(2S)-1-[(2S)-2-formylpyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]-2,3-dihydropyrrole-2-carboxamide",C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H]3CCCN3C(=O)CNC(=O)[C@@H]4CC=CN4C(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@@H]6CCCN6C(=O)CN)C=O,,,,,,
3247,3083250,3-Ketobutylidene 2-chloro-4-nitrophenylmaltopentaoside,CC(=O)CC1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@H](O2)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@H]([C@@H]([C@H]6O)O)OC7=C(C=C(C=C7)[N+](=O)[O-])Cl)CO)CO)CO)CO)O)O,,,,,,
3248,3083251,N-2-Fluoroethylketanserin,C1CN(CCC1C(=O)C2=CC=C(C=C2)[18F])CCN3C(=O)C4=CC=CC=C4N(C3=O)CC[18F],,,,,,
3249,3083252,"6-[2-[4-[4,5-Dihydroxy-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxy-5,6-dihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-4,5-dihydroxy-3-methoxyoxane-2-carboxylic acid",CC1C(C(C(C(O1)OC2C(C(COC2OC3C(COC(C3O)O)OC4C(C(C(CO4)O)O)OC5C(C(C(C(O5)C(=O)O)OC)O)O)O)O)O)O)O,,,,,,
3250,3083253,Pptoo,CC[C@H](C)C1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC([C@@H](C(=O)N[C@@H](C(=O)N1)CC2=CC=CC=C2)N)(C)C)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)NCC(=O)N)CC(=O)N)[C@@H](C)O,,,,,,
3251,3083254,"Triphenodioxazine-1,8-dicarboxylic acid",C1=CC(=C2C(=C1)OC3=CC4=NC5=C(C=CC=C5OC4=CC3=N2)C(=O)O)C(=O)O,,,,,,
3252,3083255,2-[2-[[2-Hydroxy-2-[hydroxy-(4-methoxyphenyl)methyl]sulfanylacetyl]amino]ethylsulfanyl]ethyl (4-nitrophenyl) carbonate,COC1=CC=C(C=C1)C(O)SC(C(=O)NCCSCCOC(=O)OC2=CC=C(C=C2)[N+](=O)[O-])O,,,,,,
3253,3083256,CID 3083256,CCCC[C@@H](C(=O)N[C@@H](CCCC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N,,,,,,
3254,3083257,Protochlorophyllide b,[H+].CCC1=C2C=C3C(=C4C(=O)C(C(=C5C(=C(C(=CC6=NC(=CC(=N2)C1=C[O-])C(=C6C)C=C)[N-]5)C)CCC(=O)[O-])C4=N3)C(=O)OC)C.[Mg+2],,,,,,
3255,3083258,"3-[16-Ethenyl-11-ethyl-12-(hydroxymethylidene)-3-methoxycarbonyl-17,21,26-trimethyl-4-oxo-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,5(26),6,8,10,13(25),14,16,18,20(23),21-undecaen-22-yl]propanoic acid",CCC1=C2C=C3C(=C4C(=O)C(C(=C5C(=C(C(=N5)C=C6C(=C(C(=CC(=N2)C1=CO)N6)C=C)C)C)CCC(=O)O)C4=N3)C(=O)OC)C,,,,,,
3256,3083259,"3beta,23alpha-Dihydroxy-5alpha-spirostan-26-one 3-O-alpha-rhamnopyranosyl (1-2)-(alpha-rhamnopyranosyl-(1-4))-beta-glucopyranoside",C[C@@H]1C[C@@H](C2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@@H]6[C@@]5(CC[C@@H](C6)O[C@@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)O[C@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)C)O)O)O)C)C)C)OC1=O)O,,,,,,
3257,3083260,Trichovirin I IB,CC(C)C[C@@H](CO)NC(=O)[C@@H]1CCCN1C(=O)C(C)(C)NC(=O)[C@H](CC(C)C)NC(=O)C(C)(C)NC(=O)[C@@H]2CCCN2C(=O)C(C)(C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]3CCCN3C(=O)C(C)(C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N)NC(=O)C(C)(C)NC(=O)C,,,,,,
3258,3083261,"7-[4,5-Dihydroxy-6-(hydroxymethyl)-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-[4,5-dihydroxy-6-methyl-3-(3,4,5,6-tetrahydroxyoxan-2-yl)oxyoxan-2-yl]oxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)chromen-4-one",CC1C(C(C(C(O1)OC2=C(OC3=C(C2=O)C=CC(=C3CC=C(C)C)OC4C(C(C(C(O4)CO)O)O)OC5C(C(C(C(O5)CO)O)O)O)C6=CC=C(C=C6)O)OC7C(C(C(C(O7)O)O)O)O)O)O,,,,,,
3259,3083262,4-Detca-Cu,CC(=O)OC1CCC2C1(CCC3C2CCC4=C3C=CC(=C4OC(=O)C)C(=O)[O-])C.CC(=O)OC1CCC2C1(CCC3C2CCC4=C3C=CC(=C4OC(=O)C)C(=O)[O-])C.CC(=O)OC1CCC2C1(CCC3C2CCC4=C3C=CC(=C4OC(=O)C)C(=O)[O-])C.CC(=O)OC1CCC2C1(CCC3C2CCC4=C3C=C(C=C4OC(=O)C)C(=O)[O-])C.[Cu+2].[Cu+2],,,,,,
3260,3083263,"4,17-Diacetyloxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-2-carboxylic acid",CC(=O)OC1CCC2C1(CCC3C2CCC4=C3C=C(C=C4OC(=O)C)C(=O)O)C,,,,,,
3261,3083264,"4,17-Diacetyloxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3-carboxylic acid",CC(=O)OC1CCC2C1(CCC3C2CCC4=C3C=CC(=C4OC(=O)C)C(=O)O)C,,,,,,
3262,3083265,"5-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-2-hydroxy-5-oxopentanoic acid",CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)[C@H](C(=O)NCCC(=O)NCCSC(=O)CCC(C(=O)O)O)O,,,,,,
3263,3083266,"3-[2-[[3-(2-carboxyethyl)-5-[(4-ethenyl-3-methyl-5-oxo-1,2-dihydropyrrol-2-yl)methyl]-4-methyl-1H-pyrrol-2-yl]methylidene]-5-[(3-ethenyl-4-methyl-5-oxopyrrol-2-yl)methylidene]-4-methylpyrrol-3-yl]propanoic acid",CC1=C(C(=O)NC1CC2=C(C(=C(N2)C=C3C(=C(C(=CC4=NC(=O)C(=C4C=C)C)N3)C)CCC(=O)O)CCC(=O)O)C)C=C,,,,,,
3264,3083267,Aspartyl-beta-methyl-tyrosyl-phenylalanyl-glycyl-tryptophyl-N-methyl-norleucyl-aspartyl-phenylalaninamide,CCCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)N(C)C(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)CNC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H]([C@H](C)C5=CC=C(C=C5)O)NC(=O)[C@H](CC(=O)O)N,,,,,,
3265,3083268,Glyeurysaponin,CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C,,,,,,
3266,3083269,CID 3083269,[H-].[H-].[B+3].CCOP(OCC)OCC.CO[C-]=O,,,,,,
3267,3083270,Pgxgg,CCC[C@@]1([C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H](CO3)O)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,,,,,,
3268,3083271,"[4-[4,5-Dihydroxy-6-methyl-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxy-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-(hydroxymethyl)oxan-3-yl] 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate",CC1C(C(C(C(O1)OC2C(C(C(OC2OC3C(C(OC(C3OC(=O)C=CC4=CC(=C(C=C4)O)OC)CO)OCCC5=CC(=C(C=C5)O)O)O)C)O)O)O)O)O,,,,,,
3269,3083272,"[(2R,3R,4R,5R,6R)-4-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-(hydroxymethyl)oxan-3-yl] 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H](O[C@@H]([C@H]2OC(=O)C=CC3=CC(=C(C=C3)O)OC)CO)OCCC4=CC(=C(C=C4)O)O)O)O[C@H]5[C@@H]([C@H]([C@@H](CO5)O)O)O)O)O,,,,,,
3270,3083273,"6-[6-[6-[6-[6-[6-[6-[3,4-Dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-2,2-dimethyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxine-7,8-diol",CC1(OCC2C(O1)C(C(C(O2)OC3C(OC(C(C3O)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(C(C8O)O)OC9(C(C(C(O9)CO)O)O)CO)CO)CO)CO)CO)CO)CO)O)O)C,,,,,,
3271,3083274,CID 3083274,C1=CC(=C(C=C1N=[N+]=[N-])O)C(=O)NCC=CC2=CN(C(=O)NC2=O)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)O[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O,,,,,,
3272,3083275,CID 3083275,C[C@H](C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC1C=NC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H](CC4=CC=CC=C4)N,,,,,,
3273,3083276,CID 3083276,C[C@H](OC(=O)C1=C(CS[C@H]2N1C(=O)[C@H]2NC(=O)C(=NOC)C3=CSC(=N3)N)C(=C)C)OC(=O)OC(C)C,,,,,,
3274,3083277,CID 3083277,COC1=C(C=CC(=C1)C2=CC(=C3C(=CC(=CC3=O)O[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)CO)O)O)O[C@H]5[C@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O2)O)O,,,,,,
3275,3083278,4(5)-O-Galactosylmaltopentaose,C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)OC[C@H]([C@H]([C@@H]([C@H](C=O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O)O)O,,,,,,
3276,3083279,CID 3083279,COC1=CC(=O)C2=C(C(=C(OC2=C1)C3=CC(=C(C=C3)O)O)O[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)CO)O)O)O[C@H]5[C@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O,,,,,,
3277,3083280,Magaratensin,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)N,,,,,,
3278,3083281,CID 3083281,[H+].[H+].[B+3].[B+3].CC(C)(CNCC(CCCCOC1=CC=C(C=C1)C(=O)ON2C(=O)CCC2=O)CNCC(C)(C)S)S.[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-],,,,,,
3279,3083282,"(2,5-Dioxopyrrolidin-1-yl) 4-[6-[(2-methyl-2-sulfanylpropyl)amino]-5-[[(2-methyl-2-sulfanylpropyl)amino]methyl]hexoxy]benzoate",CC(C)(CNCC(CCCCOC1=CC=C(C=C1)C(=O)ON2C(=O)CCC2=O)CNCC(C)(C)S)S,,,,,,
3280,3083283,Ethyladipoylazolamide,CCOC(=O)CCCCC(=O)NC1=NN=C(S1)S(=O)(=O)N,,,,,,
3281,3083284,CID 3083284,C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@H](C)C(=O)NCC(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N)N,,,,,,
3282,3083285,CID 3083285,CC(C1=CC=CC(=C1)C2CC3CCC(C2)N3C)C(=O)OO.CC(C1=CC=CC(=C1)C2CC3CCC(C2)N3C)C(=O)OO.CN1CC[C@]23[C@@H]4[C@@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O.OS(=O)(=O)O.Cl,,,,,,
3283,3083286,Esmalorid,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl.C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N,,,,,,
3284,3083287,30-Chloro-2-(chloromethyl)-2-decarboxy-30-deoxynigericin,CC1CCC(OC1C(C)CCl)CC2CC(C(C3(O2)C(CC(O3)(C)C4CCC(O4)(C)C5C(CC(O5)C6C(CC(C(O6)(CCl)O)C)C)C)C)C)OC,,,,,,
3285,3083288,"2-Hydroxy-7,7-dimethyl-1-((spiro(1H-indene-1,4'-piperidin)-1'-ylsulfonyl)methyl)bicyclo(2.2.1)heptane-2-acetic acid",CC1(C2CCC1(C(C2)(CC(=O)O)O)CS(=O)(=O)N3CCC4(CC3)C=CC5=CC=CC=C45)C,,,,,,
3286,3083289,Glcn-glcn-glcnac (chito),CC(=O)N[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)N)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)N,,,,,,
3287,3083290,"2,6-Dideoxy-6-fluoro-2-(3-hydroxytetradecanamido)-3-O-((3-tetradecanoyloxy)tetradecanoyl)glucopyranose 4-(dihydrogen phosphate)",CCCCCCCCCCCCCC(=O)O[C@H](CCCCCCCCCCC)CC(=O)O[C@H]([C@H](C=O)NC(=O)C[C@H](CCCCCCCCCCC)O)[C@@H]([C@@H](CF)O)OP(=O)(O)O,,,,,,
3288,3083291,Modified fad,CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)C[C@@H]([C@H]([C@H](COP(=O)(O)OP(=O)(O)OC[C@@H]4[C@H]([C@H]([C@@H](O4)N5C=NC6=C(N=CN=C65)N)O)O)O)O)O,,,,,,
3289,3083292,"L-Glutamine, N2-(N-(N-(N-(N-(1-(N-(1-(N-(N-(3-carboxy-1-oxopropyl)-L-phenylalanyl)-L-alpha-glutamyl)-L-prolyl)-L-isoleucyl)-L-prolyl)-L-alpha-glutamyl)-L-alpha-glutamyl)-L-tyrosyl)-3-cyclohexyl-L-alanyl)-",CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N([C@@H](CCC(=O)N)C(=O)O)C(=O)[C@H](CC3CCCCC3)N)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)CCC(=O)O,,,,,,
3290,3083293,CID 3083293,CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCNC(=O)C(F)(F)F)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
3291,3083294,"1-Palmitoyl-2-(N-(12-((7-nitrobenz-2-oxa-1,3-diazole-4-yl)amino)dodecanoyl))phosphatidylserine",CCCCCCCCCCCCCCCC(=O)OC[C@@H](COP(=O)(O)OC[C@@H](C(=O)O)N)OC(=O)CCCCCCCCCCCNC1=CC=C(C2=NON=C12)[N+](=O)[O-],,,,,,
3292,3083295,"Vasotocin, dansyl-lys(8)-",CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCCNS(=O)(=O)C4=CC=CC5=C4C=CC=C5N(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,,,,,,
3293,3083296,"[4-[3,4-Dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-5-hydroxy-6-[2-(4-hydroxy-3-methoxyphenyl)ethoxy]-2-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-3-yl] 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate",CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OCCC3=CC(=C(C=C3)O)OC)O)OC4C(C(CO4)(CO)O)O)OC(=O)C=CC5=CC(=C(C=C5)O)OC)O)O)O,,,,,,
3294,3083297,Glpsd,CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)O)C)C=CC5=C6CC(C(CC6(CCC53C)C)OC7C(C(C(C(O7)C(=O)O)O)O)O)(C)C(=O)O)C)C,,,,,,
3295,3083298,Glnsf,C[C@]12CC[C@](CC1=C3C=C[C@@H]4[C@]5(CC[C@@H]([C@]([C@@H]5CC[C@]4([C@@]3(C(=O)C2)C)C)(C)CO)O)C)(C)C(=O)O,,,,,,
3296,3083299,Vipsogal,CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H](C3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)OC(=O)CC.CC(=O)OCC(=O)[C@@]12[C@H](C[C@@H]3[C@@]1(C[C@@H](C4([C@H]3C[C@@H](C5=CC(=O)C=C[C@@]54C)F)F)O)C)OC(O2)(C)C.CC(C)(CO)[C@H](C(=O)NCCCO)O.CNC1C(COC(C1O)OC2C(CC(C(C2O)OC3C(C(C(C(O3)CO)O)O)N)N)N)O,,,,,,
3297,3083300,"2-((2S,6aS,7S,8aS,8bS,11aS,12aS,12bS)-2,6b-difluoro-7-hydroxy-6a,8a,10,10-tetramethyl-4-oxo-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)[C@@]12[C@H](C[C@@H]3[C@@]1(C[C@@H](C4([C@H]3C[C@@H](C5=CC(=O)C=C[C@@]54C)F)F)O)C)OC(O2)(C)C,,,,,,
3298,3083301,Sceptrumgenin 3-O-lycotetraoside,CC1C2C(CC3C2(CCC4C3CC=C5C4(CCC(C5)OC6C(C(C(C(O6)CO)OC7C(C(C(C(O7)CO)O)OC8C(C(C(CO8)O)O)O)OC9C(C(C(C(O9)CO)O)O)O)O)O)C)C)OC11CCC(=C)CO1,,,,,,
3299,3083302,CID 3083302,CC(C)C(C(=O)NC(=CC1=CC=CC=C1)C(=O)NC)NC(=O)C(=CC2=CC=CC=C2)NC(=O)C,,,,,,
3300,3083303,2-Deoxy-2-((3R)-3-hydroxy-tetradecanamido)-3-O-(3-hydroxytetradecanyl)-4-O-phosphonoglucopyranose,CCCCCCCCCCC[C@H](CCO[C@H]([C@H](C=O)NC(=O)C[C@@H](CCCCCCCCCCC)O)[C@@H]([C@@H](CO)O)OP(=O)(O)O)O,,,,,,
3301,3083304,CID 3083304,C1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C([O+]=C4C=C(C=C(C4=C3)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)C6=CC(=C(C=C6)O)O)COC(=O)C=CC7=CC=C(C=C7)O)O)O)O)O)O.[Cl-],,,,,,
3302,3083305,CID 3083305,C1[C@H]([C@H]([C@H]([C@H](O1)O[C@@H]2[C@@H]([C@H]([C@@H](O[C@@H]2OC3=C(OC4=CC(=O)C=C(C4=C3)O[C@@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)CO)O)O)O)C6=CC(=C(C=C6)O)O)COC(=O)C=CC7=CC=C(C=C7)O)O)O)O)O)O,,,,,,
3303,3083306,Marsdekoiside B,CC1C(C(C(C(O1)OC2C(OC(CC2OC)OC3C(OC(CC3OC)OC4CCC5(C(C4)CCC6(C5CC(C7(C6(CCC7(C(C)O)O)O)C)OC(=O)C8=CC=CC=C8)O)C)C)C)O)OC)O,,,,,,
3304,3083307,CID 3083307,[B+3].CC1=CC(=NC1=CC2=CC=C([N-]2)CCC(=O)NC3=CC=CC(=C3)CCN(C)CCCC(C#N)(C4=CC(=C(C(=C4)OC)OC)OC)C(C)C)C.[F-].[F-],,,,,,
3305,3083308,"N-[3-[2-[[4-cyano-5-methyl-4-(3,4,5-trimethoxyphenyl)hexyl]-methylamino]ethyl]phenyl]-3-[5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]pyrrol-2-yl]propanamide",CC1=CC(=C(N1)C=C2C=CC(=N2)CCC(=O)NC3=CC=CC(=C3)CCN(C)CCCC(C#N)(C4=CC(=C(C(=C4)OC)OC)OC)C(C)C)C,,,,,,
3306,3083309,3-Rxgsd,C[C@@H]1CCC2([C@H]([C@H]3[C@@H](O2)CC4[C@@]3(CCC5C4CCC6[C@@]5(CC(C(C6)[C@]7([C@@H]([C@H]([C@@H]([C@@H](O7)CO)O)O)O)O[C@@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O[C@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)C)O)O)O)O[C@@H]2[C@@H]([C@H]([C@@H](CO2)O)O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)C)C)C)OC1,,,,,,
3307,3083310,Cu(GABA(mpy)2),C1=CC=NC(=C1)CN(CCCC(=O)[O-])CC2=CC=CC=N2.[Cu+2].[Br-],,,,,,
3308,3083311,"Butanoic acid, 4-[bis(2-pyridinylmethyl)amino]-",C1=CC=NC(=C1)CN(CCCC(=O)O)CC2=CC=CC=N2,,,,,,
3309,3083312,CID 3083312,CN(CC(=O)N[C@@H]1CC[C@]2([C@@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)O)CCN3CC6CC6)O)C7=CC=C(C8=NON=C78)[N+](=O)[O-],,,,,,
3310,3083313,CID 3083313,CC12CCC3C(C1CCC2=NN=C4CCC5(C6CC7=C8C5(C4OC8=C(C=C7)O)CCN6CC9CC9)O)CCC1=C3C=CC(=C1)O,,,,,,
3311,3083314,Desferriferribactin,C[C@H]([C@@H](C(=O)N[C@H](CO)C(=O)NC(=O)[C@H](CCCN(C(=O)C)O)N(C1CCCN(C1=O)O)C(=O)[C@@H](C)NC(=O)C2CCN=C(N2)C(CC3=CC=C(C=C3)O)NC(=O)CCC(C(=O)O)N)NC(=O)[C@H](CCCCN)N)O,,,,,,
3312,3083315,Leucasin,CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CCC4[C@]([C@@]3(CC2)C)(CC[C@@H]5[C@@]4(CC(C(C5(C)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O)C)C)C,,,,,,
3313,3083316,Valproyl-adenylic acid,CCCC(CCC)C(=O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O,,,,,,
3314,3083317,CID 3083317,C[N+](C)(C)C.C1CC(=C(C1=CC(C#N)C#N)Cl)C=C(C#N)C2=NC3=C(O2)C=CC(=C3)Cl,,,,,,
3315,3083318,"2-[[2-Chloro-3-[2-(5-chloro-1,3-benzoxazol-2-yl)-2-cyanoethenyl]cyclopent-2-en-1-ylidene]methyl]propanedinitrile",C1CC(=C(C1=CC(C#N)C#N)Cl)C=C(C#N)C2=NC3=C(O2)C=CC(=C3)Cl,,,,,,
3316,3083319,CID 3083319,C[C@@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@H](C=CC(=O)O)C=O)N,,,,,,
3317,3083320,"3beta-(alpha-L-Rhamnosyl-(1-2),beta-D-glucopyranosyl-(1-3)-beta-D-glucopyranosyl(beta-D-xylopyranosyl-(1-4)-alpha-L-rhamnopyranosyl-(1-2))-beta-D-glucopyranosyl)-25R-5alpha-spirostane",CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)OC7C(C(C(C(O7)CO)O)OC8C(C(C(C(O8)CO)O)OC9C(C(C(CO9)O)O)O)OC2C(C(C(C(O2)C)O)O)O)OC2C(C(C(C(O2)CO)OC2C(C(C(C(O2)C)O)O)O)O)O)C)C)C)OC1,,,,,,
3318,3083321,"N-[4-[(2S,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxyphenyl]prop-2-enamide;prop-2-enamide",C=CC(=O)N.C=CC(=O)NC1=CC=C(C=C1)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O)O)O,,,,,,
3319,3083322,4-(Acryloylamino)phenyl 4-O-beta-D-galactopyranosyl-beta-D-glucopyranoside,C=CC(=O)NC1=CC=C(C=C1)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O)O)O,,,,,,
3320,3083323,Poly-N(5)-(3-hydroxypropylglutamine)-prazosin carbamate,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)NC(=O)OCCCN[C@@H](CCC(=O)N)C(=O)O)OC,,,,,,
3321,3083324,"2-[2-[(1S,2R,3aS,7aS)-2-hydroxy-1-[(3S)-3-hydroxy-4,4-dimethylnona-1,6-diynyl]-2,3,3a,6,7,7a-hexahydro-1H-inden-5-yl]ethoxy]acetic acid",CCC#CCC(C)(C)[C@@H](C#C[C@@H]1[C@H]2CCC(=C[C@H]2C[C@H]1O)CCOCC(=O)O)O,,,,,,
3322,3083325,4-Nitrophenyl 4(5)-O-galactosylmaltopentaoside,C1=CC(=CC=C1[C@]2([C@@H]([C@H]([C@@H]([C@H](O2)CO[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O)O[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O[C@@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O[C@@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)[N+](=O)[O-],,,,,,
3323,3083326,Tyrosyl-prolyl-phenylalanyl-phenylalanyl-phenylalanyl-tryptophyl-methioninamide,CSCC[C@@H](C(=O)N)NC(=O)[C@@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@@H](CC3=CC=CC=C3)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)NC(=O)[C@@H]6CCCN6C(=O)[C@H](CC7=CC=C(C=C7)O)N,,,,,,
3324,3083327,4-Azido-2-nitrophenyl polyethylene glycol,C1=CC(=C(C=C1N=[N+]=[N-])[N+](=O)[O-])OCOCCO,,,,,,
3325,3083328,"(6S)-N,N-dipropyl-5,6,7,8-tetrahydroindolizin-6-amine",CCCN(CCC)[C@H]1CCC2=CC=CN2C1,,,,,,
3326,3083329,3-Cdbmt-zinc,CC(C)(CNC1CCCCC1NCC(C)(C)[S-])[S-].[Zn+2],,,,,,
3327,3083330,2-Methyl-1-[[2-[(2-methyl-2-sulfanylpropyl)amino]cyclohexyl]amino]propane-2-thiol,CC(C)(CNC1CCCCC1NCC(C)(C)S)S,,,,,,
3328,3083331,"8-Azido-2',3'-O-(2,4,6-trinitro-2,4-cyclohexadien-1-ylidene)-5'-adenylic acid ion(1-)",C1C(=C(C=C(C12O[C@@H]3[C@H](O[C@H]([C@@H]3O2)N4C5=NC=NC(=C5N=C4N=[N+]=[N-])N)COP(=O)(O)[O-])[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],,,,,,
3329,3083332,"[(3aR,4R,6R,6aR)-4-(6-amino-8-azidopurin-9-yl)-1',2',4'-trinitrospiro[3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxole-2,5'-cyclohexa-1,3-diene]-6-yl]methyl dihydrogen phosphate",C1C(=C(C=C(C12O[C@@H]3[C@H](O[C@H]([C@@H]3O2)N4C5=NC=NC(=C5N=C4N=[N+]=[N-])N)COP(=O)(O)O)[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],,,,,,
3330,3083333,CID 3083333,CC[C@@H]1C=C(C[C@@H](C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC1=O)O)C)C(=C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)O)C)OC)O)C)C,,,,,,
3331,3083334,CID 3083334,C[C@@]12CCN([C@@H]1N(C3=C2C=C(C=C3Br)O)C)C.C(=CC(=O)O)C(=O)O,,,,,,
3332,3083335,"(3aS)-7-Bromo-1,2,3,3a,8,8aalpha-hexahydro-1,3aalpha,8-trimethylpyrrolo[2,3-b]indol-5-ol",C[C@@]12CCN([C@@H]1N(C3=C2C=C(C=C3Br)O)C)C,,,,,,
3333,3083336,2-(N-Dansyl-4-aminophenylthio)-N-acetyl-9-O-acetylneuraminic acid,CC(=O)N[C@@H]1[C@H](C[C@@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)SC2=CC=C(C=C2)NS(=O)(=O)C3=CC=CC4=C3C=CC=C4N(C)C)O,,,,,,
3334,3083337,CID 3083337,CC(=O)NC1[C@H]([C@@H]([C@H](O[C@@H]1OO[C@H]2C([C@H]([C@@H]([C@H](O2)C(O)P(=O)OO[C@@H]3C[C@H]([C@@H]([C@H](O3)CO)O)O)O)OO[C@@H]4C[C@H]([C@@H]([C@H](O4)C[O-])[O-])[O-])N(C(=O)CP(=O)OC5=C(C=C(C=C5)[N+](=O)[O-])NC(=O)CP(=O)O)NC(=O)C)CO)O)O.[NH4+].[NH4+].[NH4+],,,,,,
3335,3083338,CID 3083338,CC(=O)NC1[C@H]([C@H]([C@@H](O[C@@H]1OO[C@@H]2C([C@H]([C@H]([C@@H](O2)C(O)P(=O)OO[C@@H]3C[C@H]([C@H]([C@@H](O3)CO)O)O)O)OO[C@@H]4C[C@H]([C@H]([C@@H](O4)CO)O)O)N(C(=O)CP(=O)OC5=C(C=C(C=C5)[N+](=O)[O-])NC(=O)CP(=O)O)NC(=O)C)CO)O)O,,,,,,
3336,3083339,CID 3083339,CCOC1=CC(=CC(=N1)N=CNN=CC2=CC=C(O2)[N+](=O)[O-])C3=CC(=CC(=C3)C#N)C#N,,,,,,
3337,3083340,Songarosaponin B,CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(C(OC(C3OC4C(C(C(C(O4)CO)O)O)O)OC5CCC6(C(C5(C)CO)CCC7(C6C=CC8(C7(CCC9(C8CC(CC9)(C)C)CO)C)O)C)C)C)O)CO)O)O)O,,,,,,
3338,3083341,Copper;potassium;ZINC;iron(3+);manganese(2+);pentachloride;iodide;disulfate,[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[K+].[Mn+2].[Fe+3].[Cu+2].[Zn+2].[I-],,,,,,
3339,3083342,CID 3083342,C[C@H]1[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)C(=C)N(C(=O)CC[C@@H](NC1=O)C(=O)O)C)CO)CC(C)C)C(=O)O)C)CCCN=C(N)N)C=CC(=C[C@H](C)[C@H](CC2=CC=CC=C2)OC(=O)C)C,,,,,,
3340,3083343,CID 3083343,C[C@H]1[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](N(C(=O)CC[C@@H](NC1=O)C(=O)O)C)CO)C)CC(C)C)C(=O)O)C)CCCN=C(N)N)C=CC(=C[C@H](C)[C@H](CC2=CC=CC=C2)OC(=O)C)C,,,,,,
3341,3083344,"3,4-Pyrrolidinediol, 1,1'-(1,6-hexanediyl)bis(2-(phenylmethyl)-, dihydrochloride",C1C(C(C(N1CCCCCCN2CC(C(C2CC3=CC=CC=C3)O)O)CC4=CC=CC=C4)O)O.Cl.Cl,,,,,,
3342,3083345,"2-Benzyl-1-[6-(2-benzyl-3,4-dihydroxypyrrolidin-1-yl)hexyl]pyrrolidine-3,4-diol",C1C(C(C(N1CCCCCCN2CC(C(C2CC3=CC=CC=C3)O)O)CC4=CC=CC=C4)O)O,,,,,,
3343,3083346,Acarviosin,C[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)OC)O)O)N[C@@H]2C=C([C@@H]([C@H]([C@@H]2O)O)O)CO,,,,,,
3344,3083347,CID 3083347,CC1=CC(=O)CC([C@@]1(C=C[C@H](C)O[C@@H]2[C@@H]([C@@H]([C@H]([C@@H](O2)CO)O)O[C@@H]3[C@@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)O)O[C@@H]4[C@@H]([C@@H]([C@@H](CO4)O)O)O)O)(C)C,,,,,,
3345,3083348,Dai-tunicamine,CC1(OC(C(O1)C(C(CC2C3C(C4C(O2)OC(O4)(C)C)OC(O3)(C)C)O)O)C=O)C,,,,,,
3346,3083349,Vgagathpgy,CC(C)C(C(=O)NC(C(C)OC1C(C(C(C(O1)CO)O)OC2C(C(C(C(O2)CO)O)O)O)NC(=O)C)C(=O)NC(CC3=CN=CN3)C(=O)N4CCCC4C(=O)NCC(=O)NC(CC5=CC=C(C=C5)O)C(=O)O)N,,,,,,
3347,3083350,CID 3083350,C[C@H](C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC2=CC=C(C=C2)Cl)C(=O)N)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H](CC5=CC=CC=C5)N,,,,,,
3348,3083351,Nlfpc,C1=CC(=CC=C1C(=O)CSCCNCC(C(C(C(CO)O)OC2C(C(C(C(O2)CO)O)O)O)O)O)[18F],,,,,,
3349,3083352,9-Dihydro-13-acetylbaccatin III,CC1=C2[C@H]([C@@H]([C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)C)O)OC(=O)C5=CC=CC=C5)(CO4)OC(=O)C)O)C)O)OC(=O)C,,,,,,
3350,3083353,3FAPE-Hhh,C1=CC(=CC=C1CCO[C@H]2[C@H]([C@H]([C@@H](C(O2)[C@@H](CO)O)O)O[C@H]3[C@H]([C@H]([C@@H](C(O3)[C@@H](CO)O)O)O)O)O[C@H]4[C@H]([C@H]([C@@H](C(O4)[C@@H](CO)O)O)O)O)NC(=O)C(F)(F)F,,,,,,
3351,3083354,Cycloviracin B2,CC(CCCCCC(CCCCCCCCCCCCCCCC1CC(=O)OCC2C(C(C(C(O2)OC(CC(=O)OCC3C(C(C(C(O1)O3)O)O)O)CCCCCCCCCCCCCC(CCCCCC(=O)C)OC4C(C(C(C(O4)CO)O)O)OC)O)O)O)OC5C(C(C(C(O5)CO)O)O)OC)OC6C(C(C(C(O6)CO)O)O)OC,,,,,,
3352,3083355,CID 3083355,CCC1=CC2=C3C4=C(C5=C(CC4OCO3)C(=C6C(=C(C7=C(O6)C(CCC7O)O)O)C5=O)OC)C(=O)C2=C(N1C)O,,,,,,
3353,3083356,CID 3083356,CC[C@H](C(=O)NCC=CC=C(C)[C@H]([C@@H](C)[C@H]1C[C@H]([C@H](O1)C=CC=CC=CC(=O)O)O)OC)[C@@]2([C@@H]([C@@H](C([C@@H](O2)C=CC=CC)(C)C)O)O)O,,,,,,
3354,3083357,Glutamyl-leucyl-valyl-isoleucyl-serine,CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)N,,,,,,
3355,3083358,Technetium Tc 99m 4-iodophenethyldiaminodithiol,CC(C)(C[N-]C(C)(C)CN(CCC1=CC=C(C=C1)I)CC(C)(C)[S-])[S-].O=[99Tc+3],,,,,,
3356,3083359,1-[[1-[2-(4-Iodophenyl)ethyl-(2-methyl-2-sulfanylpropyl)amino]-2-methylpropan-2-yl]amino]-2-methylpropane-2-thiol,CC(C)(CNC(C)(C)CN(CCC1=CC=C(C=C1)I)CC(C)(C)S)S,,,,,,
3357,3083360,"21-Amino-6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-(2-methylpropyl)-1,4,7,10,13,16,19-heptazacyclotricosane-2,5,8,11,14,17,20-heptone;sulfuric acid",CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CCN)N)C(C)O)CCN)CCN.OS(=O)(=O)O,,,,,,
3358,3083361,H-DL-Dab(1)-DL-Dab-DL-Phe-DL-Leu-DL-Dab-DL-Dab-DL-xiThr-(1),CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CCN)N)C(C)O)CCN)CCN,,,,,,
3359,3083362,Glutathiolactaldehyde dimethylacetal,COC([C@H](CSC[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)O)N)O)OC,,,,,,
3360,3083363,Berchemolide,CC1=C(C=CC(=C1)C(=O)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(C=C(C=C3)C(=O)O)OC)O)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,,,,,,
3361,3083364,Adomac,C[S+](C1CC(C=C1)N)C([C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)O)O.OS(=O)(=O)O.OS(=O)(=O)[O-],,,,,,
3362,3083365,"(4-aminocyclopent-2-en-1-yl)-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]-hydroxymethyl]-methylsulfanium",C[S+](C1CC(C=C1)N)C([C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)O)O,,,,,,
3363,3083366,1-Octyl-2-(N-dodecanoylamino)-2-deoxyglycero-3-phosphoglycol,CCCCCCCCCCCC(=O)N[C@H](COCCCCCCCC)COP(=O)(O)OCCO,,,,,,
3364,3083367,CID 3083367,CC1C(C(C(C(O1)OC2C(C(C(OC2OC3=C(OC4=C(C(=CC(=O)C4=C3O)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)CC=C(C)C)C7=CC=C(C=C7)OC)C)O)O)O)O)O,,,,,,
3365,3083368,"(4aS,6aR,6aR,6bR,8aR,12aR,14bS)-6a-[3-(3,4-dihydroxyphenyl)prop-2-enoyloxymethyl]-2,2,6b,9,9,12a-hexamethyl-10-oxo-3,4,5,6,6a,7,8,8a,11,12,13,14b-dodecahydro-1H-picene-4a-carboxylic acid",C[C@]12CCC(=O)C([C@@H]1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@H]4CC(CC5)(C)C)C(=O)O)COC(=O)C=CC6=CC(=C(C=C6)O)O)C)(C)C,,,,,,
3366,3083369,Stevisalioside A,CC(=O)OC1C(C(OC(C1OC(=O)C)OC(=O)C2(CCCC3(C2CCC45C3C(C(C(=C)C4)C(=O)C5)O)C)C)CO)OC6C(C(C(CO6)O)O)O,,,,,,
3367,3083370,Cyclic (acleu-asp-gln-trp-phe-glynh2),CC(=C)C[C@@H](C=O)NC(=O)CNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)O)N,,,,,,
3368,3083371,Ardicrenin,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2CO[C@H]([C@@H]([C@H]2O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O[C@H]5CC[C@@]6([C@H]7CCC89C1C[C@](C[C@@H](C1(CC[C@]8([C@@]7(CCC6C5(C)C)C)C)CO9)O)(C)C=O)C)O)O)O,,,,,,
3369,3083372,N-(1-(2-Naphthol))phosphatidylethanolamine,CCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCNCC1=C(C=CC2=CC=CC=C21)O)OC(=O)CCCCCCCCCCCCC,,,,,,
3370,3083373,Cyclo-cadagac,CC(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)N([C@@H](C=S)C(=O)O)C(=O)[C@H](CC(=O)O)NC(=O)C=NC(=O)[C@H](CC1=CC(C(C=C1)(C(=O)C2NCCS2)N)(C)C)N,,,,,,
3371,3083374,Ddtmsp,CC1=CC=C(C=C1)S(=O)(=O)NC2CC(C(C3C2OC(O3)(C)C)OC4C5C(N5S(=O)(=O)C6=CC=C(C=C6)C)C7C(O4)COC(O7)(C)C)NS(=O)(=O)C8=CC=C(C=C8)C,,,,,,
3372,3083375,Polyvinyl alcohol-triethylene glycol diacrylate copolymer,C=CC(=O)OCCOCCOCCOC(=O)C=C.C=CO,,,,,,
3373,3083376,Pseudo-ginsenoside-RI3,CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(C(O6)COC7C(C(C(C(O7)C(=O)O)O)O)OC8C(C(C(C(O8)CO)O)O)O)O)O)O)C)C)C2C1)C)C(=O)OC9C(C(C(CO9)O)O)O)C,,,,,,
3374,3083377,"2-O-methyl 4a-O-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 10-[3,4-dihydroxy-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-11-hydroxy-9-(hydroxymethyl)-2,6a,6b,9,12a-pentamethyl-1,3,4,5,6,7,8,8a,10,11,12,14b-dodecahydropicene-2,4a-dicarboxylate",CC1(CCC2(CCC3(C(=CC=C4C3(CCC5C4(CC(C(C5(C)CO)OC6C(C(C(CO6)OC7C(C(C(C(O7)CO)O)O)O)O)O)O)C)C)C2C1)C)C(=O)OC8C(C(C(C(O8)CO)O)O)O)C(=O)OC,,,,,,
3375,3083378,"(2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-2-[(10R,12S,14R)-12-hydroxy-17-[(2S,4S,5S)-4-hydroxy-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,4,6,10,14-pentamethyl-1,2,3,5,6,7,8,9,11,12,13,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]-6-(hydroxymethyl)-2-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@]2(C3CC[C@@]4(C5C[C@@H](C6C(CC[C@@]6(C5CC(C4C3(C)C)C)C)[C@@]7(C[C@@H]([C@H](O7)C(C)(C)O)O)C)O)C)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)CO)O)O)O)O)O,,,,,,
3376,3083379,Nematocyphol,CC(C)[C@H]1CC[C@]2([C@H]1[C@@]3(CC[C@H]4C(=CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)O)C)[C@]3(CC2)C)C)C,,,,,,
3377,3083380,"Di-myo-inositol-1,1'-phosphate",[C@H]1([C@H](C([C@@H]([C@@H](C1O)O)O)OP(=O)(O)OC2[C@@H]([C@H](C([C@H]([C@H]2O)O)O)O)O)O)O,,,,,,
3378,3083381,Yibeissine,C[C@H]1C[C@@H]2[C@H]([C@H]([C@]3(O2)CC[C@H]4[C@@H]5CC(=O)[C@H]6C[C@H](CC[C@@]6([C@H]5[C@H](C4=C3C)O)C)O)C)NC1,,,,,,
3379,3083382,(KDO)2-lipid IVA,CCCCCCCCCCC[C@H](CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1OP(=O)(O)O)CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO[C@@]3(C[C@H]([C@H]([C@H](O3)[C@@H](CO)O)O)O[C@@]4(C[C@H]([C@H]([C@H](O4)[C@@H](CO)O)O)O)C(=O)O)C(=O)O)OP(=O)(O)O)OC(=O)C[C@@H](CCCCCCCCCCC)O)NC(=O)C[C@@H](CCCCCCCCCCC)O)O)OC(=O)C[C@@H](CCCCCCCCCCC)O)O,,,,,,
3380,3083383,"(3Z,17E,21E,39E)-8,10,16,20,24,26,28,30,32,34,36,38-dodecahydroxy-42-[(1R)-1-(5-hydroxyoxolan-2-yl)ethyl]-3,7,9,15,19,21,31,33-octamethyl-23-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1-oxacyclodotetraconta-3,13,17,21,39-pentaen-2-one",CC1CCC=C(C(=O)OC(CC=CC(CC(CC(C(C(C(C(CC(CC(CC(C(C=C(C(C(C=CC(C(C=CCCC(C(C1O)C)O)C)O)C)O)C)O[C@@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)O)O)C)O)C)O)O)O)[C@H](C)C3CCC(O3)O)C,,,,,,
3381,3083384,"2',4'-Dinitrophenyl 2-deoxy-2-fluorogalactopyranoside",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)F,,,,,,
3382,3083385,(2S)-1-[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-4-methylpentanoyl]-N-[2-[[(2S)-1-[[(2S)-4-methyl-1-oxo-1-[(2S)-2-(2-oxoethylidenecarbamoyl)pyrrolidin-1-yl]pentan-2-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]pyrrolidine-2-carboxamide,C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N=CC=O)N,,,,,,
3383,3083386,CID 3083386,CC1C(C(C(C(O1)OC2C(C(C(OC2OC3C(OC(C(C3O)O)OCCCN)C)CO)OC4C(C(C(C(O4)CO)O)O)O)OP(=O)([O-])OC(CO)CO)O)O)O.[Na+],,,,,,
3384,3083387,"[2-[6-(3-Aminopropoxy)-4,5-dihydroxy-2-methyloxan-3-yl]oxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-4-yl] 1,3-dihydroxypropan-2-yl hydrogen phosphate",CC1C(C(C(C(O1)OC2C(C(C(OC2OC3C(OC(C(C3O)O)OCCCN)C)CO)OC4C(C(C(C(O4)CO)O)O)O)OP(=O)(O)OC(CO)CO)O)O)O,,,,,,
3385,3083388,"3,3-Dimethyl-7-oxo-6-[[2-(phenoxy)acetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;hydron;mercury(2+);chloride",[H+].CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=C[C-]=C3)C(=O)[O-])C.[Cl-].[Hg+2],,,,,,
3386,3083389,5-Apthp,C1=CC(=CC=C1C[C@H]([C@H]([C@H](CO)O)O)O)N,,,,,,
3387,3083390,"[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2R,3R,4S,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3,4-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate",C[C@]12CC[C@@H](C(C1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@@H]4CC(CC5)(C)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)(C)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O,,,,,,
3388,3083391,Elatoside F,C[C@]12CC[C@@H](C(C1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@@H]4CC(CC5)(C)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)(C)C)O[C@H]7[C@@H]([C@H]([C@H](CO7)O)O[C@@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O[C@H]9[C@@H]([C@H]([C@@H](CO9)O)O)O,,,,,,
3389,3083392,CID 3083392,CC(C)N(CCN)C1=NC(=C(N=C1Cl)C(=O)N=CNNC(=O)C2=C(C=C(C=C2)N=[N+]=[N-])O)N,,,,,,
3390,3083393,1-Apeahg,C1=CC(=CC=C1CCNCC(C(C(C(COC2C(C(C(C(O2)COC3C(C(C(C(O3)COC4C(C(C(C(O4)COC5C(C(C(C(O5)CO)O)O)O)O)OC6C(C(C(C(O6)CO)O)O)O)O)O)O)O)O)OC7C(C(C(C(O7)CO)O)O)O)O)O)O)O)O)N,,,,,,
3391,3083394,Chl-betacd,CC(C)CC1C(=O)NC(C(=O)N1)CC2=CN(C=N2)CC3C4C(C(C(O3)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(C(C8O)O)OC9C(OC(C(C9O)O)OC1C(OC(O4)C(C1O)O)CO)CO)CO)CO)CO)CO)O)O.CC(C)CC1C(=O)NC(C(=O)N1)CC2=CN(C=N2)CC3C4C(C(C(O3)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(C(C8O)O)OC9C(OC(C(C9O)O)OC1C(OC(O4)C(C1O)O)CO)CO)CO)CO)CO)CO)O)O.CC(C)CC1C(=O)NC(C(=O)N1)CC2=CN(C=N2)CC3C4C(C(C(O3)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(C(C8O)O)OC9C(OC(C(C9O)O)OC1C(OC(O4)C(C1O)O)CO)CO)CO)CO)CO)CO)O)O.CC(C)CC1C(=O)NC(C(=O)N1)CC2=CN(C=N2)CC3C4C(C(C(O3)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(C(C8O)O)OC9C(OC(C(C9O)O)OC1C(OC(O4)C(C1O)O)CO)CO)CO)CO)CO)CO)O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O,,,,,,
3392,3083395,"3-(2-Methylpropyl)-6-[[1-[[36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecahydroxy-10,15,20,25,30,35-hexakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-5-yl]methyl]imidazol-4-yl]methyl]piperazine-2,5-dione",CC(C)CC1C(=O)NC(C(=O)N1)CC2=CN(C=N2)CC3C4C(C(C(O3)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(C(C8O)O)OC9C(OC(C(C9O)O)OC1C(OC(O4)C(C1O)O)CO)CO)CO)CO)CO)CO)O)O,,,,,,
3393,3083396,"(2R,11R)-5,14-bis[(3aR,8bR)-3-methyl-1,2,3a,4-tetrahydropyrrolo[2,3-b]indol-8b-yl]-19,24-dimethyl-3,12,21,24-tetrazahexacyclo[9.7.3.32,10.01,10.04,9.013,18]tetracosa-4,6,8,13,15,17-hexaene",CC1CN[C@H]2C34C1([C@H](NC5=C(C=CC=C53)[C@]67CCN([C@H]6NC8=CC=CC=C78)C)N(CC4)C)C9=CC=CC(=C9N2)[C@]12CCN([C@H]1NC1=CC=CC=C21)C,,,,,,
3394,3083397,CID 3083397,C[C@@H](C(=O)OC(C)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@](C)(C(=O)C(C)O[C@@H]1[C@H]([C@H](O[C@H]([C@@H]1O)COP(=O)(O)OP(=O)(O)OC[C@H]2[C@@H]([C@H]([C@@H](O2)N3C=CC(=O)NC3=O)O)O)O)N)NC(=O)C,,,,,,
3395,3083398,CID 3083398,CC[C@H]1[C@H]([C@@H](CC(=CC=C[C@@H]([C@H](OC(=O)C(=CC(=C[C@H]([C@H]1O)C)C)OC)[C@@H](C)[C@H]([C@H](C)[C@]2(C[C@H]([C@@H]([C@H](O2)C=CC)C)O)O)O)OC)C)C)O,,,,,,
3396,3083399,Puberulin,CC(=O)N1[C@@H]2[C@@](C[C@@H]3N2C(=O)[C@@H](NC3=O)CC4=CC=CC=C4)(C5=CC=CC=C51)C(C)(C)C=C,,,,,,
3397,3083400,CID 3083400,CC(=C)C(=O)OC.C=CC(=O)[O-].[K+],,,,,,
3398,3083401,CID 3083401,[H+].[B+3].CC1=NC(=CC2=CC=C([N-]2)CCCCCCCCCCCC(=O)[O-])C=C1.[F-].[F-],,,,,,
3399,3083402,12-[5-[(5-methyl-1H-pyrrol-2-yl)methylidene]pyrrol-2-yl]dodecanoic acid,CC1=CC=C(N1)C=C2C=CC(=N2)CCCCCCCCCCCC(=O)O,,,,,,
3400,3083403,3-Dttctp,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(OC)OC3CC(OC3COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)N7C=C(C(=O)NC7=O)C)OC(=O)C89CCC(C8(C)C)(C(=O)O9)C,,,,,,
3401,3083404,alpha-Hydroxyalprazolam glucuronide,C1C2=NN=C(N2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4)CO[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O,,,,,,
3402,3083405,"[30-[3,4-Dihydroxy-6-(hydroxymethyl)-5-(2-methylbut-2-enoyloxy)oxan-2-yl]oxy-4,5,11,12-tetrahydroxy-6-(hydroxymethyl)-13,31-dimethyl-27-oxo-17-pentyl-2,7,9,14,16,28,32-heptaoxatetracyclo[27.3.1.03,8.010,15]tritriacontan-33-yl] 2-methylbutanoate",CCCCCC1CCCCCCCCCC(=O)OC2C(C(OC(C2OC(=O)C(C)CC)OC3C(C(C(OC3OC4C(C(C(OC4O1)C)O)O)CO)O)O)C)OC5C(C(C(C(O5)CO)OC(=O)C(=CC)C)O)O,,,,,,
3403,3083406,Antazoline nitrate,C1CN=C(N1)CN(CC2=CC=CC=C2)C3=CC=CC=C3.[N+](=O)(O)[O-],,,,,,
3404,3083407,Lantanose B,C([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)OC[C@H]([C@H]([C@@H]([C@H](C=O)O[C@@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O[C@@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O)O[C@@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)O[C@@H]5[C@@H]([C@H]([C@H]([C@H](O5)CO)O)O)O)O)O)O)O,,,,,,
3405,3083408,Strontium cation Sr-89,[89Sr+2],,,,,,
3406,3083409,"(10S,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylhept-5-en-2-yl]-3-oxo-1,2,5,6,7,11,12,15,16,17-decahydrocyclopenta[a]phenanthrene-14-carboxylic acid",C[C@H](CCC=C(C)C)[C@H]1CC[C@@]2([C@@]1(CCC3=C2CCC4[C@@]3(CCC(=O)C4(C)C)C)C)C(=O)O,,,,,,
3407,3083410,Methyl 3-O-(2-acetamido-2-deoxy-6-thioglucopyranosyl)galactopyranoside,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O[C@H]2[C@H]([C@H](O[C@H]([C@@H]2O)OC)CO)O)CS)O)O,,,,,,
3408,3083411,Cyclo(acetylpenicillamyl-arginyl-glycyl-aspartyl-cysteinamide),CC(=O)N[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C=S)C(=O)N)C(C)(C)S,,,,,,
3409,3083412,Aucl(S2CPEt3),CCP(=C([S-])[S-])(CC)CC.[Cl-].[Au+3],,,,,,
3410,3083413,(Triethyl-lambda5-phosphanylidene)methanedithiol,CCP(=C(S)S)(CC)CC,,,,,,
3411,3083414,"(2R,3R,4R,5R)-4-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[[(4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-(2-oxopropyl)-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,5,6-tetrahydroxyhexanal",CC(=O)CC1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@H](O2)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@H]([C@@H](CO)O)[C@@H]([C@H](C=O)O)O)CO)CO)CO)O)O,,,,,,
3412,3083415,CID 3083415,CCCO[C@H]1C([C@]([C@H]([C@H](O1)CO[C@@H]2[C@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O)(O)OC(=O)CCCCCCCC=CCC=CCC=CCC)(O)O,,,,,,
3413,3083416,CID 3083416,CC1C(C(CC(O1)OC2(C3CC4(C(C(=O)C(=C(N)O)C(=O)C4(C(=O)C3=C(C5=C2C(=C(C=C5O)OC)Cl)O)O)N(C)C)O)C)(C)O)OC,,,,,,
3414,3083417,CID 3083417,CCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)O[C@]1([C@H]([C@@H]([C@H]([C@@H]([C@@H]1O[C@@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)[O-])O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)N)OC=CCCCCCCCCCCCC.[Na+],,,,,,
3415,3083418,CID 3083418,CCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)O[C@@]1([C@@H]([C@@H]([C@H]([C@H]([C@H]1O[C@@H]2[C@@H]([C@@H]([C@H]([C@@H](O2)CO)O)O)O)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@H]([C@@H](O3)CO)O)O)N)OC=CCCCCCCCCCCCC,,,,,,
3416,3083419,N-Acetyl-9-O-acetylneuraminic acid 4-aminophenylthioketoside,CC(=O)N[C@@H]1[C@H](C[C@@](O[C@H]1[C@@H]([C@@H](COC(=O)C)O)O)(C(=O)O)SC2=CC=C(C=C2)N)O,,,,,,
3417,3083420,Calotroposide A,CC1C(C(CC(O1)OC2C(OC(CC2OC)OC3C(OC(CC3OC)OC4C(OC(CC4OC)OC5C(OC(CC5OC)OC6CCC7(C8CC(C9(C(CCC9(C8(CC=C7C6)O)O)C(=O)C)C)OC(=O)C1=CC=CC=C1)C)C)C)C)C)OC)O,,,,,,
3418,3083421,Calotroposide B,CC1C(C(CC(O1)OC2C(OC(CC2OC)OC3C(OC(CC3OC)OC4C(OC(CC4OC)OC5C(OC(CC5OC)OC6CCC7(C8CC(C9(C(CCC9(C8(CC=C7C6)O)O)(C(=O)C)O)C)OC(=O)C1=CC=CC=C1)C)C)C)C)C)OC)O,,,,,,
3419,3083422,"3-(1-(4-Chlorobenzyl)-4-methyl-6-(5-phenylpyridin-2-ylmethoxy)-4,5-dihydro-1H-thiopyrano(2,3,4-c,d)indol-2-yl)-2,2-dimethylpropanoic acid",CC1CC2=C(C=CC3=C2C(=C(N3SC4=CC=C(C=C4)Cl)CC(C)(C)C(=O)O)O1)CCC5=NC=C(C=C5)C6=CC=CC=C6,,,,,,
3420,3083423,CID 3083423,[B+3].C1=CC(=CC2=CC=C[N-]2)N=C1.C1=CC(=CC=C1C(C(C[O-])NC(=O)C(Cl)Cl)[O-])[N+](=O)[O-],,,,,,
3421,3083424,Dipyrrin,C1=CC(=CC2=CC=CN2)N=C1,,,,,,
3422,3083425,Quat-dtz,CC[N+](C)(C)N1C2=CC=CC=C2S[C@H]([C@H](C1=O)OC(=O)C)C3=CC=C(C=C3)OCC.[I-],,,,,,
3423,3083426,"[(2S,3S)-3-acetyloxy-2-(4-ethoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]-ethyl-dimethylazanium",CC[N+](C)(C)N1C2=CC=CC=C2S[C@H]([C@H](C1=O)OC(=O)C)C3=CC=C(C=C3)OCC,,,,,,
3424,3083427,"6-[[11-Carboxy-9-[4,5-dihydroxy-3-[2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]oxyoxan-2-yl]oxy-4-(hydroxymethyl)-4,6a,6b,8a,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-5-[4,5-dihydroxy-6-(hydroxymethyl)-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxy-3,4-dihydroxyoxane-2-carboxylic acid",CC1C(C(C(C(O1)OC2C(C(C(OC2OC3C(C(C(OC3OC4CCC5(C(C4(C)CO)CCC6(C5CC=C7C6(CCC8(C7CC(CC8OC9C(C(C(CO9)O)O)OC1C(C(C(OC1O)CO)O)O)(C)C(=O)O)C)C)C)C)C(=O)O)O)O)CO)O)O)O)O)O,,,,,,
3425,3083428,"[3,5-Diacetyloxy-2-[[2-(hydroxymethyl)-10-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,9-dioxatricyclo[4.4.0.02,4]dec-7-en-5-yl]oxy]-6-methyloxan-4-yl] 3-phenylprop-2-enoate",CC1C(C(C(C(O1)OC2C3C=COC(C3C4(C2O4)CO)OC5C(C(C(C(O5)CO)O)O)O)OC(=O)C)OC(=O)C=CC6=CC=CC=C6)OC(=O)C,,,,,,
3426,3083429,"1,2-Bis(15-oxapentacosa-10,12-diynoyl)-sn-phosphocholine",CCCCCCCCCCOCC#CC#CCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCC#CC#CCOCCCCCCCCCC,,,,,,
3427,3083430,"2-[[(2R)-2,3-bis(14-decoxytetradeca-10,12-diynoyloxy)propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium",CCCCCCCCCCOCC#CC#CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCC#CC#CCOCCCCCCCCCC,,,,,,
3428,3083431,"[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-2-(methoxymethyl)oxolan-3-yl] phosphono hydrogen phosphate",COC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=O)NC2=O)O)OP(=O)(O)OP(=O)(O)O,,,,,,
3429,3083432,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-(methoxymethyl)oxolan-3-yl] phosphono hydrogen phosphate",COC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)OP(=O)(O)O,,,,,,
3430,3083433,5-(2-Carboxyethyl)-6-[6-(4-methoxyphenyl)hex-5-enoxy]-9-oxoxanthene-2-carboxylic acid,COC1=CC=C(C=C1)C=CCCCCOC2=C(C3=C(C=C2)C(=O)C4=C(O3)C=CC(=C4)C(=O)O)CCC(=O)O,,,,,,
3431,3083434,CID 3083434,CC(=O)OC[C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@H](O[C@@H]([C@H]2OC(=O)C)COC(=O)C)SC3=CC=CC=C3)N4C(=O)C5=CC=CC=C5C4=O)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
3432,3083435,CID 3083435,C[C@]12C(=O)CC[C@@]3([C@]14CCN([C@H]3CC5=C4C(=C(C=C5)O)O2)C)NC(=O)C=CC6=CC=C(C=C6)[N+](=O)[O-],,,,,,
3433,3083436,Karsoside,COC1C2C=COC(C2C3(C1O3)CO)OC4C(C(C(C(O4)COC5C(C(C(CO5)O)O)O)O)O)O,,,,,,
3434,3083437,Kadsurenin L,C[C@@H]1[C@H]([C@H]2[C@@H]([C@@]1(C=C(C2=O)CC=C)OC)OC(=O)C)C3=CC(=C(C=C3)OC)OC,,,,,,
3435,3083438,Kadsurenin K,C[C@@H]1[C@H]([C@@H]2C(=O)C(=C[C@]1(C2=O)OC)CC=C)C3=CC(=C(C=C3)O)OC,,,,,,
3436,3083439,"Benzo(a)pyren-3-amine, N-hydroxy-",C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C(C=CC(=C54)C=C3)NO,,,,,,
3437,3083440,Carazolol FD,CC(C)N(CC(COC1=CC=CC2=C1C3=CC=CC=C3N2)O)C(C(C(F)(F)F)(F)F)(F)F.I,,,,,,
3438,3083441,"1-(9H-carbazol-4-yloxy)-3-[1,1,2,2,3,3,3-heptafluoropropyl(propan-2-yl)amino]propan-2-ol",CC(C)N(CC(COC1=CC=CC2=C1C3=CC=CC=C3N2)O)C(C(C(F)(F)F)(F)F)(F)F,,,,,,
3439,3083442,"2-Propanol, 1-((heptafluoropropyl)(1-methylethyl)amino)-3-(1-naphthalenyloxy)-, hydroiodide",CC(C)N(CC(COC1=CC=CC2=CC=CC=C21)O)C(C(C(F)(F)F)(F)F)(F)F.I,,,,,,
3440,3083443,3-(1-Naphthyloxy)-2-hydroxy-N-isopropyl-N-(heptafluoropropyl)-1-propanamine,CC(C)N(CC(COC1=CC=CC2=CC=CC=C21)O)C(C(C(F)(F)F)(F)F)(F)F,,,,,,
3441,3083444,Idraparinux sodium,CO[C@@H]1[C@H](O[C@@H]([C@@H]([C@H]1OC)OC)O[C@H]2[C@@H]([C@H]([C@@H](O[C@@H]2C(=O)[O-])O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3OS(=O)(=O)[O-])OS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H](O[C@H]4C(=O)[O-])O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5OS(=O)(=O)[O-])OS(=O)(=O)[O-])OC)COS(=O)(=O)[O-])OC)OC)COS(=O)(=O)[O-])OC)OC)COS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,,['Endogenous factors and drugs that inhibit or block the activity of FACTOR XA. (See all compounds classified as Factor Xa Inhibitors.)'],,,
3442,3083445,Idraparinux,CO[C@@H]1[C@H](O[C@@H]([C@@H]([C@H]1OC)OC)O[C@H]2[C@@H]([C@H]([C@@H](O[C@@H]2C(=O)O)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3OS(=O)(=O)O)OS(=O)(=O)O)O[C@H]4[C@@H]([C@H]([C@@H](O[C@H]4C(=O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5OS(=O)(=O)O)OS(=O)(=O)O)OC)COS(=O)(=O)O)OC)OC)COS(=O)(=O)O)OC)OC)COS(=O)(=O)O,"['Investigated for use/treatment in thrombosis, venous thromboembolism, strokes, heart disease, and atrial fibrillation.']",,['Endogenous factors and drugs that inhibit or block the activity of FACTOR XA. (See all compounds classified as Factor Xa Inhibitors.)'],,,
3443,3083446,"GNFFRF-amide protein, Moniezia expansa",C1=CC=C(C=C1)C[C@@H](C(=O)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)N)NC(=O)CN,,,,,,
3444,3083447,Macrostemonoside E,CC1=C(O[C@@H]2[C@H]1[C@]3(CCC4C(C3C2)CCC5[C@@]4(CCC(C5)[C@@]6([C@@H]([C@H]([C@H]([C@@H](O6)CO)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O)C)C)CC[C@@H](C)CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O,,,,,,
3445,3083448,Moricizine sulfone,CCOC(=O)NC1=CC2=C(C=C1)S(=O)(=O)C3=CC=CC=C3N2C(=O)CCN4CCOCC4,,,,,,
3446,3083449,Cyclamiretin A rgga,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2CO[C@H]([C@@H]([C@H]2O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O[C@H]5CC[C@@]6([C@H]7CCC89C1C[C@](CCC1(CO8)[C@@H](C[C@]9([C@@]7(CCC6C5(C)C)C)C)O)(C)C=O)C)O)O)O,,,,,,
3447,3083450,CID 3083450,[B+3].CC1=CC(=NC1=CC2=CC=C([N-]2)CCCCCCCCCCCC(=O)OC3CCC4(C5CCC6(C(C5CC=C4C3)CCC6C(C)CCCC(C)C)C)C)C.[F-].[F-],,,,,,
3448,3083451,"[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 12-[5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]pyrrol-2-yl]dodecanoate",CC1=CC(=C(N1)C=C2C=CC(=N2)CCCCCCCCCCCC(=O)OC3CCC4(C5CCC6(C(C5CC=C4C3)CCC6C(C)CCCC(C)C)C)C)C,,,,,,
3449,3083452,Doixc-pth,C1=CC2=C(C=C1C(=O)NNC(=O)CSP(=O)(O)O)C3(C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)O)OC2=O,,,,,,
3450,3083453,Clinoposaponin VIII,CC1(CCC23COC4(C2C1)C=CC5C6(CCC(C(C6CCC5(C4(CC3OC7C(C(C(C(O7)CO)O)O)O)C)C)(C)CO)OC8C(C(C(C(O8)CO)OC9C(C(C(C(O9)CO)O)O)O)OC1C(C(C(C(O1)CO)O)O)O)O)C)C,,,,,,
3451,3083454,"[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl] 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate",COC1=C(C=CC(=C1)C=CC(=O)OC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)O,,,,,,
3452,3083455,Dipsacus saponin C,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2CO[C@H]([C@@H]([C@H]2O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O[C@H]4[C@@H]([C@H]([C@@H](CO4)O)O)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O[C@H]6[C@@H]([C@@H]([C@H]([C@@H](O6)C)O)O)O)O[C@H]7CC[C@@]8([C@H]9CC=C1[C@H]2CC(CC[C@@]2(CC[C@]1([C@@]9(CCC8C7(C)CO)C)C)C(=O)O)(C)C)C)O)O)O,,,,,,
3453,3083456,N-Phprop-fphetp,C1CN(CC=C1C2=CC=C(C=C2)F)CCC(=O)C3=CC=CC=C3,,,,,,
3454,3083457,N-Phprop-clphetp,C1CN(CC=C1C2=CC=C(C=C2)Cl)CCC(=O)C3=CC=CC=C3,,,,,,
3455,3083458,CID 3083458,CCC1=CC(=C(C=C1OCCCCCC(C)(C)C2=NNN=N2)[O-])C3=CC(=CC=C3)F.[Na+],,,,,,
3456,3083459,4-ethyl-2-(3-fluorophenyl)-5-[6-methyl-6-(2H-tetrazol-5-yl)heptoxy]phenol,CCC1=CC(=C(C=C1OCCCCCC(C)(C)C2=NNN=N2)O)C3=CC(=CC=C3)F,,,,,,
3457,3083460,CID 3083460,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC2CCC3N(C2=O)C(CS3)C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,,,,,,
3458,3083461,CID 3083461,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@@H]2CC6=C4C(=C(C=C6)OCC7=CC=CC=C7)O5)O,,,,,,
3459,3083462,Methyl fucopyranosyl(1-4)-2-acetamido-2-deoxyglucopyranoside,C[C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)NC(=O)C)OC)CO)O)O)O,,,,,,
3460,3083463,N-(4-Azidobenzoyl)fnlrfamide,CCCC[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)C3=CC=C(C=C3)N=[N+]=[N-],,,,,,
3461,3083464,CID 3083464,C1CCC(CC1)NCCCCOC2=CC3=C(C=C2)NC4=NC(=O)NC4=C3,,,,,,
3462,3083465,CID 3083465,CCCCCCCCCC(=O)O[C@@H]1[C@H]([C@@]2(O[C@@H]([C@]([C@]1(O2)C(=O)O)(C(=O)O)O)C(=O)O)CCCC(C(C)CC=CC3=CC=CC=C3)OC(=O)C)O,,,,,,
3463,3083466,Neoarctin B,COC1=CC(=CC(=C1O)OC)C[C@@H]2[C@H](COC2=O)CC3=CC(=C(C=C3)C4=C(C=C(C=C4)C[C@H]5COC(=O)[C@@H]5CC6=CC(=C(C(=C6)OC)O)OC)OC)OC,,,,,,
3464,3083467,"N-[6-(hydroxymethyl)-9-(1H-indol-3-ylmethyl)-17-methyl-2,5,8,11,15-pentaoxo-1-oxa-4,7,10,14-tetrazacycloheptadec-16-yl]-2-(9-hydroxyoctadeca-10,12-dienoylamino)pentanediamide",CCCCCC=CC=CC(CCCCCCCC(=O)NC(CCC(=O)N)C(=O)NC1C(OC(=O)CNC(=O)C(NC(=O)C(NC(=O)CCNC1=O)CC2=CNC3=CC=CC=C32)CO)C)O,,,,,,
3465,3083468,"N-[6-(hydroxymethyl)-9-(1H-indol-3-ylmethyl)-17-methyl-2,5,8,11,15-pentaoxo-1-oxa-4,7,10,14-tetrazacycloheptadec-16-yl]-2-[(17-hydroxy-9-oxooctadeca-10,12-dienoyl)amino]pentanediamide",CC1C(C(=O)NCCC(=O)NC(C(=O)NC(C(=O)NCC(=O)O1)CO)CC2=CNC3=CC=CC=C32)NC(=O)C(CCC(=O)N)NC(=O)CCCCCCCC(=O)C=CC=CCCCC(C)O,,,,,,
3466,3083469,"(4aS,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-5-hydroxy-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid",C[C@]12CC[C@@H](C(C1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@@H]4CC(CC5)(C)C)C(=O)O)C)C)(C)C)O[C@H]6[C@@H]([C@H]([C@H](CO6)O)O[C@@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O[C@H]8[C@@H]([C@H]([C@@H](CO8)O)O)O,,,,,,
3467,3083470,4-[4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]-3-methoxyphenyl]but-3-en-2-one,CC(C)NCC(COC1=C(C=C(C=C1)C=CC(=O)C)OC)O,,,,,,
3468,3083471,2-Thiosophorose,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O)S[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)O,,,,,,
3469,3083472,Cedmi-Pt(II) nitrate,CN1C=CN=C1.C(CN)N.[N+](=O)([O-])[O-].[Cl-].[Pt+2],,,,,,
3470,3083473,"PHYD protein, Arabidopsis",CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CCSC)N,,,,,,
3471,3083474,CID 3083474,CC1=NN2C(=C(N=C2S1)C3=CC=CC=C3)C=NNC(=O)CN(C)C,,,,,,
3472,3083475,"3-Pentyl-6,7,7a,8,9,11a-hexahydro-1,7-dihydroxy-7,10-dimethyldibenzo(b,d)oxepin",CCCCCC1=CC(=C2C3C=C(CCC3C(COC2=C1)(C)O)C)O,,,,,,
3473,3083476,Htsip,C1CC2(CCN(CC2)[C@@H]3CC4=CC=CC=C4C[C@H]3O)C5=CC=CC=C51,,,,,,
3474,3083477,"9-(4-Azido-2,3,5,6-tetrafluorophenyl)-3,7-dimethylnona-2,4,6,8-tetraenal",CC(=CC=O)C=CC=C(C)C=CC1=C(C(=C(C(=C1F)F)N=[N+]=[N-])F)F,,,,,,
3475,3083478,N-Dodecoxycarbonylvaline,CCCCCCCCCCCCOC(=O)N[C@@H](C(C)C)C(=O)O,,,,,,
3476,3083479,9-Octadecen-16-ynoic acid,CC#CCCCCCC=CCCCCCCCC(=O)O,,,,,,
3477,3083480,"3,4-Dhspp",C1CC2(CCN(CC2)CCC3=CC=CC=C3)C(C4=CC=CC=C41)O.Cl,,,,,,
3478,3083481,"1'-Phenethylspiro[tetralin-2,4'-piperidine]-1-ol",C1CC2(CCN(CC2)CCC3=CC=CC=C3)C(C4=CC=CC=C41)O,,,,,,
3479,3083482,Hoet-PO,CCC(C)C(=O)O[C@H]1C[C@H]2[C@@H](CC[C@H]3[C@@]2(C=C[C@H](C3)O)C)[C@H]4[C@]1([C@H](CC4)CC[C@H](C[C@H](CC=O)O)O)C,,,['Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. (See all compounds classified as Hydroxymethylglutaryl-CoA Reductase Inhibitors.)'],,,
3480,3083483,Foliumin,C[C@@H]1C[C@H](C2([C@H]([C@H]3[C@@H](O2)[C@@H]([C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)C)C)O)C)OC1=O)O,,,,,,
3481,3083484,4-Hydroxy-3-((trimethylammonio)methyl)catechol,C[N+](C)(C)CC1=C(C=CC(=C1O)O)O.[Br-],,,,,,
3482,3083485,5-Hydroxy-3-((trimethylammonio)methyl)catechol,C[N+](C)(C)CC1=C(C(=CC(=C1)O)O)O.[Br-],,,,,,
3483,3083486,Trimethyl(1-methyl-6-oxabicyclo(3.1.0)hex-3-yl)methylammonium,C[C@]12C[C@@H](C[C@H]1O2)C[N+](C)(C)C.[I-],,,,,,
3484,3083487,"trimethyl-[[(1S,3R,5R)-1-methyl-6-oxabicyclo[3.1.0]hexan-3-yl]methyl]azanium",C[C@]12C[C@@H](C[C@H]1O2)C[N+](C)(C)C,,,,,,
3485,3083488,L-Napamp,CC1CCN(CC1)C(=O)[C@H](CC2=CC(=CC=C2)C(=N)N)NS(=O)(=O)C3=CC4=CC=CC=C4C=C3,,,,,,
3486,3083489,Gal-1-4-glcnac-1-3-fuc,C[C@H]1[C@H]([C@H]([C@@H]([C@](O1)(CCCCCN)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O[C@@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O)NC(=O)C)O)O)O,,,,,,
3487,3083490,Bz-Dab(nbd)-awfpp-nle-NH2,CCCC[C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H]2CCCN2C(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@@H](CC4=CNC5=CC=CC=C54)NC(=O)[C@H](C)NC(=O)[C@H](CCNC6=CC=C(C7=NON=C67)[N+](=O)[O-])NC(=O)C8=CC=CC=C8,,,,,,
3488,3083491,CID 3083491,C[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NC(=O)[C@H](C(C)C)NCCNC2=CC=CC3=C2C=CC=C3S(=O)(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)C5=CC=C(C=C5)N=NC6=CC=C(C=C6)N(C)C,,,,,,
3489,3083492,CID 3083492,C[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CN=CN2)C(=O)OC)NC(=O)[C@H](CS)NC(=O)OCC3=CC=CC=C3.Cl,,,,,,
3490,3083493,CID 3083493,C[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CN=CN2)C(=O)OC)NC(=O)[C@H](CS)NC(=O)OCC3=CC=CC=C3,,,,,,
3491,3083494,"[(1R)-1-(2-nitrophenyl)ethyl]sulfanyl-[(1S,2R,3S,4S,5R,6S)-2,4,5-trihydroxy-3,6-diphosphonooxycyclohexyl]oxyphosphinic acid",C[C@H](C1=CC=CC=C1[N+](=O)[O-])SP(=O)(O)O[C@H]2[C@@H]([C@H]([C@H]([C@H]([C@@H]2OP(=O)(O)O)O)O)OP(=O)(O)O)O,,,,,,
3492,3083495,"[(3S,7R,8R,9S,10R,13S,14S,17S)-17-acetyloxy-7-(4-methoxyphenyl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate",CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3[C@H](C=C2C1)C5=CC=C(C=C5)OC)CC[C@@H]4OC(=O)C)C)C,,,,,,
3493,3083496,methyl 3-hydroxy-2-[[3-[[3-hydroxy-2-[[3-hydroxy-2-(1H-pyrrole-2-carbonylamino)butanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]butanoate,CC(C(C(=O)NC(CO)C(=O)NC(CC(=O)NC(C(C)O)C(=O)OC)C1=CC=CC=C1)NC(=O)C2=CC=CN2)O,,,,,,
3494,3083497,CID 3083497,C[C@@H]1C[C@H](OC1=O)C[C@@H]([C@H](C)[C@H]2CC[C@@H]3[C@]4(CC[C@@H](C([C@@H]4CC[C@]3([C@]25CC(=O)OC5)C)(C)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O[C@H]7[C@@H]([C@@H]([C@H]([C@@H](O7)C)O)O)O)C)OC(=O)C,,,,,,
3495,3083498,Hovenidulcioside B2,C[C@@H]1C[C@H](OC1=O)C[C@@H]([C@H](C)[C@H]2CC[C@@H]3[C@]4(CC[C@@H](C([C@@H]4CC[C@]3([C@]25CC(=O)OC5)C)(C)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)OC(=O)C,,,,,,
3496,3083499,CID 3083499,COC1=C(C=C(C(=C1)COP(=O)(O)OC[C@@H]2C=C([C@@H](O2)N3C4=C(C(=O)N=C(N4)N)N=C3Br)O)[N+](=O)[O-])OC,,,,,,
3497,3083500,Fusaricide,CC[C@@H]1[C@]2(C[C@H](C[C@H]([C@@H]2C3=C(O1)C=CN(C3=O)O)C)C)C,,,,,,
3498,3083501,"Olean-12-en-28-oic acid, 3-((O-beta-D-glucopyranosyl-(1-2)-O-(O-beta-D-glucopyranosyl-(1-3)-beta-D-glucopyranosyl-(1-3))-beta-D-glucopyranosyl)oxy)-23-hydroxy-, (3beta,4alpha)-",C[C@]12CC[C@@H](C(C1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@@H]4CC(CC5)(C)C)C(=O)O)C)C)(C)CO)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O,,,,,,
3499,3083502,CID 3083502,CCC(C)CC(C)C=C(C)C1C(CCC(O1)C2=C(N(C=C(C2=O)C3(CCC(=O)CC3O)O)C)O)C,,,,,,
3500,3083503,Dibromophakellstatine,C1CC23[C@@H](NC(=O)N2)N4C(=CC(=C4Br)Br)C(=O)N3C1,,,,,,
3501,3083504,CID 3083504,CCC(C)C=CC(=O)C(=O)C=CC=CC=CC=CC=CC=C[C@@H]1C[C@H]([C@@H](O1)C(=O)O)O,,,,,,
3502,3083505,CID 3083505,CCCCCCCCCCCC(=O)CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1OP(=O)([O-])[O-])CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)COC)OP(=O)([O-])[O-])OCC[C@@H](CCCCCCC)OC)NC(=O)CCCCCCCCCC=CCCCCCC)O)OCCCCCCCCCC.[Na+].[Na+].[Na+].[Na+],,,,,,
3503,3083506,"[(2R,3R,4R,5S,6R)-4-decoxy-5-hydroxy-6-[[(2R,3R,4R,5S,6R)-4-[(3R)-3-methoxydecoxy]-6-(methoxymethyl)-3-(octadec-11-enoylamino)-5-phosphonooxyoxan-2-yl]oxymethyl]-3-(3-oxotetradecanoylamino)oxan-2-yl] dihydrogen phosphate",CCCCCCCCCCCC(=O)CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1OP(=O)(O)O)CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)COC)OP(=O)(O)O)OCC[C@@H](CCCCCCC)OC)NC(=O)CCCCCCCCCC=CCCCCCC)O)OCCCCCCCCCC,,,,,,
3504,3083507,"3-Acetyl-1-hexadecyl-1,5-dihydro-5-hydroxy-4,5-dimethyl-2H-pyrrol-2-one",CCCCCCCCCCCCCCCCN1C(=O)C(=C(C1(C)O)C)C(=O)C,,,,,,
3505,3083508,CID 3083508,CC1CC2[C@](CCC(C2(C)C)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)(C5C1[C@]6(CC[C@@H](C6[C@H](C5)O)C(=CCC=C(C)C)C)C)C,,,,,,
3506,3083509,Bismuth sucrose octasulfate,C([C@@H]1[C@H]([C@@H]([C@H]([C@@](O1)([C@@]2([C@H]([C@@H]([C@H](O2)COS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])COS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])O.C([C@@H]1[C@H]([C@@H]([C@H]([C@@](O1)([C@@]2([C@H]([C@@H]([C@H](O2)COS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])COS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])O.C([C@@H]1[C@H]([C@@H]([C@H]([C@@](O1)([C@@]2([C@H]([C@@H]([C@H](O2)COS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])COS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])O.[Bi+3].[Bi+3].[Bi+3].[Bi+3].[Bi+3].[Bi+3].[Bi+3].[Bi+3],,,['Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)'],,,
3507,3083510,Nedocromil Zinc,CCCC1=C2C(=CC3=C1OC(=CC3=O)C(=O)[O-])C(=O)C=C(N2CC)C(=O)[O-].O.O.O.O.O.[Zn+2],,,,,,
3508,3083511,Imepitoin,C1COCCN1C2=NC(=O)N(C2)C3=CC=C(C=C3)Cl,['For the reduction of the frequency of generalised seizures due to idiopathic epilepsy in dogs for use after careful evaluation of alternative treatment options.'],,,,,
3509,3083512,Tonkinelin,CCCCCCCCCCCCCCCC[C@H]([C@@H](CCCCCCCCCCCCCCC1=C[C@@H](OC1=O)C)O)O,,,,,,
3510,3083513,3-Hydroxymethylphenytoin valproic acid ester,CCCC(CCC)C(=O)OCN1C(=O)C(NC1=O)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
3511,3083514,Danshenol A,C[C@H]1COC2=C1C(=O)[C@@](C3=C2C=CC4=C(C=CC=C43)C)(CC(=O)C)O,,,,,,
3512,3083515,Danshenol B,C[C@H]1COC2=C1C(=O)[C@@](C3=C2C=CC4=C3CCCC4(C)C)(CC(=O)C)O,,,,,,
3513,3083516,CID 3083516,C[C@H](CCC=C(C)C)C=CC=C(C)C(=O)NC[C@@H]1CC[N+]2([C@@H]1CCCC2)C.[Cl-],,,,,,
3514,3083517,CID 3083517,C[C@H](CCC=C(C)C)C=CC=C(C)C(=O)NC[C@@H]1CC[N+]2([C@@H]1CCCC2)C,,,,,,
3515,3083518,"1-hydroxy-13-[(3R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypyrrolidin-2-yl]tridecan-5-one",C(CCCCC(=O)CCCCO)CCCC1[C@H]([C@H]([C@H](N1)CO)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
3516,3083519,"(2R,3S)-2-[(3,4-dihydroxyphenyl)methyl]-2-hydroxy-3-[3-(4-hydroxyphenyl)prop-2-enoyloxy]butanedioic acid",C1=CC(=CC=C1C=CC(=O)O[C@H](C(=O)O)[C@](CC2=CC(=C(C=C2)O)O)(C(=O)O)O)O,,,,,,
3517,3083520,"(2S)-2-methyl-4-[(2R,13R)-2,8,9,13-tetrahydroxy-13-[5-[(1R)-1-hydroxytridecyl]oxolan-2-yl]tridecyl]-2H-furan-5-one",CCCCCCCCCCCC[C@H](C1CCC(O1)[C@@H](CCCC(C(CCCCC[C@H](CC2=C[C@@H](OC2=O)C)O)O)O)O)O,,,,,,
3518,3083521,"2-methyl-4-[(2R,13R)-2,6,10,13-tetrahydroxy-13-[5-[(1R)-1-hydroxytridecyl]oxolan-2-yl]tridecyl]-2H-furan-5-one",CCCCCCCCCCCC[C@H](C1CCC(O1)[C@@H](CCC(CCCC(CCC[C@H](CC2=CC(OC2=O)C)O)O)O)O)O,,,,,,
3519,3083522,"6-Hydroxy-3-(hydroxy(phenyl)methyl)-5,6-dihydrobenzofuran-2(4H)-one",C1CC2=C(C(=O)OC2=CC1O)C(C3=CC=CC=C3)O,,,,,,
3520,3083523,Pharanox selenate,C1=CC(=CC=C1CC(=O)O)[N+](CCCl)(CCCl)[O-].O[Se](=O)(=O)O,,,,,,
3521,3083524,Lucyoside R,C[C@@]12CCC3[C@@]([C@H]1CC=C4[C@]2(CC[C@@]5([C@@H]4CC([C@H](C5)O)(C)C)C(=O)O)C)(C[C@H]([C@@H]([C@@]3(C)CO)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O)C,,,,,,
3522,3083525,"4-[4-[4-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]piperazin-1-yl]phenyl]-2-[[4-(trifluoromethyl)phenyl]methyl]-1,2,4-triazol-3-one",C[C@H]([C@](CN1C=NC=N1)(C2=C(C=C(C=C2)F)F)O)N3CCN(CC3)C4=CC=C(C=C4)N5C=NN(C5=O)CC6=CC=C(C=C6)C(F)(F)F,,,,,,
3523,3083526,"3H-1,2,4-Triazol-3-one, 4-(4-(4-((1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl)-1-piperazinyl)-3-fluorophenyl)-2,4-dihydro-2-((4-(trifluoromethyl)phenyl)methyl)-",C[C@H]([C@](CN1C=NC=N1)(C2=C(C=C(C=C2)F)F)O)N3CCN(CC3)C4=C(C=C(C=C4)N5C=NN(C5=O)CC6=CC=C(C=C6)C(F)(F)F)F,,,,,,
3524,3083527,1alpha-Methoxycephalostatin 1,C[C@H]1[C@H]2CC=C3C2(COC14[C@@H](CC(O4)(C)C)O)C(=O)C[C@H]5[C@H]3CC[C@@H]6[C@@]5([C@H](C7=NC8=C(C[C@]9([C@H](C8)CC[C@@H]1[C@@H]9C[C@H]([C@]2(C1=C[C@H]1[C@@]2([C@@H](C2(O1)[C@@H](C[C@@](O2)(C)CO)O)C)O)C)O)C)N=C7C6)OC)C,,,,,,
3525,3083528,CID 3083528,C[C@H]1[C@H]2CC=C3C2(COC14[C@@H](CC(O4)(C)C)O)C(=O)C[C@H]5[C@H]3CC[C@@H]6[C@@]5(CC7=C(C6)N=C8[C@@H]([C@]9([C@@H](CC[C@@H]1[C@@H]9C[C@H]([C@]2(C1=C[C@H]1[C@@]2([C@@H](C2(O1)[C@@H](C[C@@](O2)(C)CO)O)C)O)C)O)CC8=N7)C)OC)C,,,,,,
3526,3083529,"Pyrazine, 1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydro-4-(1,2,3,4-tetrahydro-2-oxo-6-quinolinyl)-",COC1=C(C=C(C=C1)C(=O)N2CCN(C=C2)C3=CC4=C(C=C3)NC(=O)CC4)OC,,,,,,
3527,3083530,CID 3083530,CC1=C(N2[C@@H]([C@H](C2=O)OC)S(=O)(=O)C13CC34CCCC4)C(=O)N5CCN(CC5)CC(=O)[O-].[Na+],,,,,,
3528,3083531,CID 3083531,CC1=C(N2[C@@H]([C@H](C2=O)OC)S(=O)(=O)C13CC34CCCC4)C(=O)N5CCN(CC5)CC(=O)O,,,,,,
3529,3083532,CID 3083532,CC1=C(N2[C@@H]([C@H](C2=O)OC)S(=O)(=O)C13CC34CCCC4)C(=O)N5CCN(CC5)C(=O)[O-].[Na+],,,,,,
3530,3083533,CID 3083533,CC1=C(N2[C@@H]([C@H](C2=O)OC)S(=O)(=O)C13CC34CCCC4)C(=O)N5CCN(CC5)C(=O)O,,,,,,
3531,3083534,"(2R,3S)-2-hydroxy-3-[3-(3-hydroxy-4-methoxyphenyl)prop-2-enoyloxy]-2-[(4-hydroxyphenyl)methyl]butanedioic acid",COC1=C(C=C(C=C1)C=CC(=O)O[C@H](C(=O)O)[C@](CC2=CC=C(C=C2)O)(C(=O)O)O)O,,,,,,
3532,3083535,"3H-1,2,4-Triazol-3-one, 4-(4-(4-((1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl)-1-piperazinyl)-3-fluorophenyl)-2,4-dihydro-2-((4-(trifluoromethoxy)phenyl)methyl)-",C[C@H]([C@](CN1C=NC=N1)(C2=C(C=C(C=C2)F)F)O)N3CCN(CC3)C4=C(C=C(C=C4)N5C=NN(C5=O)CC6=CC=C(C=C6)OC(F)(F)F)F,,,,,,
3533,3083536,"(2R)-N-(2-aminoacetyl)-2-[[(2S)-4-[(3-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-[(3-fluorophenyl)methyl]amino]-3,3-dimethylbutanamide",CC(C)CN(CC([C@H](CC1=CC=CC=C1)N(CC2=CC(=CC=C2)F)[C@@H](C(=O)NC(=O)CN)C(C)(C)C)O)S(=O)(=O)C3=CC=CC(=C3)N,,,,,,
3534,3083537,CID 3083537,CC(=O)NC1=CC=C(C=C1)O.CN1CC[C@]23[C@@H]4[C@@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O,,,,,,
3535,3083538,"Pyrrolo(1,2-a)pyrimidin-6(2H)-one, 1-(dichloroacetyl)hexahydro-3,3,7-trimethyl-",CC1CC2N(C1=O)CC(CN2C(=O)C(Cl)Cl)(C)C,,,,,,
3536,3083539,(S)-Flamprop,C[C@@H](C(=O)O)N(C1=CC(=C(C=C1)F)Cl)C(=O)C2=CC=CC=C2,,,,,,
3537,3083540,Triclodazol,C1NC(C(=O)N1C(C(Cl)(Cl)Cl)O)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
3538,3083541,Sulocarbilate,C1=CC(=CC=C1NC(=O)OCCO)S(=O)(=O)N,,,,,,
3539,3083542,Ajulemic acid,CCCCCCC(C)(C)C1=CC(=C2[C@@H]3CC(=CC[C@H]3C(OC2=C1)(C)C)C(=O)O)O,,,['Compounds that interact with and stimulate the activity of CANNABINOID RECEPTORS. (See all compounds classified as Cannabinoid Receptor Agonists.)'],,,
3540,3083543,Furametpyr,CC1C2=C(C=CC=C2NC(=O)C3=C(N(N=C3C)C)Cl)C(O1)(C)C,,,,,"['Furametpyr has known human metabolites that include 3-Chloro-5-methyl-N-(1,1,3-trimethyl-3H-2-benzofuran-4-yl)-1H-pyrazole-4-carboxamide.']",
3541,3083544,Arformoterol,C[C@H](CC1=CC=C(C=C1)OC)NC[C@@H](C2=CC(=C(C=C2)O)NC=O)O,"['Arformoterol is indicated in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.']","['Arformoterol, the active (R,R)-enantiomer of formoterol, is a selective long-acting β2-adrenergic receptor agonist (beta2-agonist) that has two-fold greater potency than racemic formoterol (which contains both the (S,S) and (R,R)-enantiomers). The (S,S)-enantiomer is about 1,000-fold less potent as a β2-agonist than the (R,R)-enantiomer. Arformoterol seems to have little or no effect on β1-adrenergic receptors.']","['Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)', 'Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS. (See all compounds classified as Adrenergic beta-2 Receptor Agonists.)']","['In patients with COPD, the mean peak plasma concentration (C<sub>max</sub>) and AUC<sub>0-12h</sub> following twice daily administration for 14 days were 4.3 pg/mL and 34.5 pg.hr/mL, respectively. The time to peak plasma concentration (T<sub>max</sub>) was approximately 0.5 hours.', 'Following the administration of a single oral dose of arformoterol to eight healthy subjects, 63% of the administered dose was recovered in the urine and 11% in the feces within 48 hours. After 14 days, a total of 89% of the total dose had been recovered - 67% in the urine and 22% in the feces - with approximately 1% remaining unchanged in the urine.', 'In healthy male subjects, the clearance of a single oral dose of arformoterol was 8.9 L/h.', 'Protein binding: Moderate 61-64%. Serum albumin binding was 31% to 38% over a range of 5 to 500 ng/mL.', 'Bioavailability: Pulmonary: 21-37%; Total systemic: 46%.', 'It is not known whether formoterol is distributed in human breast milk. However, it is distributed in rat milk after oral administration.', 'In asthma patients following a 12 or 24 ug dose: 10% and 15 to 18% excreted unchanged in the urine, respectively. In chronic obstructive pulmonary disease (COPD) patients following a 12 or 24 ug dose: 7% and 6 to 9% excreted unchanged in the urine; respectively.', 'For more Absorption, Distribution and Excretion (Complete) data for FORMOTEROL (8 total), please visit the HSDB record page.']","['Arformoterol was almost entirely metabolized following oral administration of 35 mcg of radiolabeled arformoterol in eight healthy subjects. Direct conjugation of arformoterol with glucuronic acid was the major metabolic pathway. O-Desmethylation is a secondary route catalyzed by the CYP enzymes CYP2D6 and CYP2C19.', ""Formoterol is metabolized primarily by direct glucuronidation at either the phenolic or aliphatic hydroxyl group and O-demethylation followed by glucuronide conjugation at either phenolic hydroxyl groups. Minor pathways involve sulfate conjugation of formoterol and deformylation followed by sulfate conjugation. The most prominent pathway involves direct conjugation at the phenolic hydroxyl group. The second major pathway involves O-demethylation followed by conjugation at the phenolic 2'-hydroxyl group. Four cytochrome P450 isozymes (CYP2D6, CYP2C19, CYP2C9 and CYP2A6) are involved in the O-demethylation of formoterol. Formoterol did not inhibit CYP450 enzymes at therapeutically relevant concentrations. Some patients may be deficient in CYP2D6 or 2C19 or both. Whether a deficiency in one or both of these isozymes results in elevated systemic exposure to formoterol or systemic adverse effects has not been adequately explored."", 'Formoterol was conjugated to inactive glucuronides and a previously unidentified sulfate. The phenol glucuronide of formoterol was the main metabolite in urine. Formoterol was also O-demethylated and deformylated. Plasma exposure to these pharmacologically active metabolites was low. O-demethylated formoterol was seen mainly as inactive glucuronide conjugates and deformylated formoterol only as an inactive sulfate conjugate. Intact formoterol and O-demethylated formoterol dominated recovery in feces. Mean recovery of unidentified metabolites was 7. 0% in urine and 2.0% in feces.']","['In COPD patients given 15 mcg inhaled arformoterol twice a day for 14 days, the mean terminal half-life of arformoterol was 26 hours.', 'Mean terminal: 10 hours']"
3542,3083545,Fluazolate,CC(C)OC(=O)C1=C(C=C(C(=C1)C2=NN(C(=C2Br)C(F)(F)F)C)F)Cl,,,,,,
3543,3083546,Flufenpyr-ethyl,CCOC(=O)COC1=C(C=C(C(=C1)N2C(=O)C(=C(C=N2)C(F)(F)F)C)F)Cl,,,,,"[""Flufenpyr-ethyl's known metabolites in animals include S-3135-acid ([2-chloro-4-fluoro-5-(5-methyl-6-oxo-4-trifluoromethyl-1,6-dihydropyridazin-1-yl)phenoxy]-acetic acid) and S-3153-acid-5-CH2OH ([2-chloro-4-fluoro-5-(5-hydroxymethyl-6-oxo-4-trifluoromethyl-1,6-dihydropyridazin-1-yl)phenoxy]-acetic acid) (L2087).""]",
3544,3083547,Flufenpyr,CC1=C(C=NN(C1=O)C2=CC(=C(C=C2F)Cl)OCC(=O)O)C(F)(F)F,,,,,,
3545,3083548,Ibogamin-12-ol,CC[C@H]1C[C@@H]2C[C@@H]3[C@H]1N(C2)CCC4=C3NC5=C4C=C(C=C5)O,,,,,,
3546,3083549,azane;6-methyl-2-(4-methyl-5-oxo-4-propan-2-yl-1H-imidazol-2-yl)pyridine-3-carboxylic acid,CC1=NC(=C(C=C1)C(=O)O)C2=NC(C(=O)N2)(C)C(C)C.N,,,,,,
3547,3083550,"6-Methyl-2-[5-methyl-4-oxo-5-(propan-2-yl)-4,5-dihydro-1H-imidazol-2-yl]pyridine-3-carboxylic acid",CC1=NC(=C(C=C1)C(=O)O)C2=NC(C(=O)N2)(C)C(C)C,,,,,,
3548,3083551,"(2R,4S,5R,6R)-5-amino-2,4-dihydroxy-6-(1,2,3-trihydroxypropyl)oxane-2-carboxylic acid",C1[C@@H]([C@H]([C@@H](O[C@]1(C(=O)O)O)C(C(CO)O)O)N)O,,,,,,
3549,3083552,"(4S,4aR,7aR,12bS)-9-hydroxy-3,7a-dimethyl-2,4,4a,5,6,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydrochloride",C[C@]12C(=O)CC[C@@H]3[C@]14CCN([C@H]3CC5=C4C(=C(C=C5)O)O2)C.Cl,,,,,,
3550,3083553,"(4S,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol;hydroiodide",CN1CC[C@]23[C@@H]4[C@@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O.I,,,,,,
3551,3083554,"(2R,3S)-2,3-dihydroxybutanedioic acid;N-(1-hydroxypropan-2-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide",CC(CO)NC(=O)C1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C.[C@@H]([C@@H](C(=O)O)O)(C(=O)O)O,,,,,,
3552,3083555,Ammonium 2-(aminocarbonyl)benzoate,C1=CC=C(C(=C1)C(=O)N)C(=O)[O-].[NH4+],,,,,,
3553,3083556,Einecs 205-330-0,C1=CC(=CC=C1NCS(=O)(=O)O)S(=O)(=O)N.[Na+],,,,,,
3554,3083557,bis[(S)-[(5S)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methyl] carbonate,COC1=CC2=C(C=CN=C2C=C1)[C@@H](C3CC4CCN3C[C@H]4C=C)OC(=O)O[C@H](C5CC6CCN5C[C@H]6C=C)C7=C8C=C(C=CC8=NC=C7)OC,,,,,,
3555,3083558,Primulaverin,COC1=CC(=C(C=C1)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO[C@H]3[C@@H]([C@H]([C@@H](CO3)O)O)O)O)O)O)C(=O)OC,,,,,,
3556,3083559,10H-Phenoselenazine,C1=CC=C2C(=C1)NC3=CC=CC=C3[Se]2,,,,,,
3557,3083560,3H-Indole,C1C=NC2=CC=CC=C21,,,,,,
3558,3083561,"Acenaphthylene, eicosafluorododecahydro-",C12(C3(C(C(C1(C(C(C(C2(C(C(C3(F)F)(F)F)(F)F)F)(F)F)(F)F)(F)F)F)(F)F)(F)F)F)F,,,,,,
3559,3083562,"Tris(2,2,3,3,4,4,5,5-octafluoropentyl)phosphine",C(C(C(C(C(F)F)(F)F)(F)F)(F)F)P(CC(C(C(C(F)F)(F)F)(F)F)(F)F)CC(C(C(C(F)F)(F)F)(F)F)(F)F,,,,,,
3560,3083563,Fluorodimethoxyborane,B(OC)(OC)F,,,,,,
3561,3083564,Triethylsulphonium tetrafluoroborate(1-),[B-](F)(F)(F)F.CC[S+](CC)CC,,,,,,
3562,3083565,4-Fluorothioanisole,CSC1=CC=C(C=C1)F,,,,,,
3563,3083566,"2-Bromo-1-chloro-1,1-difluoroethane",C(C(F)(F)Cl)Br,,,,,,
3564,3083567,"2,2-Dimethyl-6-oxoheptanoic acid",CC(=O)CCCC(C)(C)C(=O)O,,,,,,
3565,3083568,Lupane,CC(C)[C@H]1CC[C@]2(C1C3CCC4[C@]5(CCCC(C5CC[C@]4([C@@]3(CC2)C)C)(C)C)C)C,,,,,,
3566,3083569,CID 3083569,CC=C1CN2[C@H]3C[C@@H]1[C@@H]4[C@@H]2C[C@@]5(C3N(C6=CC=CC=C65)C)C4OC(=O)C7=CC(=C(C(=C7)OC)OC)OC,,,,,,
3567,3083570,Thiotetrabarbital,CCCC(CC)C1(C(=O)NC(=S)NC1=O)CC,,,,,,
3568,3083571,"(3S,4R,5R)-1-[(3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,4,5,6-tetrahydroxyhexan-2-one",C([C@@H]1[C@H]([C@@H](C(O1)(CO)OCC(=O)[C@H]([C@@H]([C@@H](CO)O)O)O)O)O)O,,,,,,
3569,3083572,CID 3083572,CC=C(CCC(C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=CC[C@@H]4[C@@]3(CC[C@@H]([C@H]4C)O)C)C)C(C)C,,,,,,
3570,3083573,CID 3083573,C1=C(C2=C3C(=C(OC2=C(C1=O)O)O)C=C(C(=C3O)O)O)C(=O)O,,,,,,
3571,3083574,Picropodopyllotoxone,COC1=CC(=CC(=C1OC)OC)[C@H]2[C@H]3[C@H](COC3=O)C(=O)C4=CC5=C(C=C24)OCO5,,,,,,
3572,3083575,Obtusifolin,CC1=CC2=C(C(=C1O)OC)C(=O)C3=C(C2=O)C=CC=C3O,,,,,,
3573,3083576,CID 3083576,CCCC1=C2C(=C(C(=C(C2=O)C(=O)CC(C)C)O)CC=C(C)C)OC(=C1)O,,,,,,
3574,3083577,cis-Ergoline,C1CC2C(CC3=CNC4=CC=CC2=C34)NC1,,,,,,
3575,3083578,"Ergoline, 6,8-dimethyl-, (8alpha)-",C[C@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)C,,,,,,
3576,3083579,Convolvulanic acid B,CC1=CC(=C2COC(=O)C2=C1OC)C(=O)O,,,,,,
3577,3083580,"Benzoic acid, 2-hydroxy-4-methoxy-3,6-dimethyl-",CC1=CC(=C(C(=C1C(=O)O)O)C)OC,,,,,,
3578,3083581,Eugenitin,CC1=CC(=O)C2=C(C(=C(C=C2O1)OC)C)O,,,,,,
3579,3083582,"2-[(3,4-dihydroxyphenyl)methylidene]-6-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1-benzofuran-3-one",C1=CC(=C(C=C1C=C2C(=O)C3=C(O2)C=C(C=C3O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)O,,,,,,
3580,3083583,Unii-qvg5S7bce6,C[C@@H]1[C@@H]([C@@](C(=O)OC[C@@H]2CCN3[C@H]2[C@@H](CC3)OC1=O)(C)O)C,,,,,,
3581,3083584,CID 3083584,CCC(C=CC(C)[C@H]1CC[C@@H]2[C@@]1(CCC3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)C(C)C,,,,,,
3582,3083585,"Naphthalene-1,4,5-triol",C1=CC2=C(C=CC(=C2C(=C1)O)O)O,,,,,,
3583,3083586,Pongapin,COC1=C(OC2=C(C1=O)C=CC3=C2C=CO3)C4=CC5=C(C=C4)OCO5,,,,,,
3584,3083587,Flavipin,CC1=C(C(=C(C(=C1O)O)O)C=O)C=O,,,,,,
3585,3083588,"1-(1-Benzofuran-5-yl)-3-phenylpropane-1,3-dione",C1=CC=C(C=C1)C(=O)CC(=O)C2=CC3=C(C=C2)OC=C3,,,,,,
3586,3083589,"Angiotensin I, val(5)-",CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CC=C(C=C5)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N,,,,,,
3587,3083590,Sylvatesmin,COC1=C(C=C(C=C1)[C@H]2[C@H]3CO[C@@H]([C@H]3CO2)C4=CC(=C(C=C4)O)OC)OC,,,,,,
3588,3083591,Bufotenidine,C[N+](C)(C)CCC1=CNC2=C1C=C(C=C2)[O-],,,,,,
3589,3083592,Lactarazulene,CC1=C2C=CC(=C2C=C(C=C1)C(=C)C)C,,,,,,
3590,3083593,"(2S)-2-(3,8-dimethylazulen-5-yl)propanoic acid",CC1=C2C=CC(=C2C=C(C=C1)[C@H](C)C(=O)O)C,,,,,,
3591,3083594,"(Z)-2-(3,4-dihydroxybenzylidene)-7-hydroxy-6-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)benzofuran-3(2H)-one",C1=CC(=C(C=C1C=C2C(=O)C3=C(O2)C(=C(C=C3)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)O,,,,,,
3592,3083595,"(2S)-4-hydroxy-2-(2-hydroxypropan-2-yl)-7-methyl-2,3-dihydrouro[3,2-g]chromen-5-one",CC1=CC(=O)C2=C(C3=C(C=C2O1)O[C@@H](C3)C(C)(C)O)O,,,,,,
3593,3083596,"2,6-Dideoxy-2,6-diaminoglucose",C([C@@H]1[C@H]([C@@H]([C@H](C(O1)O)N)O)O)N,,,,,,
3594,3083597,Ayapin,C1OC2=C(O1)C=C3C(=C2)C=CC(=O)O3,,,,,,
3595,3083598,Tropine isobutyrate,CC(C)C(=O)OC1C[C@H]2CC[C@@H](C1)N2C,,,,,,
3596,3083599,Stearylsulfamide,CCCCCCCCCCCCCCCCCC(=O)NS(=O)(=O)C1=CC=C(C=C1)N,,,,,,
3597,3083600,"5-Propylbenzene-1,3-diol",CCCC1=CC(=CC(=C1)O)O,,,,,,
3598,3083601,Thyronamine,C1=CC(=CC=C1CCN)OC2=CC=C(C=C2)O,,,,,,
3599,3083602,"3,5,14,19-Tetrahydroxybufa-20,22-dienolide",CC12CCC3C(C1(CCC2C4=COC(=O)C=C4)O)CCC5(C3(CCC(C5)O)CO)O,,,,,,
3600,3083603,CID 3083603,CCN1C[C@@]2(CC[C@H]([C@@]34[C@@H]2[C@@H]([C@@](C31)([C@]5(C[C@@H]([C@H]6C[C@@H]4[C@@H]5[C@H]6OC)OC)O)O)OC)OC)COC(=O)C7=CC=CC=C7NC(=O)CCC(=O)N,,,,,,
3601,3083604,"[(1S,2R,3R,4S,5R,6S,8R,9S,13S,16R,17R,18S)-11-ethyl-8,9-dihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-13-yl]methyl 2-acetamidobenzoate",CCN1C[C@@]2(CC[C@H]([C@@]34[C@@H]2[C@@H]([C@@](C31)([C@]5(C[C@@H]([C@H]6C[C@@H]4[C@@H]5[C@H]6OC)OC)O)O)OC)OC)COC(=O)C7=CC=CC=C7NC(=O)C,,,,,,
3602,3083605,"2,3-Dihydrodeacetyltatsiensine",CCN1C[C@@]2(CC[C@@H]([C@@]34[C@@H]2[C@@H]([C@@]5(C31)[C@]6(C[C@@H]([C@H]7C[C@@H]4[C@@H]6[C@H]7OC)OC)OCO5)O)OC)C,,,,,,
3603,3083606,CID 3083606,CC(C)C(C)CCC(C)[C@H]1CCC2[C@@]1(CCCC2=CC=C3C[C@H](CCC3=C)O)C,,,,,,
3604,3083607,"5-(1,2-Dibromo-2-phenylethyl)-5-methylimidazolidine-2,4-dione",CC1(C(=O)NC(=O)N1)C(C(C2=CC=CC=C2)Br)Br,,,,,,
3605,3083608,Yuccagenin,C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(C[C@H]([C@@H](C6)O)O)C)C)C)OC1,,,,,,
3606,3083609,"Furo(2,3-b)quinolin-4(9H)-one, 6,8-dimethoxy-9-methyl-",CN1C2=C(C=C(C=C2OC)OC)C(=O)C3=C1OC=C3,,,,,,
3607,3083610,"6,8-Dimethyl-9,10-didehydroergoline",C[C@H]1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C,,,,,,
3608,3083611,CID 3083611,CCC1=C2C=C3C(=C4C(=O)[C@@H](C(=C4[N-]3)C5=NC(=CC6=NC(=CC(=N2)C1=C[O-])C(=C6C)C=C)[C@H]([C@@H]5CCC(=O)OCC=C(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C)C(=O)OC)C.[Mg+2],,,,,,
3609,3083612,"methyl (3R,21S,22S)-16-ethenyl-11-ethyl-12-(hydroxymethylidene)-17,21,26-trimethyl-4-oxo-22-[3-oxo-3-[(7R,11R)-3,7,11,15-tetramethylhexadec-2-enoxy]propyl]-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,5(26),6,8,10,13(25),14,16,18(24),19-decaene-3-carboxylate",CCC1=C2C=C3C(=C4C(=O)[C@@H](C(=C5[C@H]([C@@H](C(=CC6=NC(=CC(=N2)C1=CO)C(=C6C)C=C)N5)C)CCC(=O)OCC=C(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C4=N3)C(=O)OC)C,,,,,,
3610,3083613,Capillene,CC#CC#CCC1=CC=CC=C1,,,,,,
3611,3083614,CID 3083614,COC1=C(C=C(C=C1)C2=CC(=C3C(=CC(=O)C=C3O2)O)O)C4=C5C(=C(C=C(O5)C6=CC=C(C=C6)O)O)C(=CC4=O)O,,,,,,
3612,3083615,"1,4-Naphthoquinone, 2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-3-methyl-",CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,,,,,,
3613,3083616,Fraxidin,COC1=C(C(=C2C(=C1)C=CC(=O)O2)O)OC,,,,,,
3614,3083617,Thesin,C1C[C@@H]2[C@@H](CCN2C1)COC(=O)C3C(C(C3C4=CC=C(C=C4)O)C(=O)OC[C@@H]5CCN6[C@@H]5CCC6)C7=CC=C(C=C7)O,,,,,,
3615,3083618,"(2R)-7-hydroxy-2-(4-hydroxyphenyl)-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3-dihydrochromen-4-one",C1[C@@H](OC2=C(C1=O)C(=CC(=C2)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C4=CC=C(C=C4)O,,,,,,
3616,3083619,Tremuloidin,C1=CC=C(C=C1)C(=O)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=CC=CC=C3CO)CO)O)O,,,,,,
3617,3083620,3-(1H-imidazol-5-yl)-2-(trimethylazaniumyl)propanoate,C[N+](C)(C)C(CC1=CN=CN1)C(=O)[O-],,,,,,
3618,3083621,N-[1-Carboxy-2-(1H-imidazole-5-yl)ethyl]trimethylaminium,C[N+](C)(C)C(CC1=CN=CN1)C(=O)O,,,,,,
3619,3083622,Aposcopolamine,CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)C(=C)C4=CC=CC=C4,,,,,,
3620,3083623,Choline borate,B(O)(O)OCC[N+](C)(C)C,,,,,,
3621,3083624,"(1R,11S,13R,15R)-15-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.01,13.02,10.04,8]nonadeca-2,4(8),9,16-tetraene-11,18-diol",CO[C@@H]1C[C@@H]2[C@]3(C=C1)C(CN2[C@H](C4=CC5=C(C=C34)OCO5)O)O,,,,,,
3622,3083625,Copper;4-hydroxybenzenesulfonic acid,C1=CC(=CC=C1O)S(=O)(=O)O.[Cu+2],,,,,,
3623,3083626,CID 3083626,COC1=CC=C(C=C1)C2=CC(=C3C(=CC(=O)C(=C3O2)C4=C(C=CC(=C4)C5=CC(=C6C(=CC(=O)C=C6O5)O)O)OC)O)O,,,,,,
3624,3083627,CID 3083627,C1=CC(=C(C=C1C2=C(C(=C3C(=CC(=C(C3=O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O2)O)O)O)O,,,,,,
3625,3083628,Nickel benzoate,C1=CC=C(C=C1)C(=O)O.[Ni],,,,,,
3626,3083629,Magnesium;butanedioic acid;hydride,[H-].[H-].C(CC(=O)O)C(=O)O.[Mg+2],,,,,,
3627,3083630,Pseudobrucine,COC1=C(C=C2C(=C1)[C@]34CCN5[C@]3(C[C@@H]6[C@@H]7[C@@H]4N2C(=O)C[C@@H]7OCC=C6C5)O)OC,,,,,,
3628,3083631,"(2S,5'R,6R,7S,9S,13R,16S,18S,19S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16,19-diol",C[C@@H]1CC[C@@]2([C@H](C3C(O2)C[C@@H]4[C@@]3(CCC5C4C[C@@H]([C@@H]6[C@@]5(CC[C@@H](C6)O)C)O)C)C)OC1,,,,,,
3629,3083632,Leptospermone,CC(C)CC(=O)C1C(=O)C(C(=O)C(C1=O)(C)C)(C)C,,,,,,
3630,3083633,Fallacinol,COC1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3O)CO,,,,,,
3631,3083634,"1-(2,4-Dihydroxy-3,5-dimethylphenyl)ethanone",CC1=CC(=C(C(=C1O)C)O)C(=O)C,,,,,,
3632,3083635,Ditophal,CCSC(=O)C1=CC(=CC=C1)C(=O)SCC,,,,,,
3633,3083636,CID 3083636,CCCC(=O)[O-].[K+],,,,,,
3634,3083637,Soyasapogenol C,C[C@@]12CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H]([C@]5(C)CO)O)C)C)[C@@H]1CC(C=C2)(C)C)C,,,,,,
3635,3083638,Aminophenazone salicylate,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)C.C1=CC=C(C(=C1)C(=O)O)O,,,,,,
3636,3083639,Methacholine iodide,CC(C[N+](C)(C)C)OC(=O)C.[I-],,,,,,
3637,3083640,CID 3083640,CC=C1CN2[C@H]3C[C@H]1[C@@]([C@@H]2CC4=C3NC5=CC=CC=C45)(CO)C(=O)OC,,,,,,
3638,3083641,"4,9,13-Trimethyl-15-(2,6,6-trimethylcyclohexen-1-yl)pentadeca-2,4,6,8,10,12,14-heptaenal",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=O)C)C,,,,,,
3639,3083642,Acacipetalin,CC(=C(C#N)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)C,,,,,,
3640,3083643,Trimethylsulfonium tetrafluoroborate,[B-](F)(F)(F)F.C[S+](C)C,,,,,,
3641,3083644,CID 3083644,CC(C)[O-].[Na+],,,,,,
3642,3083645,"3-Acetyl-5-isopropyl-2,4-pyrrolidinedione",CC(C)C1C(=O)C(C(=O)N1)C(=O)C,,,,,,
3643,3083646,Piperidine phosphate,C1CCNCC1.OP(=O)(O)O,,,,,,
3644,3083647,Cadmium oxalate,C(=O)(C(=O)O)O.[Cd],,,,,,
3645,3083648,Hexacosyl acetate,CCCCCCCCCCCCCCCCCCCCCCCCCCOC(=O)C,,,,,,
3646,3083649,"Ethanone, 1-(1,8-dihydroxy-2-naphthalenyl)-",CC(=O)C1=C(C2=C(C=CC=C2O)C=C1)O,,,,,,
3647,3083650,"(4S,7S,12bS)-9-methoxy-1,2,3,4,4a,5,6,7,7a,13-decahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol",COC1=C2C3=C(C[C@H]4C5[C@]3(CCN4)C(O2)[C@H](CC5)O)C=C1,,,,,,
3648,3083651,N4-Acetylsulfaphenazole,CC(=O)NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=NN2C3=CC=CC=C3,,,,,,
3649,3083652,CID 3083652,C(C(=O)O)C(CC(=O)[O-])(C(=O)O)O.[K+],,,,,,
3650,3083653,Lead(2+) acrylate,C=CC(=O)[O-].C=CC(=O)[O-].[PbH2+2],,,,,,
3651,3083654,Einecs 212-831-8,[H-].C1CCN(C1)C(=S)S.[Na+],,,,,,
3652,3083655,2-(1H-imidazol-5-yl)ethanol,C1=C(NC=N1)CCO,,,,,,
3653,3083656,Benzoic acid;plumbane,C1=CC=C(C=C1)C(=O)O.[PbH4],,,,,,
3654,3083657,Ethyl (aminophenyl)acetate hydrochloride,CCOC(=O)C(C1=CC=CC=C1)N.[Cl-],,,,,,
3655,3083658,1-[4-(Trifluoromethyl)phenyl]propan-2-amine hydrochloride,CC(CC1=CC=C(C=C1)C(F)(F)F)N.Cl,,,,,,
3656,3083659,alpha-Methyldopa hydrochloride,C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)N.Cl,,,,,,
3657,3083660,"potassium;(2S,6R)-3,3-dimethyl-7-oxo-6-[(2-prop-2-enylsulfanylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",CC1([C@@H](N2C(S1)[C@@H](C2=O)NC(=O)CSCC=C)C(=O)O)C.[K+],,,,,,
3658,3083661,"(2S,6R)-3,3-dimethyl-7-oxo-6-[(2-prop-2-enylsulfanylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",CC1([C@@H](N2C(S1)[C@@H](C2=O)NC(=O)CSCC=C)C(=O)O)C,,,,,,
3659,3083662,Rubazoic acid,CC1=NN(C(=O)C1N=C2C(=NN(C2=O)C3=CC=CC=C3)C)C4=CC=CC=C4,,,,,,
3660,3083663,Triglycine selenate,C(C(=O)O)N.O[Se](=O)(=O)O,,,,,,
3661,3083664,Pulcherriminic acid,CC(C)CC1=C([N+](=C(C(=O)N1O)CC(C)C)[O-])O,,,,,,
3662,3083665,"17-(2-chloroethynyl)-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol",CC12CCC3C(C1CCC2(C#CCl)O)CCC4=C3C=CC(=C4)OC,,,,,,
3663,3083666,"(3beta,20S,21R)-21-(4,5-Dihydro-4-methyl-3H-pyrrol-2-yl)-3-hydroxy-20-methylpregn-5-en-21-one",C[C@@H]1CC(=NC1)C(=O)C(C)[C@H]2CCC3[C@@]2(CCC4C3CC=C5[C@@]4(CC[C@@H](C5)O)C)C,,,,,,
3664,3083667,"(19S,20S)-19-(furan-3-yl)-12-hydroxy-9,9,13,20-tetramethyl-4,8,15,18-tetraoxahexacyclo[11.9.0.02,7.02,10.014,16.014,20]docosane-5,17-dione",C[C@@]12CCC3C(C14C(O4)C(=O)O[C@H]2C5=COC=C5)(C(CC6C37COC(=O)CC7OC6(C)C)O)C,,,,,,
3665,3083668,Tetracosyl tetracosanoate,CCCCCCCCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCCCCCCCC,,,,,,
3666,3083669,Bufotenin oxide,C[N+](C)(CCC1=CNC2=C1C=C(C=C2)O)[O-],,,,,,
3667,3083670,3-Morpholinopropiophenone hydrochloride,C1COCCN1CCC(=O)C2=CC=CC=C2.Cl,,,,,,
3668,3083671,Tolpentamide,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCC2,,,,,,
3669,3083672,CID 3083672,C1C(N=C(C=C1C=CNC(CCC(=O)O)C(=O)O)C(=O)O)C(=O)O,,,,,,
3670,3083673,Dicesium oxalate,[H-].C(=O)(C(=O)O)O.[Cs+],,,,,,
3671,3083674,CID 3083674,C(C#N)C(=O)[O-].[Na+],,,,,,
3672,3083675,CID 3083675,CCCCCCCCCCCOS(=O)(=O)[O-].[Na+],,,,,,
3673,3083676,"1,3-Dithiolan-2-imine, hydrochloride",C1CSC(=N)S1.[Cl-],,,,,,
3674,3083677,5-Aminotryptamine,C1=CC2=C(C=C1N)C(=CN2)CCN,,,,,,
3675,3083678,Ketocaine hydrochloride,CCCC(=O)C1=CC=CC=C1OCCN(C(C)C)C(C)C.Cl,,,,,,
3676,3083679,"4-[2-(3,4-Diaminophenyl)-1,1,1,3,3,3-hexafluoropropan-2-yl]benzene-1,2-diamine",C1=CC(=C(C=C1C(C2=CC(=C(C=C2)N)N)(C(F)(F)F)C(F)(F)F)N)N,,,,,,
3677,3083680,CID 3083680,CC=C(C)C(=O)O[C@H]1C[C@H]([C@]2(CO[C@@H]3C2C1(C(C4([C@@H]3OC5C4=C([C@@H](C5)C6=COC=C6)C)C)CC(=O)OC)C)C)O,,,,,,
3678,3083681,"2,2'-Bithiophene, 5-(3-buten-1-ynyl)-5'-methyl-",CC1=CC=C(S1)C2=CC=C(S2)C#CC=C,,,,,,
3679,3083682,Einecs 214-518-1,C[C@]12CCCC([C@H]3C1CCC3C2CO)(C)C,,,,,,
3680,3083683,"1,5-Bis(4-trimethylammoniumphenyl)pentan-3-one diiodide",C[N+](C)(C)C1=CC=C(C=C1)CCC(=O)CCC2=CC=C(C=C2)[N+](C)(C)C.[I-].[I-],,,,,,
3681,3083684,Trimethyl-[4-[3-oxo-5-[4-(trimethylazaniumyl)phenyl]pentyl]phenyl]azanium,C[N+](C)(C)C1=CC=C(C=C1)CCC(=O)CCC2=CC=C(C=C2)[N+](C)(C)C,,,,,,
3682,3083685,CID 3083685,CC=CCCC=CCCC=CCCC=CCCC=CCC1=C(C(=O)C2=CC=CC=C2C1=O)C,,,,,,
3683,3083686,6-Mercaptopurine sodium salt,C1=NC2=C(N1)C(=S)N=CN2.[Na+],,,,,,
3684,3083687,4-Ammonio-1-benzylpiperidinium dichloride,C1CN(CCC1N)CC2=CC=CC=C2.[Cl-],,,,,,
3685,3083688,Vanilloylglycine,COC1=C(C=CC(=C1)C(=O)NCC(=O)O)O,,,,,,
3686,3083689,CID 3083689,C[C@@]12CC[C@@H]3C4(C=CC(=O)C(C4=C(C(=O)C3(C15C(O5)C[C@H]2C6=COC=C6)C)O)(C)C)C,,,,,,
3687,3083690,"[1-[(1-Hydroxy-2-oxoazepan-3-yl)amino]-2-methyl-1-oxopentan-3-yl] 2-[[2-(2-hydroxy-6-methylphenyl)-4,5-dihydro-1,3-oxazole-4-carbonyl]amino]-6-[hydroxy(octadec-2-enoyl)amino]hexanoate",CCCCCCCCCCCCCCCC=CC(=O)N(CCCCC(C(=O)OC(CC)C(C)C(=O)NC1CCCCN(C1=O)O)NC(=O)C2COC(=N2)C3=C(C=CC=C3O)C)O,,,,,,
3688,3083691,Einecs 215-096-1,CCCCCCCCC(C(CCCCCCCCCCCC(=O)O)Br)Br.[Ca+2],,,,,,
3689,3083692,"13,14-Dibromobehenic acid",CCCCCCCCC(C(CCCCCCCCCCCC(=O)O)Br)Br,,,,,,
3690,3083693,CID 3083693,C1CN2CC3=CCO[C@H]4CC(=O)N5[C@@H]6[C@H]4[C@H]3C[C@H]2C61C7=CC=CC=C75.C(C(COP(=O)(O)O)O)O,,,,,,
3691,3083694,"(4aR,5aS,13aR,15aS,15bR)-4a,5,5a,7,8,13a,15,15a,15b,16-decahydro-2H-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinolin-14-one",C1CN2CC3=CCO[C@H]4CC(=O)N5[C@@H]6[C@H]4[C@H]3C[C@H]2C61C7=CC=CC=C75,,,,,,
3692,3083695,"1-But-2-en-2-yl-2,8,10-trichloro-9-hydroxy-3-methoxy-4,7-dimethylbenzo[b][1,4]benzodioxepin-6-one",CC=C(C)C1=C2C(=C(C(=C1Cl)OC)C)OC(=O)C3=C(C(=C(C(=C3O2)Cl)O)Cl)C,,,,,,
3693,3083696,"(2S,5'R,6R,7S,18R)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]",C[C@@H]1CC[C@@]2([C@H](C3C(O2)C[C@@H]4C3(CCC5C4CC[C@@H]6C5(CCCC6)C)C)C)OC1,,,,,,
3694,3083697,Titanium trioxide,OO.O=[Ti],,,,,,
3695,3083698,Clivatine,CC(CC(=O)O[C@H]1C[C@H]2CCN([C@H]2[C@H]3[C@H]1OC(=O)C4=CC5=C(C=C34)OCO5)C)O,,,,,,
3696,3083699,CID 3083699,CCN1C[C@@H]2CC[C@@H]([C@@]34C2C[C@@H](C31)[C@]5(CC([C@]6(CC4C5[C@H]6O)O)OC)O)OC,,,,,,
3697,3083700,Mycosubtilin,CCC(C)CCCCCCCCCCC1CC(=O)N[C@H](C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)CO)CC(=O)N)CC(=O)N)CC3=CC=C(C=C3)O)CCC(=O)N)CC(=O)N,,,,,,
3698,3083701,Kosotoxin,CC1=C(C(=C(C(=C1OC)C(=O)C(C)C)O)CC2(C(=C(C(=C(C2=O)C(=O)C(C)C)O)C)O)C)O,,,,,,
3699,3083702,Mycobactin,C1CCN(C(=O)C(C1)NC(=O)CCOC(=O)C(CCCCCN(C=O)O)NC(=O)C2COC(=N2)C3=CC=CC=C3O)O,,,"['Low-molecular-weight compounds produced by microorganisms that aid in the transport and sequestration of ferric iron. (The Encyclopedia of Molecular Biology, 1994) (See all compounds classified as Siderophores.)', 'Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems. (See all compounds classified as Iron Chelating Agents.)']",,,
3700,3083703,"Ergotoxine, dihydro-, monoethanesulfonate (salt)",CCS(=O)(=O)O.CC(C)[C@]1(C(=O)N2C(C(=O)N3CCCC3[C@]2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C,,,,,,
3701,3083704,"N-[(2R,4S)-7-benzyl-2-hydroxy-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide",CC(C)[C@]1(C(=O)N2C(C(=O)N3CCCC3[C@]2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C,,,,,,
3702,3083705,"4-[[2-[[3-Amino-1-[[3-methyl-1-[2-[(3-methyl-1,5-dioxo-2,3,4,7,8,9,10,10a-octahydropyrido[1,2-a][1,4]diazepin-4-yl)carbamoyl]pyrrolidin-1-yl]-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-3-[[2-[[3-carboxy-2-[[3-carboxy-2-[[3-carboxy-2-(10-methyldodec-3-enoylamino)propanoyl]-methylamino]propanoyl]amino]propanoyl]amino]acetyl]amino]-4-oxobutanoic acid",CCC(C)CCCCCC=CCC(=O)NC(CC(=O)O)C(=O)N(C)C(CC(=O)O)C(=O)NC(CC(=O)O)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NCC(=O)NC(C(C)N)C(=O)NC(C(C)C)C(=O)N1CCCC1C(=O)NC2C(NC(=O)C3CCCCN3C2=O)C,,,,,,
3703,3083706,CID 3083706,C[C@@H]1[C@H]([C@@H]([C@@H](C(O1)OC2CC(C(C(CC(=O)CC(=O)CC(CC(CC(CC(CC(CC(=O)O/C(=C(\C=CC=CC=CC=CC=CC=CC=C2)/C)/C(C)CCC(CC(=O)C3=CC=C(C=C3)NC)O)O)O)O)O)O)O)C)O)O)O)N,,,,,,
3704,3083707,CID 3083707,CC1COC(=O)C=CC=CC=CC=CC=CC=CCC(C(C(CC(CC(CC(CC(CC(CC(CC(C=C1)O)O)O)O)O)O)O)O)C)O,,,,,,
3705,3083708,Polymyxin B sulfate,CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CCN)NC(=O)C(CCN)NC(=O)C(CCO)NC(=O)C(CCN)NC=O)CCO)CCN)CCN.OS(=O)(=O)O,,,,,,
3706,3083709,For-DL-Dab-DL-Hse-DL-Dab-DL-Dab(1)-DL-Dab-DL-Phe-DL-Leu-DL-Dab-DL-Dab-DL-Hse-(1),CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CCN)NC(=O)C(CCN)NC(=O)C(CCO)NC(=O)C(CCN)NC=O)CCO)CCN)CCN,,,,,,
3707,3083710,Sulfomyxin,CCCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)[C@@H](C)O,,,,,,
3708,3083711,Bacitracin zinc,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCCCC(C(=O)NC(C(=O)N1)CCCN)NC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CSC(=N2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3C=NC=N3)CC4=CC=CC=C4.[Zn],,,,,,
3709,3083712,"4-[[2-[[2-(1-amino-2-methylbutyl)-4,5-dihydro-1,3-thiazole-4-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[1-[[3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-butan-2-yl-6-(carboxymethyl)-9-(4H-imidazol-4-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclopentacos-21-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid",CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCCCC(C(=O)NC(C(=O)N1)CCCN)NC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CSC(=N2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3C=NC=N3)CC4=CC=CC=C4,,,,,,
3710,3083713,Neomycin undecylenate,C=CCCCCCCCCC(=O)O.C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O)O)N,,,,,,
3711,3083714,Polymyxin,C[C@H]([C@H]1C(=O)NCC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCN)CCN)CC(C)C)CC2=CC=CC=C2)CCN)NC(=O)[C@H](CCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)O)O,,,['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)'],,,
3712,3083715,2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[(2-aminoacetyl)amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]acetic acid,CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)NCC(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)NCC(=O)NCC(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CN,,,,,,
3713,3083716,Albomycin,CC(=O)N(CCCC(C(=O)NC(CCCN(C(=O)C)O)C(=O)NC(CCCN(C(=O)C)O)C(=O)NC(CO)C(=O)NC(C([C@@H]1[C@H]([C@H]([C@@H](S1)N2C=CC(=O)N(C2=O)C)O)O)O)C(=O)O)N)O.[Fe+3],,,['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)'],,,
3714,3083717,"2-[[2-[[5-[acetyl(hydroxy)amino]-2-[[5-[acetyl(hydroxy)amino]-2-[[5-[acetyl(hydroxy)amino]-2-aminopentanoyl]amino]pentanoyl]amino]pentanoyl]amino]-3-hydroxypropanoyl]amino]-3-[(2R,3S,4R,5R)-3,4-dihydroxy-5-(3-methyl-2,4-dioxopyrimidin-1-yl)thiolan-2-yl]-3-hydroxypropanoic acid",CC(=O)N(CCCC(C(=O)NC(CCCN(C(=O)C)O)C(=O)NC(CCCN(C(=O)C)O)C(=O)NC(CO)C(=O)NC(C([C@@H]1[C@H]([C@H]([C@@H](S1)N2C=CC(=O)N(C2=O)C)O)O)O)C(=O)O)N)O,,,,,,
3715,3083718,Dihydronormorphine,C1C[C@@H]([C@H]2[C@@]34[C@@H]1[C@H](CC5=C3C(=C(C=C5)O)O2)NCC4)O,,,,,,
3716,3083719,"24-Methylidene-9,19-cyclolanostan-3-one",CC(C)C(=C)CCC(C)[C@H]1CC[C@@]2([C@@]1(CC[C@]34C2CCC5[C@]3(C4)CCC(=O)C5(C)C)C)C,,,,,,
3717,3083720,2-Amino-6-guanidinohexanoic acid hydrochloride,C(CCN=C(N)N)CC(C(=O)O)N.Cl,,,,,,
3718,3083721,Einecs 216-182-1,C1=CC=C(C=C1)[P+](CC[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6.[I-].[I-],,,,,,
3719,3083722,(3-Methyl-2-butenyl)triphenyl-phosphonium Bromide,CC(=CC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)C.[Br-],,,,,,
3720,3083723,(Diphenylmethyl)triphenylphosphonium chloride,C1=CC=C(C=C1)C(C2=CC=CC=C2)[P+](C3=CC=CC=C3)(C4=CC=CC=C4)C5=CC=CC=C5.[Cl-],,,,,,
3721,3083724,CID 3083724,CC1=C(OC(=C2C1=CC=CC2=O)O)C,,,,,,
3722,3083725,(alpha-Methylphenethyl)(1-methyl-2-phenoxyethyl)ammonium hydrogen fumarate,CC(CC1=CC=CC=C1)NC(C)COC2=CC=CC=C2.C(=CC(=O)O)C(=O)O,,,,,,
3723,3083726,8-Hydroxybergapten,COC1=C2C=COC2=C(C3=C1C=CC(=O)O3)O,,,,,,
3724,3083727,Heminthosporic acid,CC1=C(C2C(CCC1(C2CO)C)C(C)C)C(=O)O,,,,,,
3725,3083728,Astiron,CCOC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC2=CC=C(C=C2)N(CCCl)CCCl)NC(=O)C,,,,,,
3726,3083729,Chrysene-D12,[2H]C1=C(C(=C2C(=C1[2H])C(=C(C3=C2C(=C(C4=C(C(=C(C(=C43)[2H])[2H])[2H])[2H])[2H])[2H])[2H])[2H])[2H])[2H],,,,,,
3727,3083730,Unii-jtt4JX9GU8,C1CC2=CC=CC=C2CC1N.[Cl-],,,,,,
3728,3083731,Papaverine nicotinate,COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC.C1=CC(=CN=C1)C(=O)O,,,,,,
3729,3083732,((Methylthio)methyl)triphenylphosphonium chloride,CSC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3.[Cl-],,,,,,
3730,3083733,[(Methylthio)methyl]triphenylphosphonium,CSC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
3731,3083734,L-Tame,CC1=CC=C(C=C1)S(=O)(=O)NC(CCCN=C(N)N)C(=O)OC.Cl,,,,,,
3732,3083735,Cethexonium bromide,CCCCCCCCCCCCCCCC[N+](C)(C)C1CCCCC1O.[Br-],,,"['Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)', 'Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. (See all compounds classified as Surface-Active Agents.)']",,,
3733,3083736,"1-(4-Amino-2,3,4-trideoxyhex-2-enopyranuronosyl)-4-imino-1,4-dihydropyrimidin-2-ol",C1=CC(OC(C1N)C(=O)O)N2C=CC(=NC2=O)N,,,,,,
3734,3083737,"Carbamic acid, (phenylmethoxy)(phenylmethyl)-, ethyl ester",CCOC(=O)N(CC1=CC=CC=C1)OCC2=CC=CC=C2,,,,,,
3735,3083738,Sodium sulfaethylthiadiazole,[H-].CCC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N.[Na+],,,,,,
3736,3083739,7-Chloroindole-3-acetic acid,C1=CC2=C(C(=C1)Cl)NC=C2CC(=O)O,,,,,,
3737,3083740,"N,N'-((3-Oxo-1(3H)-isobenzofuranylidene)bis((6-hydroxy-2-methyl-5-(1-methylethyl)-3,1-phenylene)methylene))bis(N-(carboxymethyl)glycine)",CC1=C(C=C(C(=C1C[NH+](CC(=O)O)CC(=O)[O-])O)C(C)C)C2(C3=CC=CC=C3C(=O)O2)C4=C(C(=C(C(=C4)C(C)C)O)C[NH+](CC(=O)O)CC(=O)[O-])C,,,,,,
3738,3083741,7-Deoxynivalenol,CC1=C[C@@H]2[C@](CC1=O)([C@]3([C@@H]([C@H]([C@H]([C@@]34CO4)O2)O)O)C)CO,,,,,,
3739,3083742,"(1,5-Dimethylhexyl)ammonium (1)-2-oxobornane-10-sulphonate",CC(C)CCCC(C)N.CC1(C2CCC1(C(=O)C2)CS(=O)(=O)O)C,,,,,,
3740,3083743,CID 3083743,C1OC2=C(O1)C=C3C(=C2)C4=C(OC5=CC(=O)C=CC5=C4O3)O,,,,,,
3741,3083744,"1,4-Naphthalenedione, 6-acetyl-5-hydroxy-7-methyl-",CC1=CC2=C(C(=O)C=CC2=O)C(=C1C(=O)C)O,,,,,,
3742,3083745,Dianellinone,CC1=CC2=C(C(=C1C(=O)C)O)C(=O)C(=CC2=O)C3=CC(=O)C4=C(C3=O)C(=C(C(=C4)C)C(=O)C)O,,,,,,
3743,3083746,"1-(2,4,5-Trimethoxyphenyl)propan-2-one",CC(=O)CC1=CC(=C(C=C1OC)OC)OC,,,,,,
3744,3083747,"(9R)-N,N-diethyl-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide",CCN(CC)C(=O)[C@H]1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C,,,,,,
3745,3083748,CID 3083748,C[N+]1(CCC2=CC(=C(C3=C2[C@@H]1CC4=C3C(=C(C=C4)OC)O)O)OC)C.C1=C(C(=O)C(=[N+](O)[O-])C(=O)C1=[N+]([O-])[O-])[N+](=O)[O-],,,,,,
3746,3083749,"Methanone, (3-chloro-2-hydroxy-4,6-dimethoxyphenyl)(4-hydroxy-2-methoxy-6-methylphenyl)-",CC1=CC(=CC(=C1C(=O)C2=C(C(=C(C=C2OC)OC)Cl)O)OC)O,,,,,,
3747,3083750,Zirconium(4+) propan-2-olate,CC(C)[O-].CC(C)[O-].CC(C)[O-].CC(C)[O-].[Zr+4],,,,,,
3748,3083751,(3-Methoxycarbonyl-2-propenyl)triphenylphosphonium bromide,COC(=O)C=CC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3.[Br-],,,,,,
3749,3083752,(4-Methoxy-4-oxobut-2-enyl)-triphenylphosphanium,COC(=O)C=CC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
3750,3083753,"D-Ribitol, 1-deoxy-1-(3,4-dihydro-7-hydroxy-6-methyl-2,4-dioxo-8(2H)-pteridinyl)-",CC1=NC2=C(NC(=O)NC2=O)N(C1=O)C[C@H]([C@H]([C@H](CO)O)O)O,,,,,,
3751,3083754,Pyrrocaine hydrochloride,CC1=C(C(=CC=C1)C)NC(=O)CN2CCCC2.Cl,,,,,,
3752,3083755,"5,6-Dihydro-9,10-dimethoxy-13-methylbenzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium iodide",CC1=C2C=CC(=C(C2=C[N+]3=C1C4=CC5=C(C=C4CC3)OCO5)OC)OC.[I-],,,,,,
3753,3083756,"(3beta)-17-(Acetyloxy)-3-hydroxy-6-methylpregna-4,6-dien-20-one",CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=C[C@H](CC4)O)C,,,,,,
3754,3083757,CID 3083757,C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O[C@@H]3[C@H](O[C@H]([C@@H]3O)N4C=NC5=C4NC(=NC5=O)N)CO)OP(=O)(O)O)O,,,,,,
3755,3083758,5-Chlorocytosine,C1=NC(=O)NC(=C1Cl)N,,,,,,
3756,3083759,Adenylyl(3'-5')cytidine-3'-phosphate,C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O[C@@H]3[C@H](O[C@H]([C@@H]3O)N4C=NC5=C(N=CN=C54)N)CO)OP(=O)(O)O)O,,,,,,
3757,3083760,"2-Ethylbenzene-1,4-diol",CCC1=C(C=CC(=C1)O)O,,,,,,
3758,3083761,"4-[(3R,5R,6S,7S,10R,13R)-3,6,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid",CC(CCC(=O)O)C1CCC2[C@@]1(CCC3C2[C@@H]([C@H]([C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,,,,,,
3759,3083762,"4-[(3R,5R,6S,7R,10R,13R)-3,6,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid",CC(CCC(=O)O)C1CCC2[C@@]1(CCC3C2[C@H]([C@H]([C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,,,,,,
3760,3083763,"Potassium;hydride;2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluorooctanoic acid",[H-].C(=O)(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)O.[K+],,,,,,
3761,3083764,1-Methyl-4(1H)-quinolinimine,CN1C=CC(=N)C2=CC=CC=C21,,,,,,
3762,3083765,Heptadecanedioic acid,C(CCCCCCCC(=O)O)CCCCCCCC(=O)O,,,,,,
3763,3083766,CID 3083766,CC=C1CN2CC[C@@]34C5=CC=CC=C5N(C36[C@@H]2C[C@@H]1C4(CO6)C(=O)OC)C,,,,,,
3764,3083767,CID 3083767,CC1=C(OC2=CC(=O)C=CC2=C1O)C,,,,,,
3765,3083768,Theodrenaline hydrochloride,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCNCC(C3=CC(=C(C=C3)O)O)O.Cl,,,"['Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)']",,,
3766,3083769,Pinaverdol,CC1=CC2=C(C=C1)N(C(=CC3=CC=[N+](C4=CC=CC=C34)C)C=C2)C.[I-],,,,,,
3767,3083770,"1,6-Dimethyl-2-[(1-methylquinolin-4(1H)-ylidene)methyl]quinolinium",CC1=CC2=C(C=C1)N(C(=CC3=CC=[N+](C4=CC=CC=C34)C)C=C2)C,,,,,,
3768,3083771,"Quinolinium, 1-methyl-2-(methylthio)-4-phenyl-, iodide",C[N+]1=C(C=C(C2=CC=CC=C21)C3=CC=CC=C3)SC.[I-],,,,,,
3769,3083772,1-Methyl-2-methylsulfanyl-4-phenylquinolin-1-ium,C[N+]1=C(C=C(C2=CC=CC=C21)C3=CC=CC=C3)SC,,,,,,
3770,3083773,"[8-[2-(2-Methylbut-2-enoyloxy)propan-2-yl]-2-oxo-8,9-dihydrofuro[2,3-h]chromen-9-yl] 2-methylbut-2-enoate",CC=C(C)C(=O)OC1C(OC2=C1C3=C(C=C2)C=CC(=O)O3)C(C)(C)OC(=O)C(=CC)C,,,,,,
3771,3083774,"1,1-Dichloro-2-butanone",CCC(=O)C(Cl)Cl,,,,,,
3772,3083775,Einecs 220-204-5,[H-].CC1=C(C=CC(=C1)O)[N+](=O)[O-].[Na+],,,,,,
3773,3083776,(1-Methyl-2-oxo-2-phenylethyl)triphenylphosphonium bromide,CC(C(=O)C1=CC=CC=C1)[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4.[Br-],,,,,,
3774,3083777,(1-Benzoylethyl)triphenylphosphonium,CC(C(=O)C1=CC=CC=C1)[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
3775,3083778,Triethylmethylammonium bromide,CC[N+](C)(CC)CC.[Br-],,,,,,
3776,3083779,17-Methyloctadecanoic acid,CC(C)CCCCCCCCCCCCCCCC(=O)O,,,,,,
3777,3083780,"alpha,alpha,beta-Trimethylphenethylammonium (R-(R*,R*))-hydrogen tartrate",CC(C1=CC=CC=C1)C(C)(C)N.C(C(C(=O)O)O)(C(=O)O)O,,,,,,
3778,3083781,Zygacine,C[C@H]1CC[C@H]2[C@@]([C@@H]3[C@@H](CN2C1)C4CC56C(C4(C(C3O)O)O)CCC7[C@@]5(CCC(C7(O6)O)OC(=O)C)C)(C)O,,,,,,
3779,3083782,5-Ethyl-2-methoxyphenol,CCC1=CC(=C(C=C1)OC)O,,,,,,
3780,3083783,"4H-1-Benzopyran-4-one, 5,8-dihydroxy-6,7-dimethoxy-2-(4-methoxyphenyl)-",COC1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C(=C3O2)O)OC)OC)O,,,,,,
3781,3083784,CID 3083784,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OS(=O)(=O)[O-])C)C.[Na+],,,,,,
3782,3083785,Ethyl L-methionate hydrochloride,CCOC(=O)[C@H](CCSC)N.Cl,,,,,,
3783,3083786,"2,3-Dihydroxybutanedioic acid;iron(2+)",C(C(C(=O)O)O)(C(=O)O)O.[Fe+2],,,,,,
3784,3083787,"Butanedioic acid, 2-hydroxy-2-(hydroxymethyl)-",C(C(=O)O)[C@@](CO)(C(=O)O)O,,,,,,
3785,3083788,Sideroxylin,CC1=C(C2=C(C(=C1OC)C)OC(=CC2=O)C3=CC=C(C=C3)O)O,,,,,,
3786,3083789,Cytidylyl(5'.3')cytidylyl(5'.3')adenosine,C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O[C@@H]3[C@H](O[C@H]([C@@H]3O)N4C=CC(=NC4=O)N)COP(=O)(O)O[C@@H]5[C@H](O[C@H]([C@@H]5O)N6C=NC7=C(N=CN=C76)N)CO)O)O,,,,,,
3787,3083790,Calcium Tartrate 20% 40M,[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.[Ca+2],,,,,,
3788,3083791,Nalorphine dinicotinate,C=CCN1CC[C@]23[C@@H]4[C@@H]1CC5=C2C(=C(C=C5)OC(=O)C6=CN=CC=C6)O[C@H]3[C@H](C=C4)OC(=O)C7=CN=CC=C7,,,,,,
3789,3083792,"3,5-Dihydroxyphthalic acid",C1=C(C=C(C(=C1C(=O)O)C(=O)O)O)O,,,,,,
3790,3083793,Ocotein,CN1CCC2=C3C1CC4=CC(=C(C=C4C3=C5C(=C2OC)OCO5)OC)OC,,,,,,
3791,3083794,Manganese diformate,C(=O)O.[Mn],,,,,,
3792,3083795,Aspergillomarasmine B,C([C@@H](C(=O)O)NC[C@H](C(=O)O)NCC(=O)O)C(=O)O,,,,,,
3793,3083796,Ergostinine,CC[C@@]1(C(=O)N2[C@@](C(=O)N3CCC[C@@H]3[C@@]2(O1)O)(C)C4=CC=CC=C4)NC(=O)C5CN([C@@H]6CC7=CNC8=CC=CC(=C78)C6=C5)C,,,,,,
3794,3083797,N-[2-(4-methoxyphenyl)ethyl]benzamide,COC1=CC=C(C=C1)CCNC(=O)C2=CC=CC=C2,,,,,,
3795,3083798,Methyl 12-methoxy-19-oxoibogamine-18-carboxylate,CCC1CC2CC3(C1N(C2=O)CCC4=C3NC5=C4C=C(C=C5)OC)C(=O)OC,,,,,,
3796,3083799,"3-(But-3-en-1-yl)decahydro-8H-1,5-methanopyrido[1,2-a][1,5]diazocin-8-one",C=CCCN1CC2CC(C1)[C@H]3CCCC(=O)N3C2,,,,,,
3797,3083800,(2-Aminoethyl)trimethyl chloride hydrochloride,C[N+](C)(C)CCN.[Cl-],,,,,,
3798,3083801,"(9R)-9-Hydroxy-7,13-diazatetracyclo[7.7.1.02,7.013,17]heptadecan-6-one",C1CC2C3CCCN4C3[C@@](CCC4)(CN2C(=O)C1)O,,,,,,
3799,3083802,Mefexamide hydrochloride,CCN(CC)CCNC(=O)COC1=CC=C(C=C1)OC.Cl,,,,,,
3800,3083803,Dehydrodeguelin,CC1(C=CC2=C(O1)C=CC3=C2OC4=C(C3=O)C5=CC(=C(C=C5OC4)OC)OC)C,,,,,,
3801,3083804,"D-Xylo-5-hexulosonic acid, calcium salt",C(C(=O)C(C(C(C(=O)O)O)O)O)O.[Ca+2],,,,,,
3802,3083805,2-Phenylpent-2-enal,CCC=C(C=O)C1=CC=CC=C1,,,,,,
3803,3083806,Vadrine,C1=CC(=C(C=C1N)O)C(=O)O.C1=CN=CC=C1C2=NNC(=O)O2,,,,,,
3804,3083807,"Quinuclidinium, 1,1'-hexamethylenebis(3-benzyl-, dichloride",C1C[N+]2(CCC1C(C2)CC3=CC=CC=C3)CCCCCC[N+]45CCC(CC4)C(C5)CC6=CC=CC=C6.[Cl-].[Cl-],,,,,,
3805,3083808,3-Benzyl-1-[6-(3-benzyl-1-azoniabicyclo[2.2.2]octan-1-yl)hexyl]-1-azoniabicyclo[2.2.2]octane,C1C[N+]2(CCC1C(C2)CC3=CC=CC=C3)CCCCCC[N+]45CCC(CC4)C(C5)CC6=CC=CC=C6,,,,,,
3806,3083809,Mundoserone,COC1=CC2=C(C=C1)C(=O)[C@@H]3[C@H](O2)COC4=CC(=C(C=C34)OC)OC,,,,,,
3807,3083810,CID 3083810,CC1=CC(=C2C(=O)C=C3C=C(C=C(C3=C2O1)OC)OC)O,,,,,,
3808,3083811,Capillarin,CC#CCC1=CC2=CC=CC=C2C(=O)O1,,,,,,
3809,3083812,1-Octene-1-sulfonic acid,CCCCCCC=CS(=O)(=O)O,,,,,,
3810,3083813,lithium;hydride;N-methylmethanamine,[H-].[Li+].CNC,,,,,,
3811,3083814,CID 3083814,CC1(CC2=CC(=O)C(=CC(=C2CO1)O)O)O,,,,,,
3812,3083815,N-Methylmorpholine hydrochloride,CN1CCOCC1.Cl,,,,,,
3813,3083816,O-Ethyl-S-hexyl-methylthiophosphonate,CCCCCCSP(=O)(C)OCC,,,,,,
3814,3083817,Prodeconium bromide,CCCOC(=O)C[N+](C)(C)CCOCCCCCCCCCCOCC[N+](C)(C)CC(=O)OCCC.[Br-].[Br-],,,,,,
3815,3083818,Prodeconium,CCCOC(=O)C[N+](C)(C)CCOCCCCCCCCCCOCC[N+](C)(C)CC(=O)OCCC,,,,,,
3816,3083819,Thiohexamide,CSC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2,,,,,,
3817,3083820,"Sodium;4-[(7-chloro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl)oxy]-4-oxobutanoic acid",C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)OC(=O)CCC(=O)O.[Na+],,,,,,
3818,3083821,"1-Allyl-2,4-dimethoxybenzene",COC1=CC(=C(C=C1)CC=C)OC,,,,,,
3819,3083822,Disodium 5-hydroxy-6-((4-sulphonatonaphthyl)azo)naphthalenesulphonate,[H-].C1=CC=C2C(=C1)C(=CC=C2S(=O)(=O)O)N=NC3=C(C4=C(C=C3)C(=CC=C4)S(=O)(=O)O)O.[Na+],,,,,,
3820,3083823,2-(Chloromethyl)quinoline hydrochloride,C1=CC=C2C(=C1)C=CC(=N2)CCl.Cl,,,,,,
3821,3083824,Sodium;2-(2-carbamoylphenoxy)acetic acid,C1=CC=C(C(=C1)C(=O)N)OCC(=O)O.[Na+],,,,,,
3822,3083825,"3,4,6,7-Tetramethyldibenzothiophene",CC1=C(C2=C(C=C1)C3=C(S2)C(=C(C=C3)C)C)C,,,,,,
3823,3083826,sec-Butyltriphenylphosphonium bromide,CCC(C)[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3.[Br-],,,,,,
3824,3083827,"6-Acetamido-3-(3-(4-phenyl-1-piperazinyl)propyl)-2,4(1H,3H)-quinazolinedione maleate",CC(=O)NC1=CC2=C(C=C1)NC(=O)N(C2=O)CCCN3CCN(CC3)C4=CC=CC=C4,,,,,,
3825,3083828,(3S)-3-(carboxymethyl)-4-prop-1-en-2-ylpyrrolidine-2-carboxylic acid,CC(=C)C1CNC([C@H]1CC(=O)O)C(=O)O,,,,,,
3826,3083829,[[4-(4-Aminophenyl)sulfonylphenyl]methylideneamino]thiourea,C1=CC(=CC=C1C=NNC(=S)N)S(=O)(=O)C2=CC=C(C=C2)N,,,,,,
3827,3083830,CID 3083830,[Li+].CC(C)[N-]C(C)C,,,,,,
3828,3083831,9-Oxooctadecanoic acid,CCCCCCCCCC(=O)CCCCCCCC(=O)O,,,,,,
3829,3083832,"(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2S,3S,4S,5R,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol;sulfuric acid",C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@H]4[C@H]([C@@H]([C@H]([C@H](O4)CN)O)O)N)O)O)N.OS(=O)(=O)O,,,,,,
3830,3083833,"(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2S,3S,4S,5R,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol",C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@H]4[C@H]([C@@H]([C@H]([C@H](O4)CN)O)O)N)O)O)N,,,,,,
3831,3083834,(+)-alpha-Curcumene,CC1=CC=C(C=C1)[C@@H](C)CCC=C(C)C,,,,,,
3832,3083835,"2,5-dihydro-1H-pyrazol-3-amine hydrochloride",C1C=C(NN1)N.Cl,,,,,,
3833,3083836,"2-Hydroxy-N,N,N-trimethylethan-1-aminium 3,7,12-trioxocholan-24-oate",CC(CCC(=O)[O-])[C@H]1CC[C@@H]2C1(C(=O)C[C@H]3C2C(=O)CC4C3(CCC(=O)C4)C)C.C[N+](C)(C)CCO,,,,,,
3834,3083837,"4-[(9S,14S,17R)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid",CC(CCC(=O)O)[C@H]1CC[C@@H]2C1(C(=O)C[C@H]3C2C(=O)CC4C3(CCC(=O)C4)C)C,,,,,,
3835,3083838,"Sodium;2,2,3-trimethyl-3-(1-phenylpentoxycarbonyl)cyclopentane-1-carboxylic acid",CCCCC(C1=CC=CC=C1)OC(=O)C2(CCC(C2(C)C)C(=O)O)C.[Na+],,,,,,
3836,3083839,"Benzoic acid, 4-amino-, compd. with (2,5-dioxo-4-imidazolidinyl)urea (1:1)",C1=CC(=CC=C1C(=O)O)N.C1(C(=O)NC(=O)N1)NC(=O)N,,,,,,
3837,3083840,"Isoflavone, 7-hydroxy-4',6-dimethoxy-, acetate",CC(=O)OC1=C(C=C2C(=C1)OC=C(C2=O)C3=CC=C(C=C3)OC)OC,,,,,,
3838,3083841,3-Dimethylamino-2-methylpropyl chloride hydrochloride,CC(CN(C)C)CCl.Cl,,,,,,
3839,3083842,"Carbamimidothioic acid, pentyl ester, monohydrobromide",CCCCCSC(=N)N.[Br-],,,,,,
3840,3083843,Einecs 224-313-9,CC(=C)C[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3.[Br-],,,,,,
3841,3083844,(2-Methyl-2-propenyl)triphenylphosphonium,CC(=C)C[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
3842,3083845,Demethoxysudachitin,COC1=C(C(=C2C(=C1O)C(=O)C=C(O2)C3=CC=C(C=C3)O)OC)O,,,,,,
3843,3083846,"(R-(R*,R*))-6,7-Dimethoxy-3-(5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-1(3H)-isobenzofuranone",CC12C(CC3=C(C1C4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)C=CN=C3)OCO2,,,,,,
3844,3083847,Tris(2-diethylaminoethyl) phosphate trihydrochloride,CCN(CC)CCOP(=O)(OCCN(CC)CC)OCCN(CC)CC.Cl,,,,,,
3845,3083848,Bakuchicin,C1=CC2=C(C=CC(=O)O2)C3=C1C=CO3,,,,,,
3846,3083849,CID 3083849,CC1([C@H](N2[C@@H](S1)[C@H](C2=O)NC(=O)C(=CC3=CC=CC=C3Cl)SC)C(=O)O)C.[Na+],,,,,,
3847,3083850,CID 3083850,CC1([C@H](N2[C@@H](S1)[C@H](C2=O)NC(=O)C(=CC3=CC=CC=C3Cl)SC)C(=O)O)C,,,,,,
3848,3083851,"9,10[1',2']-Benzenoanthracene-9(10H)-carboxylic acid",C1=CC=C2C(=C1)C3C4=CC=CC=C4C2(C5=CC=CC=C35)C(=O)O,,,,,,
3849,3083852,"(1R,3aR,5aR,5bR,7aR,9R,11aR,13aR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-ol",CC(=C)[C@@H]1CC[C@]2(C1[C@H]3CCC4[C@]5(CC[C@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)C,,,,,,
3850,3083853,"sodium;4-[(Z)-[4-(ethylamino)-3-methylphenyl]-(4-ethylimino-3-methylcyclohexa-2,5-dien-1-ylidene)methyl]-6-hydroxybenzene-1,3-disulfonic acid;hydride",[H-].CCNC1=C(C=C(C=C1)/C(=C/2\C=CC(=NCC)C(=C2)C)/C3=CC(=C(C=C3S(=O)(=O)O)S(=O)(=O)O)O)C.[Na+],,,,,,
3851,3083854,Dibutyl(2-chloroethyl)ammonium chloride,CCCCN(CCCC)CCCl.Cl,,,,,,
3852,3083855,Methyl 6-hydroxyhexanoate,COC(=O)CCCCCO,,,,,,
3853,3083856,Potassium p-vinylbenzenesulphonate,C=CC1=CC=C(C=C1)S(=O)(=O)[O-].[K+],,,,,,
3854,3083857,Neocnidilide,CCCC[C@H]1[C@@H]2CCCC=C2C(=O)O1,,,,,,
3855,3083858,Einecs 224-947-6,CC1=C(SC=[N+]1CC2=CC=CC=C2)CCO.Cl,,,,,,
3856,3083859,CID 3083859,COC1=CC(=O)C=C2C1=C(C(=CO2)C3=CC=C(C=C3)O)O,,,,,,
3857,3083860,"aluminum;(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylate",C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)(C)C(=O)[O-].[Al+3],,,,,,
3858,3083861,N-Ethylbenzisoxazolium tetrafluoroborate,[B-](F)(F)(F)F.CC[N+]1=CC2=CC=CC=C2O1,,,,,,
3859,3083862,"2-Ethyl-1,2-benzisoxazol-2-ium",CC[N+]1=CC2=CC=CC=C2O1,,,,,,
3860,3083863,Hexazole,CCC1=NN=CN1C2CCCCC2,,,,,,
3861,3083864,"2'-Deoxycytidine 3',5'-diphosphate",C1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)N)COP(=O)(O)O)OP(=O)(O)O,,,,,,
3862,3083865,CID 3083865,CCCCCCCCCCCCCCCCCC(=O)NC(CO[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)OC2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O)O)C(C=CCCCCCCCCCCCCC)O,,,,,,
3863,3083866,"Acetonitrile, (p-chloroanilino)phenyl-",C1=CC=C(C=C1)C(C#N)NC2=CC=C(C=C2)Cl,,,,,,
3864,3083867,Pentamoxane hydrochloride,CC(C)CCNCC1COC2=CC=CC=C2O1.Cl,,,,,,
3865,3083868,Pentamoxane,CC(C)CCNCC1COC2=CC=CC=C2O1,,,,,,
3866,3083869,p-(Dimethylamino)benzoyl chloride;4-(Dimethylamino)benzoic acid chloride,CCNC1=CC=C(C=C1)C(=O)Cl,,,,,,
3867,3083870,Oxomemazine hydrochloride,CC(CN1C2=CC=CC=C2S(=O)(=O)C3=CC=CC=C31)CN(C)C.Cl,,,,,,
3868,3083871,"(7S,7aR)-9-methoxy-3-methyl-1,2,4,7,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7-diol",CN1CCC23[C@@H]4[C@H](C=CC2(C1CC5=C3C(=C(C=C5)OC)O4)O)O,,,,,,
3869,3083872,"Brucine, hydrate",COC1=C(C=C2C(=C1)C34CCN5C3CC6C7C4N2C(=O)CC7OCC=C6C5)OC.OS(=O)(=O)O,,,,,,
3870,3083873,Einecs 225-485-8,CN(C)C1CCN(CC1)CC2=CC=CC=C2.[Cl-],,,,,,
3871,3083874,Einecs 225-486-3,CN(C)C1CCNCC1.[Cl-],,,,,,
3872,3083875,"1,4''-Bipiperidinedihydrochloride",C1CCN(CC1)C2CCNCC2.[Cl-],,,,,,
3873,3083876,Palmatine iodide,COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC.[I-],,,,,,
3874,3083877,"N,N,2,2-tetradeuterio-2-(dideuterioamino)acetamide",[2H]C([2H])(C(=O)N([2H])[2H])N([2H])[2H],,,,,,
3875,3083878,"(6-Amino-1-benzyl-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazireno[2',3':3,4]pyrrolo[1,2-a]indol-8-yl)methyl hydrogen carbonimidate",CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4CC5=CC=CC=C5)N,,,,,,
3876,3083879,Pyrocatechol sulfate,C1=CC=C(C(=C1)O)OS(=O)(=O)O,,,,,['Catechol sulfate is a known human metabolite of Catechol.'],
3877,3083880,"(1S,2S,3R,4S)-cyclohex-5-ene-1,2,3,4-tetrol",C1=C[C@@H]([C@@H]([C@@H]([C@H]1O)O)O)O,,,['Compounds that inhibit or block the activity of GLYCOSIDE HYDROLASES such as ALPHA-AMYLASES and ALPHA-GLUCOSIDASES. (See all compounds classified as Glycoside Hydrolase Inhibitors.)'],,,
3878,3083881,"1-Benzyl-4-pyrrolidin-1-ylpiperidine, dihydrochloride",C1CCN(C1)C2CCN(CC2)CC3=CC=CC=C3.[Cl-],,,,,,
3879,3083882,CID 3083882,COC1=C2C(=C(C(=C(O2)C3=CC(=C(C=C3)O)O)OC)O)C(=CC1=O)O,,,,,,
3880,3083883,"2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11-Icosafluoroundecyl acrylate",C=CC(=O)OC(C(C(C(C(C(C(C(C(C(CF)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)F,,,,,,
3881,3083884,Betoxycaine hydrochloride,CCCCOC1=C(C=C(C=C1)C(=O)OCCOCCN(CC)CC)N.Cl,,,,,,
3882,3083885,CID 3083885,C1=CC(=CC=C1C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@H](O4)CO)O)O)O,,,,,,
3883,3083886,"(1,2-Dihydro-2-oxo-3H-indol-3-ylidene)di-p-phenylene dinicotinate",C1=CC=C2C(=C1)C(C(=O)N2)(C3=CC=C(C=C3)OC(=O)C4=CN=CC=C4)C5=CC=C(C=C5)OC(=O)C6=CN=CC=C6,,,,,,
3884,3083887,3-Acetoxy-4-(trimethylammonio)butanoate hydrochloride,CC(=O)OC(CC(=O)[O-])C[N+](C)(C)C.Cl,,,,,,
3885,3083888,Mansonone D,CC1COC2=C1C3=C(C(=C2)C)C(=O)C(=O)C(=C3)C,,,,,,
3886,3083889,"(1,1'-Biphenyl)sodium",[H-].C1=CC=C(C=C1)C2=CC=CC=C2.[Na+],,,,,,
3887,3083890,"1H-(1)Benzoxepino(2,3,4-ij)isoquinolin-6-ol, 2,3,12,12a-tetrahydro-9,10-dimethoxy-1-methyl-, (S)-",CN1CCC2=C3[C@@H]1CC4=CC(=C(C=C4OC3=C(C=C2)OC)O)OC,,,,,,
3888,3083891,Cyclamiretin D,C[C@@]1(CC[C@]2([C@@H](C1)C3=CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(C[C@H]2O)C)C)(C)C)O)C)CO)C=O,,,,,,
3889,3083892,CID 3083892,CC(C)CC(=O)C1=C2C(=C(C=C(O2)O)C3=CC=CC=C3)C(=O)C(=C1O)CC=C(C)C,,,,,,
3890,3083893,CID 3083893,COC1=C(C=C2C(=C1)C3=C(OC4=CC(=O)C=CC4=C3O2)O)OC,,,,,,
3891,3083894,(2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid;2-oxopentanedioic acid,C(CC(C(=O)O)N)CN=C(N)N.C(CC(=O)O)C(=O)C(=O)O,,,,,,
3892,3083895,(Hydroxymethyl)triphenylphosphonium chloride,C1=CC=C(C=C1)[P+](CO)(C2=CC=CC=C2)C3=CC=CC=C3.[Cl-],,,,,,
3893,3083896,(Hydroxymethyl)triphenylphosphonium,C1=CC=C(C=C1)[P+](CO)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
3894,3083897,"potassium;6-chloro-1,1-dioxo-3-(trichloromethyl)-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide",C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)(Cl)Cl.[K+],,,,,,
3895,3083898,Ammonium p-hydroxybenzenesulphonate,C1=CC(=CC=C1O)S(=O)(=O)O.N,,,,,,
3896,3083899,O-Methylisourea hydrochloride,COC(=N)N.Cl,,,,,,
3897,3083900,Calcium di-L-arabinonate,C(C(C(C(C(=O)O)O)O)O)O.[Ca+2],,,,,,
3898,3083901,Sodium p-((4-amino-1-naphthyl)azo)benzenesulphonate,C1=CC=C2C(=C1)C(=CC=C2N=NC3=CC=C(C=C3)S(=O)(=O)O)N.[Na+],,,,,,
3899,3083902,Einecs 226-658-0,[H-].COC1=CC=C(C=C1)NNS(=O)(=O)O.[Na+],,,,,,
3900,3083903,"1,3-Benzenediol, 4-nitroso-, monosodium salt",C1=CC(=C(C=C1O)O)N=O.[Na+],,,,,,
3901,3083904,1-(2-Methoxyphenyl)piperazine;chloride,COC1=CC=CC=C1N2CCNCC2.[Cl-],,,,,,
3902,3083905,Silver(1+) propionate,CCC(=O)O.[Ag],,,,,,
3903,3083906,"methyl (2S)-2-(1-oxobut-2-en-2-yl)-1,2,6,7,12,12b-hexahydroindolo[2,3-a]quinolizine-3-carboxylate",CC=C(C=O)[C@@H]1CC2C3=C(CCN2C=C1C(=O)OC)C4=CC=CC=C4N3,,,,,,
3904,3083907,Icajine,CN1CC[C@]23[C@@H]4[C@H]5[C@@H](CC2=O)C(=CCO[C@H]5CC(=O)N4C6=CC=CC=C36)C1,,,,,,
3905,3083908,N-Methylnandigerine,CN1CCC2=CC3=C(C4=C2C1CC5=C4C(=C(C=C5)O)OC)OCO3,,,,,,
3906,3083909,(-)-Chimonanthine,CN1CC[C@@]2([C@H]1NC3=CC=CC=C32)[C@@]45CCN([C@@H]4NC6=CC=CC=C56)C,,,,,,
3907,3083910,2-Hydroxypropylmercury(1+);hydroxide,CC(C[Hg+])O.[OH-],,,,,,
3908,3083911,2-Hydroxypropylmercury(1+),CC(C[Hg+])O,,,,,,
3909,3083912,Methyl DL-valinate HCl,CC(C)C(C(=O)OC)N.[Cl-],,,,,,
3910,3083913,Stebisimine,COC1=C2C=C(CC3=NCCC4=CC(=C(C=C43)OC5=C6C(=CC(=C5OC)OC)CCN=C6CC7=CC=C(O2)C=C7)OC)C=C1,,,,,,
3911,3083914,Dipotassium o-benzenedisulphonate hydrate,[H-].C1=CC=C(C(=C1)S(=O)(=O)O)S(=O)(=O)O.[K+],,,,,,
3912,3083915,5-Hydroxydopamine hydrochloride,C1=C(C=C(C(=C1O)O)O)CCN.Cl,,,,,,
3913,3083916,Calcium;gold(1+);2-hydroxy-3-sulfanylpropane-1-sulfonic acid,C(C(CS(=O)(=O)O)O)S.[Ca+2].[Au+],,,,,,
3914,3083917,"8H-Furo(3,2-h)(1)benzopyran-8-one",C1=CC2=C(C3=C1C=CC(=O)O3)OC=C2,,,,,,
3915,3083918,"2-(Hydroxymethyl)quinuclidine-3,3-diol hydrochloride",C1CN2CCC1C(C2CO)(O)O.Cl,,,,,,
3916,3083919,"Valeric acid, 2,2-diphenyl-, 2-(ethylamino)ethyl ester, hydrochloride",CCCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)OCCNCC.Cl,,,,,,
3917,3083920,Sodium 5-hydroxy-4-((2-hydroxybenzylidene)amino)-7-sulfonaphthalene-2-sulfonate hydrate,C1=CC=C(C(=C1)C=NC2=C3C(=CC(=C2)S(=O)(=O)[O-])C=C(C=C3O)S(=O)(=O)O)O.O.[Na+],,,,,,
3918,3083921,Papaverine phenylethyl barbiturate,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2.COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC,,,,,,
3919,3083922,Ammonium hydrogen oxalate,C(=O)(C(=O)[O-])O.[NH4+],,,"['Materials that add an electron to an element or compound, that is, decrease the positiveness of its valence. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) (See all compounds classified as Reducing Agents.)']",,,
3920,3083923,Matricarin,C[C@H]1[C@@H]2[C@H](CC(=C3[C@@H]([C@H]2OC1=O)C(=CC3=O)C)C)OC(=O)C,,,,,,
3921,3083924,6-O-Galloylarbutin,C1=CC(=CC=C1O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)COC(=O)C3=CC(=C(C(=C3)O)O)O)O)O)O,,,,,,
3922,3083925,"N-Phenyl-1,3,5-triazine-2,4-diaminemonohydrochloride",C1=CC=C(C=C1)NC2=NC=NC(=N2)N.[Cl-],,,,,,
3923,3083926,"2,9,10-Trimethoxy-4a,8,11,13a-tetrahydro-5H-isoquinolino[2,3-a]quinolin-3-ol",COC1=C(CC2=CN3C4C=C(C(=CC4CC=C3C=C2C1)O)OC)OC,,,,,,
3924,3083927,"(3beta,5beta,16beta)-3-((6-Deoxy-4-O-beta-D-glucopyranosyl-3-O-methyl-beta-D-galactopyranosyl)oxy)-14,16-dihydroxycard-20(22)-enolide 16-formate",C[C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3CC[C@]5([C@@]4(C[C@@H]([C@@H]5C6=CC(=O)OC6)OC=O)O)C)C)O)OC)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O,,,,,,
3925,3083928,Dimethylfraxetin,COC1=C(C(=C2C(=C1)C=CC(=O)O2)OC)OC,,,,,,
3926,3083929,"Naphtho(1,2-b)furan-2,8(3H,4H)-dione, 3a,5,5a,9b-tetrahydro-4,5-dihydroxy-9-methoxy-3,5a-dimethyl-",CC1C2C(C(C3(C=CC(=O)C(=C3C2OC1=O)OC)C)O)O,,,,,,
3927,3083930,beta-Onocerin,CC1=C([C@]2(CC[C@@H](C([C@@H]2CC1)(C)C)O)C)CCC3=C(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C,,,,,,
3928,3083931,"2,3-Dihydro-7-methyl-1H-pyrrolizin-1-one",CC1=C2C(=O)CCN2C=C1,,,,,,
3929,3083932,CID 3083932,COC1=C(C=C(C=C1)C2=C(C(=C3C(=CC(=CC3=O)OC)O2)O)O)OC,,,,,,
3930,3083933,Piperphenidol hydrochloride,CC(C)C(C1=CC=CC=C1)C(CCN2CCCCC2)O.Cl,,,,,,
3931,3083934,Piperphenidol,CC(C)C(C1=CC=CC=C1)C(CCN2CCCCC2)O,,,,,,
3932,3083935,"[(8bS)-4,8b-dimethyl-3-(methylcarbamoyl)-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate",C[C@@]12CCN(C1N(C3=C2C=C(C=C3)OC(=O)NC)C)C(=O)NC,,,,,,
3933,3083936,"4-Methoxybenzene-1,3-diol",COC1=C(C=C(C=C1)O)O,,,,,,
3934,3083937,Pentanoic acid--strychnidin-10-one (1/1),CCCCC(=O)O.C1CN2CC3=CCO[C@H]4CC(=O)N5[C@@H]6[C@H]4[C@H]3C[C@H]2C61C7=CC=CC=C75,,,,,,
3935,3083938,Sodium succinate hexahydrate,C(CC(=O)[O-])C(=O)[O-].O.O.O.O.O.O.[Na+].[Na+],,,,,,
3936,3083939,CID 3083939,COC1=CC2=C(C=CN=C2C=C1)[C@H](C3CC4CCN3CC4C=C)O.O.O.Cl,,,,,,
3937,3083940,Papaverine hydrobromide,COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC.Br,,,,,,
3938,3083941,"5-Methylbenzene-1,3-diol hydrate",CC1=CC(=CC(=C1)O)O.O,,,,,,
3939,3083942,"Glucopyranosiduronic acid, 2-naphthyl, beta-D-",C1=CC=C2C=C(C=CC2=C1)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O,,,,,,
3940,3083943,Tolquinzole,CCC1(CCN2CCC3=C(C2C1)C=C(C=C3)C)O,,,,,,
3941,3083944,Cotarnine phthalate,CN1CCC2=CC3=C(C(=C2C1OC(=O)C4=CC=CC=C4C(=O)OC5C6=C(C7=C(C=C6CCN5C)OCO7)OC)OC)OCO3,,,,,,
3942,3083945,Barbetonium iodide,CCC1(C(=O)NC(=O)N(C1=O)CC[N+](C)(CC)CC)C2=CC=CC=C2.[I-],,,,,,
3943,3083946,Barbetonium,CCC1(C(=O)NC(=O)N(C1=O)CC[N+](C)(CC)CC)C2=CC=CC=C2,,,,,,
3944,3083947,CID 3083947,C[N+](C)(C)CCOC(=O)C=CC1=CN=CN1.[Cl-],,,,,,
3945,3083948,5-(2-(Diethylamino)acetamido)salicylic acid methyl ester,CCN(CC)CC(=O)NC1=CC(=C(C=C1)O)C(=O)OC,,,,,,
3946,3083949,1-(Carboxymethyl)-2-methylpyridinium chloride,CC1=CC=CC=[N+]1CC(=O)O.[Cl-],,,,,,
3947,3083950,2-Methylpyridinium-1-acetic acid,CC1=CC=CC=[N+]1CC(=O)O,,,,,,
3948,3083951,"Benzenesulfonic acid, 4-(((4-aminophenyl)sulfonyl)amino)-, sodium salt",[H-].C1=CC(=CC=C1N)S(=O)(=O)NC2=CC=C(C=C2)S(=O)(=O)O.[Na+],,,,,,
3949,3083952,Ammonium bimalate,C(C(C(=O)O)O)C(=O)O.N,,,,,,
3950,3083953,CID 3083953,C(=CC(=O)O)C(=O)O.[Ni],,,,,,
3951,3083954,Dibutylamine hydrochloride,CCCCNCCCC.Cl,,,,,,
3952,3083955,Ethyl DL-methionate hydrochloride,CCOC(=O)C(CCSC)N.[Cl-],,,,,,
3953,3083956,Archil Red,[H-].C1=CC=C2C(=C1)C(=CC(=C2N)N=NC3=CC=C(C=C3)[N+](=O)[O-])S(=O)(=O)O.[Na+],,,,,,
3954,3083957,Dipotassium epoxysuccinate,[H-].C1(C(O1)C(=O)O)C(=O)O.[K+],,,,,,
3955,3083958,CID 3083958,[H-].C1=C(C2=C(C(=C1S(=O)(=O)O)O)C(=O)C3=C(C2=O)C(=[N+]([O-])[O-])C=C(C3=O)S(=O)(=O)O)[N+](=O)O.[Na+],,,,,,
3956,3083959,CID 3083959,CCCSS(=O)(=O)[O-].[Na+],,,,,,
3957,3083960,S-Propyl thiosulfate,CCCSS(=O)(=O)O,,,,,,
3958,3083961,Sodium 7-((3-aminobenzoyl)amino)-4-hydroxy-3-(phenylazo)naphthalene-2-sulphonate,[H-].C1=CC=C(C=C1)N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)C4=CC(=CC=C4)N)S(=O)(=O)O.[Na+],,,,,,
3959,3083962,Brilliant Direct Scarlet A-CF,[H-].C1=CC=C(C=C1)N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)NC4=CC5=CC(=C(C(=C5C=C4)O)N=NC6=CC7=C(C=C6)C=C(C=C7)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O.[Na+],,,,,,
3960,3083963,Raffinose undecaacetate,CC(=O)OCC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3(C(C(C(O3)COC(=O)C)OC(=O)C)OC(=O)C)COC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
3961,3083964,Herbaline,CC1C2CN3CCC4(C3CC2[C@H](CO1)C(=O)OC)C5=CC(=C(C=C5NC4=O)OC)OC,,,,,,
3962,3083965,CID 3083965,[Li+].CCC(=O)[O-],,,,,,
3963,3083966,"[(3S,5S,8R,9S,10S,13R,14S,17S)-17-(1-acetyloxyethyl)-3-(dimethylamino)-10-methyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-13-yl]methyl acetate",CC([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@H](C4)N(C)C)C)COC(=O)C)OC(=O)C,,,,,,
3964,3083967,Adotc cpd,CC(=O)C1=C([C@@]2([C@@H](C[C@H]3C(=C(C4=C([C@@]3(C)O)C=CC=C4O)O)C2=O)[C@@H](C1=O)N(C)C)O)O,,,,,,
3965,3083968,"9H-Xanthen-9-one, 2,3,4-trimethoxy-",COC1=C(C(=C2C(=C1)C(=O)C3=CC=CC=C3O2)OC)OC,,,,,,
3966,3083969,New Methylene Blue N,CCNC1=CC2=C(C=C1C)N=C3C=C(C(=[NH+]CC)C=C3S2)C.[Cl-].Cl[Zn]Cl,,,,,,
3967,3083970,CID 3083970,COC1=CC(=O)C2=C(C(=C(OC2=C1OC)C3=CC=C(C=C3)O)OC)O,,,,,,
3968,3083971,"[(1R,3aR,5aR,5bR,7aR,9R,11aR,13aR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] acetate",CC(=C)[C@@H]1CC[C@]2(C1[C@H]3CCC4[C@]5(CC[C@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)OC(=O)C)C)C,,,,,,
3969,3083972,Einecs 229-566-9,CC1=C(SC=N1)CCCCl.CC1=C(SC=N1)CCCCl.C(CS(=O)(=O)O)S(=O)(=O)O,,,,,,
3970,3083973,"16-(Acetyloxy)-3,19-dihydroxy-14,15-epoxybufa-20,22-dienolide",CC(=O)OC1C(C2(CCC3C(C24C1O4)CCC5C3(CCC(C5)O)CO)C)C6=COC(=O)C=C6,,,,,,
3971,3083974,CID 3083974,C[N+]12[C@@H]3[C@]4(C5=CC=CC=C5N/6[C@H]4/C(=C\N7[C@H]8/C(=C6)/[C@@H]9C(=CCO)C[N+]4([C@H]([C@]8(C5=CC=CC=C75)CC4)C9)C)/[C@@H](C3)C(=CCO)C1)CC2.[Cl-],,,,,,
3972,3083975,CID 3083975,C[N+]12[C@@H]3[C@]4(C5=CC=CC=C5N/6[C@H]4/C(=C\N7[C@H]8/C(=C6)/[C@@H]9C(=CCO)C[N+]4([C@H]([C@]8(C5=CC=CC=C75)CC4)C9)C)/[C@@H](C3)C(=CCO)C1)CC2,,,,,,
3973,3083976,"Lanosta-7,9(11)-dien-18-oic acid, 22,25-epoxy-3,20-dihydroxy-, gamma-lactone, (3beta)-",C[C@]12CC[C@@H](C(C1CC=C3C2=CC[C@@]45[C@]3(CC[C@@H]4[C@@](OC5=O)(C)C6CCC(O6)(C)C)C)(C)C)O,,,,,,
3974,3083977,2-Hydroxy-3-(2-hydroxyphenyl)propanoic acid,C1=CC=C(C(=C1)CC(C(=O)O)O)O,,,,,,
3975,3083978,Sciadin,C[C@@]12CCC[C@@]34[C@H]1CCC(=C)[C@@H]3C[C@H](OC4OC2=O)C5=COC=C5,,,,,,
3976,3083979,"Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 2-(dimethylamino)ethyl ester, hydrochloride",CN(C)CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O.Cl,,,,,,
3977,3083980,3-Methyl-5-phenylhydantoin,CN1C(=O)C(NC1=O)C2=CC=CC=C2,,,,,,
3978,3083981,"8-(Acetyloxy)-20-ethyl-13-hydroxy-1,6,16-trimethoxy-4-(methoxymethyl)aconitan-14-yl benzoate",CCN1C[C@@]2(CC[C@@H]([C@]34C1[C@@H]([C@@H](C23)OC)[C@]5(C[C@@H]([C@]6(CC4C5[C@H]6OC(=O)C7=CC=CC=C7)O)OC)OC(=O)C)OC)COC,,,,,,
3979,3083982,"(4S,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol;sulfuric acid",CN1CC[C@]23[C@@H]4[C@@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O.OS(=O)(=O)O,,,,,,
3980,3083983,Dehydrocorydalmine,COC1=C(C=C2C(=C1)CC[N+]3=C2C=C4C=CC(=C(C4=C3)OC)O)OC,,,,,,
3981,3083984,"(1R,11S,17S)-12-ethylidene-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2,4,6,9-tetraene-10-carbaldehyde",CC=C1CN2CC[C@@]34[C@@H]2C[C@@H]1C(=C3NC5=CC=CC=C45)C=O,,,,,,
3982,3083985,Undulatine,CO[C@@H]1C[C@@H]2[C@@]3(CCN2CC4=C(C5=C(C=C43)OCO5)OC)[C@@H]6[C@H]1O6,,,,,,
3983,3083986,Spegazzinine,CC[C@]12CCCN3[C@H]1[C@@]4(CC3)[C@@H]([C@H](C2)O)N(C5=C4C=CC=C5O)C(=O)C,,,,,,
3984,3083987,Ribalinium,CC(C)(C1CC2=C(C3=C(C=CC(=C3)O)[N+](=C2O1)C)OC)O,,,,,,
3985,3083988,6-methyl-1H-pyrimidine-2-thione chloride,CC1=CC=NC(=S)N1.[Cl-],,,,,,
3986,3083989,"Sodium 4-((4-amino-2,5-xylyl)azo)-m-xylene-5-sulphonate",[H-].CC1=CC(=C(C(=C1)S(=O)(=O)O)N=NC2=CC(=C(C=C2C)N)C)C.[Na+],,,,,,
3987,3083990,"(1R,4S,5R,8R,10S,13R,18S,21S)-10-hydroxy-4,5,9,9,13,20,20-heptamethyl-22-oxahexacyclo[19.2.1.01,18.04,17.05,14.08,13]tetracos-16-en-23-one",C[C@]12CC[C@@H](C([C@@H]1CC[C@@]3(C2CC=C4[C@]3(CC[C@]56[C@H]4CC([C@H](C5)OC6=O)(C)C)C)C)(C)C)O,,,,,,
3988,3083991,"(2-Hydroxy-1,1-bis(hydroxymethyl)ethyl)ammonium hydrogen sulphate",C(C(CO)(CO)N)O.C(C(CO)(CO)N)O.OS(=O)(=O)O,,,,,,
3989,3083992,"(2-Hydroxy-1,1-bis(hydroxymethyl)ethyl)ammonium dihydrogen phosphate",C(C(CO)(CO)N)O.OP(=O)(O)O,,,,,,
3990,3083993,Practolol hydrochloride,CC(C)NCC(COC1=CC=C(C=C1)NC(=O)C)O.Cl,,,,,,
3991,3083994,"alpha-d-Glucopyranose, 1-(dihydrogen phosphate), calcium salt (1:1)",C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)OP(=O)(O)O)O)O)O)O.[Ca+2],,,,,,
3992,3083995,"Sodium;2,3,4,5,6-pentahydroxy-1-[4-(hydroxymethylsulfamoyl)anilino]hexane-1-sulfonic acid",C1=CC(=CC=C1NC(C(C(C(C(CO)O)O)O)O)S(=O)(=O)O)S(=O)(=O)NCO.[Na+],,,,,,
3993,3083996,1-Deoxy-1-{4-[(hydroxymethyl)sulfamoyl]anilino}-1-sulfohexitol,C1=CC(=CC=C1NC(C(C(C(C(CO)O)O)O)O)S(=O)(=O)O)S(=O)(=O)NCO,,,,,,
3994,3083997,8-Methyl-8-azabicyclo[3.2.1]octan-3-YL 2-phenyl-3-(propanoyloxy)propanoate,CCC(=O)OCC(C1=CC=CC=C1)C(=O)OC2CC3CCC(C2)N3C,,,,,,
3995,3083998,Nitricholine perchlorate,C[N+](C)(C)CCO[N+](=O)[O-].[O-]Cl(=O)(=O)=O,,,,,,
3996,3083999,CID 3083999,CCCC(=C[C@@H](CC)C(=O)OC)C,,,,,,
3997,3084000,28-Hydroxyolean-12-en-3-yl acetate,CC(=O)O[C@H]1CC[C@]2(C(C1(C)C)CC[C@@]3(C2CC=C4[C@]3(CC[C@@]5(C4CC(CC5)(C)C)CO)C)C)C,,,,,,
3998,3084001,Magnesium methacrylate,CC(=C)C(=O)[O-].CC(=C)C(=O)[O-].[Mg+2],,,,,,
3999,3084002,"Methyl Green, zinc chloride salt",CC[N+](C)(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C.[Cl-].[Cl-].Cl[Zn]Cl,,,,,,
4000,3084003,"Disodium 3-hydroxy-4-((4-nitrophenyl)azo)naphthalene-2,7-disulphonate",C1=CC(=CC=C1N=NC2=C3C=CC(=CC3=CC(=C2O)S(=O)(=O)[O-])S(=O)(=O)[O-])[N+](=O)[O-].[Na+].[Na+],,,,,,
4001,3084004,Hexadecyl trimethyl ammonium iodide,CCCCCCCCCCCCCCCC[N+](C)(C)C.[I-],,,,,,
4002,3084005,"5-Methoxy-2-methyl-3-(3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl)cyclohexa-2,5-diene-1,4-dione",CC1=C(C(=O)C(=CC1=O)OC)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,,,,,,
4003,3084006,6-Acetaminocaproic acid,CC(=O)NCCCCCC(=O)O.[Na+],,,,,,
4004,3084007,"Phenanthro(3,4-d)-1,3-dioxole-5-carboxylic acid, 10-methoxy-6-nitro-",COC1=CC2=C3C(=C(C=C2C=C1)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)O,,,,,,
4005,3084008,Lead(2+) octanoate,CCCCCCCC(=O)[O-].CCCCCCCC(=O)[O-].[PbH2+2],,,,,,
4006,3084009,Sativol,COC1=C(C2=C(C=C1)C3=C(C4=C(O3)C=C(C=C4)O)C(=O)O2)O,,,,,,
4007,3084010,CID 3084010,C1=CC=C2C(=C1)C3=CC=NC(=O)C3=CN2,,,,,,
4008,3084011,"(1S,2R,6aR,6aS,6bR,8aR,12aR)-10-acetyloxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid",C[C@@H]1CCC2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CCC(C5(C)C)OC(=O)C)C)C)C2[C@H]1C)C)C(=O)O,,,,,,
4009,3084012,2-Chloro-1-methylpyridinium toluene-p-sulphonate,CC1=CC=C(C=C1)S(=O)(=O)O.C[N+]1=CC=CC=C1Cl,,,,,,
4010,3084013,Piperazine sebacate,C1CNCCN1.C(CCCCC(=O)O)CCCC(=O)O,,,,,,
4011,3084014,1-(4-Hydroxyphenyl)-2-methyl-2-methylaminoethanol hydrochloride,CC(C(C1=CC=C(C=C1)O)O)NC.Cl,,,,,,
4012,3084015,"1,10-Decanediamine, N,N'-bis(2-chloroethyl)-N,N'-dimethyl-, dihydrochloride",CN(CCCCCCCCCCN(C)CCCl)CCCl.Cl.Cl,,,,,,
4013,3084016,Methyl 2-amino-4-methylpentanoate hydrochloride,CC(C)CC(C(=O)OC)N.Cl,,,,,,
4014,3084017,DL-Phenylalanine methyl ester hydrochloride,COC(=O)C(CC1=CC=CC=C1)N.Cl,,,,,,
4015,3084018,(2S)-2-[[(2R)-2-[(2-amino-2-oxoethyl)amino]-2-carboxyethyl]amino]butanedioic acid,C([C@@H](C(=O)O)NC[C@H](C(=O)O)NCC(=O)N)C(=O)O,,,,,,
4016,3084019,H-Lys(ME)-OH hcl,CNCCCCC(C(=O)O)N.Cl,,,,,,
4017,3084020,"20-Ethyl-16-methoxy-4-(methoxymethyl)aconitane-1,8,14-triol",CCN1C[C@]2(CC[C@@H]([C@@]34C2CC(C31)[C@]5(C[C@@H]([C@H]6CC4C5C6O)OC)O)O)COC,,,,,,
4018,3084021,Sodium dihydrogenphosphate monohydride,[H-].OP(=O)(O)O.[Na+],,,,,,
4019,3084022,3-(Methoxycarbonyl)-1-methylpyridinium chloride,C[N+]1=CC=CC(=C1)C(=O)OC.[Cl-],,,,,,
4020,3084023,1-Salicylate glucuronide,C1=CC=C(C(=C1)C(=O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O,,,,,,
4021,3084024,Etisazole hydrochloride,CCNC1=NSC2=CC=CC=C21.Cl,,,,,,
4022,3084025,Aminoacetone hydrochloride,CC(=O)CN.Cl,,,,,,
4023,3084026,Strontium sulfate,[O-]S(=O)(=O)[O-].[Sr+2],,,,,,
4024,3084027,Magnesium carbonate hydroxide (Mg5(CO3)4(OH)2),C(=O)([O-])[O-].C(=O)([O-])[O-].C(=O)([O-])[O-].C(=O)([O-])[O-].[Mg+2].[Mg+2].[Mg+2].[Mg+2],,,,,,
4025,3084028,"beta-D-Mannopyranose, 2-(acetylamino)-2-deoxy-",CC(=O)NC1C(C(C(OC1O)CO)O)O.O,,,,,,
4026,3084029,Mercuric nitrate monohydrate,[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].O.[Hg+2],,,,,,
4027,3084030,Barium manganate,[O-][Mn](=O)(=O)[O-].[Ba+2],,,,,,
4028,3084031,CID 3084031,O=[BiH].I,,,,,,
4029,3084032,Potassium tungstate,[O-][W](=O)(=O)[O-].[K+].[K+],,,,,,
4030,3084033,Sodium;carbonic acid;8-hydroxy-7-iodoquinoline-5-sulfonic acid,C1=CC2=C(C(=C(C=C2S(=O)(=O)O)I)O)N=C1.C(=O)(O)O.[Na+],,,,,,
4031,3084034,"Sodium ((4-((4-(anilino)phenyl)(4-(phenylimino)-2,5-cyclohexadien-1-ylidene)methyl)phenyl)amino)benzenesulphonate",CC1=C(C=CC(=C1)C(C2=CC=C(C=C2)NC3=CC=CC=C3)(C4=CC=C(C=C4)NC5=CC=C(C=C5)S(=O)(=O)[O-])O)N.[Na+],,,,,,
4032,3084035,Ergotoxine,CC(C)[C@@]1(C(=O)N2CC(=O)N3CCC[C@H]3[C@@]2(O1)O)NC(=O)[C@H]4CN([C@@H]5CC6=CNC7=CC=CC(=C67)C5=C4)C,,,,,,
4033,3084036,Oxychlorosene,CCCCCCCCCCCCCCC1=CC=C(C=C1)S(=O)(=O)O.OCl,,,,,,
4034,3084037,Cactinomycin,CC[C@H](C)[C@H]1C(=O)N2CCC[C@H]2C(=O)N(CC(=O)N([C@H](C(=O)O[C@@H]([C@@H](C(=O)N1)NC(=O)C3=C(C(=O)C(=C4C3=NC5=C(C=CC(=C5O4)C)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@@H](NC6=O)C(C)C)C)C)C(C)C)C)C)N)C)C(C)C)C)C,,,"['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)', 'Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)', 'Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)']",,,
4035,3084038,Polyethadene,C1CN1.C1C(O1)C2CO2,,,,,,
4036,3084039,"Cellulose, acetate propanoate",CCC(=O)OCC1C(C(C(C(O1)OC(=O)CC)OC(=O)CC)OC(=O)CC)OC2C(C(C(C(O2)COC(=O)CC)OC(=O)CC)OC(=O)CC)OC(=O)CC.CC(=O)OCC1C(C(C(C(O1)OC(=O)C)OC(=O)C)OC(=O)C)OC2C(C(C(C(O2)COC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C.C(C1C(C(C(C(O1)OC2C(OC(C(C2O)O)O)CO)O)O)O)O,,,,,,
4037,3084040,"[4,5,6-Tri(propanoyloxy)-3-[3,4,5-tri(propanoyloxy)-6-(propanoyloxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl propanoate",CCC(=O)OCC1C(C(C(C(O1)OC(=O)CC)OC(=O)CC)OC(=O)CC)OC2C(C(C(C(O2)COC(=O)CC)OC(=O)CC)OC(=O)CC)OC(=O)CC,,,,,,
4038,3084041,"2-[[(2R,3S,4S,5R,6R)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxycarbonyl]benzoic acid",C1=CC=C(C(=C1)C(=O)O)C(=O)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)O)O)O)O,,,,,,
4039,3084042,"9-Octadecenoic acid, 12-hydroxy-, 2-hydroxyethyl ester, (9Z,12R)-",CCCCCCC(CC=CCCCCCCCC(=O)OCCO)O,,,,,,
4040,3084043,Circulin,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N1)CC(C)C)CCN)NC(=O)[C@H](CCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC=O)[C@@H](C)O)CCN)CCN,,,,,,
4041,3084044,Polyphloroglucinol phosphate,C1=C(C=C(C=C1O)OP(=O)(O)O)O,,,,,,
4042,3084045,"(10R,11R,21S)-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),12,17,19,25(28)-pentaene-2,8,14,23-tetrone",C[C@@H]1C=CC(=O)NCC=CC(=C[C@H](CC(=O)CC2=NC(=CO2)C(=O)N3CCCC3C(=O)O[C@@H]1C(C)C)O)C,,,,,,
4043,3084046,Sephadex G 25,C([C@@H]1[C@H]([C@H]([C@H]([C@@H](O1)O)O)O)O)O.C(C(CO)O)O,,,"['Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)']",,,
4044,3084047,"Cellulose, hydroxybutyl methyl ether",CCC(COCC1C(C(C(C(O1)OC2C(OC(C(C2OCC(CC)O)OCC(CC)O)OCC(CC)O)COCC(CC)O)OCC(CC)O)OCC(CC)O)OCC(CC)O)O.COCC1C(C(C(C(O1)OC2C(OC(C(C2OC)OC)OC)COC)OC)OC)OC,,,,,,
4045,3084048,"2-Hydroxybutyl 2,3,6-tris-O-(2-hydroxybutyl)-4-O-[2,3,4,6-tetrakis-O-(2-hydroxybutyl)hexopyranosyl]hexopyranoside",CCC(COCC1C(C(C(C(O1)OC2C(OC(C(C2OCC(CC)O)OCC(CC)O)OCC(CC)O)COCC(CC)O)OCC(CC)O)OCC(CC)O)OCC(CC)O)O,,,,,,
4046,3084049,Sodium hyaluronate,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O)CO)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O)NC(=O)C)O)O.[Na+],,,"['Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)', 'Viscoelastic solutions that are injected into JOINTS in order to alleviate symptoms of joint-related disorders such as OSTEOARTHRITIS. (See all compounds classified as Viscosupplements.)']",,,
4047,3084050,"(2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid",CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O)CO)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O)NC(=O)C)O)O,,,,,,
4048,3084051,Deoxyfrenolicin,CCC[C@@H]1C2=C(C[C@H](O1)CC(=O)O)C(=O)C3=C(C2=O)C(=CC=C3)O,,,,,,
4049,3084052,"Thiotaurine S-(2-aminoethyl) ester, dihydrochloride",C(CSS(=O)(=O)CCN)N.Cl,,,,,,
4050,3084053,"2-Hydroxy-N,N,N-trimethylethan-1-aminium 3-[(1,2,4-trihydroxy-3,3-dimethylbutylidene)amino]propanoate",CC(C)(CO)C(C(=O)NCCC(=O)[O-])O.C[N+](C)(C)CCO,,,,,,
4051,3084054,Glumitocin,CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CS)N,,,,,,
4052,3084055,"sodium;6-[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]carbonylcyclohex-3-ene-1-carboxylic acid",C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)COC(=O)C4CC=CCC4C(=O)O)O)CCC5=CC(=O)C=C[C@]35C)O.[Na+],,,,,,
4053,3084056,(+)-Dolineone,C1C2[C@H](C3=CC4=C(C=C3O1)OCO4)C(=O)C5=C(O2)C=C6C(=C5)C=CO6,,,,,,
4054,3084057,Trimeprazine sulfoxide,CC(CN1C2=CC=CC=C2S(=O)C3=CC=CC=C31)CN(C)C,,,,,,
4055,3084058,Acefylline heptaminol,CC(CCCC(C)(C)O)N.CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(=O)O,,,,,,
4056,3084059,Prochlorperazine Sulfoxide,CN1CCN(CC1)CCCN2C3=CC=CC=C3S(=O)C4=C2C=C(C=C4)Cl,,,,,,
4057,3084060,Asperthecin,C1=C(C(=C(C2=C1C(=O)C3=C(C2=O)C(=CC(=C3O)O)O)O)O)CO,,,,,,
4058,3084061,Metamfepramone hydrochloride,CC(C(=O)C1=CC=CC=C1)N(C)C.Cl,,,,,,
4059,3084062,Flavaphosphine G,CC1=CC2=C(C3=C(C=C(C=C3)N)N=C2C=C1)C4=CC=C(C=C4)N.[N+](=O)([O-])[O-],,,,,,
4060,3084063,9-(4-Aminophenyl)-7-methylacridin-3-amine,CC1=CC2=C(C3=C(C=C(C=C3)N)N=C2C=C1)C4=CC=C(C=C4)N,,,,,,
4061,3084064,Xylaric acid,C1=COC=C(C1=O)CC(=O)O,,,,,,
4062,3084065,"6,6',12-Trimethoxy-2,2'-dimethylberbaman-7-ol (1'beta)-",CN1CCC2=CC(=C3C=C2[C@H]1CC4=CC=C(C=C4)OC5=C(C[C@@H]6C7=C(O3)C(=C(C=C7CCN6C)OC)O)C=CC=C5OC)OC,,,,,,
4063,3084066,Ladanein,COC1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC)O)O,,,,,,
4064,3084067,Cerium(3+) hydrogen sulfate sulfate--water (1/1/1/4),O.O.O.O.OS(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Ce+3],,,,,,
4065,3084068,"2,6-Dihydroxypyridine hydrochloride",C1=CC(=O)NC(=C1)O.Cl,,,,,,
4066,3084069,(S)-2-Amino-4-methylvaleramide HCl,CC(C)CC(C(=O)N)N.[Cl-],,,,,,
4067,3084070,Hexaamminecobalt(3+) trinitrate,[NH2-].[NH2-].[NH2-].[NH2-].[NH2-].[NH2-].[N+](=O)(O)[O-].[Co+3],,,,,,
4068,3084071,"3-[[15-[10-(Diaminomethylideneamino)dec-6-en-2-yl]-5,7,9,23,25,27,31,33,34,35-decahydroxy-10,14,18,22,26,30-hexamethyl-17-oxo-16,37-dioxabicyclo[31.3.1]heptatriaconta-10,12,18,20-tetraen-3-yl]oxy]-3-oxopropanoic acid",CC1CCC(C(C(CC(C(C=CC=C(C(=O)OC(C(C=CC=C(C(CC(CC(CC(CC2CC(C(C(O2)(CC1O)O)O)O)OC(=O)CC(=O)O)O)O)O)C)C)C(C)CCCC=CCCCN=C(N)N)C)C)O)O)C)O,,,,,,
4069,3084072,Olivomycin,C[C@@H]1[C@@H]([C@@H](C[C@@H](O1)OC2=CC(=C3C(=C2)C=C4C[C@H]([C@@H](C(=O)C4=C3O)O[C@@H]5C[C@@H]([C@H]([C@@H](O5)C)O)OC6C[C@@H]([C@H]([C@@H](O6)C)O)O)[C@@H](C(=O)[C@H]([C@@H](C)O)O)OC)O)O[C@H]7C[C@@H]([C@@H]([C@@H](O7)C)OC)O)O,,,"['Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)', 'Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)', 'Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)']",,,
4070,3084073,Lanatoside,C[C@@H]1[C@H]([C@H](CC(O1)O[C@H]2CC[C@@]3([C@H]4CC[C@@]5([C@H](CCC5(C4CCC3C2)O)C6=CC(=O)OC6)C)C)O)OC7C[C@@H]([C@@H]([C@H](O7)C)OC8C[C@@H]([C@@H]([C@H](O8)C)OC9[C@H]([C@@H]([C@H]([C@@H](O9)CO)O)O)O)OC(=O)C)O,,,,,,
4071,3084074,CID 3084074,CC=CC1C(O1)(C)C2=CC(=O)C3=C(O2)C4=C(C=C3C)C(=O)C5=C(C4=O)C(=C(C=C5[C@H]6C[C@H]([C@@H]([C@H](O6)C)O)N(C)C)[C@H]7C[C@]([C@@H]([C@@H](O7)C)O)(C)N(C)C)O,,,,,,
4072,3084075,CID 3084075,C1=CC(=CC=C1C2=C(C(=C3C(=CC(=O)C(=C3O2)O[C@@H]4[C@H]([C@@H]([C@H]([C@@H](O4)CO)O)O)O)O)O)O)O,,,,,,
4073,3084076,"Methyl 3-[[2-[[2-[[amino-[1-[2-[[3,3-dimethyl-2-(4-methylpent-2-enoylamino)butanoyl]amino]-3-methylbutanoyl]-3,4-dimethylpyrrolidin-2-yl]methylidene]amino]acetyl]amino]-3-phenylbutanoyl]amino]-3-(1,3-thiazol-2-yl)propanoate",CC1CN(C(C1C)C(=NCC(=O)NC(C(C)C2=CC=CC=C2)C(=O)NC(CC(=O)OC)C3=NC=CS3)N)C(=O)C(C(C)C)NC(=O)C(C(C)(C)C)NC(=O)C=CC(C)C,,,,,,
4074,3084077,Amanitins,CCC(C)C1C(=O)NCC(=O)NC2CSC3=C(CC(C(=O)NCC(=O)N1)NC(=O)C(NC(=O)C4CC(CN4C(=O)C(NC2=O)CC(=O)O)O)C(C)C(CO)O)C5=C(N3)C=C(C=C5)O,,,"['Compounds that inhibit cell production of DNA or RNA. (See all compounds classified as Nucleic Acid Synthesis Inhibitors.)', 'Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)', 'Substances which, when ingested, inhaled, or absorbed, or when applied to, injected into, or developed within the body in relatively small amounts may, by their chemical action, cause damage to structure or disturbance of function. (From Dorland, 27th ed) (See all compounds classified as Poisons.)']",,,
4075,3084078,"Calcium;6-[2,2-bis[di(propan-2-yl)amino]acetyl]oxy-2,3,4,5-tetrahydroxyhexanoic acid",CC(C)N(C(C)C)C(C(=O)OCC(C(C(C(C(=O)O)O)O)O)O)N(C(C)C)C(C)C.[Ca+2],,,,,,
4076,3084079,CID 3084079,CC(CCC=C(C)C)[C@H]1CC[C@@]2([C@@]1(CC[C@]34C2CCC5[C@]3(C4)CC[C@@H](C5(C)C)OC(=O)C=CC6=CC(=C(C=C6)O)OC)C)C,,,,,,
4077,3084080,"1,3-Dimethyl-2-(3-methylocta-1,3-dienyl)-4-oxocyclohex-2-ene-1-carboxylic acid",CCCCC=C(C)C=CC1=C(C(=O)CCC1(C)C(=O)O)C,,,,,,
4078,3084081,"Methyl 3-[[2-[[2-[[amino-[1-[2-[[3,3-dimethyl-2-(4-methylpent-2-enoylamino)butanoyl]amino]-3-methylbutanoyl]pyrrolidin-2-yl]methylidene]amino]acetyl]amino]-3-phenylbutanoyl]amino]-3-(1,3-thiazol-2-yl)propanoate",CC(C)C=CC(=O)NC(C(=O)NC(C(C)C)C(=O)N1CCCC1C(=NCC(=O)NC(C(C)C2=CC=CC=C2)C(=O)NC(CC(=O)OC)C3=NC=CS3)N)C(C)(C)C,,,,,,
4079,3084082,CID 3084082,C[C@@H]1[C@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2OC)O[C@@H]3[C@H](O[C@H](C[C@@H]3OC)O[C@H]4CC[C@]5(C(C4)CCC6C5[C@@H]([C@H]([C@]7([C@@]6(CC[C@@H]7C(=O)C)O)C)OC(=O)C=CC8=CC=CC=C8)OC(=O)C)C)C)C)O)OC)O,,,,,,
4080,3084083,"6-(Acetyloxy)-4a,5,6,7,8,8a-hexahydro-8-(3-hydroxy-3-methyl-4-pentenyl)-4,4a,7,8-tetramethyl-2(1H)-naphthalenone",CC1C(CC2(C(C1(C)CCC(C)(C=C)O)CC(=O)C=C2C)C)OC(=O)C,,,,,,
4081,3084084,"6-(Acetyloxy)-8-(3-(acetyloxy)-3-methyl-4-pentenyl)-4a,5,6,7,8,8a-hexahydro-4,4a,7,8-tetramethyl-2(1H)-naphthalenone",CC1C(CC2(C(C1(C)CCC(C)(C=C)OC(=O)C)CC(=O)C=C2C)C)OC(=O)C,,,,,,
4082,3084085,"8-(3-(Acetyloxy)-3-methyl-4-pentenyl)-4a,5,6,7,8,8a-hexahydro-6-hydroxy-4,4a,7,8-tetramethyl-2(1H)-naphthalenone",CC1C(CC2(C(C1(C)CCC(C)(C=C)OC(=O)C)CC(=O)C=C2C)C)O,,,,,,
4083,3084086,"1-[2-hydroxy-4-methoxy-6-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3-(4-hydroxyphenyl)propan-1-one",COC1=CC(=C(C(=C1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)CO)O)O)O)C(=O)CCC3=CC=C(C=C3)O)O,,,,,,
4084,3084087,Penitrem B,CC(=C)[C@@H]1[C@@H]([C@@H]2[C@@]3(O2)[C@@H](O1)CC[C@]4([C@]3(CC[C@@H]5[C@@]4(C6=C7[C@H]5OC([C@H]8C[C@H]9[C@@H]8C1=C(CC9=C)C=CC(=C17)N6)(C)C)C)O)C)O,,,,,,
4085,3084088,"(8,10-Diacetyloxy-4,8-dimethyl-7,13-dioxo-3,14-dioxatricyclo[9.3.0.02,4]tetradec-11-en-12-yl)methyl acetate",CC(=O)OCC1=C2C(CC(C(=O)CCC3(C(C2OC1=O)O3)C)(C)OC(=O)C)OC(=O)C,,,,,,
4086,3084089,Partricin,C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)OC2CC3C(C(CC(O3)(CC(CC(CC(CC(CC(=O)CC(CC(=O)OC(C(C=CC=CC=CC=CC=CC=CC=C2)C)C(C)CCC(CC(=O)C4=CC=C(C=C4)N)O)O)O)O)O)O)O)O)C(=O)O)O)N)O,,,,,,
4087,3084090,CID 3084090,CCOP(=O)(CC)OC(=CCl)C1=CC(=C(C=C1)Cl)Cl,,,,,,
4088,3084091,"(2R,3S,4R,5R)-2-[(1S,2R,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol",C[C@@]1(CO[C@@H]([C@H]([C@H]1NC)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@H]2O)O[C@@H]3[C@@H](CC[C@H](O3)CN)N)N)N)O,,,,,,
4089,3084092,Fusafungine,CC(C)[C@H]1C(=O)OC(C(=O)N([C@H](C(=O)OC(C(=O)N([C@H](C(=O)OC(C(=O)N1C)C(C)C)C(C)C)C)C(C)C)C(C)C)C)C(C)C,,,['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)'],,,
4090,3084093,Polyoxin,C1=C(C(=O)NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)C(C=O)N)O)O)C(=O)O,,,,,,
4091,3084094,Monamycin,CC(C)CC1C(=O)C2CC(CN2)C(=O)NC(C(=O)OC(C(=O)N3C(CCCN3)C(=O)N4CC(CCN4)C(=O)N1C)C(C)C)C(C)C,,,,,,
4092,3084095,Ammonium tungstate(VI),[NH4+].[NH4+].[O-][W](=O)(=O)[O-],,,,,,
4093,3084096,Calcium;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;piperazine,C1CNCCN1.C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O.[Ca+2],,,,,,
4094,3084097,Sitosterols,CC[C@@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4[C@@]3(CC[C@@H](C4)O)C)C)C(C)C,,,,,,
4095,3084098,Calcium tin oxide,[O-][Sn](=O)[O-].[Ca+2],,,,,,
4096,3084099,Silicon nitride,N12[Si]34N5[Si]16N3[Si]25N46,,,"['Toxic air-borne matter related to work performed They are usually produced by the specific nature of the occupation. (See all compounds classified as Air Pollutants, Occupational.)']",,,
4097,3084100,"aluminum;(2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol;hydroxide",C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)CO)O)O)CO)O)O)O)O.[OH-].[Al+3],,,,,,
4098,3084101,Copper chromite,O=[Cr]O[Cr]=O.O=[Cu].O=[Cu],,,,,"[""Copper is mainly absorbed through the gastrointestinal tract, but it can also be inhalated and absorbed dermally. It passes through the basolateral membrane, possibly via regulatory copper transporters, and is transported to the liver and kidney bound to serum albumin. The liver is the critical organ for copper homoeostasis. In the liver and other tissues, copper is stored bound to metallothionein, amino acids, and in association with copper-dependent enzymes, then partitioned for excretion through the bile or incorporation into intra- and extracellular proteins. The transport of copper to the peripheral tissues is accomplished through the plasma attached to serum albumin, ceruloplasmin or low-molecular-weight complexes. Copper may induce the production of metallothionein and ceruloplasmin. The membrane-bound copper transporting adenosine triphosphatase (Cu-ATPase) transports copper ions into and out of cells. Physiologically normal levels of copper in the body are held constant by alterations in the rate and amount of copper absorption, compartmental distribution, and excretion. Chromium is absorbed from oral, inhalation, or dermal exposure and distributes to nearly all tissues, with the highest concentrations found in kidney and liver. Bone is also a major storage site and may contribute to long-term retention. Hexavalent chromium's similarity to sulfate and chromate allow it to be transported into cells via sulfate transport mechanisms. Inside the cell, hexavalent chromium is reduced first to pentavalent chromium, then to trivalent chromium by many substances including ascorbate, glutathione, and nicotinamide adenine dinucleotide. Chromium is almost entirely excreted with the urine. (A12, L16, L277, L279)""]",
4099,3084102,Ammonium molybdenum oxide,[NH4+].O.[O-2].[Mo],,,,,,
4100,3084103,Ammonium hexafluoroniobate(1-),[NH4+].[F-].F[Nb](F)(F)(F)F,,,,,,
4101,3084104,Tris(ethylenediamine)platinum(IV) chloride,C(C[NH-])[NH-].C(C[NH-])[NH-].C(C[NH-])[NH-].[Cl-].[Pt],,,,,,
4102,3084105,CID 3084105,CC1=[C-][C-]=[C-][CH-]C1=N.[C-]#[O+].[C-]#[O+].[C-]#[O+].[Cr],,,,,,
4103,3084106,CID 3084106,CC1=C([C-]=[C-][C-]=C1)[NH-],,,,,,
4104,3084107,"Dichlorozirconium(2+);1-methylcyclopenta-1,3-diene;5-methylcyclopenta-1,3-diene",CC1C=C[C-]=C1.CC1=C[C-]=CC1.Cl[Zr+2]Cl,,,,,,
4105,3084108,Hexasodium tungstate hydrate,[O-][W](=O)(=O)[O-].[O-][W](=O)(=O)[O-].[O-][W](=O)(=O)[O-].O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,,,,,
4106,3084109,CID 3084109,CO[C-]=O.C1=CC=C(C(=C1)C(=O)O)O.C(C(C(C(C(C(=O)O)O)O)O)O)O.[Na+].[Al+3],,,,,,
4107,3084110,"N-[(4,6-dichloro-1,3,5-triazin-2-yl)methyl]-6-(naphthalen-2-yldiazenyl)naphthalen-2-amine",C1=CC=C2C=C(C=CC2=C1)N=NC3=CC4=C(C=C3)C=C(C=C4)NCC5=NC(=NC(=N5)Cl)Cl,,,,,,
4108,3084111,CID 3084111,CC(=[OH+])CC(=[OH+])C.C1C[C-]=[C-]CC[C-]=[C-]1.[Rh],,,,,,
4109,3084112,"Sodium;4-ethyl-1,3-dimethyl-8-sulfanyl-7,9-diazaspiro[4.5]decane-6,10-dione",CCC1C(CC(C12C(=O)NC(NC2=O)S)C)C.[Na+],,,,,,
4110,3084113,Spirobarbital,CCC1C(CC(C12C(=O)NC(NC2=O)S)C)C,,,,,,
4111,3084114,Ferric fructose,C1[C@H]([C@H]([C@@H]([C@@](O1)(CO)O)O)O)O.[K+].[Fe+3],,,,,,
4112,3084115,Cobaltocenium hexafluorophosphate,C.[CH-]1C=CC=C1.[CH-]1C=CC=C1.F[P-](F)(F)(F)(F)F.[Co+3],,,,,,
4113,3084116,Aluminum magnesium silicate,[O-][Si]([O-])([O-])[O-].[Mg+2].[Al+3],,,,,,
4114,3084117,"Uranium, tetrakis(tetrahydroborato(1-))-",B.B.B.B.[U],,,,,,
4115,3084118,"Manganese, bis((2xi)-D-gluco-heptonato)-",C([C@@H]([C@@H]([C@@H]([C@@H]([C@@H](C(=O)O)O)O)O)O)O)O,,,,,,
4116,3084119,"(2S,3R,4S,5S,6R)-2-[(2R,3R,4R,5R,6R)-6-[(6R,7S,9S,10S,13S,15R,16R)-10,15-dihydroxy-7,9,13-trimethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol",C[C@H]1C2C(CC3[C@@]2([C@H](CC4C3CCC5[C@@]4(C[C@H]([C@@H](C5)O[C@H]6[C@@H]([C@H]([C@H]([C@H](O6)CO)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O)O)O)C)O)C)O[C@]18CCCCO8,,,,,,
4117,3084120,CID 3084120,[CH-]=[NH+]C1=CC2C(C1)(O2)C=CC(=O)O,,,,,,
4118,3084121,3-[3-(Methylideneamino)-6-oxabicyclo[3.1.0]hex-3-en-1-yl]prop-2-enoic acid,C=NC1=CC2C(C1)(O2)C=CC(=O)O,,,,,,
4119,3084122,Lutenurine,C[C@@H]1CC[C@H](N2[C@H]1CC[C@@]3([C@H]2O)C[C@]4(C[C@H]5[C@@H](CC[C@H](N5[C@H](C4)O)C6=COC=C6)C)SC3)C7=COC=C7.CC1CC[C@H](N2[C@H]1CCC3(C2)CC4(C[C@H]5C(CC[C@H](N5[C@H](C4)O)C6=COC=C6)C)SC3)C7=COC=C7,,,,,,
4120,3084123,CID 3084123,CC1CC[C@H](N2[C@H]1CCC3(C2)CC4(C[C@H]5C(CC[C@H](N5[C@H](C4)O)C6=COC=C6)C)SC3)C7=COC=C7,,,,,,
4121,3084124,CID 3084124,C[C@@H]1CC[C@H](N2[C@H]1CC[C@@]3([C@H]2O)C[C@]4(C[C@H]5[C@@H](CC[C@H](N5[C@H](C4)O)C6=COC=C6)C)SC3)C7=COC=C7,,,,,,
4122,3084125,Desertomycin,CC1CCC=C(C(=O)OC(CC=CC(CC(CC(C(C(C(C(CC(CC(CC(C(C=C(C(C(C=CC(C(C=CCCC(C(C1O)C)O)C)O)C)O)C)O[C@@H]2[C@@H]([C@@H]([C@H]([C@@H](O2)CO)O)O)O)O)O)O)O)C)O)C)O)O)O)C(C)C(CCCN)O)C,,,,,,
4123,3084126,Verticillin,C[C@]12C(=O)N3[C@@H]4[C@](C[C@@]3(C(=O)N1C)SS2)(C5=CC=CC=C5N4)[C@]67C[C@]89C(=O)N([C@](C(=O)N8[C@H]6NC1=CC=CC=C71)(SS9)C)C,,,,,,
4124,3084127,CID 3084127,CC=C(C)C(=O)O[C@@H]1C[C@@H]([C@H]2CC(=O)C(=C2C[C@@H]1C(C)(C)OC(=O)C)C)C,,,,,,
4125,3084128,Tocinamide,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CS)N,,,,,,
4126,3084129,Terbuprol,CC(C)(C)OCC(COC)O,,,,,,
4127,3084130,"Carbamodithioic acid, (4-methylphenyl)-, monoammonium salt",CC1=CC=C(C=C1)NC(=S)S,,,,,,
4128,3084131,Paulownin,C1[C@@H]2[C@H](OC[C@@]2([C@H](O1)C3=CC4=C(C=C3)OCO4)O)C5=CC6=C(C=C5)OCO6,,,,,,
4129,3084132,Propyl aminoacetate HCl,CCCOC(=O)C[NH3+].[Cl-],,,,,,
4130,3084133,Thorium(4+) acetate,CC(=O)O.[Pa],,,,,,
4131,3084134,(4R)-4-methylhept-1-ene,CCC[C@@H](C)CC=C,,,,,,
4132,3084135,"3,7,12-Trihydroxy-N-(2-phosphonoethyl)cholan-24-imidic acid",CC(CCC(=O)NCCP(=O)(O)O)[C@H]1CCC2[C@@]1([C@H](CC3C2[C@@H](CC4[C@@]3(CC[C@H](C4)O)C)O)O)C,,,,,,
4133,3084136,Yttrium(III) Oxalate Nonahydrate,C(=O)(C(=O)[O-])[O-].C(=O)(C(=O)[O-])[O-].C(=O)(C(=O)[O-])[O-].O.O.O.O.O.O.O.O.O.[Y+3].[Y+3],,,,,,
4134,3084137,"1,2-Benzenediol, 4-methyl-, diacetate",CC1=CC(=C(C=C1)OC(=O)C)OC(=O)C,,,,,,
4135,3084138,CID 3084138,C1=CC=NC(=C1)N=NC2=C(C=C(C=C2)O)[O-].[Na+],,,,,,
4136,3084139,"3,5-Dichloroaniline hydrochloride",C1=C(C=C(C=C1Cl)Cl)N.Cl,,,,,,
4137,3084140,"Acetamide, N-(4-((6-methoxy-2-methyl-4-pyrimidinyl)aminosulfonyl)phenyl)-",CC1=NC(=CC(=N1)OC)NS(=O)(=O)C2=CC=C(C=C2)NC(=O)C,,,,,,
4138,3084141,CID 3084141,CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)(O)O[C@@H](C)CNC(=O)CC[C@@]4([C@H](C5[C@]6([C@@]([C@@H](C(=N6)/C(=C\7/[C@@]([C@@H](C(=CC8=NC(=C(C4=N5)C)[C@H](C8(C)C)CCC(=O)N)N7)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[60Co+3],,,,,,
4139,3084142,"[(2R,5S,10S,13S,17S)-2,10,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] heptanoate",CCCCCCC(=O)O[C@H]1CCC2[C@@]1(CCC3C2CC[C@@H]4[C@@]3(C[C@H](C(=O)C4)C)C)C,,,,,,
4140,3084143,Diethyl aminomalonate hydrochloride,CCOC(=O)C(C(=O)OCC)N.Cl,,,,,,
4141,3084144,"Thallium chloride (TlCl3), tetrahydrate",O.[Cl-].[Cl-].[Cl-].[Tl+3],,,,,,
4142,3084145,Thallium(3+);trinitrate;hexahydrate,[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].O.O.O.O.O.O.[Tl+3],,,,,,
4143,3084146,CID 3084146,OI(=O)=O.[O-]I(=O)=O.[K+],,,,,,
4144,3084147,"Cadmium dibromide, tetrahydrate",O.O.O.O.[Br-].[Br-].[Cd+2],,,,,,
4145,3084148,Indium(III) nitrate hydrate,[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].O.[In+3],,,,,,
4146,3084149,Silver sulfite,[O-]S(=O)[O-].[Ag+].[Ag+],,,,,,
4147,3084150,Sodium pyrophosphate decahydrate,O.O.O.O.O.O.O.O.O.O.[O-]P(=O)([O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
4148,3084151,CID 3084151,CC1=CCCC23[C@@H](O2)[C@H](C4=C(C1)OC=C4C)OC3=O,,,,,,
4149,3084152,Trinickel bis(arsenate),O[As](=O)(O)O.[Ni],,,,,"['Nickel is absorbed mainly through the lungs and gastrointestinal tract. Once in the body it enters the bloodstream, where it binds to albumin, L-histidine, and _2-macroglobulin. Nickel tends to accumulate in the lungs, thyroid, kidney, heart, and liver. Absorbed nickel is excreted in the urine, wherease unabsorbed nickel is excreted in the faeces. Arsenic is absorbed mainly by inhalation or ingestion, as to a lesser extent, dermal exposure. It is then distributed throughout the body, where it is reduced into arsenite if necessary, then methylated into monomethylarsenic (MMA) and dimethylarsenic acid (DMA) by arsenite methyltransferase. Arsenic and its metabolites are primarily excreted in the urine. Arsenic is known to induce the metal-binding protein metallothionein, which decreases the toxic effects of arsenic and other metals by binding them and making them biologically inactive, as well as acting as an antioxidant. (L20, L41)']",
4150,3084153,Copper monofluoride,F[Cu],,,,,"['Copper is mainly absorbed through the gastrointestinal tract, but it can also be inhalated and absorbed dermally. It passes through the basolateral membrane, possibly via regulatory copper transporters, and is transported to the liver and kidney bound to serum albumin. The liver is the critical organ for copper homoeostasis. In the liver and other tissues, copper is stored bound to metallothionein, amino acids, and in association with copper-dependent enzymes, then partitioned for excretion through the bile or incorporation into intra- and extracellular proteins. The transport of copper to the peripheral tissues is accomplished through the plasma attached to serum albumin, ceruloplasmin or low-molecular-weight complexes. Copper may induce the production of metallothionein and ceruloplasmin. The membrane-bound copper transporting adenosine triphosphatase (Cu-ATPase) transports copper ions into and out of cells. Physiologically normal levels of copper in the body are held constant by alterations in the rate and amount of copper absorption, compartmental distribution, and excretion. (L277, L279)']",
4151,3084154,CID 3084154,CO[C@H]1CC=C2CCN3[C@]2(C1)C4=C(CC3)COC4=O,,,,,,
4152,3084155,Silver vanadium trioxide,[O-][V](=O)=O.[Ag+],,,,,,
4153,3084156,Ytterbium(3+) perchlorate,O.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[Yb+3],,,,,,
4154,3084157,Bunamidine oxynaphthoate,CCCCCCOC1=CC=C(C2=CC=CC=C21)C(=N)N(CCCC)CCCC.C1=CC=C2C=C(C(=CC2=C1)C(=O)O)O,,,,,,
4155,3084158,Caesium dichromate,[O-][Cr](=O)(=O)O[Cr](=O)(=O)[O-].[Cs+].[Cs+],,,,,,
4156,3084159,Einecs 236-924-8,C1C2=C(C=CC(=C2)N)C3=C1C=C(C=C3)N.Cl,,,,,,
4157,3084160,Samarium(3+) perchlorate,O.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[Sm+3],,,,,,
4158,3084161,Magnesium tungsten oxide,[O-][W](=O)(=O)[O-].[Mg+2],,,,,,
4159,3084162,2-(Sulfooxy)benzamide,C1=CC=C(C(=C1)C(=O)N)OS(=O)(=O)O,,,,,,
4160,3084163,"Rhenate (ReO41-), ammonium, (T-4)-",[NH4+].[O-][Re](=O)(=O)=O,,,,,,
4161,3084164,Prozapine hydrochloride,C1CCCN(CC1)CCC(C2=CC=CC=C2)C3=CC=CC=C3.Cl,,,,,,
4162,3084165,Nickel dithiocyanate,C(#N)[S-].C(#N)[S-].O.O.O.O.O.O.[Ni+2],,,,,,
4163,3084166,CID 3084166,O[As](=O)(O)O.[BiH3],,,,,,
4164,3084167,2-Methyl-3-oxoandrostan-17-yl hexanoate,CCCCCC(=O)O[C@H]1CCC2[C@@]1(CCC3C2CC[C@@H]4[C@@]3(C[C@H](C(=O)C4)C)C)C,,,,,,
4165,3084168,Barium dimetaphosphate,[O-][P+](=O)[O-].[O-][P+](=O)[O-].[Ba+2],,,,,,
4166,3084169,Phosphonic acid,O[P+](=O)O,,,,,,
4167,3084170,Magnesium molybdate,[O-][Mo](=O)(=O)[O-].[Mg+2],,,,,,
4168,3084171,"Aluminum, tris(tetrahydroborato(1-)-kappaH,kappaH')-, (OC-6-11)-",B.B.B.[AlH3],,,,,,
4169,3084172,CID 3084172,CC1=C2CC3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=CC=CC=C14)O)O)N(C)C.Cl,,,,,,
4170,3084173,CID 3084173,CC1=C2CC3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=CC=CC=C14)O)O)N(C)C,,,,,,
4171,3084174,Altenin,CCOC(=O)C1CC(=O)C(O1)(C(C)O)O,,,,,,
4172,3084175,Hexothiocaine,CCCCCCOC1=C(C=CC(=C1)N)C(=S)OCCN(CC)CC,,,,,,
4173,3084176,Terbium(3+) perchlorate,O.O.O.O.O.O.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[Tb+3],,,,,,
4174,3084177,"Perchloric acid,gadolinium(3+) salt (8CI,9CI)",O.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[Gd+3],,,,,,
4175,3084178,Holmium(3+) perchlorate,O.O.O.O.O.O.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[Ho+3],,,,,,
4176,3084179,Yttrium perchlorate,O.O.O.O.O.O.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[Y+3],,,,,,
4177,3084180,"Methyl 2-hydroxy-19-methyl-1,2-didehydroformosanan-16-carboxylate",C[C@@H]1[C@H]2CN3CC[C@]4([C@H]3C[C@@H]2C(=CO1)C(=O)OC)C5=CC=CC=C5NC4=O,,,,,,
4178,3084181,Tris(2-thenoyltrifluoroacetonate)gadolinium,C1=CSC(=C1)C(=[OH+])CC(=[OH+])C(F)(F)F.C1=CSC(=C1)C(=[OH+])CC(=[OH+])C(F)(F)F.C1=CSC(=C1)C(=[OH+])CC(=[OH+])C(F)(F)F.[Gd],,,,,,
4179,3084182,Tris(2-thenoyltrifluoroacetonate)samarium,C1=CSC(=C1)C(=[OH+])CC(=[OH+])C(F)(F)F.C1=CSC(=C1)C(=[OH+])CC(=[OH+])C(F)(F)F.C1=CSC(=C1)C(=[OH+])CC(=[OH+])C(F)(F)F.[Sm],,,,,,
4180,3084183,Tris(2-thenoyltrifluoroacetonate)terbium,C1=CSC(=C1)C(=[OH+])CC(=[OH+])C(F)(F)F.C1=CSC(=C1)C(=[OH+])CC(=[OH+])C(F)(F)F.C1=CSC(=C1)C(=[OH+])CC(=[OH+])C(F)(F)F.[Tb],,,,,,
4181,3084184,CID 3084184,COC1=CC2=C(C=C1)OC3=C(C(=C(C(=O)C3=C2O)OC)OC)OC,,,,,,
4182,3084185,3-Hydroxy-2-pyridinemethanol hydrochloride,C1=CC(=C(N=C1)CO)O.Cl,,,,,,
4183,3084186,"Tris(pentane-2,4-dionato-O,O')lanthanum",CC(=[OH+])CC(=[OH+])C.CC(=[OH+])CC(=[OH+])C.CC(=[OH+])CC(=[OH+])C.[La],,,,,,
4184,3084187,CID 3084187,COC1=CC(=O)C2=C(C(=C(OC2=C1)C3=CC(=C(C(=C3)OC)OC)O)OC)O,,,,,,
4185,3084188,CID 3084188,C[C@@]1(C2CC3[C@@H](C(=O)C(=C(N)O)C(=O)[C@]3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)N(C)C)O,,,,,,
4186,3084189,Praseodymium phosphate,[O-]P(=O)([O-])[O-].[Pr+3],,,,,,
4187,3084190,"Terbium, tris(1-phenyl-1,3-butanedionato)-",CC(=[OH+])CC(=[OH+])C1=CC=CC=C1.CC(=[OH+])CC(=[OH+])C1=CC=CC=C1.CC(=[OH+])CC(=[OH+])C1=CC=CC=C1.[Tb],,,,,,
4188,3084191,(3H)Phosphoric acid,[2H]OP(=O)(O[2H])O[2H],,,,,,
4189,3084192,Dehydroemetine (+-)-form dihydrochloride,CCC1=C(C[C@H]2C3=CC(=C(C=C3CCN2C1)OC)OC)C[C@@H]4C5=CC(=C(C=C5CCN4)OC)OC.Cl,,,,,,
4190,3084193,Einecs 238-328-3,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(=O)O.C(C(CO)(CO)N)O,,,,,,
4191,3084194,Thioctate trometamol,C1CSSC1CCCCC(=O)O.C(C(CO)(CO)N)O,,,,,,
4192,3084195,N-Acetyl-S-propyl-L-cysteine,CCCSC[C@@H](C(=O)O)NC(=O)C,,,,,,
4193,3084196,CID 3084196,CCC1=C(C2=NC1=CC3=C(C4=C(CC(=C5[C@H]([C@@H](C(=CC6=NC(=C2)C(=C6C)C=C)N5)C)CCC(=O)OCC=C(C)CCCC(C)CCCC(C)CCCC(C)C)C4=N3)O)C)C,,,,,,
4194,3084197,CID 3084197,C1=CC=C2C=C(C=CC2=C1)OP(=O)(O)[O-].[Na+],,,,,,
4195,3084198,"Calcium;4-oxo-4-[[2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydrochromen-6-yl]oxy]butanoic acid",CC1=C(C(=C(C2=C1OC(CC2)(C)CCCC(C)CCCC(C)CCCC(C)C)C)OC(=O)CCC(=O)O)C.[Ca+2],,,,,,
4196,3084199,"Nitric acid, praseodymium(3+) salt, pentahydrate",[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].O.O.O.O.O.[Pr+3],,,,,,
4197,3084200,Manganese oxyquinolate,C1=CC2=C(C(=C1)O)N=CC=C2.C1=CC2=C(C(=C1)O)N=CC=C2.[Mn],,,,,,
4198,3084201,"Phosphorothioic acid, O-(3-chlorophenyl) O,O-dimethyl ester",COP(=S)(OC)OC1=CC(=CC=C1)Cl,,,,,,
4199,3084202,"Tris(pentane-2,4-dionato-O,O')neodymium",CC(=[OH+])CC(=[OH+])C.CC(=[OH+])CC(=[OH+])C.CC(=[OH+])CC(=[OH+])C.[Nd],,,,,,
4200,3084203,Lutetium(3+) perchlorate,O.O.O.O.O.O.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[Lu+3],,,,,,
4201,3084204,"Tris(1,1,1-trifluoropentane-2,4-dionato-O,O')rhodium",CC(=[OH+])CC(=[OH+])C(F)(F)F.CC(=[OH+])CC(=[OH+])C(F)(F)F.CC(=[OH+])CC(=[OH+])C(F)(F)F.[Rh],,,,,,
4202,3084205,"6-[1-[(4-Methylphenyl)methyl]piperidin-4-yl]-6-phenylpiperidine-2,3-dione",CC1=CC=C(C=C1)CN2CCC(CC2)C3(CCC(=O)C(=O)N3)C4=CC=CC=C4,,,,,,
4203,3084206,Tiapirinol,CC1=NC=C(C(=C1O)C2NC(CCS2)C(=O)O)CO,,,,,,
4204,3084207,Einecs 238-856-4,CCC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CC(C)N(C)C.OP(=O)(O)O,,,,,,
4205,3084208,(Cyclopropylmethyl)triphenylphosphonium bromide,C1CC1C[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4.[Br-],,,,,,
4206,3084209,Cyclopropylmethyltriphenylphosphonium,C1CC1C[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
4207,3084210,Hexadecyltriphenylphosphonium bromide,CCCCCCCCCCCCCCCC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3.[Br-],,,,,,
4208,3084211,Cetyltriphenylphosphonium,CCCCCCCCCCCCCCCC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
4209,3084212,CID 3084212,C[C@H]1C=CC=C(C(=O)NC2=CC(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(OC=C[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C.[Na+],,,,,,
4210,3084213,"7-[(6R)-6,7-dihydroxy-3,7-dimethyloct-2-enoxy]chromen-2-one",CC(=CCOC1=CC2=C(C=C1)C=CC(=O)O2)CC[C@H](C(C)(C)O)O,,,,,,
4211,3084214,Sulfuric acid--2-amino-2-deoxyhexopyranose (1/1),C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)N)O)O)O.OS(=O)(=O)O,,,,,,
4212,3084215,2-Amino-2-deoxyhexopyranose--hydrogen iodide (1/1),C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)N)O)O)O.I,,,,,,
4213,3084216,Aurasperone A,CC1=CC(=O)C2=C(O1)C=C3C=C(C(=C(C3=C2O)OC)C4=C5C(=C(C6=C4C=C(C=C6OC)OC)O)C(=O)C=C(O5)C)OC,,,,,,
4214,3084217,tert-Butyl 3-phenyl-L-alaninate hydrochloride,CC(C)(C)OC(=O)C(CC1=CC=CC=C1)N.Cl,,,,,,
4215,3084218,3-Aminobenzoic acid hydrochloride,C1=CC(=CC(=C1)N)C(=O)O.Cl,,,,,,
4216,3084219,"N-Octyl-N,N-dimethyl-3-ammonio-1-propanesulfonate",CCCCCCCC[N+](C)(C)CCCS(=O)(=O)[O-],,,,,,
4217,3084220,Dimethyl-octyl-(3-sulfopropyl)azanium,CCCCCCCC[N+](C)(C)CCCS(=O)(=O)O,,,,,,
4218,3084221,"Sulfuric acid, cadmium salt (1:1), hydrate",O.O.O.O.O.O.O.O.[O-]S(=O)(=O)[O-].[Cd+2],,,,,,
4219,3084222,CID 3084222,C(=[OH+])(N)N.C(=[OH+])(N)N.C(=[OH+])(N)N.C(=[OH+])(N)N.C(=[OH+])(N)N.C(=[OH+])(N)N.OS(=O)(=O)O.[Al+3].I[IH]I,,,,,,
4220,3084223,Dichloroplatinum;diethylsulfanium,CC[SH+]CC.CC[SH+]CC.Cl[Pt]Cl,,,,,,
4221,3084224,Oxonantenine,COC1=C(C2=C3C(=C1)C=CN=C3C(=O)C4=CC5=C(C=C42)OCO5)OC,,,,,,
4222,3084225,CID 3084225,[ClH3].Cl,,,,,,
4223,3084226,CID 3084226,[ClH3],,,,,,
4224,3084227,Rhazidine,CCC12CCC[N+]3(C1)CCC4(C3(CC2)NC5=CC=CC=C54)O,,,,,,
4225,3084228,Nornantenine,COC1=C(C2=C3C(CC4=CC5=C(C=C42)OCO5)NCCC3=C1)OC,,,,,,
4226,3084229,CID 3084229,C1=CC2=C(C=C1O)OC3=C4C=C(C(=O)C=C4OC(=C23)O)O,,,,,,
4227,3084230,Prop-2-ynylamine hydrochloride,C#CC[NH3+].[Cl-],,,,,,
4228,3084231,"2-Methoxy-6-propylcyclohexa-2,5-diene-1,4-dione",CCCC1=CC(=O)C=C(C1=O)OC,,,,,,
4229,3084232,CID 3084232,C1=CC=C(C(=C1)C(=O)[O-])O.[Al+3],,,,,,
4230,3084233,"Ytterbium, tris(2,2,6,6-tetramethyl-3,5-heptanedionato-kappaO3,kappaO5)-, (OC-6-11)-",CC(C)(C)C(=[OH+])CC(=[OH+])C(C)(C)C.CC(C)(C)C(=[OH+])CC(=[OH+])C(C)(C)C.CC(C)(C)C(=[OH+])CC(=[OH+])C(C)(C)C.[Yb],,,,,,
4231,3084234,Tetrabutylammonium tetraphenylborate,[B-](C1=CC=CC=C1)(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4.CCCC[N+](CCCC)(CCCC)CCCC,,,,,,
4232,3084235,Terbuficin,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C(C2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C)C(=O)O,,,,,,
4233,3084236,"Phosphonothioic acid, methyl-, O,S-dibutyl ester",CCCCOP(=O)(C)SCCCC,,,,,,
4234,3084237,Tetramethylenebis(triphenylphosphonium) dibromide,C1=CC=C(C=C1)[P+](CCCC[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6.[Br-].[Br-],,,,,,
4235,3084238,CID 3084238,CS(=O)CCCC(=NOS(=O)(=O)[O-])S[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O.[K+],,,,,,
4236,3084239,Thallium(3+) perchlorate,O.O.O.O.O.O.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[Tl+3],,,,,,
4237,3084240,Cerium(3+);4-oxopent-2-en-2-olate,CC(=CC(=O)C)[O-].CC(=CC(=O)C)[O-].CC(=CC(=O)C)[O-].[Ce+3],,,,,,
4238,3084241,"N,N-Diethyl-beta-alanine hydrochloride",CCN(CC)CCC(=O)O.Cl,,,,,,
4239,3084242,WA6UR3ZU3W,C1=CC=C2C(=C1)C(=O)C(=C(C2=O)Cl)N=[N+]=[N-],,,,,,
4240,3084243,CID 3084243,[H-].C1=CN(C(=O)N=C1N)C2C3C(C(O2)CO)OP(=O)(O3)O.[Na+],,,,,,
4241,3084244,Lead(2+) decanoate,CCCCCCCCCC(=O)O.[PbH4],,,,,,
4242,3084245,Hexanoate;lead(2+) dihydride,CCCCCC(=O)[O-].CCCCCC(=O)[O-].[PbH2+2],,,,,,
4243,3084246,1-(3-Trifluoromethylphenyl)piperazine hydrochloride,C1CN(CCN1)C2=CC=CC(=C2)C(F)(F)F.Cl,,,,,,
4244,3084247,Einecs 240-573-6,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)C.C1=CC2=C(C=CC(=C2N=C1)O)S(=O)(=O)O,,,,,,
4245,3084248,Einecs 240-578-3,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl.C1=CC(=C(C=C1O)C(=O)O)O,,,,,,
4246,3084249,Clioquinol sulfate,C1=CC2=C(C(=C(C=C2Cl)I)OS(=O)(=O)O)N=C1,,,,,,
4247,3084250,"2-[5-(Cyclopropylmethyl)-11,15-dimethoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11,18-tetraen-16-yl]butan-2-ol",CCC(C)(C1CC23C=CC1(C4C25CCN(C3CC6=C5C(=C(C=C6)OC)O4)CC7CC7)OC)O,,,,,,
4248,3084251,"(1R,2S,6R,14R,15S)-5-(cyclopropylmethyl)-19-(2-hydroxypropan-2-yl)-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11,16-tetraen-11-ol;hydrochloride",CC(C)(C1C[C@@]23C=C[C@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O.Cl,,,,,,
4249,3084252,"(1R,2S,6R,14R,15S)-5-(cyclopropylmethyl)-19-(2-hydroxypropan-2-yl)-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11,16-tetraen-11-ol",CC(C)(C1C[C@@]23C=C[C@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,,,,,,
4250,3084253,"but-2-enedioic acid;N,N-dimethyl-2,2-diphenoxyethanamine",CN(C)CC(OC1=CC=CC=C1)OC2=CC=CC=C2.C(=CC(=O)O)C(=O)O,,,,,,
4251,3084254,Magnesium;4-(4-methoxynaphthalen-1-yl)-4-oxobutanoic acid,COC1=CC=C(C2=CC=CC=C21)C(=O)CCC(=O)O.[Mg+2],,,,,,
4252,3084255,Calcium;2-(carbamoylamino)butanedioic acid,C(C(C(=O)O)NC(=O)N)C(=O)O.[Ca+2],,,,,,
4253,3084256,Benzyl pyrrolidine-2-carboxylate hydrochloride,C1CC(NC1)C(=O)OCC2=CC=CC=C2.Cl,,,,,,
4254,3084257,Methyl S-benzyl-L-cysteinate hydrochloride,COC(=O)C(CSCC1=CC=CC=C1)N.Cl,,,,,,
4255,3084258,12-O-Dodecanoylphorbol 13-acetate,CCCCCCCCCCCC(=O)O[C@@H]1[C@H]([C@]2(C(C=C(C[C@]3(C2C=C(C3=O)C)O)CO)[C@H]4[C@@]1(C4(C)C)OC(=O)C)O)C,,,,,,
4256,3084259,Boranuide;copper;triphenylphosphane,[BH4-].C1=CC=C(C=C1)P(C2=CC=CC=C2)C3=CC=CC=C3.C1=CC=C(C=C1)P(C2=CC=CC=C2)C3=CC=CC=C3.[Cu],,,,,,
4257,3084260,Dipotassium hexakis(cyano-C)platinate,[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[K+].[K+].[Pt],,,,,,
4258,3084261,gold(1+);N-phenyl-2-sulfanylacetamide,C1=CC=C(C=C1)NC(=O)CS.[Au+],,,,,,
4259,3084262,"Borate (1-), hydrotrimethoxy-, sodium",[BH-](OC)(OC)OC.[Na+],,,,,,
4260,3084263,Trimethoxyboranuide,[BH-](OC)(OC)OC,,,,,,
4261,3084264,Ammonium hexafluorogermanate(4),[NH4+].[NH4+].[F-].[F-].F[Ge](F)(F)F,,,,,,
4262,3084265,"Methyl 11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylate--hydrogen chloride (1/1)",CO[C@@H]1C(C[C@H]2CN3CCC4=C(C3C[C@H]2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC.Cl,,,,,,
4263,3084266,"methyl (15R,18S,20R)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate",CO[C@@H]1C(C[C@H]2CN3CCC4=C(C3C[C@H]2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,,,,,,
4264,3084267,Amitriptyline embonate,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31.C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)O)O)C(=O)O,,,,,,
4265,3084268,Disodium hexafluorotitanate,[F-].[F-].F[Ti](F)(F)F.[Na+].[Na+],,,,,,
4266,3084269,Clemizole sulfate,C1CCN(C1)CC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)Cl.OS(=O)(=O)O,,,,,,
4267,3084270,"(2R,3S)-2,3-dihydroxybutanedioic acid;3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol",CNC[C@@H](C1=CC(=CC=C1)O)O.[C@@H]([C@@H](C(=O)O)O)(C(=O)O)O,,,,,,
4268,3084271,Calcium DL-glutamate (1:1),C(CC(=O)O)C(C(=O)O)N.[Ca+2],,,,,,
4269,3084272,"Calcium;5,5-diphenylimidazolidine-2,4-dione",C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3.[Ca+2],,,,,,
4270,3084273,Visnafylline,CC1=CC(=O)C2=C(C3=C(C(=C2O1)OC)OC=C3)OCC[N+](C)(C)C.CN1C(=C2C(=NC=N2)N(C1=O)C)[O-],,,,,,
4271,3084274,"2-[(9-Methoxy-7-methyl-5-oxo-5H-furo[3,2-g][1]benzopyran-4-yl)oxy]-N,N,N-trimethylethan-1-aminium",CC1=CC(=O)C2=C(C3=C(C(=C2O1)OC)OC=C3)OCC[N+](C)(C)C,,,,,,
4272,3084275,Triclofylline,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCOC(C(Cl)(Cl)Cl)O,,,,,,
4273,3084276,14-Hydroxytetradecanoic acid,C(CCCCCCC(=O)O)CCCCCCO,,,,,,
4274,3084277,N-Acetonylpyridinium bromide,CC(=O)C[N+]1=CC=CC=C1.[Br-],,,,,,
4275,3084278,Aspaminol,CC(CC(C1=CC=CC=C1)(C2=CC=CC=C2)O)N3CCCCC3,,,,,,
4276,3084279,Hematoporphyrin monohydrochloride,CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C(C)O)C)C(=C4CCC(=O)O)C)C(=C3C)CCC(=O)O)C(C)O.Cl,,,,,,
4277,3084280,CID 3084280,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(OC4=CC(=O)C=C(C4=C3O)O)C5=CC=C(C=C5)O)O)O)O)O)O)O,,,,,,
4278,3084281,Cyclohexylmethyl(dimethoxy)silane,CO[SiH](CC1CCCCC1)OC,,,,,,
4279,3084282,"(3S,4aR,6aR,6aS,8aS,12aS,14aR,14bR)-8a-(hydroxymethyl)-4,4,6a,6a,11,11,14b-heptamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-ol",C[C@]12CC[C@@H](C([C@@H]1CC[C@@]3([C@@H]2CC[C@@]4(C3=CC[C@@]5([C@H]4CC(CC5)(C)C)CO)C)C)(C)C)O,,,,,,
4280,3084283,Einecs 241-901-0,CC(C)(C)C(=[OH+])CC(=[OH+])C(C(C(F)(F)F)(F)F)(F)F.CC(C)(C)C(=[OH+])CC(=[OH+])C(C(C(F)(F)F)(F)F)(F)F.CC(C)(C)C(=[OH+])CC(=[OH+])C(C(C(F)(F)F)(F)F)(F)F.[Nd],,,,,,
4281,3084284,Diisobutyldimethoxysilane,CC(C)C[Si](CC(C)C)(OC)OC,,,,,,
4282,3084285,CID 3084285,[Li+].CC(=CC(=O)C)[O-],,,,,,
4283,3084286,"12-Chloro-8,9-dihydroxy-13,14-dimethoxy-4,5,16-trimethyl-4,7-bis(methylsulfanyl)-2,5,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-10,12,14-triene-3,6-dione",CC1(C(=O)N2C3C(C(C2(C(=O)N1C)SC)O)(C4=CC(=C(C(=C4N3C)OC)OC)Cl)O)SC,,,,,,
4284,3084287,Dodicin hydrochloride,CCCCCCCCCCCCNCCNCCNCC(=O)O.Cl,,,,,,
4285,3084288,Thalifendine,COC1=C(C=CC2=CC3=[N+](CCC4=CC5=C(C=C43)OCO5)C=C21)O,,,,,"['Berberrubine has known human metabolites that include (2S,3S,4S,5R)-3,4,5-trihydroxy-6-[(16-methoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaen-17-yl)oxy]oxane-2-carboxylic acid.']",
4286,3084289,CID 3084289,C1=CC=C2C(=C1)C3=NC4=NC(=NC5=C6C=CC=CC6=C([N-]5)N=C7C8=CC=CC=C8C(=N7)N=C2[N-]3)C9=CC=CC=C94.Cl[Sn]Cl,,,,,,
4287,3084290,"Sodium N,N-dimethylglycinate",[H-].CN(C)CC(=O)O.[Na+],,,,,,
4288,3084291,"6,6,7,7,8,8,8-Heptafluoro-2,2-dimethyl-5-oxooct-3-en-3-olate;ytterbium(3+)",CC(C)(C)C(=CC(=O)C(C(C(F)(F)F)(F)F)(F)F)[O-].CC(C)(C)C(=CC(=O)C(C(C(F)(F)F)(F)F)(F)F)[O-].CC(C)(C)C(=CC(=O)C(C(C(F)(F)F)(F)F)(F)F)[O-].[Yb+3],,,,,,
4289,3084292,CID 3084292,CC(C)(C)C(=CC(=O)C(C(C(F)(F)F)(F)F)(F)F)O.CC(C)(C)C(=CC(=O)C(C(C(F)(F)F)(F)F)(F)F)O.CC(C)(C)C(=CC(=O)C(C(C(F)(F)F)(F)F)(F)F)O.[Ho],,,,,,
4290,3084293,CID 3084293,CC(C)(C)C(=CC(=O)C(C(C(F)(F)F)(F)F)(F)F)O.CC(C)(C)C(=CC(=O)C(C(C(F)(F)F)(F)F)(F)F)O.CC(C)(C)C(=CC(=O)C(C(C(F)(F)F)(F)F)(F)F)O.[Dy],,,,,,
4291,3084294,"Pentanoic acid, 3-methyl-, 6-(acetyloxy)-4a,5,6,7a-tetrahydro-4-((3-methyl-1-oxobutoxy)methyl)spiro(cyclopenta(c)pyran-7(1H),2'-oxiran)-1-yl ester",CCC(C)CC(=O)O[C@H]1C2C(C[C@@H](C23CO3)OC(=O)C)C(=CO1)COC(=O)CC(C)C,,,,,,
4292,3084295,Nigracin,C1=CC=C(C=C1)C(=O)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(C=C(C=C3)O)CO)O)O)O,,,,,,
4293,3084296,Eugenyl glucoside,COC1=C(C=CC(=C1)CC=C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
4294,3084297,"2,3-Diaminopropanoic acid hydrobromide",C(C(C(=O)O)N)N.Br,,,,,,
4295,3084298,Org NA13,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)N(C)C)O)C,,,,,,
4296,3084299,Glucose-1-phosphate of arginine,C(CC(C(=O)O)N)CN=C(N)N.C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)OP(=O)(O)O)O)O)O)O,,,,,,
4297,3084300,Toliodium chloride,CC1=CC=C(C=C1)[I+]C2=CC=C(C=C2)C.[Cl-],,,,,,
4298,3084301,Perchloric (2H)acid,[2H]OCl(=O)(=O)=O,,,,,,
4299,3084302,Normolaxol,C1=CC=C2C(=C1)C=CC(=N2)C(C3=CC=C(C=C3)O)C4=CC=C(C=C4)O.Cl,,,,,,
4300,3084303,Quinolinylmethylene bis phenol,C1=CC=C2C(=C1)C=CC(=N2)C(C3=CC=C(C=C3)O)C4=CC=C(C=C4)O,,,,,,
4301,3084304,Einecs 242-822-4,CC(C)(C)C(=[OH+])CC(=[OH+])C(C(C(F)(F)F)(F)F)(F)F.CC(C)(C)C(=[OH+])CC(=[OH+])C(C(C(F)(F)F)(F)F)(F)F.CC(C)(C)C(=[OH+])CC(=[OH+])C(C(C(F)(F)F)(F)F)(F)F.[La],,,,,,
4302,3084305,"Glucopyranosiduronic acid, 4-biphenylyl, beta-D-",C1=CC=C(C=C1)C2=CC=C(C=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O,,,,,,
4303,3084306,Potassium;hexanedioic acid,C(CCC(=O)O)CC(=O)O.[K+],,,,,,
4304,3084307,Marticin,CC12CC3=C(C(O1)CC(O2)C(=O)O)C(=C4C(=O)C=C(C(=O)C4=C3O)OC)O,,,,,,
4305,3084308,Isomarticin,CC12CC3=C(C(O1)C[C@@H](O2)C(=O)O)C(=C4C(=O)C=C(C(=O)C4=C3O)OC)O,,,,,,
4306,3084309,CID 3084309,C1=CC(=C(C=C1C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)O)OC4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O,,,,,,
4307,3084310,Aptocaine hydrochloride,CC1=CC=CC=C1NC(=O)C(C)N2CCCC2.Cl,,,,,,
4308,3084311,delta-Cadinol,CC1=C[C@H]2[C@@H](CC[C@@]([C@H]2CC1)(C)O)C(C)C,,,,,,
4309,3084312,CID 3084312,CC(C)C(=O)[O-].[K+],,,,,,
4310,3084313,Dihydro-beta-ergocryptine,CCC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@@H]4C[C@H]5[C@@H](CC6=CNC7=CC=CC5=C67)N(C4)C)O,,,,,,
4311,3084314,CID 3084314,CC(=CC1=CC=CC=C1)CC(=O)O.[Na+],,,,,,
4312,3084315,Einecs 243-122-1,CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3.CC1=C(C(=O)N(N1C)C2=CC=CC=C2)NC(=O)C(C)N(C)C,,,,,,
4313,3084316,CID 3084316,COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC.CS(=O)(=O)OC1=C2C=C(C(=O)C=C2OC(=C1)O)O,,,,,,
4314,3084317,CID 3084317,CS(=O)(=O)OC1=C2C=C(C(=O)C=C2OC(=C1)O)O,,,,,,
4315,3084318,CID 3084318,CCCCCCCCCCCCCCCCCC(=O)NCC(C(C=CCCCCCCCCCCCCC)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@@H]2[C@H]([C@@H]([C@@H]([C@@H](O2)CO)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H](O3)CO)O)O[C@@H]4[C@H]([C@@H]([C@@H]([C@@H](O4)CO)O)O)O)NC(=O)C)O[C@]5(C[C@@H]([C@H]([C@@H](O5)C(C(CO[C@@]6(C[C@H]([C@@H]([C@H](O6)C(C(CO)O)O)N)O)C(=O)O)O)O)N)O)C(=O)O)O)O)O,,,,,,
4316,3084319,"[(8bS)-4,8b-dimethyl-1,2,3,3a-tetrahydropyrrolo[2,3-b]indol-7-yl] N-methylcarbamate",C[C@@]12CCNC1N(C3=C2C=C(C=C3)OC(=O)NC)C,,,,,,
4317,3084320,CID 3084320,CN1CC(=O)N=C1NP(=O)(O)O.[Na+],,,,,,
4318,3084321,(4-Chloro-2-methylphenyl)hydrazine hydrochloride,CC1=C(C=CC(=C1)Cl)NN.Cl,,,,,,
4319,3084322,"1,3,4-Thiadiazol-2(3H)-one, 5-methoxy-3-((methylthio)methyl)-",COC1=NN(C(=O)S1)CSC,,,,,,
4320,3084323,"3,4-Dichlorophenylhydrazine hydrochloride",C1=CC(=C(C=C1NN)Cl)Cl.Cl,,,,,,
4321,3084324,"Salicin, 6'-acetate",CC(=O)OC[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)OC2=CC=CC=C2CO)O)O)O,,,,,,
4322,3084325,Ammonium methyl sulphate,COS(=O)(=O)O.N,,,,,,
4323,3084326,Dehydrodicentrine,CN1CCC2=CC3=C(C4=C5C=C(C(=CC5=CC1=C24)OC)OC)OCO3,,,,,,
4324,3084327,CID 3084327,C(=CC(=O)O)C(=O)O.[Ca+2],,,,,,
4325,3084328,Nagilactone A,CC(C)C1=C2[C@H]([C@@H]3[C@H]4[C@](CC[C@H]([C@@]4(C2=CC(=O)O1)C)O)(C(=O)O3)C)O,,,,,,
4326,3084329,Nagilactone B,CC(C)C1=C2[C@H]([C@@H]3[C@H]4[C@](C[C@H]([C@H]([C@@]4(C2=CC(=O)O1)C)O)O)(C(=O)O3)C)O,,,,,,
4327,3084330,Nagilactone D,CCC1=C2C[C@@H]3[C@H]4[C@]([C@H]([C@@H]5[C@H]([C@@]4(C2=CC(=O)O1)C)O5)O)(C(=O)O3)C,,,,,,
4328,3084331,T-Muurolol,CC1=C[C@H]2[C@@H](CC[C@]([C@H]2CC1)(C)O)C(C)C,,,,,,
4329,3084332,1-Aminomethyl-1-cyclohexanol hydrochloride,C1CCC(CC1)(CN)O.Cl,,,,,,
4330,3084333,CID 3084333,CC1=C2C(=C3C=CC=CC3=N2)C(=CN1)C4CCCN4C,,,,,,
4331,3084334,CID 3084334,C1=NC(=[SH+])C2=C(N1)N=C[N-]2.C1=NC(=[SH+])C2=C(N1)N=C[N-]2.[Pt+2],,,,,,
4332,3084335,Magnolioside,COC1=C(C=C2C=CC(=O)OC2=C1)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
4333,3084336,Homodihydrocapsaicin,CC(C)CCCCCCCC(=O)NCC1=CC(=C(C=C1)O)OC,,,,,,
4334,3084337,Ethylbenzene-d5,[2H]C([2H])([2H])C([2H])([2H])C1=CC=CC=C1,,,,,,
4335,3084338,Tolpiprazole,CC1=CC(=CC=C1)N2CCN(CC2)CCC3=NNC(=C3)C,,,,,,
4336,3084339,Cannabichromenic acid,CCCCCC1=CC2=C(C=CC(O2)(C)CCC=C(C)C)C(=C1C(=O)O)O,,,,,,
4337,3084340,"(7R)-3-(cyclopropylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol",C1CC2(C3CC4=C5C2(CCN3CC6CC6)C([C@@H]1O)OC5=C(C=C4)O)O,,,,,,
4338,3084341,Terchebin,C1=C(C=C(C(=C1O)O)O)C(=O)OC[C@@H]2[C@@H]3[C@@H]([C@H]([C@@H](O2)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C6=C5[C@@H]7C(=CC(=O)C(C7(O6)O)(O)O)C(=O)O3)O)O)OC(=O)C8=CC(=C(C(=C8)O)O)O,,,,,,
4339,3084342,"Titanium, chlorotris(2-propanolato)-, (T-4)-",CC(C)[O-].CC(C)[O-].CC(C)[O-].[Cl-].[Ti+4],,,,,,
4340,3084343,"2,4-Dimethoxybenzylamine hydrochloride",COC1=CC(=C(C=C1)CN)OC.Cl,,,,,,
4341,3084344,Methyl N-alpha-acetyl-L-lysinate hydrochloride,CC(=O)NC(CCCCN)C(=O)OC.Cl,,,,,,
4342,3084345,"Escin, monosodium salt",CC(C(C)OC(=O)C)C(=O)OCC12[C@H]3C[C@@]4(C(=CCC5C4(CCC6C5(CCC([C@]6(C)CO)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O[C@@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O[C@H]9[C@@H]([C@H]([C@@H](CO9)O)O)O)C)C)C1CC([C@@H](C2O)O3)(C)C)C.[Na+],,,,,,
4343,3084346,"(2S,3S,4S,5R,6R)-6-[[(1R,3S,8S,20S)-22-[(3-acetyloxy-2-methylbutanoyl)oxymethyl]-21-hydroxy-8-(hydroxymethyl)-3,4,8,12,19,19-hexamethyl-23-oxahexacyclo[18.2.1.03,16.04,13.07,12.017,22]tricos-15-en-9-yl]oxy]-4-hydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxane-2-carboxylic acid",CC(C(C)OC(=O)C)C(=O)OCC12[C@H]3C[C@@]4(C(=CCC5C4(CCC6C5(CCC([C@]6(C)CO)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O[C@@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O[C@H]9[C@@H]([C@H]([C@@H](CO9)O)O)O)C)C)C1CC([C@@H](C2O)O3)(C)C)C,,,,,,
4344,3084347,Nichlotest,C[C@]12CCC3C(C1CC[C@@H]2O[N+](=O)[O-])CCC4=C(C(=O)CC[C@]34C)Cl,,,,,,
4345,3084348,CID 3084348,[C@@H]12[C@H](O1)[C@@H]3C4[C@@H]2C5C3C6(C4(C(=O)C5(C6(Cl)Cl)Cl)Cl)Cl,,,,,,
4346,3084349,Calcium;2-oxopropanedioic acid,C(=O)(C(=O)O)C(=O)O.[Ca+2],,,,,,
4347,3084350,CID 3084350,C[C@@H]1C=CC(=O)NCC=CC(=C[C@H](CC(=O)CC2=NC(=CO2)C(=O)N3CC[C@@H](C3)C(=O)O[C@@H]1C(C)C)O)C,,,,,,
4348,3084351,3-Methoxy-4-(3-phenyl-2-propenyl)phenol,COC1=C(C=CC(=C1)O)CC=CC2=CC=CC=C2,,,,,,
4349,3084352,"[(2S,3R,4S,5S,6R)-2-[[(4R,4aR)-4-ethenyl-4a-hydroxy-8-oxo-3,4,5,6-tetrahydropyrano[3,4-c]pyran-3-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] 2,4-dihydroxy-6-(3-hydroxyphenyl)benzoate",C=C[C@H]1C(OC=C2[C@]1(CCOC2=O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)OC(=O)C4=C(C=C(C=C4O)O)C5=CC(=CC=C5)O,,,,,,
4350,3084353,"2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-phenyl-, compd. with (17R,21alpha)-ajmalan-17,21-diol",CC[C@@H]1[C@@H]2CC3C4C5(C[C@@H](C2C5O)N3[C@H]1O)C6=CC=CC=C6N4C.CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,,,,,,
4351,3084354,"(12R,13R,14S,16S)-13-ethyl-8-methyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol",CC[C@@H]1[C@@H]2CC3C4C5(C[C@@H](C2C5O)N3[C@H]1O)C6=CC=CC=C6N4C,,,,,,
4352,3084355,CID 3084355,F[PH-](F)(F)(F)F.[Na+],,,,,,
4353,3084356,CID 3084356,F[PH-](F)(F)(F)F,,,,,,
4354,3084357,"Propanoic acid, 2-((4'-chloro(1,1'-biphenyl)-4-yl)oxy)-2-methyl-",CC(C)(C(=O)O)OC1=CC=C(C=C1)C2=CC=C(C=C2)Cl,,,,,,
4355,3084358,Eisenin,CC(C(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C1CCC(=O)N1,,,,,,
4356,3084359,Dichlorflurenol,C1=CC2=C(C=C1Cl)C(C3=C2C=CC(=C3)Cl)(C(=O)O)O,,,,,,
4357,3084360,"Bis(1,10-phenanthroline)copper(2+) sulfate",C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1.C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1.OS(=O)(=O)O.[Cu+2],,,,,,
4358,3084361,"[(3R,4R)-2,2-dimethyl-3-(2-methylbut-2-enoyloxy)-8-oxo-3,4-dihydropyrano[3,2-g]chromen-4-yl] 2-methylbut-2-enoate",CC=C(C)C(=O)O[C@H]1[C@H](C(OC2=C1C=C3C=CC(=O)OC3=C2)(C)C)OC(=O)C(=CC)C,,,,,,
4359,3084362,"4-([1,1'-Biphenyl]-4-yl)-2-{2-[4-(dimethylamino)phenyl]ethenyl}-3-methyl-1,3-thiazol-3-ium iodide",C[N+]1=C(SC=C1C2=CC=C(C=C2)C3=CC=CC=C3)C=CC4=CC=C(C=C4)N(C)C.[I-],,,,,,
4360,3084363,4-(4-Biphenylyl)-2-[p-(dimethylamino)styryl]-3-methylthiazol-3-ium,C[N+]1=C(SC=C1C2=CC=C(C=C2)C3=CC=CC=C3)C=CC4=CC=C(C=C4)N(C)C,,,,,,
4361,3084364,CID 3084364,CNC1=NCCC(N1C)C(C(=O)O)N,,,,,,
4362,3084365,CID 3084365,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=CC(=O)C3=C(C(=C(OC3=C2)C4=CC(=C(C=C4)O)O)O)O)O)O)O,,,,,,
4363,3084366,"Dibenzyl ethane-1,2-diyl bis[(diethoxyphosphoryl)carbonodithioimidate]",CCOP(=O)(N=C(SCCSC(=NP(=O)(OCC)OCC)SCC1=CC=CC=C1)SCC2=CC=CC=C2)OCC,,,,,,
4364,3084367,Isobauerenol,C[C@@H]1CC[C@@]2(CC[C@@]3(C4=C(CC[C@]3([C@@H]2[C@H]1C)C)[C@]5(CC[C@@H](C([C@@H]5CC4)(C)C)O)C)C)C,,,,,,
4365,3084368,CID 3084368,CN(C)C1=CC=C(C=C1)P(=O)O.[Na+],,,,,,
4366,3084369,sporidesmin E,CC12C(=O)N3C4C(C(C3(C(=O)N1C)SSS2)O)(C5=CC(=C(C(=C5N4C)OC)OC)Cl)O,,,,,,
4367,3084370,"4-Methoxy-3-methyl-6-[4-methyl-5-(4-nitrophenyl)penta-2,4-dien-2-yl]-2H-pyran-2-one",CC1=C(C=C(OC1=O)C(=CC(=CC2=CC=C(C=C2)[N+](=O)[O-])C)C)OC,,,,,,
4368,3084371,CID 3084371,CC1CCC(CC1=CC=C2CCCC3(C2CCC3C(C)CCC(C)C(C)C)C)O,,,,,,
4369,3084372,N-(4-ethoxyphenyl)-2-hydroxyacetamide,CCOC1=CC=C(C=C1)NC(=O)CO,,,,,,
4370,3084373,CID 3084373,C([C@@H]1C([C@@H]([C@H]([C@@H](O1)S)O)O)O)O,,,,,,
4371,3084374,(2-(Benzylthio)ethyl)ammonium hydrogen malate,C1=CC=C(C=C1)CSCCN.C(C(C(=O)O)O)C(=O)O,,,,,,
4372,3084375,Triacontanal,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC=O,,,,,,
4373,3084376,Octacosanal,CCCCCCCCCCCCCCCCCCCCCCCCCCCC=O,,,,,,
4374,3084377,"1-Propanone, 2-methyl-1,2-di-3-pyridinyl-, hydrochloride",CC(C)(C1=CN=CC=C1)C(=O)C2=CN=CC=C2.Cl,,,,,,
4375,3084378,"Benzo(g)quinolin-4-amine, N-butyl-",CCCCNC1=CC=NC2=CC3=CC=CC=C3C=C12,,,,,,
4376,3084379,Cycloheptyltriphenylphosphonium bromide,C1CCCC(CC1)[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4.[Br-],,,,,,
4377,3084380,Cycloheptyltriphenylphosphonium,C1CCCC(CC1)[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
4378,3084381,CID 3084381,CC=C(C)C(=O)OC1CC2CCC(C1)N2C.Br,,,,,,
4379,3084382,Pentamethylenebis(triphenylphosphonium) bromide,C1=CC=C(C=C1)[P+](CCCCC[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6.[Br-].[Br-],,,,,,
4380,3084383,"1,5-Pentanediylbis(triphenylphosphonium)",C1=CC=C(C=C1)[P+](CCCCC[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6,,,,,,
4381,3084384,"N,2-dimethyl-4,5,6,7-tetrahydro-2H-indazol-3-amine; but-2-enedioic acid",CNC1=C2CCCCC2=NN1C.C(=CC(=O)O)C(=O)O,,,,,,
4382,3084385,Polyoxin E,C1=C(C(=O)NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)C(C(=O)O)NC(=O)C(CC(COC(=O)N)O)N)O)O)C(=O)O,,,,,,
4383,3084386,"beta-D-Allofuranuronic acid, 5-((2-amino-5-O-(aminocarbonyl)-2-deoxy-L-xylonoyl)amino)-1,5-dideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-",CC1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)C(C(=O)O)NC(=O)C(C(C(COC(=O)N)O)O)N)O)O,,,,,,
4384,3084387,"Naphtho(2,3-b)furan-4,9-dione, 3,5-dimethyl-",CC1=C2C(=CC=C1)C(=O)C3=C(C2=O)C(=CO3)C,,,,,,
4385,3084388,CID 3084388,COC1=CC(=O)C2=CC=C(OC2=C1)O,,,,,,
4386,3084389,"(1S,2R,5S,9S,10S,11R,12R,13R)-9,12-dihydroxy-2,6,10,16-tetramethyl-14-oxatetracyclo[11.2.1.02,11.05,10]hexadec-6-ene-3,8,15-trione",CC1[C@@H]2[C@@H]([C@@H]3[C@@]4([C@@H](CC(=O)[C@]3([C@H]1C(=O)O2)C)C(=CC(=O)[C@H]4O)C)C)O,,,,,,
4387,3084390,Sorbifolin,COC1=C(C(=C2C(=C1)OC(=CC2=O)C3=CC=C(C=C3)O)O)O,,,,,,
4388,3084391,"1,2-Ethenediamine, N-(5-bromoselenophene-2-yl)-N',N'-dimethyl-N--pyridinyl-, monohydrochloride",CN(C)CCN(C1=CC=CC=N1)C2=CC=C([Se]2)Br.Cl,,,,,,
4389,3084392,Dimethyl DL-Glutamate Hydrochloride,COC(=O)CCC(C(=O)OC)N.Cl,,,,,,
4390,3084393,"1,1,1,3,3-Pentachloropropane",C(C(Cl)Cl)C(Cl)(Cl)Cl,,,,,,
4391,3084394,"(2xi)-D-Gluco-heptonic acid, potassium salt",C([C@@H]([C@@H]([C@H]([C@@H]([C@@H](C(=O)O)O)O)O)O)O)O.[K+],,,,,,
4392,3084395,"(2S,3S,4R,5S,6S)-2,3,4,5,6,7-hexahydroxyheptanoic acid",C([C@@H]([C@@H]([C@H]([C@@H]([C@@H](C(=O)O)O)O)O)O)O)O,,,,,,
4393,3084396,Trimethoprim lactate,CC(C(=O)O)O.COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,,,,,,
4394,3084397,3-Amino-L-tyrosine HCl hydrate,C1=CC(=C(C=C1CC(C(=O)O)N)N)O.O.Cl.Cl,,,,,,
4395,3084398,3-Aminotyrosine,C1=CC(=C(C=C1CC(C(=O)O)N)N)O,,,,,,
4396,3084399,"Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((3,4,5-trimethoxybenzoyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)-, mono(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodobenzeneacetate)",CO[C@@H]1C(C[C@H]2CN3CCC4=C(C3C[C@H]2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC.C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(=O)O)I)I)O,,,,,,
4397,3084400,p-Phenoxyphenol methanesulfonate,CS(=O)(=O)OC1=CC=C(C=C1)OC2=CC=CC=C2,,,,,,
4398,3084401,"1(2H)-Isoquinolinone, 5,6,7-trimethoxy-2-methyl-",CN1C=CC2=C(C(=C(C=C2C1=O)OC)OC)OC,,,,,,
4399,3084402,Dimethylprop-2-ynylsulphonium bromide,C[S+](C)CC#C.[Br-],,,,,,
4400,3084403,Propargyldimethylsulfonium,C[S+](C)CC#C,,,,,,
4401,3084404,Barium N-formimidoyl-L-glutamate (1:2),[H-].[H-].C(CC(=O)O)C(C(=O)O)N=CN.[Ba+2],,,,,,
4402,3084405,2-(1-Hydroxycyclohexyl)butanoic acid;2-(trimethylazaniumyl)acetate,CCC(C(=O)O)C1(CCCCC1)O.C[N+](C)(C)CC(=O)[O-],,,,,,
4403,3084406,Sodium;2-hydroxy-4-methylsulfanylbutanoic acid,CSCCC(C(=O)O)O.[Na+],,,,,,
4404,3084407,Vicenin 2,C1=CC(=CC=C1C2=CC(=O)C3=C(C(=C(C(=C3O2)C4C(C(C(C(O4)CO)O)O)O)O)C5C(C(C(C(O5)CO)O)O)O)O)O,,,,,,
4405,3084408,Methyl (2H)formate,[2H]C(=O)OC,,,,,,
4406,3084409,"Aluminum;potassium;2,3,4,5,6-pentahydroxyhexanoic acid;hydrate",C(C(C(C(C(C(=O)O)O)O)O)O)O.O.[Al+3].[K+],,,,,,
4407,3084410,Trebenzomine hydrochloride,CC1C(CC2=CC=CC=C2O1)N(C)C.Cl,,,,,,
4408,3084411,"alpha-(Methylamino)furan-2-acetonitrile, monohydrochloride",CNC(C#N)C1=CC=CO1.[Cl-],,,,,,
4409,3084412,"2H-Furo(2,3-h)-1-benzopyran-2-one, 5-methoxy-6-((3-methyl-2-butenyl)oxy)-",CC(=CCOC1=C(C2=C(C3=C1OC=C3)OC(=O)C=C2)OC)C,,,,,,
4410,3084413,"N,N'-bis(2-hydroxy-5-oxocyclopenten-1-yl)hexadeca-2,4,6,8,10,12,14-heptaenediamide",C1CC(=O)C(=C1O)NC(=O)C=CC=CC=CC=CC=CC=CC=CC(=O)NC2=C(CCC2=O)O,,,,,,
4411,3084414,Simalikalactone A,C[C@@H]1C=C(C(=O)[C@]2([C@H]1C[C@@H]3[C@@]4([C@@H]2[C@@H](C([C@@H]([C@@H]4CC(=O)O3)C)OC)O)C)C)OC,,,,,,
4412,3084415,"(5S)-5-(2,4,5-trimethoxyphenyl)-5a,8,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-6-one",COC1=CC(=C(C=C1[C@H]2C3C(CC4=CC5=C(C=C24)OCO5)COC3=O)OC)OC,,,,,,
4413,3084416,CID 3084416,COC1=C(C=C(C=C1)C2=COC3=CC(=O)C=CC3=C2O)OC,,,,,,
4414,3084417,"2-[(3S,5R,14R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-enoic acid",CC(=CCCC(C1CC[C@@]2(C1(CCC3=C2CC[C@@H]4C3(CC[C@@H](C4(C)C)O)C)C)C)C(=O)O)C,,,,,,
4415,3084418,Aluminium tris(2-((3-(trifluoromethyl)phenyl)amino)nicotinate),C1=CC(=CC(=C1)NC2=C(C=CC=N2)C(=O)[O-])C(F)(F)F.[Al+3],,,,,,
4416,3084419,CID 3084419,CC1=CCCC(=C[C@@H]2[C@@H](C2(C)C)CCC(=CCC1)C)C,,,,,,
4417,3084420,"Abieta-8,11,13-triene-1,18-diol",CC(C)C1=CC2=C(C=C1)[C@]3([C@H](CC[C@@](C3CC2)(C)CO)O)C,,,,,,
4418,3084421,Phenamazoline hydrochloride,C1CN=C(N1)CNC2=CC=CC=C2.Cl,,,,,,
4419,3084422,Phenamazoline,C1CN=C(N1)CNC2=CC=CC=C2,,,,,,
4420,3084423,Antazoline Sulfate,C1CN=C(N1)CN(CC2=CC=CC=C2)C3=CC=CC=C3.OS(=O)(=O)O,,,,,,
4421,3084424,Pentaphonate,CCCCCCCCCCCC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3.C1(=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)[O-],,,,,,
4422,3084425,Strontium;nitrate,[N+](=O)([O-])[O-].[Sr+2],,,,,,
4423,3084426,"3-Buten-2-ol, 2-methyl-, acetate",CC(=O)OC(C)(C)C=C,,,,,,
4424,3084427,Potassium deuteroxide,[2H][O-].[K+],,,,,,
4425,3084428,Einecs 246-491-7,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)C.C(CC(C(=O)O)N)CN=C(N)N,,,,,,
4426,3084429,12-Tricosanol,CCCCCCCCCCCC(CCCCCCCCCCC)O,,,,,,
4427,3084430,Methyl alpha-methylpiperidine-1-propionate hydrochloride,CC(CN1CCCCC1)C(=O)OC.Cl,,,,,,
4428,3084431,Methyl alpha-methyl-4-morpholinepropionate hydrochloride,CC(CN1CCOCC1)C(=O)OC.[Cl-],,,,,,
4429,3084432,N-Cyclohexylhydroxylamine hydrochloride,C1CCC(CC1)NO.Cl,,,,,,
4430,3084433,(2S)-2-butoxybutan-1-ol,CCCCO[C@@H](CC)CO,,,,,,
4431,3084434,"1,3-Pentadiene, homopolymer",CC[C@]1(C[C@@H](C2=CC3=C(C(=C2C1O)O)C(=O)C4=C(C3=O)C(=CC=C4)OC)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)NC)O,,,,,,
4432,3084435,"2-(3,4-Dichlorophenoxyacetamido)-N-(3-chloro-2-fluorosulfonylbenzyl)pyridinium bromide",C1=CC(=C(C(=C1)Cl)S(=O)(=O)F)C[N+]2=CC=CC(=C2)NC(=O)COC3=CC(=C(C=C3)Cl)Cl.[Br-],,,,,,
4433,3084436,"(7,7-Dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid--6,7-dimethoxy-3-(4-methoxy-6-methyl-5,6,7,8-tetrahydro-2H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-2-benzofuran-1(3H)-one (1/1)",CC1(C2CCC1(C(=O)C2)CS(=O)(=O)O)C.CN1CCC2=CC3=C(C(=C2[C@@H]1[C@@H]4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)OC)OCO3,,,,,,
4434,3084437,"(2S,3R)-2-(dimethylamino)-3-methyl-N-[(3S,4S,7S)-7-(2-methylpropyl)-5,8-dioxo-3-propan-2-yl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),10,12,15-tetraen-4-yl]pentanamide",CC[C@@H](C)[C@@H](C(=O)N[C@H]1[C@@H](OC2=CC=C(C=C2)C=CNC(=O)[C@@H](NC1=O)CC(C)C)C(C)C)N(C)C,,,,,,
4435,3084438,4-(4-Fluorobenzoyl)piperidine hydrochloride,C1CNCCC1C(=O)C2=CC=C(C=C2)F.Cl,,,,,,
4436,3084439,"(6-Hydroxy-5,8a-dimethyl-1-methylidene-2,8-dioxo-3a,4,5,5a,6,7,9,9a-octahydroazuleno[6,5-b]furan-9-yl) 2-methylbut-2-enoate",CC=C(C)C(=O)OC1C2C(CC(C3C1(C(=O)CC3O)C)C)OC(=O)C2=C,,,,,,
4437,3084440,"2,9-dimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-1,10-diol",CN1CCC2=CC(=C(C3=C2C1CC4=CC(=C(C=C43)O)OC)O)OC,,,,,,
4438,3084441,Desulfated cholecystokinin-8,CSCC[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)C(=O)[C@H](CC(=O)O)N)NC(=O)CNC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC4=CC=CC=C4)NN,,,,,,
4439,3084442,Triphenyl(tetradecyl)phosphonium Bromide,CCCCCCCCCCCCCC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3.[Br-],,,,,,
4440,3084443,Triphenyltetradecylphosphonium,CCCCCCCCCCCCCC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
4441,3084444,Suloxifen,CCN(CC)CCN=S(=O)(C1=CC=CC=C1)C2=CC=CC=C2,,,,,,
4442,3084445,Suloxifen oxalate,CCN(CC)CCN=S(=O)(C1=CC=CC=C1)C2=CC=CC=C2.C(=O)(C(=O)O)O,,,,,,
4443,3084446,"2-Butenoic acid, 3-[(dimethoxyphosphinyl)oxy]-, 1-[4-(methylthio)phenyl]ethyl ester",CC(C1=CC=C(C=C1)SC)OC(=O)C=C(C)OP(=O)(OC)OC,,,,,,
4444,3084447,Piclobetol,C1CN(CCC1CC2=CC=C(C=C2)Cl)CCOCCO,,,,,,
4445,3084448,"L-Phenylalanine, N-(1-oxodecyl)-",CCCCCCCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O,,,,,,
4446,3084449,Trazitiline,CN1CCN(CC1)C23CCC(C4=CC=CC=C42)C5=CC=CC=C35,,,,,,
4447,3084450,"1-Methyl-1,2,5,6-tetrahydropyridine-3-(N,N-diethylcarboxamide)",CCN(CC)C(=O)C1=CCCN(C1)C,,,,,,
4448,3084451,"(2S,4S,6R,7S,9R,17S)-4-Hydroxy-15-methoxy-2,6,14,17-tetramethyl-10-oxatetracyclo[7.7.1.02,7.013,17]heptadec-14-ene-3,11,16-trione",C[C@@H]1C[C@@H](C(=O)[C@]2([C@H]1C[C@@H]3[C@@]4(C2C(=O)C(=C(C4CC(=O)O3)C)OC)C)C)O,,,,,,
4449,3084452,CID 3084452,CC1=NC=C(C(=N1)N)CN(C=O)/C(=C(\CCO)/SC=CC(=O)C2=CC=CC=C2)/C,,,,,,
4450,3084453,"Benzenaminium, 4,4'-(carbonyldiimino)bis(N,N,N-trimethyl-, bis(methyl sulfate)",C[N+](C)(C)C1=CC=C(C=C1)NC(=O)NC2=CC=C(C=C2)[N+](C)(C)C.CS(=O)(=O)[O-].CS(=O)(=O)[O-],,,,,,
4451,3084454,Trimethyl-[4-[[4-(trimethylazaniumyl)phenyl]carbamoylamino]phenyl]azanium,C[N+](C)(C)C1=CC=C(C=C1)NC(=O)NC2=CC=C(C=C2)[N+](C)(C)C,,,,,,
4452,3084455,"4,4'-Methylenebis(3-hydroxynaphthalene-2-carboxylic acid)--1,1-diphenyl-4-(piperidin-1-yl)butan-1-ol (1/1)",C1CCN(CC1)CCCC(C2=CC=CC=C2)(C3=CC=CC=C3)O.C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)O)O)C(=O)O,,,,,,
4453,3084456,Docos-13-en-1-amine,CCCCCCCCC=CCCCCCCCCCCCCN,,,,,,
4454,3084457,CID 3084457,[H-].[H-].CN1C(CNC2=C1C(=O)N=C(N2)N)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O.[Ca+2],,,,,,
4455,3084458,"Zinc, bis(O-(2-ethylhexyl) O-(2-methylpropyl) phosphorodithioato-kappaS,kappaS')-, (T-4)-",CCCC[C@@H](CC)COP(=S)(OCC(C)C)S,,,,,,
4456,3084459,Einecs 247-818-6,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@@]5([C@H]6CC([C@@]7([C@H](CC[C@@]7(C6CCC5C4)OC(=O)C)C8=CC(=O)OC8)C)OC(=O)C)C)C)C)O)O,,,,,,
4457,3084460,Alisol B 23-monoacetate,CC(CC(C1C(O1)(C)C)OC(=O)C)C2=C3C[C@@H](C4[C@]5(CCC(=O)C(C5CC[C@@]4([C@]3(CC2)C)C)(C)C)C)O,,,,,,
4458,3084461,CID 3084461,CC=C(C)C(=O)O[C@H]1CCC2=CC(=O)[C@H](C[C@]2([C@@H]1C)C)C(=C)C,,,,,,
4459,3084462,Hexacosanal,CCCCCCCCCCCCCCCCCCCCCCCCCC=O,,,,,,
4460,3084463,1-Hexadecanoyl-sn-glycerol,CCCCCCCCCCCCCCCC(=O)OC[C@H](CO)O,,,,,,
4461,3084464,"(6S)-3,6,6a-trihydroxy-6-(1H-indol-3-ylmethyl)-3,3a-dihydro-2H-furo[3,2-b]furan-5-one",C1C(C2C(O1)([C@](C(=O)O2)(CC3=CNC4=CC=CC=C43)O)O)O,,,,,,
4462,3084465,"Pyridine, 4-ethenyl-, 1-oxide, homopolymer",C=CC1=CC=[N+](C=C1)[O-],,,,,,
4463,3084466,"2-Propenal, polymer with formaldehyde",C=CC=O.C=O,,,,,,
4464,3084467,"Adenosine, 5'-((3-amino-3-carboxypropyl)ethylsulfonio)-5'-deoxy-, hydroxide, inner salt",CC[S+](CCC(C(=O)[O-])N)[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O,,,,,,
4465,3084468,"(3-amino-3-carboxypropyl)-[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]-ethylsulfanium",CC[S+](CCC(C(=O)O)N)[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O,,,,,,
4466,3084469,Propranolol phenobarbital,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2.CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,,,,,,
4467,3084470,"myo-Inositol, tetrakis(dihydrogen phosphate)",[C@H]1([C@@H](C([C@H]([C@@H](C1O)OP(=O)(O)O)OP(=O)(O)O)O)OP(=O)(O)O)OP(=O)(O)O,,,,,,
4468,3084471,Antimycin A2,CCCCCCC1C(C(OC(=O)C(C(OC1=O)C)NC(=O)C2=C(C(=CC=C2)NC=O)O)C)OC(=O)CCC,,,,,,
4469,3084472,Antimycin A4,CCCCC1C(C(OC(=O)C(C(OC1=O)C)NC(=O)C2=C(C(=CC=C2)NC=O)O)C)OC(=O)CCC,,,,,,
4470,3084473,CID 3084473,CC1=NN(C(=O)C1=CC2=CC=C(C=C2)N(C)C)C3=CC=C(C=C3)S(=O)(=O)[O-].[K+],,,,,,
4471,3084474,Betamethasone succinate,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COC(=O)CCC(=O)O)O)C)O)F)C,,,,,,
4472,3084475,"4'-Chloro-2-(2,4-di-tert-pentylphenoxy)-3'-nitrobutyranilide",CCC(C(=O)NC1=CC(=C(C=C1)Cl)[N+](=O)[O-])OC2=C(C=C(C=C2)C(C)(C)CC)C(C)(C)CC,,,,,,
4473,3084476,"2,5-Pyrrolidinedione, 1-(4-(hexahydro-1H-azepin-1-yl)-1-methyl-2-butynyl)-",CC(C#CCN1CCCCCC1)N2C(=O)CCC2=O,,,,,,
4474,3084477,"16-Butan-2-yl-10,11-dimethyl-3-(2-methylpropyl)-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone",CCC(C)C1C(=O)NC(C(=O)N(C(C(=O)NCCC(=O)OC(C(=O)N2CCCC2C(=O)N1)CC(C)C)C)C)C(C)C,,,,,,
4475,3084478,"16-Butan-2-yl-3-(3-hydroxy-2-methylpropyl)-10,11,14-trimethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone",CCC(C)C1C(=O)N(C(C(=O)N(C(C(=O)NCCC(=O)OC(C(=O)N2CCCC2C(=O)N1)CC(C)CO)C)C)C(C)C)C,,,,,,
4476,3084479,"NCGC00380598-01_C30H49N5O9_3-(3-sec-Butyl-6-isopropyl-5,8,9-trimethyl-1,4,7,10,14,17-hexaoxoicosahydropyrrolo[1,2-d][1,4,7,10,13,16]oxapentaazacyclononadecin-16-yl)-2-methylpropanoic acid",CCC(C)C1C(=O)N(C(C(=O)N(C(C(=O)NCCC(=O)OC(C(=O)N2CCCC2C(=O)N1)CC(C)C(=O)O)C)C)C(C)C)C,,,,,,
4477,3084480,Dihydropicromycin,CCC1C(CCC(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC2C(C(CC(O2)C)N(C)C)O)C)C)(C)O,,,,,,
4478,3084481,"Benzoic acid, 4-amino-, compd. with alpha-(((1,1-dimethyl-2-phenylethyl)amino)methyl)-3-hydroxybenzenemethanol (1:1)",CC(C)(CC1=CC=CC=C1)NCC(C2=CC(=CC=C2)O)O.C1=CC(=CC=C1C(=O)O)N,,,,,,
4479,3084482,3-[1-Hydroxy-2-[(2-methyl-1-phenylpropan-2-yl)amino]ethyl]phenol,CC(C)(CC1=CC=CC=C1)NCC(C2=CC(=CC=C2)O)O,,,,,,
4480,3084483,Einecs 248-615-5,[H-].[H-].C(CC(=O)O)C(=O)O.[Ca+2],,,,,,
4481,3084484,Thalfine,CN1CCC2=C3C(=C(C=C2[C@@H]1CC4=CC(=C(C=C4)OC)OC5=CC=C(CC6=NC=CC7=C6C(=C8C(=C7OC)OCO8)O3)C=C5)OC)OC,,,,,,
4482,3084485,"Uridine 5'-(trihydrogen diphosphate), disodium salt",C1=CN(C(=O)NC1=O)[C@H]2C(C([C@H](O2)COP(=O)(O)OP(=O)([O-])[O-])O)O.[Na+].[Na+],,,,,,
4483,3084486,"[(2R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate",C1=CN(C(=O)NC1=O)[C@H]2C(C([C@H](O2)COP(=O)(O)OP(=O)(O)O)O)O,,,,,,
4484,3084487,"4,4'-Methylenebis(3-hydroxynaphthalene-2-carboxylic acid)--3,4-dimethyl-2-phenylmorpholine (1/1)",CC1C(OCCN1C)C2=CC=CC=C2.C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)O)O)C(=O)O,,,,,,
4485,3084488,"Cyclopenta(c)pyran-4-carboxylic acid, 1-(beta-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-4a,7-dihydroxy-7-methyl-, methyl ester",C[C@@]1(CC[C@]2([C@@H]1[C@@H](OC=C2C(=O)OC)OC3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O,,,,,,
4486,3084489,"Fructose, 1-amino-1-deoxy-",C1[C@H]([C@H]([C@@H]([C@](O1)(CO)N)O)O)O,,,,,,
4487,3084490,"Acetamide, N-(2-hydroxy-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)-",CC(C)NCC(COC1=CC(=C(C=C1)NC(=O)C)O)O,,,,,,
4488,3084491,"2,6,6-Trimethyl-8-methylidenebicyclo[5.3.1]undec-2-en-4-ol",CC1=CC(CC(C2CC1CCC2=C)(C)C)O,,,,,,
4489,3084492,"2-Propenoic acid, polymer with 2-propenal",C=CC=O.C=CC(=O)O,,,,,,
4490,3084493,"1,8-dihydroxy-3-(hydroxymethyl)-10-[(2R,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-10H-anthracen-9-one",C1=CC2=C(C(=C1)O)C(=O)C3=C(C2[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C=C(C=C3O)CO,,,,,,
4491,3084494,Solaradixine,C[C@@H]1CC[C@@]2([C@H](C3C(O2)CC4[C@@]3(CCC5C4CC=C6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)CO)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O)O[C@H]2[C@@H]([C@@H]([C@H]([C@@H](O2)C)O)O)O)C)C)C)NC1,,,,,,
4492,3084495,"3-Methyl-1-(3-methylfuran-2-yl)butane-2,3-diol",CC1=C(OC=C1)CC(C(C)(C)O)O,,,,,,
4493,3084496,"6-methyl-11-[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)oxy]-11H-benzo[c][1,2]benzothiazepine 5,5-dioxide",CN1C2CCC1CC(C2)OC3C4=CC=CC=C4N(S(=O)(=O)C5=CC=CC=C35)C,,,,,,
4494,3084497,"1,2,3,4,7,7-Hexachloro-5-hexa-1,5-dienylbicyclo[2.2.1]hept-2-ene",C=CCCC=CC1CC2(C(=C(C1(C2(Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
4495,3084498,CID 3084498,CC1=CC(=C2C(=CC(=O)C=C2O1)CC(=O)C)O,,,,,,
4496,3084499,"2,16,20-Trihydroxy-9,10,14-trimethyl-1,11,22-trioxo-4,9-cyclo-9,10-secocholesta-2,5-dien-25-yl acetate",CC(=O)OC(C)(C)CCC(=O)C(C)([C@H]1[C@@H](C[C@@]2([C@@]1(CC(=O)[C@@]3(C2CC=C4C3C=C(C(=O)C4(C)C)O)C)C)C)O)O,,,,,,
4497,3084500,"1-Undecyne, 11-chloro-",C#CCCCCCCCCCCl,,,,,,
4498,3084501,CID 3084501,C1CN(CCN1C(=NC(=NC2=CC=C(C=C2)Cl)N)N)C(=NC(=NC3=CC=C(C=C3)Cl)N)N.C([C@H]([C@H]([C@@H]([C@H](C(=O)O)O)O)O)O)O,,,,,,
4499,3084502,"1,3,5-Triazin-1-ium-2,4,6-triamine;bromide",C1(=[NH+]C(=NC(=N1)N)N)N.[Br-],,,,,,
4500,3084503,Erythrinine,CO[C@@H]1C[C@@]23C(=CCN2C[C@@H](C4=CC5=C(C=C34)OCO5)O)C=C1,,,,,,
4501,3084504,5-(2-Aminopropyl)-o-phenol hydrochloride,CC1=C(C=C(C=C1)CC(C)N)O.Cl,,,,,,
4502,3084505,"Glycine, N-(S-(1,4-dihydro-3-methyl-1,4-dioxo-2-naphthalenyl)-N-L-gamma-glutamyl-L-cysteinyl)-",CC1=C(C(=O)C2=CC=CC=C2C1=O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)O)N,,,,,,
4503,3084506,CID 3084506,COC1=C(C(=O)C2=C(C(=C(OC2=C1)C3=CC=C(C=C3)O)O)O)OC,,,,,,
4504,3084507,Gardenin C,COC1=CC(=CC(=C1OC)O)C2=CC(=O)C3=C(C(=C(C(=C3O2)OC)OC)OC)O,,,,,,
4505,3084508,Gardenin E,COC1=C(C=C(C=C1O)C2=CC(=O)C3=C(C(=C(C(=C3O2)OC)OC)OC)O)O,,,,,,
4506,3084509,Chloroformamidine hydrochloride,C(=N)(N)Cl.Cl,,,,,,
4507,3084510,CID 3084510,CC1C2C=CC=CC(=O)O[C@@H]3CC4[C@]5(C3([C@]6(CCC(=C[C@H]6O4)C)COC(=O)C=C(CC(O1)O2)C)C)CO5,,,,,,
4508,3084511,(1-Ethoxy-1-oxopropan-2-yl)triphenylphosphonium bromide,CCOC(=O)C(C)[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3.[Br-],,,,,,
4509,3084512,Potassium;hydride;4-hydroxybenzenesulfonic acid,[H-].C1=CC(=CC=C1O)S(=O)(=O)O.[K+],,,,,,
4510,3084513,CID 3084513,C[C@H](C(=O)N1CCC[C@H]1C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]4CCC(=O)N4,,,,,,
4511,3084514,1-(3-Phenylpropylamino)guanidine hydrochloride,C1=CC=C(C=C1)CCCNN=C(N)N.Cl,,,,,,
4512,3084515,Calcium bis(hydroxytoluenesulphonate),CC1=CC(=CC(=C1)S(=O)(=O)O)O.[Ca+2],,,,,,
4513,3084516,CID 3084516,CC(C)(C)S[IH]C(C)(C)C,,,,,,
4514,3084517,"Acetic acid, chloro-, isooctyl ester",CC(C)CCCCCOC(=O)CCl,,,,,,
4515,3084518,"2-Propenethioic acid, 2-methyl-, S-[3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,12,12,12-eicosafluoro-11-(trifluoromethyl)dodecyl] ester",CC(=C)C(=O)SCCC(C(C(C(C(C(C(C(C(C(F)(F)F)(C(F)(F)F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
4516,3084519,"2-Propenethioic acid, 2-methyl-, S-[3,3,4,4,5,5,6,6,7,8,8,8-dodecafluoro-7-(trifluoromethyl)octyl] ester",CC(=C)C(=O)SCCC(C(C(C(C(C(F)(F)F)(C(F)(F)F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
4517,3084520,Bradykinin potentiator B,CCC(C)C(C(=O)N1CCCC1C(=O)N2CCCC2C(=O)O)NC(=O)C(CCCCN)NC(=O)C3CCCN3C(=O)C(CCCN=C(N)N)NC(=O)C4CCCN4C(=O)C5CCCN5C(=O)C(CC(C)C)NC(=O)CNC(=O)C6CCC(=O)N6,,,,,,
4518,3084521,1-(2-Amino-5-hydroxyphenyl)ethanone,CC(=O)C1=C(C=CC(=C1)O)N,,,,,,
4519,3084522,"Bicyclo(2.2.1)heptane-1-methanesulfonic acid, 7,7-dimethyl-2-oxo-, (1S)-, compd. with N-(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-3-pyridinecarboxamide (1:1)",CC1=C(C(=O)N(N1C)C2=CC=CC=C2)NC(=O)C3=CN=CC=C3.CC1(C2CCC1(C(=O)C2)CS(=O)(=O)O)C,,,,,,
4520,3084523,"Pyridinium, 3-hydroxy-1-methyl-, bromide",C[N+]1=CC=CC(=C1)O.[Br-],,,,,,
4521,3084524,"Stigmast-7-en-6-one, 3-(benzoyloxy)-22-hydroxy-4-methyl-, (3beta,4alpha,5alpha,22R)-",CC[C@H](C[C@H]([C@@H](C)[C@H]1CC[C@@H]2C1(CC[C@H]3C2=CC(=O)[C@@H]4C3(CCC([C@H]4C)OC(=O)C5=CC=CC=C5)C)C)O)C(C)C,,,,,,
4522,3084525,"(1,1'-Biphenyl)-4,4'-disulfonic acid, disodium salt",C1=CC(=CC=C1C2=CC=C(C=C2)S(=O)(=O)O)S(=O)(=O)O.[Na+],,,,,,
4523,3084526,Pentyl palmitate,CCCCCCCCCCCCCCCC(=O)OCCCCC,,,,,,
4524,3084527,"5,7-dinitro-5H-indazole",C1=C2C=NN=C2C(=CC1[N+](=O)[O-])[N+](=O)[O-],,,,,,
4525,3084528,"2-Naphthalenol, nonyl-",CCCCCCCCCC1=CC(=CC2=CC=CC=C21)O,,,,,,
4526,3084529,CID 3084529,CCC(C)C(=O)O[C@@H]1C[C@]2([C@H](OC(=O)CC23C45C1(C6([C@@H](C7(CC6(C([C@@H]4OC(=O)C)(C7OC(=O)C8(C(O8)C)C)O)O)C)CC(=O)OC)C)OC(O3)(O5)C)C9=COC=C9)C,,,,,,
4527,3084530,(2-Chloroethyl)triphenylphosphonium bromide,C1=CC=C(C=C1)[P+](CCCl)(C2=CC=CC=C2)C3=CC=CC=C3.[Br-],,,,,,
4528,3084531,(2-Chloroethyl)triphenylphosphonium,C1=CC=C(C=C1)[P+](CCCl)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
4529,3084532,CID 3084532,CC=C1[C@H](N2C3CC1C4C2CC5(C4OC(=O)C)C3=NC6=CC=CC=C56)O[C@@H]7[C@@H]([C@@H]([C@H]([C@H](O7)CO)O)O)O,,,,,,
4530,3084533,3-Iodohexanato(2-),CCC[C@H](CC)I,,,,,,
4531,3084534,"1-Nonanol, 4,4,8,8-tetramethyl-",CC(C)(C)CCCC(C)(C)CCCO,,,,,,
4532,3084535,Thioformin,CN(C=S)O,,,,,,
4533,3084536,Diiodomethyl m-tolyl sulfone,CC1=CC(=CC=C1)S(=O)(=O)C(I)I,,,,,,
4534,3084537,Diiodomethyl o-tolyl sulfone,CC1=CC=CC=C1S(=O)(=O)C(I)I,,,,,,
4535,3084538,Diiodomethyl benzyl sulfone,C1=CC=C(C=C1)CS(=O)(=O)C(I)I,,,,,,
4536,3084539,"2,4,5,6(1H,3H)-Pyrimidinetetrone, 5-[(4-methoxy-2-nitrophenyl)hydrazone]",COC1=CC(=C(C=C1)N=NC2=C(NC(=O)NC2=O)O)[N+](=O)[O-],,,,,,
4537,3084540,"1,3,5,7-Tetrabromocyclooctane",C1C(CC(CC(CC1Br)Br)Br)Br,,,,,,
4538,3084541,Sodium 4-hydroxy-1-butanesulfonate,[H-].C(CCS(=O)(=O)O)CO.[Na+],,,,,,
4539,3084542,3-(Dimethylamino)propylurea,CN(C)CCCNC(=O)N,,,,,,
4540,3084543,p-Methoxybenzyl phenyl carbonate,COC1=CC=C(C=C1)COC(=O)OC2=CC=CC=C2,,,,,,
4541,3084544,Deacylcynaropicrin,C=C1CC(C2C(C3C1CC(C3=C)O)OC(=O)C2=C)O,,,,,,
4542,3084545,"Ethyl 2,4-dihydroxy-3,6-dimethylbenzoate",CCOC(=O)C1=C(C(=C(C=C1C)O)C)O,,,,,,
4543,3084546,"3-((2-(2,4-Bis(tert-pentyl)phenoxy)butyryl)amino)-N-(4,5-dihydro-5-oxo-1-(2,4,6-trichlorophenyl)-1H-pyrazol-3-yl)benzamide",CCC(C(=O)NC1=CC=CC(=C1)C(=O)NC2=NN(C(=O)C2)C3=C(C=C(C=C3Cl)Cl)Cl)OC4=C(C=C(C=C4)C(C)(C)CC)C(C)(C)CC,,,,,,
4544,3084547,"1-Pentanone, 2,3,4,5-tetrabromo-1,5-diphenyl-",C1=CC=C(C=C1)C(C(C(C(C(=O)C2=CC=CC=C2)Br)Br)Br)Br,,,,,,
4545,3084548,Einecs 250-741-0,[H-].C(=O)(C(C(=O)O)(O)O)O.[Na+],,,,,,
4546,3084549,"2,2,2-Trichloro-1-phenylethyl benzoate",C1=CC=C(C=C1)C(C(Cl)(Cl)Cl)OC(=O)C2=CC=CC=C2,,,,,,
4547,3084550,Ethyl 3-hydrazino-5-methyl-1H-pyrazole-4-carboxylate monohydrochloride,CCOC(=O)C1=C(NN=C1NN)C.[Cl-],,,,,,
4548,3084551,"7-Ethylidene-1a,2,3,7-tetrahydrocyclopenta[b]oxireno[c]pyridine",CC=C1C=CC2=NCC[C@@H]3[C@]12O3,,,,,,
4549,3084552,"9,10-Anthracenedione, 1-[(4-cyclohexylphenyl)amino]-4-hydroxy-",C1CCC(CC1)C2=CC=C(C=C2)NC3=C4C(=C(C=C3)O)C(=O)C5=CC=CC=C5C4=O,,,,,,
4550,3084553,"Dibenzo(a,h)phenazine-1,8-diol, tetrabromo-",C1=CC(=C2C=C(C3=C(C2=C1O)N=C4C=C(C5=CC(=CC(=O)C5=C4N3)Br)Br)Br)Br,,,,,,
4551,3084554,"1,3,5-trihydroxy-2,7-dimethyl-8-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyanthracene-9,10-dione",CC1=CC(=C2C(=C1OC3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C(=O)C4=C(C(=C(C=C4C2=O)O)C)O)O,,,,,,
4552,3084555,"3-[12,14-dihydroxy-3-[4-hydroxy-5-[4-hydroxy-5-(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)OC)O,,,,,,
4553,3084556,(12S)-12-hydroxyoctadec-9-enoic acid,CCCCCC[C@@H](CC=CCCCCCCCC(=O)O)O,,,,,,
4554,3084557,"4,4'-Bis(2-diethylaminoethyl carbamate)diphenylmethane",CCN(CC)CCOC(=O)NC1=CC=C(C=C1)CC2=CC=C(C=C2)NC(=O)OCCN(CC)CC,,,,,,
4555,3084558,Sumetizide,C1CC(=O)N(C1=O)CC2NC3=CC(=C(C=C3S(=O)(=O)N2)S(=O)(=O)N)Cl,,,,,,
4556,3084559,Heptacosan-14-ol,CCCCCCCCCCCCCC(CCCCCCCCCCCCC)O,,,,,,
4557,3084560,DL-Aspartic acid dimethyl ester hydrochloride,COC(=O)CC(C(=O)OC)N.Cl,,,,,,
4558,3084561,Decyltriphenylphosphonium bromide,CCCCCCCCCC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3.[Br-],,,,,,
4559,3084562,"Phosphonium, decyltriphenyl-",CCCCCCCCCC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
4560,3084563,D-Norpropoxyphene,CCC(=O)O[C@](CC1=CC=CC=C1)(C2=CC=CC=C2)[C@H](C)CNC,,,,,,
4561,3084564,"2-Phenazinamine, 8-chloro-3,5-dihydro-3-((1-methylethyl)imino)-N,5-diphenyl-",CC(C)C(=N)C1C=C2C(=NC3=C(N2C4=CC=CC=C4)C=CC(=C3)Cl)C=C1NC5=CC=CC=C5,,,,,,
4562,3084565,"(7,7-Dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid--N,N-diethyl-2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethan-1-amine (1/1)",CCN(CC)CCC1=NC(=NO1)C2=CC=CC=C2.CC1(C2CCC1(C(=O)C2)CS(=O)(=O)O)C,,,,,,
4563,3084566,Trifezolac,C1=CC=C(C=C1)C2=C(C(=NN2C3=CC=CC=C3)C4=CC=CC=C4)CC(=O)O,,,,,,
4564,3084567,"(2S-(2alpha,5alpha,6beta))-6-(((Hexahydro-1H-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid monohydrochloride",CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)N=CN3CCCCCC3)C(=O)O)C.Cl,,,,,,
4565,3084568,Einecs 251-319-9,CCCCNCC(C1=CC=C(C=C1)O)O.C1=CC(=CN=C1)C(=O)O,,,,,,
4566,3084569,Cyanidin 3-sambubioside,C1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=CC4=C(C=C(C=C4[O+]=C3C5=CC(=C(C=C5)O)O)O)O)CO)O)O)O)O)O.[Cl-],,,,,,
4567,3084570,"3-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5-hydroxychromen-7-one",C1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C(OC4=CC(=O)C=C(C4=C3)O)C5=CC(=C(C=C5)O)O)CO)O)O)O)O)O,,,,,,
4568,3084571,Prenyl thioacetate,CC(=CCSC(=O)C)C,,,,,,
4569,3084572,"8H-1,3-Dioxolo(4,5-h)(1)benzopyran-8-one, 5-(3-methyl-2-oxobutoxy)-",CC(C)C(=O)COC1=C2C=CC(=O)OC2=C3C(=C1)OCO3,,,,,,
4570,3084573,"[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl] (4aS,6aS,6bR,9R,10S,12aR)-10-[(2S,3R,4S,5S)-4,5-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@H](CO[C@H]2O[C@H]3CC[C@]4(C([C@]3(C)CO)CC[C@@]5(C4CC=C6[C@]5(CC[C@@]7(C6CC(CC7)(C)C)C(=O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O)O)O)O)C)C)C)O)O)O)O)O,,,,,,
4571,3084574,"Oxirane, 2,2'-((1-methylethylidene)bis((2,6-dibromo-4,1-phenylene)oxymethylene))bis-, homopolymer",CC(C)(C1=CC(=C(C(=C1)Br)OCCCO)Br)C2=CC(=C(C(=C2)Br)OCCOC)Br,,,,,,
4572,3084575,"1H-Imidazole, 1-(2-(2,4-dichlorophenyl)-2-(2-propenyloxy)ethyl)-, mononitrate",C=CCOC(CN1C=CN=C1)C2=C(C=C(C=C2)Cl)Cl.[N+](=O)([O-])[O-],,,,,,
4573,3084576,3-Chloroquinuclidine hydrochloride,C1CN2CCC1C(C2)Cl.Cl,,,,,,
4574,3084577,Congasin,CC1=CC(=C2C=C(C=CC2=N1)NC3=NC(=NC(=N3)N)NC4=CC5=C(C=C(N=C5C=C4)C)N)N.Cl,,,,,,
4575,3084578,"2-N,4-N-bis(4-amino-2-methylquinolin-6-yl)-1,3,5-triazine-2,4,6-triamine",CC1=CC(=C2C=C(C=CC2=N1)NC3=NC(=NC(=N3)N)NC4=CC5=C(C=C(N=C5C=C4)C)N)N,,,,,,
4576,3084579,"Copper(4+), ((N,N',N'',N'''-((29H,31H-phthalocyaninetetrayl-kappaN29,kappaN30,kappaN31,kappaN32)tetrakis(methylenethio((dimethylamino)methylidyne)))tetrakis(N-methylmethanaminiumato))(2-))-, tetrachloride",CN(C)C(=[N+](C)C)SCC1=CC2=C(C=C1)C3=NC4=NC(=NC5=C6C=C(C=CC6=C([N-]5)N=C7C8=C(C=CC(=C8)CSC(=[N+](C)C)N(C)C)C(=N7)N=C2[N-]3)CSC(=[N+](C)C)N(C)C)C9=C4C=CC(=C9)CSC(=[N+](C)C)N(C)C.[Cl-].[Cl-].[Cl-].[Cl-].[Cu+2],,,,,,
4577,3084580,"[Dimethylamino-[[15,24,34-tris[[dimethylamino(dimethylazaniumylidene)methyl]sulfanylmethyl]-2,11,20,29,37,38,39,40-octazanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12(39),13(18),14,16,19,21,23,25,27,30(37),31(36),32,34-nonadecaen-6-yl]methylsulfanyl]methylidene]-dimethylazanium",CN(C)C(=[N+](C)C)SCC1=CC2=C(C=C1)C3=NC2=NC4=NC(=NC5=NC(=NC6=C7C=C(C=CC7=C(N6)N3)CSC(=[N+](C)C)N(C)C)C8=C5C=C(C=C8)CSC(=[N+](C)C)N(C)C)C9=C4C=C(C=C9)CSC(=[N+](C)C)N(C)C,,,,,,
4578,3084581,"Phenol, 2-methoxy-4-propyl-, acetate",CCCC1=CC(=C(C=C1)OC(=O)C)OC,,,,,,
4579,3084582,"[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-[2-hydroxy-4-(hydroxymethyl)phenoxy]oxan-2-yl]methyl 3-phenylprop-2-enoate",C1=CC=C(C=C1)C=CC(=O)OC[C@@H]2[C@H]([C@H]([C@H]([C@@H](O2)OC3=C(C=C(C=C3)CO)O)O)O)O,,,,,,
4580,3084583,"3,3-Dimethyl-3H,7H-pyrano[2',3':6,7][1]benzofuro[3,2-c][1]benzopyran-6b,10(12bH)-diol",CC1(C=CC2=C(O1)C=CC3=C2OC4C3(COC5=C4C=CC(=C5)O)O)C,,,,,,
4581,3084584,"Ethanone, 1-(4-(2-(methylamino)propyl)phenyl)-, (R)-",CC(CC1=CC=C(C=C1)C(=O)C)NC,,,,,,
4582,3084585,"Diethyl(2-(2-methoxyphenoxy)-2-oxoethyl)ammonium (2S-(2alpha,5alpha,6beta(S*)))-6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate",CCN(CC)CC(=O)OC1=CC=CC=C1OC.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)C,,,,,,
4583,3084586,"N,N-Diethylglycine 2-methoxyphenyl ester",CCN(CC)CC(=O)OC1=CC=CC=C1OC,,,,,,
4584,3084587,Pteleatinium,CC(C)([C@H]1CC2=C(C3=C(C(=CC=C3)O)[N+](=C2O1)C)OC)O.[Cl-],,,,,,
4585,3084588,N-Acetylprocainamide ethobromide,CC[N+](CC)(CC)CCNC(=O)C1=CC=C(C=C1)NC(=O)C.[Br-],,,,,,
4586,3084589,CID 3084589,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@H]([C@H](O[C@H]2OC(=O)C34CC[C@@]5(C(=CCC6C5(CCC7[C@@]6(CC(C([C@@]7(C)C(=O)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)C)C)C3CC(CC4)(C)C)CO)C)OC(=O)C=CC9=CC(=C(C=C9)OC)OC)O)O)O)O[C@H]1[C@@H]([C@H]([C@@H](CO1)O[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)O)O,,,,,,
4587,3084590,Otobanone,C[C@H]1[C@@H](C(=O)C2=C([C@@H]1C3=CC4=C(C=C3)OCO4)C5=C(C=C2)OCO5)C,,,,,,
4588,3084591,"14-Methyl-9,19-cycloergost-24(28)-en-3-ol",CC(C)C(=C)CCC(C)[C@H]1CC[C@@]2([C@@]1(CCC34C2CCC5C3(C4)CC[C@@H](C5)O)C)C,,,,,,
4589,3084592,Temodox,CC1=C([N+](=O)C2=CC=CC=C2N1[O-])C(=O)OCCO,,,,,,
4590,3084593,Fenalcomine hydrochloride,CCC(C1=CC=C(C=C1)OCCNC(C)CC2=CC=CC=C2)O.Cl,,,,,,
4591,3084594,"3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl hexadecanoate",CCCCCCCCCCCCCCCCC1(CCC2=C(O1)C(=C(C(=C2C)OC(=O)CCCCCCCCCCCCCCC)C)C)C,,,,,,
4592,3084595,Amidinomalonamide hydrochloride,C(C(=N)N)C(=O)N.Cl,,,,,,
4593,3084596,Niclosamide piperazine,C1CNCCN1.C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O,,,,,,
4594,3084597,Einecs 252-300-8,C(F)(F)(F)S(=O)[O-].C(F)(F)(F)S(=O)[O-].[Cu+2],,,,,"['Copper is mainly absorbed through the gastrointestinal tract, but it can also be inhalated and absorbed dermally. It passes through the basolateral membrane, possibly via regulatory copper transporters, and is transported to the liver and kidney bound to serum albumin. The liver is the critical organ for copper homoeostasis. In the liver and other tissues, copper is stored bound to metallothionein, amino acids, and in association with copper-dependent enzymes, then partitioned for excretion through the bile or incorporation into intra- and extracellular proteins. The transport of copper to the peripheral tissues is accomplished through the plasma attached to serum albumin, ceruloplasmin or low-molecular-weight complexes. Copper may induce the production of metallothionein and ceruloplasmin. The membrane-bound copper transporting adenosine triphosphatase (Cu-ATPase) transports copper ions into and out of cells. Physiologically normal levels of copper in the body are held constant by alterations in the rate and amount of copper absorption, compartmental distribution, and excretion. (L277, L279)']",
4595,3084598,Trifluoromethanesulfinic acid anion,C(F)(F)(F)S(=O)[O-],,,,,,
4596,3084599,Chlorazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3.C(C(Cl)(Cl)Cl)(O)O,,,,,,
4597,3084600,"Dihydrogen bis(L-glutamato(2-)-N,O1)zincate(2-)",C(CC(=O)O)C(C(=O)O)N.[Zn+2],,,,,,
4598,3084601,Ethyl menthyl carbonate,CCOC(=O)O[C@@H]1C[C@@H](CC[C@H]1C(C)C)C,,,,,,
4599,3084602,"L-Proline, 1-(1-(N-(N2-(1-(N-(1-(N-(N2-(5-oxo-L-prolyl)-L-asparaginyl)-L-tryptophyl)-L-prolyl)-L-histidyl)-L-prolyl)-L-glutaminyl)-L-isoleucyl)-L-prolyl)-",CCC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N2CCC[C@H]2C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CC4=CN=CN4)NC(=O)[C@@H]5CCCN5C(=O)[C@H](CC6=CNC7=CC=CC=C76)NC(=O)[C@H](CC(=O)N)NC(=O)C8CCC(=O)N8,,,,,,
4600,3084603,Benafentrine,CC(=O)NC1=CC=C(C=C1)C2=N[C@H]3CCN(C[C@H]3C4=CC(=C(C=C42)OC)OC)C,,,,,,
4601,3084604,"Bicyclo[2.2.1]heptane, 2,2-dimethyl-3-methylene-, dimer",CC1(C2CCC(C2)C1C=CC3C4CCC(C4)C3(C)C)C,,,,,,
4602,3084605,Natsudaidain,COC1=C(C=C(C=C1)C2=C(C(=O)C3=C(O2)C(=C(C(=C3OC)OC)OC)OC)O)OC,,,,,,
4603,3084606,"1-(2,6-Dihydroxy-4-methoxyphenyl)-3-(4-methoxyphenyl)propan-1-one",COC1=CC=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OC)O,,,,,,
4604,3084607,Copper diundec-10-enoate,C=CCCCCCCCCC(=O)O.[Cu+2],,,,,,
4605,3084608,Dimethyl diallylmalonate,COC(=O)C(CC=C)(CC=C)C(=O)OC,,,,,,
4606,3084609,CID 3084609,C(C(C1C(=O)C(=C(O1)O)O)O)O.C(C(C(=O)O)N)S,,,,,,
4607,3084610,Einecs 252-568-6,[H-].CCSC(=S)S.[K+],,,,,,
4608,3084611,"1,1'-Fluoranthene-3,9-diylbis(2-(dimethylamino)ethan-1-one) dihydrochloride",CN(C)CC(=O)C1CCC2C3CCCC4C3C(C2C1)CCC4C(=O)CN(C)C.Cl.Cl,,,,,,
4609,3084612,"2-(Dimethylamino)-1-[4-[2-(dimethylamino)acetyl]-1,2,3,3a,4,5,6,6a,6b,7,8,9,10,10a,10b,10c-hexadecahydrofluoranthen-8-yl]ethanone",CN(C)CC(=O)C1CCC2C3CCCC4C3C(C2C1)CCC4C(=O)CN(C)C,,,,,,
4610,3084613,CID 3084613,CC1=C(OC(C1=O)CC(C)CCCC(=CCCC2=COC(=C2)CC3=COC=C3)C)O,,,,,,
4611,3084614,"7,8-Didehydro-4,5-epoxy-17-methyl-(5alpha,6alpha)morphinan-3,6-diol 3-(hydrogen sulfate)",CN1CC[C@]23[C@@H]4[C@@H]1CC5=C2C(=C(C=C5)OS(=O)(=O)O)O[C@H]3C(C=C4)O,,,,,,
4612,3084615,3-Methylpentyl isovalerate,CCC(C)CCOC(=O)CC(C)C,,,,,,
4613,3084616,4-Methylpentyl isobutyrate,CC(C)CCCOC(=O)C(C)C,,,,,,
4614,3084617,benzyl (2S)-2-amino-3-(1H-indol-3-yl)propanoate hydrochloride,C1=CC=C(C=C1)COC(=O)C(CC2=CNC3=CC=CC=C32)N.Cl,,,,,,
4615,3084618,Tetrabutylammonium trifluoroacetate,CCCC[N+](CCCC)(CCCC)CCCC.C(=O)(C(F)(F)F)[O-],,,,,,
4616,3084619,Tetrapropylammonium trifluoromethanesulphonate,CCC[N+](CCC)(CCC)CCC.C(F)(F)(F)S(=O)(=O)[O-],,,,,,
4617,3084620,Calciumglycinate,C(C(=O)O)N.[Ca+2],,,,,,
4618,3084621,p-(Phenoxypropoxy)aniline,C1=CC=C(C=C1)OCCCOC2=CC=C(C=C2)N.[Cl-],,,,,,
4619,3084622,"N,N'-Dicyclohexyl-N-methylcarbodiimidium iodide",C[N+](=C=NC1CCCCC1)C2CCCCC2.[I-],,,,,,
4620,3084623,N-(Cyclohexylcarbonimidoyl)-N-methylcyclohexanaminium,C[N+](=C=NC1CCCCC1)C2CCCCC2,,,,,,
4621,3084624,exo-8-Methyl-8-azabicyclo(3.2.1)oct-3-yl diphenylglycolate hydrochloride,CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O.Cl,,,,,,
4622,3084625,Sodium;[4-[(4-phosphonooxyphenyl)-pyridin-2-ylmethyl]phenyl] dihydrogen phosphate,C1=CC=NC(=C1)C(C2=CC=C(C=C2)OP(=O)(O)O)C3=CC=C(C=C3)OP(=O)(O)O.[Na+],,,,,,
4623,3084626,Picofosforic acid,C1=CC=NC(=C1)C(C2=CC=C(C=C2)OP(=O)(O)O)C3=CC=C(C=C3)OP(=O)(O)O,,,,,,
4624,3084627,"2-(dimethylamino)-N-[7-(1H-indol-3-ylmethyl)-5,8-dioxo-3-propan-2-yl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),10,12,15-tetraen-4-yl]-3-methylpentanamide",CCC(C)C(C(=O)NC1C(OC2=CC=C(C=C2)C=CNC(=O)C(NC1=O)CC3=CNC4=CC=CC=C43)C(C)C)N(C)C,,,,,,
4625,3084628,Ethanolamine oxiniacate,C1=CC(=C[N+](=C1)[O-])C(=O)O.C(CO)N,,,,,,
4626,3084629,Herbarin,CC1(CC2=C(CO1)C(=O)C3=C(C2=O)C=C(C=C3OC)OC)O,,,,,,
4627,3084630,"Hexanoic acid, calcium salt (2:1)",CC(=O)NCCCCCC(=O)O.[Ca+2],,,,,,
4628,3084631,Zinc dithizonate,C1=CC=C(C=C1)[N-]NC(=[SH+])N=NC2=CC=CC=C2.C1=CC=C(C=C1)[N-]NC(=[SH+])N=NC2=CC=CC=C2.[Zn+2],,,,,,
4629,3084632,Zirconium carbonate,C(=O)([O-])[O-].C(=O)([O-])[O-].[Zr+4],,,,,,
4630,3084633,"4-Chloro-3,5-dinitrocumene",CC(C)C1=CC(=C(C(=C1)[N+](=O)[O-])Cl)[N+](=O)[O-],,,,,,
4631,3084634,Polyglycerin-6,C([C@@H](COC[C@@H](COC[C@H](COC[C@H](COC[C@H](COC[C@H](CO)O)O)O)O)O)O)O,,,,,,
4632,3084635,"N,N'-Bis(1-amino-2-propyl)ethanediamine",C[C@H](CN)NCCN[C@@H](C)CN,,,,,,
4633,3084636,"1-Piperazinecarboxylic acid, 4-(5,5-dimethyl-3-methylene-1-cyclohexen-1-yl)-, ethyl ester",CCOC(=O)N1CCN(CC1)C2=CC(=C)CC(C2)(C)C,,,,,,
4634,3084637,"(1S,2S,3S,4R,7S,8R,10R,11R)-pentacyclo[9.2.1.14,7.02,10.03,8]pentadeca-5,12-diene",C1[C@@H]2C=C[C@H]1[C@H]3[C@@H]2C[C@H]4[C@@H]3[C@@H]5C[C@H]4C=C5,,,,,,
4635,3084638,"Benzenepropanoic acid, 3-(1,1-dimethylethyl)-4-hydroxy-, methyl ester",CC(C)(C)C1=C(C=CC(=C1)CCC(=O)OC)O,,,,,,
4636,3084639,"erythro-2,5-Hexodiulose, 1,6-dideoxy-",CC(=O)[C@@H]([C@@H](C(=O)C)O)O,,,,,,
4637,3084640,"Benzeneethanaminium, 4-((4-amino-2-methylphenyl)azo)-N,N,N-trimethyl-beta-oxo-, chloride",CC1=C(C=CC(=C1)N)N=NC2=CC=C(C=C2)C(=O)C[N+](C)(C)C.[Cl-],,,,,,
4638,3084641,"4-[(4-Amino-2-methylphenyl)azo]-N,N,N-trimethyl-beta-oxobenzeneethanaminium",CC1=C(C=CC(=C1)N)N=NC2=CC=C(C=C2)C(=O)C[N+](C)(C)C,,,,,,
4639,3084642,CID 3084642,C1=C(NC=N1)CC(C(=O)[O-])N.O.O.[AlH2+],,,,,,
4640,3084643,Xantifibrate,CC(C)(C(=O)O)OC1=CC=C(C=C1)Cl.CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CN(C)CCO)O,,,,,,
4641,3084644,"1,3,5-Triazine-2,4-diamine, N-(4-fluorophenyl)-6-propyl-",CCCC1=NC(=NC(=N1)NC2=CC=C(C=C2)F)N,,,,,,
4642,3084645,"ar,ar'-Dimethyl 4,4'-carbonyldiphthalate",COC(=O)C1=C(C=C(C=C1)C(=O)C2=CC(=C(C=C2)C(=O)OC)C(=O)O)C(=O)O,,,,,,
4643,3084646,"[4,5'-Biisobenzofuran]-1,1',3,3'-tetrone",C1=CC(=C2C(=C1)C(=O)OC2=O)C3=CC4=C(C=C3)C(=O)OC4=O,,,,,,
4644,3084647,"(+)-2,2-Dimethyl-4,5-((diphenylphosphino)dimethyl)dioxolane",CC1(O[C@@H]([C@H](O1)CP(C2=CC=CC=C2)C3=CC=CC=C3)CP(C4=CC=CC=C4)C5=CC=CC=C5)C,,,,,,
4645,3084648,Dipentylcyanamide,CCCCCN(CCCCC)C#N,,,,,,
4646,3084649,"Adenosine sodio-2',3'-phosphate hydrate",[H-].C1=NC(=C2C(=N1)N(C=N2)C3C4C(C(O3)CO)OP(=O)(O4)O)N.[Na+],,,,,,
4647,3084650,CID 3084650,C[C@@]12[C@@H]3[C@@H](C=C4[C@H](OC(=O)CC4[C@]3([C@@H]5[C@H]([C@@H]1O)O5)C)C=C)OC2=O,,,,,,
4648,3084651,m-Aminobenzamidine dihydrochloride,C1=CC(=CC(=C1)N)C(=N)N.Cl.Cl,,,,,,
4649,3084652,"2-methyl-5-[(1S,2R,4R)-2-methyl-3-methylidene-2-bicyclo[2.2.1]heptanyl]pent-2-en-1-ol",CC(=CCC[C@@]1([C@H]2CC[C@H](C2)C1=C)C)CO,,,,,,
4650,3084653,"(1R,2S)-2-hexyl-3-oxocyclopentane-1-carboxylic acid",CCCCCC[C@H]1[C@@H](CCC1=O)C(=O)O,,,,,,
4651,3084654,CID 3084654,CCCOP(=O)(C=C(C)O[C@@H](C)CCl)OCCC,,,,,,
4652,3084655,Citromycin,CC1=CC(=O)C2=C(O1)C3=CC(=C(C=C3OC2)O)O,,,,,,
4653,3084656,Detralfate,C[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@H](O2)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)O,,,,,,
4654,3084657,CID 3084657,CC(=O)OC[C@@]12[C@H]([C@H]([C@H]3C([C@@]14C(C([C@H]([C@H]2OC(=O)C)OC(=O)C)[C@](O4)(COC(=O)C5=C(CCC(C(=O)O3)(C)O)N=CC=C5)C)OC(=O)C)(C)O)OC(=O)C6=CC=CC=C6)OC(=O)C,,,,,,
4655,3084658,meta-Phosphoric acid,OP(=O)=O,,,,,,
4656,3084659,CID 3084659,C[C@@H]1CC=CC=C[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@@H]3CC([C@@H]([C@H](O3)C)O)(C)C)N(C)C)O)CC=O)C)O.C(C(C(=O)O)O)(C(=O)O)O,,,,,,
4657,3084660,CID 3084660,C[C@H]1CC=CC=C[C@H]([C@@H](C[C@H]([C@H]([C@@H]([C@@H](CC(=O)O1)O)OC)O[C@@H]2[C@@H]([C@@H]([C@H]([C@@H](O2)C)O[C@@H]3CC([C@@H]([C@@H](O3)C)O)(C)C)N(C)C)O)CC=O)C)O,,,,,,
4658,3084661,Colestipol hydrochloride,C(CNCCNCCNCCN)N.Cl,,,"['Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)', 'High-molecular-weight insoluble polymers that contain functional cationic groups capable of undergoing exchange reactions with anions. (See all compounds classified as Anion Exchange Resins.)', 'Compounds that bind to and reduce the biological availability of a chemical or pharmaceutical agent. (See all compounds classified as Sequestering Agents.)']",,,
4659,3084662,CID 3084662,CCOCCO[IH](O)(O)SO,,,,,,
4660,3084663,"Acetamide, N-[5-[bis(2-hydroxyethyl)amino]-2-[(2-bromo-4,6-dinitrophenyl)azo]-4-methoxyphenyl]-",CC(=O)NC1=CC(=C(C=C1N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])[N+](=O)[O-])OC)N(CCO)CCO,,,,,,
4661,3084664,"1,2,4,6-Tetramethylthialdine",C[C@H]1N([C@@H](SC(S1)C)C)C,,,,,,
4662,3084665,"Phenol, 2-[[2-[[4,12-bis(1,1-dimethylethyl)-2,14-dimethyl-10,6-nitrilo-6H-dibenzo[h,k][1,7,10,3,5]dioxathiadiazacyclododecin-8-yl]oxy]-3-(1,1-dimethylethyl)-5-methylphenyl]thio]-6-(1,1-dimethylethyl)-4-methyl-",CC1=CC(=C2C(=C1)SC3=CC(=CC(=C3OC4=NC(=NC(=N4)O2)OC5=C(C=C(C=C5SC6=CC(=CC(=C6O)C(C)(C)C)C)C)C(C)(C)C)C(C)(C)C)C)C(C)(C)C,,,,,,
4663,3084666,Einecs 253-563-1,C[C@H]1[C@@H]([C@@H](C[C@H](O1)O[C@H]2CC[C@@]3([C@H]4CC[C@@]5([C@H](CC[C@@]5([C@@H]4CC[C@@]3(C2)O)O)C6=CC(=O)OC6)C)CO)OC)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO[C@@H]8[C@H]([C@@H]([C@H]([C@@H](O8)CO)O)O)O)O)O)O,,,,,,
4664,3084667,Ciclazindol hydrochloride,C1CN=C2C(C3=CC=CC=C3N2C1)(C4=CC(=CC=C4)Cl)O.Cl,,,,,,
4665,3084668,CID 3084668,CCCC=CCO[C@H](C)OCC,,,,,,
4666,3084669,"1H-Isoindole-1,3(2H)-dione, 4,5,6,7-tetrabromo-2-(2,4,6-tribromophenyl)-",C1=C(C=C(C(=C1Br)N2C(=O)C3=C(C2=O)C(=C(C(=C3Br)Br)Br)Br)Br)Br,,,,,,
4667,3084670,"2,4,6-Tribromophenyl methacrylate",CC(=C)C(=O)OC1=C(C=C(C=C1Br)Br)Br,,,,,,
4668,3084671,"Ethyl 2-(3,3-dimethylcyclohexylidene)acetate",CCOC(=O)C=C1CCCC(C1)(C)C,,,,,,
4669,3084672,Myristoyl isethionate,CCCCCCCCCCCCCC(=O)OCCS(=O)(=O)O,,,,,,
4670,3084673,N-p-Hydroxyphenyl-t-butylamine,CC(C)(CC1=CC=C(C=C1)O)NCC(C2=CC(=CC(=C2)O)O)O.Br,,,,,,
4671,3084674,"5-[2-[[2-(4-Hydroxyphenyl)-1,1-dimethylethyl]amino]-1-hydroxyethyl]benzene-1,3-diol",CC(C)(CC1=CC=C(C=C1)O)NCC(C2=CC(=CC(=C2)O)O)O,,,,,,
4672,3084675,(2R)-1-chloro-2-nitropropane,C[C@H](CCl)[N+](=O)[O-],,,,,,
4673,3084676,5-Hydroxy-1H-pyrazole-3-carboxylic acid,C1=C(NNC1=O)C(=O)O,,,,,,
4674,3084677,CID 3084677,CC=CC=CCCCCCCCO[C@@H]1CCCCO1,,,,,,
4675,3084678,"(1S)-1-(2,3-dimethoxy-6-nitrophenyl)ethanol",C[C@@H](C1=C(C=CC(=C1OC)OC)[N+](=O)[O-])O,,,,,,
4676,3084679,Peuarenine,CC1C(O1)(C)C(=O)O[C@H]2[C@H](C(OC3=C2C=C4C=CC(=O)OC4=C3)(C)C)OC(=O)C5(C(O5)C)C,,,,,,
4677,3084680,Iodoacetyl chloride,C(C(=O)Cl)I,,,,,,
4678,3084681,"Pyrazine, 2-ethyl-3-(2-methylpropyl)-",CCC1=NC=CN=C1CC(C)C,,,,,,
4679,3084682,"praseodymium(3+);(1E)-2,2,2-trifluoro-1-(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanylidene)ethanolate;(1Z)-2,2,2-trifluoro-1-(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanylidene)ethanolate",CC1(C2(C(=O)/C(=C(/[O-])\C(F)(F)F)/C1CC2)C)C.CC1(C2(C(=O)/C(=C(/[O-])\C(F)(F)F)/C1CC2)C)C.CC1(C2(C(=O)/C(=C(\[O-])/C(F)(F)F)/C1CC2)C)C.[Pr+3],,,,,,
4680,3084683,"Bicyclo[2.2.1]heptan-2-one, 1,7,7-trimethyl-3-(2,2,2-trifluoro-1-hydroxyethylidene)-",CC1(C\2CCC1(C(=O)/C2=C(/C(F)(F)F)\O)C)C,,,,,,
4681,3084684,"1,7,7-Trimethyl-3-(2,2,2-trifluoro-1-hydroxyethylidene)bicyclo[2.2.1]heptane-2-one",CC1(C\2CCC1(C(=O)/C2=C(\C(F)(F)F)/O)C)C,,,,,,
4682,3084685,"Tris(1,7,7-trimethyl-3-(trifluoroacetyl)bicyclo(2.2.1)heptan-2-onato-O,O')ytterbium",CC1(C2(C(=O)/C(=C(/[O-])\C(F)(F)F)/C1CC2)C)C.CC1(C2(C(=O)/C(=C(/[O-])\C(F)(F)F)/C1CC2)C)C.CC1(C2(C(=O)/C(=C(/[O-])\C(F)(F)F)/C1CC2)C)C.[Yb+3],,,,,,
4683,3084686,"2,6-Pyridinediamine, N,N'-bis(2,4,6-trinitrophenyl)-",C1=CC(=NC(=C1)NC2=C(C=C(C=C2[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-])NC3=C(C=C(C=C3[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],,,,,,
4684,3084687,"[2-[(6,7-dimethoxy-1-methyl-3,4-dihydro-1H-isoquinolin-2-yl)methyl]-1-(3,4-dimethylphenyl)-4-methylpentyl] acetate;hydrochloride",CC1C2=CC(=C(C=C2CCN1CC(CC(C)C)C(C3=CC(=C(C=C3)C)C)OC(=O)C)OC)OC.Cl,,,,,,
4685,3084688,"[2-[(6,7-dimethoxy-1-methyl-3,4-dihydro-1H-isoquinolin-2-yl)methyl]-1-(3,4-dimethylphenyl)-4-methylpentyl] acetate",CC1C2=CC(=C(C=C2CCN1CC(CC(C)C)C(C3=CC(=C(C=C3)C)C)OC(=O)C)OC)OC,,,,,,
4686,3084689,"Phosphorochloridic acid, bis[4-(1,1-dimethylethyl)phenyl] ester",CC(C)(C)C1=CC=C(C=C1)OP(=O)(OC2=CC=C(C=C2)C(C)(C)C)Cl,,,,,,
4687,3084690,"(3,3'-Bi-7H-benz(de)anthracene)-7,7'-dione, 9,9'-dinitro-",C1=CC2=C(C=CC3=C2C(=C1)C(=O)C4=C3C=CC(=C4)[N+](=O)[O-])C5=C6C=CC=C7C6=C(C=C5)C8=C(C7=O)C=C(C=C8)[N+](=O)[O-],,,,,,
4688,3084691,CID 3084691,C1=CC2=C3C(=C4C=CC(=CC4=C(C3=C1)O)N)C=CC2=C5C=CC6=C7C=CC(=N)C=C7C(=O)C8=CC=CC5=C68,,,,,,
4689,3084692,"(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[6-[(4-hydroxy-3-methylbut-2-enyl)amino]purin-7-yl]oxane-3,4,5-triol",CC(=CCNC1=NC=NC2=C1N(C=N2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)CO,,,,,,
4690,3084693,"9(10H)-Anthracenone, 1,8-bis(acetyloxy)-",C1C2=C(C(=CC=C2)CC(=O)O)C(=O)C3=C1C=CC=C3CC(=O)O,,,,,,
4691,3084694,"9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-di(valerate)",CCCCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)OC(=O)CCCC,,,,,,
4692,3084695,4-((3-Methyl-4-(1-pyrrolidinyl)phenyl)azo)benzenesulfonic acid,CC1=C(C=CC(=C1)N=NC2=CC=C(C=C2)S(=O)(=O)O)N3CCCC3,,,,,,
4693,3084696,Methyl 2-(4-hydroxyphenyl)-2-oxoacetate,COC(=O)C(=O)C1=CC=C(C=C1)O,,,,,,
4694,3084697,"Carbonic acid, diphenylmethyl phenyl ester",C1=CC=C(C=C1)C(C2=CC=CC=C2)OC(=O)OC3=CC=CC=C3,,,,,,
4695,3084698,CID 3084698,COC(=O)CC(=O)[O-].[K+],,,,,,
4696,3084699,"Mercaptoacetic acid, strontium salt",C(C(=O)O)S.[Sr+2],,,,,,
4697,3084700,"1,2-Anthracenedione, 7-hydroxy-8-methoxy-6-methyl-",CC1=CC2=CC3=C(C=C2C(=C1O)OC)C(=O)C(=O)C=C3,,,,,,
4698,3084701,"Benzoic acid, 4-(hexyloxy)-, 4-butylphenyl ester",CCCCCCOC1=CC=C(C=C1)C(=O)OC2=CC=C(C=C2)CCCC,,,,,,
4699,3084702,"Benzoic acid, 4-butyl-, 4-[(4-butylphenoxy)carbonyl]phenyl ester",CCCCC1=CC=C(C=C1)C(=O)OC2=CC=C(C=C2)C(=O)OC3=CC=C(C=C3)CCCC,,,,,,
4700,3084703,4-(Hexyloxy)phenyl 4-Butylbenzoate,CCCCCCOC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)CCCC,,,,,,
4701,3084704,2-Dodecyloxy-2-phenylacetophenone,CCCCCCCCCCCCO[C@@H](C1=CC=CC=C1)C(=O)C2=CC=CC=C2,,,,,,
4702,3084705,2-(2-Ethylhexyloxy)-2-phenylacetophenone,CCCC[C@@H](CC)CO[C@@H](C1=CC=CC=C1)C(=O)C2=CC=CC=C2,,,,,,
4703,3084706,"2,2,4-Trimethyladipic acid, 6-decyl 1-octyl ester",CCCCCCCCCCOC(=O)C[C@H](C)CC(C)(C)C(=O)OCCCCCCCC,,,,,,
4704,3084707,(4-methyl-1H-imidazol-5-yl)methanol hydrochloride,CC1=C(N=CN1)CO.Cl,,,,,,
4705,3084708,Groenlandicine,COC1=C(C=C2CC[N+]3=C(C2=C1)C=C4C=CC5=C(C4=C3)OCO5)O,,,,,,
4706,3084709,3-Bromo-5-chloroaniline,C1=C(C=C(C=C1Cl)Br)N,,,,,,
4707,3084710,"(3aR,5aS,7R,8S,8aR,9aR)-7,8-dihydroxy-1,5,8-trimethyl-1,3a,5a,6,7,8a,9,9a-octahydroazuleno[6,5-b]furan-2-one",CC1[C@H]2C[C@@H]3[C@H](C[C@H]([C@@]3(C)O)O)C(=C[C@@H]2OC1=O)C,,,,,,
4708,3084711,1-(p-Chlorophenyl)-3-(m-3-isobutylguanidinophenyl)urea hydrochloride,CC(C)CN=C(N)NC1=CC(=CC=C1)NC(=O)NC2=CC=C(C=C2)Cl.Cl,,,,,,
4709,3084712,tert-Butylphenyl dichlorophosphate,CC(C)(C)C1=CC=C(C=C1)OP(=O)(Cl)Cl,,,,,,
4710,3084713,"8H-Benzo(g)-1,3-benzodioxolo(6,5,4-de)quinolin-8-one, 9,10-dimethoxy-",COC1=C(C2=C(C=C1)C3=C4C(=CC5=C3OCO5)C=CN=C4C2=O)OC,,,,,,
4711,3084714,1-(1-Propoxyethoxy)butane,CCCCO[C@@H](C)OCCC,,,,,,
4712,3084715,"Praseodymium, tris(3-(2,2,3,3,4,4,4-heptafluoro-1-(oxo-kappaO)butyl)-1,7,7-trimethylbicyclo(2.2.1)heptan-2-onato-kappaO)-",CC1(C2(C(=O)/C(=C(/[O-])\C(F)(F)C(F)(F)C(F)(F)F)/C1CC2)C)C.CC1(C2(C(=O)/C(=C(/[O-])\C(F)(F)C(F)(F)C(F)(F)F)/C1CC2)C)C.CC1(C2(C(=O)/C(=C(/[O-])\C(F)(F)C(F)(F)C(F)(F)F)/C1CC2)C)C.[Pr+3],,,,,,
4713,3084716,"1,7,7-Trimethyl-3-(1-hydroxy-2,2,3,3,4,4,4-heptafluorobutylidene)bicyclo[2.2.1]heptan-2-one",CC1(C\2CCC1(C(=O)/C2=C(\C(C(C(F)(F)F)(F)F)(F)F)/O)C)C,,,,,,
4714,3084717,"1,3-dihydroxy-6-methyl-8-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyanthracene-9,10-dione",CC1=CC2=C(C(=C1)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C(=O)C4=C(C2=O)C=C(C=C4O)O,,,,,,
4715,3084718,(-)-Cycleapeltine,CN1CCC2=CC(=C(C3=C2[C@@H]1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)C[C@H]6C7=CC(=C(C=C7CCN6C)OC)O3)OC)O)OC,,,,,,
4716,3084719,CID 3084719,[Li+].CCCCC(=O)[O-],,,,,,
4717,3084720,1-(4-Chlorophenyl)piperazine Hydrochloride,C1CN(CCN1)C2=CC=C(C=C2)Cl.Cl,,,,,,
4718,3084721,Einecs 254-166-6,COC1=CC=C(C=C1)N2CCNCC2.[Cl-],,,,,,
4719,3084722,"1,1,3-Triethoxynonane",CCCCCC[C@@H](CC(OCC)OCC)OCC,,,,,,
4720,3084723,CID 3084723,CC(C)C1=C2C(=NC(=NC2=O)C(C)(C)C)NO1,,,,,,
4721,3084724,O-Allylhydroxylamine hydrochloride,C=CCON.Cl,,,,,,
4722,3084725,"Sodium 3,4-dichlorobenzenesulphonate",[H-].C1=CC(=C(C=C1S(=O)(=O)O)Cl)Cl.[Na+],,,,,,
4723,3084726,Neocitrullamon,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)CCCC(C(=O)O)N)C3=CC=CC=C3,,,,,,
4724,3084727,"(S)-2-(3,4-Dihydroxyphenyl)-7-(beta-D-glucopyranosyloxy)-2,3-dihydro-5-hydroxy-4H-1-benzopyran-4-one",C1C(OC2=CC(=CC(=C2C1=O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C4=CC(=C(C=C4)O)O,,,,,,
4725,3084728,2'-O-Methylperlatolic acid,CCCCCC1=C(C(=CC(=C1)OC)O)C(=O)OC2=CC(=C(C(=C2)OC)C(=O)O)CCCCC,,,,,,
4726,3084729,"17,21-Dihydroxypregna-1,4-diene-3,11,20-trione 21-hexadecanoate",CCCCCCCCCCCCCCCC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)C)O,,,,,,
4727,3084730,"4-(1-Hydroxy-4,7-dimethyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-3-yl)but-3-en-2-one",CC1CCC2C1C(OC(=C2C)C=CC(=O)C)O,,,,,,
4728,3084731,Z/E-Guggulsterone,CC=C1C(=O)CC2[C@@]1(CCC3C2CCC4=CC(=O)CC[C@]34C)C,,,,,,
4729,3084732,CID 3084732,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)OCOC(=O)C(C)(C)C)C.C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)O)O)C(=O)O,,,,,,
4730,3084733,"4-Amino-3,5-dibromobenzenesulfonamide",C1=C(C=C(C(=C1Br)N)Br)S(=O)(=O)N,,,,,,
4731,3084734,"Benzonitrile, 4-[[(4-butylphenyl)imino]methyl]-",CCCCC1=CC=C(C=C1)N=CC2=CC=C(C=C2)C#N,,,,,,
4732,3084735,"Acetamide, N-(5-((2-(acetyloxy)ethyl)(2-cyanoethyl)amino)-2-((4-(phenylazo)phenyl)azo)phenyl)-",CC(=O)NC1=C(C=CC(=C1)N(CCC#N)CCOC(=O)C)N=NC2=CC=C(C=C2)N=NC3=CC=CC=C3,,,,,,
4733,3084736,"5-Hydroxy-6,7:22,26-diepoxyergosta-2,24-diene-1,12,26-trione",CC1=C(C(=O)OC(C1)[C@@H](C)[C@H]2CCC3[C@@]2(C(=O)CC4C3[C@H]5[C@H](O5)[C@@]6([C@@]4(C(=O)C=CC6)C)O)C)C,,,,,,
4734,3084737,Dibunate sodium,CC(C)(C)C1=CC2=C(C=C1)C(=C(C=C2)C(C)(C)C)S(=O)(=O)O.[Na+],,,,,,
4735,3084738,Antibiotic EM49,CCC(C)CCCCC(CC(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCN)CCN)CC(C)C)CC(C)C)CCN)CCN)CC(C)C)O,,,,,,
4736,3084739,"2-[[22-[(3S,4R,5S,6R)-4-amino-5-hydroxy-3,6-dimethyloxan-2-yl]oxy-4,8,10,12,14,18,20-heptahydroxy-38-[5-hydroxy-7-[4-(methylamino)phenyl]-7-oxoheptan-2-yl]-37-methyl-2,6,16-trioxo-1-oxacyclooctatriaconta-23,25,27,29,31,33,35-heptaene-19-carbonyl]amino]acetic acid",C[C@H]1[C@H]([C@@H]([C@H](OC1OC2CC(C(C(CC(=O)CC(CC(CC(CC(CC(=O)CC(CC(=O)OC(C(C=CC=CC=CC=CC=CC=CC=C2)C)C(C)CCC(CC(=O)C3=CC=C(C=C3)NC)O)O)O)O)O)O)O)C(=O)NCC(=O)O)O)C)O)N,,,,,,
4737,3084740,CID 3084740,CC[C@H](C)C=CC(=O)N1CC(C[C@H]1C(=O)N[C@@H](CC(C)CC(CC(=O)CC)O)C(=O)N[C@@H](C(C(C)C)O)C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)NC(C)(C)C(=O)NCCCC(=O)N)C,,,,,,
4738,3084741,Ezomycin A1,C1C(C(C(OC1C(=O)NC(CCSCC(C(=O)O)N)C(=O)O)OC2C(C3C(C(C(O3)N4C=CC(=NC4=O)N)O)OC2C(=O)O)NC(=O)N)O)N,,,,,,
4739,3084742,Eleuthreo,COC1=CC(=CC(=C1O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)OC)C3C4COC(C4CO3)C5=CC(=C(C(=C5)OC)O[C@@H]6[C@H]([C@@H]([C@H]([C@@H](O6)CO)O)O)O)OC,,,,,,
4740,3084743,9-Tricosyne,CCCCCCCCCCCCCC#CCCCCCCCC,,,,,,
4741,3084744,Isoamoenylin,COC1=CC(=CC(=C1OC)OC)CCC2=CC=C(C=C2)O,,,,,,
4742,3084745,"(10S)-dodecane-1,10-diol",CC[C@@H](CCCCCCCCCO)O,,,,,,
4743,3084746,"Acetamide, 2,2',2''-nitrilotris[N-butyl-",CCCCNC(=O)CN(CC(=O)NCCCC)CC(=O)NCCCC,,,,,,
4744,3084747,"2-Anthracenesulfonic acid, 1-amino-9,10-dihydro-4-[[3-[(2-hydroxyethyl)sulfonyl]phenyl]amino]-9,10-dioxo-",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3NC4=CC(=CC=C4)S(=O)(=O)CCO)S(=O)(=O)O)N,,,,,,
4745,3084748,6-Ethoxypyridazin-3-amine,CCOC1=NN=C(C=C1)N,,,,,,
4746,3084749,"N-(2,6-dimethylphenyl)pyridine-2-carboxamide",CC1=C(C(=CC=C1)C)NC(=O)C2=CC=CC=N2,,,,,,
4747,3084750,"(1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexane-1-carbonyl chloride",C[C@@H]1CC[C@H]([C@@H](C1)C(=O)Cl)C(C)C,,,,,,
4748,3084751,Methyl 2-(methylideneamino)acetate,COC(=O)CN=C,,,,,,
4749,3084752,CID 3084752,C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)O[C@@H]2[C@H]([C@@H](O[C@@H]([C@@H]2O)OC[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)OC4=C(OC5=CC(=CC(=O)C5=C4O)OC)C6=CC=C(C=C6)O)O)O)O)C)O)O)O)O,,,,,,
4750,3084753,Hederoside B,C[C@]12CC[C@@H]([C@@](C1CC[C@@]3(C2CC=C4[C@]3(CC[C@@]5([C@H]4CC(CC5)(C)C)C(=O)O)C)C)(C)CO)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O,,,,,,
4751,3084754,"Benzoic acid, 4-(chlorocarbonyl)-, butyl ester",CCCCOC(=O)C1=CC=C(C=C1)C(=O)Cl,,,,,,
4752,3084755,"Caryoptinol, 2-hydroxy-, 3-(2-(acetyloxy)-2-methylbutanoate), (2alpha,3beta(R))-",CC[C@](C)(C(=O)O[C@H]1[C@@H](CC2[C@@]([C@H](C[C@@H]([C@]2([C@@]13CO3)COC(=O)C)OC(=O)C)C)(C)[C@@H]4C[C@H]5C=CO[C@H]5O4)O)OC(=O)C,,,,,,
4753,3084756,Eledoisin perfluoroacetate,CCC(C)C(C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C2CCCN2C(=O)C3CCC(=O)N3.C(=O)(C(F)(F)F)O,,,,,,
4754,3084757,Benzylpenicilline-d7 N-ethylpiperidinium salt,CCN1CCCCC1.CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C,,,,,,
4755,3084758,"1-[(1R,6R)-2,2,6-trimethylcyclohexyl]but-2-en-1-one",CC=CC(=O)[C@@H]1[C@@H](CCCC1(C)C)C,,,,,,
4756,3084759,"Benzamide, N-(5,8-dichloro-9,10-dihydro-9,10-dioxo-1-anthracenyl)-4-nitro-",C1=CC2=C(C(=C1)NC(=O)C3=CC=C(C=C3)[N+](=O)[O-])C(=O)C4=C(C=CC(=C4C2=O)Cl)Cl,,,,,,
4757,3084760,CID 3084760,CC1=CC=C(C=C1)N=C2C=CC(=NC3=CC=C(C=C3)C)C4=C2C(=O)C5=C(C4=O)C(=CC=C5)NC(=O)C6=CC=C(C=C6)N(O)O,,,,,,
4758,3084761,"Formamide, N-methyl-N-(3-methylphenyl)-",CC1=CC(=CC=C1)N(C)C=O,,,,,,
4759,3084762,CID 3084762,C1=C(SC(=C1)N(O)O)C(=O)N=N,,,,,,
4760,3084763,"N'-(3-(Dimethylureidylmethyl)-3,5,5-trimethylcyclohexyl)-N,N-dimethylurea",C[C@@]1(C[C@@H](CC(C1)(C)C)NC(=O)N(C)C)CNC(=O)N(C)C,,,,,,
4761,3084764,3-Acetyl-5-butyldihydro-2(3H)-furanone,CCCC[C@H]1C[C@@H](C(=O)O1)C(=O)C,,,,,,
4762,3084765,Angustoline,CC(C1=C2C=C3C4=C(CCN3C(=O)C2=CN=C1)C5=CC=CC=C5N4)O,,,,,,
4763,3084766,"4,4'-(3H-2,1-Benzoxathiol-3-ylidene)bis(3-bromo-2,5-dimethylphenol) S,S-dioxide",C[C@H]1[C@H](C=C([C@@H]([C@@H]1Br)O)C)[C@@]2(C3=CC=CC=C3S(=O)(=O)O2)C4=C(C(=C(C(=C4)C)O)Br)C,,,,,,
4764,3084767,"3,4-Dimethylpent-1-en-3-ol",CC(C)C(C)(C=C)O,,,,,,
4765,3084768,Benzyl-2-hydroxyethyl-trisulfide,C1=CC=C(C=C1)CSSSCCO,,,,,,
4766,3084769,"1H-Isoindole-1,3(2H)-dione, 2-(9,10-dihydro-9,10-dioxo-1-anthracenyl)-",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=CC=C3)N4C(=O)C5=CC=CC=C5C4=O,,,,,,
4767,3084770,Angustidine,CC1=CC2=C(C=N1)C(=O)N3CCC4=C(C3=C2)NC5=CC=CC=C45,,,,,,
4768,3084771,"Cholest-5-en-3-ol (3beta)-, 2-methoxyethyl carbonate",C[C@H](CCCC(C)C)[C@@H]1CC[C@@H]2[C@@]1(CC[C@@H]3[C@@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)OCCOC)C)C,,,,,,
4769,3084772,"2-Heptanone, 5-ethyl-",CCC(CC)CCC(=O)C,,,,,,
4770,3084773,"9-Fluoro-11beta,17-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 21-(tricyclo(3.3.1.13,7)dec-1-ylformate)",C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COC(=O)C56CC7CC(C5)CC(C7)C6)O)C)O)F)C,,,,,,
4771,3084774,4-Oxo-4-((4-((2-pyridylamino)sulphonyl)phenyl)amino)butyric acid,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NC(=O)CCC(=O)O,,,,,,
4772,3084775,N-(2-Naphthalene)sulfonyl-DL-tryptophan,C1=CC=C2C=C(C=CC2=C1)S(=O)(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O,,,,,,
4773,3084776,"Benzothiazolium, 3-(2-carboxyethyl)-6-methoxy-2-methyl-, iodide",CC1=[N+](C2=C(S1)C=C(C=C2)OC)CCC(=O)O,,,,,,
4774,3084777,"Benzoic acid, 3,5-diamino-4-chloro-, butyl ester",CCCCOC(=O)C1=CC(=C(C(=C1)N)Cl)N,,,,,,
4775,3084778,2-Bromo-4-chloro-5-nitrotoluene,CC1=CC(=C(C=C1Br)Cl)[N+](=O)[O-],,,,,,
4776,3084779,Hexyl (4-chloro-2-methylphenoxy)acetate,CCCCCCOC(=O)COC1=C(C=C(C=C1)Cl)C,,,,,,
4777,3084780,Ethyl (1)-2-(4-chloro-2-methylphenoxy)propionate,CCOC(=O)[C@H](C)OC1=C(C=C(C=C1)Cl)C,,,,,,
4778,3084781,3-Hydroxybutyl 2-(4-chloro-2-methylphenoxy)propionate,CC1=C(C=CC(=C1)Cl)O[C@H](C)C(=O)OCC[C@H](C)O,,,,,,
4779,3084782,2-Butoxyethyl (1)-2-(4-chloro-2-methylphenoxy)propionate,CCCCOCCOC(=O)[C@H](C)OC1=C(C=C(C=C1)Cl)C,,,,,,
4780,3084783,Hexyl (1)-2-(4-chloro-2-methylphenoxy)propionate,CCCCCCOC(=O)[C@H](C)OC1=C(C=C(C=C1)Cl)C,,,,,,
4781,3084784,2-Hydroxy-2-phenylethyl (R-(-))-p-toluenesulphonate,CC1=CC=C(C=C1)S(=O)OCC(C2=CC=CC=C2)O.C=O,,,,,,
4782,3084785,(2-Hydroxy-2-phenylethyl) 4-methylbenzenesulfinate,CC1=CC=C(C=C1)S(=O)OCC(C2=CC=CC=C2)O,,,,,,
4783,3084786,"2-Anthracenesulfonyl chloride, 1-amino-4-bromo-9,10-dihydro-9,10-dioxo-",C1=CC=C2C(=C1)C(=O)C3=C(C=C(C(=C3C2=O)N)S(=O)(=O)Cl)Br,,,,,,
4784,3084787,CID 3084787,CC(=O)N(C=CC1=[N+](C2=CC=CC=C2C1(C)C)C)C3=CC=CC=C3.[I-],,,,,,
4785,3084788,"2-[2-[(Acetyl)phenylamino]ethenyl]-1,3,3-trimethyl-3H-indolium",CC(=O)N(C=CC1=[N+](C2=CC=CC=C2C1(C)C)C)C3=CC=CC=C3,,,,,,
4786,3084789,"2,2,4-Trimethyladipic acid, 1-decyl 6-octyl ester",CCCCCCCCCCOC(=O)C(C)(C)C[C@H](C)CC(=O)OCCCCCCCC,,,,,,
4787,3084790,Butoxymethylene furosemide,CCCCOCNS(=O)(=O)C1=C(C=C(C(=C1)C(=O)O)NCC2=CC=CO2)Cl,,,,,,
4788,3084791,"(2S)-2-(3-hydroxyquinolin-2-yl)-1,3-dioxoindene-5-carboxylic acid",C1=CC=C2C(=C1)C=C(C(=N2)[C@H]3C(=O)C4=C(C3=O)C=C(C=C4)C(=O)O)O,,,,,,
4789,3084792,"Benzene, ((2S)-2-methylbutyl)-",CC[C@@H](C)CC1=CC=CC=C1,,,,,,
4790,3084793,"(2'R,4'R,5R,10'R,14'S)-10',14'-dimethylspiro[oxolane-5,15'-pentacyclo[9.7.0.02,4.05,10.014,18]octadec-5-ene]-2,7'-dione",C[C@]12CCC(=O)C=C1[C@@H]3C[C@@H]3C4C2CC[C@]5(C4CC[C@@]56CCC(=O)O6)C,,,,,,
4791,3084794,Einecs 254-989-0,CC(=O)OCC1C(C(C(C(O1)SC(=N)N)OC(=O)C)OC(=O)C)OC(=O)C.Br,,,,,,
4792,3084795,"Propanamide, 3-chloro-N-(3-chloro-1-oxopropyl)-",C(CCl)C(=O)NC(=O)CCCl,,,,,,
4793,3084796,Cornoside,C1=CC(C=CC1=O)(CCO[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)CO)O)O)O)O,,,,,,
4794,3084797,"7H-Benzo(e)perimidin-7-one, 4-bromo-6-((4-methylphenyl)amino)-2-phenyl-",CC1=CC=C(C=C1)NC2=CC(=C3C4=C2C(=O)C5=CC=CC=C5C4=NC(=N3)C6=CC=CC=C6)Br,,,,,,
4795,3084798,"2,2-Diphenylpropan-1-amine hydrochloride",CC(CN)(C1=CC=CC=C1)C2=CC=CC=C2.Cl,,,,,,
4796,3084799,Tisoquone,CCC1(CNC(=S)C2=CC=CC=C21)C3=CC=CC=C3,,,,,,
4797,3084800,"2-Propanone, 1,3-bis(2-fluoro-2,2-dinitroethoxy)-",C(C(=O)COCC([N+](=O)[O-])([N+](=O)[O-])F)OCC([N+](=O)[O-])([N+](=O)[O-])F,,,,,,
4798,3084801,Tetradodecylammonium iodide,CCCCCCCCCCCC[N+](CCCCCCCCCCCC)(CCCCCCCCCCCC)CCCCCCCCCCCC.[I-],,,,,,
4799,3084802,"1,4-Benzenedimethanamine, N,N,N',N'-tetraethyl-",CCN(CC)CC1=CC=C(C=C1)CN(CC)CC,,,,,,
4800,3084803,"Acetamide, N-[4-[[(3-chloropyrazinyl)amino]sulfonyl]phenyl]-",CC(=O)NC1=CC=C(C=C1)S(=O)(=O)NC2=NC=CN=C2Cl,,,,,,
4801,3084804,Hexadec-9-en-1-amine,CCCCCCC=CCCCCCCCCN,,,,,,
4802,3084805,2-Methoxyphenyl 2-phenylbutyrate,CCC(C1=CC=CC=C1)C(=O)OC2=CC=CC=C2OC,,,,,,
4803,3084806,CID 3084806,C[C@]1(C2CC3[C@H](C(=O)C(=C(N)O)C(=O)[C@@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O.C1=CC2=C(C=C1N)C(=O)NC(O2)CCCl.OS(=O)(=O)O.OS(=O)(=O)O,,,,,,
4804,3084807,CID 3084807,C[C@]1(C2CC3[C@H](C(=O)C(=C(N)O)C(=O)[C@@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,,,,,,
4805,3084808,"1-Butanol, 2-amino-, hydrochloride (1:1), (2R)-",CC[C@@H](CO)NCl,,,,,,
4806,3084809,Cinnamylidene acetyl chloride,C1=CC=C(C=C1)C=CC=CC(=O)Cl,,,,,,
4807,3084810,"Formamide, N,N'-[(methylimino)di-3,1-propanediyl]bis-",CN(CCCNC=O)CCCNC=O,,,,,,
4808,3084811,"1-Propanaminium, N-(2-(ethylphenylamino)ethyl)-3-(formylamino)-N,N-dimethyl-, chloride",CCN(CC[N+](C)(C)CCCNC=O)C1=CC=CC=C1,,,,,,
4809,3084812,"Morpholinium, 4,4-dimethyl-, bromide",C[N+]1(CCOCC1)C.[Br-],,,,,,
4810,3084813,"Ethanol, 2-(ethyl(3-methylphenyl)amino)-, hydrogen sulfate (ester)",CCN(CCOS(=O)(=O)O)C1=CC=CC(=C1)C,,,,,,
4811,3084814,"Methanesulfonic acid, trifluoro-, 2-propynyl ester",C#CCOS(=O)(=O)C(F)(F)F,,,,,,
4812,3084815,"2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11-Icosafluoroundecyl methacrylate",CC(=C)C(=O)OC(C(C(C(C(C(C(C(C(C(CF)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)F,,,,,,
4813,3084816,"Benzoic acid, 3-chloro-4-[(4-pentylbenzoyl)oxy]-, 4-pentylphenyl ester",CCCCCC1=CC=C(C=C1)C(=O)OC2=C(C=C(C=C2)C(=O)OC3=CC=C(C=C3)CCCCC)Cl,,,,,,
4814,3084817,"Benzoic acid, 2-chloro-4-[(4-heptylbenzoyl)oxy]-, 4-octylphenyl ester",CCCCCCCCC1=CC=C(C=C1)OC(=O)C2=C(C=C(C=C2)OC(=O)C3=CC=C(C=C3)CCCCCCC)Cl,,,,,,
4815,3084818,Dichloromethanesulfonyl chloride,C(S(=O)(=O)Cl)(Cl)Cl,,,,,,
4816,3084819,"Cyclobutane, 1-ethenyl-1-methyl-2-(1-methylethenyl)-, (1R,2S)-rel-",CC(=C)[C@@H]1CC[C@]1(C)C=C,,,,,,
4817,3084820,CID 3084820,C[IH](C)(NS[IH](C)(C)Cl)SN[IH](C)(C)SCl,,,,,,
4818,3084821,Aluminum;sodium;hydrogen carbonate;hydroxide,C(=O)(O)[O-].[OH-].[Na+].[Al+3],,,,,,
4819,3084822,"[1,1'-Biphenyl]-4,4'-diol, 2,2',6,6'-tetrachloro-",C1=C(C=C(C(=C1Cl)C2=C(C=C(C=C2Cl)O)Cl)Cl)O,,,,,,
4820,3084823,"1H,3H-Naphtho[1,8-cd]pyran-1,3-dione, 6-[(2-aminophenyl)thio]-",C1=CC=C(C(=C1)N)SC2=C3C=CC=C4C3=C(C=C2)C(=O)OC4=O,,,,,,
4821,3084824,CID 3084824,CC[N+]1=C(SC2=CC=CC=C21)C=CC=CN(C3=CC=CC=C3)C(=O)C.[I-],,,,,,
4822,3084825,CID 3084825,CC[N+]1=C(SC2=C1C3=CC=CC=C3C=C2)C=C(C)Cl.[Cl-],,,,,,
4823,3084826,"2-(2-Chloroprop-1-enyl)-1-ethylbenzo[e][1,3]benzothiazol-1-ium",CC[N+]1=C(SC2=C1C3=CC=CC=C3C=C2)C=C(C)Cl,,,,,,
4824,3084827,"1-Naphthalenol, 4-(1-methylethoxy)-",CC(C)OC1=CC=C(C2=CC=CC=C21)O,,,,,,
4825,3084828,Bruceantarin,CC1=C(C(=O)C[C@]2([C@H]1C[C@@H]3[C@]45[C@@H]2[C@H]([C@@H]([C@]([C@@H]4[C@H](C(=O)O3)OC(=O)C6=CC=CC=C6)(OC5)C(=O)OC)O)O)C)O,,,,,,
4826,3084829,2-(Diisopropylamino)ethanethiol hydrochloride,CC(C)N(CCS)C(C)C.Cl,,,,,,
4827,3084830,Daturadiol,C[C@@]12CC[C@@]3(C(=CC[C@H]4[C@]3(C[C@H]([C@@H]5[C@@]4(CC[C@@H](C5(C)C)O)C)O)C)[C@@H]1CC(CC2)(C)C)C,,,,,,
4828,3084831,CID 3084831,CN(C)C(=S)S(CCCS(=O)(=O)O)C(=S)N(C)C,,,,,,
4829,3084832,"Spiro(1,4-methanoazulene-9,2'-oxirane), decahydro-4,8,8-trimethyl-",C[C@@]12CCCC([C@@H]3[C@H]1CC[C@@H]3[C@]24CO4)(C)C,,,,,,
4830,3084833,"Urea, ((4-amino-3-methoxyphenyl)(4-(diethylamino)-2-methylphenyl)methyl)-",CCN(CC)C1=CC(=C(C=C1)[C@H](C2=CC(=C(C=C2)N)OC)NC(=O)N)C,,,,,,
4831,3084834,"N,N-Bis(2-hydroxyethyl)-N-methyl-1-octanaminium chloride",CCCCCCCC[N+](C)(CCO)CCO.[Cl-],,,,,,
4832,3084835,CID 3084835,CN=C1C=CC2=C(C1=NN=C3C=CC(=CC3=O)N(O)O)C=CC(=C2)S(=O)(=O)N,,,,,,
4833,3084836,"Phenol, 4,4'-[(2,4,6-trimethyl-1,3-phenylene)bis(methylene)]bis[2,6-bis(1,1-dimethylethyl)-",CC1=CC(=C(C(=C1CC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C)C)CC3=CC(=C(C(=C3)C(C)(C)C)O)C(C)(C)C)C,,,,,,
4834,3084837,"1,4-Benzenedicarboxylic acid, 2,5-bis((4-methoxyphenyl)amino)-",COC1=CC=C(C=C1)NC2=CC(=C(C=C2C(=O)O)NC3=CC=C(C=C3)OC)C(=O)O,,,,,,
4835,3084838,2-Phenoxybutyryl chloride,CCC(C(=O)Cl)OC1=CC=CC=C1,,,,,,
4836,3084839,Triacontyl acetate,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCOC(=O)C,,,,,,
4837,3084840,"1-(3,4-Dimethoxyphenyl)-2-(methylamino)ethanol",CNCC(C1=CC(=C(C=C1)OC)OC)O,,,,,,
4838,3084841,Hallolactone A,CC(C)C1=C2CC3[C@H]4[C@]([C@H]([C@H]5[C@@H]([C@@]4(C2=CC(=O)O1)C)O5)O)(C(=O)O3)C,,,,,,
4839,3084842,W-10294A dihydrochloride,COC1=C(C=C2C(=C1)C3=C(CN(CC3)CCN4CCCCC4)C(=O)O2)OC.Cl,,,,,,
4840,3084843,"Phenoxazin-5-ium, 3,7-bis(ethylamino)-2,8-dimethyl-, perchlorate",CCNC1=CC2=C(C=C1C)N=C3C=C(C(=NCC)C=C3O2)C,,,,,,
4841,3084844,CID 3084844,C([C@@H]1[C@H]([C@H]([C@H](O1)C2=C(C(=NN2)C(=O)N)O)O)O)O,,,,,,
4842,3084845,"7-Hexadecyne, 1,1-dimethoxy-",CCCCCCCCC#CCCCCCC(OC)OC,,,,,,
4843,3084846,7-Dodecyn-1-ol,CCCCC#CCCCCCCO,,,,,,
4844,3084847,Ethyl 2-acetyl-4-oxopentanoate,CCOC(=O)C(CC(=O)C)C(=O)C,,,,,,
4845,3084848,Noroxyclothepin decanoate,CCCCCCCCCC(=O)OCCN1CCN(CC1)C2CC3=CC=CC=C3SC4=C2C=C(C=C4)Cl,,,,,,
4846,3084849,Brombuterol,CC(C)(C)NCC(C1=CC(=C(C(=C1)Br)N)Br)O,,,,,,
4847,3084850,"Phosphorochloridic acid, ethyl 3-methyl-4-(methylthio)phenyl ester",CCOP(=O)(OC1=CC(=C(C=C1)SC)C)Cl,,,,,,
4848,3084851,Piperidin-4-one hydrochloride,C1CNCCC1=O.Cl,,,,,,
4849,3084852,"[(3aR,4S,9aS,9bR)-3-acetyloxy-3,6,9-trimethyl-2,7-dioxo-4,5,9a,9b-tetrahydro-3aH-azuleno[4,5-b]furan-4-yl] 2-methylprop-2-enoate",CC1=C2[C@@H]([C@@H]3[C@@H]([C@H](C1)OC(=O)C(=C)C)C(C(=O)O3)(C)OC(=O)C)C(=CC2=O)C,,,,,,
4850,3084853,"Ethanone, 2,2-diethoxy-1,2-diphenyl-",CCOC(C1=CC=CC=C1)(C(=O)C2=CC=CC=C2)OCC,,,,,,
4851,3084854,Dec-1-ene-1-sulfonic acid,CCCCCCCCC=CS(=O)(=O)O,,,,,,
4852,3084855,Octyltriphenylphosphonium bromide,CCCCCCCC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3.[Br-],,,,,,
4853,3084856,Octyltriphenylphosphonium,CCCCCCCC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
4854,3084857,Magnesium 2-oxoglutarate,C(CC(=O)O)C(=O)C(=O)O.[Mg+2],,,,,,
4855,3084858,"3,4-Dimethyl-3'-nitrobenzophenone",CC1=C(C=C(C=C1)C(=O)C2=CC(=CC=C2)[N+](=O)[O-])C,,,,,,
4856,3084859,"(3R)-2,2-dimethyl-5-methylideneoct-7-en-3-ol",CC(C)(C)[C@@H](CC(=C)CC=C)O,,,,,,
4857,3084860,1-Propargyl-5-nitroimidazole,C#CCN1C=NC=C1[N+](=O)[O-],,,,,,
4858,3084861,"2-Naphthalenecarboxamide, N-[4-[2,4-bis(1,1-dimethylpropyl)phenoxy]butyl]-1-hydroxy-4-[(4-methoxyphenyl)azo]-",CCC(C)(C)C1=CC(=C(C=C1)OCCCCNC(=O)C2=C(C3=CC=CC=C3C(=C2)N=NC4=CC=C(C=C4)OC)O)C(C)(C)CC,,,,,,
4859,3084862,"2-Naphthalenecarboxamide, 4-amino-N-[4-[2,4-bis(1,1-dimethylpropyl)phenoxy]butyl]-1-hydroxy-",CCC(C)(C)C1=CC(=C(C=C1)OCCCCNC(=O)C2=C(C3=CC=CC=C3C(=C2)N)O)C(C)(C)CC,,,,,,
4860,3084863,ethyl 2-cyano-3-[4-(N-phenylanilino)phenyl]prop-2-enoate,CCOC(=O)C(=CC1=CC=C(C=C1)N(C2=CC=CC=C2)C3=CC=CC=C3)C#N,,,,,,
4861,3084864,"2,5-Dimethoxysulfanilic acid",COC1=CC(=C(C=C1N)OC)S(=O)(=O)O,,,,,,
4862,3084865,12-Chlorododec-5-ene,CCCCC=CCCCCCCCl,,,,,,
4863,3084866,"7H-Benz[de]anthracen-7-one, 8,11-dichloro-",C1=CC2=C3C(=C1)C4=C(C=CC(=C4C(=O)C3=CC=C2)Cl)Cl,,,,,,
4864,3084867,"methyl 2-[(1S,2S)-3-oxo-2-pent-2-enylcyclopentyl]acetate",CCC=CC[C@H]1[C@@H](CCC1=O)CC(=O)OC,,,,,,
4865,3084868,3-Ethoxymethacrolein,CCO/C=C(\C)/C=O,,,,,,
4866,3084869,"1-Eicosanol, hydrogen phosphate",CCCCCCCCCCCCCCCCCCCCOP(=O)(O)OCCCCCCCCCCCCCCCCCCCC,,,,,,
4867,3084870,"1-Docosanol, hydrogen phosphate",CCCCCCCCCCCCCCCCCCCCCCOP(=O)(O)OCCCCCCCCCCCCCCCCCCCCCC,,,,,,
4868,3084871,CID 3084871,COC1=C(C=C2C3=CC(=O)C=C(C3=C(OC2=C1)O)O)O,,,,,,
4869,3084872,3-(Ethyl(phenylmethyl)amino)benzenesulfonic acid,CC1=CC=C(C=C1)[C@H](CC2=CC(=CC=C2)S(=O)(=O)O)N,,,,,,
4870,3084873,10-Hydroxyusambarine,CN1CCC2=C([C@@H]1C[C@H]3C[C@H]4C5=C(CCN4C[C@@H]3C=C)C6=C(N5)C=CC(=C6)O)NC7=CC=CC=C27,,,,,,
4871,3084874,"Acetamide, N-[2-[ethyl(3-methylphenyl)amino]ethyl]-",CCN(CCNC(=O)C)C1=CC=CC(=C1)C,,,,,,
4872,3084875,4-Guanidinobenzoic acid hydrochloride,C1=CC(=CC=C1C(=O)O)N=C(N)N.Cl,,,,,,
4873,3084876,"Quinoline, 1,2,3,4-tetrahydro-2,7-dimethyl-",C[C@@H]1CCC2=C(N1)C=C(C=C2)C,,,,,,
4874,3084877,Benzyl 2-aminopropanoate 4-methylbenzenesulfonate,CC1=CC=C(C=C1)S(=O)(=O)O.CC(C(=O)OCC1=CC=CC=C1)N,,,,,,
4875,3084878,"4,5-Dimethoxy-2-nitrobenzyl carbonochloridate",COC1=C(C=C(C(=C1)COC(=O)Cl)[N+](=O)[O-])OC,,,,,,
4876,3084879,"N'-(3-Acetylphenyl)-N,N-dimethylurea",CC(=O)C1=CC(=CC=C1)NC(=O)N(C)C,,,,,,
4877,3084880,"Benzene, 2-Chloro-1-(3-methylphenoxy)-4-(trifluoromethyl)-",CC1=CC(=CC=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl,,,,,,
4878,3084881,"9,10-Anthracenedione, 1-[(4-butylphenyl)amino]-",CCCCC1=CC=C(C=C1)NC2=CC=CC3=C2C(=O)C4=CC=CC=C4C3=O,,,,,,
4879,3084882,"1-([1,1'-Biphenyl]-4-yl)pentan-1-one",CCCCC(=O)C1=CC=C(C=C1)C2=CC=CC=C2,,,,,,
4880,3084883,1-Butyl-2-methyl-1H-indole,CCCCN1C(=CC2=CC=CC=C21)C,,,,,,
4881,3084884,"Benzenesulfonic acid, 4-((3-aminobenzoyl)amino)-",C1=CC(=CC(=C1)N)C(=O)NC2=CC=C(C=C2)S(=O)(=O)O,,,,,,
4882,3084885,"Ethanol, 2-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl]ethylamino]-, benzoate (ester)",CCN(CCOC(=O)C1=CC=CC=C1)C2=CC=C(C=C2)N=NC3=C(C=C(C=C3)[N+](=O)[O-])Cl,,,,,,
4883,3084886,"Benzamide, N-(9,10-dihydro-4,5-bis((4-methylphenyl)amino)-9,10-dioxo-1-anthracenyl)-",CC1=CC=C(C=C1)NC2=C3C(=C(C=C2)NC(=O)C4=CC=CC=C4)C(=O)C5=C(C3=O)C(=CC=C5)NC6=CC=C(C=C6)C,,,,,,
4884,3084887,"(2S,5R)-2,6,6,9-tetramethyl-1-oxaspiro[4.5]dec-8-ene",C[C@H]1CC[C@@]2(O1)CC(=CCC2(C)C)C,,,,,,
4885,3084888,((2-Methylbutyl)thio)formamidine,CC[C@@H](C)CSC(=N)N,,,,,,
4886,3084889,"2-Propenamide, N,N-bis(2-hydroxyethyl)-2-methyl-",CC(=C)C(=O)N(CCO)CCO,,,,,,
4887,3084890,"1-Decanol, 2-octyl-",CCCCCCCCC(CCCCCCCC)CO,,,,,,
4888,3084891,"Propanenitrile, 3,3',3'',3'''-(1,2-ethanediyldinitrilo)tetrakis-",C(CN(CCC#N)CCN(CCC#N)CCC#N)C#N,,,,,,
4889,3084892,"Benzeneethanamine, alpha-(1-methylethyl)-",CC(C)[C@H](CC1=CC=CC=C1)N,,,,,,
4890,3084893,"Dihydro-3-hexyl-2,5-furandione",CCCCCC[C@@H]1CC(=O)OC1=O,,,,,,
4891,3084894,"1,4-Bis(2-amino-1-propyl)piperazine",C[C@H](CN)N1CCN(CC1)[C@@H](C)CN,,,,,,
4892,3084895,"4-Bromo-3,5-dihydroxy-N-(2-hydroxyethyl)benzamide",C1=C(C=C(C(=C1O)Br)O)C(=O)NCCO,,,,,,
4893,3084896,4-Oxo-4-(2-phenoxyethoxy)but-2-enoic acid,C1=CC=C(C=C1)OCCOC(=O)C=CC(=O)O,,,,,,
4894,3084897,"Benzoyl chloride, 4,4'-azoxybis-",C1=CC(=CC=C1C(=O)Cl)N=[N+](C2=CC=C(C=C2)C(=O)Cl)[O-],,,,,,
4895,3084898,"Ethanol, 2,2'-iminobis-, dibenzoate (ester)",C1=CC=C(C=C1)C(=O)OCCNCCOC(=O)C2=CC=CC=C2,,,,,,
4896,3084899,Boc-D-Tyr(2-Br-Z)-OH,CC(C)(C)OC(=O)N[C@H](CC1=CC=C(C=C1)OC(=O)OCC2=CC=CC=C2Br)C(=O)O,,,,,,
4897,3084900,"(3,3-Diphenylpropyl)(3-(phenylthio)propyl)ammonium chloride",C1=CC=C(C=C1)C(CCNCCCSC2=CC=CC=C2)C3=CC=CC=C3.Cl,,,,,,
4898,3084901,Milliamine C,C[C@@H]1C[C@@H]2[C@@H](C2(C)C)[C@@H]3C=C([C@H]([C@]4([C@@]1(C3=O)C=C([C@@H]4OC(=O)C5=CC=CC=C5NC(=O)C6=C(C(=CC=C6)O)NC(=O)C7=CC=CC=C7N(C)C)C)O)O)CO,,,,,,
4899,3084902,Nandazurine,C[N+]1=C2C3=C(C4=CC5=C(C=C4C2=O)OCO5)C(=C(C=C3C=C1)OC)O,,,,,,
4900,3084903,6-Amino-1H-purin-2(7H)-one sulfate,C1=NC2=NC(=O)NC(=C2N1)N.OS(=O)(=O)O,,,,,,
4901,3084904,"2-[(4-chlorophenyl)-pyridin-2-ylmethoxy]-N,N-dimethylethanamine;(2R,3S)-2,3-dihydroxybutanedioic acid",CN(C)CCOC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.[C@@H]([C@@H](C(=O)O)O)(C(=O)O)O,,,,,,
4902,3084905,"4,6-Diamino-2,3-dihydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",C[C@@]1(CO[C@@H]([C@H]([C@H]1NC)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@H]2O)O)N)N)O,,,,,,
4903,3084906,[4-[(4-Ethoxyphenyl)diazenyl]phenyl] but-2-enoate,CCOC1=CC=C(C=C1)N=NC2=CC=C(C=C2)OC(=O)C=CC,,,,,,
4904,3084907,"Carbonic acid, 4-(((4-methoxyphenyl)imino)methyl)phenyl pentyl ester",CCCCCOC(=O)OC1=CC=C(C=C1)C=NC2=CC=C(C=C2)OC,,,,,,
4905,3084908,"Pentanoic acid, 4-[[[4-[[(pentyloxy)carbonyl]oxy]phenyl]imino]methyl]phenyl ester",CCCCCOC(=O)OC1=CC=C(C=C1)N=CC2=CC=C(C=C2)OC(=O)CCCC,,,,,,
4906,3084909,"Carbonic acid, 4-(((4-(1-oxopentyl)phenyl)imino)methyl)phenyl pentyl ester",CCCCCOC(=O)OC1=CC=C(C=C1)C=NC2=CC=C(C=C2)C(=O)CCCC,,,,,,
4907,3084910,"Pentanoic acid, 4-formylphenyl ester",CCCCC(=O)OC1=CC=C(C=C1)C=O,,,,,,
4908,3084911,"Hexanoic acid, 4-formylphenyl ester",CCCCCC(=O)OC1=CC=C(C=C1)C=O,,,,,,
4909,3084912,"Carbonic acid, ethyl 4-formylphenyl ester",CCOC(=O)OC1=CC=C(C=C1)C=O,,,,,,
4910,3084913,"Carbonic acid, 4-formylphenyl propyl ester",CCCOC(=O)OC1=CC=C(C=C1)C=O,,,,,,
4911,3084914,"Carbonic acid, butyl 4-formylphenyl ester",CCCCOC(=O)OC1=CC=C(C=C1)C=O,,,,,,
4912,3084915,"Carbonic acid, 4-formylphenyl pentyl ester",CCCCCOC(=O)OC1=CC=C(C=C1)C=O,,,,,,
4913,3084916,"Carbonic acid, 4-formylphenyl hexyl ester",CCCCCCOC(=O)OC1=CC=C(C=C1)C=O,,,,,,
4914,3084917,"Pyridine, 2,4,6-triethyl-",CCC1=CC(=NC(=C1)CC)CC,,,,,,
4915,3084918,"Furo[3,4-b]pyridin-5(7H)-one, 7,7-bis(1-ethyl-2-methyl-1H-indol-3-yl)-",CCN1C(=C(C2=CC=CC=C21)C3(C4=C(C=CC=N4)C(=O)O3)C5=C(N(C6=CC=CC=C65)CC)C)C,,,,,,
4916,3084919,5-Fluoropolyoxin L,C1=C(C(=O)NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)C(C(=O)O)NC(=O)[C@H]([C@@H]([C@H](COC(=O)N)O)O)N)O)O)F,,,,,,
4917,3084920,"Octanoic acid, 4-formylphenyl ester",CCCCCCCC(=O)OC1=CC=C(C=C1)C=O,,,,,,
4918,3084921,"beta-D-Glucopyranosiduronic acid, (5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxymorphinan-6-yl",COC1=C2C3=C(CC4C5C3(CCN4)[C@@H](O2)[C@H](C=C5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O)C=C1,,,,,,
4919,3084922,3-Chloro-1-ethylpiperidine hydrochloride,CCN1CCCC(C1)Cl.Cl,,,,,,
4920,3084923,"Dichlorobis(1,1'-thiobis(benzene))platinum",C1=CC=C(C=C1)[SH+]C2=CC=CC=C2.C1=CC=C(C=C1)[SH+]C2=CC=CC=C2.Cl[Pt]Cl,,,,,,
4921,3084924,1-Benzylpiperidin-3-one hydrochloride,C1CC(=O)CN(C1)CC2=CC=CC=C2.Cl,,,,,,
4922,3084925,(2R)-2-ethyl-N-[(2R)-2-ethylhexyl]hexan-1-amine,CCCC[C@@H](CC)CNC[C@H](CC)CCCC,,,,,,
4923,3084926,"Imidazo(2,1-b)thiazole, 6-(3-bromophenyl)-5,6-dihydro-, (+-)-, ethanedioate (1:1)",C1C(N=C2N1C=CS2)C3=CC(=CC=C3)Br.C(=O)(C(=O)O)O,,,,,,
4924,3084927,"6-(3-Bromophenyl)-5,6-dihydroimidazo[2,1-b][1,3]thiazole",C1C(N=C2N1C=CS2)C3=CC(=CC=C3)Br,,,,,,
4925,3084928,"Benzoic acid, 4-(pentyloxy)-, 4-pentylphenyl ester",CCCCCC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)OCCCCC,,,,,,
4926,3084929,"Benzoic acid, 4-(pentyloxy)-, 4-cyanophenyl ester",CCCCCOC1=CC=C(C=C1)C(=O)OC2=CC=C(C=C2)C#N,,,,,,
4927,3084930,"Ethyl 5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolane-2-carboxylate hydrochloride",CCOC(=O)C1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O.Cl,,,,,,
4928,3084931,"2,2,2-Trifluoro-N-(hydroxymethyl)acetamide",C(NC(=O)C(F)(F)F)O,,,,,,
4929,3084932,"Furo[3,4-b]pyridin-7(5H)-one, 5,5-bis(1-ethyl-2-methyl-1H-indol-3-yl)-",CCN1C(=C(C2=CC=CC=C21)C3(C4=C(C(=O)O3)N=CC=C4)C5=C(N(C6=CC=CC=C65)CC)C)C,,,,,,
4930,3084933,"Benzoic acid, 3-chloro-4-hydroxy-, 4-pentylphenyl ester",CCCCCC1=CC=C(C=C1)OC(=O)C2=CC(=C(C=C2)O)Cl,,,,,,
4931,3084934,"Benzoic acid, 2-chloro-4-hydroxy-, 4-pentylphenyl ester",CCCCCC1=CC=C(C=C1)OC(=O)C2=C(C=C(C=C2)O)Cl,,,,,,
4932,3084935,"Benzoic acid, 2-chloro-4-hydroxy-, 4-octylphenyl ester",CCCCCCCCC1=CC=C(C=C1)OC(=O)C2=C(C=C(C=C2)O)Cl,,,,,,
4933,3084936,3-hydroxy-1-methylpyridin-4(1H)-one,CN1C=CC(=O)C(=C1)O,,,,,,
4934,3084937,"2,5-Dichlorophenylhydrazine hydrochloride",C1=CC(=C(C=C1Cl)NN)Cl.Cl,,,,,,
4935,3084938,1-Butylpiperazine dihydrochloride,CCCCN1CCNCC1.Cl,,,,,,
4936,3084939,"Quinolinium, 1-ethyl-2-(ethylthio)-, iodide (1:1)",CC[N+]1=C(C=CC2=CC=CC=C21)SCC.[I-],,,,,,
4937,3084940,N-(3-Guanidinopropionyl)-2-hydroxy-n-heptylamine,CCCCCC(CNC(=O)CCN=C(N)N)O,,,,,,
4938,3084941,N-(3-Guanidinoisobutyryl)-2-methoxy-n-heptylamine,CCCCCC(CNC(=O)C(C)CN=C(N)N)OC,,,,,,
4939,3084942,"Bis(1-methylpropyl) 1,3-dithiolan-2-ylidenepropanedioate",CC(C)COC(=O)C(=C1SCCS1)C(=O)OC(C)(C)C,,,,,,
4940,3084943,"Propanedioic acid, 1,3-dithiolan-2-ylidene-, ethyl 1-methylethyl ester",CCOC(=O)C(=C1SCCS1)C(=O)OC(C)C,,,,,,
4941,3084944,"Benzoic acid, 4-(octyloxy)-, 4-cyanophenyl ester",CCCCCCCCOC1=CC=C(C=C1)C(=O)OC2=CC=C(C=C2)C#N,,,,,,
4942,3084945,4-(Hexyloxy)phenyl 4-pentylbenzoate,CCCCCCOC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)CCCCC,,,,,,
4943,3084946,"Benzoic acid, 4-pentyl-, 4-(heptyloxy)phenyl ester",CCCCCCCOC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)CCCCC,,,,,,
4944,3084947,Treburon,COC1C(C(C(C(O1)C(=O)OC)O)O)OS(=O)(=O)O,,,,,,
4945,3084948,"2H-Pyran, 2-(9-dodecyn-1-yloxy)tetrahydro-",CCC#CCCCCCCCCO[C@@H]1CCCCO1,,,,,,
4946,3084949,[(2S)-1-hydroxypropan-2-yl] prop-2-enoate,C[C@@H](CO)OC(=O)C=C,,,,,,
4947,3084950,2-Methoxyethyl dimethylcarbamate,CN(C)C(=O)OCCOC,,,,,,
4948,3084951,2-Hydroxy-1-naphthaldehyde-o-aminobenzoyl hydrazone,C1=CC=C2C(=C1)C=CC(=C2C=NNC(=O)C3=CC=CC=C3N)O,,,,,,
4949,3084952,"C(16a)-Homo-21-norsenecionan-11,16a-dione, 12,15-epoxy-1,2,15,20-tetrahydro-, (1alpha,12R,15R)-",C[C@@H]1C[C@]2(CC(=O)O[C@@H]3CCN4[C@@H]3[C@H](CC4)COC(=O)[C@@]1(O2)C)C,,,,,,
4950,3084953,Myomycin,C(CC(CC(=O)NCCCC(CC(=O)O[C@H]1[C@H]([C@@H]([C@H]([C@@H]([C@H]1OC(=O)N)O[C@@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)N=C(N)N)O)O)O)OC(=O)N)N)N)CN,,,,,,
4951,3084954,Cyclomethycaine sulfate,CC1CCCCN1CCCOC(=O)C2=CC=C(C=C2)OC3CCCCC3.OS(=O)(=O)O,,,,,,
4952,3084955,"N,N'-Bis(2-amino-1-propyl)ethanediamine",C[C@H](CNCCNC[C@H](C)N)N,,,,,,
4953,3084956,"Cyclopenta(c)pyrrole-1,3(2H,4H)-dione, 5,6-dihydro-4-hydroxy-, (+)-",C1CC2=C([C@H]1O)C(=O)NC2=O,,,,,,
4954,3084957,"1,2-Benzenedicarboxylic acid, 4,4'-carbonylbis-, ar,ar'-diethyl ester",CCOC(=O)C1=C(C=C(C=C1)C(=O)C2=CC(=C(C=C2)C(=O)O)C(=O)OCC)C(=O)O,,,,,,
4955,3084958,CID 3084958,C1=C[N+](=CC=C1C=NO)C[N+]2=CC=C(C=C2)C=NO.[Cl-],,,,,,
4956,3084959,Ammonium thymolphthalein monophosphate,CC1=CC(=C(C=C1C2(C3=CC=CC=C3C(=O)O2)C4=CC(=C(C=C4C)OP(=O)([O-])[O-])C(C)C)C(C)C)O.[NH4+].[NH4+],,,,,,
4957,3084960,Phenylalanyl-arginyl-tryptophyl-glycine,C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)NCC(=O)O)N,,,,,,
4958,3084961,Oroxindin,COC1=C(C=C(C2=C1OC(=CC2=O)C3=CC=CC=C3)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O,,,,,,
4959,3084962,Pyratrione,CC1=CC(=O)C(C(=O)O1)C(=O)CCC2=CC(=CC=C2)O,,,,,,
4960,3084963,1-Allyl-3-carbamoylpyridinium bromide,C=CC[N+]1=CC=CC(=C1)C(=O)N.[Br-],,,,,,
4961,3084964,"1-Propanesulfonic acid, 2-methyl-2-((1-oxo-2-propenyl)amino)-, polymer with ethenylbenzene",CC(C)(CS(=O)(=O)O)NC(=O)C=C.C=CC1=CC=CC=C1,,,,,,
4962,3084965,Secalonic acid E,C[C@@H]1CC(=O)C2=C(C3=C(C=CC(=C3O)C4=C(C5=C(C=C4)O[C@@]6([C@@H]([C@@H](CC(=O)C6=C5O)C)O)C(=O)OC)O)O[C@@]2([C@@H]1O)C(=O)OC)O,,,,,,
4963,3084966,Ethylene Glycol Glycerol,C(CO)O.C(C(CO)O)O,,,,,,
4964,3084967,Substance P (7-11),CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)CNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC2=CC=CC=C2)N,,,,,,
4965,3084968,Substance P (3-11),CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N)NC(=O)[C@H](CCSC)N,,,,,,
4966,3084969,"Propanenitrile, 3-[[2-(acetyloxy)ethyl](3-methylphenyl)amino]-",CC1=CC(=CC=C1)N(CCC#N)CCOC(=O)C,,,,,,
4967,3084970,(4-Hydroxyphenyl)(4-pyridyl)methanone,C1=CC(=CC=C1C(=O)C2=CC=NC=C2)O,,,,,,
4968,3084971,"2,3-Bis(2-hydroxyethoxy)propyl dodecanoate",CCCCCCCCCCCC(=O)OCC(COCCO)OCCO,,,,,,
4969,3084972,4-Methylburimamide,CC1=C(N=CN1)CCCCNC(=S)NC,,,,,,
4970,3084973,4-Cyano-4-phenylpiperidine hydrochloride,C1CNCCC1(C#N)C2=CC=CC=C2.Cl,,,,,,
4971,3084974,9-Chloro-1-nonanol,C(CCCCO)CCCCCl,,,,,,
4972,3084975,"2,5-Ionene",CCCCC[N+](C)(C)CC[NH+](C)C.[Br-].[Br-],,,,,,
4973,3084976,2-(Dimethylamino)ethyl-dimethyl-pentylazanium,CCCCC[N+](C)(C)CCN(C)C,,,,,,
4974,3084977,"(1alpha,7alpha,7abeta)-(-)-(Hexahydro-7-hydroxy-1H-pyrrolizin-1-yl)methyl 3-methyl-2-butenoate",CC(=CC(=O)OCC1CCN2C1C(CC2)O)C,,,,,,
4975,3084978,"Benzoic acid, 2-((1-ethyl-2-methyl-1H-indol-3-yl)carbonyl)-",CCN1C(=C(C2=CC=CC=C21)C(=O)C3=CC=CC=C3C(=O)O)C,,,,,,
4976,3084979,Momilacton B,C[C@]1(CC[C@@H]2C(=CC3[C@@H]4[C@]25CCC([C@@]4(C(=O)O3)C)(OC5)O)C1)C=C,,,,,,
4977,3084980,"Cyclohexane, 1-bromo-2-fluoro-, trans-",C1CC[C@@H]([C@H](C1)F)Br,,,,,,
4978,3084981,CID 3084981,CCCCC1CC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(CC(CC=CC(=O)O1)O)O)O)C(=O)O)O)O[C@H]2[C@H]([C@H]([C@@H]([C@H](O2)C)O)N)O,,,,,,
4979,3084982,"Naphtho(2,3-b)furan, 9-methoxy-3,4,5-trimethyl-",CC1=C2C(=C3C(=COC3=C(C2=CC=C1)OC)C)C,,,,,,
4980,3084983,"Pyrimidine, 5-hexyl-2-[4-(nonyloxy)phenyl]-",CCCCCCCCCOC1=CC=C(C=C1)C2=NC=C(C=N2)CCCCCC,,,,,,
4981,3084984,CID 3084984,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)O)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O[C@H]4C[C@H]([C@H]([C@@H](O4)C)O)N(C)C)C)C)O)(C)O.OP(=O)(O)[O-].[K+],,,,,,
4982,3084985,N-[(1-Ethyl-2-pyrrolidinyl)methyl]-2-methoxy-5-(methylsulfamoyl)benzamide,CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)NC)OC,,,,,,
4983,3084986,"2,3-Dichloro-6-(trichloromethyl)pyridine",C1=CC(=NC(=C1Cl)Cl)C(Cl)(Cl)Cl,,,,,,
4984,3084987,"1H-Indole, 4,5,6,7-tetrahydro-1,2-diphenyl-",C1CCC2=C(C1)C=C(N2C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
4985,3084988,CID 3084988,C[C@H]1CC[C@]2(C[C@@H]3C[C@@H](O2)CC=C(C[C@H](C=CC=C([C@@]4(C[C@@H](C(=C[C@H]4C(=O)O3)C)OC)O)CO)C)C)O[C@@H]1C,,,,,,
4986,3084989,CID 3084989,C[C@H](C(=O)NC(=O)C[C@@H]([C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)C(C)C)O)NN[C@@H](CC(C)C)[C@H](CC(=O)O)O,,,,,,
4987,3084990,L-Histidine monohydrobromide,C1=C(NC=N1)C[C@@H](C(=O)O)N.Br,,,,,,
4988,3084991,CID 3084991,CCCCC(C)C(=O)O[C@@H]1[C@@H]([C@H](O[C@]2([C@H]1O)C[C@@H]3C[C@H](O2)CC=C(C[C@H](C=CC=C4CO[C@H]5C4[C@@H](C=C(C5O)C)C(=O)O3)C)C)C)C,,,,,,
4989,3084992,Hydron;platinum;hexahydroxide,[H+].[H+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Pt],,,,,,
4990,3084993,Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate sulfate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2.OS(=O)(=O)O,,,,,,
4991,3084994,10-(3-Dimethylamino-2-methylpropyl)-2-valeroylphenothiazine hydrochloride,CCCCC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CC(C)CN(C)C,,,,,,
4992,3084995,Isoschaftoside,C1[C@@H]([C@@H]([C@H]([C@@H](O1)C2=C(C(=C3C(=C2O)C(=O)C=C(O3)C4=CC=C(C=C4)O)[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O)O)O,,,,,,
4993,3084996,"(4S,6S)-4-[2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl]-5-ethylidene-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylic acid",CC=C1[C@@H](C(=CO[C@H]1O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)C(=O)O)CC(=O)OCCC3=CC(=C(C=C3)O)O,,,,,,
4994,3084997,Cacalohastine,C[C@H]1CC=CC2=C1C(=C3C(=COC3=C2OC)C)C,,,,,,
4995,3084998,Sulfoevernan,C([C@@H]1[C@H](O[C@@H]([C@@H]([C@@H]1O)O)O[C@H]2[C@@H]([C@H](O[C@@H]([C@@H]2O)O[C@H]3[C@@H]([C@H](O[C@@H]([C@@H]3O)O[C@H]4[C@@H]([C@H](O[C@@H]([C@@H]4O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@@H]5O)O)CO)COS(=O)(=O)[O-])COS(=O)(=O)[O-])O)COS(=O)(=O)[O-])O)COS(=O)(=O)[O-])O)COS(=O)(=O)[O-])O,,,,,,
4996,3084999,"[(2R,3R,4S,5R,6R)-4-[(2R,3R,4R,5S,6S)-3,4-dihydroxy-5-(hydroxymethyl)-6-(sulfooxymethyl)oxan-2-yl]oxy-6-[(2R,3R,4S,5R,6R)-2-[(2R,3R,4S,5R,6R)-2-[(2R,3S,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-(sulfooxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-6-(sulfooxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(sulfooxymethyl)oxan-4-yl]oxy-3,5-dihydroxyoxan-2-yl]methyl hydrogen sulfate",C([C@@H]1[C@H](O[C@@H]([C@@H]([C@@H]1O)O)O[C@H]2[C@@H]([C@H](O[C@@H]([C@@H]2O)O[C@H]3[C@@H]([C@H](O[C@@H]([C@@H]3O)O[C@H]4[C@@H]([C@H](O[C@@H]([C@@H]4O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@@H]5O)O)CO)COS(=O)(=O)O)COS(=O)(=O)O)O)COS(=O)(=O)O)O)COS(=O)(=O)O)O)COS(=O)(=O)O)O,,,,,,
4997,3085000,"Sodium 2,9-dimethyl-4,7-diphenyl-1,10-phenanthrolinesulphonate",CC1=CC(=C2C=CC3=C(C=C(N=C3C2=N1)C)C4=CC(=CC=C4)S(=O)(=O)O)C5=CC(=CC=C5)S(=O)(=O)O,,,,,,
